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R1885
Concurrent nasopharyngeal squamous cell
carcinoma and lymphoproliferative disorder
during HIV infection. Possible pathogenetic
interactions among retroviral infection, Epstein-
Barr virus infection, and inhalatory cocaine abuse
R.Manfredi, S. Sabbatani, U. Gianelli, F. Chiodo (Bologna, Milan, IT)
Introduction: Only two human cells types allow the replication of
EBV: B-lymphocytes and squamous epithelium. Burkitt lym-
phoma recognizes a pathogenetic role for both EBV and multiple
co-factors inﬂuenced by geographic issues, too. The nasopharyn-
geal carcinoma predominates in South-Eastern Asia where the
exposure to some inhalants (i.e. phenoles) seems more frequent,
but antibodies against the early EBV antigen VCA are commonly
found, as well as the isolation of EBV genomic sequences from
neoplastic cells. The staging of rhinopharyngeal carcinoma also
includes a poorly differentiated variety with a prominent lym-
phoid inﬁltrate, which may raise the suspect of an extranodal
lymphoma, although the residentT-cells arenotmalignant.During
HIV disease, malignant lymphomas and EBV-associated lympho-
proliferative disorders prove more frequent than in the general
population, but nasopharingeal carcinoma remains an extremely
infrequent occurrence with only anecdotal cases reported.
Case report: Our patient,HIV-infected since 20 yr andwith a long
history of inhalatory cocaine abuse, 18 months ago developed a
remarkable laterocervical lymphadenopathy, whose histopatho-
logic studydisclosedapolymorphicEBV-associatedB-cell lympho-
proliferative disorder. A TC scan concurrently showed a right
nasopharyngeal mass and detected multiple cervical, axillary, and
ilar-mediastinal lymphadenopathies. A biopsy of rhinopharingeal
lesion disclosed a poorly differentiated squamous carcinoma also
EBV-positive at biomolecular testing. A cytotoxic chemotherapy
was performed with ten consecutive cycles of cisplatinum-ﬂuor-
ouracil-bleomycin, associated with HAART, which achieved dis-
ease remission. A CT re-staging performed four months later
showed sparse parapharyngeal andparavertebral inﬁltrates so that
the suspected recurrence prompted a still ongoing radiotherapy
course, while the immune recovery was not attained, as expressed
by a CD4+ count of 83 cells/lL despite HIV virologic control.
Conclusions: Ourpatient suffered fromtwodistinctmalignantand
pre-malignant disorders with some intriguing pathogenetic associ-
ations mainly linked to EBV but also HIV and related immunode-
ﬁciency and perhaps the chronically inhaled cocaine. Both
squamous carcinoma and lymphoproliferative disorder of the
nasopharynx are more frequent in the immunocompromised host
and deserve further pathogenetic investigation to clarify and
eventual shared or addictive role of some viral and environmental
risk factors.
R1886
Community-acquired septicaemic pneumonia
caused by a multiresistant Staphylococcus aureus
strain, resulting in multiple organ involvement
exacerbated by extensive immune activation
R. Manfredi, S. Sabbatani, G. Marinacci, F. Chiodo (Bologna, IT)
Background: Antibiotic-resistant Gram-positive cocci are of
increasing concern, and immune activation promped by
microbial products (bacterial superantigens) may play a major
role in the pathogenesis of disseminated, life-threatening
S. aureus infection.
Methods: An exceptional case report of community-acquired,
severe infection caused by a methicillin-resistant S. aureus strain,
responsible for pneumonia, septic shock, and scattered septic
embolism, and accompanied by diffuse polyvisceritis and
thrombophlebitis as signs of an extensive immune system
activation, was observed in a otherwise healthy 40-year-old man.
Results: The striking features of S. aureus polyvisceral disease
(pneumonia, sepsis, and pulmonary and hepato-splenic septic
embolism) were associated with multiple immune-mediated
focal manifestations (massive pleuric-pericardial effusion,
mycocarditis, and multiple lower limb thrombophlebitis).
In vitro resistance to all beta-lactams, ﬂuoroquinolones, macro-
lides, and aminoglycosides, apparently did not justify the
clinical-microbiological failure of a glycopeptide-based combi-
nation therapy. Only the administration of linezolid-rifampicin-
tetracycline together with intensive care support, achieved a
slowly progressive ameliorement, while the polyvisceritis
(associated by an immune-activation syndrome documented
by increased CD4+, CD34+ and CD4-CD8- T-lymphocyte
subsets), caused directive disease at multiple body sites, and
required a prolonged high-dose steroid therapy. A complete
clinical, laboratory, and instrumental recovery was reached only
three months after admission.
Conclusions: This report raises multiple questions about the
epidemiology, pathogenesis, manifestations, and management
of complicated S. aureus infection, with special focus on the
immune system activation triggered by microbial antigens, and
the therapeutic role of steroids and novel antibiotics targeted
against resistant Gram-positive cocci.
R1887
Status of interleukin-5 and interleukin-13 in
peripheral blood of adults with bronchial asthma
K. Bedewy, N.G. Rizk, Y.N. Ibrahim, E. Hasaneen (Alexandria,
EG)
Objectives: To explore the possible role of IL-5 and IL-13 in the
pathophysiology of asthma, and to deﬁne the source of these
cytokines in peripheral blood.
Methods: Forty-two patients with acute asthma, 25 patients
with asymptomatic asthma (4 weeks or more without exacer-
bation) and 20 healthy controls were subjected to quantitative
measurements of serum IL-5 and IL-13. In addition, IL-5 and
IL-13 mRNA expression in peripheral blood mononuclear cells
was deﬁned by reverse transcription-polymerase chain reaction
(RT-PCR). Spirometric parameters including: forced vital capa-
city (FVC), forced expiratory volume in one second (FEV1),
forced expiratory ﬂow rate at 25%, 50%, and 75% of the vital
capacity (FEF 25, 50, 75) and peak expiratory ﬂow rate (PEFR)
were recoded in acute asthma patients.
Results: Serum IL-5 and IL-13 levels were signiﬁcantly higher
in patients with acute asthma than asymptomatic asthma and
healthy controls, and in asymptomatic asthma patients than
healthy controls. Serum IL-5 and IL-13 levels were signiﬁcantly
and positively correlated with each other in patients with acute
asthma but signiﬁcantly and inversely correlated with the
spirometric parameters. The frequencies of IL-5 and IL-13
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mRNA in PBMC from patients with acute asthma (90.9% and
81.8% respectively) were signiﬁcantly higher than that from
patients with asymptomatic asthma (27.3% P = 0.0024 and
36.4% P = 0.03 respectively) and healthy controls (0.0%,
P = 0.00003 and 0.0%, P = 0.0002 respectively). However, the
difference between asymptomatic asthmatic and healthy con-
trols was insigniﬁcant regarding the frequency of positive
PBMC- based IL-5 mRNA expression but signiﬁcant regarding
the frequency of positive PBMC- based IL-13 mRNA expression
(P = 0.034).
Conclusion: Serum levels of IL-5 and IL-13 may be useful in
monitoring of bronchial asthma particularly as they correlated
signiﬁcantly with severity of the disease as indicated by
Spirometric parameters. PBMC contribute to serum levels of
IL-5 and IL-13 and that spill over from the airways might be an
additional source of these cytokines in serum of patients with
acute asthma.
R1888
The study of cellular and tissue mechanisms of
homeostasis of the system ‘‘helminth – host’’
during muscular trichinellosis and the
phytoorigin antihelminthic effect
H. Zanginyan, A. Asatryan, L. Ghazaryan, L. Melkonyan,
R. Mkrtchyan (Yerevan, AM)
Objectives: The purpose of our work was the study of the
inﬂuence of phytoantihelminthic on the structure and functional
activity of tissues of larva of trichinella and on the structure and
micromorphofunctional condition of muscles and barrier-organs
of their hosts during mixed invasion by larvas of T. spiralis and
T. pseudospiralis.
Methods: The experiment was undertaken to test rats of Wistar
line.The animals were infected with per.os. of T. spiralis and
T. pseudospiralis larvas. The infection dose was 10 larvas of each
species for 1 gram body weight of rat.The following medicinal
herbs were used as phytoantihelminthics in the ratio of 2:2:1–
Plantago major L., Satureja Montana L. and Ranunculus acris L.
Animals received the substance in food in a dose of 50 mg/kg
body weight. The animals were lanced on 35th day after being
infected.
Results: Since 16-th day after infection destruction of the larvas
of the trichinell of both species and destruction of capsules
round the larvas of the T. spiralis were observed among the
infected animals. The intracapsular sarcoplasm completely
changed into coarse-grained mass. In most of larvas of T. spiralis
and T. pseudospiralis the tincterial properties of cuticle broke and
the latter became hard-knobbed and teared away from the
hypoderm here and there. Metachromasia of reproductive
glands and of digestive system was observed. On specimen
the dead larvas of T. pseudospiralis revealed. In muscles, in livers
and intestines of rats the factors of pathogenesis were weaken-
ing and the characteristic lines of the compensatory and the
regenerative processes were observed. In muscular tissue
the connective-tissue cicatrixes were formated, sudstituting the
destruction of the muscular ﬁbres and their fragments. In the
liver partial recovery of structure and architectonics of trabe-
cules were observed. In the result of phytotherapy as a whole
the inﬁltration of parenchyma of liver by leucocytal elements
descended. In muscles, in livers and in intestines of rats as a
whole the synthesis of RNA and formation of glycogen
noticeably became intensive.
Conclusion: The phytoantihelminthic detained encapsulation
of larvas of T.spiralis caused death of particular number of larvas
of trichinella of both species. This work is of interest for the
development and for application of plant origin antihelminthic
during the therapy of helminthosies especially trichinellosis.
R1889
Soft tissue infections by Stenotrophomonas
maltophilia in immunocompromised rats.
Implication of bacterial translocation
I. Koutelidakis, T. Tsaganos, A. Papadopoulos, P. Koutoukas,
E.J. Giamarellos-Bourboulis, H. Giamarellou, K. Atmatzidis
(Athens, GR)
Objectives: The aim of the present study was to investigate the
role of bacterial translocation in the overall mortality in an
animal model of soft tissue infection by Stenotrophomonas
maltophilia.
Methods: Soft tissue infection was induced in twenty-seven
immunocompromised Wistar rats. Neutropenia was achieved
by the intramuscular infusion of cyclophosphamide at a dose of
100 mg/kg on day 1 and 150 mg/kg on day 3. Animals were
challenged in the left thigh by an 8log10 cfu/kg inoculum of
S. maltophilia on day 5 and randomised into three groups. Group
A consisted of eight rats observed for survival; group B of 10
animals sacriﬁced two hours post inoculation and group C of
nine rats sacriﬁced four hours post inoculation. Through a
midline incision 4 ml of blood were drawn from the inferior
vena cava vein of rats in groups B and C for quantitative culture
upon euthanasia; liver, spleen and lung samples were collected
and quantitatively cultured. For the evaluation of culture
results, stool specimens were obtained from ﬁve healthy rats.
Results: Mean ± SE survival of group A was 34.6 ± 5.56 hours;
all animals in this group died within 51 hours. Stool specimens
from healthy rats yielded Enterococcus spp, Escherichia coli, and
Enterobacter cloacae. Mean log10 (±SE) bacterial counts in blood
and tissue cultures of rats in groups B and C are shown in the
table. The same pathogens isolated in blood samples were also
isolated from respective tissue samples.
Conclusion: Soft tissue infection in immunocompromised rats
results in rapid spread of S. maltophilia and translocation of
intestinal ﬂora to liver, spleen and lung two hours post
inoculation, whereas four hours post inoculation only growth
of normal intestinal ﬂora is observed. Bacterial translocation
may account for mortality from soft tissue infection by
S. maltophilia in rats.
R1890
Serum and stool levels of interleukin-1beta,
interleukin – 1ra, interleukin-6, interleukin-10,
interleukin-12, tumour-necrosis factor-alpha and
interferon-gamma in patients with salmonellosis
M. Stoycheva-Vartigova, M. Murdjeva (Plovdiv, BG)
Objectives: The information on the types of cytokines produced
in serum and stool of patients with salmonellosis is still
very little. Elucidation of the cytokine cascade can improve
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
understanding the mechanisms of inﬂammation, induced by
Salmonella, and may allow the identiﬁcation of leading patho-
genetic links in the disease. The purpose of this study was to
investigate the level of some cytokines (IL-1beta, IL-1ra, IL-6, IL-
10, IL-12, TNF-alpha and IFN-gamma) in serum and stool of
patients at the acute stage of salmonellosis.
Methods: The study included 48 patients with culture con-
ﬁrmed gastro-intestinal salmonellosis. Cytokine concentrations
were determined by ELISA (BioSource, Belgium).
Results: Serum levels of IL-1beta, IL-1ra, IL-6, IL-10, IL-12,
TNF-alpha and IFN-gamma were signiﬁcantly elevated in
patients in comparison with the healthy controls. In the stool
IL-12, TNF-alpha and IFN-gamma were not increased, IL-10 was
high and corresponded with the serum concentration whereas
IL-1 beta, IL-1ra and IL-6 were more sharply raised than in the
sera.
Conclusion: Dissemination of Salmonella in the gut stimulates
local production of pro-inﬂammatory cytokines IL-1beta, IL-6
and IL-1ra. Their elevated serum concentrations mirrored the
intestinal inﬂammation.
R1891
Characterisation and comparison between the
proteomes of Brucella abortus, B. melitensis and
B. suis by 2-dimensional HPLC mass
spectrometry
R.E. Thirlwall, N.G. Coldham, S.J. Cutler (Surrey, UK)
Objectives: Brucellosis is caused by a Gram-negative intracel-
lular pathogen of the genus Brucella. This genus consists of at
least six distinct species; of which, B. abortus, B. suis and
B. melitensis are considered the most pathogenic to man as well
as their principle hosts of cattle, pigs and goats respectively. A
common cause of infections in humans is due to the consump-
tion of un-pasteurised dairy produce such as cheese and milk.
New identiﬁcation and speciation methods are required to
replace bacterial culture and traditional bio-typing which is both
time consuming and hazardous. The aim of the present study
was to determine differences in the proteomes of three Brucella
species that may account for host speciﬁcation and could be
utilized as diagnostic targets.
Methods: Recent isolates of B. abortus, B. melitensis, and B. suis
were cultured on serum dextrose agar for three days at 37C and
10% CO2. Bacterial cells were harvested into PBS and inactivated
with methanol. The proteomes were extracted with urea and
detergent and digested (100 mg) with trypsin. The tryptic
peptides were separated in the ﬁrst dimension by strong
cation exchange chromatography and in the second by reverse
phase HPLC with on line mass analysis. Proteins were identiﬁed
and proteomes compiled with SEQUEST. The proteomes were
further compared based on the spectrum count as a measure of
relative protein expression using Microsoft Access.
Results: The proteomes of B. abortus, melitensis and suis
contained 470, 554, 493, proteins respectively following analysis
by 2D-HPLC-MSn. Over 281 proteins were detected in all three
species of Brucella; of these 65 were only evident in the
proteomes of B. abortus, 119 in B. melitensis and 72 in B. suis.
The most predominant proteins in the proteome of B. abortus
were heat shock proteins (GroEL), outer membrane proteins
(Omp2b) and elongation factors (Tuf1). Similar proteins were
evident in the other species.
Conclusions: This study extends previous proteomic analyses
by 2D gel electrophoresis and provides new insights into
microbial speciﬁc differences between three species of Brucella
at the protein level. Further studies are required to determine
the biological relevance of the differences observed in protein
expression.
R1892
Serotypes of Salmonella and antibiotic resistance
in outpatients in a Greek district hospital
E. Gatsouli, N. Miari, I. Katsoula, M. Douska, S. Kosteletos,
E. Krikoni, E. Klonou (Corfu, GR)
Objective: A comparative study of the resistance patterns and
serotypes of enteric Salmonella isolated in the same number of
outpatients in Corfu General Hospital (Greece) between A
period: 2001–2003 and B: 2004–2005.
Methods: 88 enteric Salmonella strains were isolated of 1080
coprocultures the three years 2001–03. 137 enteric Salmonella
strains were isolated of 1093 coprocultures the two last years
2004–2005 and 58% of the strains were isolated from children
in both periods. The stools were inoculated in Selenit broth and
SM agar (BioMerieux). The identiﬁcation and susceptibility
were performed by VITEK II (BioMerieux). The disk diffusion
method of Kirby Bawer was used when necessary. The
serotyping was tested in Salmonella-Shigella Center of the
Univercity in Athens.
Results: The serotypes of Salmonella isolated in A and B period,
were: A: S. enteritidis 68, S. typhymurium 12, other 8 B: S.
enteritidis 110, typhymurium 13, other 14. All the isolated strains
were 100% susceptible to AMC, SAM, CXT, S/T, C, NA and CIP,
except AM (85%).
Conclusions: 1. In the last 2 years there is a 62% increase of
isolated strains than in the ﬁrst 3 years, in the same number of
coprocultures. 2. S. enteritidis was the serotype isolated most
frequent in both periods. 3. Children are susceptible to
Salmonella. 4. The resistantance rates are low. The rational use
of antibiotics and the foodborn infection surveillance are
essential to prevent the resistant Salmonella strains emergency.
R1893
Serratia marcescens causing bloodstream and
urinary tract infections and their abilities of
penetration and cytotoxicity
L-H. Su, C.H. Chiu, P-Y. Huang, C. Chu, T-L. Wu, J.T. Ou,
T.V. Riley, B.J. Chang (Taoyuan, Chiayi, TW; Perth, AU)
Objectives: Most infections associated with Serratia marcescens
are urinary tract infections (UTIs) or bloodstream infections
(BSIs), the pathogenesis of which remains poorly understood. To
address this question, the present study was conducted using
methods from both clinical and laboratory approaches to
elucidate whether any speciﬁc factor(s) may have contributed
to the occurrence of invasive infections associated with the
bacterium.
Methods: A total of 38 patients, 19 each with BSIs or UTIs
caused by S. marcescens, were retrospectively selected for further
analysis. Clinical features of the patients and results of
laboratory investigation among the associated isolates were
analysed using a STATA System for Windows (version 8.2).
Results: Clinical characteristics of the patients, including
gender, age, and underlying diseases, were similar in both
groups. Fever and mortality occurred more frequently in the BSI
group. Urinary isolates were generally more resistant to mul-
tiple antimicrobial agents and possessed plasmids of various
sizes. Genotyping analysis by infrequent-restriction-site PCR
revealed 18 genotypes, 12 of which were found in the BSI group
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and 10 in the UTI group. Pigment production was found in three
isolates from each group, respectively. Virulence factors, such as
penetration and cytotoxicity, were assayed by using Madin-
Darby canine kidney (MDCK) epithelial cells grown on ﬁlters.
After 6-h incubation of the bacteria with the cell monolayer,
signiﬁcantly more blood (94.7%) than urinary (52.6%) isolates
were detected in the basolateral medium. A close association
between the penetrative ability of bacteria and their cytotoxicity
to MDCK cells was noted. Although several signiﬁcant factors
were found in the univariate analysis, only the abilities of
penetration and cytotoxicity retained the signiﬁcant association
in the ﬁnal multivariate model.
Conclusion: The ability to penetrate through epithelial barriers
as well as the concurrent cytotoxicity may be important factors
for S. marcescens to cause invasive infections.
R1894
The prevalence of Listeria monocytogenes in
neonetal sepsis in a Tajrish hospital, Iran during
2003–04
H. Goudarzi, M. Mousavi, G. Eslami, F. Fallah, A. Rahbar,
R. Khanipourroshan (Tehran, IR)
Introduction: Neonatal sepsis is a clinical syndrome character-
ized by systemic signs and symptoms and bacteraemia during
the ﬁrst month of life. Listeria monocytogenes is one of the
newborn sepsis causes. The incidence is relatively low (one to
eight cases /1000 live birth), yet the risk mortality is
approximately 25%. Recent seroepidemiologic studies show
that the infection is foodborn.
Materials & methods: This study was performed in Tajrish
hospital during 2003–04. Between 1680 hospitalized neonatals
910 cases, which suffered from sepsis were admitted to NICU.
These newborn were evaluated according to: birth weight, sex,
blood group, clinical and laboratory evidences and recent
antibiotics therapy.
Results: Between 910 sepsis cases, 7 (0.76%) of them were
Listeria positive according to positive blood culture or positive
CSF culture. Out of these 7 patients 4 (57%) were male and 3
(42%) were female. Among them 5 (72%) had low birth weight
and 2 (28%) were weighted more than 2500 gram. The most
frequent symptoms were, positive CPR: 6 (85%), Positive Icter: 5
(71%), Thrombocytopenia: 5(71%), PCRP & low PLT: 3(42%) and
Leukopenia: 2(28%). Through these patients 14% were Ampi-
cillin resistance, 28% were Gentamicin resistance and 14% were
Amikacin resistance.
R1895
Anti-Yersinia antibodies in patients with Behc¸et’s
disease
A. Yesilkaya, L. Altintai, H. Polat, O. Memikoglu, F. C¸okc¸a
(Ankara, Kocaeli, TR)
Objectives: As the etiopathogenesis of Behc¸et’s disease (BD) is
still unknown, we planned to investigate the relationship
between Behc¸et’s disease and Yersinia infection because: a)
Yersinia virulence factor-YopP- distrupt ubiquitin in a way that
might lead to the induction of an autoimmune response, b)
Yersinia HSP60 is involved in the pathogenesis of uveitis in
Behc¸et’s patients, c) clinical ﬁndings of Yersinia infection
resembles Behc¸et’s disease ﬁndings such as uveitis, erythema
nodosum, arthritis, and ﬁnally d) Behc¸et’s disease clinically
mimic the seronegative spondyloartropathies, mainly reactive
arthritis developing after enteric or urinary tract infection.
Methods: Yersinia IgG, IgM and IgA antibodies were tested by
quantitative micro ELISA in the sera of patients with Behc¸et’s
disease (n = 101), rheumatoid arthritis (RA) patients as disease
controls (n = 38) and healthy controls (HC) (n = 43).
Results: Serum Yersinia IgM antibody levels were signiﬁcantly
elevated in BD (13.6 + 0.93 U/ml) compared to RA
(7.97 + 3.55 U/ml) and HC (7.34 + 3.11 U/ml) cases
(p = 0.000). The quantitative test results are grouped as positive,
low titre positive and negative. Yersinia IgA, IgM, IgG serop-
ositivity (>24 U/ml) in BD and RA were 4%, 4%, 15% and 13%,
0%, 18%, respectively. Yersinia IgA, IgM, IgG antibody positiv-
ity in HC group were 7%, 0%, 11%, respectively. Yersinia IgG
and IgA antibody levels were not signiﬁcantly different between
groups. No correlation was found between Yersinia antibody
titers and duration of disease, immunosuppressive therapy or
activation in BD.
Conclusion: These results do not suggest a role for Yersinia
enterocolitica and Yersinia pseudotuberculosis infection in the
etiopathogenesis of Behc¸et’s disease. However as recent data
suggest that Yersinia HSP60 – virulence factor is involved in the
pathogenesis of uveitis in Behc¸et’s patients and YopP might lead
to the induction of an autoimmune anti-ubiquitin response, the
role of Yersinia infection in the etiopathogenesis of Behc¸et’s
disease should be clariﬁed in future studies.
R1896
The effect of laser on morphology of
protoscoleces of hydatid cyst
R. Ghasemikhah, H. Ghasemikhah, M. Sharbatkhory,
R. Ghasemikhah (Tehran, IR)
Objectives: According to application of laser in medicine and
its various effects on body tissues. The present work was design
to exhibit a method for killing hydatid cyst protoscoleces, using
energy of laser (ﬂuencies) with pulse dye laser device in vitro
condition.
Materials & methods: Liver and lungs infected with hydatid
cyst were collected from a slaughter house. They were
immediately transferred to laboratory. The cysts were opened
under the sterile condition then the hydatid ﬂuid as well as
protoscoleces of the cysts were transferred into a sterile dishes.
1000 of live and fresh protoscolese in identical volume, were
subjected to different ﬂuencies of laser ranging from 2 to 9.8 J/
cm2 for different time periods. The morphology and viability of
the parasite was tested under light microscope.
Results: The results indicated that, although 2–4.5 J/cm2
ﬂuencies of laser have not effect on the morphology of
protoscoleces, but dehydration, contraction, early evagination,
granulation and death of the parasite were observed following
inducing with 4.6 to 9.8 J/cm2.
R1897
The role of infecting agents and systemic markers
of inﬂammation in COPD patients
L. Konopkina, T. Pertseva (Dnipropetrovs’k, UA)
COPD patients (pts) have an active local and systemic inﬂam-
matory response due to infection/colonization. Systemic mark-
ers of inﬂammation were investigated during a stable phase of
their illness, because continued inﬂammation could affect their
general health and be involved in disease progression.
Aim: To describe the clinical/microbiological/biochemical
characteristics of COPD pts.
Abstracts
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Study population: 70 COPD pts (II and III st.) were studied
from February 2004 till November 2005.
Methods: Clinical data (CD) in stable period (SP) and during
acute exacerbation (AE); lung function (LF); serum systemic
markers of inﬂammatory (TNF-alpha, sICAM, GM-CSF);
sputum cultures (SC).
Results: Pts were grouped according to the results of SC in SP:
1-st gr. – 43 (61.4%) pts without pathogens; 2-nd gr. – 27 (38.6%)
pts with pathogens: 7 pts – Ps. aeruginosa, 7 – Kl. pneumonia, 5 –
E. coli, 3 – St. aureus, 2 – Str. pneumonia; 3 – mixture. CD and LF
were signiﬁcantly poor in the 2-nd gr. There were no signiﬁcant
differences between the groups during AE: there were isolated
H. inﬂuenzae and Str. pneumonia in 30%. TNF-alpha and sICAM
were elevated and correlated with the extend of disease, poor LF
and SC. But there were no signiﬁcant differences between
groups for GM-CSF.
Conclusions: 1. SB correlated with CD and LF. 2. The main role
of the bacterial infection/colonization in the SP of COPD pts are
Gram-negative bacilli. 3. The great role of AE COPD are
H. inﬂuenzae and Str. pneumonia. 4. The level of some inﬂamma-
tory agents may determine disease progression.
R1898
Susceptible clone of Staphylococcus aureus
dormant in the human host?
A.R. Gomes, C. Alonso-Tarre´s, C. Corte´s-Lletget,
M. Villegas-Urbano, H. de Lencastre (Oeiras, PT; Barcelona, ES;
New York, US)
Objectives: A fully susceptible strain of Staphylococcus aureus
isolated from a purulent lesion in the leg of a 77-year old
diabetic patient was the trigger for this study. There had been
no trauma to the infected area. However, it had been the site of
osteomyelitis, more than six decades ago, when the patient was
a child. The isolate was fully susceptible to all antimicrobial
agents tested: penicillin, cloxacillin, clindamycin, erythromycin,
gentamicin, rifampicin, tetracycline, ciproﬂoxacin, chloramphe-
nicol, cotrimoxazol, mupirocin, tobramycin, linezolid, teicopla-
nin and vancomycin. We sought to investigate the genetic
background of this isolate, one among the 2.4% fully
susceptible isolates collected in the hospital in 2004, and
whether it could represent the osteomyelitis strain that
remained dormant in the host only to surface after the
development of diabetes.
Methods: We analyzed the colonization status of the patient
and studied the initial isolate and 53 S. aureus strains recovered
from osteomyelitis and other bone-related infections in different
hospitals or from carriage. Strains were characterized by
multilocus sequence typing (MLST) and spa typing. Presence
of the Panton-Valentine leukocydin (PVL) and collagen-binding
protein (cna) genes and polymorphisms in the repeat region of
the clumping factor gene B (clfB) were determined.
Results: The patient was not colonized by S. aureus. The genetic
background of the strain isolated from the lesion was ST121,
PVL+ and cna+, a genotype frequent among community
carriage isolates and also present in 20% (4/20) of the
osteomyelitis and bone infection isolates, in this study. Ninety-
four percent (34/36) of the ST121 isolates were cna+.
Conclusions: ST121 was identiﬁed in carriage and osteomyelitis
isolates. Although this genetic background could not be
unequivocally traced to the episode of osteomyelitis in this
patient’s childhood, the clinical diagnosis of the lesion and
presence of virulence factors, such as the cna gene, in most
isolates indicate that this genotype, which is common in carriage
in the community, is also well-equipped to cause osteomyelitis
and other diseases.
R1899
A report of Staphylococcus aureus isolates
presenting CA-ORSA proﬁle in a Brazilian
hospital
K.R.N. Santos, R.P. Schuenck, C.O. Winter, A.L.P. Ferreira, L.F.S.
Moreira, L.A. Mascarenhas, S.A. Noue´r, F. Rossi (Rio de Janeiro,
BR)
Oxacillin-resistant Staphylococcus aureus (ORSA) presents the
mecA gene that is carried by a staphylococcal chromosomal
cassete mec (SCCmec). There are ﬁve SCCmec types: I, II and III,
normally, present in hospital ORSA isolates (HA-ORSA), that
encode resistance to the majority of the antibiotics and, types IV
and V that are found in community-acquired ORSA strains (CA-
MRSA) and encode resistance only to beta-lactam antibiotics.
Moreover, the pathogenicity of CA-ORSA isolates is related to
extra cellular virulence factors, like Panton-Valentine leukocidin
(PVL) and gama-haemolysin (Hlg).
Objective: To analyze characteristics of ORSA strains isolated
from patients in Clementino Fraga Filho Hospital University
(CFFHU), Rio de Janeiro, Brazil, that presented resistance only
to beta-lactam by the disk diffusion test.
Methods: Eleven S. aureus strains were isolated from eight
patients, between Nov/2004 and Aug/2005, and were obtained
mainly from the ninth ﬂoor at hospital (45.5%). Six strains were
isolated from bloodstream infections, three from cutaneous
abscess and the others from broncheoalveolar liquid and nostril.
Strains identiﬁcation and the disk diffusion susceptibility test
were conﬁrmed, according to Bannerman (2003) and CLSI
(2005), respectively. Detection of mecA, pvl and hlg genes and
SCCmec type was performed by PCR. Genotypic relationship
was evaluated by using rep-PCR and PFGE.
Results: Two patients died, one with pneumonia and another
with cutaneous abscess, by the acquired infection by ORSA; all
isolates were resistant to penicillin, oxacillin and cefoxitin and
susceptible to trimethoprim-sulfamethoxazole, rifampin and
tetracycline. Besides that, all strains presented the SCCmec
type IV. PVL gene was found in ﬁve strains, while hlg gene was
observed in nine. Clonal relationship was observed among the
11 strains of ORSA isolated.
Conclusion: Reports of ORSA isolation presenting SCCmec
type IV proﬁle are important to encourage about the more
pathogenicity showed by these strains, mainly in hospitalized
patients.
R1900
The prevalence of CDT genes in clinical
Campylobacter jejuni isolates
O. Darka, A. Pinar, Y. Akyon (Samsun, Ankara, TR)
Campylobacter jejuni (C. jejuni) the major cause of acute diarrhoea
in humans throughout the world, encodes a toxin termed
cytolethal distending toxin (CDT) which is considered to be an
important virulence factor. In this study, 28 C. jejuni strains from
epidemiologically unrelated patients with diarrhoea were
screened for presence of CDT genes (cdtA, cdtB, cdtC) by
PCR. Bacterial DNA was extracted by CTAB (cetyltrimethylam-
monium bromide) method and PCR was performed by using the
previously described primers cdt A, cdt B, cdt C. Following
PCR, ampliﬁcation products were seperated by gel electrophor-
esis, stained with ethidium bromide and visualized under an
UV transilluminator. All isolates were found positive for these
three CDT genes. A high prevalence (100%) was found for the
toxin genes. Presence of the CDT genes appear to be
indispensable for Campylobacter jejuni to cause the human
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disease. For veriﬁcation of the presented data, further compera-
tive studies, including both strains isolated from asymptomatic
carriers and clinically ill patients are required.
R1901
Bordetella pertossis infection, Isfahan, Iran,
2002–2005
R. Sherkat, H. Salehi, R. Yazdani, M. Tiemoori, M. Matinfar,
M. Shoaie, A. Hasanzadeh, B. Hedayat Poor (Isfahan, IR)
Objectives: Over the last decade several changes occurred in
the ﬁeld of pertussis. Immunization controlled the diseases in
children but did not disrupt circulation of the organism.
Bordetella pertussis illnesses are common and endemic in adults
and these infections are the reservoir for pertussis in susceptible
children and infants. But what about pertussis in Isfahan?
Methods: In a case control study 50 patients more than 18 years
old with paroxysmal cough lasting more 2 weeks and no history
of COPD or Asthma were age and sex matched with 50 controls
and without history of cough. For laboratory conﬁrmation of B. p
infection in cases their nasopharyngeal swabs were cultured in
Bordet-Gengou Agar and ‡4-fold increase in IgG antibody titres
to Bordetella antigens by ELISA methods between the acute and
convalescent serum samples were evaluated and compared with
antibody titre against B.p in controls.
Results: Anti-pertussis antibody was 12% positive, 16% equi-
vocal, 72% negative in control and 48% positive, 6% equivocal
and 46% negative in cases and this difference was statistically
signiﬁcant (P value < 0.001). The mean level of IgG antibody
against B.p in acute sera was higher in cases than controls
(18.2 ± 32.4, 28.8 ± 70.6) Also the increase of mean antibody titre
between acute and convalescent serum in cases after two weeks
was statistically signiﬁcant (P value: 0.04) and in 12% the serum
antibody had been increased ‡4 rise. The level of antibody titre
in 28% of cases was >100 IU/ml. B.p was not isolated from any
of nasopharangeal cultures. No direct relation has been found
between age and antibody titre in controls in contrast a weak
invert relation in cases.
Conclusion: It is clear that immunity after immunization and
even infection is not life long. Sensitivity of organism isolation is
less than optimal especially if the specimen is obtained in a
vaccinated person, after antibiotic treatment has been started or
if taken late in the course of illness. IgG antibody assays provide
sufﬁcient sensitivity for diagnosis in paired acute and conva-
lescent specimens. However single specimen analysis is more
practical for routine purposes. The frequent ﬁnding of asymp-
tomatic antibody boosting in an immune person proves suscep-
tibility for infection, and probably active transmission despite
protection from disease. Until pertussis in adults is universally
prevented through immunization clinicians must be on the alert
of the clinical disease
R1902
Seronegative spondyloarthritis after Chlamydia
trachomatis disease
I. Kosmidou, H. Papadopoulos, E. Kakasi, I. Diamanti,
B. Galanopoulou, P. Bounotripidis, E. Georgakopoulou
(Thessaloniki, GR)
Objectives: Ankylosing Spondilitis, Reiter Syndrome, non-dif-
ferential arthritis and other arthritis belong to group of
seronegative spondiloarthritis. This study was conducted to
determine the relation between urogenital diseases from Chla-
mydia trachomatis and seronegative spondiloarthropathies.
Methods: We examined samples of urethral or vaginal secretion
and blood serum from 100 patients hospitalized in the Rheu-
matologic unit of our hospital (14 with Ankylosing Spondilitis,
28 with Reiter syndrome, 24 with non differential arthritis and
38 with other arthritis non seronegative as control group.The
urethral and vaginal excretion was examined for antigen
Chlamydia trachomatis with immunoﬂuoresce (IFA) method,
and the blood serum for detection antibodies IgG and IgA
with immunoassay (ELISA) method.
Results: Frequency of Chlamydia trachomatis in seronegative
spondiloarthritis
Conclusion: Antigen of Chlamydia trachomatis or antibodies or
both of them have the highest frequency 41% in non differential
arthritis and 39% in Reiter syndrome while they are less
frequent in ankylosing spondilitis 28.5% and in control group
26.5%.
Results: The results match with the international biblio-
graphy and they show the relationship between sexually
transmitted diseases and non-differential arthritis and Reiter
syndrome.
R1903
The correlation between infection with
Helicobacter pylori and the levels of hs-CRP and
lipoproteins in women patients, which appear
dyslipidaemia
H. Papadopoulos, I. Kosmidou, A. Vakaloudi, H. Tapsi,
E. Gouridou, S. Koutgidou, E. Georgakopoulou,
E. Vlachogiannis (Thessaloniki, GR)
Objective: The purpose of the study was the investigation of
the hs-CRP’s and the lipoproteins’ inﬂuence from the presence
of systematic infection with Helicobacter pylori in feminine
population.
Method: In the study 26 women with age 42–68 years old with
BMI 23–41 kg/m2 with known individual case history of
dyslipidaemia took part. During the checking the presence of
antigen Hp was determined in the stools as well as the presence
of antibodies IgG and IgA of Hp in the serum, the levels of
hs-CRP and the levels of Cholesterol, Triglycerides, HDL-Chol,
LDL-Chol and the non-HDL-Chol. From the study patients who
had gastro-oesophagus retrogression, small intestine ulcer,
infection or inﬂammation were being excluded.
Results: The statistical consideration of the results was made
by the Student t-test Results. From the total of studying
persons to 17 from 29 (group A) an infection with Hp in
development was found in contrast with 9 (group B) where
there was not a recent infection. The persons of group A had
considerable higher levels of hs-CRP (p < 0.001), of cholesterol
(p < 0.001), of triglycerides (p < 0.02) and of LDL-chol
(p < 0.002) than the patients of group B, although the average
level didn’t differ.
Conclusion: The conclusion is that the presence of infection
with Hp is being correlated with the presence of high levels of
hs-CRP chol of triglycerides and of LDL-chol, which are the risk
factors for the cardiovascular disease.
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Animal models incl. experimental treatment
R1904
Moxiﬂoxacin is highly active in a murine
granuloma pouch model of complicated skin and
skin structure infections
K. Merfort, S. Obertegger, R. Endermann (Wuppertal, DE)
Objectives: MXF has recently been indicated for the treatment
of complicated skin and skin structure infections (cSSSIs), so this
study was designed to evaluate the efﬁcacy of moxiﬂoxacin
(MXF) vs methicillin-susceptible Staphylococcus aureus (MSSA) in
a murine model of cSSSI and to compare MXF with levoﬂoxacin
(LFX), vancomycin (VAN), linezolid (LIN), amoxicillin-clavula-
nate (AMOX-CLAV) and ceftriaxone (CEF).
Methods: Granuloma pouches were formed by injecting 5 mL
of air + 0.5 mL of 0.1% croton oil in olive oil under the loose
connective tissue on the back of mice (5 mice/group). After 72 h,
the air was replaced by 1 mL of 0.25% agar in saline. 48 h later, a
S. aureus DSM 11823 suspension (0.5 mL; grown anaerobically in
Columbia broth; logarithmic growth phase) was injected into the
pouch. Antibiotics were given intravenously at doses of 1.25 and
5 mg/kg at 0.5 h, 4 h, 24 h and 32 h post-infection. At 48 h post-
infection the viable bacterial load in pouch exudates was
determined by plating serial tenfold dilutions on sheep blood
agar plates. Bacterial colony forming units (CFU) were counted
after overnight incubation of the plates at 37C).
Results: The bacterial loads at 48 h post-infection are shown in
the Table. MXF showed similar antibacterial efﬁcacy to LFX and
AMOX-CLAV. At doses of 1.25 and 5 mg/kg, VAN, LIN and
CEF were less effective than MXF in the reduction of CFUs in the
pouch.
Conclusion: In the granuloma pouch model, MXF has higher
antibacterial efﬁcacy than VAN or LIN and is at least as effective
as LFX and AMOX-CLAV vs MSSA infection. Therefore, MXF is
likely to be an effective treatment for abscesses caused by MSSA.
R1905
Changes in serum C3 complement protein levels
during early and late experimental sepsis
B. Kulah, D. Tezeren, S. Aksaray, A. Ozmutlu, F. Coskun,
A. Toyran, E. Guvener (Ankara, TR)
Objective: Complement system comprises an important part of
innate immunity. Sepsis leads to profound activation of the
complement system and this activation occurs in the early phase
of the sepsis. C3 Complement protein acts as acute phase
reactant in the presence of sepsis. This study aimed to observe
the changes of the serum C3 complement protein levels during
early and late experimental sepsis.
Methods: Twenty-four male Wistar Albino rats were randomly
divided into three groups. Cecal ligation and puncture (CLP)
was induced and serum C3 protein levels were measured six
hours after CLP in group II (early sepsis group; n = 8), CLP was
induced and serum C3 protein levels were measured 48 hours
after CLP in group III (late sepsis group; n = 8) and results were
compared with the serum C3 protein levels of group I (control
group; n = 8) animals. Results were analysed statistically by
using Tukey post hoc test and p < 0.05 values were accepted as
signiﬁcant.
Results: Compared with the control group (I) animals, serum
C3 protein levels were found signiﬁcantly (p < 0.001) high in
late sepsis group (III) animals (0.21 g/l and 0.36 g/l respec-
tively). There were no signiﬁcant differences in serum C3
protein levels between the control (I) and early sepsis group (II)
animals (0.21 g/l and 0.19g/l respectively).
Conclusion: Serum C3 protein levels may be normal during
initial phase of experimental sepsis and signiﬁcantly elevated
serum C3 protein levels indicate a late phase of experimental
sepsis. Thus signiﬁcantly elevated serum C3 protein levels may
be an indicator for poor prognosis in sepsis.
R1906
In vivo antifungal activity of Akacid cream for
experimental cutaneous candidiasis in guinea
pigs
C. Kratzer, S. Tobudic, W. Graninger, A. Buxbaum,
A. Georgopoulos (Vienna, AT)
Objectives: The polymeric guanidine Akacid, a novel
member of the cationic family of antimicrobials, shows broad
in vitro activity against bacteria and fungi. In the present study
the antifungal activity of Akacid was evaluated against
Candida albicans in vitro and in vivo.
Methods: In vitro susceptibility of Akacid was tested against
C. albicans ATCC 90029 and ATCC 10231. The fungicidal activity
of Akacid in 15 and 60 minutes contact time was investigated by
suspension-neutralization method and the effect of Akacid on
the morphogenetic transformation by yeast-phase cells to
hyphal forms was studied. The in vivo efﬁcacy of Akacid
cream at concentrations of 0.1, 0.5 and 2% was evaluated in a
model of cutaneous candidiasis caused by C. albicans ATCC
90029 in guinea pigs compared to clotrimazole 1% cream. Each
therapy regime was topically applied three times daily for a
period of 7 days, starting on the ﬁrst day after the initial
infection. Quantitative cultures of the infective lesions in
neutralizing solution were performed one day after end of
therapy.
Results: After exposure to Akacid at a concentration of ‡0.1%
in vitro, C. albicans was eliminated in 60 minutes contact time
and the transformation to hyphal forms was inhibited. In vivo,
Akacid cream at a concentration of ‡0.5% and clotrimazole 1%
cream caused a signiﬁcant reduction of the viable fungal count.
Akacid 2% cream achieved the highest mycological eradication
rate with in 75%. Akacid 0.5% cream with in 62.5% was found
to be as effective as clotrimazole 1% cream with in 56% in
eradicating C. albicans.
Conclusion: These results suggest that Akacid cream could
have clinical usability for superﬁcial infections caused by
C. albicans.
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R1907
Impact of colostomy on intestinal microﬂora and
bacterial translocation in young rats fed
heat-killed Lactobacillus acidophilus
K. Rigon-Zimmer, C. Mullie´, N. Fontaine, A. Meddah,
P. Buisson, A. Le´ke´, J. Canarelli (Amiens, FR; Mascara, DZ)
Objectives: Neonatal digestive diseases of the gut sometimes
lead to surgical treatments. Such treatments, along with
concomitant antibiotherapy, are causes of intestinal microbial
imbalances. These imbalances favour intestinal disorders and/
or infectious conditions through bacterial translocation from the
gut. To help regulating the neonatal intestinal ﬂora and avoid
infectious complications, products such as Lacte´ol (heat-killed
Lactobacillus acidophilus) have been proposed. An experimental
approach of colostomy-induced modiﬁcations to the intestinal
ﬂora and bacterial translocation was set using young rats fed an
oral daily dose of Lacte´ol.
Methods: Three-week-old Wistar rats received a daily dose of
5.109 heat-killed L. acidophilus (Lacte´ol) from Day 0 till Day 28
of the experiment. Six rats served as control (Group C), six
underwent laparotomy (Group L = sham-operated) and seven
colostomy (Group Op = Operated) on Day 0. On Day 28, all rats
were anaesthetised and ileum, caecum, colon removed for
intestinal colonisation assessment as well as kidney, spleen, liver
and mesenteric lymph nodes for bacterial translocation evalu-
ation.
Results: Colostomy induced a lasting growth retardation in
group Op (inferior weight from Day 9 till Day 28, p < 0.01). In
the ileum, groups L and Op more frequently harboured
lactobacilli (p = 0.04 and p = 0.025, respectively). In the
caecum, both bacilli and staphylococci were detected more
frequently in group L when compared to group Op (p = 0.016
and p = 0.049, respectively). Bacillus colonisation frequency was
also signiﬁcantly lower in group C when compared to that of
group L (p = 0.001). Biﬁdobacteria were isolated more
frequently in the caecum of group C animals compared to
group L (p = 0.03). Overall bacterial translocation was signiﬁ-
cantly higher in the spleen of group L compared to groups C
and Op (100 vs. 33 and 43% p = 0.03 and p = 0.049, respec-
tively). Staphylococci in the spleen had a higher translocation
rate in group L when compared to the two other groups (83 vs. 0
et 29%, p = 0.008 for group C and p = 0.016 for group Op,
respectively).
Conclusion: Lacte´ol did not prevent colostomy-induced chan-
ges in the intestinal microﬂora. However, these changes, as well
as bacterial translocation (staphylococci and total bacteria), were
less important than in animals undergoing laparotomy.
Bioﬁlm
R1908
Comparison of the capacity to form a bioﬁlm on
medical materials as well as sensitivity to
disinfectants of multiresistant Gram-negative
rods isolated from children
I. Mirska, Z. Muszynski (Poznan˜, PL)
Objectives: The objective of this paper was to assess the
capacity of multiresistant Gram-negative rods (MRGN) rods to
form bioﬁlm on the surface of polymers widely used in
medicine and to compare the resistance of those rods to
antibiotics and cationic disinfectants.
Methods: 72 MRGN were chosen for the research, among them
30 strains of Enterobacteriaceae rods (K. pneumoniae, E. coli,
P. mirabilis, Serratia spp., Enterobactr spp., C. freundii) and 42
strains of non-fermentative rods (P. aeruginosa, A. baumanii,
A. lwofﬁi, Stenotrophomonas maltophilia) which are resistant to
karbapenems, ﬂuoroquinolones and aminoglycosides. The
strains were isolated from lower respiratory tract, wounds,
blood and urine of children. The strains were identiﬁed bymeans
of Sceptor (Becton-Dickinson) system. Sensitivity to antibacterial
medicines and beta-laktamaz reactivity (ESBL,MBL)wasmarked
according to the NCCLS standard. Bacteria sensitivity to cationic
disinfectants was marked for chlorhexidine digluconate (CH)
and for benzalconium bromate (BZ). The adhesion of rods to
polymers and forming of a bacterial bioﬁlm was examined using
TTC method. Ureteral catheters made from polychloride vinyl
(PCV), latex (L) and latex covered with silicone (LS) were used.
Results: Statistical analysis of the outcome showed that, MRGN
strains from Enterobacteriaceae family with reduced sensitivity to
CH and BZ were signiﬁcantly often (p < 0.05) resistant to
amikacin than strains sensitive to CH and BZ. However, for
P. aeruginosa strains with reduced sensitivity to CH and BZ the
resistance to ciproﬂoxacin was signiﬁcantly more frequent. All
examined strains of Enterobacteriaceae rods adhered and formed
a bioﬁlm on the surface of polymers from PV, L, LS, while non-
fermentative rods actually adhered more frequently and formed
a bioﬁlm on the surface of PCV rather than on latex and silicone
latex (p < 0.01). No statistical differences (p > 0.05) were found
in forming a bioﬁlm by non-fermentative rods on the surface of
L and LS; furthermore, there have been no differences in the
ability of forming a bioﬁlm between P. aeruginosa and Acinetob-
acter spp. strains.
Conclusion: The resistance of Gram-negative rods to numerous
antibiotics and the ability to form a bioﬁlm on the surface of
widely used in medicine polymers in addition to lowered
sensitivity to disinfectants make it easier for Gram-negative rods
to survive in hospital conditions.
R1909
Role of glycocalyx and bound moisture in
formation of Streptococcus mutans EK2 8184 and
TK18 bioﬁlms
M.Y. Li, Z. Liu (Shanghai, CN)
Objective: To investigate the role of glycocalyx (glycoproteins
or exopolysaccharides-protein) and bound moisture in forma-
tion of Streptococcus mutans EK2 8184 and TK18 Bioﬁlms.
Methods: Streptococcus mutans EK2 8184 and TK18 were resti-
tuted, identiﬁed and incubated anaerobically in Trypticase soy
broth (TSB) supplemented with 2 g/L sucrose in a incubator at
37C for 18 hours. Bioﬁlms were collected from plate, -20
freezed for one night, thawed. Bioﬁlm ﬂuid were collected after
centrifuged. Total protein concentration was detected with
Lowry method and exopolysaccharide was measured by the
phenol-sulphate method. The state of moisture in bioﬁlms was
analysed by oven drying.
Results: The percentage of free and bound moisture in bioﬁlm
to S. mutans EK2 and TK18 were 90.94% and 1.09% vs 91.67%
and 0.23%. The corresponding percentage in bioﬁlm ﬂuid values
were 93.50% and 0.46% vs 93.17% and 0.25% accordingly. The
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ratio of protein to exopolysaccharide in the bioﬁlms to S. mutans
EK2, 8184 and TK18 were 0.019 0.017 and 0.019. The corres-
ponding ratio in the bioﬁlms ﬂuid values were 0.08, 0.09 and
0.03 accordingly.
Conclusions: The glycocalyx may be form various types
framework of structures within a bioﬁlm. The bound water
molecules were accumulated around the glycocalyx but not
polysaccharide, taking the important role of bioﬁlm formation.
R1910
Microbial quality of water in dental unit
waterlines
M. Nikaeen, M. Hatamzadeh, H. Mirhendi, Z. Sabzevari,
O. Zareh (Isfahan, Tehran, IR)
Objectives: Dental unit waterlines (DUWL) are ideal environ-
ment for developing of bacterial bioﬁlms. Microbial contamin-
ation of water in DUWLs is though to be the result of bioﬁlm
formation as it could serves as a haven for pathogens. Thus,
microbial quality monitoring in a dental unit (DU) is of
considerable importance, since patients and dental staff are
exposed to water and aerosols generated from the DU. The aim
of this study was to assess microbial quality of water in dental
unit waterlines of 25 dental units located at the dental school of
Isfahan University of Medical Sciences, Isfahan, Iran.
Methods: Water samples were collected from air-water syringe
and high-speed handpiece at the beginning of the work day after
a 2-min purge, and examined for total viable heterotrophic
bacteria, fungi and legionella. The media used in the study were
including R2A agar, sabouraud dextrose agar and Buffered
charcoal yeast extract agar for bacteria, fungi and legionella
respectively.
Results: The heterotrophic plate count (HPC) levels were
signiﬁcantly exceeded the American Dental Association recom-
mendations for DUWL water quality (<200 CFU/ml), in both
air-water syringe (84%, CFU/ml: 500–20000) and high-speed
handpiece (96%, CFU/ml: 710–36800) samples. However, there
was no signiﬁcant statistical difference between the level of
contamination in the air-water syringe and high-speed hand-
piece. Fungal elements were found in 28% and 36% of air-water
syringe and high-speed handpiece samples respectively. All
water samples were negative for legionella spp.
Conclusion: DUWLs should be subjected to routine microbial
monitoring and to a decontamination protocol in order to
minimize the risk of exposure to potential pathogens from
dental units.
R1911
Evaluation of the ability of ﬁve Candida species
to produce in vitro bioﬁlms on the surface of
teﬂon, polyurethane and polyvinyl chloride
D. Estivill, A´. Torres-Lana, A´. Arias, M.P. Are´valo (Manresa,
La Laguna, ES)
Objectives: To assess the in vitro ability of ﬁve Candida species
to produce adherence and bioﬁlms on the surface of three
synthetic material commonly used in Medicine: teﬂon, polyur-
ethane and polyvinyl chloride (PVC).
Material and methods: We have studied 82 clinically relevant
isolates of yeasts from genus Candida: 23 C. albicans, 23 C.
parapsilosis, 17 C. glabrata, 16 C. tropicalis and 5 C. krusei.
Catheters were carefully cut into 1 cm segments and sterilised
with ethylene oxide. A surface of 28 mm2 was estimated for
polyurethane, 36 mm2 for PVC and 45 mm2 for teﬂon. The
segments were incubated together with an adjusted inoculum of
yeasts (optical density of 1.0 at 540 nm wavelength). The
incubation was 35C for 90 minutes to establish baseline
adherence and further 72 hours to assess the bioﬁlm production.
Nonadherent organisms were removed by washing three times
with 1 ml of PBS. Results are shown as logarithm (log) of viable
cells in colony forming units per millilitre (CFU/ml). In both
cases results are adjusted according surface size as estimated
previously.
Results: For polyurethane C. albicans and C. parapsilosis showed
the lesser adherence (6.88 log and 7.29 log respectively) and
bioﬁlms production (9.00 log and 9.31 log respectively) with this
material, whereas C. tropicalis showed the similar values for
adherence and higher values for bioﬁlm production (7.22 log for
adherence and 9.43 log respectively). The difference was not
signiﬁcant. For PVC, C. albicans and C. glabrata had the lower
measures for adherence (7.20 log and 7.82 log respectively) and
again C. tropicalis showed the intermediate value (7.29 log). In
the case of bioﬁlm formation on PVC the results were 9.39 log
for C. albicans, 9.79 log for C. parapsilosis, 8.93 log for C. glabrata,
8.24 log for C. krusei and 9.04 log for C. tropicalis. No statistic
signiﬁcation was found. For teﬂon, we found that C. albicans had
the lower result in adherence (6.56 log) and C. parapsilosis the
highest (7.54 log) and it was statistically signiﬁcant. In the case
of bioﬁlm production, C. parapsilosis and C. albicans had the
greater growth (10.37 log and 10.17 log, respectively) and
C. glabrata had the lower bioﬁlm formation (8.93 log) and these
differences were statistically signiﬁcant.
R1912
In vitro study of interactions between bacteria
and prostheses used in vaginal surgery
A. Bafghi, H. Carsenti-Dellamonica, M. Piche, C. Trastour,
J. Michiels, A. Bongain, P. Dellamonica (Nice, FR)
Gynaecological prolapse occurs permanently or upon physical
effort through the vagina. The main treatment is surgical repair,
and surgeons increasingly use prostheses. Several materials are
available, which lead to infectious problems because of the
vaginal surgical approach. Several cases of infected prostheses
have been reported in the literature. The aim of this study was to
compare the adhesion of several bacteria to different types of
prosthetic tissue used in vaginal surgery.
Materials and methods: Seven types of prostheses were stud-
ied: - ﬁve polypropylene prostheses: 1 low- and 1 high-mesh
monoﬁlament, 1 multiﬁlament, 1 non-knitted and non-woven
and 1 monoﬁlament with collagen- one prosthesis with porcine
collagen- one polyester prosthesis with polyurethane.Three
adherent bacteria from infected uro-gynaecological prostheses
were selected: Staphylococcus aureus, Pseudomonas aeruginosa,
Escherichia coli.Four samples, 5 · 5 mm, of each type of pros-
thesis were infected with 106 CFU/ml of each species and
cultured at 37C. Non-adherent bacteria were eliminated by at
least 10 washes in sterile phosphate buffer. Adherent bacterial
colonies were counted after vortex and trypsine treatment. Each
experiment was done in duplicate after 1, 2, 4 and 6 hrs of
incubation at 37C. Two samples were examined after staining
using optical microscopy.
Results (Figure 1): Counting of adherent bacteria: - kinetic
studies of adhesion showed differences between prostheses, -
S. aureus had higher afﬁnity for prostheses containing collagen, -
Bacterial afﬁnity varied according to the type of prosthesis.Type
of ﬁxation: On all types of multiﬁlament prostheses (polypro-
pylene, polyester), non-woven and porcine collagen, bacteria
were attached diffusely along ﬁlaments, whereas on monoﬁla-
ment prostheses, ﬁxation appeared only on knots.
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Conclusion: Infection rate in vaginal surgery varies greatly
according to prostheses. Our in vitro results showed that
infection is linked to the molecular type, manufacturing type,
bacteria properties, and mesh of each prosthesis. Knowledge of
interactions between bacteria and prostheses would improve
understanding of infection mechanisms in order to optimise the
quality of materials and treatment of infection. We suggest that
all multiﬁlament prostheses should be removed when infected,
whereas conservative treatment may be tried for monoﬁlament
prostheses (with partial excision in case of erosion).
R1913
Effect of hydrogen peroxide and N-propanol on
bioﬁlms formed by clinical strains of
Staphylococcus epidermidis
E. Presterl, M. Suchomel, S. Reichmann, B. Parschalk, M. Rotter,
W. Graninger (Vienna, AT)
Objective: Staphylococcus epidermidis is the leading organism
causing infections of implanted or inserted foreign material or
devices generally associated with bioﬁlm formation. We tested
the effects of disinfectants commonly used in clinically practice
on bioﬁlms of clinical strains of S. epidermidis.
Methods: Thirty bioﬁlm-forming strains of S. epidermidis isola-
ted from blood of patients with conﬁrmed pacemaker infection,
catheter-related bacteremia or from the skin of healthy controls
were investigated using the static bioﬁlm microtitre plate model.
Bioﬁlms were grown for 24 hours, then incubated with either
hydrogen peroxide in 3 concentrations (0.5, 3 and 5 percent) and
N-propanol (60 percent) for 1, 5, 15, 30 and 60 minutes. Bioﬁlm
formation was ascertained by electrone microscopy. For quan-
tiﬁcation bioﬁlms were ﬁxed with 2% glutaraldehyde and dyed
with 1 percent crystal violet to measure the mean optical density
(OD) using a microtitre-plate-reader at 550 nm wavelength. To
test the bactericidal activity wells were not ﬁxed and dyed, but
the contents were seeded to Columbia agar plates, which were
examined for growth after 24 and 38 hours.
Results: Incubation of the bioﬁlms with 0.5 percent hydrogen
peroxide for 1 and 5 minutes reduced the OD of the bioﬁlms to
71 ± 26 and 72 ± 35 percent (mean, SD), respectively; incubation
with 3 percent hydrogen peroxide for 1 and 5 minutes reduced
the OD to 37 ± 22 and 48 ± 28 percent, respectively; and
incubation of the bioﬁlms with 5 percent hydrogen peroxide
for 1 and 5 minutes reduced the OD to 31 ± 18 and 50 ± 14
percent of the OD of the untreated bioﬁlm, respectively
(p < 0.05). Incubation for 15, 30 or 60 minutes resulted in no
further decrease of the OD. Incubation of the bioﬁlms with 60
percent N-propanol led to an increase of the OD of the bioﬁlms.
There was no growth of bacteria recovered from all treated
bioﬁlms.
Conclusions: Hydrogen peroxide at a concentration of 3
percent reduces the density of bioﬁlms formed by S. epidermidis
to the same extent as 5 percent hydrogen peroxide. Sixty percent
N-propanol does not reduce the OD at all and even seems to ﬁx
the bioﬁlms. Hydrogen peroxide and N-propanol are bacteri-
cidal on the bioﬁlms. Thus, hydrogen peroxide can be used
topically in foreign body infections.
R1914
The adhesion intensity of Staphylococcus
epidermidis, Salmonella typhimurium and
Pseudomonas aeruginosa on the surface of
bioactive glass 4N
A. Reinis, J. Kroica, J. Vetra, V. Kuznecova, R. Cimdins,
L. Berzina, D. Rostoka (Riga, LV)
Objectives: To estimate the adhesion intensity of different
microorganisms on the surface of originally synthesized bioma-
terial - bioactive glass 4N.
Materials and methods: In this research the bioactive glass 4N,
S. epidermidis strain ATCC 12228, S. typhimurium strain ATCC
14028, Ps. aeruginosa strain ATCC 27853 were used. The
biomaterial discs were incubated for 1 and 2 hours in 37C in
following bacterial suspensions: 10 CFU/ml, 100 CFU/ml, and
1000 CFU/ml. Several cultivations from every sample were
prepared on TSA plate to estimate the total amount of micro-
organisms and the number of CFU per 1 mm2 of the surface of
biomaterial disc. The Fisher test was used for statistical analysis.
Results: The adhesion intensity of S. epidermidis: no bacteria
adhered to bioactive glass 4N after 1 h of incubation in
concentration 10 CFU/ml, 100 CFU/ml and 1000 CFU/ml,
and in concentrations 10 CFU/ml and 100 CFU/ml after 2 h
of incubation. The intensity of adhesion after 2 h of incubation in
concentration 1000 CFU/ml was 4 10)3 CFU/mm2 (p < 0.001).
The adhesion intensity of S. typhimurium: 2.5 10)3 CFU/mm2
after 1 h of incubation. However after 2 h of incubation no
adherence was detected in concentration 10 CFU/ml; in con-
centration 100 CFU/ml accordingly 11.5 10)3 CFU/mm2 after
1 h of incubation and 18 10)3 CFU/mm2 after 2 h of incubation
were detected; in concentration 1000 CFU/ml after 1 h of
incubation 73 10)3 CFU/mm2 and 207 10)3 CFU/mm2 after
2 h of incubation were detected (p < 0.001). The adhesion
intensity of Ps. aeruginosa: 2 10)3 CFU/mm2 after 1 h of incu-
bation and 18 10)3 CFU/mm2 after 2 h of incubation in
concentration 10 CFU/ml were detected; in concentration
100 CFU/ml accordingly 25 10)3 CFU/mm2 after 1 h of incu-
bation and 91 10)3 CFU/mm2 after 2 h of incubation; in
concentration 1000 CFU/ml - 171 10)3 CFU/mm2 after 1 h of
incubation and 309 10)3 CFU/mm2 after 2 h of incubation
(p < 0.001).
Conclusions: Ps. aeruginosa and S. typhimurium present higher
tendency for adhesion on bioactive glass 4N than S. epidermidis
in this experiment. The minimal infectious dose of S. epidermidis
on bioactive glass was equal or even higher than 1000 CFU/ml
after 1 h of incubation, or 100 CFU/ml after 2 h of incubation.
The minimal infectious dose of S. typhimurium and Ps. aeruginosa
on bioactive glass was equal or even higher than 10 CFU/ml
after 1 h of incubation. This research was supported by ESF NP
‘‘Support for medical science doctoral studies’’.
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Antimicrobial pharmacokinetics, pharmacodynamics, general
pharmacology
R1915
Potential for improved pharmacokinetics of
enroﬂoxacin in poultry following modiﬁed
dosage regimens
L.P. Randall, S.W. Cooles, K. Stapleton, N.G. Coldham, M.J.
Woodward (New Haw, UK)
Objectives: Optimal antimicrobial dosage regimens aim to
achieve successful clinical outcomes without drug toxicity or
emergence of bacterial resistance. For concentration dependant
antibiotics, such as the ﬂuoroquinolones, a Cmax:MIC ratio of
>10 is considered more important for efﬁcacy and reduced
selection of resistance than prolonged antibiotic concentrations
just above the MIC. Fluoroquinolone resistance in zoonotic
bacteria such as Campylobacter and Salmonella is a matter of
public health concern, and ﬂuoroquinolone treatment of poultry
can rapidly select for bacteria with reduced ﬂuoroquinolone
susceptibility. In this study we compared basic pharmacokinetic
parameters for the recommended dose of Baytril (enroﬂoxacin)
10% oral solution in poultry to 2.5x this dose for birds dosed by
continuous water (standard) treatment compared to pulsed
water treatment and dosing by gavage.
Methods: For the pulsed versus continuous water treatments,
groups of chickens received Baytril 10% oral solution at 50
(recommended) or 125 ppm continuously in the water or at 10
(recommended) or 25 mg/kg pulsed in the water. For each
group, three birds were killed at 0, 2, 4, 6, 8, 10 and 24 hours
after start of antibiotic treatment and caecal contents, liver, lung
and sera were taken for analysis by ﬂuorescence HPLC for
ﬂuoroquinolones. For gavage treatment, dosing was at 10 and
25 mg/kg by crop intubation and four birds were killed in each
group at 2, 6 and 24 hours after gavage, caecal contents, liver
and sera were taken for analysis. Basic pharmacokinetic
parameters were determined using PK solutions software.
Results: Determined mean ﬂuoroquinolone Cmax in caecal
contents (and sera) for gavage, pulsed water and continuous
water treatments was 78.01 (1.81), 53.19 (1.17) and 24.73
(0.73) mcg/ml (recommended dose) and 115.86 (3.86), 115.63
(2.74) and 68.02 (1.17) mcg/ml (2.5x recommended dose)
respectively. Cmax of antibiotic in liver and lung was increased
by the modiﬁed regimens in similar proportions to above. Both
pulsed water and gavage treatment not only resulted in higher
Cmax values, but also a faster rate of clearance than continuous
water treatment (Figure 1).
Conclusion: Dosing by gavage is not practical for thousands of
chickens. However, pulsed dosing at 2.5x the recommended
dose can increase the Cmax about fourfold and should improve
efﬁcacy and reduce selection of resistance, compared to the
50 ppm continuous water treatment regime (recommended).
R1916
Comparative bactericidal activities of
daptomycin, glycopeptides, linezolid, and
tigecycline against blood isolates of
Gram-positive bacteria, Taiwan
P.R. Hsueh (Taipei, TW)
Objectives: To determine the in vitro bactericidal activities of
daptomycin, linezolid, tigecycline, vancomycin, and teicoplanin
against resistant gram-positive bacteria.
Methods: MICs and MBCs of the above agents were deter-
mined for ten each of blood isolates of methicillin-susceptible
Staphylococcus aureus (MSSA) and methicillin-resistant .S. aureus
(MRSA) including two vancomycin heteroresistant S. aureus
(MIC, 6 lg/ml), and vancomycin-resistant Enterococcus faecium
and E. faecalis (VRE).
Results: Vancomycin had better bactericidal activities against
MRSA and MSSA than that of teicoplanin. Forty percent of
MRSA, 90% of MSSA and vancomycin-resistant E. faecium, and
100% of vancomycin-resistant E. faecalis exhibited tolerance
(MIC/MBC ratio more than 16) to tigecycline. Linezolid had
poorest bactericidal activities against isolates tested and toler-
ance of this agent was found 100% for MSSA and VRE isolates
and 90% for MRSA. Daptomycin had most potent bactericidal
activities against all isolates tested without tolerance.
Conclusion: The excellent in vitro bactericidal activity of
daptomycin presents the potential role of treatment of severe
infections due to these resistant bacteria.
R1917
Comparative study of ﬂuconazole and
clotrimazole for the treatment of vulvovaginal
candidiasis
K. Diba, A. Namaki (Tehran, Kermanshah, IR)
About 75% of women in theworld are involved by Vulvo Vaginal
Candidiasis atleast once in their whole life. Candida albicans,
opportunistic yeast, causes 85-90% of vaginal mycotic infections.
Volve and vaginal itching and cottage cheese like discharge, are
most common signs of VVC. The best treatments for this infection
are topical Azoles; Clotrimazole and Miconazole or systemic
Azoles for example; Fluconazole. The oral administration of
Fluconazole has advantages about easily using and high effect on
recurrent infections caused by hyper colonization of Candida
albicans in intestinal tract. In this study Clotrimazole cream for
application to the vulvo vaginal area mycosis in a single-blind
clinical study. A randomized controlled trial was conducted at
Kowsar Uromia Hospital. There were 60 women in the group
treated with ﬂuconazole and 60 in the group treated with
clotrimazole, there was no signiﬁcant difference between the two
groups regarding age and length of follow-up period. Mycolog-
ical cure rates approximately 1 week after treatment were 79.3%
in the Clotrimazole group and 90% in the Fluconazole group. The
side effects were minimal and results were not statistically
signiﬁcant. As a conclusionwe recommend that a single oral dose
of 150 mg of Fluconazole be used as an alternative method of
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treating VulvoVaginal Candidiasis because of short time and
easily using of oral, single dose capsule.
R1918
Evaluation of antibacterial activity of ethanol
extracts of some medicinal plants against Listeria
monocytogenes
M. Jalali, N. Ghassemi, D. Abedi, A. Charmahali (Isfahan, IR)
Objective: Listeria monocytogenes is a foodborne pathogen
capable of causing outbreak or sporadic episodes in human.
Most of the outbreak or sporadic episodes were in the last two
decades and due to high rate of mortality, caused a great
concern in the food industry. There are various medicinal plants
with the high performance of antibacterial activity in Iran. The
aim of present study was to determine the anti-listerial effects of
Thymus vulgaris L., Eucalyptus globules Labill., Matricaria recutita
L., Rosmarinus ofﬁcinalis L., and Saliva ofﬁcinalis L., extracts.
Method: The plants were selected and identiﬁed by Depart-
ment of pharmacognosy of Isfahan Faculty of Pharmacy.
Extracts of the selected plants were prepared. Then antibacterial
activity of extracts was determined by disc diffusion method.
The Minimal Inhibitory Concentration (MIC) was also deter-
mined by tube dilution method.
Results: Results showed that ethanolic extract of Eucalyptus
poses antibacterial effects against L. monocytogenes in both disc
diffusion and tube dilution method. MIC and MBC of this
extract were 31.25 lg/mL and 500 lg/mL, respectively.
Conclusion: The results of present study indicate that only the
extract of Eucalyptus showed antibacterial effects on both
serotypes of L. monocytogenes. Extracts of other plants did not
show anti-listerial effects against L. monocytogenes.
R1919
Mutant prevention concentrations of
ciproﬂoxacin for Brucella melitensis
A.Y. Coban, E. Tanyel, N. Tasdelen Fisgin, O. Darka, N. Tulek,
B. Durupinar (Samsun, TR)
Objectives: We determined mutant prevention concentration
(MPC) of ciproﬂoxacin against 28 Brucella melitensis clinical
isolates.
Methods: MICs of ciproﬂoxacin were determined using broth
microdilution method with brucella broth while MPCs were
determined using agar dilution method with brucella agar. The
MPC was recorded as the lowest concentration of ciproﬂoxacin
to inhibit growth from an inoculum of 1010 cfu.
Results: MIC of 12 isolates were 0.5 lg/ml and MIC of 16 were
1 lg/ml. Ranges of MPCs were 2–8 lg/ml. MIC-MPC of 9, 12, 3,
2, 1 and 1 strains were 0.5–8 lg/ml, 1–8 lg/ml, 1–4 lg/ml, 0.5–
4 lg/ml, 1–2 lg/ml and 0.5–2 lg/ml, respectively.
Conclusion: According to our results, MPC/MIC ratios of
ciproﬂoxacin against B. melitensis were reported as highly.
MPC values will be useful for dosing strategies of B. melitensis.
R1920
Fluoroquinolones concentrations in infected
human bone: preliminary results
S. Garazzino, F.G. De Rosa, A. D’Avolio, A. Aprato, A. Masse´,
A. Biasibetti, G. Di Perri (Turin, IT)
Objectives: The management of post-traumatic bone infections
relies on prolonged antibiotic therapy and surgical debride´-
ment. However, a main determinant of clinical response is
drug concentration at the infected site. Antibiotic penetration
into bone depends primarily on pharmacological characteristics
but can be inﬂuenced by degree of vascularisation and
presence of necrotic sequestra. Aim of our study was to
assess ciproﬂoxacin and levoﬂoxacin concentrations in infected
human bone.
Methods: Patients with a post-traumatic septic pseudoarthrosis
undergoing debride´ment of infected tissue, who received
antibiotic therapy for more than 1 week, were studied. Plasma
and bone specimens were collected intraoperatively for phar-
macokinetic and microbiologic assays at a mean of 4.2 hours
after antibiotic administration. Bone samples were crushed and
eluted into sterile phosphate buffer and antibiotic concentrations
were measured by a validated HPLC method. Literature data on
ﬂoroquinolones penetration in non-infected bone were used as
control.
Results: Two patients were studied. The ﬁrst patient received
iv ciproﬂoxacin 400 mg bid and E. coli was cultured from the
bone (MIC = 0.5 mg/L). Plasma concentration of ciproﬂoxacin
at the time of osteotomy was 3.6 mcg/mL. Bone concentra-
tions were 0.7 mcg/mL and 30.2 mcg/mL, respectively in
cortical and newly formed bone, with respective bone/plasma
ratios of 0.2 and 8.4. The second patient was administered iv
levoﬂoxacin 500 mg qd and Enterobacter cancerogenus was
isolated (MIC = 1 mg/L). Plasma concentration at the time
of surgery was 2.5 mcg/mL. Bone concentrations were
0.3 mcg/mL and 26.9 mcg/mL in cortical and cancellous
bone, respectively (bone/plasma ratios: 0.12 and 10.8 respect-
ively).
Conclusion: At steady state, only ciproﬂoxacin provided
cortical bone concentrations higher than the susceptibility
breakpoint of the infecting agent, and similar to those reported
in non-infected bone. However, levoﬂoxacin concentrations ten
times higher than plasma levels were measured in cancellous
bone and ciproﬂoxacin concentration in bony callus were eight
times higher than those detected in plasma. This original
observation may be related to an augmented vascularisation
and/or selective accumulation of ﬂuoroquinolones into regen-
erating bone, as observed in children’s cartilage growth plate.
These preliminary results suggest that ciproﬂoxacin may be
preferred to levoﬂoxacin for the treatment of post-traumatic
bone infections.
R1921
X-ray diffraction evidence for antifungal action of
Cassia ﬁstula linn. fruit pulp extract
K. Sharma, G. Dak, L. Nambakkat, V. Kanipotth (Udaipur, IN)
Objectives: Cassia ﬁstula Linn is implicated in Indian ethno
medicinal literature as having antifungal properties. Hence a
study was undertaken to evaluate the inhibitory effect of fruit
pulp of this plant against Aspergillus fumigatus. Crude alcohol
extract and petroleum ether, benzene, alcohol, chloroform and
water fractions of Cassia ﬁstula Linn. fruit pulp were assayed for
antifungal activity. X-Ray diffraction studies of all fractions and
the treated fungal biomass were done to study the inhibitory
effect of the extract on the fungus.
Method: Cassia ﬁstula fruit pulp was scraped out and dried at
45C. Crude alcohol, extract was prepared according to the
modiﬁed method of Shadomy and Ingroff (1974). Partially
puriﬁed fractions in petroleum ether, benzene, chloroform,
alcohol and water were prepared by successive extraction by
reﬂux method of extraction (Harborne 1984). Antifungal activity
was assayed by agar dilution method (Joan Stokes 1975) against
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Aspergillus fumigatus.15 ml of sterile medium and 1 ml of
respective extracts were dispensed in borosilicate glass tubes
and autoclaved. Tubes were then inoculated with pure cultures
of the test fungus and incubated at 37C. growth of fungus was
observed on 3rd, 6th and 9th day. X-ray diffraction studies were
done by exposing the extract/ treated as well as untreated
fungal biomass to X-rays from a copper source at an angle of 2
theta for 20 minutes.
Result: Crude as well as partially puriﬁed fractions of Cassia
ﬁstula Linn. fruit pulp inhibited the growth of fungus as
inhibition of fungal growth was observed from 3rd day
onwards. The magnitude of inhibition differed and maximum
inhibition was observed with chloroform fraction. Crystalline
nature of extracts was established by presence of sharp peaks in
the X-ray diffraction spectra of the various fractions of the
extract. Peak identiﬁcation suggests that these peaks correspond
to several primary and secondary metabolites. Several peaks
present in the control spectra were absent in the treated spectra
suggesting a change in crystalline nature of fungal biomass after
treatment.
Conclusion: Cassia ﬁstula Linn. fruit pulp possesses antifungal
property. Secondary metabolites present in the extract are
possibly responsible for the inhibition of fungus. Absence
of well-deﬁned peaks in the spectra of treated biomass
suggests degradation of functional as well as structural
metabolites.
R1922
Serum and ascitic ﬂuid concentrations following
a single IV dose of 400 mg moxiﬂoxacin
S. Metallidis, G. Lazaraki, A. Tsona, E. Koumentaki,
E. Alexiadou, J. Nikolaidis, V. Gogou, M. Chatzidimitriou,
A. Gikas, P. Nikolaidis (Thessaloniki, Heraklion, GR)
Objectives: Ascitic ﬂuid is a favourable milieu for bacterial
proliferation. Consequently, spontaneous bacterial peritonitis is
not an uncommon complication in patients with ascites. A
variety of pathogens have been implicated, the most common
being Escherichia coli and Streptococci. So we estimated the
concentrations of moxiﬂoxacin, a new quinolone with activity
against gram-negative and gram-positive (especially strepto-
cocci), into serum and ascitic ﬂuid in patients with ascites and
cirrhosis.
Methods: Six patients with decompecated cirrhosis and ascites
were enrolled to the study. The Ethics committee of the hospital
approved the study and all patients gave written consent.
Patients were given a single 400 mg of moxiﬂoxacin as a 60 min
IV infusion and 2 hours after the end of infusion blood and
ascetic ﬂuid samples were collected. Samples were assayed for
the presence of moxiﬂoxacin by a high-performance liquid
chromatography (HPLC) method.
Results: Following a single 400 mg infusion of moxiﬂoxacin,
mean serum concentration for the six patients was 4.29 mg/L
(range 3.9–5.9 mg/L) 2 hours after the end of infusion. The
concentration of moxiﬂoxacin into ascetic ﬂuid at the same time
was 3.05 mg/L (range 2.6–4 mg/L). The penetration of moxiﬂ-
oxacin into ascetic ﬂuid was 71.1%.
Conclusion: The levels that were achieved in the ascites are
well above the MICs for E. coli (0.016 mg/L) and other
members of the family Enterobacteriaceae, such as Proteus
mirabilis and Klebsiella pneumoniae (0.03 mg/L). On the basis
of the present ﬁndings of high levels of moxiﬂoxacin in ascitic
ﬂuid and the excellent in vitro activity against members of the
family Enterobacteriaceae, this ﬂuroquinolone appears to be very
promising for the treatment of spontaneous bacterial perito-
nitis.
R1923
Pharmacokinetic/pharmacodynamic analysis and
evaluation of clinical effectiveness of nomogram
based dosing regimen in critically ill patients
R. Benko, M. Matuz, E. Hajdu, Z. Peto, A. Molnar, G.
Soos (Szeged, HU)
Objectives: There is limited data on the association of vanco-
mycin serum concentrations, pharmacokinetic/pharmacody-
namic (pk/pd) parameters and clinical efﬁcacy. In the present
study we aimed to analyze the pk/pd proﬁle and parallel
evaluate the clinical effectiveness of our routinely used vanco-
mycin dosing regimen in critically ill patients.
Methods: A prospective, open-label, descriptive pilot study in
a 6-bed, surgical, adult intensive care unit (ICU) has taken
place. Nine critically ill patients with normal renal function
were enrolled in whom vancomycin therapy for documented
Staphylococci infection had to be started. Patients were dosed
according to a previously developed nomogram [Moise-Broder
et al. Clin Pharmacokinet 2004]. As all eligible patients
belonged to the same dosing group, vancomycin 1 g twice
daily was infused intravenously over 60 minutes. Timed blood
samples were taken prior to and during two dosing interval at
steady state. Vancomycin serum concentrations were deter-
mined by the Abbot TDx system. MIC values were determined
for the causative organisms. WinNonLin 5.0 package was used
for pharmacokinetic analysis. Clinical outcome (recovery or
death) and nephrotoxicity (increased serum creatinine by
40 lmol/l or by 50% on consecutive measurements) was also
evaluated.
Results: Our main results are summarized as follows.
Conclusion: Our nomogram based dosing proved to be
successful in 88% of cases despite the relatively low AUC/
MIC ratios in some cases. No toxic effects were detected. The
current ﬁndings support the justiﬁcation of this simpliﬁed
dosing nomogram in stable critically ill patients with normal
renal function. However AUC/MIC probably drives outcome
further investigations are needed to clarify the optimal target
value.
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R1924
Continuous infusion versus intermittent
administration of meropenem in critically ill
patients
R. Trittler, D. Mlangeni, H. Egle, K. Kuemmerer, U. Frank
(Freiburg i.Br., DE)
Background: Meropenem is a broad-spectrum carbapenem
antibiotic, which is usually given intravenously as a short
infusion over 30 min, three times a day (TID). This intermittent
application, however, is likely to be suboptimal for therapy since
the time of antibiotic concentrations above the minimal inhib-
itory concentrations (MICs) of relevant bacterial pathogens may
be too short. A continuous infusion of the drug may provide
constant adequate concentrations over 24 h and be the better
choice.
Objective: To determine meropenem serum concentrations
during continuous infusion of 2 g/day versus intermittent
dosing of 1 g TID in critically ill patients.
Methods: Serum meropenem levels were determined in two
groups of critically ill intensive care unit (ICU) patients who
received either intermittent short time infusion therapy of 1g
over 30 min TID or 1 g loading dose followed by a 2 g
continuous infusion over 24 h. Meropenem serum concentra-
tions were determined by HPLC. Antibiotic serum concentra-
tions were analysed in correlation to creatinine levels.
Results: In both patient groups, antimicrobial serum levels
were suboptimal. In patients who received intravenous infusion
over 30 min, serum concentrations did not surpass the MIC90 of
Pseudomonas aeruginosa (8 lg/ml) at any time. Similarly, serum
drug levels in patients with normal renal function who received
continuous infusion were persistently lower than 8lg/ml; only
patients with impaired renal function (creatinine level >1 mg/
dl) showed meropenem serum concentrations >8 lg/ml.
Conclusions: Continuous infusion of meropenem may have the
potential of improving antimicrobial therapy in critically ill
patients, but should be investigated in further studies. In
patients with impaired renal function receiving continuous
infusion therapy, creatinin levels are the most important factor
for predicting effective serum concentrations of the drug.
Mechanisms of action, resistance and resistance surveillance
R1925
A new mandatory enhanced methicillin-resistant
Staphylococcus aureus surveillance system for
England. An explanation of the new web-based
surveillance system
A.D. Pearson, M. Painter, E. Robinson, K. Wagner, A. Talebi
(London, UK)
Summary Sentence: On the 1st of October 2005 the Health
Protection Agency (HPA) introduced a new enhanced MRSA
mandatory surveillance scheme, designed to capture a more
detailed data set to inform a national intervention target.
Objectives: The enhanced system captures information on each
MRSA bacteraemia episode, in order to give Trusts a more
accurate picture of their situation and to contribute to building a
better evidence base for intervention. The system enables reports
to be entered in ‘real time’ as they occur. As well as recording
the age and sex of each patient, the system allows Trusts to
specify the hospital, speciality and sub-specialty where the
patient was located when the infection was identiﬁed, and
whether the patient was on dialysis. The date the specimen was
taken and the date of admission of the patient are both recorded
which allows for the separation of MRSA bacteraemia infections
identiﬁed within 2 days of admission. The source or provenance
of the patient, such as home or nursing home can also be
recorded.
Methods: There will ultimately be two different methods
available to Trusts by which they can report the enhanced
dataset to the HPA; either via the electronic reporting system
CoSurv, or via an MRSA Enhanced Surveillance System website.
Details of the MESS website will be given, and a summary of the
results from the pilot study described below.
Results: The website was piloted in 21 acute Trusts between
May and July 2005. 246 records were entered, of which 60% had
a specialty of general medicine, geriatric medicine or general
surgery. The majority of patients with MRSA positive bacterae-
mia were listed as inpatients or emergency assessment patients;
27% of these inpatients had been admitted for less than 2 days,
and 70% admitted directly from home.
Conclusion: Feedback from the pilot demonstrated that the
collection of the proposed dataset was achievable by the
majority of Trusts and the time taken to collect and enter the
data was acceptable. All 173 acute Trusts in England have access
to the website, and are required to enter this mandatory national
data set on MRSA bacteraemia. The key ﬁnding from the pilot
study was that 27% of the MRSA positive bacteraemias were
present on admission.
R1926
Evolution of antibiotic resistance in non-invasive
clinical isolates of Streptococcus pneumoniae
collected in Belgium from 1995 to 2005
R. Vanhoof, J. Van Eldere, J. Verhaegen and the Belgian SP Study
Group
A total of 1971 non-invasive clinical isolates of Streptococcus
pneumoniae collected during 7 surveys (1995, 1997, 1999, 2001,
2003, 2004 and 2005) by 15 laboratories evenly spread through-
out Belgium, were included. Susceptibility to Penicillin (PEN),
Amoxicillin (AMX), Cefuroxime (CRX), Cefotaxime (CTX),
Ciproﬂoxacin (CIP), Moxiﬂoxacin (MOX), Erythromycin (ERY)
and Tetracycline (TET) was determined using the NCCLS
standardised microdilution test. Overall, 26.1% (18.5%–31.0%)
of the isolates were from children (0–15 y) and the mean age for
the children and adults varied from 1.6 to 3.4 y and 62.5 to
66.4 y respectively. The insusceptibility rates (% I + R following
NCCLS) in the various surveys were as follows: PEN (12.1; 12.2,
14.9; 19.8; 15.0; 14.7; 15.2), AMX (0; 0; 1.3; 2.0; 2.6; 1.2; 0.9), CRX
(7.9; 9.8; 14.8; 17.0; 13.6; 12.7; 11.9), CTX (0, 0.6; 7.7; 4.0; 4.9; 6.2;
3.1), CIP (Not tested = NT; NT; 16.1; 12.9; 13.8; 9.0; 7.3), MOX
(NT; NT; NT; NT; 0.6; 0.2; 0.2), ERY (20.0; 29.2; 32.9; 28.3; 26.1;
24.7; 29.9) and TET (26.4; 29.2; 21.9; 37.2; 32.3; 22.1; 26.4). In every
survey we found a bimodal distribution for the beta-lactams.
The MIC50 for PEN shifted with 3 dilutions to the right side of
the curve from 1995 (0.008 lg/ml) to 2003 (0.06 lg/ml) and
returned to 0.015 lg/ml in 2005. The same phenomenon was
found for AMX (2 dilutions, return 1 dilution, from 0.008 to
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0.015), CRX (2 dilutions, return 1 dilution, from 0.015 to 0.03)
and CTX (3 dilutions, return 2 dilutions, from 0.008 to 0.015).
CIP and MOX had a mono-modal distribution and their MIC50
remained between 0.5–1.0 (CIP) and 0.06 lg/ml (MOX). The
MIC50 of ERY and TET shifted with 3 and 2 dilutions (0.008/
0.06 and 0.12/0.25 lg/ml) respectively. Resistance rates for CIP
were systematically higher in lower respiratory tract (LRT)
isolates while TET rates were always higher in upper respiratory
tract (URT) isolates. However, signiﬁcant differences were only
found for PEN (1995, 2005/URT) and ERY (1999, 2004/URT).
Overall, the resistance rates for ERY and TET were always
higher in children than in adults but signiﬁcant differences were
only found in 1997, 2004 (ERY), 2004 (TET) and 1995 (PEN).
Throughout the years, capsular types 6, 9, 14, 19 and 23 were the
most frequent in the PEN-R isolates. Type 23 evolved from 61%
in 1995 to 20.6% in 2005. Type 14 appeared in 2001 (22.7%) and
became the most important type (2004; 41.7%/2005; 28%).
R1927
Investigation of inducible clindamycin resistance
among hospital and community-acquired
Staphylococcus aureus isolates in the Aegean
region of Turkey
V. Avkan Oguz, N. Yapar, N. Sezak, S. Alp Cavus, S. Kurutepe,
N. Cakir, A. Yuce (Izmir,TR)
Objective: Clindamycin is a good alternative for the empirical
treatment of Staphylococcus aureus infections. But clindamycin-
susceptible and erythromycin resistant S. aureus may develop
inducible clindamycin resistance; this resistance is detected by
the disk diffusion induction test (D-test) and varies according to
geographic location and bacterial susceptibility proﬁle. The aim
of this study was to investigate some antibiotic susceptibilities
and inducible clindamycin resistance of S. aureus in our region.
Methods: In this study, 152 S. aureus strains were investigated.
Of these strains, 89 were isolated from inpatients, 63 from
outpatients attending to two distinct university hospitals. The
antibiotic susceptibilities were determined by Kirby Bauer disk
diffusion method using Mueller-Hinton agar (OXOID) and
inducible clindamycin resistance by disk diffusion induction test
(D-test) according to the recommendations of CLSI. The
susceptibilities to oxacillin (OX), cefoxitin (FOX), clindamycin
(DA), rifampin (R), erythromycin (E), trimethoprim-sulfameth-
oxazole (SXT), tetracycline (TE), gentamicin (CN), ciproﬂoxacin
(CIP) and vancomycin were examined. Quality control was
performed with S. aureusATCC 25923 and ATCC 43300 (MRSA).
Results: Susceptibility rates of S. aureus strains isolated from
hospital and community to oxacillin were 13.4%, and 100 %,
respectively. Community acquired MRSA was not detected. Of
152 strains, 12 (13.4 %) were D-test positive. Of these D-test
positive strains, 10 (83.2 %) were nosocomial MRSA, 1 (8.4 %)
was nosocomial MSSA and 1 (8.4 %) was community acquired
MSSA. All of E resistant and DA susceptible isolates were
positive by D-test. Among D-test positive strains, only one (8.4
%) strain was found as resistant to SXT whereas R, CN and CIP
resistance rates were 9 (75%), 10 (83.3%) and 11 (91.6%),
respectively. All strains included in the study were susceptible
to vancomycin. Other antibiotic susceptibility rates of isolates
are shown in Table.
Conclusion: The ratio of inducible clindamycin resistance is
important in cases treated with clindamycin empirically and it
varies between hospitals. Therefore, it must be known inducible
clindamycin resistance in every region. According to our data,
clindamycin still can be used empirically in MSSA infections but
especially D-test should be evaluated for E resistance strains in
each individual laboratory.
R1928
Factors of pathogenicity of Pseudomonas
aeruginosa treated with amikacin, ciproﬂoxacin
and meropenem
A. Hostacka, I. Ciznar (Bratislava,SK)
Objectives: Gram-negative nonfermenting bacteria P. aerugi-
nosa are one of the bacterial species very often responsible for
nosocomial infections as well as for chronic lung infections
including cystic ﬁbrosis. Effect of subinhibitory concentrations
(sub-MICs) (1/4, 1/8, 1/16 of the MICs) of amikacin, ciproﬂ-
oxacin and meropenem on some potential factors of pathogen-
icity of two clinical P. aeruginosa strains (1010, 2643) was tested.
Methods: Potential factors of pathogenicity were evaluated
in vitro using test for hydrophobicity (adherence to xylene),
motility (0.35 % agar), production of bioﬁlm (microtitre plate
assay), HSLs (biosensors: Chromobacterium violaceum 026 and
Agrobacterium tumefaciensNTL4) and response to oxidative stress
evoked by hydrogen peroxide.
Results: Amikacin at 1/4 of the MICs, ciproﬂoxacin and
meropenem at two or at all sub-MICs concentrations decreased
surface hydrophobicity both of strains to 90.1–99.6% of the
control values. Swimming motility of strain 2643 treated by all
antibiotics ranged between 85.0% and 98.8% of the control
values. Decrease of this activity in strain 1010 was found only
after incubation with ciproﬂoxacin. The tested antibiotics at all
concentrations (with the exception of 1/16 of the MIC of
amikacin in strain 2643) reduced production of bioﬁlm (to 90.6–
99.4% of the control values). On the other hand, increase of
resistance to oxidative stress was observed after effect of
ciproﬂoxacin /two or three concentrations/ for both strains,
after amikacin and meropenem /two concentrations/ only for
strain 2643. Production of N-acylhomoserine lactone signal
molecules (C4-HSL and 3-oxo-C12-HSL) by antibiotic treated
bacteria was not changed.
Conclusion: The tested antibiotics at sublethal concentrations
that do not kill bacteria in the majority of cases affected potential
factors of P. aeruginosa in a dependence on strain, antibiotic and
concentration.
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R1929
Relationship between the presence of
pathogenicity islands and serotypes,
antimicrobial resistance and geographical origin
in Salmonella spp.
R. Cabrera, J. Ruiz, M. Ramı´rez, L. Bravo, A. Ferna´ndez, S. Soto,
J. Gasco´n, P.L. Alonso, J. Vila (Barcelona, ES; Ciudad Habana, CU)
Objective: A potential relationship between acquisition of
antimicrobial resistance and the presence of Pathogenicity
Islands (PAIs) has previously been described in other microor-
ganisms. Our main objective was to analyse the relationship
between the presence of PAIs and antimicrobial resistance,
serotypes and geographical origin in a collection of Salmonella
spp. strains.
Methods: A total of 29 Salmonella strains causing traveller’s
diarrhoea and 26 Salmonella strains causing acute gastroenteritis
in Cuba were analysed. The susceptibility to antimicrobial
agents was determined by the Kirby-Bauer method. The
different PAIs were detected by PCR with speciﬁc primers for
each.
Results: All the Salmonella strains studied presented resistance
to at least one antimicrobial agent. The PAIs studied were
present in all the strains analysed. In some serotypes the PAIs
were detected for the ﬁrst time, corresponding to: Haifa,
Goldcoast, Risseu, Paratyphi, kiambu and Wangata. These
serotypes were isolated from the patients with traveller’s
diarrhoea. No relationship was found between antimicrobial
resistance and the presence of PAIs.
Conclusions: The presence of PAIs was independent of the
serotype and antimicrobial resistance. Moreover, these PAIs
were detected for the ﬁrst time in many different serotypes.
R1930
Trends in the antimicrobial resistance of some
worldwide monitored pathogens during 2002–
2004: data from BulSTAR
A. Bachvarova, M. Petrov, T. Velinov, T. Kantardjiev (Soﬁa, BG)
We present data on the antimicrobial resistance of some
important bacteria collected during the 2002–2004 period in
the Bulgarian Surveillance Tracking Antimicrobial Resistance –
BulSTAR. The sources monitored in BulSTAR are blood
cultures, cerebrospinal ﬂuid, upper and lower respiratory
tract, urine and wound samples. All participating laboratories
use the Clinical and Laboratory Standards Institute methodo-
logy. Presented results concern some worldwide monitored
pathogens – Staphylococcus aureus, Streptococcus pneumoniae,
Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae and
Pseudomonas aeruginosa and their resistance to indicator antimi-
crobial agents. In most of the cases the resistant levels are rising
during the period as in the case of Methicillin Resistant
Staphylococcus aureus – from 6.0% to 13.9% and the Extended-
spectrum beta-lactamases Escherichia coli producers – from 1.0%
to 4.8%. An interesting exception is the observed decrease in
macrolide resistance among Streptococcus pyogenes isolates –
from 10.4% to 6.6%.
R1931
Staphylococcus aureus and coagulase negative
Staphylococcus bacteraemia: epidemiology and
antimicrobial resistance between 2001 and 2004 in
the Ile de France microbiologists network
Y. Pe´an, M. Bingen, D. Barraud, E. Valle´e, A. Boisivon, Y. Costa,
B. Hacquard, F. Faibis, M.C. Demachy, B. Ferre´, H. Porcheret,
F. Richardin, L. Be´rardi-Grassias, A. Scanvic for the Re´seau des
Microbiologistes d’Ile de France
Objectives: To survey epidemiology and antimicrobial resist-
ance of community acquired (CAB) and hospital acquired
(HAB) Staphylococci bacteraemia
Methods: Since 1st January 2001 to 31st December 2004, all
bacteraemia (7222) occurring in surgical, medical obstetrical and
re-adaptation wards, were included in the prospective survey
study. CA and HA bacteraemia were separated according to the
clinical history. Incidence rates were calculated for 1000 days of
hospitalisation (HInc) and for 100 hospital admission (AInc).
Antimicrobial susceptibility and resistance surveillance were
studied according to the french recommendations: CA-SFM
(www.sfm.asso.fr) and ONERBA (www.onerba.org). Statistical
analysis were performed using Chi2 tests.
Results: For 4 years, 1144 S. aureus and 335 coagulase negative
staphylococci (CNS) bacteremia have been included. HAB
S. aureus HInc (2001–2004 respectively : 0.18, 0.20, 0.22, 0.20)
was twice CAB S. aureus HInc and both were stable. Almost all
CNS bacteraemia were HAB with a lower stable incidence
(2001–2004 : 0.08, 0.09, 0.10, 0.08). Oxacillin resistant S. aureus
signiﬁcantly decreased, reaching 29% in 2004, followed by
tobramycin resistance (25% in 2004), but no decrease of
ﬂuoroquinolones resistance was observed; Oxacillin susceptible
and ﬂuoroquinolones resistant strains seemed to increase (10%
in 2004). Only one strain in 2003 was not fully susceptible to
vancomycin. For CNS, increasing resistance was observed for
oxacillin, gentamycin, erythromycin and fusidic acid (respect-
ively in 2004: 60%, 46%, 60%, 47%). The increase of CNS
resistance to ﬂuoroquinolones (54%) and rifampicin (21%) was
not signiﬁcant. No vancomycin resistant CNS was isolated.
Conclusion: For severe infection like bacteraemia, routine
surveillance (epidemiology and antimicrobial resistance) allow
to update recommendations for initial antimicrobial therapy and
participate to the impact evaluation of infection control and
drug resistance monitoring measures.
R1932
Antibiotic resistance of staphylococci isolated
from bloodstream infections
A. Koutsoukou, S. Tsiplakou, A. Stylianakis, M. Tachtatzis,
E. Tsakona, A. Vourtsi, A. Ntouroupi (Athens, GR)
Objective: The aim of the present study was to examine the
resistance of Staphylococcus aureus and coagulase negative
Staphylococci isolated from blood samples to vancomycin,
teicoplanin, and quinupristin/dalfopristin during a 2 year
period (October 2003–September 2005).
Methods: 492 non-repetitive isolates of Staphylococci, derived
from blood cultures (Bactec, Becton Dickinson) of patients
hospitalized in different wards of our hospital, were examined.
The identiﬁcation and the susceptibility testing were performed
by the automated system VITEK-2 (Biomerieux). The MICs of
the examined antibiotics were conﬁrmed by E-test (AB Biodisk,
Sweden), according to NCCLS guidelines.
Results: Identiﬁcation resulted in 60 strains of Staphylococcus
aureus and 432 strains of coagulase negative Staphylococci
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CoNS. High levels of oxacillin-resistance were observed among
both S. aureus and CoNS (65% and 73% respectively). Resistance
rates didn’t vary between the 2 years of the study for the rest
antimicrobials. Resistance to fusidic acid was at 72% for S. aureus
and 90% for CoNS, to gentamicin rates reached 69% for S. aureus
and 84% for CoNS. Erythromycin-resistance rates were 69% for
S. aureus and 84% for CoNS. Ciproﬂoxacin resistance rates were
33% for S. aureus and 70% for CoNS and as for trimethoprim/
sulfamethoxazole resistance rates were 13% for S. aureus and
42% for CoNS. The ﬁrst year (October 2003–September 2004) 1
resistant and 14 intermediately resistant to teicoplanin CoNS
strains were isolated. The latter year (October 2004–September
2005) 1 intermediately resistant to teicoplanin strain of S. aureus
was isolated. Also, 1 resistant to teicoplanin, 19 intermediately
resistant to teicoplanin, 1 intermediately resistant to vancomycin
and 2 resistant to quinupristin/dalfopristin strains of CoNS
were isolated.
Conclusions: The coagulase negative Staphylococci resistance to
antimicrobial agents was higher than that of S. aureus. The
emergence of resistance to glycopeptides and streptogramins is
being documented and shows an increasing tendency during the
last two years. It is essential to survey for antimicrobial resistance
in blood stream infections as new resistant strains appear to
agents that were previously active against all Staphylococci.
R1933
Extended-spectrum beta-lactamases producing
isolates of Enterobacteriaceae among hospitalised
patients in a university hospital, Zagreb, Croatia
I. Jajic-Bencic, B. Bedenic, B. Djuras-Cuculic, I. Bencic (Zagreb,
HR)
Objectives: The aim was to determine the prevalence of ESBLs
in Enterobacteriaceae isolates from hospitalized patients, their
antibiotic susceptibilities and the transferability of resistance to
oxymino-cephalosporins and aztreonam.
Methods: In total 76 ESBL producers were investigated (27 E.
coli, 37 K. pneumoniae, 6 P. mirabilis, 4 K. oxytoca and 2 E. cloacae).
Antibiotic susceptibility of ESBL producing isolates and their E.
coli transconjugants was determined by disk-diffusion and broth
microdilution method according to NCCLS. MICs were tested
for: amoxycilline/clavulanic acid, piperacillin/tazobactam, ceft-
azidime alone and in combination with clavulanic acid, cef-
triaksone, cefotaxime, cefepime, aztreonam, imipenem,
meropenem, gentamicin, and ciproﬂoxacin. Antibiotic suscepti-
bilities to chloramphenicol, tetracycline and cotrimoxazole were
determined by disk-diffusion method. ESBLs were detected by
double-disc synergy method, and by >8-fold reduction in
ceftazidime MIC in the presence of clavulanate. Transferability
of R plasmids was determined by conjugation (broth mating
method) employing an E. coli A15 R – strain resistant to
rifampicin as recipient. Frequency of conjugation was expressed
relatively to the number of donor cells. Cotransfer of resistance
to non beta-lactam antibiotics was tested as well.
Results: The percentage of ESBL producers was as follows: 3%
of E. coli, 17% of K. pneumoniae, 2% of P. mirabilis, 1% of K.
oxytoca. There was no resistance detected to imipenem, merope-
nem, cefoxitin and ciproﬂoxacin among E. coli isolates. 67% of
these strains were resistant to amoxycillin/clavulonate and
ceftazidime, 70% to aztreonam and 78% to gentamicin. All K.
pneumoniae strains were susceptible to imipenem, meropenem
and cefoxitin, but 78% of the strains were resistant to ciproﬂ-
oxacin, 86% to amoxycillin/clavulanic acid and 92% to aztreo-
nam. All K. pneumoniae isolates were resistant to ceftazidime.
38% of K. pneumoniae strains transferred the plasmid encoding
ESBL to E. coli recipient with the frequency ranging from 10)5 to
10)10. Transfer of plasmid was successful in 96% of E. coli
isolates with the frequency of 10)5 to 10)10. Transconjugants had
similar resistance patterns to beta-lactam antibiotics as their
respective donors.
Conclusions: No resistance to carbapenems among Enterobac-
teriaceae was observed so far. The prevalence of ESBL isolates is
in concordance with the prevalence in Croatia. Further analysis
of the type of beta-lactamase is necessary.
R1934
Detection of production of extended-spectrum
beta-lactamases in Escherichia coli and Klebsiella
spp. isolated from hospitalised patients as part of
the MYSTIC Program Brazil 2004
C. Mendes, C. Kiffer, J.L. Sampaio, P.J. Turner, A.C. Arruda, S.I.
Sinto on behalf of the MYSTIC Group Brazil
Objective: To determine the ESBL production in clinical isolates
of E. coli and Klebsiella spp from the MYSTIC Program Brazil
2004, identifying possible differences among conﬁrmatory
methods.
Methods: One hundred and thirty (130) clinically relevant
isolates of E. coli (29), K. pneumoniae (94) and K. oxytoca (7)
collected as part of the MYSTIC program Brazil 2004 were
randomly selected for the study if their minimal inhibitory
concentration (MIC) for cefepime (CPM), ceftazidime (CTZ) or
cefotaxime (CTX) by E-test methodology was ‡ 2mcg/mL
(NCCLS, 2004). ESBLs were conﬁrmed via CTZ/clavulanate
(CTZ/TZ) and CTX/clavulanate (CTX/TX) E-Test for all
isolates. A difference of more than three dilutions in the results
was considered positive for ESBL, according to manufacturer’s
instructions. Disc approximation tests were applied in all
isolates, but a positive reading was only considered conﬁrmat-
ory when at least one of the E-test ESBL results was either
positive or indeterminate for the same isolate.
Results: All isolates as a group (E. coli and Klebsiella spp) were
88.5% positive when both ESBL E-testwere used, CTZ/TZ and
CTX/TX, with 11.5% indeterminate. For E. coli, the consolidated
E-test results were 93.1% positive, with no negative results. For
E. coli, no negative results were observed with either ESBL
E-test separately. For Klebsiella spp, the consolidated E-tests
were 89.1% positive, with no negative results. For Klebsiella spp,
CTZ/TZ ESBL test presented ﬁve negative results and 16
indeterminate, while CTX/TX had only one negative result and
15 indeterminate. Disc approximation tests were positive for all
indeterminate isolates.
Conclusions: The quantitative method used for conﬁrmation of
ESBLs showed thepresenceof these enzymes in themajorityof the
isolates, althoughwith technical limits of detection. Consolidated
results were guided by the CTX/TX test, since positive results
weremore frequent andnegative results occurred lesswith this E-
test. This seems to conﬁrm that cefotaximewas a better substrate
for the detection of ESBLs in the environment analyzed.
R1935
Nosocomial strain of Serratia marcescens
producing new type of extended-spectrum beta-
lactamase transfers the multidrug-resistance
M. Babalova, J. Blahova, K. Kralikova, V. Krcmery
Sr. (Bratislava, SK)
Objectives: To monitor the production of extended-spectrum
beta-lactamases and transferability of antibiotic resistance from
clinical isolates of Serratia marcescens.
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Methods: The strain No. 37/364 was isolated from the sputum
of a patient hospitalized in the Dept. of Anesthesiology of the
Regional Hospital Pribram, Czech Republic. Antimicrobial
susceptibility testing was performed by the disc diffusion test.
ESBLs proﬁle of strain was performed using double-disc
diffusion test. Transfer of genes for antibiotic resistance was
performed in mixed liquid cultures. As recipient strains were
used Escherichia coli K-12 No. 3110 rif+ and Proteus mirabilis P-38
rif+.
Results: The double disc diffusion test demonstrated an
unusual broad spectrum of the activity of ESBLs hydrolyzing
cephalosporins of higher generations (cefotaxime, ceftazidime,
cefepime, cefoperazone) and aztreonam. The multidrug resistant
strain of Serratia marcescens transferred directly to E. coli K-12
No. 3110 rif+ determinants of resistance to kanamycin, ticarcil-
lin, cephalosporins of all generations (cephalothin, cefotaxime,
ceftazidime, cefoperazon) as well as to aztreonam. Indirect
selection procedure conﬁrmed co-transfer of total spectrum of
antibiotic resistance: kanamycin, ticarcillin, cephalosporins of all
generations and aztreonam.
Conclusion: Production of ESBL(s) hydrolyzing cephalosporins
of higher generations and transferability of resistance showed
the possibility of spreading of antibiotic resistance in clinically
important strains in hospital environment.
R1936
Results from the meropenem yearly susceptibility
test information collection (MYSTIC) programme:
report from two Croatian hospitals
B. Bedenic, M. Tonkic, I. Goic-Barisic, L. Mihaljevic, M. Bubonja,
S. Suto, S. Kalenic, V. Punda-Polic, Z. Bosnjak (Zagreb, Split,
Rijeka, HR; Livno, BA)
Objectives: Meropenem Yearly Susceptibility test Information
Collection (Mystic) Programme is a global, longitudinal resist-
ance surveillance network that monitors the activity of merope-
nem, only in selected centres that are prescribing meropenem.
We now report the four years period results (2002-2005) for the
antimicrobial potency of meropenem compared to other agents,
from the two Croatian Hospitals.
Materials and methods: The 2 hospitals in Croatia (Clinical
Hospital Center Zagreb and University Hospital Split) partici-
pate in the MYSTIC Programme. The minimum-inhibitory
concentrations (MICs) were determined by broth microdilution
method according to NCCLS.
Results: There was no resistance to either imipenem or me-
ropenem observed for E. coli, K. pneumoniae and Proteus mirabilis
in both medical centres. E. coli strains from Split were more
resistant to ceftazidime (8%) and cefepime (4%) than those from
Zagreb (1%, and 0.7%, 2% respectively) whereas isolates from
Zagreb were more resistant to ciproﬂoxacin (7%) and gentam-
icin (13%) compared to those from Split (2% and 12% respect-
ively). There was a higher percentage of resistance among K.
pneumoniae isolates in comparison to E. coli from both centers to
ceftazidime (28% from Zagreb and 44% from Split) and to
cefepime (14% from Zagreb and 20% from Split). Genamicin and
ciproﬂoxacin were also less active against K. pneumoniae from
both centres (28% strains resistant to gentamicin from Zagreb
and 37% from Split, 10% of the strains resistant to ciproﬂoxacin
from Zagreb and 8% from Split). Meropenem was the most
potent agent against A. baumannii and P. aeruginosa strains from
both centres. There was a high percentage of A. baumanii strains
from Split resistant to all beta-lactam agents (above 80%). More
P. aeruginosa strains from Zagreb were resistant to gentamicin
and ciproﬂoxacin compared to those from Split. Imipenem
showed best activity against Gram-positive cocci from both
centres.
Conclusions: According to our results meropenem remains the
antibiotic of choice for the treatment of severe infections caused
by Gram-negative bacteria. Resistance to carbapenems observed
in some P. aeruginosa strains could be due to production of
metallo-beta-lactamases, which are already detected in some of
our strains (unpublished data), alterations in outer membrane
proteins and efﬂux. Carbapenem resistance found in A. bau-
mannii isolates from Split could be explained by the production
of oxacillinases (unpublished data).
R1937
Subinhibitory concentrations of clarithromycin
in vitro readily select for resistance in clinical
isolates of Streptococcus pneumoniae
M. van der Linden, I. Breuer, R. Reinert (Aachen, DE)
Objectives: Subinhibitory concentrations were described to
have an inﬂuence on resistance development to antibiotics.
Methods: 20 clinical isolates of S. pneumoniae, 14 clarithromycin
susceptible, 2 clarithromycin intermediate and 4 clarithromycin
resistant (MICs: 0.031 to 16 mg/L), were exposed to subinhib-
itory concentrations of clarithromycin. Multistep resistance
selection was performed by subculturing the strains in 1 ml
medium with antibiotic concentrations varying from 3 doubling
dilutions above to 3 doubling dilutions below the MIC of each
strain. Daily passages were performed with the strain growing
at the highest concentration. Serotypes, macrolide resistance
genotypes and phenotypes and presence of the ermB and the
mefE gene were determined.
Results: 10 of 20 isolates showed a 4 to 2048 times increase in
MIC after 15 to 20 days of subculturing under subinhibitory
selection pressure. The increase was not steady. Most strains
needed a long ’lag phase’ before the MIC started to increase. In 7
out of 20 cases the strains ’fell back’ to a lower MIC (or even full
sensitivity) but then continued their increase to higher MICs.
The highest increase in MIC was 2048 fold (0.125 to 64 mg/L).
The highest obtained MIC was 256 mg/L for a strain with a
starting MIC of 16 mg/L. The reference strain S. pneumoniae
ATCC 49629 (CLSI MIC: 0.03-0.125 mg/L) showed no difference
in its MIC after 20 days under antibiotic pressure at subinhib-
itory levels. None of the strains had obtained either an ermB or a
mefE gene. Therefore other resistance mechanism must be
responsible for resistance development.
Conclusions: Subinhibitory macrolide concentrations readily
lead to the selection of resistant strains even within a relatively
short period of 20 days. This implies that non or poor compli-
ance in antibiotic treatments leads to accelerated resistance
development.
R1938
Macrolides resistance evolution and
telithromycin utility in Streptococcus pyogenes
strains from faringeal origin. Five-year study
L. Garcı´a Picazo, S. Garcı´a Pacheco, S. Rubio Zurdo (El Escorial,
ES)
Streptococcus pyogenes is the most common cause of bacterial
pharyngitis, penicillin continues to be the drug of choice for
treatment of streptococcal infections and macrolides are its
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alternative in patients who cannot take penicillin. However, the
utility of this group of antibiotics is being limited by the
acquisition of different resistance mechanisms.
Objectives: 1 To know the rate of macrolides resistance and its
phenotypes distribution among pharyngeal strains as well as its
evolution during 5 years. 2 To see the utility of telithromycin as
therapeutic alternative in macrolides-resistant strains.
Methods: During the period, 2000–2004 a total of 853 SPY
strains were studied in our laboratory. They were isolated from
throat swabs cultured in SSA plates (BD Diagnostics) and
incubated at 35C in anaerobic atmosphere 24–48 hours. The
identiﬁcation was done by commercial antigenic extraction (Bio-
Merieux). Strains were studied for susceptibility to penicillin,
erythromycin, clindamycin, and tetracycline. Telithromycin was
only tested last year (2004). We used the disk diffusion method
in Muller-Hinton agar supplemented with 5% sheep blood
according to NCCLS standards. In this way we were also able to
detect the inducible MLSB phenotype by the double diffusion
disk test.
Results: Overall, the number of erythromycin resistant strains
during the ﬁve years was 195 (23%), 145 (74%) of them
expressed M phenotype, 41 (21%) constitutive MLSB phenotype
and 9 (5%) inducible MLSB phenotype. The global resistance,
the annual rates, the different phenotypes and the resistance to
telithromycin are shown in the next table.
Conclusions: 1 The frequency of resistance to erythromycin in
SPY from pharyngeal exudates increased twice during the study
period. Both the medium resistance (23%) and the range (14.3%–
32.3%) remain within the published limits for Spain.2 The
resistance mechanism also suffered a substantial change during
the 5 years: M phenotype decreased (95%–74%) while the
constitutive MLSB phenotype increased (5%–21%). This implies
resistance not only to erythromycin but to all macrolides and
clindamycin. Therefore it would leave penicillin allergic patients
without any therapeutic alternative.3 Telithromicyn displayed a
good activity in vitro against erythromycin resistant SPY.
According to these results, telithromicyn offers a wide coverage
against SPY in patients where we cannot use penicillin,
macrolides or clindamycin.
R1939
Surveillance of methicillin-resistant
staphylococci among small animal isolates from
otitis externa in Portugal
C. Pomba, I. Couto, M. Costa, C.L. Vilela, H. de Lencastre,
J.H. Duarte Correia (Lisbon, PT; New York, US)
Objectives: To characterize resistance to methicillin among
staphylococci causing otitis externa in cats and dogs, in order
to evaluate the impact of antibacterial mechanisms resistance in
small animal clinical strains.
Methods: The samples were collected at the Veterinary Teach-
ing Hospital of the Faculty of Veterinary Medicine and at
Veterinary private practices in the Lisbon area. From January
1999 until October 2005, a total of 217 staphylococci were
isolated from dogs and cats with otitis externa. Cytology
conﬁrmed otitis externa and the presence of Gram-positive
cocci. BBL Crystal Gram Positive ID System (Becton Dickinson)
was used for identiﬁcation at the species level. All isolates were
screened for methicillin resistance by disc diffusion with a 1 lg
oxacillin disc, according to NCCLS (1). Methicillin resistance
was conﬁrmed by the presence of the mecA gene using PCR.
Results: Three coagulase-negative isolates (1.4%) (2 Staphylo-
coccus haemolyticus and 1 S. epidermidis) were phenotypically
resistant to methicillin and carried mecA. Regarding coagulase-
positive isolates, none of the 122 (56%) S. intermedius and 8 (36%)
S. aureus isolates were methicillin resistant. Resistance to
methicillin was also not detected among the remaining staphy-
lococci isolated in the study: 30 (13.8%) S. schleiferi, 10 (46%) S.
simulans, 4 (18%) both S. haemolyticus and S. felis, 1 (0.5%) both S.
lentus and S. caprae, and 35 (16%) Staphylococcus spp.
Conclusions: Staphylococcal methicillin-resistance surveillance
is a major concern worldwide. Our results are different from
recent data (2), in the fact that we only found methicillin
resistance among otitis externa coagulase negative staphylo-
cocci, which points out to the importance of local surveillance
studies. Our ﬁndings are of critical relevance, as they may have
a direct impact in therapeutic decision in the management of
companion animal’s infections. Furthermore, transfer of resist-
ance markers and resistance strains between animals and
owners/caretakers is a strong possibility either by infection or
direct contact.
References:
(1) NCCLS (2002) Performance standards for antimicrobial disk
and dilution susceptibility for bacteria isolated from animals;
approved standards – second edition – M31 – A2.
(2) Duquette R. A. and Nutall T. J. (2004) Methicillin-resistant
Staphylococcus aureus in dogs and cats: an emerging problem?
Journal of Small Animal Practice 45, 591–7.
R1940
Beta-lactam resistance in Haemophilus parasuis
A. San Millan, J.A. Escudero, A.M. Catalan, M.C. Porrero, L.
Dominguez, M.A. Moreno, B. Gonzalez-Zorn (Madrid, ES)
Objectives: Haemophilus parasuis is a commensal organism of
the upper respiratory tract of conventional pigs that, under
appropriate conditions, can cause the Glasser disease, charac-
terized by severe systemic infection, ﬁbrinous polyserositis,
arthritis and meningitis. This is an emerging infection with
increasing importance in swine production. In our laboratory,
we are detecting an increase in the prevalence of resistance to
beta-lactam antibiotics in H. parasuis, being this antimicrobial
family the ﬁrst clinical election against respiratory tract infec-
tions in swine. Resistance to beta-lactam antimicrobials has yet
not been described nor characterized in H. parasuis.
Methods: Antimicrobial susceptibility test and MICs were
performed folowing NCCLS standard procedures. Identiﬁca-
tion by PCR was performed with modiﬁed procedure of
Oliveira, S. et al, 2001. Nitroceﬁne test was done using
OXOID beta-lactamase identiﬁcation sticks. CAMP test was
performed following standard procedures. DNA digestions
and cloning manipulation were performed following standard
procedures.
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Results: Phenotypic characteristics and speciﬁc tests were used
for presumptive identiﬁcation of H. parasuis. We have developed
a PCR based on speciﬁc ampliﬁcation of 821 pb from the coding
gene of the 16S subunit rRNA. We conﬁrmed 67 H. parasuis
isolates and tested them for antimicrobial susceptibility, 10 were
highly resistant to ampicillin (MIC ‡ 32 microg/ml). All resist-
ant isolates showed positive reaction to the nitroceﬁne test,
indicating that beta-lactamases enzymes are involved in this
phenomenon. This kind of resistance mechanism is usually
harboured in plasmid in other swine respiratory pathogens. The
plasmid proﬁle analysis of these strains in agarose gel electro-
phoresis, after digestion with PstI, was indifferenciable in 8 of
the 10 strains. We attempted to transform plasmid DNA directly
into E. coli altuogh results were negative, indicating that
replication origin is speciﬁc to Haemophilus spp. Currently we
are cloning the gene responsible for this phenotype inH. parasuis.
Conclusion: We have identiﬁed beta-lactam resistance in
H. parasuis. Resistance is due to beta-lactamases. We are
characterizating the genetic determinants responsible for this
emerging phenotype.
R1941
In vitro susceptibility to antibiotics of anaerobic
bacteria isolates from periodontal pockets
F.S. Alecu, M. Giurgiu, A. Dumitriu, C. Defta, G. Bancescu,
B. Dabu, S. Dumitriu (Bucharest, RO)
Introduction: The studies having as objective the sampling
from periodontal pockets have conﬁrmed constant implication
of Gram-negative anaerobic bacteria belonging to Bacteroides,
Fusobacterium, Porphyromonas, Prevotella and Treponema genera.
Facing a microbial mixture with synergic action over marginal
periodontium, the antimicrobial therapy should take account of
the susceptibility of the germ complex, as a whole.
Method: The sampling – made by means of sterile paper points
was followed by direct microscopy of smears and then microbial
isolation on culture media (Schaedler Agar supplemented with
5% sheep blood) incubated in anaerobiosis. Identiﬁcation of the
isolates was made by biochemical tests performed using
commercially available kits – Rapid ID 32 A (Biomerieux,
France) and antibiotic sensibility testing by means of Etest at 5
agents: Ampicillin/ Sulbactam; Azithromicine; Doxiciclyne;
Erithromicyne and Tetraciclyne.
Results and conclusions: In our studies, the most frequent
bacteria isolated fromperiodontal pockets belonged to Prevotella,
with Prevotella oralis on ﬁrst position, followed by Fusobacterium,
Bacteroides and Porphyromonas, and a few isolates of Peptostrepto-
coccus. Sensibility of isolateswas 100% at Ampicillin/ Sulbactam;
Doxiciclyne and Erithromicyne (91.7 %); Azithromicine (83.3%);
Tetraciclyne (66.6 %). The resistant isolates belonging to Pepto-
streptococci and Fusobacteria and shown resistance to Tetracic-
lyne and Azithromicine. According to our ﬁndings, for the
treatment of periodontitis it is recommended either:- The use of a
commercially available association a betalactamic agent with a
betalactamase inhibitor or- Doxicicline.
R1942
Community-acquired urinary tract infections in
2004: results from BulSTAR
M. Petrov, T. Velinov, A. Bachvarova, T. Kantardjiev (Soﬁa, BG)
Bulgarian Surveillance Tracking Antimicrobial Resistance –
BulSTAR monitors the isolation and antimicrobial susceptibility
of clinically signiﬁcant microorganisms from blood cultures,
cerebrospinal ﬂuid, upper and lower respiratory tract, urine and
wound samples in the participating Bulgarian microbiology
laboratories since 1997. In 2004 the number of participants was
103 – 23 public, 53 hospital and 27 private microbiology
laboratories. Clinical and Laboratory Standards Institute meth-
odology was used in all participating centres. This presentation
provides an update on the current state of etiological structure
and antimicrobial resistance of community-acquired urine
pathogens in Bulgaria based on BulSTAR data for 2004. The
number of positive samples was 21 202–14 298 from female
outpatients and 6904 from male outpatients. The etiological
structure in both sexes is similar with the leading pathogen
Escherichia coli – 65.2% and 51.8% respectively, followed by
Proteus mirabilis – 8.3% and 12.0%. The difference is in the third
position taken by Enterococcus faecalis – 4.6% among women and
by Pseudomonas aeruginosa – 8.1% among men. The main
therapeutic problem is Pseudomonas aeruginosa with it’s resist-
ance to ceftazidime – 21.7%, to gentamicin – 31.5 and to
ciproﬂoxacin – 32.1%. High-levels of resistance are also found
against the two important antibacterial agents for ambulatory
treatment of Escherichia coli – ampicillin and trimethoprim/
sulfamethoxazole.
R1943
Surveillance of Antimicrobial Susceptibility of
the Bacteroides fragilis group at a teaching
hospital in Maribor, Slovenia, between 2002 and
2004
S. Lorencic-Robnik (Maribor, SI)
Objectives: Antibiotic resistance among anaerobic organisms
started to increase in recent years. The aim of the present study
was to investigate the susceptibility of the Bacteroides fragilis
group isolates to metronidazole, ampicillin – sulbactam (AM-SB)
or amoxicillin-clavulanate (AM-CL), clindamycin and penicillin.
Methods: A total of 153 isolates of anaerobic bacteria were
collected at the Department of Gynecology from clinical samples
(wounds, ﬁstulae, abscesses, endometrium, peritoneal cavity,
blood) of 116 patients during a 3-year period (2002–2004). The
isolates included: B. fragilis group 32 (21%), other Bacteroides spp.
9 (5.9%), Fusobacterium spp.16 (10.5%), Prevotella spp. 7 (4.6%),
other anaerobic gram-negative bacilli 13 (8.5%), Propionibacteri-
um spp. 18 (19.8%), Eubacterium spp. 5 (3.3%), Clostridium spp. 3
(2%), Actinomyces spp. 3 (2%), other gram-positive bacilli 8
(5.2%), Peptostreptococcus spp. 36 (23.5%), Peptococcus spp. 1
(1.3%) and anaerobic gram-negative cocci 1 (1.3%). We investi-
gated the susceptibility of the predominant gram-negative
isolate B. fragilis group. Antimicrobials tested were metroni-
dazole, AM-SB or AM-CL, clindamycin and penicillin. Routine
in vitro susceptibility testing was performed using the EtestR
(AB Biodisk, Solna, Sweden) according to recommendations of
the producer.
Results: Metronidazole (32) and AM-SB or AM-CL (32) were all
highly active (resistance rates 0%), whereas 8 (25%) isolates were
resistant to clindamycin. All isolates (32) were resistant to
penicillin.
Conclusion: The present data show an emergence of resist-
ance of the B. fragilis group against clindamycin. Conse-
quently the importance of routine in vitro susceptibility
testing of anaerobic bacteria is growing, especially as clinda-
mycin is used in empirical therapy to treat anaerobes at the
Department of Gynecology. With the local susceptibility data
it is possible to choose the most active antibiotics for
treatment of anaerobes.
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R1944
Determine variation of antimicrobial
susceptibility patterns according to ﬁve years in
intensive care unit of a university hospital
I. Koksal, G. Yilmaz, K. Aydin, N. Sucu, R. Caylan, A.C.
Senel (Trabzon, TR)
Background: Antimicrobial resistance is a signiﬁcant problem
in the intensive care unit (ICU). There are many factors that
contribute to the high rate of antibiotic resistance in the ICU, but
one factor having major impact is the ecological pressure exerted
by high usage of antibiotics in critically ill patients.
Methods: We conducted a ﬁve-years prospective study of the
hospital-acquired infections and colonization causative micro-
organisms and antimicrobial resistance in a 11-bed medical and
surgical ICU of a Karadeniz Technical University Hospital,
Trabzon, Tu¨rkiye. From 2000 to 2004 all patients staying in ICU
more than 48 h were consecutively enrolled and followed
prospectively until discharge or death. From every patient,
common specimens were sent for bacteriologic culture and
sensitivity analysis.
Results: A total of 1400 bacterial pathogens were obtained from
728 patients in ICU during the study period. Of these, 1306
(93.3%) were single isolates and 94 (6.7%) were polymicrobial
isolates. The isolates consisted of 797 (56.9%) Gram-negative
strains, 495 (35.4%) Gram-positive strains and 108 (7.7%) Candida
spp. The most common isolates were Pseudomonas aeruginosa
(277; 19.8%), methicillin resistant Staphylococcus aureus (MRSA)
(174; 12.4%), Acinetobacter spp (166; 11.9%), methicillin resistant
coagulase-negative staphylococci (MRCNS) (122; 8.7%), Enterob-
acter spp (92; 6.6%). The most active agents were ticarcillin/
clavulanate and amikacin against P. aeruginosa, imipenem
against Acinetobacter spp, imipenem-cefoperazone/sulbactam-
ciproﬂoxacin and amikacin against Enterobacter spp, Klebsiella
spp and E. coli, trimetoprim/sulfamethoxazole against S. malto-
philia, vancomycin against S. aureus , CNS and Enterococcus spp.
Conclusions: In determine variation of microorganisms accord-
ing to ﬁve years, P. aeruginosa was the most prevalant micro-
organism, while MRSA and Acinetobacter spp remained to be
less frequent. An increasing rathe of Gr( + ) microorganisms has
been overemphasised in recent years. We observed the presence
of multiple antimicrobial resistant microorganisms, which play
an important roll in massive colonization of patients and in the
aetiology of nosocomial infections. In approach to empirical
treatment, such microorganisms and their susceptibilities were
primarily considered. This fact is very worrisome, exception a
few therapeutic options are failure to treat infections caused by
this multidrug-resistant microorganisms.
R1945
Antibiotic resistance for Streptococcus
pneumoniae isolated from otitis media and
invasive infections in children between 2001 and
2004 in Iasi, Romania
G.V. Coman, R. Filip, E. Petrariu, C. Dahorea, M. Cirlan (Iasi,
Sucaeva, RO)
Background: S. pneumoniae belongs to community species
which developed multiple antibiotic resistance. Resistance
proﬁles and ratio recognize regional differences.
Objectives: To follow-up the sensitivity against different anti-
biotic classes for S. pneumoniae strains isolated from two
infection types: otitis media (characterized by frequency and
motivation of antibiotic prescribing) and invasive infections
(rare, but extremely severe).
Material and method: Our study comprised a number of 109
S. pneumoniae strains isolated from children aged between
2 months and 14 years old (68 children less than 2 years old),
admitted in the ‘‘Sf. Maria" Emmergency Pediatric Hospital
from Iasi, Romania during 2001–2004, 26 strains being from
invasive infections (pleural effusion, peritonitis, meningitis,
arthritis, bacteraemia). Sensitivity testing was performed by
standard disk diffusion method against following agents:
Erythromycin (E), Clindamycin (DA), Tetracycline (TE), Chlo-
ramphenicol (C), Trimethoprim-sulfamethoxazole (SXT) and
Linezolid (LNZ). Oxacillin (OXA)(1 microgram), Norﬂoxacin
(NOR) (5 microgram)or Ciproﬂoxacin (CIP) (5 microgram) were
used as ‘‘indicator antibiotics" to detect Penicillin (P) and
ﬂuoroquinolone resistance, respectively. MICs for P, Cefotaxime
(CTX), Clarithromycin (CLR), Levoﬂoxacin (LVX) and Gatiﬂ-
oxacin for resistant isolates were detected by E-test (AB Biodisk,
Solna, Sweden).
Results: Global P resistance was extremely high, 76.1%, the
number of high level resistance (HLR) strains being approx.
equal with that of low level resistance (LRR) strains: 43 and 40
strains, respectively. In strains isolated from invasive infections ,
the resistance ratio was 63.4%. In 24.8% of cases, P resistance
was associated with CTX resistance. We found that the number
of HLR strains was approx. equal with that of LRR-13 and 14
strains, respectively. Only two HLR strains were isolated from
invasive infections (bacteremia). We also found high resistance
ratio for antibiotics belonging to other classes: E, DA, TE, SXT,
57.8%, 56.9%, 56.9% and 82.6% respectively. With only one
exception, macrolide resistance was associated with DA resist-
ance, CLR MIC for these strains being ‡256 micrograms/mL.
The lowest resistance ratios were found for C and ﬂuoroquino-
lones, 4.6% and 0.92%, respectively. No LNZ resistant strain was
found.
Conclusion: In our region, Vancomycin, LNZ, C or new
ﬂuoroquinolones are alternatives for multiresistant S. pneumo-
niae strains.
R1946
Multiresistant Pseudomonas aeruginosa isolations
in a critical care unit
J.L. Navarro, J.M. Azcona, N. Arenal, E. Garcia-Pen˜uela, E.
Aznar, M.C. De las Cuevas, T. Alarcon, M. Lopez-Brea (Madrid,
ES)
Objective: To describe the incidence of multiresistant Pseudo-
monas aeruginosa isolations in blood cultures, bronchoaspirates,
urinary specimens and surgical wounds from January 2004 to
December 2004 in critical patients from a teaching hospital in
Madrid.
Methods: A 1-year, retrospective, observational study was
conducted. We studied a total of 1370 specimens from 393
patients. All blood cultures (n = 487), bronchoaspirates
(n = 582), urinary specimens (n = 170) and surgical wounds
(n = 131) from critical patients were cultured. Identiﬁcation and
susceptibility testing was performed in all positive samples
using a standard microdilution broth method (MicroScan,
Dade Behring). Susceptibility breakpoints were based on Clin-
ical and Laboratory Standards Institute (formerly NCCLS). No
universal criteria of multiresistant strains have been accepted.
Resistance to two or more of the following groups of antibiotics
has been the criterium to deﬁne a multiresistant strain: carbap-
enems, monobactams, antipseudomonal cephalosporins, ﬂuoro-
quinolones, aminoglycosides and aminopenicillins.
Colonization and infection were not discriminated.
Results: Pseudomonas aeruginosa was isolated from 35 samples
(2.6%) corresponding to 22 patients (5.6%). The distribution was
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as follows: 22 (62.9%) from bronchoaspirates, 5 (14.3%) from
blood cultures, 1 (2.9%) from urine culture and 7 (20.0%) from
surgical wounds. Amikacin, imipenem, tobramycin, ciproﬂoxa-
cin and cefepime were the most effective antibiotics. Five strains
(14.3%) showed resistance or reduced susceptibility to imipe-
nem; 19 strains (54.3%) were susceptible to all tested betalactams
and 4 (11.4%) were resistant to all of them. Only 3 strains (8.8%)
were amikacin resistant, and none was resistant to all amino-
glycosides (table 1). Finally, 20 strains (57.1%) could be consid-
ered multiresistant.
Conclusions: Pseudomonas aeruginosa can be considered one of
the most important resistant pathogen in critical care units.
Although susceptibility to some antipseudomonal antibiotics
remains acceptable, multiresistant strains are an increasing
problem reducing the number of available effective drugs. In
addition, Pseudomonas aeruginosa easily acquires multiple resist-
ance mechanisms and therapeutic choices decrease.
R1947
Staphylococcus aureus susceptibility to three
antibiotics isolated from hospitalised vs.
outpatients in a local area of Madrid
J.M. Azcona, J.L. Navarro, E. Aznar, N. Arenal, D. Domingo,
M. Lopez-Brea (Madrid, ES)
Objective: To describe the differences between susceptibility
patterns to cloxacillin, erythromycin and ciproﬂoxacin of
Staphylococcus aureus (SA) strains isolated from skin lesions
and wound exudates from hospitalized and outpatients atten-
ded in a local health care area of Madrid.
Methods: A total of 2108 skin lesions and wound exudates were
analysed, 1123 corresponded to hospitalized patients and 985 to
outpatients from January 2003 to December 2004. Cloxacillin,
erythromycin and ciproﬂoxacin susceptibility patterns using a
commercial microdilution broth method (MicroScan, Dade
Behring laboratories) were performed. Susceptibility break-
points were based on Clinical and Laboratory Standards
Institute (formerly NCCLS). Resistance rates are described as
percentage and have been analysed using Chi2-test. Statistical
signiﬁcance has be considered in all cases with p < 0.05 values.
Results: Staphylococcus aureus was isolated from 153 (13.6%)
inpatient specimens and 226 (22.9%) from ambulatory samples
(p < 0.001). Cloxacillin resistance was observed in 41 (26.8%)
inpatient samples and in 52 (23%) ambulatory samples
(p = 0.47). Erythromycin resistance was observed in 48 (31.3%)
inpatients and in 71 (31.4%) outpatients (p = 0.92). Finally, 49
(32%) inpatient samples and 57 (25.2%) outpatient samples were
resistant to ciproﬂoxacin (p = 0.18) (table 1).
Conclusions: Staphylococcus aureus isolations were more fre-
quent in outpatients specimens than in hospitalized samples.
Erythromycin susceptibility patterns were similar between
hospitalized and ambulatory patients. Although cloxacillin
and ciproﬂoxacin resistance differences have been found, there
was not statistical signiﬁcance.
R1948
Two-year surveillance of antimicrobial
susceptibility in Pseudomonas aeruginosa isolates
from a hospital centre, Coimbra, Portugal
O.M. Cardoso, A.F. Alves, R.M. Leita˜o (Coimbra, PT)
Objective: Pseudomonas aeruginosa (PA) is one of the leading
causes of nosocomial infections. Severe infections, such pneu-
monia or bacteraemia are associated with high mortality rates,
often difﬁcult to treat, because useful anti-pseudomonal agents
are limited. Surveillance of antimicrobial susceptibility of PA
clinical isolates has been monitored in this study, since the
determination of guidelines for empirical regimens and prompt
enforcement of infection control measurers are of great import-
ance.
Methods: Isolates (N = 787) were collected during April 2003 to
April 2005. They were identiﬁed with VITEK (BioMe´rieux) and
MicroScan WalkAway (Dadebehring) and susceptibility pat-
terns were determined with these panels. Susceptibilities to
Piperacillin (PIP), Piperacillin plus Tazobactam (TZP), Aztreo-
nam (AZT), Ceftazidime (CAZ), Imipenem (IP), Meropenem
(MP), Amikacin (AMK), Tobramicin (NN), Gentamicin (GN),
and Ciproﬂoxacin (CIP) were guideline by NCCLS.
Results: In the set of 787 isolates, 522 were obtained from
nosocomial infections and 265 from community acquired
infections of different clinical specimens, including urine
(15.5%, 36.6%, respectively), sputum (49.2%, 32.1%), exudates
(14.6%, 14.3%), blood (4.4%, 4.5%), and others sources (16.3%,
12.5%). Among all isolates MP was most potent antibiotic
(89.8% susceptible), GN and CIP were the worst agents (63.8%
and 69.0% of susceptibility, respectively). Susceptibilities rates
varied signiﬁcantly between nosocomial and ambulatory infec-
tions. Among the nosocomial, TZP (83.5%), CAZ (80.3%), and
PIP (79.5%) demonstrated better activity than IP (76.4%), but
MP had better result (85.2%). Amikacin had improved suscep-
tibility (82.0%), but GN is the worst (58.4%). CIP inhibited
64.6% of these isolates. Ambulatory isolates were more
susceptible, and susceptibilities were above ninety per cent,
except to CIP (77.7%) and GN (74.3%). Carbapenems resistance
had increased in second year relatively to ﬁrst year (7.9% for IP
and 6.4% for MP) and equal to CAZ (5.3%). Amikacin
improved activity (7.5%).
Conclusions: Considering the results and the high prevalence
of multidrug resistant strains (10.2%) (resistance to three or four
of these agents: PIP, CAZ, IP and CIP) in this hospital
environment, it is necessary to detect and follow sources of
infection, in order to prevent the spreading and transmission of
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these strains. Susceptibility rates should be determined and
effective antibiotics usage policy should be performed.
R1949
Antibiotic resistance in the community
environment: a regional epidemic survey in the
Pays de la Loire region by MedQual
S. Thibaut, H. Drugeon, G. Potel, P. Lombrail, F.
Ballereau (Nantes, FR)
Objectives: MedQual was created in January 2004 in the Pays
de la Loire Region, supported by public health insurance funds
(FAQSV), as an answer to the circular DHOS/E2-DGS/SD5A n
272, May 2nd 2002 ‘‘concerning the good use of antibiotics in
health care centres and the setting up of experimental centres to
give advice to physicians on the good use of antibiotics’’. This
resource network for the community and hospital health
workers of the Region is in accordance with the ‘‘plan to
preserve the effectiveness of antibiotics’’ of the Health Ministry.
MedQual is doing an epidemiologic survey on E. coli in the
Region to see the evolution of some antibiotics’ susceptibility for
E. coli community samples. We survey the resistance to
antibiotics currently used for these infections.
Methods: A regional prospective epidemiologic survey of E. coli
has been carried out with 18 microbiology laboratories in 2004 of
the 5 departments of the Pays de la Loire region. They send their
results monthly to MedQual. They use data collection sheets
developed and validated by MedQual. The resistance of E. coli to
aminopenicillin, amoxicillin + clavulanic acid, nalidixic acid,
norﬂoxacin, ciproﬂoxacin, oﬂoxacin, and peﬂoxacin is super-
vised. The results of this survey are given on the MedQual
website (http://www.sante.univ-nantes.fr/medqual) monthly,
for the physicians to adapt their antibiotics prescriptions to the
local microbial ecology.
Results: After one year of survey, we have obtained 16367
samples for E. coli; 95.94% are urine samples. The rates of E. coli
resistance in the Region are 39.01% for aminopenicillin, 22.54%
for amoxicillin + clavulanic acid, 11.15% for nalidixic acid,
10.11% for oﬂoxacin, 8.29% for norﬂoxacin, 6.56% for peﬂoxacin
and 5.49% for ciproﬂoxacin.
Conclusion: This regional survey of E. coli continued with 30
microbiology laboratories in 2005. The variabilily amongst
different departments conﬁrms the need for local resistance
prevalence data to be available to the practitioners who treat
urinary infection. Ongoing surveillance studies are required to
assess the evolving resistance patterns in community environ-
ment. MedQual shows an efﬁcient collaboration with the private
medicine network (URML) for a joint action aiming at the good
use of antibiotics and at the survey of the evolution of the
bacterial resistances of E. coli.
R1950
Antibiotic susceptibility pattern of nosocomial
Gram-negative pathogens: results from MYSTIC
study in a university hospital, Ankara, Turkey
(2000–2004)
P. Zarakolu, G. Hascelik, S. Unal (Ankara, TR)
Objectives: The aim of this study was to present the suscep-
tibility pattern of 559 Gram negative nosocomial isolates
involved in the MYSTIC programme in Hacettepe University
Adult Hospital between 2000 and 2004.
Methods: Only 45% of the isolates were from patients in
intensive care units. The susceptibility testing was performed by
Etest (AB BIODISK, Solna, Sweden) using CLSI citeria and
percentage susceptibilities of Escherichia coli (n = 144), Klebsiella
pneumoniae (n = 133), Pseudomonas aeruginosa (n = 144) and
Acinetobacter baumannii (n = 138) against different antimicrobials
were determined. Extended-spectrum ß-lactamase (ESBL) pro-
duction of E. coli and K. pneumoniae were also obtained.
Results: The ESBL production rate of E. coli and K. pneumoniae
isolates were 28.0% and 46.6%, respectively. All E. coli and
K. pneumoniae isolates were susceptible to carbapenems. The
susceptibility of ESBL (+) E. coli isolates to ceftazidim, cefepime,
piperacillin + tazobactam and tobramicin were in between 60%
and 75%. The susceptibility of ESBL (-) E. coli isolates to
ceftazidim, cefepime, piperacillin + tazobactam and tobramicin
were in between 84 and 95%, 57.8% to ciproﬂoxacin. The
susceptibility rate of ESBL (+) K. pneumoniae isolates to pipera-
cillin + tazobactam and cefepime was 51–55%, 42–49% to
ceftazidim, tobramicin and ciproﬂoxacin. The susceptibility
rate of ESBL (-) K. pneumoniae isolates to seftazidim, piperacil-
lin + tazobactam and ciproﬂoxacin was 60–70%, 87–92% to
cefepim and tobramicin. Of the P. aeruginosa isolates, 77% were
multi-drug resistant. The susceptibility of P. aeruginosa isolates
to piperacillin + tazobactam, carbapenems and ciproﬂoxacin
was 50%. Of the A. baumannii isolates, 67% were multi-drug
resistant with the higher susceptibility rates to meropenem and
tobramicin 53% and 44%, respectively.
Conclusions: The ESBL production of E. coli and K. pneumoniae
are high and carbapenems are reliable choices for the treatment
of their infections. However, most of the infections caused by P.
aeruginosa and A. baumannii have limited options.
R1951
Susceptibility patterns of Klebsiella pneumoniae
to quinolones and beta-lactams
V.P. Pliatsika, G.T. Tsilika, E. Pronotariou, M.T. Tsivitanidou,
D.S. Soﬁanou (Thessaloniki, GR)
Objectives: Klebsiella pneumoniae is has been recognized as
major human pathogen and an important source of transferable
antibiotic resistance. During the last decade an increasing
resistance to commonly used antibiotics has been noticed. This
fact is extremely worrying and limits the selection of antibiotics
for the effective treatment of severe K. pneumoniae infections. The
aim of the present study was to evaluate the resistance rates of
K. pneumoniae strains to quinolones and b-lactams throughout a
three year period and to identify trends, if possible, in the
susceptibility patterns.
Methods: K. pneumoniae stains isolated from clinical specimens
were reviewed from January 2002 to December 2004. The
identiﬁcation of microorganisms and susceptibility testing were
performed using the Vitek 2 automated system (bioMerieux,
France).
Results: A total of 824 non duplicate K. pneumoniae isolates were
recorded. The sources of these K. pneumoniae strains were: blood
cultures:(39.5%), wounds:(31.5%), urine:(19%), respiratory tract
secretions:(9%) and cerebrospinal ﬂuid:(1%).The resistance rates
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of K. pneumoniae isolates are shown in the table: According to the
statistical analysis performed using the z-test, an increasing
resistance trend towards b-lactams and ciproﬂoxacin was
observed during the study period.
Conclusions: The resistance rates of K. pneumoniae to ciproﬂ-
oxacin, piperacillin/tazobactam, ticarcillin/clavulanic acid, and
ceftazidime during the 3 year period of the study has increased
signiﬁcantly. What is really alarming is the emergence in 2004 of
K. pneumoniae strains resistant to imipenem, which renders the
selection of antimicrobial therapy difﬁcult. More effective
infection control measures, rational antibiotics policies and
rapid laboratory detection of resistance are required to prevent
the spread of resistant isolates in the hospital.
R1952
Antimicrobial susceptibility of six members of
the family Enterobacteriaceae collected from 28
centres in a Central European area, 2004
K. Kresken, D. Hafner (Rheinbach, Dusseldorf, DE)
Objectives: Members of the family Enterobacteriaceae frequently
cause nosocomial infections. The publication of current anti-
microbial susceptibility data is a prerequisite for the optimal
management of patients with hospitalized infections. The
objective of this study was to evaluate the in vitro susceptibil-
ities of clinical isolates of Enterobacter cloacae (ECL), Escherichia
coli (ECO), Klebsiella pneumoniae (KPN), Klebsiella oxytoca (KOX),
Proteus mirabilis (PMI), and Serratia marcescens (SMA) to various
frequently used broad-spectrum antibacterial agents.
Methods: In November 2004, a total of 1786 isolates (ECL,
n = 267; ECO, n = 745; KPN, n = 288; KOX, n = 169; PMI,
n = 208; SMA, n = 109) were prospectively collected from 28
microbiology laboratories distributed throughout three Central
European countries (Austria, Germany, and Switzerland). Min-
imal inhibitory concentrations of ceftriaxone, ceftazidime, ce-
fepime, ertapenem, meropenem, piperacillin-tazobactam,
ciproﬂoxacin, and tobramycin were determined by the broth
microdilution method according to the standard of the German
DIN.
Results: Of the ECO, PMI, KPN, and KOX isolates, 5.1%, 1.9%,
7.3%, and 12.4% produced extended-spectrum beta-lactamases.
Ertapenem (100%) and meropenem (99.9%) were the most
active compounds against ECO. The susceptibility of ECO to
cefepime, ceftazidime, and ceftriaxone ranged from 94.5 to
96.1%. In contrast, susceptibility of ECO to ciproﬂoxacin was
77.7%. For PMI, susceptibility was highest for ertapenem and
meropenem (each 99.0%) and lowest for tobramycin (88.9%).
Among KPN and KOX isolates, susceptibility to cefepime,
ceftazidime, and ceftriaxone ranged from 93.4 to 95.8% and
78.7 to 97.0%, respectively. Susceptibility to piperacillin-tazo-
bactam was 85.1% and 75.1% for KPN and KOX, respectively.
The carbapenems were the most active drugs against KPN and
KOX, with susceptibilities of >98% each for ertapenem and
meropenem. For SMA, susceptibilities varied from 77.1%
(piperacillin-tazobactam) to 97.2% (ertapenem). Susceptibility
patterns of ECL showed the highest susceptibility to merope-
nem (99.6%) followed by ertapenem (98.9%), ciproﬂoxacin
(95.1%) and tobramycin (95.1%), whereas susceptibilities to
ceftazidime, ceftriaxone and piperacillin-tazobactam were each
below 70%.
Conclusion: The carbapenems seem to be the most active
antimicrobial agents against isolates of ECL, ECO, KPN, KOX,
PMI, and SMA recovered from patients in hospitals located in
Germany, Austria, and Switzerland.
R1953
Four patients with a Pseudomonas aeruginosa
BEL-1 clavulanic acid-inhibited extended-
spectrum beta-lactamase: what’s the connection?
L. Ide, A. Verlinde, P. Descheemaeker, E. De Laere,
I. Surmont (Roeselare, Brugge, BE)
Objective: A 72-year-old male patient was admitted to our
hospital with a dissecting aneurism of the left arteria renalis. A
scrotal swab yielded a Pseudomonas aeruginosa strain producing a
novel Extended-Spectrum Beta-Lactamase (ESBL), coded by a
BEL-1 gene. The relatively low-level MICs of extended-spectrum
betalactams in the BEL-1 carrying P. aeruginosa strains may
hinder accurate detection in routine laboratory practice. Never-
theless we discovered 3 other patients with the same BEL-1
producing P. aeruginosa.
Methods: Screening for ESBL genes was performed using
double-disk synergy test and PCR techniques. Sequence analysis
identiﬁed the Ambler class beta-lactamase BEL-1 in all strains.
Consecutively PFGE was performed.
Results: The 4 samples strongly suggest to be closely related if
not identical. To the best of our knowledge all patients had no
contact with each other. Admissions were separated in time and
place. One of the patients wasn’t even hospitalized in our
hospital. This patient underwent a Bricker deviation and
continues to shed the strain until now.
Conclusion: We believe that BEL-1 carrying P. aeruginosa is
highly underestimated especially when using VITEK-2 or
Phoenix sensitivity testing systems, since they hardly detect
synergy in an accurate way. There is a consensus that most P.
aeruginosa infections are acquired from the environment, but no
environmental sources have ever been proved to be high risk for
certain populations. Only a very small part of the population
carries P. aeruginosa in faeces; and although this accounts for a
large number of people in absolute numbers, the bacterial
counts are usually low while a high inoculum seems to be
required in order to transmit strains. Beside tomatoes, which are
notorious for yielding the highest numbers of P. aeruginosa
among vegetables, possible other sources are mushrooms and
bean sprouts. The use of antimicrobials such as streptomycin
and oxytetracycline in agriculture could be responsible for
transferring resistance genes. Although there is no evidence for
a correlation between the agricultural use of azoles as fungicides
and fungal resistance in humans, such concerns have been
expressed. The same concerns are justiﬁed when using antibac-
terial agents. More research on this issue is warranted.
R1954
Antimicrobial resistance patterns of Escherichia
coli isolates
P. Karapavlidou, K. Koraki, D. Soﬁanou (Thessaloniki, GR)
Objectives: To determine and compare antimicrobial suscepti-
bility patterns of Escherichia coli isolated from both hospitalized
and outpatients in a tertiary-care hospital in Greece.
Methods: E. coli strains isolated from clinical specimens were
reviewed. Identiﬁcation of microorganisms and susceptibility
testing was performed using the Vitek 2 automated system
(bioMerieux, France).
Results: A total of 3023 E. coli strains were recorded during a
three year period (2002–2004). 74.2% were isolated from inpa-
tients and 25.8% from outpatients. The most common source of
E. coli strains was the urine, followed by pus, wounds, blood
and other sources. Susceptibility rates to commonly used
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antimicrobial agents like ampicillin, amoxicillin/clavulanate,
ceftazidime, amikacin, ciproﬂoxacin, piperacillin/tazobactam,
cotrimoxazole were 46%, 82%, 88%, 95%, 88%, 98% and 75% for
inpatients and 55%, 90%, 95%, 98%, 91%, 99% and 77% for
outpatients, respectively. All isolates were sensitive to imipe-
nem. According to statistical analysis E. coli strains isolated from
outpatients were signiﬁcantly more susceptible to all drugs
tested (p < 0.05), except for cotrimoxazole and piperacillin/
tazobactam. The incidence of extended spectrum b-lactamase
(ESBL) producing strains among E. coli isolated from inpatients
and outpatients was 8.2% (185/2244) and 3.7% (29/779),
respectively.
Conclusion: Outpatient’s strains showed higher susceptibility
to all drugs tested. 8.2% and 3.7% of E. coli strains isolated from
inpatients and outpatients, respectively, were found to be ESBL-
producers demonstrating the dissemination of those strains in
the community.
Surveys molecular epidemiology of resistance and resistance
genes, strains or serotypes
R1955
Characterisation of Campylobacter jejuni strains
isolated in the United Arab Emirates
A´. Sonnevend, T. Pa´l (Al Ain, AE)
Objectives: Although the Middle East has been known as a
high-risk area for campylobacteriosis, little is known about the
features and variety of the local Campylobacter jejuni isolates. The
aim of the study was to investigate the type distribution and
antibiotic susceptibility of strains isolated in Al Ain, United
Arab Emirates.
Methods: Forty one C. jejuni strains isolated from different
patients during a two year-long period (2002 September–2004
September) in Tawam Hospital, Al Ain, Eastern Region of the
United Arab Emirates, were studied. The isolates were speciated
by biochemical tests, their heat stable antigens were determined
by passive haemagglutination and the strains were further
typed by molecular techniques, i.e. by restriction fragment
length polymorphism (RFLP) of the ﬂaA gene and by pulse-ﬁeld
gel electrophoresis (PFGE) following SmaI digestion of the
genome. The susceptibility of the isolates to erythromycin,
nalidixic acid and ciproﬂoxacin were determined by agar
dilution. The presence of the Thr-86-to-Ile mutation of in the
gyrA gene of quinolone and/or ﬂuroquinolone resistant isolates
was investigated by mismatch ampliﬁcation mutation assay
PCR.
Results: 75.6% of the isolates were serotypable representing 10
different serogroups. Beyond the non-typable strains, those
expressing heat-stable antigen HS 4, 13, 16, 43, 50 (21.9%) and
HS 2 (14.6%) were the most frequently encountered ones. All
isolates were sensitive to erythromycin (MIC 0.5–4 mg/L), but
85.4% of them showed nalidixic acid and ciproﬂoxacin resist-
ance with MIC values between 128–512 mg/L and 8–64 mg/L,
respectively. All resistant isolates carried the Thr-86-to-Ile
mutation. The 35 ﬂuoroquinolone resistant isolates belonged to
17 different RFLP and 20 different PFGE groups. Among them a
cluster of 8 isolates (22.8% of all resistant ones) with indistin-
guishable RFLP and PFGE patterns was identiﬁed with isolation
dates spanning a one year-long period of time.
Conclusions: Our data show that ﬂuoroquinolone resistance
among C. jejuni is remarkably high in this region of the Middle
East. While most isolates seem to be independent strains, a
resistant clone present in the region for an extended period of
time could be identiﬁed.
R1956
Antibiotic susceptibility of Campylobacter
species isolated in West-Tallinn Central hospital
in 2000–2004
I. Zolotuhhina, K. Kirs (Tallinn, EE)
Objectives: Campylobacter remains one of the most important
intestinal pathogens in Estonia. Of all bacterial diarrhoeal
diseases diagnosed in West-Tallinn Central Hospital, infections
due to Campylobacter showed a steady increase of the prevalence
from 14.7% in 2000 to 30.5% in 2004. The objective of the study
was to determine susceptibility patterns of isolated strains
against commonly used antibiotics.
Methods: During the study period (2000–2004) Campylobacter
cultures were isolated from stool samples of patients admitted to
the hospital and identiﬁed to species level using conventional
laboratory methods. Antimicrobial susceptibility tests were
performed by disk diffusion method according to the recom-
mendations of the NCCLS. A total of 219 strains were studied,
211(96.3%) belonged to Campylobacter jejuni and 8 (3.7%) to
Campylobacter coli. The antibiotics tested were ciproﬂoxacin
(CIP), erythromycin (ERY), tetracycline (TET), nalidixic acid
(NAL).
Results: Susceptibility rates of all 219 strains tested were as
follows: CIP – 94.5%, TET – 87.7%, ERY – 86.3%, NAL – 62.6%.
The percentage of Campylobacter isolates reported as resistant to
NAL signiﬁcantly increased from 25 in 2000 to 40.4 in 2004.
Resistance to NAL was detected in both Campylobacter jejuni and
Campylobacter coli with the same prevalence – 37.4% and 37.5%
respectively. Most of the isolates were susceptible to TET and
ERY. However there was a little increase in the occurence of
ERY-resistant strains over time. Resistance to CIP increased
from 3.1% in 2000 to 10.6% in 2004. 12.3% of isolates were found
to be simultaneously resistant to 2 and 4.6% to 3 antibiotics.
Conclusions: Resistant rates of Campylobacter species in
Estonia are increasing. Co-resistance to several drugs has been
detected. The high incidence of NAL-resistant isolates indicates
that susceptibility to NAL can no longer be considered a reliable
test for differentiating between Campylobacter species. ERY
remains relatevily effective for the treatment of campylobacte-
riosis. Although the resistance of Campylobacter to CIP is
increasing it has not yet emerged as a signiﬁcant problem in
Estonia.
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R1957
Genotypic evaluation of high-level resistant
enterococci to glycopeptides isolated from blood
cultures in a tertiary hospital
A. Koutsoukou, A. Stylianakis, S. Tsiplakou, M. Tachtatzis,
I. Anagnosti, I. Feskou (Athens, GR)
Objective: The purpose of the present study was to analyse
enterococci recovered from blood stream infections during a 3-
year period (from 2003 to 2005) with regard to their resistance to
glycopeptide antimicrobials and to characterise the mechanism
of resistance to vancomycin and teicoplanin.
Methods: Enterococci were isolated from blood cultures (Bactec
system, Becton Dickinson) of patients hospitalized in different
wards of our hospital. Identiﬁcation and antibiotic susceptibility
testing of enterococci were performed by the Vitek II automated
system (Biomerieux). The MICs for vancomycin and teicoplanin
were conﬁrmed by E-test (AB Biodisk, Solna, Sweden), accord-
ing to NCCLS guidelines. Further analysis of the vancomycin
resistance genes (vanA, and vanB) was performed by sandwich
hybridization method (EVIGENE VRE detection kit, Statens
Serum Institut, Denmark).
Results: Identiﬁcation resulted in 42 vancomycin resistant
enterococci (VRE) that consisted of 29 Enterococcus faecalis, 10
Enterococcus faecium, and 3 Enterococcus gallinarum. MIC values
were higher than 64 lg/ml for vancomycin and higher or equal
to 32 lg/ml for teicoplanin. Genotypic analysis of the isolates
yielded that all glycopeptide resistant enterococci possessed the
vanA gene.
Conclusions: The resistance of enterococci to glycopeptides
consists a major problem, as these antimicrobials are the last
therapeutic resource especially when isolated from patients with
bloodstream infections and in the hospital environment. The
possession of vanA gene, conferring high-level resistance to
both vancomycin and teicoplanin, is limiting the therapeutic
options for VRE infections.
R1958
Detection of VIM-2 metallo-beta-lactamase in
Pseudomonas aeruginosa isolates from a cystic
ﬁbrosis patient
O.M. Cardoso, A.F. Alves, R.M. Leita˜o (Coimbra, PT)
Objective: Pseudomonas aeruginosa (PA) is a major pathogen in
cystic ﬁbrosis (CF) patients and leading cause of morbidity and
mortality. Once chronic infection is established with PA, it is
virtually impossible to eradicate. The development of resistance to
antibiotics frequently occurs in CF due to intensive selective
pressure provided by large amount of antibiotics used in these
patients. The aim of this study was to identify metallo-beta-
lactamases (MBLs) in amulti-resistant PA isolate fromaCFpatient.
Methods: Paediatric Hospital of Coimbra has collected from
April 2003 to December 2004, eight samples of sputum
harboured a multi-resistant PA that colonize a fourteen years
old girl with CF. Identiﬁcation and susceptibility was performed
by MicroScan WalkAway (Dadebehering) system. Double-disk
synergy test was used for screening MBLs. For research of
blaVIM, blaIMP, and class 1 integron, PCR was done. PCR
products obtained were sequencing and analysed. Samples were
typed by Random Ampliﬁed Polymorphic DNA (RAPD) ana-
lysis using sequences of 10-mer RAPD primers 272 and 208.
RAPD patterns were visually compared.
Results: These strains were resistant to all antimicrobials used
in this system, except to colistin. The double disk synergy test
was positive for all samples. The presence of blaVIM was
positive but blaIMP was negative, and DNA sequencing showed
the presence of blaVIM-2 gene. This genetic determinant was
inserted in a class 1 integron about 3000 bp. The RAPD typing
demonstrated that banding patterns were very similar, indica-
ting a single RAPD type. This genotype has been conserved
during the chronic infection.
Conclusions: The presence of a MBL in a strain of CF is of great
concern because these patients are outpatients, but are in close
proximity to other CF patients. Capacity of this gene cassette to
excise from the integron and insert into another integron within
another bacterium of the same or different species is of
particular signiﬁcance when the new host is pathogenic.
Therefore it is eminent a regular screening/monitoring system
to prevent the wider spread of this worrisome resistance
determinant, especially among these CF isolates.
R1959
Detection of vancomycin-resistance genes and
virulence factors in vancomycin-resistant
enterococci isolated from patients hospitalised in
a large university clinical hospital during a two-
year period
M. Przybylski, H. Marchel, J. Rudnicka, M. Wroblewska,
M. Luczak (Warsaw, PL)
Objectives: Our aim was to analyze group of 98 vancomycin-
resistant enterococci (VRE) strains isolated from patients hos-
pitalized in large university clinical hospital in Warsaw, Poland
during two-year period (2000–2002). Strains were isolated from
blood, wound, peritoneal cavity, bile and feces. We tested VRE
strains for their ampicillin and glycopeptides susceptibility, type
of van genes carried and presence of enterococcal virulence
factors genes.
Methods: Strains were identiﬁed with commercial API identi-
ﬁcation system (bioMerieux) and subsequently checked for
species-speciﬁc Enterococcus faecium and Enterococcus faecalis ddl
genes by PCR. MIC for ampicillin, vancomycin and teicoplanin
was determined according to CLSI standards. PCR was used for
van genes detection using primers for vanA, vanB, vanC and
vanD genes. Virulence factors genes were detected using PCR
method with primers speciﬁc for ﬁve genes from cytolysin
complex, gelatinase (gelE), aggregation substance (agg), entero-
coccal protein A (AefaAfs, efaAfm) and enterococcal surface
protein (esp) genes.
Results: Among 98 strains of VRE, the most prevalent was
E. faecium (82.7%), according to biochemical identiﬁcation results.
Other VRE species embraced E. faecium, E. durans, E gallinarum
and two strains considered as Enterococcus spp. There was
discrepancy between identiﬁcation results using phenotypic
and genetic methods in case of 11.2% of strains. Resistance to
teicoplanin was detected in 96.9% of strains. Three strains of VRE
were ampicillin susceptible. The most prevalent glycopeptide
resistance gene was vanA (92.9% of VRE strains). Other types of
glycopeptide resistance geneswere vanB (three strains) and vanD
(one strain). In two strains of VRE, we were unable to detect any
van gene. The most prevalent virulence factor gene was efaA
(88.8%of strains).Other virulence factors geneswere also present:
esp in 72.4 % of strains, gelE (12.2%) and agg (10.2%). Various
genes of cytolysin complex were found in 11.2% of strains, but
there was no strain carrying complete set of cyl genes.
Conclusions: Basing on obtained results, we can assume, that
there was multiple insertion of different VRE strains into
hospital environment during analyzed two-years period. We
also characterized two groups of epidemic strains, and 7 groups
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of VRE, which were not responsible for epidemic infections.
Only in case of esp gene we were able to ﬁnd signiﬁcant
correlation between site of infection (blood) and carried
virulence factor (U-test, p < 0.01).
R1960
Evolution of antibiotic resistance and genetic
characteristics of Pseudomonas aeruginosa
isolates resistant to imipenem
E. Sevillano, C. Valderrey, F. Calvo, A. Umaran, L. Gallego
(Bilbao, ES)
Objectives: The aim of this study was to analyse the evolution
of the antibiotic resistance and genetic relatedness among
clinical isolates of P. aeruginosa resistant to imipenem during
the years 1999 and 2002.
Methods: The study included all imipenem resistant isolates
obtained at a Hospital from Bilbao (Northern Spain) during 1999
and 2002 (19 and 33 isolates respectively, both representing the
14% of total isolates). Susceptibility to antimicrobial agents was
determined by the disk diffusion method following the NCCLS
recommendations. The antibiotics tested were imipenem, me-
ropenem, ticarcillin, cefotaxime, ceftazidime, cefepime, amika-
cin, gentamicin and ciproﬂoxacin. Total DNA was used as target
for PCR-ﬁngerprinting experiments with primers RD1 and
ERIC2. To detect class 1 integrons, primers 3´CS and 5´CS were
used in ampliﬁcation experiments.
Results: Resistance to antibiotics tested was as follows (1999/
2002): meropenem (63%/46%), ticarcillin (21%/60%), cefotaxime
(63%/75%), ceftazidime (41%/33%), cefepime (32%/36%) ami-
kacin (0%/0%), gentamicin (37%/76%) and ciproﬂoxacin (47%/
64%). Using the RAPD technique, 10 distinct genotypes were
identiﬁed in 1999 and 23 in 2002. Patients with several isolates
maintained the same clone along time, being each clone speciﬁc
for each patient. Class 1 integrons of 1700, 1400 and 800 bp. were
detected in 50% of isolates from 1999. 82% of isolates from 2002
showed integrons ranging in size from 1700 to 600 bp (10
isolates bored combinations of two or three structures).
Conclusions: Amikacin showed the best activity against imipe-
nem resistant P. aeruginosa isolates but the results obtained
showed an increasing level of resistance to ticarcillin, cefotax-
ime, cefepime, gentamicin and ciproﬂoxacin. These ﬁndings
could be related to the increasing percentage of isolates boring
class 1 integrons. Despite the high genetic diversity found by
PCR-ﬁngerprinting, it is remarkable that the same integron
structures were present in different clones.
R1961
Multiresistant strains ofMannheimia haemolytica
isolated from lambs
G. Greco, M. Corrente, V. Martella, M.S. Lucente, D. Narcisi,
C. Buonavoglia (Valenzano, IT)
Objectives: To analyse the antimicrobial susceptibility of
Mannheimia haemolytica isolates from ill and healthy lambs.
Methods: Thirteen strains of M. haemolytica were isolated from
13 lambs. Nine isolates were obtained from the lungs of 9 lambs
affected with fatal pneumonia (mean age of 3 months) while 4
isolates were obtained from the nasal swabs of healthy lambs
(mean age of 6 weeks). All the strains were tested for suscep-
tibility to 20 antimicrobial drugs of different classes by the agar
diffusion method. The strains were also analysed by a PCR
speciﬁc for the sul2, strA and catA3 genes that encode for
resistances to sulfonamides, streptomycin and chloramphenicol.
Results: All of the 13 M. haemolytica strains (100%) displayed
a multiresistant pattern, i.e. they were resistant to drugs of
four or more different classes. In detail, 100% of the strains
were resistant to ampicillin, sulfamethoxazole, streptomycin
and fusidic acid. Seven out of 9 M. haemolytica strains
(77.7%) isolated from ill lambs were resistant to kanamicin; 5
(55.5%) to tetracyclines, 4 (44.4%) to erythromycin, 3 (33.3%)
to tilmicosina and 3 (33.3%) to co-trimoxazole. None of the
nasal isolates displayed resistance to those molecules. None of
the 13 strains displayed resistance to ampicillin combined
with sulbactam, augmentin, cephalosporins, norﬂoxacin, chlo-
ramphenicol and ﬂorfenicol. By PCR, the sul2 and strA genes
were detected in all the isolates, while the catA3-type gene
was not detected.
Conclusion: Analysis of M. haemolytica strains of ovine origin
revealed resistance to old-generation and low-cost molecules,
that are used commonly for the control of respiratory bacterial
infections, such as ampicillin, sulfonamides, streptomycin and
tetracyclines. No drug resistance was observed to high- cost
molecules such as beta-lactam combined with beta-lactamase
inhibitor or cephalosporins that are used rarely in ovine
breedings. The high rate of resistance observed in the isolates
from ill lambs suggests the need for surveillance of antibiotic
resistance in M. haemolytica strains of ovine origin, and the need
for adoption of therapeutic protocols based on the proﬁles of
sensivity/resistance to antimicrobials exhibited by the various
M. haemolytica isolates.
R1962
Screening for the presence of class 1 and 2
integrons in non-fermenting isolates from a
tertiary hospital: association with antibiotic
resistance phenotypes
D. Perimeni, K. Tryﬁnopoulou, P. Giakouppi, S. Vourli,
I. Tsimettas, D. Gianneli, A. Vatopoulos (Athens, Piraeus, GR)
Objectives: We assessed the association between multiresistant
(MDR) non-fermenting clinical isolates and the presence of class
1 & 2 integrons in a tertiary hospital.
Methods: A sample of 110 Pseudomonas aeruginosa and Acineto-
bacter calcoaceticus baumannii from various infections were
collected between 2002 and 2004 and tested for patterns of
resistance to beta-lactams (piperacillin, piperacillin/tazobac-
tame, ceftazidime, cefepime, imipenem), aminoglycosides
(amikacin, gentamicin, netilmicin, tobramycin) and ﬂuoroqui-
nolones. The isolates were screened for the presence of class 1
and class 2 integrons using sets of primers speciﬁc for 5 and 3 CS
of the integrase 1 and 2 genes respectively.
Results: Of the 110 non-fermenting isolates tested (70 P.
aeruginosa and 40 Ac. calco. baumannii) 30 (43%) isolates of P.
aeruginosa and 32 (80%) of Ac. calco. baumannii were multiresist-
ant (resistant in ‡2 of the following: beta-lactams, aminoglyco-
sides or quinolones). Screening for class 1 and class 2 integrons
showed 29 (41.4%) isolates of P. aeruginosa and 28 (70%) isolates
of Ac. calco.baumannii containing class 1 integron, while no
isolate contained integron class 2. 96.6% of the MDR Pseudo-
monas and 87.5% of the MDR Acinetobacter were class 1
integron positive (92% of total MDR isolates), while no integron
class 1 positive isolates were detected among the non-MDR
groups.
Conclusions: No class 2 integrons were detected in a two-year
period collection of non-fermenting clinical isolates in a tertiary
hospital covering a large Athens area. Yet, the presence of class 1
integrons in 92% of the MDR isolates show the importance of
these elements in multidrug resistance epidemiology.
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In vitro antibacterial susceptibility & drug interaction studies
R1963
Antibacterial, antifungal, and antiviral activities
of the lipophylic extracts of Pistacia vera
B. O¨zc¸elik, M. Aslan, I. Orhan, T. Karaoglu (Ankara, TR)
Objective: Antibacterial, antifungal, and antiviral properties of
ﬁfteen lipophylic extracts obtained from different parts (leaf,
branch, stem, kernel, shell skins, seeds) of Pistacia vera were
screened against both standard and the isolated strains for
antimicrobial activity.
Material and methods: Strains of Escherichia coli, Pseudomonas
aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Candida
albicans and C. parapsilosis were investigated by microdilution
method. Both Herpes simplex (DNA) and Parainﬂuenza viruses
(RNA) were used for the determination of antiviral activity of
the P. vera extracts by using Vero cell line. Ampicilline,
oﬂoxacin, ketoconazole, ﬂuconazole, acyclovir and oseltamivir
were used as the control agents.
Results: The extracts showed little antibacterial activity
between the range of 128–256 lg/ml concentrations whereas
they had noticeable antifungal activity at the same concentra-
tions. Kernel and seed extracts showed signiﬁcant antiviral
activity compared to the rest of the extracts as well as the
controls.
R1964
Antimicrobial resistance and ESBLs production
among Salmonella enterica non-typhi clinical
isolates in Plovdiv region, Southern Bulgaria
M. Murdjeva, M. Stoycheva-Vartigova (Plovdiv, BG)
Objectives: Adequate antibacterial therapy in salmonellosis
when necessary requires constant monitoring of the antibiotic
susceptibility. This together with careful consideration of the
phramacodynamics, pharmacokinetics and the in vitro distri-
bution of antibiotics is also a prerequisite for the successful
therapy. The aim of this study was focussed on antimicrobial
resistance of Salmonella enterica non-typhi isolates, the frequency
of multiresistant strains and the ESBLs producers in Plovdiv
region, Southern Bulgaria for 3 years period (2002-2004).
Methods: The study included 274 S. enterica non-typhi clinical
fecal isolates tested for in vitro antibacterial susceptibility. The
Kirby-Bauer testing was applied to a number of antibacterial
agents most of which in current use in medical practice when
certain indications are present. The double-disk synergism test
was performed for ESBLs production.
Results: The frequency of resistance among Salmonella isolates
was highest to ampicillin (94%), then to nalidixic acid (43%) and
chloramphenicol (26%) and lowest to ciproﬂoxacin and ceftri-
axone. The dominant Salmonella serogroup – OD, showed
signiﬁcantly higher resistance to nalidixic acid (55%) than OB,
which was more resistant (71%) to chloramphenicol. The
development of multiresistant strains (10%, mainly to ampicil-
lin, nalidixic acid, chloramphenicol and trimethorpim/sulfa-
methoxazole) marked an anxious trend. ESBLs producers were
limited – 7.5% among all tested strains.
Conclusion: We conﬁrm the highest worldwide in vitro sus-
ceptibility of S. enterica non-typhi serotypes to 3d generation
cephalosporins and ﬂuoro-quinolones in Plovdiv region, Bul-
garia. Resistance to chloramphenicol among the commonest
isolate – S. enterica serotype Typhimurium, which can poten-
tially give extraintestinal complications, may exclude applica-
tion of chloramphenicol in these forms of salmonellosis. ESBLs
producing strains although in low rate, indicate the necessity of
regular phenotypic screening for enzyme production. This may
lead to better treatment and strategies for prevention and
limitation of Salmonella spread in Southern Bulgaria.
R1965
Streptococcus agalactiae and neonatal infections:
place of pristinamycin in their prevention?
H.B. Drugeon, M.E. Juvin, C. Dib-Smahi, A. Bensalah (Nantes,
Paris, Levallois Perret, FR)
Objectives: The objective of this study was to evaluate the
in vitro activity of pristinamycin (PRI), belonging to the
synergistin group of antibiotics, against Streptococcus agalactiae
(group B streptococci, SGB), the main cause of neonatal
infections.
Methods: In total, 100 strains of SGB recently isolated from the
vagina of pregnant women and from newborns were tested.
MICs of PRI, penicillin (PEN), amoxicillin (AMX), erythromycin
A (ERY) and clindamycin (CL) were determined by agar
dilution according to the recommendations of the Comite´ de
l’Antibiogramme de la socie´te´ Franc¸aise de Microbiologie.
Results: 100% of isolates were susceptible to PEN (MICs: 0.03–
0.06 mg/L), AMX (MICs: 0.03–0.125 mg/L), PRI (MICs: 0.125–
0.25 mg/L), 77% were susceptible to ERY (MICs: 0.03–0.25 mg/
L) and 88% to CL (MICs: 0.03–0.5 mg/L). Twelve per cent of
isolates were highly resistant (MICs: 4 ‡ 16 mg/L) to ERY and
CL (ermB methylase), 9% were resistant (MICs: 1–2 mg/L) and
2% highly resistant (MICs > 16 mg/L) to ERY only.
Conclusions: Penicillin G or amoxicillin are recommended as
prophylaxis by French guidelines in women colonized with SGB
either during delivery or during the last month of pregnancy.
Macrolides are alternative, in penicillin-allergic patients. How-
ever, resistance to macrolides has risen restricting therefore their
use. Based on these in vitro study results, pristinamycin may be
an alternate treatment of SGB infections in penicillin-allergic
patients.
R1966
Evaluation of the antibiotic susceptibility of
Brucella strains by MIC method
O. Kaya, F.Z. Akcam, G. Yayli (Isparta, TR)
Objectives: Brucellosis is a zoonosis caused by several species
of the genus Brucella. It is a worldwide common infection
disease. The disease, which is generally seen in the country side,
is endemic for our region. The aim of this study is to evaluate
using the MIC50 and MIC90 values of various antibiotics against
clinical isolates of Brucella spp. from a brucellosis endemic
region.
Methods: Thirty-four Brucella isolates were collected between
1999-2005 from blood cultures of adult patients with brucellosis
at Suleyman Demirel University department of Clinical Bac-
teriology and Infection Diseases. Brucella species were identi-
ﬁed on the basis of typical Gram staining, carbon dioxide
requirements for growth, production of hydrogen sulphide and
urease, dye sensitivity (20–40 lg/ml basic fuchsin) and growth
in thionine. Sensitivity of the 34 strains was tested by using
Broth microdilution method. The lowest concentration that
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completely inhibited visual growth was recorded and inter-
preted as the MIC.
Results: All of the isolates were determined as B. melitensis. In
vitro activity of doxycycline, tetracycline, rifampin, streptomy-
cin, ciproﬂoxacin, levoﬂoxacin, ceftriaxone, amoxicillin against
clinical isolates of Brucella melitensis is shown in Table 1.
Conclusions: In conclusion, there is no important resistance
problem for antibiotics targeted to Brucella melitensis strains in
Isparta region. Thus, routine antibiotic susceptibility tests for B.
melitensis strains are not necessary. However, antimicrobial
resistance must be examined periodically.
R1967
An antibiotic sensitivity of Escherichia coli
strains in nosocomial surgical site infections
T. Pertseva, R. Bontsevych, K. Bogats’ka, O. Bratus’
(Dnipropetrovs’k, UA)
Objective: To study antibacterial sensitivity of Escherichia coli
(E. coli) strains in nosocomial surgical site infections (NSSI).
Signiﬁcance: We’ve established that E. coli is one of the most
problem pathogen of NSSI because of high resistant to antibi-
otics. Its sensitivity was determined.
Study design: Prospective case series study.
Setting: Eight surgical departments and 4 surgical intensive
care units in a central region’s hospital, city hospitals #4 and #6.
Study population: All patients with clinic and criteria of NSSI.
Methods: Thanks to nosocomial infections control programs
in 3 Dnipropetrovsk’s hospitals 118 strains of pathogens in
NSSI were isolated, 22 of which were are E. coli. Their
sensitivity to the antibacterial medicines (ampicillin, amoxy-
cillin/clavulanate, ciproﬂoxacin, peﬂoﬂoxacin, moxiﬂoxacin,
gentamicin, netilmicin, amikacin, cefazolin, cefuroxime, ceftri-
axone, cefoperazone, ceftazidime, cefepime, imipenem, me-
ropenem) was studied. The microbiological research was
accomplished using the ‘‘BioMerieux’’ growth mediums and
antibiotic disks.
Results: It was established that E. coli strains’ sensitivity was
minimal to ampicillin (0%), to cefazolin (18%), to ciproﬂoxacin,
cefuroxime, ceftriaxone, cefoperazone (27%), to peﬂoﬂoxacin
and ceftazidime (36.4 %) was intermediate to amoxycillin/
clavulanate, cefepime (41%), to gentamicin, amikacin (50%) and
to netilmicin (59%), was maximal to imipenem, meropenem
(100%) and to moxiﬂoxacin (77%).
Conclusions: It was established that E. coli are high resistant
pathogen of NSSI. Pathogens had the highest sensitivity only to
imipenem, meropenem, and moxiﬂoxacin. The seriousness of
problem is resistance to 2nd generation ﬂuoroquinolones.
R1968
In vitro susceptibility of Brucella melitensis to
antibiotics
E. Tanyel, A.Y. Coban, S. Tekin Koruk, S. Hepsert, O. Cirit,
H. Simsek, N. Tulek (Samsun, Aksaray, Ankara, TR)
Objectives: In this study, the in vitro susceptibilities of 50
clinical isolates of Brucella melitensis obtained from blood
cultures were determined to tetracycline, gentamycine, strepto-
mycin, ceftriaxone, ciproﬂoxacin, levoﬂoxacin, oﬂoxacin and
rifampin.
Methods: The isolates were identiﬁed on the basis of colony
morphology, CO2 requirement, H2S production, dye sensitivity
(basic fucsin and thionin), slide agglutination with monospeciﬁc
A and M antiserum and susceptibility to Tbilisi bacteriophage.
The microdilution method was performed in 96-well trays by
using Brucella broth. Two-fold dilutions of each drug were
prepared. All drugs were tested at 11 different concentrations
with one well used as a bacterial growth control. Final drug
concentrations were 32–0.03 lg/ml for all drugs. The MICs of
the antimicrobial agents were determined and according to it
MIC50 and MIC90 values were calculated.
Results: In this study, Brucella species were all isolated from
blood cultures and were identiﬁed as B. melitensis biotype-3. In
our study, while MIC90 value (0.25 lg/ml) of tetracyclin was
observed the lowest, MIC90 values of streptomycin and ceftri-
axone were obtained as 8 lg/ml.
Conclusion: In our study, MICs of ceftriaxone and streptomy-
cin were reported highly, so susceptibility of strains to these
agents should be followed during therapy.
R1969
Antimicrobial resistance and serotype
distribution of Streptococcus pneumoniae isolated
from patients with community-acquired
pneumonia in Crete, Greece
S. Maraki, E. Nioti, A. Georgiladakis, I. Neonakis, Z. Gitti,
Y. Tselentis (Heraklion, Crete, GR)
Objective: To determine the antimicrobial susceptibilities and
serotypes of Streptococcus pneumoniae isolated from clinical
specimens of patients with community-acquired pneumonia in
the University Hospital of Crete, Greece.
Material and methods: One hundred and one Streptococcus
pneumoniae isolates were studied. Seventy-one (70.3%) isolates
were recovered from sputum, 24 (23.7%) from bronchoalveolar
lavage, 3 (3%) from blood and 3 (3%) from pleural ﬂuid.
Susceptibility tests were done by the E-test method according to
manufacturer’s reccomendations and were interpreted accord-
ing to the NCCLS guidelines. The following antibiotics were
tested: penicillin G, cefuroxime, cefotaxime, ceftriaxone, cefep-
ime, imipenem, meropenem, erythromycin, clarithromycin,
clindamycin, roxithromycin, azithromycin, ciproﬂoxacin, levo-
ﬂoxacin, sparﬂoxacin, moxiﬂoxacin, chloramphenicol, tetracyc-
line, trimethoprim/sulfamethoxazole, and vancomycin.
Serotyping was performed by the capsular swelling method
with speciﬁc antisera.
Results: Nineteen isolates (18.8%) showed intermediate resist-
ance and 14 (13.9%) high-level resistance to penicillin. Erythro-
mycin, clarithromycin, clindamycin, roxithromycin,
azithromycin, chloramphenicol, tetracycline, and trimetho-
prim/sulfamethoxazole resistance rates were 21.8, 21.8, 6.9,
21.8, 21.8, 7.9, 16.8 and 14.8%, respectively. Multiple resistance
was observed in 11 strains. All isolates were sensitive to
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vancomycin and to all 4 quinolones tested. The most prevalent
serotype was 19, followed by 9, 3 and 14.
Conclusion: Our results emphasize the importance of contin-
ued surveillance of antimicrobial resistance proﬁles of S.
pneumoniae in our region for determining appropriate empiric
therapeutical regimens.
R1970
Resistance patterns in Pseudomona aeruginosa
M.A. Orellana, M. Aramendi, G. Galera, M.T. Sanchez, T.
Fernandez, V. Aparicio, M.A. Ame´rigo (Madrid, ES)
Objective: To study the sensibility and the resistance patterns
of P. aeruginosa isolated in different clinic samples in outpatients.
Methods: 180 P. aeruginosa strains were studied between Janu-
ary 2004 and September 2005. The identiﬁcation and sensibility
were performed by the MicroScan Walkaway System (DADE-
Behring) according to NCCLS criteria. The antibiotics studied
were: Amikacin (Ak), Aztreonam (AZT), Cefepime (Cpe),
Cefotaxime (Cft),Ceftazidime (Caz), Ciproﬂoxacin (Cp), Gen-
tamicin (Gm), Imipenem (Im), Meropenem (Me), Oﬂoxacin (Oﬂ),
Piperacillin/Tazobactam (P/T), Piperacillin (Pi), Ticarcillin (Ti)
and Tobramicin (To).
Results: P. aeruginosa were isolated in: urine 37 (20.56%),
wounds 61 (33.89%), otics exudates (ex.) 45 (25.0%), sputum 10
(5.56%), conjunctival ex. 8 (4.44%), nasopharingeal ex. 6 (3.33%),
vaginal ex. 3 (1.67%), urhetral ex.2 (1.11%), nasal ex. 1 (0.56%)
and other 7 (3.89%).-The sensibility to antibiotics studied were:
Ak 93.9%, Azt 86.1%, Cpe 95.6%, Cft 19.4%, Caz 97.8%, Cp
87.8%, Gm 85.6%, Im 93.9%, Me 99.5%, Oﬂ 74.6%, P/T 99.6%, Pi
97.8%, Ti 95.0% and To 95.6%.-The resistance patterns more
frequent were: Sensitive to all antibiotics studied 17 (9.44%);
resistance to Cft: 95 (52.78%); resistance to Cp + Oﬂ + Cft: 12
(6.67%); Cft + Gm: 4 (2.22%); Cp + Oﬂ + Cft + Azt: 7 (3.89%);
Cp + Oﬂ: 4 (2.22%); Cft + Azt: 6 (3.33%); Cft + Im: 3 (1.67%);
Gm: 3 (1.67%); Cp + Oﬂ + Im: 3 (1.67%); Gm + To + Ak + C-
p + Oﬂ + Cft + Caz + Cpe + Azt: 3(1.67%) and other 23
(12.78%).
Conclusions: Wounds were the samples where P. aeruginosa
was isolated most frequent.-The antibiotics studied have a good
activity against P. aeruginosa, excep Cefotaxime (only 19.4%).-
There is a low percentage of P. aeruginosa sensitive to all
antibiotics studied.-The resistance patterns most frequent were:
resistance to Cefotaxime and Cefotaxime with quinolones
(Cp + Oﬂ).
R1971
In vitro activities of four new antibiotics against
blood isolate VGS collected in Southwest
Finland, 1993 - 2004
M. Lindgren, O. Meurman, J. Jalava Turku, FI
Objectives: The aim of our study was to evaluate the variation
of the in vitro activities of the new antibiotics telithromycin,
linezolid, quinupristin/dalfopristin and levoﬂoxacin against 263
viridans group streptococcae, collected in Turku, Finland.
Methods: 263 viridans group streptococci (VGS) isolated from
blood samples in Turku University Central Hospital from 1993
to 2004 were tested. The isolates were identiﬁed with an API 20
Strep test and a Vitek 2 GPC-card. Antibiotic susceptibility
testing was done with agar dilution method on Mu¨ller-Hinton II
medium, according to CLSI. MIC values were tested against
levoﬂoxacin, linezolid, quinupristin/dalfopristin and telithro-
mycin. Linezolid susceptibility was conﬁrmed with Disk diffu-
sion method and levoﬂoxacin susceptibility with Etest.
Results: Based on the minimum inhibitory concentrations all
the VGS isolates were susceptible to telithromycin. Rank order
of the antibiotic susceptibility was: Telithromycin (100%) >
linezolid (98.9%) > levoﬂoxacin (94.6%) > quinupristin/dalfopr-
istin (57.0%). Based on the agar dilution method, 3 isolates were
non-susceptible to linezolid (MIC 4 mcg/ml). However, the disk
diffusion method revealed that those isolates were susceptible to
linezolid (zone range 26–33 mm). Levoﬂoxacin non-susceptibil-
ity rate was 5.4%, and high-level resistance was noted in ﬁve
(1.9%) isolates. Results from the levoﬂoxacin Etests conﬁrmed
that those 5 isolates were resistant to levoﬂoxacin. Only 57% of
the VGS isolates were susceptible to quinupristin/dalfopristin
(Q/D) whereas the amount of Q/D resistant isolates was 11%.
Conclusion: In our material, telithromycin was the most active
antimicrobial agent towards VGS. Linezolid was the second
effective antibiotic tested. The reason for higher linezolid MIC
values with an agar dilution method was probably due to the
method’s inferior accuracy and sensitivity compared to the disk
diffusion method. Also levoﬂoxacin showed good in vitro
activity against VGS, although the susceptibility rate was
lower than has been reported earlier. Contrary to the previous
studies, quinupristin/dalfopristin was the least effective of the
new antimicrobial agents.
R1972
Tigecycline in vitro activity against Acinetobacter
spp. resistant to other drugs from Europe –
T.E.S.T. Program 2006
T. Stevens, J. Johnson, D. Hoban, B. Johnson, S. Bouchillon,
M. Dowzicky (Schaumburg, Collegeville, US)
Background: Tigecycline is a glycylcycline, a new generation of
tetracyclines signiﬁcantly different to be classiﬁed as a separate
antimicrobial class. Glycylcyclines are being developed to
overcome the problem of bacterial resistance to tetracyclines
and other antimicrobials. Tigecycline is better tolerated and is
more active than tetracyclines against a wide variety of Gram-
positive and Gram-negative bacteria including Acinetobacter
spp. The T.E.S.T. program determined the in vitro activity of
TIG against Acinetobacter resistant to two or more of pipera-
cillin-tazobactam (PT), levoﬂoxacin (LVX), ceftriaxone (CAX),
cefepime (CPE), amikacin (AK), minocycline (MIN), ceftazidime
(CAZ), and imipenem (IMP). Study strains were collected from
33 hospitals in Europe throughout 2004-2006.
Methods: A total of 435 clinical isolates were identiﬁed to
species level in participating sites and conﬁrmed by the central
laboratory. Minimum Inhibitory Concentrations (MICs) were
determined by the local laboratory using supplied broth
microdilution panels and interpreted according to CLSI guide-
lines, with TIG susceptible breakpoint deﬁned as < 2 mcg/ml.
Results: Resistance rates for comparator drugs were CAX 35%,
CAZ 35%, LVX 29%, PT 28%, CPE 23%, AK 18%, IMP 12%, and
MIN 3.2%. TIG inhibited 100% of all strains of Acinetobacter
resistant to 2 or more drugs. There were no TIG-resistant
(>8 mcg/mL) strains found. TIG MIC50/90 was 0.5/1 mcg/ml,
respectively, for strains resistant to CAX, AK, IMP, CAZ and 1/
2 mcg/ml for strains resistant to LVX, PT, CPE and MIN. The
modal TIG MIC for resistant strains was 1 mcg/ml compared to
0.12 mcg/ml for strains without resistant parameters, indicating
an 8-fold diminishment of activity.
Conclusions: TIG inhibited most Acinetobacter strains resistant
to one or more other drugs in this study, although the higher
TIG MICs seen for these strains suggests some linkage to
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resistance mechanisms for other drugs. TIG remained effective
in inhibiting multi-drug resistant Acinetobacter spp., further
broadening its wide spectrum of activity vs. drug-resistant
bacteria.
R1973
Penetration and activity of linezolid and
vancomycin in S. epidermidis bioﬁlms
S. Ballesta, J.M. Rodrı´guez-Martı´nez, I. Garcı´a, M.C. Conejo,
A. Pascual (Seville, ES)
Objectives: The aim of this study was to study the activity of
linezolid and vancomycin against S. epidermidis bioﬁlms on
silicone catheters and to evaluate the penetration of both
compounds in the bioﬁlms.
Methods: S. epidermidis ATCC 12228 (slime producer, ica+)
and S. epidermidis RP62A (non slime producer, ica-) were
used. The activity of the drugs at different concentrations
against 6 and 24 hour-old bioﬁlms was evaluated by colony
counting. The penetration of both antibiotics in bioﬁlms was
also analized. For bioﬁlms preparation, 50 ll of diluted
overnight planktonic cultures were inoculated on individual
sterile, black, polycarbonate membrane ﬁlters resting on agar
culture medium and incubated at 35C for 24 h. To measure
antibiotic penetration, black polycarbonate membrane ﬁlters
were placed on top of 24-h old bioﬁlms. A concentration disk
(30 lg) of linezolid or vancomycin was placed on top of this
structure. Disk was removed after speciﬁed exposure times.
The drug concentrations in disk were measured by a bioassay
method.
Results: The MICs values of linezolid for both strains were
1 mg/L. The MICs value of vancomycin for slime and non-slime
producing S. epidermidis strains were 1 and 2 mg/L, respect-
ively. None of the concentrations evaluated of linezolid or
vancomycin were able to completely sterilize the catheter
surface. At low concentrations (1 mg/L), linezolid was signiﬁ-
cantly more active than vancomycin against sessile S. epider-
midis. For the slime producing strain, bacterial survival in
bioﬁlms incubated with 1 mg/L of either linezolid or vancomy-
cin were 0.25% and 27% respectively respect to the controls
without antimicrobial. At high concentrations (16 mg/L), the
number of surviving bacteria of bioﬁlms incubated with linezo-
lid was 58 times lower than that observed with vancomycin for
the slime producing strain. For both strains, more than 60% of
the initial concentration of linezolid in the disk was released
through the bioﬁlm in the ﬁrst 60 minutes. These percentages
increased until 75% after 3 or 6 hour incubations. No differences
were observed between slime producing and non-producin
strains. At 3 hours, only 20% of the initial load of vancomycin in
the disk penetrates into the bioﬁlms of both S. epidermidis strains.
Conclusion: Linezolid showed high bactericidal activity against
S. epidermidis bioﬁlm on silicon elastomer. This activity is
partially owed to its high penetration and concentration in
bioﬁlms.
R1974
Oral streptococcal strains isolated from
odontogenic infections and their susceptibility to
antibiotics
G. Bancescu, S. Dumitriu, A. Bancescu, M. Pana, M. Andrei,
N. Skaug (Bucharest, RO; Bergen, NO)
Objectives: Oral streptococci are the main facultatively anaer-
obic bacteria involved in odontogenic infections. The aim of this
study was to identify at species level and to investigate the
antibiotic susceptibility of oral streptococcal strains isolated in
pure culture or in association with other bacteria from 100 pus
samples collected from Romanian patients with different odon-
togenic infections.
Methods: The isolates were identiﬁed at species level using the
Rapid ID 32 STREP system (Bio-Merieux, France). Susceptibility
testing of the isolates to: penicillin G (PG), ampicillin (AM),
erythromycin (EM), clindamycin (CM) and tetracycline (TC) was
performed by the Etest (AB Biodisk, Sweden). In addition, the
phenotype of EM resistance was identiﬁed using a double disk
diffusion test.
Results: The isolates belonged to the following species: Strep-
tococcus anginosus, Streptococcus constellatus, Streptococcus
intermedius, Streptococcus mitis, Streptococcus oralis, Strepto-
coccus sanguinis (formerly known as S. sanguis) and Strepto-
coccus gordonii. The MICs (mg/l) ranges were: PG 0.008 to 0.75
(85.3% Susceptible), AM 0.016 to 0.5 (97.9% Susceptible), EM
0.016 to 4 (90.5% Susceptible), CM 0.016 to 0.047 (100%
Susceptible) and 0.047 to 256 TC (50.5% Susceptible). The
isolates with intermediate susceptibility to beta-lactam antibiot-
ics belonged to: S. sanguinis, S. mitis and S. oralis species.
Resistance to EM was detected among all species, except for: S.
constellatus, S. intermedius and S. gordonii, and M phenotype
was established. Resistance to TC was found within all species
but S. gordonii.
Conclusions: Reduced susceptibility to PG or to both PG and
AM was found among S. oralis, S. mitis and S. sanguinis strains,
while resistance to EM has also been detected in some S.
anginosus strains. In contrast, CM was fully active and therefore
might be an alternative for antimicrobial therapy of odontogenic
infections in Romanian patients. As these are mostly mixed
infections, often involving strictly anaerobic bacteria too, which
are frequently beta-lactamase producers, the association of a
penicillin and a beta-lactamase inhibitor, like Amoksiklav, is
recommended.
R1975
Telithromycin resistance in clinical isolates of
beta-haemolytic streptococci
P.A. Romero, A. Go´mez, S. Cortizo, L. Moldes, M. Trevin˜o, F.
Pardo, B.J. Regueiro (Santiago de Compostela, ES)
Objective: This study evaluated the current status of antimi-
crobial resistance in clinical isolates of beta-haemolytic strepto-
cocci.
Methods: From January 2004 to September 2005, 180 different
isolates of beta-haemolytic streptococci (54% Group A, 7%
Group B, 27% Group C, 4% Group F and 14% Group G) were
collected from clinical samples of in and out patients. Suscep-
tibility testing was assayed by disk-diffusion method according
to CLSI (previously NCCLS) guidelines.
Results: All of the isolates were susceptibles to penicillin,
cefotaxime, imipenem and vancomycin. There were 3% of
strains intermediate or resistant to levoﬂoxacin. Not suscepti-
bility to erythromicin was detected in 26% of the isolates (8
Group A, 2 Group B and 1 Group C), and 14% to clyndamicin.
Eleven strains (6%) were not susceptibles to telithromycin. All of
these were resistant to erythromicyn and belonged to Group A
(n = 8), Group B (n = 2) and Group C (n = 1) beta-haemolytic
streptococci.
Conclusion: The low prevalence of resistance to telithromycin
suggests the potential utility of this drug to treat infections
produced by beta-haemolytic streptococci in our Health Care
Area.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
R1976
The susceptibility of Escherichia coli strains
isolated from urinary tract infections in an
infectious diseases clinic in Romania
M. Delagramatic, S. Iacob, G. Ene, I. Ene, S. Botea,
M. Popoiu (Bucharest, RO)
Objectives: Establishing the compared susceptibility of E. Coli
strains isolated from patients with uncomplicated UTI hospit-
alized in 2002 compared to year 2004 in the ‘‘Prof. Dr. Matei
Bals’’ Institute for Infectious Diseases, Bucharest.
Methode: Retrospective study regarding the in vitro testing
susceptibility of 1496 strains of E. Coli isolated from urine
cultures. The standard disk diffusion method was used for
susceptibility testing, and the results were interpreted according
to NCCLS standards. The antibiotics used for testing were:
nalidixic acid (An), Nitrofurantoin (Fd), Ciproﬂoxacin (Cp),
Amoxicillin/Clavulanate (Aug), Cefoperazone (Cpr), Piperacil-
lin (Pi), Ticarcillin (Ti), Ticarcillin/Clavulanate (Ti/C), Ampicil-
lin (Am).
Results: The cumulative results of the susceptibility are showed
bellow. The presence of ESBL producing strains has been
determined in 7 cases (5.78%) from 121 analyzed.
Compared susceptibility 2002–2004: Antibiotics 20022004 Fd
96.65%97.05%An 76.54%81.81%Cp 80.01%82.01%Aug
68.04%71.99%Cpr 80.81%85.02%Pi 50%42.98%Ti
33.33%37.67%TI/C 75%80.76%Am 36.89%35.02%
Conclusions: The results suggest a constant susceptibility of
E. coli strains for the tested antibiotics during 2002–2004. A high
susceptibility for Nf, An, Cp, Cpr has been maintained, also a
moderate one for Aug and Ti/C and a very low susceptibility
for Pi, Ti, Am. ESBL producing strains were isolated in 5.78% of
the cases.
R1977
The importance of occurrence of the Enterococcus
faecalis multiresistant isolates to antibacterial
drugs
B. Kocic, S. Antic, G. Randjelovic, P. Stojanovic (Nis, CS)
Objectives: of our paper were to establish the frequency of the
resistance of the Enterococcus faecalis isolates to penicillin,
ampicilin, vancomycin, gentamycin (high level of resistance,
RHL), streptomycin (RHL), tetracycline, chloramphenicol,
amoksicilyn with clavulanic acid, ciproﬂoxacyn, norphloxacin,
ryphampin, by the application of the standard methods. The
study included 112 enterococcus isolates of different sample
types taken within the Institute for Public Health Nisˇ.
Methods: The sensitivity to antibiotics was tested by the disc-
diffusive method of Kirby-Bauer. The isolates that expressed
resistance to these antibiotics in the disc-diffusive test were
submitted to the agar-diluting test or E- test.
Results: Among the types of E. faecalis there were 29 isolates
resistant to penicillin (MIK ‡ 64 lg/mL) and at the same time
were sensitive to vancomycin. There is a statistically signiﬁ-
cant difference in the resistance to penicillin and ampicillin
(v2 = 17.83 for p < 0.01). Resistance of E. faecalis to chloram-
phenicole (26.6%), tetracycline (48.5%) and rifampin has been
noticed. The testing results of 17 enterococcus isolates to
gentamicin and streptomycin showed resistance of a high
level. The differences in resistance between gentamicin and
streptomycin were statistically insigniﬁcant for p = 0.005. As
compared to penicillin, vancomycin performed a signiﬁcantly
greater efﬁciency (v2 = 33.16 for p < 0.01), while the efﬁciency
related to ampicillin was on the border of statistical
signiﬁcance (v2 = 6.14 for p < 0.01). Ciproﬂoxacin showed
signiﬁcantly higher efﬁciency as compared to norﬂoxacin
(v2 = 17.59 for p < 0.01). We registered the resistance of E.
faecalis to chloramphenicol, tetracycline and rifampin. As
compared to penicillin, vancomycin performed a signiﬁcantly
greater efﬁciency (v2 = 33.16 for p < 0.01), while the efﬁciency
related to ampicillin was on the border of statistical
signiﬁcance (v2 = 6.14 for p < 0.01). Ciproﬂoxacin showed
signiﬁcantly higher efﬁciency as compared to norﬂoxacin
(v2 = 17.59 for p < 0.01). RVN frequency to aminoglycozides is
high.
Conclusion: Levee and found mechanisms of the enterococcal
isolate resistance are seriously limiting abilities of antibiotic
therapy and indicate the necessity of the usage, especially of the
wide spectrum cephalosporine and vancomycine.
R1978
Antibiotic susceptibilities of group
A beta-haemolytic streptococci clinical isolates
B. Bayraktar, F. Basari, B.A. Borsa, E. Bulut (Istanbul, TR)
Objectives: The aim of this study was to determine penicillin G
(PG) and erythromycin (E) MIC values and antibiotic resistance
in Group A beta-haemolytic streptococci (GABHS) isolated from
various clinical samples in our hospital between February 2004-
October 2005 prospectively.
Methods: Total 49 GABHS strains isolated from throat (n: 34),
and wound (n: 15) specimens were included. Identiﬁcation
based on characteristic haemolysis on sheep blood agar;
sensitivity to bacitracin, and resistance to trimethoprim-sulfa-
methoxazole; a commercial latex agglutination test for group-
ing streptococcal strains (AVIPATH STREP, Omega
Diagnostics, Scotland, UK ). E and PG MIC values were
determined by the E-test method. Antimicrobial susceptibility
testings of wound isolates were performed for clindamicyne
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(DA), levoﬂoxacine (LEV), and tetracycline (TE) by disc
diffusion method.
Results: All of the isolates were found susceptible to PG and 6
(12.2%) strains resistant to E by E-test method. All of the wound
isolates were susceptible to LEV, 2 resistant to DA and 4
resistant to TE by disc diffusion method.
Conclusion: Penicillin is still the ﬁrst choice of the treatment of
GABHS infections. Although erythromycin is an alternative in
patients who have penicillin hypersensitivity, there is an
increasing resistance against it. Levoﬂoxacin and clindamycin
could be the other therapy options. Therefore antibiotic suscep-
tibility testing and resistance surveillance of GABHS should be
done.
R1979
In vitro activity of cefepime against clinical
isolates from patients in Tehran, Iran
A. Rastegar Lari, S. Razavi, H. Mostafavi, B. Mostafavi,
M. Habibi (Tehran, IR)
Objective: Infections caused by resistant bacterial pathogens,
including Gram positive and Gram-negative bacteria, have
become an increasing problem with respect to therapy in many
of the Irananian medical center. Cefepime has been recently
introduced in Iran, which is highly effective against these
organisms. The purpose of this study was to determine in vitro
activity of this antibiotic against isolated organism from
patients, before introducing to the market, in Iran.
Methods: In vitro activity of Cefepime were tested against 304
clinical isolates samples including Escherichia coli (n = 167),
Klebsiella (n = 49), Staphylococcus (n = 52), Pseudomonas (n = 18)
and other isolates (n = 18), obtained during January–May 2005
from patients of Hazrat Rasoul hospital in Tehran, Iran.
Minimum Inhibitory Concentration (MIC) of antibiotics was
adjusted using an agar dilution method, described by NCCLS.
Results: The overall susceptibility rate for Cefepime against all
isolates was 75%. Against Pseudomonas aeroginosa and Staphylo-
coccus spp strains Cefepime was less active (40% resistance) and
against Enterobacteriaceae Cefepime was excellent activity (more
than 80% susceptibility).
Conclusion: Cefepime could be a valuable alternative for the
treatment of infections due to multiply resistant organisms in
Iran. Hence, it seems this drug could be suitable for empiric
coverage of serious nosocomial infections.
R1980
Inhibitory activity and killing activity of extracts
from the gall of Quercus infectoria against
methicillin-resistant Staphylococcus aureus
S. Voravuthikunchai, S. Chusri, P. Kleiner (Hatyai, Songkla, TH;
Munich, DE)
Objectives: Methicillin-resistant S. aureus has been well-docu-
mented as a major cause of hospital-acquired infection. Medi-
cinal plants have been increasingly used to reduce the problem
of antibiotic-resistant bacteria. Quercus infectoria was previously
reported from this laboratory to produce high antibacterial
activity. The aims of this study were to closely investigate the
antibacterial activities of the extracts from Q. infectoria galls and
to determine the effects of these extracts on the growth of clinical
MRSA strains.
Methods: Fifty-one clinical isolates of MRSA were collected
from Hat-Yai hospital. All isolates were multidrug-resistant.
Galls of Q. infectoria were extracted with acetone, ethyl acetate,
95% ethanol, and water. Paper disc agar diffusion method was
used to determine the antibacterial activity of these extracts.
Minimal inhibitory concentration (MIC) and minimal bacteri-
cidal concentration (MBC) were evaluated by modiﬁed broth
microdilution method according to National Committee for
Clinical Laboratory Standards. Growth curves demonstrating
bacteriostatic and bactericidal activities of Q. infectoria against
MRSA strains were documented for 24 h.
Results: All extracts of Q. infectoria show antibacterial activities
against all strains of MRSA. The inhibition zones ranged from
11–23 mm. The ethanolic extract demonstrated the largest
inhibition zone. Most of the MRSA strains treated by the
ethanolic extract of Q. infectoria exhibited the MIC and MBC
values at 0.4 and at 1.6 mg/ml, respectively. At the MIC
concentration, the growth of a representative was inhibited and
gradually decreased after 16 h incubation. The survival cells of
the MRSA were not detected within 2 h after treated with the
extract at its MBC concentration. Staphylococcus aureus ATCC
25923, a reference strain showed similar results.
Conclusion: The ethanolic extract of the galls of Q. infectoria
have a high potential as antibacterial agent against MRSA. More
detailed studies on the extract may provide an alternative way
to treat infections caused by MRSA. Use of the active com-
pounds could be developed as antibacterial agent in order to
reduce problems with antibiotic-resistant bacteria in the hospi-
tals.
Acknowledgement: This work was supported by Thailand
Research Fund, Fiscal year 2005–2008.
New antimicrobials
R1981
Plant extracts as new anti-tuberculous agents,
evaluation by MRA
E. Banﬁ, G. Scialino, F. Cateni, G. Innocenti (Trieste, Padua, IT)
Objectives: Tuberculosis (TB) is a disease of antiquity, which is
thought to have evolved sometime between the seventh and
sixth millennia BC. Current estimates suggest that one third of
world’s population are infected resulting in some 2 million
deaths per year. Pulmonary TB, the most common type of the
disease, is usually acquired by inhalation of the bacillus and
causes irreversible lung destruction, although other organs are
sometimes involved. 50 years ago the introduction of the ﬁrst
drugs for TB treatment (streptomycin, para-aminosalicylic acid,
isoniazid) led to optimism that the disease could be controlled if
not eradicated. However, since the late 1980s the disease has
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
been undergoing a resurgence driven by variety of changes in
social, medical and economic factors. Concomitant with the
resurgence of TB has been the occurrence of multidrug-resistant
mycobacterium strains MDR, which has exposed the weakness
of the current drug armamentarium. Given that in many regions
of the world, effective, indigenous therapeutic antimycobacterial
agents may be crucial to improving overall public health, and
therefore enhancing economic well-being, we must make every
effort to develop anti-tuberculous agents which are based on
renewable, relatively inexpensive materials, to get novel therapy
starting from natural products
Methods: Plant extracts were obtained by distillation or pur-
chased from manufacturers. The antimycobacterial activity of
crude or puriﬁed plant extracts and essential oils was evaluated
in vitro against Mycobacterium tuberculosis reference and
clinical strains, including MDR isolates. MRA, microdilution
resazurin assay, was employed as a short-term test that has been
already evaluated to measure antibiotic susceptibility of tuber-
cular clinical isolates (Banﬁ E et al JAC 2003 52: 796-800; Scialino
G et al Chemotherapy 2006 in press)
Results: Interesting inhibiting activity comparable to standard
anti-TB drugs were obtained for Euphorbia cerebrosides and
Cetraria usnic acid; Rhododendron, Melaleuca and Leptosper-
mum essential oils had minimal inhibiting concentrations in a
range of 0.25–0.025% (v/v). Most plant extracts had no toxic
effect against human cells in vitro
Conclusion: Novel therapy can start from natural products,
developing anti-tuberculous agents based on renewable, relat-
ively inexpensive materials like plant extracts; MRA proved to
be a rapid assay suitable to evaluate the antitubercular activity
of different preparations
R1982
Antimicrobial activity of novel N1-benzylidene-
pyridine-4-carboxamidrazones against
Clostridium difﬁcile
L.J. Wheeldon, T. Worthington, D.L. Rathbone, A.C. Hilton, P.A.
Lambert, T.S.J. Elliott (Birmingham, UK)
Objectives: Clostridium difﬁcile is the leading cause of hospital
acquired antibiotic-associated diarrhoea and colitis. Although
the incidence of C. difﬁcile infection has risen signiﬁcantly over
the past decade, there have been very few developments in the
treatment and prevention of infection. Recent studies have
demonstrated that a novel N1-benzylidene-pyridine-4-carbox-
amidrazone (compound LW/1/1) and several analogues devel-
oped at Aston University have signiﬁcant antimicrobial activity
against many Gram-positive organisms associated with hospi-
tal-acquired infections, including Staphylococcus aureus and
coagulase-negative staphylococci. This study was undertaken
to investigate the antimicrobial efﬁcacy of compound LW/1/1
and analogues against clinical isolates of C. difﬁcile.
Methods: Antimicrobial efﬁcacy of 8 novel N1-benzylidene-
pyridine-4-carboxamidrazones was assessed by agar diffusion
against thirty-two clinical isolates of C. difﬁcile and C. difﬁcile
NCTC 11204. Minimum inhibitory and bactericidal concentra-
tions were determined in line with NCCLS guidelines on
those compounds demonstrating antimicrobial activity by agar
diffusion. Data were analysed by the two-tailed Mann–Whitney
U-test.
Results: The novel N1-benzylidene-pyridine-4-carboxamidra-
zone compound LW/1/1 and an analogue, designated LW/1/
16, demonstrated activity against all 33 strains of C. difﬁcile
tested. The mean minimum inhibitory concentration for com-
pounds LW/1/1 and LW/1/16 was 6.43 ug/ml (range 4 to 8)
and 29.21 ug/ml (range 2 to 256) (p = 0.1958) respectively. The
minimum bactericidal concentration for compounds LW/1/1
and LW/1/16 was 7.27 ug/ml (range 4 to 16) and 37.76 ug/ml
(range 2 to 256) (p = 0.0004) respectively.
Conclusion: Compound LW/1/1 and L/W1/16 are novel N1-
benzylidene-pyridine-4-carboxamidrazones demonstrating
excellent in vitro antimicrobial activity against clinically relevant
strains of C. difﬁcile.
R1983
A pilot study on the efﬁcacy of ertapenem for
early-onset ventilator-associated pneumonia
M. Saballs, M. Pujol, L. Garcia Huete, J. Ballu´s, F. Tubau,
F. Gudiol (L’hospitalet de Llobregat, ES)
Background: Early ventilator-associated pneumonia (VAP) is a
frequent complication of unconscious patients with central
nervous system disorders. Ertapenem might be useful for this
indication, which has not been considered for licensing in the
drug approval process.
Objective: To evaluate the usefulness and safety of ertapenem
in the treatment of VAP.
Methods: From July 2004 to July 2005, we administered
ertapenem (1 gr iv/24 h) to 15 adult patients hospitalized for
less than 72 hours and diagnosed of early-onset VAP. Pts with
prior antibiotics or recent hospitalization were not considered
candidates. Administration of other antibiotics was not allowed.
Assessment of efﬁcacy and safety was done at the end of
therapy and a month thereafter. MICs of ertapenem were
determined by E-test.
Results: Nine men and 6 women were included, with a mean
age of 43 years, and a mean APACHE II score on admission of
19.8, who received a mean of 7.4 days of ertapenem therapy.
Underlying conditions were: cranial trauma (4), intracranial
haemorrhage (4), stroke (1), drug intoxication (3), polytrauma-
tism (2), Guillain-Barre´ syndrome (1). Causative organisms
were: H. inﬂuenzae (alone in 5 cases, with S. aureus in 3, and
with S. pneumoniae in 1), MS – S. aureus (2), S. pneumoniae (2),
E. coli (1) and unknown (1). One patient was withdrawn at day
7due to thrombocytopenia and was considered a failure,
although pneumonia was improving. The remaining 14 pts
were considered clinically cured at all assessments. We did not
observe emergence of resistance nor respiratory superinfec-
tions, but 2 pts had catheter-related bacteraemia due to MR-S.
epidermidis. The drug was well-tolerated; 3 pts presented a
transient increase in aminotransferase levels. Two pts died of
unrelated causes (progressive brain damage) lately during
hospitalization.
Conclusions: Ertapenem appears to be suitable for early-VAP
therapy. This pilot study opens the door for subsequent
controlled trials considering this indication
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Epidemiology of MRSA, VRE & other Gram-positives
R1984
A mortal case of methicillin-resistant
Staphylococcus aureus prosthetic aortic valve
endocarditis with a paravalvular abscess and
mediastinitis
O. Memikoglu, A. Yesilkaya, E. O¨zc¸inar, C. Tolunay Kaya,
S. Eryilmaz (Ankara, TR)
Objectives: To present an aortic valve endocarditis with para-
valvular aortic abscess and mediastinitis that required extensive
surgical debridement in addition to broad-spectrum antimicro-
bial chemotherapy.
Methods: The record of 53-year-old man with prosthetic aortic
valve admitted to Cardiovascular Surgery Department with
fever and purulent drainage after 3 weeks postoperatively was
evaluated in detail.
Results: A 53-year-old male with a history of aortic valve
replacement and coronary artery bypass (CABG) surgery
3 weeks ago was readmitted to our institution on the 5th day
of discharge with fever greater than 38C and purulent drainage
from sternum. On admission the following sings were noted:
blood pressure 110/70 mmHg, pulse rate 124/min, body tem-
perature of 39.7C, a systolic murmur, C-reactive protein
350 mg/L, erythrocyte sedimentation rate 98 mm/hour, hae-
moglobin 11.4 g/dl, white blood cell 17.9 · 109/L, platelet
count 379 · 109/L, creatinine 1 mg/dl. Because of mediastinitis
and history of cardiovascular surgery vancomycin plus gen-
tamicin plus rifampin began empirically due to risk of endo-
carditis. On the 3rd day of the therapy MRSA was isolated from
2 blood and surgical wound cultures. Transesophageal echocar-
diographic examination revealed a huge (3.5 · 1.5 cm) pros-
thetic aortic valvular vegetation, mild aort and mitral valve
regurgitation. An ill-deﬁned hypoechoic area located between
prosthetic aortic and native mitral valves, which was considered
as an abscess. Colour Doppler showed features of blood entry
into this space. On the same day the diagnosis of aortic valve
endocarditis and paravalvular abscess was made on the basis of
physical examination, laboratory ﬁndings and transoesophageal
echocardiography. Urgent surgical intervention by means of
complete debridement of all infected tissue was made on under
antimicrobial chemotherapy, because of haemodynamic deteri-
oration and risk of embolization. Despite intensive surgical and
appropriate medical intervention, patient was died because of
sepsis and biventricular failure on the same day of operation.
Conclusion: The complicated prosthetic aortic valve endocar-
ditis with an abscess formation requires extensive surgical
debridement plus appropriate antibiotic therapy. However,
treatment will fail to control infection and as a result of sepsis,
mortality will occur.
R1985
Outbreak of PVL-producing MRSA among
newborns in a Greek tertiary hospital
A. Vasdeki, E. Akrivoussi, I. Pachiadakis, V. Drossou, A. Gaki,
E. Petinaki, A. Maniatis (Larissa, GR)
Objectives: To describe an outbreak of MRSA PVL-producing
strains caused impetigo among newborns in a Labour Ward of a
tertiary Greek Hospital.
Methods: From June to September 2005, cultures from skin
lesions were collected from 24 newborns in the Labour Ward of
the University Hospital of Larissa that suffering from impetigo.
Gram stain of pus showed many polymorphonuclear leucocytes
with intracellular or extracellular gram-positive cocci, while the
cultures yielded pure growth of staphylococci on blood agar
plates. Strains were identiﬁed as S. aureus by Gram stain,
catalase and coagulase activity. Susceptibility tests to various
antimicrobial agents (penicillin, co-trimoxazole, oﬂoxacin, clin-
damycin, erythromycin, gentamicin, tobramycin, kanamycin,
amikacin, rifampicin, tetracycline, fusidic acid, vancomycin and
teicoplanin) were performed by disk diffusion method and by E-
test. The presence of PVL-gene was assessed by PCR. The
clonality of the isolates was examined by pulse-ﬁeld gel
electrophoresis analysis. Nasal screening for carriage of S.
aureus was performed ﬁrst in the personnel of the Labour
Ward (25 persons) and next in the mothers of the infected
children. Isolates identiﬁed as S. aureus were further analyzed
for antibiotic susceptibilities, genetic relatedness by PFGE, and
PCR for the detection of the PVL-gene.
Results: All isolates were resistant to oxacillin (MRSA), and
surprisingly, exhibited the same resistant phenotype, compri-
sing resistance to kanamycin, tetracycline and fusidic acid. The
presence of PVL-gene was detected in all MRSA. PFGE analysis
revealed that all MRSA were genetically identical, and belonged
to clone C, that predominates in the Greek community. Nasal
screening revealed that ﬁve nurses were colonized by S. aureus
isolates, and two of them were carriers of PVL(+) MRSA, that
was the causative agent for the outbreak.
Conclusions: Outbreak was controlled when the two nurses
were excluded from the Labour Ward.
R1986
Prevalence of Streptococcus pneumonia isolated
with reduced susceptibility to penicillin in
northeast of Iran
T. Rashed, K. Ghazvini, A. Heidari, M. Faramarzi (Mashhad, IR)
Objectives: Streptococcus pneumonia is common cause of pneu-
monia, meningitis, acute otitis media and many other infections.
The introduction of antibiotics heralded a new era in the
chemotherapy of infectious diseases, but over the ensuing years
bacteria have developed resistance to virtually every known
antibiotic. Historically, penicillin was highly active against
S. pneumoniae, but with the reports of decline in the suscepti-
bility to penicillin the importance of susceptibility testing of S.
pneumoniae is apparent. The intent of the present surveillance
was to evaluated the susceptibilities of S. pneumoniae strains to
penicillin in northeast of Iran.
Methods: During 2002 and 2003, 105 isolates of S. pneumoniae
were subjected to quantitative MIC testing against penicillin by
using antimicrobial gradient strips (E-test) in two major labor-
atories of Mashhad University of Medical Sciences, Iran. In this
study, breakpoints used to conﬁrm the susceptibility of S.
pneumoniae to penicillin was those which recommended by the
NCCLS. (<0.06 mg/L: Sensitive, 0.12–1.0 mg/L: Intermediate,
>2.0 mg/L: Resistant).
Results: Among 105 S. pneumoniae strains tested, 69 (65.71%)
were isolated from male patients and 36 (34.28%) were isolated
from female patients. Overall, 27.61% of the isolates were
sensitive to penicillin, 59.04% of the isolates showed intermedi-
ate to penicillin and 13.33% of the isolates were resistant to
penicillin.
Conclusion: The prevalence of penicillin-resistant strains varies
geographically. Some studies have shown very high rates of
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penicillin-resistant S. pneumoniae in certain areas (e.g. Spain,
Eastern Europe, some Asian countries and…), ranging from 25
to 86%. By contrast, penicillin-resistant strains remain uncom-
mon (<5%) in some other countries. Once resistant strains are
present in a geographic locale, subsequent spread may escalate
rapidly by selection pressure. The dramatic rises in resistance
have major implications for the appropriate selection of
antibiotics and brought empiric use of penicillin into question.
R1987
Heterogeneity of methicilin-sensitive
Staphylococcus aureus at a German university
hospital: a potential source of new emerging
MRSA clones
F. Layer, B. Ghebremedhin, W. Ko¨nig, B. Ko¨nig (Magdeburg, DE)
Objectives: Recently we could demonstrate rapid dissemination
of different methicillin-resistant Staphylococcus aureus (MRSA)
clones at the University Hospital. The majority of them har-
boured the readily transmissible mec cassette type IV. Thus,
theoretically MSSA might capture the mecA gene from circula-
ting MRSA or MRSA strains may catch mobile toxin genes from
MSSA. The aim of the present study was to characterize the
MSSA strains at the University Hospital in Magdeburg and the
nearby chronic care facility (RCCF) and to compare these with
the simultaneously circulating MRSA clones.
Methods: To serve this purpose, we determined their antibiotic
resistance phenotypes and used a combination of different
molecular typing methods including MLST, spa typing, agr
speciﬁcity, and analysis of their pathogenicity proﬁles.
Results: Among a total of 84 MSSA strains under study about
40% possessed the tst gene and up to four additional enterotoxin
genes. Tst-positive MSSA strains belonged to all known agr
groups (I-IV), to 14 different spa types (t008/t012/t015/t019/
t024/t056/t065/t127/t133/t162/t271/t287/t399/t400) and were
classiﬁed by MLST as ST1/ST8/ST30/ST39/ST45/ST101/
ST121/ST395 and ST426. In contrast, simultaneously circulating
MRSA (n = 24) harboured in general two or three genes of the
enterotoxin gene cluster and the tst-positive MRSA belonged to
the well known epidemic strains ST22, ST45, ST228 and were
classiﬁed as spa types t001, t028 and t032.
Conclusion: From our results one may conclude that the pool of
circulating MSSA is an important parameter with regard to the
epidemiology of hospital- and community aquired MRSA and
their potential virulence.
R1988
Streptococcus pneumoniae in adults: serotype
distribution and antimicrobial resistance
S. Levidiotou, G. Vrioni, C. Pappa, H. Gesouli, C. Gartzonika,
D. Papamichail, D. Stefanou (Ioannina, GR)
Objectives: The aim of this study was to investigate the
serotypes and the antimicrobial resistance of Streptococcus
pneumoniae among adults of northwestern Greece.
Methods: A total of 106 strains of Streptococcus pneumoniae were
isolated from various sites: 40 strains from patients with
invasive pneumococcal diseases (IPD) and 66 with non-IPD.
Serotype was performed by Quellung reaction (Statens Serum
Institute). Susceptibility testing to 8 antibiotics was performed
by E-test (AB Biodisk). According to our results, the most
common serotype found among the isolates from IPD and non-
IPD was 19F (45% and 27.3%, respectively). The 7-valent
pneumococcal conjugate vaccine (7vPCV) and the 23-valent
pneumococcal capsular polysaccharides (23vPPV) were able to
cover 65% and 95% of IPD isolates. Overall, 22 isolates (20.75%)
were resistant to at least one antibiotic tested. 6 (15%) IPD
isolates and 20 (30.3%) non-IPD isolates were resistant to one or
more antibiotic tested. 20.8% of the isolates were penicillin
nonsusceptible (PNS), and 45.5% belonged in serotype 19F.
Penicillin intermediate resistance pattern was the most frequent
phenotypes accounted for 63.63% (14/22) of resistant strains and
for 13.2% (14/106) of the total isolates. Multi drug resistant
isolates (resistance to three or more antibiotic) accounted for
5.66% (n = 6) of the 106 S. pneumoniae isolates. All the isolates
remained fully susceptible to amoxicillin, cefotaxime, linezolid,
vancomycin and levoﬂoxacin. 9.4% were resistant to erythro-
mycin, 1.9% to co-trimoxazole and clindamycin.
Conclusions: The data presented here highlight not only the
epidemiology of pneumococcal serotypes and the emergence of
drug resistant strains, but also the impact of prevention
programmes such as vaccination.
R1989
Prevalence of carriers of methicillin-resistant
Staphylococcus aureus in 100 staff of a hospital in
Kashan, Iran
A. Khorshidi, G. Shajari, M. Nadi Ravandi, A. Hosseini
Nejad (Kashan, IR)
Background: Staphylococcus aureus is recognized as one of the
most important bacterial pathogens seriously contributing to the
problem of hospital infections all over the world. The source of
infection is nasal carrier hospital personnel. Determination of
antibiotic resistance pattern of isolated strains is essential for
treatment of carrier.
Objective: The aim of this study was access the incidence of
methicillin resistant S. aureus (MRSA) carriage in the Shahid
Beheshti University Hospital, Kashan (Iran).
Material and methods: To ﬁnd prevalence of MRSA carrier, A
prospective survey was conducted over 100 personnel in Shahid
Beheshti Hospital of Kashan, from March 2001 to Sep 2002, total
specimens were taken from the anterior nares of staff, were
cultured on the selective media, isolates were identiﬁed based
on coagulase and conventional biochemical reactions according
in Standard Method. All staphylococcus isolates were screened
for methicillin resistance by in oculation of Muller-Hinton agar
supplemented with salt and oxacillin 6 lg/ml, according to
National Committee for Clinical Laboratory Standards (NCCLS)
guidelines, other tested antibiotics included amoxicillin (20 lg),
ciproﬂoxacin (5 lg), penicillin (10 units), gentamycin (10 lg),
rifampin (30 lg) vancomycin (30 lg), then the results were
presented by descriptive analysis.
Results: The results showed (12%) of Staphylococcal isolates
were coagulase positive, of the total Staphylococcus aureus, 7
(58.3%) were resistant to methicillin.
Conclusion: Resistance pattern of Staphylococcus aureus to var-
ious antibiotics, especially methicillin is towards increasing
trend, it seems the prevalence of MRSA clonisation in the staff of
University Hospitale of Kashan(Iran) is increasing.
R1990
Prevalence of methiciilin-resistant
Staphylococcus aureus among health care staff
working in a general hospital, Yazd, Iran
A. Dehghani, M. Kalili (Yazd, IR)
Introduction: S. aureus is a common cause of pyogenic infection.
Between 20% and 30% of people carry S. aureus in their nose and
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may also carry the organism on their skin. Methicillin -resistant
strains cause the same infections as sensitive, but are particularly
associated with hospitalization, exposure to invasive procedures
and treatment in intensive care. The aim of this study was to
determine the prevalence of MRSA among Health care staff
working in different wards of the Shahid Sadughi General
Hospital from June to oct.2005 in the city of Yazd/IRAN.
Method: Samples from nose of 340 Health staff (155 male and
85 female) working in 17 different wards were swabbed and
inoculated on the MSA medium. Following incubation at 37C.
for 24 hrs, the colonies were further examined for S. aureus and
then Anti-microbial sensitivity testing was performed using 0.5
Mcfarland suspension of the islated organism. The entire surface
of a Muller - Hinton medium was swabbed with organism and a
standard methicilin disk was embedded on the medium. After
18 hrs incubation, the zone of inhibition was measured and
noted.
Results: A total of 340 health staff working in 17 different wards
at the Shahid Sadughi General Hospital were participated in this
survey. 38 samples (11.2%) were positive for S. aureus, in which
22 (57. 9%) were found to be MRSA. Five wards; Emergency,
ophthalmology, orthopedic and nerve department were all
negative for MRSA. In comparison, person of Operation room
and Gynecology were the most contaminated.
Conclusion: The results show that 22 (6.5%) of hospital workers
were colonized for MRSA. Although this result is satisfactory,
but it is necessary to emphasize that transmission to patients
may threaten their life. Therefore, following cleaning up the
carriers, intensive care and control program must be implicated
to stop further transmission.
R1991
Detection of methicillin resistance in
Staphylococcus aureus
E. Alepopoulou, A. Grapsa, M. Panopoulou, M. Kantzanou,
S. Kartali (Alexandroupolis, GR)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA)
is among the major pathogens. The most common methods
currently used for identifying methicillin (oxacillin) resistance in
many clinical laboratories are susceptibility tests. The perform-
ance of these tests has been erratic because the expression of
resistance is variable and commonly heterogeneous within
strains.
Methods: A retrospective laboratory-based study carried out
with clinical isolates of S. aureus from active infections in
patients of intensive care units in a tertiary University hospital
during 2001–2002. Sixty one strains of S. aureus recovered from
various specimens, as blood cultures, tracheal aspirates, wound
swabs and venous catheters. Methicillin (oxacillin) susceptibility
tested by ﬁve different methods:(1) agar screening test [MH-
oxacillin ( 6 mg/ml ) agar supplemented with 4% NaCl], (2)
susceptibility determination by microdilution method (Vitek 2,
BioMerieux), (3) MIC determination by E-test (AB Biodisk), (4)
Penicillin-binding protein (PBP) 2a detection by latex agglutin-
ation test (BioMerieux), (5) mecA gene detection by real-time
PCR (Light Cycler, Roche), using speciﬁc primers and probes.
The strains evaluated by using the presence of mecA gene
detected by PCR, as deﬁnitive criteria for MRSA and non-
MRSA. The susceptibility tests carried out as recommended by
the NCCLS.
Results: Among all the isolates, 31 (51%) identiﬁed as mecA
positive and the remaining 30 (49%) as mecA-negative. The
percentages of sensitivity were: oxacillin agar screen 98%, latex
agglutination test 95%, E-test 93%, and Vitek2 93%. Three
isolates, negative for the mecA gene by real-time PCR, recog-
nized by at least one phenotyping method as oxacillin resistant.
Two strains, mecA positive, incorrectly identiﬁed as oxacillin
sensitive by the oxacillin agar screening test.
Conclusions: As shown in this and other studies, no pheno-
typic method is completely reliable for detection of oxacillin
resistance in S. aureus. The sensitivity was higher with the agar-
screening test than with the other conventional methods. In
particular, the oxacillin agar screening test and PBP2a latex
agglutination test were the most accurate methods and they
approached the accuracy of PCR, so they should be applied in
association with the other susceptibility methods, to improve the
ability to accurately detect oxacillin susceptibility in S. aureus.
R1992
Prevalence of methicı´llin-resistant
Staphylococcus aureus among health care staff
working in a general hospital, Yazd, Iran
M.B. Khalili (Yazd, IR)
Introduction: S. aureus is a gram positive bacterium which may
cause different pyogenic infection in the body. Today, it is well
known that between 20% and 30% of people carry S. aureus in
their nose and may also carry the organism on their skin.
Methicillin-resistant strains cause the same infections as sensi-
tive, but are particularly associated with hospitalization, expo-
sure to invasive procedures and treatment in intensive care. The
aim of this study was to determine the prevalence of MRSA
among Health care staff working in different wards of the
Rahnemoon General Hospital from June to October 2005 in the
city of Yazd/IRAN.
Method: Samples from nose of 171 Health staff working in 8
different wards were swabbed and inoculated on the MSA
medium. Following incubation at 37C for 24 hrs, the colonies
were further examined for S. aureus and then Anti-microbial
sensitivity testing was performed using 0.5 Mcfarland suspen-
sion of the islated organism. The entire surface of a Muller -
Hinton medium was swabbed with organism and a standard
methicilin disk was embeded on the medium. After 18 hrs,
incubation, the zone of inhibition was measured and noted.
Results: Out of 171 nose samples, 62 were male and 109 female.
33(19.3%) were positive for S. aureus, in which 25 samples
(14.6%) were found to be MRSA (table I).
Conclusion: The results show that 25 (19/3%) of hospital
workers were colonized for MRSA. Although this results is
satisfactory, but it is necessary to emphasise that transmission to
patients may threaten their life Therefore, following cleaning up
the carriers, intensive care and control program must be
implicated to stop further transmission.
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R1993
Clinical review of Staphylococcus aureus
bacteraemia in a Belgium tertiary centre
M. Libert, S. Cheriﬁ, J. Massaut, M. Elkholti, G. Mascart
(Brussels, BE)
Staphylococcus aureus bacteraemia (SAB) continues to be a major
problem related to both community and nosocomially acquired
infection. Nevertheless few clinical data are presently available
about SAB in Belgium. Knowledge of our hospital population’s
characteristics is essential for better management.
Objectives: We aimed to identify and to compare institution
speciﬁc risk factors, clinical characteristics and mortality rates
associated with methicillin resistant Staphylococcus aureus
(MRSA) bacteraemia and methicillin sensitive Staphylococcus
aureus (MSSA) bacteraemia.
Methods: We retrospectively reviewed the charts of 147
patients, admitted between January 1, 2002 and December 31,
2004, who had at least one blood culture positive for MRSA or
MSSA. The following data were recorded: demographic data,
clinical course of infection, comorbidities, microbiological data,
adequate treatment (at least vancomycin or teicoplanine for
MRSA bacteremia and at least Beta-lactamines for MSSA
bacteremia), complications and outcome.
Results: We found 59 patients with MRSA bacteraemia (40.14%)
and 88 with MSSA bacteraemia (59.86%). Most cases of MRSA
blood stream infection (BSI) were nosocomial (72.88%), whereas
most cases of MSSA BSI (67.05%) were community acquired
(P < 0.001). In multivariate analysis, risk factors associated with
MRSA BSI were previous exposure to antibiotic therapy (OR
5.21, 95% CI 1.51–10.34; P: 0.001), and MRSA colonisation (OR
26.31, 95% CI 9.92–69.84; P < 0.001). Only intravenous drug use
was identiﬁed as signiﬁcant risk factor for MSSA BSI. Overall
hospital mortality was 38.1%; there was no signiﬁcant difference
in terms of mortality attributable to infection between MRSA
and MSSA BSI. Presence of respiratory infection (OR 3.43, 95%
CI 1.37–8.53; P: 0.008), septic shock at presentation (OR 6.04, 95%
CI 2.35–15.52; P < 0.001), endocarditis (OR 6.07, 95% CI 1.53–
24.07; P: 0.01) and inadequate treatment (12/147) (OR 7.36, 95%
CI 1.74–31.00; P: 0.007) were independent factors predictor of
mortality.
Conclusion: Our study emphasizes the importance of early
detection of MRSA nasal carriage and underlines the importance
of an appropriate choice of antibiotic drugs. Vigorous manage-
ment is recommended for patients presenting SAB at admission
with pneumonia, septic shock or endocarditis.
R1994
Study of nasal carriage rate of Staphylococcus
aureus in hospital personnel in Ilam, Iran
N. Sadeghifard, F. Azizi Jalilian , N. Najafyyan, J. Zaeimi Yazdi,
A. Seidkhani (Ilam, Tehran, IR)
Objectives: The aim of this study was to detect the nasal
carriage rate of Staphylococcus aureus in Hospital personnel and
determination of methicillin resistance.
Methods: In a cross sectional study two hundred nasal swabs
were collected, and cultured on blood agar and manitol salt agar
for isolation of S. aureus. Carbohydrate fermentation tests,
sensitivity to lysostaphin and novobiocin disks and also coag-
ulase test were used to conﬁrm the organism.
Results: S. aureus was isolated from 76 (38%) of 200 samples.
According to the results, there was no signiﬁcant relationship
between carriage rate and age and also carriage rate and sex
(P > 0.05). Of 76 isolates of S. aureus, 28 isolates (36.8%) were
resistant to methicillin.
Conclusion: Our results showed that the high rate of nasal
carriage of S. aureus among Hospital personnel and most of S.
aureus isolates were resistant to methicillin.
R1995
Prognosis of enterococcal bacteraemia in critically
ill patients
A. Artero, R. Zaragoza, S. Sancho, J.J. Camarena, R. Gonza´lez,
J.M. Nogueira, J. Tamarit, C. Merino (Valencia, ES)
Objectives: The aims of this study were to know the preval-
ence, clinical characteristics, and prognosis of critically ill
patients with enterococcal bacteremia, in an intensive care unit.
Material and methods: From 1996 to 2005, 322 patients with
clinically signiﬁcant bacteraemia admitted in an intensive care
unit were prospectively evaluated. Clinical characteristics and
related mortality of cases produced by Enterococci are presen-
ted. A multivariate analysis was performed to determine the
inﬂuence of Enterococci on related mortality.
Results: Thirty (9.3%) of 320 blood stream infections were due
to Enterococci. All cases except one was hospital acquired. In
twenty-eight cases (93.3%) the specie isolated was E. faecalis, and
in 2 cases E. faecium. Fifty percent of cases were polymicrobian:
Acinetobacter baumnannii (n = 5), Pseudomonas aeruginosa (n = 4),
Staphylococcus aureus (n = 3), Candida spp (n = 3), Escherichia coli
(n = 2). The mean age of patients was 66.8 ± 1.6 years, and the
relation between men/women was 1.7. The identiﬁed focus of
bacteraemia were catheter (20%), urinary (17%), and abscesses
(8%). The mean APACHE II score at the onset of bacteraemia
was 19.5 ± 8.1. Diabetes mellitus was present in 20% of cases.
Eighty percent of patients had received previous antibiotic
treatment. Severe sepsis or septic shock was present in 66.6%.
There was no case of vancomycin-resistant enterococci. The
incidence of inadequate empirical antibiotic treatment was 23.3
%, and the related mortality rate for enterococcal bacteremia was
20% (not signiﬁcantly different from the mean of mortality by
other signiﬁcant microorganisms, 27.4%). Septic shock and
APACHE II score at the onset of bacteremia were related to
mortality, but not enterococcal bacteraemia, by multivariate
analysis.
Conclusions: Enterococci are a signiﬁcant cause of blood
stream infections in intensive care, and the related mortality to
enterococcal bacteraemia (20%) is not signiﬁcantly lower than
the cause by other microorganisms in critically ill patients.
R1996
Distinguished features in systemic
staphylococcal infections with S. aureus and
coagulase-negative staphylococci
L. Cochior, E. Miftode, O. Dorneanu, D. Leca, V. Luca,
D. Dumitriu, E. Nastase (Iasi, RO)
Objectives: The aim of this study was to evaluate the actual
epidemiological, clinical, bacteriological and evolutive differ-
ences in systemic infections with S. aureus (SA) and coagulase-
negative staphylococci (CNS) in the era of major susceptibility
variations of staphylococcal strains.
Methods: We analyzed 103 patients with systemic staphylococ-
cal infection, between October 2002-September 2005. Staphylo-
coccal strains were identiﬁed by conventional methods and
using ID 32 Staph strips (bioMerieux, France). Antibiotic
susceptibility testing was performed by disk diffusion method
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according to NCCLS standards and using ATB Staph strips
(bioMerieux, France).
Results: We isolated 73 strains (71%) of S. aureus (40% meth-
icillin resistant, SAMR) and 30 strains (29%) of CNS (67%
methicillin resistant, MR-CNS). Clinical isolates were recovered
from blood cultures: 62%-SA, 66%-CNS, pus: 15%-SA, 3%-CNS,
blood and catheter cultures: 27%-CNS, 12%-SA and other
specimens normally sterile. Predisposing conditions were iden-
tiﬁed as: recent skin and soft tissue infections: 34%-SA, 7%-CNS,
catheters: 27%-CNS, 12%-SA, surgery: 23%-CNS, 14%-SA, sepsis
recurrences: 20%-CNS, 4%-SA, hospitalization: 15%-SA, 13%-
CNS prosthetic devices: 13%-CNS, 8%-SA. The dominant clinical
presentation was fever of unknown origin: 30%- CNS, 15%-SA,
pyodermitis: 19%-SA, pulmonary infection: 18%-SA, 13%-CNS,
arthritis: 19%-SA, 16%-CNS, septic shock: 20%-SA, 16%-CNS.
Multiple secondary foci of infections were found in 33% for SA
and 17% for CNS. The complications rate was 55% for SA and
33% for CNS and a severe evolution (severe sepsis, septic shock
and MSOF) marked 40% of SA infections and 26% with CNS.
Antibiotic switch was made in 68% of SA infections and 50%
with CNS. Effective therapy was represented by associations
including - betalactames: 41%-SA, 17%-CNS, glycopeptides:
37%-CNS, 29%-SA, oxazolidinones: 20%-CNS, 10%-SA, ﬂuoro-
quinolones: 14%-SA, 7%-CNS. The overall rate of mortality was
16, 50%, with 21% for SA and 12% for CNS.
Conclusion: The overall rate of methicillin resistance was 48%,
with a higher rate for CNS. 24% of SAMR and 10% of MR-CNS
were community acquired. SSI with SA had more severe
evolution, higher rate of multiple determinations and compli-
cations and higher mortality rate, while SSI with CNS had a
more insidious evolution, lower rate of complications and
mortality.
R1997
Monitoring of methicillin-resistant
Staphylococcus aureus in a Greek tertiary care
hospital: comparison between internal and
surgical units
E. Protonotariou, M. Tsivitanidou, V.P. Pliatsika, D.
Soﬁanou (Thessaloniki, GR)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA)
strains have been considered as the typical bacterial populations
presented in hospitals and therefore as a major cause of hospital-
acquired infections. This parameter needs periodical evaluation
due to its increasing frequency during the last decade. The
purpose of the present study was to monitor MRSA in our
hospital and compare its distribution between internal and
surgical units.
Methods: A retrospective analysis was performed of microbio-
logy records on bacterial isolates from patients admitted in
Hippokration Hospital, and were infected with S. aureus strains
during the period 2002–2004. Identiﬁcation and susceptibility
testing were achieved using the Vitek 2 automated system
(bioMerieux, France). Statistical analysis was accomplished with
Fisher’s exact test.
Results: A total of 275 isolates of S. aureus were reviewed from
hospitalized patients admitted in Internal (IU) and Surgical
Units (SU). Samples were collected from wounds, bronchial
secretions, blood, urine, catheter tips and other sites. The
distribution of MRSA varied signiﬁcantly between SU and IU
(65% vs 26 %, p < 0.0001). In particular, 111 out of 171 strains
isolated from SU patients were found to be MRSA (65%). On the
other hand, only 27 strains out of 104 from IU patients were
MRSA (26%). Resistance of MRSA to other antimicrobial agents
was also high. Among MRSA strains from SU, 72% were
resistant to clindamycin, 78.3% to erythromycin and 87.3% to
tetracycline. The resistance of MRSA strains isolated from IU
patients to clindamycin, erythromycin, and tetracycline was
55.5%, 59.2% and 92.5%, respectively. No strain from both units
was found resistant to vancomycin or teicoplanin.
Conclusions: a) Resistance of S. aureus to methicillin (MRSA)
was high particularly in SU (65%) and should be of concern b)
Awareness resistance to other common antimicrobial agents was
also important c) A continuous programme of surveillance of
MRSA strains as a way of active antibiotic policy is required.
R1998
Nasal carriage of S. aureus among hospital
personnel of a secondary general hospital
F. Sergouniotis, A. Sergounioti, A. Basdeki, P. Sergouniotis,
E. Papoulia, E. Petinaki (Amﬁssa, Larissa, GR)
S. aureus nasal carriage in hospital personnel has been identiﬁed
as an important risk factor for nosocomial infections.
Objectives: The aim of our study was to determine the
incidence of S. aureus nasal carriage in the personnel of a
Secondary General Hospital (120 beds), without signiﬁcant
prevalence of staphylococcal infections in it, and the investiga-
tion of the genotypical and phenotypical characters of the strains
recovered.
Methods: A total of 40 doctors and nurses (mostly of the
surgical section of the Hospital) were examined during autumn
2005. Samples taken from the anterior nares were cultured using
appropriate media. The strains’ identiﬁcation was performed by
catalase production, 24-hour coagulase test, and the API Staph
system (Biomerieux, Marcy L’ E´toile, France). All the strains
were tested for the production of PBP2a (Slidex MRSA,
Biomerieux, Marcy L’ E´toile, France), their susceptibility to
antibiotics was performed by the disk diffusion technique and
the results were interpreted according to the criteria of the
N.C.C.L.S. Moreover, molecular analysis for the mecA gene and
the Panton-Valentine leucocidin (PVL) - encoding genes, lukF
and lukS, was performed by PCR.
Results: 1)The incidence of S. aureus nasal carriage among
hospital personnel was 20%, and presented to be higher among
doctors(31% – 5 out of 16) than among nurses (12.5% – 3 out of
24). 2) The specimens’ cultures yielded 5 MSSA and 3 MRSA
with total prevalence 12.5% and 7.5% respectively. 3) Three
strains carried the mecA gene and produced PBP2a, whereas
another 2 strains produced PBP2a but lacked the mecA gene. 4)
Only one strain produced PVL leucocidin, isolated from the
nasal specimen of a surgeon. The PVL-positive S. aureus
belongs to MLST-80 clone. This clone circulated in Greece since
2002 and recently demonstrates an arising spread capacity. 5)
All the strains were sensitive to quinolones, glycopeptides,
cotrimoxazole, clindamycin, erythromycin, linezolid, rifampi-
cin, mupirocin and the PVL-positive strain was resistant not
only to beta-lactames, but to tetracycline and fucidic acid as
well.
Conclusions: The percentage of S. aureus nasal carriage of
doctors of our Hospital is higher compared with other hospitals
of equal potency in Greece, but with low prevalence of
staphylococcal infections. The isolated strains were multisus-
ceptible. The isolation of a PVL-positive strain should arise alert
in order to prevent the transmission of these strains, which may
cause severe disease.
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R1999
Genotyping methicillin-resistant Staphylococcus
aureus by PFGE in a clinical hospital in Szczecin,
Poland: 9-year study
K. Kopron, J. Jursa-Kulesza, S. Giedrys-Kalemba (Szczecin, PL)
Objective: The purpose of the study was genetic relatedness
between MRSA strains isolated from different patients hospit-
alized in various wards of Clinical Hospital.
Material and method: A total of 270 MRSA isolates were
cultured between 1994–2004 from various materials (blood,
bronchoalveolar washings, sputum, secretion from wounds,
catheters, drains, liquids from pleura and peritoneum) from
patients hospitalized in various wards of Clinical Hospital in
Szczecin: intensive care unit, surgery, internal medicine, urol-
ogy, dermatology, cardiology. PFGE – SmaI was applied to
analyze genetic relatedness among the isolates. Seperation of
DNA fragments was achived using a CHEF DR II apparatus
(Bio-Rad). The obtained patterns were compared by software
Molecular Analyst Fingerprinting Software, using the Dice
coefﬁcient.
Results: Among the 264 isolates macrorestriction with SmaI and
PFGE yielded 13 clonal epidemic strains, designated as A-M,
and 6 strains were identiﬁed by unique PFGE patterns. During
the period 1994–1997 two main PFGE types were detected: type
A (48 strains) - isolated in all hospitals wards and type B (6
strains) – isolated in cardiology and urology ward only. The
appearance of new genetic types were observed in the wards of
Clinical Hospital from the beginning 1998 to 2004. The most
frequently types were: type D included 86 strains and type E –
25 strains. Both clonal strains (D, E) were isolated for 3–4 years
in surgery ward and intensive care unit. Types G, H, I, K were
found in all hospital wards and the occurrence of types C, F, J, L
was typical for one ward.
Conclusion: Molecular diversity of MRSA strains isolated from
various wards for 9 years shows on their exchange and probably
different sources of MRSA strains in hospital ecosystem. On the
other hand, isolation of the same genetic types from different
wards and patients proves horizontal spreading of the MRSA
clones in Clinical Hospital. Maintenance of clonal strains MRSA
for months or years in hospital environmental needs more
effective of MRSA hospital control.
R2000
Clonal spread of community-acquired
methicillin-resistant Staphylococcus aureus in
Latvia
A. Balode, L. Cupane, U. Dumpis, I. Kannina, D. Rudzite, A.
Martinsons, E. Miklasevics (Riga, LV)
Objectives: The ﬁrst community acquired (CA) methicillin-
resistant Staphylococcus aureus (MRSA) in Latvia was isolated in
2003. Though, no study on CA-MRSA occurrence among
outpatients was carried out in Latvia strains with CA-MRSA
characteristics (very low oxacillin resistance, type IV SCCmec,
PVL) have been isolated from patients during their admission
(or within 48 h afterwards) to hospital with increasing fre-
quency. This report provides summary of CA-MRSA found at
three hospitals in Riga and Valmiera.
Methods: 513 MRSA isolates were collected at Pauls Stradins
Clinical University Hospital, Gailezers Clinical Hospital and
Valmiera Hospital from January 2004 to October 2005. Antimi-
crobial susceptibility testing on these strains was performed
according to CLSI standards by disc-diffusion method and the
presence of the mecA gene was veriﬁed by PCR. PVL positive
strains were identiﬁed by PCR and genotyped by pulse ﬁeld gel
electrophoresis (PFGE) after SmaI digest, staphylococcal cassette
chromosome mec typing, spa sequence typing and MLST.
Results: Screening of 513 MRSA strains revealed eight isolates
(six were recovered from skin lesions and two blood isolates)
harbouring genes required for the synthesis of PVL. All PVL
positive strains shared common antibiogram pattern: very low
resistance levels to oxacillin (MIC from 0.25 to 1.00 mg/l) and
susceptibility to all antibiotics tested (ERY, GEN, CIP, CHL, CLI,
RIF, TET, STX and VAN), and carried SCCmec of type IV.
Among these clones, ST30-MRSA-IV was dominant – six of eight
isolates belonged to this type. The ST30-MRSA-IV group can be
split into three factions with distinct PFGE patterns of 4, 1 and 1
clones, respectively. This division is in agreement with spa
typing which also separates the clones into three factions with
strongly related spa types: t019, t012 and t021, respectively. The
biggest faction of clones is indistinguishable by phenotypical
and molecular characteristics from the ﬁrst Latvian CA-MRSA
isolated in 2003.
Conclusion: The clonal spread of CA-MRSA in Latvia is
revealed. ST30-MRSA-IV with identical PFGE pattern and spa
type was found in two hospitals in Riga and in northern city
Valmiera hospital. Studies on CA-MRSA among outpatients are
urgently required, as well as family doctors should pay special
attention to this issue.
R2001
Surveillance of vancomycin-resistant enterococci
in high-risk patients in a tertiary hospital
H. Aygu¨n, F. C¸okc¸a, A. Azap, A. Tekeli, O. Memikoglu
(Istanbul, Ankara, TR)
Objective: The ﬁrst vancomycin resistant enterococcus (VRE)
isolate in Turkey was from a tertiary hospital in 1998 and reports
from other hospitals followed afterwards. The prevalance of
VRE ranges between 0 and 10% in different studies reported in
our country. After the isolation of vancomycin resistant entero-
coccus from the blood culture of a hepatic transplant patient in
our hospital, this surveillance study was planned.
Methods: The study was carried out in 8 intensive care units
and oncology and nephrology departments where high-risk
patients were hospitalized. In a time period of 15 months (from
May 2003 to July 2004), rectal swab cultures were collected four
times (ﬁve months apart) from a total of 467 patients. A
questionnary form was ﬁlled for each patient in order to
establish risk factors for the colonization of VRE. Enterococcosel
agar containing 6 mcg/ml vancomycin and 70 mcg/ml ceftaz-
idime was used for the screening of VRE. Enterococci were
deﬁned by standard microbiological tests and API 20 Strep (Bio-
Merieux) was used for species identiﬁcation with some
additional biochemical tests. Vancomycin and teicoplanin MIC
values were determined by agar dilution. Vancomycin resist-
ance genes (Van A, Van B) were determined by PCR analysis.
Results: Nine enterococcal isolates were deﬁned as vancomycin
resistant. The colonization rate with VRE was 1.9%. These
isolates were identiﬁed as Enterococcus faecium. All nine isolates
were highly resistant to vancomycin (MIC > 256 mcg/ml) and
teicoplanin (‡64 mcg/ml). The resistance genotypes of all strains
were Van A. All patients colonized with VRE were hospitalized
in the intesive care unit (ICU) for a mean of 30 days. Either
glycopeptide or third generation cephalosporin use was detec-
ted for these patients.
Conclusion: VRE may cause serious nosocomial infections with
high mortality rates. Since fecal carriage of VRE is an important
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source of hospital epidemics, surveillance cultures are recom-
mended. It is thought that VRE might become an important
nosocomial pathogen in our hospitals in a near future. The
restricted use of third generation cephalosporins and glycopep-
tides is warranted in addition to hospital infection control
precautions.
R2002
Surveillance of MRSA carriers among patients
and health care workers in haemodialysis units
A. Dedeic-Ljubovic, M. Hukic, H. Resic, A. Zvizdic (Sarajevo,
BA)
Objectives: Carriage with methicillin-resistant Staphylococcus
aureus (MRSA) is a prevalent and serious problem, and appears
to play a key role in the epidemiology and pathogenesis of
infection. Patients on hemodialysis represent a particular high-
risk group for infection caused by these organisms due to a
combination of their compromised immune system and the
need for repeated access to their blood system several times a
week. Carriers among hospital staff in this units can also serve
as source of colonisation and infection of patients. The aim of
this study was to determine the carriage rates of nasal and throat
MRSA in patients and hospital staff in haemodialysis units, and
efﬁcacy of mupirocin in the eradication of nasal carriage.
Methods: The study included 235 patients and 60 hospital staff
from Center for hemodialysis, Clinical Center University of
Sarajevo. A total of 474 nose and throat cultures of patients, and
120 cultures of hospital staff were performed. Methicillin
resistance of S. aureus were determined with disk-diffusion
methods according to the National Committee for Clinical
Laboratory Standards (NCCLS), and rapid latex agglutination
test (Slidex MRSA Detection-bio Merieux) by detecting PBP2’
(penicillin-binding protein 2’) product of mecA gene. S. aureus
ATCC 25923 strain was used for control.
Results: Nasal carriage rate of MRSA was 15.3% (36/235)
among patients, while the same rate was 11.6% (7/60) among
hospital staff. There were no isolates of MRSA from throat of
patients, and only one isolates from throat of hospital staff.
Results from the disk-diffusion test correlate almost 100% with
the results of test that detect PBP2’. Nasal carriage was cleared
in 34 (94.4%) of patients with 2% nasal mupirocin ointment
(Bactroban) three times a day for 5 days.
Conclusion: Our results indicate a signiﬁcant rate of MRSA
colonisation among haemodialysis dependent patients and
hospital staff, and that topical mupirocin is a highly effective
treatment for the eradication of nasal carriage. Slide latex
agglutination test for PBP2’ represent a rapid and reliable
method for the detection of MRSA carriage. Efforts to limit the
spread of MRSA in hemodialysis units must include seasonal
surveillance of MRSA carriers and appropriate infection control
measures to reduce opportunitities for patient-to-patient trans-
mission.
R2003
Nasal and axillar carriage of Staphylococcus
aureus patients among elderly population in a
nursing home
V. Avkan Oguz, N. Sezak, N. Yapar, B. Ay, N. Tekin, N. Cakir,
A. Yuce (Izmir, TR)
Objectives: Infections caused by Staphylococcus aureus are sig-
niﬁcant causes of morbidity and mortality in elderly persons in
the community, hospital and nursing home. Therefore we
attempted to investigate S. aureus colonization and risk factors
for colonization in nursing home residents. To the best of our
knowledge, this is the ﬁrst study that investigated S. aureus
colonization in nursing home population in our country.
Methods: In this prospective study whole residents of geriatric
care unit (n = 163) were investigated between September 01 and
October 31, 2005 in nursing home. Data were collected regarding
gender, age, length of stay in the unit, modiﬁed daily living
activity, underlying conditions, presence of skin lesions, local
nasal therapy, antibiotic treatments during the previous
3 months and hospital admissions within the last 6 months.
Two swabs were taken; one from the anterior nares and other
from axillary area.
Results: Of these elderly persons, 123 (72.4 %) were female and
40 (23.6 %) male. Mean age was 80 (SD; 6, 6 min.60-max. 95). We
determined S. aureus in 15 (9.3%) participants but none of them
was resistant to oxacilline. Of these colonized S. aureus, 14 (93.3
%) isolated from nares and 1 (6.7 %) from axillary area. In 14
(93.3 %) of residents colonized with S. aureus, out of these risk
factors investigated, length of stay in the geriatric unit was more
than one year, and modiﬁed daily living activity scores were
higher than 20, in spite of statistically insigniﬁcant. Other risk
factors rates are shown in Table.
Conclusion: In the study group we did not found carriage
of methicillin resistant S. aureus in crowded living conditions of
geriatric persons. However we thought that screening of
carriage for the detection of methicillin resistant S. aureus
should be performed in regular period and at the admission
time to nursing home.
R2004
Antibiotic resistance of Staphylococcus aureus: a
multicentre study 2002–2005 in a paediatric
general hospital, Greece
D. Garantziotou, M. Vlachou, O. Koureli, S. Paratiras, V. Rouli,
A. Gatopoulou, A. Spiliopoulou (Patras, GR)
Objectives: Methicillin resistant Staphylococcus aureus (MRSA)
is a major cause of nosocomial infection with a worldwide
prevalence. Furthermore, community strains are beginning to
arise and can exhibit increased virulence. In this study we
determined the incidence of MRSA among clinical isolates
during a 4-year period.
Materials and methods: A total number of 311 S. aureus strains
from children’s clinical specimens were studied during the
period 2002–2005. The cultures were performed by conventional
methods and identiﬁcation was conﬁrmed by API Staph system
(Biomerieux). Antibiotic susceptibility testing was evaluated by
disk diffusion method, according to NCCLS standards. Meth-
icillin resistance was studied by using minimum inhibitory
concentration of oxacillin (E-test strips) on Muller-Hinton agar
supplemented with 2%NaCl. We also used the agglutination test
with monoclonal antibodies against PBP2a, to detect the pres-
ence of the mec A gene.
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Results: There was a signiﬁcant statistical difference of MRSA
strains during four years period. There was not isolated any
MRSA strain resistant to Methicillin. The rates of resistance were
as follow:
Conclusions: There was no signiﬁcant change about the rate of
fucidic acid resistance. An increasing incidence of MRSA was
observed. This fact can lead to serious treatment difﬁculties,
since the MRSA strains are resistant to all beta-lactam antibiotics
and often also to other groups of antibiotics. The detection of
mecA gene by agglutination test against PBP2a, can be used as a
reliable and rapid method in the determination of resistance to
Methicillin.
R2005
Staphylococcal meningitis – an evaluation over
6 years
D. Leca, E. Miftode, C. Luca, I. Filip, C. Petrovici, L. Cochior,
V. Luca (Iasi, RO)
Objective: To evaluate the epidemiological, microbiological
and evolutive characteristics of staphylococcal meningitis cases
that were diagnosticated in our hospital.
Material and methods: We conducted a retrospective study
that include 49 cases of staphylococcal meningitis hospitalized
in our department, between January 2000 and August 2005.
Culture, isolation, identiﬁcation and susceptibility were per-
formed following standard recommendations.
Results: The patients, 15 female and 34 male with average age
48.6 years (range between one month to 76 years) were immu-
nocompromised in 13 cases (26.5%). The meningitis occurred
after neurosurgical procedures in 17 cases (34.69%) and as
secondary septic determination of sepsis in 29 cases (59.18%),
having otogenic source in 3 cases (6.12%). The strains, isolated
from CSF in 26 cases (53.06%) and from bloodstream in 27 cases
(55%) were Staphylococcus aureus in 39 cases (79.6%) and
Staphylococcus epidermidis in 10 cases (20.4%), methicilino-resist-
ant in 12 cases and 6 cases respectively. These organisms were
multiresistants to 2–13 antibiotics, with resistance rates of
22.45% for Rifampicin, 30.61% for ciproﬂoxacine, 28.57% for
cefotaxime, 8.16% for amikacine 6.12% for Imipenem and
teicoplanin, 16.32% for chloramfenicol. The antibiotics, repre-
sented by ﬂuoroquinolones (25 cases – 51%), vancomycin (20
cases – 40.81 %) especially, Rifampicin (13 cases – 26.5%)
cloramfenicol (8 cases – 16.32%), Meropenem (5 cases – 10.2%),
were administrated in majority of cases in bitherapy (38–
77.55%), for average time of 26.6 days, with modiﬁcation of
therapy in 33 cases. The evolution was marked by complications
in 16 cases – 32.65% (cerebral abscess – 3 cases, subdural
empiema, CSF ﬁstula and cranial nerves palsy in 2 cases each,
hydrocephalus – 5 cases, septic shock in 2 cases) with double
rate for patients of methicilino-resistant strains (50%) versus
those with methicilino-sensible strains (22.58%). The mortality
rate was 6.12%, with diference for the two types of patients
(11.1% versus 3.22%).
Conclusions: Staphylococcal meningitis has a low incidence
and mortality, but nosocomial context and implication of
multiresistant strains lead to therapy difﬁculties, a higher rate
of complications and deaths.
R2006
Rabbits as a human Staphylococcus aureus
reservoir? Preliminary results of a ﬁeld research
E. Circella, G. Bruni, M. Corrente, D. Pennelli, N. Mangano,
A. Camarda (Valenzano, Brescia, Potenza, IT)
Objectives: Staphylococcus (S.) aureus is responsible for human
infections of difﬁcult therapy. In intensive rabbit farms, the germ
determines diseases with a heterogeneous epidemiological,
clinical and pathological-anatomical picture. In this work,
strains of S. aureus, coming from dead rabbits for S. aureus
infections in intensive farms, have been typed. Phenotypic and
genetic methodologies have been used in order to detect the
species origin.
Methods: Research analyses have been conducted on 29 strains
of S. aureus isolated from rabbits coming from 9 different
intensive farms in the Region of Puglia, in South Italy. The
Devriese (1984) protocol for biotyping was applied. The genetic
typing has been made with Random Ampliﬁed Polymorph
DNA (Hermans et al. 2000).
Results: The biological typing showed a prominence (62%) of
NHS strains. In some cases, specie-speciﬁcity of isolates was
found; particularly, one strain belonged to the human type, two
were bovine strains, two ovine strains and two of poultry. Three
isolates were not possible to be determined. Most part of the
strains belonged to the CV:A-type (22 strains); the remaining (7
isolates) to CV:C-type. The genetic typing allowed us to
distinguish 12 different proﬁles. The most frequent of them
were n.1 and n 6. The human biotype showed a peculiar RAPD
proﬁle. The RAPD methodology highlighted in one farm a
change in the genetic type of S. aureus that were infecting the
rabbits in different times.
Conclusions: In this research heterogeneity in rabbit strains
was found. The RAPD showed a prevalent diffusion of the
RAPD-1 type infecting farms in different years Dominant
genetic types are probably characterized by a higher pathogenic
power. Higher virulence is associated to the CV:C type. On the
contrary, the CV:A type is seen to be less pathogenic. CV:C/aˆ-
strains were often found in human being (Devriese, 1984). The
dominance of strains belonging to more than one ecovar might
imply that no very strict specie-speciﬁcity relations exist. Thus,
one animal species could represent a reservoir for others.
Consequently, the temporal replacement of the strains in
intensive rabbit farms can be favoured by many vectors,
including human being, a possible reservoir of the rabbit
germ. The ﬁnd on rabbits of a human strain may suggest the
chance of a reverse transfer of the germ from rabbits to man. In
this case the rabbit could have the role of S. aureus reservoir for
human being.
R2007
Description of a methicillin-resistant
Staphylococcus aureus hospital outbreak
A. Del Arco, J.L. Prada, J. De La Torre, N. Montiel, F. Moreno, J.
Aguilar, J. Garcı´a Alegrı´a (Marbella, ES)
Introduction: Methicilin-resistant S. aureus (MRSA) is a weighty
topic in hospital infections. In 2004 our Lab listed 47 MRSA
positive cultures from a total of 242 S. aureus cultures (19.42%).
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In March to April-2005 a warned number of MRSA were
registered.
Objective: To describe the epidemiological characteristics of
MARSA infected patients in the 2005 outbreak and to set the
alert procedures for early detection.
Methods: Descriptive analysis of all the patients suffering from
MRSA infection in the outbreak, the outcome and the rules and
recommendations by the Infectious Commission (IC).
Results: From 01.03 to 02.05.2005 a total of 21 patients suffered
from MRSA infection. Our mean bed-occupation is 270. 12
patients were male and 9 females. The mean age was 70. From
40 to 59 years were 4 cases; 60–79 were 11; 6 were up than
80 years. Previous admissions in the last year were present in 12
patients. Following the IC criteria, 4 cases were hospital
acquired, 8 no certain hospital acquired (early MRSA discovery
with previous near hospital admission) and 9 possible commu-
nity-acquired (no previous admissions). By departments: 10
from Internal Medicine, 5 Neumology, 4 Surgery and 1 Trau-
matology and Hematology. Chronics obstruction to air ﬂow was
present in 7 patients, cancer in 6, heart failure and diabetes in 5
and dementia in 3. Three or more associated diseases were
present in 12 patients. MRSA was isolated from wound in 10
patients, 6 sputums and 5 blood. Two cases were simultaneously
isolated from wound and blood. Treatment was vancomycin in
19 cases and teicoplanine in 2. About the outcome, 12 patients
became dead. IC recommendations were to order the contact
isolation of the affected patients, grouping them and enforcing
the precautions by the health workers; to detect carriers between
patients and workers; to indicate decontamination treatments; to
report to hospital and health authorities and to search retro-
spective cases.
Conclusions: The affected patients were mainly elder people,
suffering from other health problems, with previous and
lengthy hospital stays. Mortality is high, and MRSA is often a
supporter cause, although usually is not directly the demise
reason. There is an important rate of community source, so
MRSA could be considered as an emergent community patho-
gen. The onset of a MRSA alert and control system must include
to elder patients with near previous admissions, former antibi-
otic therapy and/or skin infections during the admissions.
R2008
Effectiveness of hygiene measures for preventing
health care workers from acquiring undesirable
pathogens in an infectious diseases ward
D.M. Poisson, L. Hocqueloux, C. Mille, M. Demasure, L. Bret,
T. Prazuck (Orle´ans, FR)
Background: An alert was recently raised by the French
National Centre of Streptococci (CNR) about nosocomial diffu-
sion of group A-streptococci. More recently, the large spread
among health care workers of the MRSA-clone producing
Panton-Valentine leukocidin (PVL-MRSA) has been described
by H. Linde et al (2005). In 2004, a woman, was hospitalised for
34 days in our Infectious Diseases Unit (IDU) for a streptococcal
toxic shock syndrome (serogroup A). In 2005, another woman,
was transferred to the IDU from an Algerian hospital for an
antibiotic-sensitive Gram-negative rod pneumonia. At entrance
she had a perineal chronic wound, but this ward does not assess
the carriage of multi-drug resistant bacteria (MDR), nor perform
a MDR-speciﬁc isolation unless MDR are found in pathological
samples. After 3 weeks, she was transferred in the Intensive
Care Unit (ICU) where MDR-speciﬁc assessment and isolation
are active. Her wound samples yielded a PVL-MRSA with the
typical antibiotype (methicillin-R, kanamycin-R and tobramy-
cin-S).
Objective: We tested the hypothesis of healthy carriage of these
two pathogens in health care workers after discharges of the
respective patients.
Methods: After informed consent, throat swabs were obtained
during the 3rd week of hospitalisation of patient-1, from 26
involved health care workers. Streptococci were isolated by
routine techniques including CNA-agar incubated in anaerobic
conditions. Within 2 weeks after recognition of the PVL-MRSA
carrier status of patient-2, nares samples were obtained from 28
informed and agreeing health care workers of the IDU. Samples
were streaked on routine media including MRSA-agar (Biorad).
Patients of the ICU were not included.
Results: Following patient-1: 3 strains of beta-haemolytic strep-
tococci were isolated belonging to serogroups A, C and F. The A
strain was studied by the CNR comparatively to the patient’s
strain, and found different only for biochemical characters:
phenotype 1403.2141.110 vs 1403.2161.111 in the API32 Strep.
Following patient-2: we found 3 drug-sensitive S. aureus, 1
MRSA, which had not the typical antibiotype, and no PVL-
MRSA.
Conclusion: Hygiene procedures currently active in the IDU,
even if they are strictly based upon pathological samples and do
not include speciﬁc prospective MDR detection, do not allow
large spreads of Streptococcus pyogenes or PVL-MRSA. Genotyp-
ing the two available A-Streptococcus strains should be per-
formed to strengthen this conclusion.
Epidemiology of MDR-Gram-negatives
R2009
Endemic ESBL producing Enterobacteriaceae
among paediatric patients over 3 years
B. Rybak, M. Bronk, J. Wierzba, M. Neumann-Laniec, A. Samet,
A. Balcerska, J. Erycinski (Gdansk, PL)
Objective: The aim of this study was to analyse occurrence of
ESBL producing Enterobacteriaceae in patients who were hospit-
alized in the Institute of Pediatrics, Medical University of
Gdansk [IP].
Methods and materials: We analysed microbiologial records
from 2002 to 2004. Strains were identiﬁed by classical method
and VITEK cards (BioMerieux). Production of ESBL was
detected by double disk method.
Results: In the studied period 10 972 patients were hospitalized
in IP. ESBL + isolates were recovered from 393 patients. 60%
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infecting or colonising ESBL strains were detected in patients
with urinary tract infections, 14.5 % with diarrhoea, 12.5 % with
haematological malignancies, 8.4% with sepsis and 3.5% sus-
pected pneumonia. Klebsiella pneumoniae was isolated from 71
patients then E. coli (66 patients) and K. oxytoca (24 patients), E.
aerogenes (22 patients), Enterobacter cloacae (9 patients), Citrobacter
freundii and Proteus mirabilis (respectively 5 and 5 patients).
Isolates were recovered from stools and rectal swabs (43.5%),
urine (37.7 %), respiratory tract (10%), blood culture (1.2%) and
intravenous catheter tips (0.8%). All strains were susceptible to
carbapenems, about 90% to ﬂuoroquinolones and about 60%
urine isolates to nitrofurantoin, nearly 90% isolate were resistant
to aminoglyozydes and co-trimoxazole.
Conclusions: High percentage of ESBL carriage among children
complicates infection control and treatment of common urinary
tract infection. Patients on admission and before discharge
should be screened for ESBL carriage. ESBL producing bacteria
are the greatest challenge in our pediatric units.
R2010
Carbapenem-nonsusceptible Acinetobacter
baumannii in a university hospital in Poland
L. Naumiuk, M. Bronk, B. Rybak, E. Naumiuk, A. Samet
(Gdansk, PL)
Objectives: To analyse occurence and phenotype of carbapen-
ems activity of carbapenem nonsusceptible Acinetobacter bau-
mannii (CNSAB) in a university hospital in Poland.
Methods: The analysis of microbiological records with A.
baumannii nonsusceptible to imipenem or meropenem from
September 2003 to September 2005 was done. We used Vitek
GNI+ cards (bioMerieux) for identiﬁcation and disc-diffusion
technique (CLSI) to determine susceptibility to imipenem (IMP)
and meropenem (MEM).
Results: There were 655 one-per-patient A. baumannii isolates
during the study period. The susceptibility to IMP was 87% and
to MEM 80%. CNSAB was isolated from 129 patients. They were
hospitalised in ICU (53), surgery departments (47), general
medicine (17), haematology (4) and other units (8). From 46%
patients CNSAB was isolated only once and from 8% patients
there were more than 10 isolates. Two patients had isolates non-
susceptible to IMP only and 43 patients to MEM only. The
remaining 84 patients had isolates non-susceptible to both
carbapenems. In isolates from 27 patients resistance to two
carbapenems was found. CNSAB from 9 persons expressed all
possible phenotypes IMP-R, IMP-I, MEM-R, MEM-I.
Conclusion: CNSAB were isolated from about 20% patients
with A. baumannii infection/colonisation. Patients from ICU and
surgery are at the greatest risk of acquiring CNSAB during their
hospitalisation. MEM non-susceptibility is more common than
IMP non-susceptibility. CNSAB from patients with many
isolates tends to express different carbapenem resistance phe-
notypes.
R2011
Epidemiology of resistant Enterobacteriaceae in a
tertiary hospital
L.P. Andersen, I.S. Pedersen, A. Audelin, M. Tvede (Copenhagen,
DK)
Introduction: An increase of Enterobacteriaceae (most commonly
E. coli and E. cloacae) resistant to cephalosporines and ﬂuoqu-
inolones has been observed within the last years, whereas
resistance to aminoglycosides has been stationary. Compared to
their use of antibiotic and time of occurance.
Material and methods: The incidence of E. coli and E. cloacae
resistant to cephalosporins (C), ﬂuquinoloes (F) and aminogly-
coside (A) were estimated for each antibiotic and combinations
of the three antibiotics in different clinical in the years 2002–
2004. The incidences of resistant E. coli and E. cloacae were
compared to antibiotic sent from the pharmacy to the depart-
ments. To estimate the time of occurance of resistant E. coli and
E. cloacae only patients with resistant bacteria in 2003 and 2004
who have not been in this hospital in 2002 were included. To
investigate clonal spread of multiresistant bacteria all E. coli and
E. cloacae resistant to one or more of the three antibiotics were
collected and examined by automatic ribotyping.
Results: The incidence of cephlosporin resistance in E. coli and
E. cloacae was found in 134 of 4990 (2.7%) patients; in 491 of 4990
(9.8%) patients strains were found resistant to ﬂuquinolones and
aminoglycoside resistant strains were found in 76 of 4990 (1.5%)
of patients. Combined resistance were found in CA: 0.6%, CF:
1.1%, FA: 0.5% and CAF: 0.3%. No correlation to the use of
antibiotic in the departments were found. In about 75% of
patients with E. coli or E. cloacae resistant to one or more of the
three antibiotics these bacteria were found within the ﬁrst week
after admission at a time where resistance could not yet have
been developed at the hospital. The remaining 25% of the
patients include those who had a susceptible E. coli or E. cloacae
and those in whom these bacteria were not found at the time of
admission. Typing of resistant strains revealed that three clones
of resistant bacteria occurred in more than one patient. Further
typing of strains is needed.
Conclusion: The incidence of E. coli and E. cloacae resistant to
cephlosporines, ﬂuquinolones and aminoglycosides are still low.
The majority of the strains seem to be brought to the hospital
when patients are admitted but endemic clones may also occur.
R2012
Differences in bacteraemia due to multiresistant
pathogens in medical patients: a pilot study
I.F. Hager, T.A. Peppas, E. Tamvakos, S. Bousboulas,
O. Apostolou, C. Psilopatis, M. Savvala, S.I. Pappas (Piraeus,
GR)
Objective: Our aim was to assess differences in medical
patients with bacteraemia (B) due to multi-resistant (MR)
pathogens regarding epidemiology, severity and outcome com-
pared to ones with B pathogens of usually anticipated suscep-
tibilities.
Patient-methods: All medical patients admitted in a 700 bed
tertiary hospital’s department with signs of severe infection
were entered in a PC database and only patients with
documented B were proceeded to SPSS analysis. MR pathogens
deﬁned as those resistant in at least 3 antimicrobial classes.
Time: May 2004 to Oct 2005.
Results: A total of 75 patients (M:33, F:42, m.age:68.4 ± 14 yrs)
were found with B. Of those MR B occurred in 17 (22.6% of Bs)
due to Klebsiella sp: 5, MRSA: 4, Acinetobacter 3, Pseudomonas 2,
Serratia, Salmonella, S. faecalis one each. Comparing MR B to the
other bacteraemias, there were no statistical signiﬁcance in
previous antimicrobial use [47% v 36%] or hospitalization,
comoridity, origin, SIRS criteria at admission (3 v 2.5). Appro-
priateness of initial regimen was, expectedly, less in MR (59% v
95%, p < 0.001) but did not correlate with higher mortality (6 v
18%, NS). The only signiﬁcant difference noted was a
considerably longer length of stay (27.6 v 9.8 days, p < 0.0001)
in patients with.
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Conclusions: Apart from a considerable longer stay patient
characteristics and outcomes did not differ signiﬁcantly among
patients with MR B, though, obviously, a greater number may
achieve this, as documented in MR literature. The main point is
that seeking bacteriology documentation allows for regimen
modiﬁcation to allow favourable outcome in extremely difﬁcult
to treat infections.
R2013
Antimicrobial resistance of Gram-negative
pathogens isolated from intensive care unit and
non-intensive care unit patients with bacteraemia
D. Mylona-Petropoulou, G. Ganteris, A. Kyratsa, K. Vassalos,
E. Kontekaki, H. Malamou-Lada (Athens, GR)
Objectives: To investigate the epidemiology of antimicrobial
resistance of Gram-negative bacteria isolated from ICU and non
ICU (NICU) patients with bacteraemia.
Methods: From January to October 2005, a total of 508 patients
presented one or more episodes of bacteraemia. The identiﬁca-
tion and MIC determination of the isolated pathogens were
performed by the VITEK II system (BioMerieux- France) and the
E-test method (Solna, Sweden).
Results: Bacteraemia was detected in 67 ICU and 441 NICU
patients. Polymicrobial bacteraemia with two to four pathogens
was observed in 32/67 (48%) ICU patients and in 40/441 (9%)
NICU patients. Of the 303 pathogens from ICU patients, Gram-
negative bacteria were the predominant isolates (n = 161, 53%),
followed by Gram-positive (n = 133, 44%). On the other hand, of
the 745 isolates from the NICU patients 443 (59%) were Gram-
positive and 267 (36%) were Gram-negative. Bacteria more
frequently isolated from the ICUpatients were: 57 (19%)Klebsiella
pneumoniae, 45 (15%) Acinetobacter baumanii and 36 (11%) Pseudo-
monas aeruginosa. From the NICU patients 76 (10%) were Escheri-
chia coli, 69 (9.3%) Klebsiella pneumoniae, 39 (5.2%) Pseudomonas
aeruginosa and 28 (3.8%) Acinetobacter baumanii. The resistance
rates (%)ofKlebsiella pneumoniae strains isolated fromICUpatients
compared to those of the strains isolated from NICU patients
were: imipenem 94/75, cefoxitin 95/47, amikacine 50/16, gen-
tamicine 6/17 and colistin 2/0.0. The resistance rates (%) of
Acinetobacter baumanii strains isolated from ICU patients com-
pared to those of the strains isolated from NICU patients were:
imipenem 98/64, cefepime 75/64, amikacine 98/82, gentamicine
48/61, ampicillin/sulbactam 54/41. The resistance rates (%) of
Pseudomonas aeruginosa strains isolated from ICU patients com-
pared to those of the strains isolated from NICU patients were:
ticarcillin 48/14, ceftazidime 45/36, cefepime 43/25, ciproﬂoxa-
cin 52/36, amikacine 49/36, aztreonam 55/64, imipenem 67/35.
Conclusion: A very high incidence of multidrug resistant
Gram-negative strains, with rare and new phenotypes, causing
bacteraemia were isolated especially from ICU patients. The
emergence of colistin resistance in Klebsiella pneumoniae strains is
worth noticing. Continuing regular monitoring to recognize new
patterns of antimicrobial resistance is mandatory in our hospital.
R2014
Prevalence and antimicrobial resistance of
ESBL-producing Escherichia coli and Klebsiella
pneumoniae isolates in a northern Greek rural
area
A. Poulou, F. Markou, T. Kallinikidis, G. Triantaﬁllou, S. Sideri,
P. Rozi (Serres, GR)
Objectives: Detection of extended-spectrum B-lactamase
(ESBL)-producing E. coli and Klebsiella pneumoniae isolates is
crucial for the determination of treatment since all B-lactams
except B-lactams inhibitors, cephamycins and carbapenems
are inactive against them. The aim of this study is to assess
the prevalence of the ESBL-producing E. coli and K. pneumo-
niae clinical isolates in a regional hospital in northern Greece.
Methods: A total of 2342 E. coli and 215 K. pneumoniae were
isolated during a period of two-years from various clinical
specimens obtained from outpatients and inpatients. Identiﬁca-
tion and antimicrobial susceptibility testing was performed with
the Microscan system (Dade Behring). The double-disc synergy-
test (DDST) was used for ESBL production and results were
interpreted according to NCCLS guidelines.
Results: During the study, 91 (3.9%) of the E. coli and 19 (8.8%)
of the K. pneumoniae isolates were found ESBL-positive by the
DDST. As many as 67% of the ESBL-producers were recovered
from outpatient samples while 7.2% from paediatric samples.
The majority of the ESBL-positive isolates (84%) were recovered
from urine specimens. Antimicrobial resistance rates of the
DDST-positive E. coli and K. pneumoniae isolates were: 5% and
4% to amikacin, 26% and 32% to ciproﬂoxacin, 17% and 15% to
piperacillin/tazobactam and 67% and 25% to trimethoprim/
sulfamethoxazole (SXT), respectively. Antimicrobial resistance
rates of the DDST-negative E. coli and K. pneumoniae isolates
were: 2% and 2% to amikacin, 7% and 12% to ciproﬂoxacin, 3%
and 10% to piperacillin/tazobactam and 18% and 18% to SXT,
respectively. There was no signiﬁcant variation in the preval-
ence of ESBL-producing isolates during the 2 years studied
(P > 0.05).
Conclusions: ESBL-producing isolates showed considerably
higher rates of resistance to quinolones and SXT in comparison
with non-ESBL-producing isolates in our area. The high
incidence of ESBL-producers among outpatients’ samples is
worrying and is attributed to the unjustiﬁed use of antibiotics
for the treatment of urine tract infections. Surveillance of those
isolates is essential to prevent their dissemination and to
eradicate them by following the proper antibiotic treatment.
R2015
Frequency and antimicrobial susceptibility of
extended spectrum beta-lactamase producing
urinary isolates
V. Skandami-Epitropaki, A. Chimona, A. Xanthaki, A. Tsiringa,
T. Milioti, M. Toutouza (Athens, GR)
Objectives: This study was performed to ﬁnd out the frequency
and antimicrobial susceptibility of ESBL producing Enterobacte-
riaceae strains isolated from urinary tract infections.
Methods: During the study period (October 2004–October 2005)
604 strains of Escherichia coli and 97 strains of Klebsiella
pneumoniae were isolated from midstream urine samples in
our microbiology laboratory. The identiﬁcation to the species
level was performed with the VITEK TWO system (Bio-Merie-
ux) and susceptibility to antimicrobial agents was tested by the
disk diffusion method according to NCCLS recommendations.
Detection of ESBL expression was performed by the double-disk
synergy (DDS) test and with the VITEK TWO card MIC/AST for
ESBL.
Results: ESBL production was determined in 35 out of 701
strains of Enterobacteriaceae (4.99%). The ESBL phenotype was
detected in 4.8% (29 out of 604) strains of E. coli and 6.4% (6
out of 97 strains) of K. pneumoniae urine isolates. For E. coli,
ESBL production was detected in 25 out of 346 strains isolated
from hospitalized patients (7.2%) and 4 out of 258 patients of
the community (1.5%). For K. pneumoniae no ESBL producing
strains were isolated from community patients. The antibiotic
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
susceptibility rates for the ESBL producing strains were for E.
coli and K. pneumoniae respectively: Imipenem 100–100%,
gentamicin 82.7–83.3%, amikacin 79.3–50%, netilmicin 86.2–
33.3%, tobramycin 62.1–0%, chloramphenicol 62.1–83.3%, ci-
proﬂoxacin 34.5–33.3%, norﬂoxacin 34.5–33.3%, nitrofurantoin
44.8–33.3%, tetracycline 17.2–0%, piperacillin/ tazobactam
89.6–66.6%, trimethoprim/sulfamethoxazole 58.6–33.3%. ESBL
production and ﬂuoroquinolone resistance were detected in 19
out of 29 (76%) strains of E. coli and 4 out of 6 (66.7%) strains
of K. pneumoniae.
Conclusions: Our ﬁndings demonstrate an increasing inci-
dence of urinary tract infections with ESBL producing bacteria
not only in hospitalized but also in community patients. Most
of ESBL producing isolates were multidrug resistant. High
resistance rates to quinolones were observed among these
strains, but carbapenems had a good activity. Monitoring of
ESBL production and antimicrobial susceptibility testing are
necessary to avoid treatment failure in patients with urinary
tract infections.
R2016
Antibiotic resistance and plasmid proﬁles of
Acinetobacter spp. isolated from three hospitals
in Tehran, Iran
J. Zaeimi Yazdi, N. Sadeghifard, R. Ranjbar, N. Badami (Tehran,
Ilam, IR)
Objectives: This study was designed to determine antibiotic
resistance pattern and plasmid proﬁling of Iranian isolates of
Acinetobacter.
Methods: During an eight- month period, 47 Acinetobacter
isolates (including 21 A. baumannii and 26 non-baumannii
strains) were obtained from three University Hospitals in
Tehran. The source of these isolates included blood, urine,
wound, and respiratory tract. Their susceptibility to the 17
antibiotics was tested. The plasmid proﬁling method was used
for typing of isolates.
Results: The results of this study showed that all Acinetobacter
baumannii isolates were resistant to multiple antibiotics inclu-
ding cefoprazone, ceftazidime, ticarcillin/ clavulanic acid,
aztreonam, meropenem, ceftizoxime, carbenicillin, ceﬁxime,
ceftriaxone, ticarcillin, cephotaxime, and were sensitive to
colistin. All non-baumannii strains were resistant to cefexime
and with one exception to meropenem and were susceptible to
polmyxinB and colictin. Plasmid were found in 44 (93.61 %) of
47 isolates, and no plasmid were found in 3 isolates (6.39 %).
Seven different plasmid proﬁles were observed among 44
Acinetobacter isolates. Similar plasmid proﬁle was seen in two
different specimens from two different hospitals. Plasmid
proﬁles 1–7 were observed in all isolates recovered from the
blood culture. All proﬁles except proﬁle 2 were seen in all
strains isolated from urine cultures. Plasmid proﬁles were
identical in two isolates obtained from two different patients
in the same hospital. With one exception, all A. baumannii
strains could be differentiated by this method; among non-
baumannii strains, 24 of 26 were typed using plasmid proﬁling
method.
Conclusion: The results of this study revealed that most of
Acinetobacter isoltes showed multi-drug resistant pattern. Plas-
mid proﬁle analysis seems to be a rapid and simple technique
for the routine screening and typing of clinical Acinetobcter
isolates with epidemic potential.
R2017
Molecular typing of Stenotrophomonas
maltophilia causing prosthetic valve endocarditis
M. Mueller-Premru, T. Lejko-Zupanc, V. Spik (Ljubljana, SI)
Objectives: At the Department of Cardiovascular surgery of the
University Medical Centre Ljubljana, Stenotrophomonas malto-
philia caused ﬁve cases of the early postoperative prosthetic
valve endocarditis and one case of bacteraemia in a patient after
heart transplantation in the three-year period. Because bacteria
could be introduced from a common source during the opera-
tion, molecular typing was performed.
Methods: There were three male and three female patients. All
patients with endocarditis fulﬁlled Duke criteria for deﬁnite
endocarditis. All had aortic valve replacement. Three patients
with endocarditis and a patient with heart transplantation were
operated in 2005 and one patient with endocarditis in 2002 and
one in 2004. Apart from the ﬁrst patient who presented with the
symptoms 13 months postoperatively, the symptoms appeared
one to six months after the operation (mean 3 months). In two
patients the presenting symptom was a CNS embolism and in all
others temperature and signs of cardiac failure were present.
Bacteria were identiﬁed and antimicrobial susceptibility was
determined to trimethoprim/sulfamethoxazole, gentamicin,
amikacin, piperacillin/tazobactam, ceftazidime, ciproﬂoxacin
and imipenem. All patients were treated with ceftazidime in
combination with gentamicin, amikacin or ciproﬂoxacin. Three
of them died. Molecular typing of bacterial isolates was
performed by macrorestriction analysis of chromosomal DNA
by PFGE using the cutting enzyme SpeI.
Results: We detected two different PFGE patterns. The isolates
of the patients with aortic valve replacement belonged to the
same genotype, but the isolate from the patient after heart
transplantation was different. All isolates were susceptible to
ceftazidime, but only two to trimethoprim/sulfamethoxazole.
Conclusion: The results show that in ﬁve patients at the
Department of Cardiovascular surgery who developed Stenot-
rophomonas maltophilia endocarditis, the infection could be con-
nected with the contamination during aortic valve replacement.
Samples from the medical equipment and the environment
should be taken to detect the source of bacteria.
R2018
Antimicrobial susceptibility among Pseudomonas
aeruginosa isolated in an infectious disease
hospital in Bucharest
D. Nae, A. Hristea, V. Arama, A. Negoita, R. Sandu, V. Molagic,
R. Moroti, S. Botea (Bucharest, RO)
The antimicrobial resistance of Pseudomonas aeruginosa (PA) is
increasing worldwide.
Objectives: To describe the demographics and risk factors
among adults hospitalized who had infection with PA, to assess
the antimicrobial susceptibility of PA isolates.
Methods: Retrospective study of patients who were culture-
positive for PA between Jan 1–Oct 31 2005. The isolates were
identiﬁed using conventional methods. The sensitivity of strains
to selected antibiotics amikacin (AMK), ciproﬂoxacin (CIP),
piperacilline (PIP), piperacilline/tazobactam (P/T), ceftazidime
(CAZ), cefepime (CEP), imipenem (IMI) was tested with disk
diffusion method and interpretation was according to NCCLS.
We classiﬁed the isolates in three categories: I-susceptible to
three or more of the antibiotics tested, II-susceptible to imipe-
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nem only, III–multidrug resistance MDR (resistance at least
three of IMI, CAZ, CIP, AMK).
Results: We identiﬁed 75 positive cultures of PA. Clinical data
were available for review for 42 patients. Mean age was 54
(±21.3) years, 24 patients were female. The organisms had been
acquired in hospital in 29 cases (most of them were admitted
from another hospital, from ICU in 7 cases) and from immu-
nocompromised patients (17 cases). Mean duration of inpatient
stay prior to the isolation was 31.3 (±26.3) days. The strains
were isolated from wounds/soft tissues in 15 cases, urine 11
cases, respiratory tract 10 cases, blood culture 3 cases, venous
catheter 2 cases and CSF 1 case. Overall, 33 of our patients had
received antibiotic therapy within 30 days prior to admission in
our hospital. The most frequently used antibiotics were beta-
lactams, beta-lactams/betalactamase inhibitor or ciproﬂoxacin.
The most active antibiotics were IMI (24 susceptible strains),
AMK, CAZ, P/T (23), PIP (21) and the less active were CEP and
CIP (18, respectively 17). Susceptibility rates varied signiﬁcantly
between nosocomial and community acquired infections. We
noted 25, 2 and 15 isolates in category I, II and III, respectively.
Most of patients with MDR PA (13) had nosocomial infections
and all strains IMI resistant were isolated from nosocomial
infections.
Conclusion: PA is an important cause of nosocomial infections
and in immunocompromised patients. Considering the results
and the high prevalence of the multidrug resistant PA strains,
further studies for antimicrobial resistance surveillance are
needed, as well as control measures to prevent the spreading of
these strains.
R2019
Multi-resistance in K. pneumoniae in German
university hospitals, 2002–2005
I. Noll, B. Wiedemann, J. Beer, T. Pietzcker, W. Pﬁster,
S. Schubert, S. Ziesing, O. Hamouda (Berlin, Bonn, Leipzig, Ulm,
Jena, Kiel, Hannover, DE)
Objectives: K. pneumoniae is frequently involved in nosocomial
infections, the emergence of multi-resistant clones causes major
problems. We want to examine the development of multi-
resistance in K. pneumoniae within recent years using the dataset
of the GENARS-project (German Network for Antimicrobial
Resistance Surveillance), a prospective multi-centre surveillance
study designed to provide epidemiological data for German
university hospitals.
Methods: Analysis was based on non-duplicate isolates of K.
pneumoniae from ﬁve laboratories with continuous data collec-
tion from January 2002 to June 2005. Antimicrobial susceptibility
was determined as minimal inhibitory concentrations by broth
microdilution method performed by different automated test
systems for ceftazidime, cefotaxime, ciproﬂoxacin, gentamicin,
meropenem, piperacillin and piperacillin/tazobactam. Resist-
ance patterns were evaluated by using breakpoints according to
DIN guidelines; multi-drug resistance was deﬁned as resistance
to at least four of the above mentioned agents.
Results: A total of 4,108 isolates was analysed. In 2002 83.4
percent of the isolates showed no resistance to any of the
selected antibiotics, this rate decreased to 75.9 percent in 2005
due to signiﬁcant increases in resistance rates for piperacillin
(PIP: 14.7% to 23.1%; p < 0.001) and piperacillin/tazobactam
(PIT: 3.4% to 7.5%; p < 0.001). Accordingly, the most common
resistance pattern was a mono-drug resistance to PIP followed
by co-resistance to PIT. The proportion of multi-resistant strains
accounted for 2.8% in 2002 and rose to 4.2% in 2005, this increase
was not signiﬁcant. Overall multi-resistance rates were signiﬁ-
cantly higher for isolates from intensive care units (ICU) than for
those from non-ICU inpatients (7.4 versus 2.6%; p < 0.001).
Increases of multi-resistance within the subsamples were not
signiﬁcant. The peak of multi-resistance of 9.6% in 2004 in ICUs
was due to an outbreak of two phenotypes in only one centre
that could be contained.
Conclusions: With an overall proportion of 3.7 percent the
relevance of multi-resistance in K. pneumoniae as a clinical
problem is proven in German university hospitals for the period
2002 to 2005. Though there were no signiﬁcant increases in
multi-resistance neither for the complete sample nor for
subsamples of isolates from ICUs or non-ICU inpatients
within this period monitoring should continue for early detec-
tion of multi-resistance.
R2020
Transfer of antibiotic resistance in multiresistant
nosocomial isolates of Acinetobacter baumannii in
three university clinics
E. Kalavsky, M. Babalova, J. Blahova, K. Kralikova, V. Krcmery
(Trnava, Bratislava, SK)
Objectives: The aim of this study was to evaluate transferability
of antibiotic resistance in 17 multiresistant nosocomial Acinetob-
acter baumannii isolates during surveillance of antibiotic resist-
ance in 3 University Clinics in Slovak Republic.
Methods: MIC(s) of antibiotics were determined by the agar
dilution method with two-fold dilution of antibiotics. Transfer of
genes for antibiotic resistance was performed in mixed liquid
cultures of the donor and recipient strain. As recipient strains
were used E. coli K-12 3110 rif+, Proteus mirabilis P-38 rif+,
Pseudomonas aeruginosa 1008 rif+ and Pseudomonas aeruginosa
1670 rif+.
Results: 17 A. baumannii isolates caused severe infections in 13
patients hospitalised in anaesthesiology, traumatology and
haematology ICUs of 3 different University Clinics (Kosice,
Bratislava, Nitra) during years 2004 and 2005. Isolates were
resistant to various beta-lactams (ticarcilin, cefalotine, cefotax-
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ime, ceftazidime, cefoperazone, cefepime, aztreonam, merope-
nem and mipenem), aminoglycosides (kanamycin) and quino-
lones (oﬂoxacin). We observed direct transfer of cefalotine (CFL)
and cefoperazone (CFP) resistance determinants in 6 isolates
from University Clinic Kosice to E. coli and P. mirabilis recipient
strains. Similarly all isolates from University Clinic Bratislava
and University Clinic Nitra directly transferred CFL resistance, 4
isolates from Bratislava directly transferred CFP resistance and 2
isolates from Bratislava and Nitra transferred also ticarcillin
(TIC) resistance. Transfer of resistance determinants were also
observed in 2 additional Ps. aeruginosa recipient strains.
Conclusions: Although transfer of meropenem resistance in
A. baumannii isolates was not observed, strains with similar
resistance patterns and transfer of resistance determinants give
evidence of probable clonal spread of multiresistant meropenem
resistant strains in ICUs of all examined University Clinics. CFL,
CFP and TIC resistance determinants already located in
plasmids showed the possibility of mobilisation of other
resistance determinants. Moreover, transfer of these determi-
nants to 4 different recipient strains demonstrates broad host
range of this nosocomial pathogen. A. baumannii resistant to
meropenem and other previously effective antibiotics is becom-
ing more common pathogen in our country, especially in ICUs
and contribute to spread of resistance in hospital environment if
adequate infection control measures are not implemented.
R2021
Susceptibility proﬁle of Acinetobacter baumanii
isolates and evaluation of three different
susceptibility test methods
P. Fostira, A. Xanthaki, M. Kanellopoulou, E. Papafrangas,
A. Vatopoulos, A. Tsiringa, V. Skandami-Epitropaki,
M. Toutouza (Athens, GR)
Objective: To compare and evaluate the antibiotic susceptibility
of A. baumanii according to 3 different methods in common use
in laboratories.
Methods: Thirty-four A.baumanii strains were isolated from
patients in 2 general hospitals in Athens and from various
clinical specimens (blood, urine, intravenous catheters, bron-
chial secretions). Identiﬁcation to the species level was per-
formed by automated VITEK II method. Susceptibility testing
was done: 1) by Kirby-Bauer according NCCLS 2) by VITEK II
system (AST N022 card) 3) by testing imipenem and production
of metallo-b-lactamases using the E-test MBL.
Results: We classiﬁed 8 different phenotypes according sus-
ceptibility results:1) 16/34 (48%) showed sensitivity only to
colistin (C). 2) 4/34 (12.5%) showed sensitivity to colistin and
ampicillin-sulbactam (CS). 3) 1/34 (3%) showed sensitivity to
colistin and tobramycin (CT). 4) 1/34 (3%) showed sensitivity to
colistin and imipenem (CI). 5) 8/34 (24.5%) showed sensitivity
to colistin, imipenem, ampicillin-sulbactam (CSI). 6) 1/34 (3%)
showed sensitivity to colistin, imipenem, tobramycin, netilmy-
cin (CITN). 7) 1/34 (3%) showed sensitivity to colistin, imipe-
nem, tobramycin, netilmycin, cefepime (CITNF) and 8) 1/34
(3%) showed sensitivity to colistin, imipenem, tobramycin,
netylmycin, cefepime, ciproﬂoxacin and gentamycin (CIT-
NFPG). Among the total number of isolates, 20 (59%) were
imipenem-resistant and 2 (6%) showed intermediate suscepti-
bility by the disk-diffusion method. 8/20 (40%) R strains and 1/
2 (50%) IR strains produced metallo-b-lactamases by E-test MBL.
For the evaluation of susceptibilities of imipenem we used E-test
as the reference method. We observed that KB correlated well
with E-test results for A. baumanii strains. Minor discrepancies
occurred comparing E-test with VITEK II system (resistance by
E-test and intermediate susceptibility by VITEK II system) in
75% of the strains.
Conclusions: According results most A. baumanii strains of our
study showed imipenem-resistance and were also multi-drug-
resistant. By E-test as the reference method, Kirby-Bauer proved
to be efﬁcient in detecting those strains and also VITEK II system
showed minor discrepancies.
R2022
Nosocomial pseudomonal infections in a
university hospital, Adana, Turkey
N. Saltoglu, E. Akcam, A. Yaman, F. Kibar, S. Inal, Y. Tasova,
G. Seydaoglu, M. Gunduz, M. Ozalevli, A. Candevir (Adana,
TR)
Objectives: Our aim is to determine antimicrobial resistance
and risk factors for nosocomial Pseudomonas infections isolated
from various sites in a university hospital.
Methods: This prospective study was conducted in a university
hospital with 1100-bed, between January 2004 and October 2005.
Nosocomial Pseudomonas infections were investigated in hospi-
talised patients in ICUs and others. Hospital-acquired infections
were deﬁned by the criteria of CDC. The identiﬁcation and
susceptibility to antimicrobials has been performed by Vitek 2 as
described by NCCLS.
Results: One hundred and seventy nosocomial Pseudomonal
infections were diagnosed in 170 patients. One hundred and
sixteen (68%) of the patients were male. Mean age was 43.93
years. One hundred and twelve (66%) of infections were
diagnosed in ICUs. Hospitalization period was more than
20 days at 78% of the patients. Nosocomial infection types
were detected as follows: Urinary tract infections 35%, pneu-
monia 28%, bacteraemia 19%, skin and soft tissue infection 10%,
surgical wound infection 8%. Risk factors were detected as,
previously hospitalization 21.7%, previous antibiotic use 45%,
mechanical ventilation 30.6%, burn 7.6%, diabetes mellitus 7%,
malignancy 16.5%, COPD 6%, chronic liver disease 3.5%,
collagen vascular disease 6%, chronic renal failure 2%. The
results of susceptibility testing for Pseudomonas isolates are
shown in the table below. The most active antimicrobial agents
againts Pseudomonas spp. were carbapenems. Five percent of
Pseudomonas isolates were found to be resistant to all antibiotics.
Conclusion: The high resistance rates in Pseudomonal isolates
that are responsible for nosocomial infections in our hospital
suggest that susceptibility pattern should be monitorised con-
tinuous and preventive procedures should be implemented.
Besides, multidrug resistant Pseudomonas isolates are to take into
consideration.
R2023
Activity of different antimicrobials against
nosocomial cefotaxime-resistant Klebsiella
pneumoniae
E. Ryabkova, G. Reshedko, E. Khaykina (Smolensk, RU)
Objectives: To determine the activity of different antimicrobials
against cefotaxime-resistant K. pneumoniae in Russian ICUs.
Methods: During 2002–2004 K. pneumoniae strains were isolated
from ICU patients with nosocomial infections. MICs of amika-
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cin, amoxicillin/clavulanate, ampicillin, cefepime, cefoperazone,
cefoperazone/sulbactam, cefotaxime, cefotaxime/clavulanate,
ceftazidime, ceftriaxone, ciproﬂoxacin, ertapenem, gentamicin,
imipenem, levoﬂoxacin, meropenem, moxiﬂoxacin, piperacillin,
piperacillin/tazobactam, ticarcillin/clavulanate were deter-
mined by agar dilution method according with NCCLS. Inter-
mediate strains were referred to resistant category.
Results: A total of 420 nosocomial K. pneumoniae strains were
evaluated. Among them 318 (75.7%) were resistant to cefotax-
ime. More or equal to 3-fold decrease in MIC for cefotaxime/
clavulanate vs MIC of cefotaxime was observed in 299 (94%)
cefotaxime-resistant K. pneumoniae, thus suggesting ESBL pro-
duction as the main cefotaxime-resistance driver. Resistance of
cefotaxime-resistant strains to different antimicrobials was:
ampicillin – 100%, piperacillin – 100%, ticarcillin/clavulanate –
99.7%, ceftriaxone – 99.1%, cefoperazone – 98.1%, amoxicilli/
clavulanate – 91.8%, gentamicin – 89.6%, cefepime – 81.1%,
ceftazidime – 70.4%, piperacillin/tazobactam – 52.5%, ciproﬂ-
oxacin – 46.2%, amikacin – 40.3%, cefoperazone/sulbactam –
37.4%, moxiﬂoxacin – 33.3%, levoﬂoxacin – 31.4%, ertapenem –
3.5%, imipenem – 0%, meropenem – 0%. Among antimicrobials
tested only imipenem and meropenem were active against all
cefotaxime-resistant K. pneumoniae. Among inhibitor-protected
b-lactams only cefoperazone/sulbactam was outstanding
though with resistance level of 37.4%. Aminoglycosides
showed poor activity – 89.6% studied strains were resistant to
gentamicin and 40.3% - to amikacin. Levoﬂoxacin was more
active as compared to moxiﬂoxacin and ciproﬂoxacin (31.4% vs
33.3% and 46.2% resistant, respectively).
Conclusion: The tremendous increase in resistance to III gen-
eration cephalosporins, especially to cefotaxime, in nosocomial
K. pneumoniae demands search for antimicrobials active against
these strains. Our results outline imipenem and meropenem as
the most active antimicrobials against cefotaxime-resistant
K. pneumoniae.
R2024
Activity of different antimicrobials against
nosocomial ciproﬂoxacin-resistant Acinetobacter
baumannii
A. Farashchuk, G. Reshedko, E. Ryabkova on behalf of the Rosnet
Group
Objectives: Due to its unique gram-negative activity and
pharmacological properties ciproﬂoxacin historically was one
of the ﬁrst-line drugs for the treatment of nosocomial infections.
According to recent surveillance data Acinetobacter baumannii
became one of the most important nosocomial pathogens
manifesting various resistance patterns; in some Russian centres
it is the leading nosocomial gram-negative pathogen. Thus the
objective of our study was to determine the level of ciproﬂoxacin
resistance among nosocomial A. baumannii in Russia and to
reveal antimicrobials with potential to be active against ciproﬂ-
oxacin-resistant A. baumannii.
Methods: Antimicrobial activity against A. baumannii strains
isolated in 2002–2004 from Russian intensive care unit (ICU)
patients with nosocomial infections was performed in accord-
ance with NCCLS by agar dilution method. MICs of amikacin,
cefepime, cefoperazone, cefoperazone/sulbactam, cefotaxime,
ceftazidime, ciproﬂoxacin, gentamicin, imipenem, levoﬂoxacin,
meropenem, piperacillin, piperacillin/tazobactam were deter-
mined. Intermediate strains were referred to resistant category.
Results: A total of 459 nosocomial A. baumannii strains were
evaluated. Among them 339 (73.9%) were resistant to ciproﬂ-
oxacin. Resistance of ciproﬂoxacin-resistant strains to different
antimicrobials was: cefoperazone – 100%, piperacillin – 98.8%,
gentamicin – 97.1%, levoﬂoxacin – 84.4%, ceftazidime – 82.3%,
piperacillin/tazobactam – 81.7%, amikacin – 76.4%, cefepime –
69%, meropenem – 4.4%, imipenem – 2.9%, cefoperazone/
sulbactam – 2.4%. Obtained data demonstrate cefoperazone/
sulbactam as the most active against ciproﬂoxacin-resistant A.
baumannii strains followed by imipenem and meropenem. The
rest antimicrobials expressed signiﬁcantly poor in vitro activity
against studied A. baumannii population. As concerning to cross-
resistance between ciproﬂoxacin and levoﬂoxacin it should be
noticed that levoﬂoxacin was active against 15.6% of ciproﬂoxa-
cin-resistance strains, while all strains resistant to levoﬂoxacin
were resistant to ciproﬂoxacin as well.
Conclusion: Cefoperazone/sulbactam, imipenem and merope-
nem might be considered as the key antimicrobials to treat
nosocomial infections due to ciproﬂoxacin-resistant A. baumannii
in Russian ICUs.
Antibiotic usage
R2025
Efﬁcacy of linezolid in treatment of
non-approved indications
J.R. Yuste, J.L. Del Pozo, E.G. Quetglas, V. Fernandez-Gallego,
J.R. Azanza (Pamplona, ES)
Objectives: Linezolid (LZD) has been approved in the treat-
ment of Gram-positive lower respiratory tract infections and
skin and soft-tissue infections. However, few data exist about
the LZD activity in other Gram-positive infections. The aim of
this study was to evaluate our practical experience of LZD in the
treatment of non-approved Gram-positve infections.
Methods: Patients treated with LZD in non-approved indica-
tions from June 2002 to October 2005 were assessed for the
followings variables: age, gender, underlying diagnosis, isolated
microorganisms, prior treatments and outcome. Only patients
with more than 7 days of treatment and cultures with less than 3
isolated microorganisms were included. Finally, 14 patients (7
males, median age 59.8 years-old) were reviewed. Clinical
infections included: intra-abdominal abscess (4), abdominal
mesh infection (4), prosthetic joint (PJ) infection (3) and central
nervous system (CNS) infection (3).
Results: A total of 18 isolates were observed in the 14 patients.
Isolated microorganisms included: methicillin-resistant Staphy-
lococcus epidermidis (MRSE) (8), methicillin-resistant Staphylococ-
cus aureus (MRSA) (6), Enterococcus faecalis (2), Enterococcus
faecium (1) and Corynebacterium striatum (1). LZD was the initial
therapy in 3 cases and 11 patients received LZD after several
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courses of antibiotics. In these cases, previous treatments
included a glycopeptide in 9 patients (82%). LZD was started
because of failure of previous treatment in 8 patients (72.7%)
and owing to continue a treatment per os in 3 (27.3%). Included
patients received LZD for a median of 44 days (range 14 to 127)
and half of them received it in monotherapy. Initial therapy with
LZD was intravenously in 6 cases and the orally sequence went
for hospitable discharge in 5. No serious side effects were
observed and only one patient, in combined therapy with
cotrimoxazol, leucopenia was detected. Successful outcome was
observed in 85.7% (12 of 14) of patients. No failures were
observed in patients with PJ and CNS infection. Failures were
observed in one patient with an intra-abdominal abscess
(MRSA) and another with an abdominal mesh infection
(MRSE and E. faecium).
Conclusions: LZD could be a therapeutic alternative in non-
approved indications caused by Gram-positive pathogens
resistant to conventional antimicrobials or in those in which
standard therapy fails. In addition LZD allows continuing
ambulatory treatment after clinical discharge, shortening the
stay.
R2026
Bacterial and antimicrobial aspect of odontogenic
infections
A. Ozbek, S. Tozoglu, H. Uslu, H. Demir, U. Ertas,
A. Ayyildiz (Erzurum, TR)
Objectives: We aimed to determine bacterial agents and eval-
uated antimicrobial susceptibility of pus samples with odonto-
genic infections.
Methods: Seventy-one patients with odontogenic infections
included in this study. The patients had received no antibiotic
therapy in the preceding 3 months, and with chronic diseases
such as diabetes mellitus, leukaemia was excluded. Pus samples
were collected from abscess by aspiration after disinfection of
mucosa or skin. Some part of each sample was transferred into
brain heart infusion (BHI) broth for aerobic and the other was
transferred into chopped meat broth (CMB) for anaerobic
cultures. Samples for aerobic examination were cultured for
3 hours, and then sub-cultured on BHI Agar with 5% deﬁbrin-
ated sheep blood and chocolate agar for 18 hours. Samples
collected into CMB for anaerobic examination were incubated
for 7 days, and then sub-cultured on supplemented BHI Agar
with blood. Sub-cultured plates were incubated for 48 hours. All
aerobic and anaerobic bacteria were identiﬁed according to the
bacterial fatty acid proﬁles by Microbial Identiﬁcation System.
Antibiotics for aerobics were erythromycin, penicillin, amoxicil-
lin-clavulanic acid, clindamycin, tetracycline, cefazolin, and for
anaerobics were clindamycin, imipenem, metronidazol, cefox-
itin, penicillin-G, piperacillin-tazobactam. All practices were
applied according to NCCLS standarts. A chromogenic cepha-
losporin impregnated on a stick was used for the detection of
bacterial beta-lactamases.
Results: 19 and 13 different bacterial strains were identiﬁed as
aerobic and anaerobic respectively. The most part of samples
were of mix (aerobic and anaerobic) bacterial characteristic. The
most prevalent bacteria were Staphylococcus spp., viridans group
Streptococci, anaerobic Streptococci, Fusobacterium nucleatum
and Prevotella melaninogenica. The incidence of beta-lactamase
producing bacteria were Staphylococcus aureus (20 %), Bacteroides
oralis (20%), Fusobacterium nucleatum (22.2%) Bacteroides ovatus
(33.3%) Actinomyces israelli (33.3%) and Prevotella melaninogenica
(33.3%). For aerobic bacterial isolates; amoxicillin-clavulanic
acid and cefazolin were the most effective antibiotics, and for
anaerobic bacterial isolates, imipenem and piperasilin-tazobac-
tam were the most effective ones.
Conclusion: A combination of amoxicillin-clavulanic acid and
metronidazol or a combination of clindamycin and metronida-
zol seems to have well effect for mixed infections.
R2027
Clinical and microbiology activity of colistin
alone and in combination with rifampin or other
antibiotics against MDR Gram-negative rods
severe infections: four-year, single-centre
experience
C. Tascini, R. Doria, G. Gemignani, A. Leonildi, P. Malacarne,
G. Biancoﬁore, S. Ferranti, A. Piaggesi, P. Lambelet,
F. Menichetti (Pisa, Viareggio, IT)
Objectives: To study the in vitro and clinical activity of colistin
[C] alone or in combination with rifampin [R] and/or other
antimictrobial in severe MDR gram negative rods infections.
Methods: All the patients treated with C alone or in combina-
tion were reviewed. Synergism of the combination C plus R
against MDR P. aeruginosa and A. baumanniiwere tested with the
checkerboard method. Synergism was calculated using FIC
index (FICI), fully synergism was considered FICI<0.5, partially
synergism between 0.5 and <1, additivity = 1, indifference
between 1 and 4, antagonism >4.
Results: 28 patients (mean age 56 years, 19 male) were treated
with C: 9 diabetic foot infections (DFI), 7 sepsis, 6 pneumonia
(1VAP), 4 post-traumatic infections, 1 arthrytis, 1 meningitis. 25
MDR P. aeruginosa and 3 MDR A. baumannii were isolated from
these patients. 24 patients received C endovenously at a mean
daily dose of 3 MU/day. 3 patients received C alone, 9 patients
received C + R, 9 patients C + R plus another antibiotic, 7
patients received C plus another antibiotic. C therapy mean
duration time was 46 days (range 3–240 days). No adverse
effects were observed: neither in the three patients with renal
insufﬁciency nor in the two patients with diabetic neuropathy.
Positive clinic outcome was obtained in 24/28 patients (87%),
among the 4 patients with bad outcome, three died of infection.
Synergism was tested against 10 MDR P. aeruginosa: C + R was
fully synergistic aginst 2/10 strains, partially synergistic against
7/10 strains and indifferent against only one strain. C + R was
partially synergistic against the only one strain of MDR
A. baumannii tested.
Conclusion: Colistin alone and in combination with rifampin
and /or other antibiotics is safe and effective in the treatment of
severe MDR Gram-negative rods infections.
R2028
A ﬁve-day ceftriaxone and levoﬂoxacin regimen
plus early sequentation to oral levoﬂoxacin in
heart transplantation recipients with community-
acquired pneumonia
E.G. Quetglas, J.R. Azanza, J.L. Del Pozo, J.R. Yuste,
I. Gil (Pamplona, ES)
Objective: To determine the efﬁcacy of a 5-day regimen of
ceftriaxone and levoﬂoxacin followed by a 7-day regimen of the
oral quinolone in heart transplantation recipients with commu-
nity-acquired pneumonia (CAP) in comparison to established
regimens of 14-day betalactams.
Methods: Heart transplantation recipients attended in emer-
gencies that presented clinical signs and symptons of CAP
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combined with a radiologic evidence of an inﬁltrate were
included. Before antimicrobial therapy was started, samples for
respiratory cultures were obtained when possible. Clinical
outcome of patients was assessed at discharge.
Results: Study included 14 patients (median age, 62.5 years)
with a gender distribution of 13 males and one female.
Radiological tests interested right lung in 78.5% of patients
(57% lower lobe). Microbiologic testing was positive in 57.1%
(sputum collected in 9 patients). The most common isolated
pathogen was Streptococcus pneumoniae. In 10 patients regimen
was followed as pre-established. In two patients oral adminis-
tration was not possible due to acute allograft rejection and a
concomitant Herpes simplex systemic infection. In another
patient cefepime was used instead of ceftriaxone due to the
presence in blood cultures of Propionibacterium acnes. Finally, in
one patient treatment was interrupted after 5 days due to the
isolation of Parainﬂuenzae virus in bronchoscopic cultures.
Mean duration of antimicrobial treatment was 13.9 days: 6.6
intravenous and 7.2 oral administration. Mean duration of the
in-patient period was 5.8 days being the 78.6% of patients
admitted in conventional hospitalisation. Clinical successful
outcome was observed in 85.7% of patients per intention to treat
and in a 100% per protocol.
Conclusions: 5-day regimen with intravenous ceftriaxone and
levoﬂoxacin followed by a 7-day regimen of oral levoﬂoxacin
reveals as a successful outcome as established regimens in heart
transplantation recipients with CAP; otherwise, reduces the
in-patient period in 12 days.
R2029
Treatment of chronic bone and joint infections
with peroral linezolid
A. Friis-Møller, J. Hvolris, M. Boye Petersen, A. Friis-
Møller (Hvidovre, Copenhagen, DK)
Objectives: To evaluate the efﬁcacy and side effects of long-
term treatment of chronic osteomyelitis and joint infections
caused by multiresistant Gram-positive bacteria with the oxa-
zolidinone Linezolid.
Methods: Included were patients (ptt) with chronic osteomy-
elitis and joint infections with multiresistant Gram-positive
bacteria, sensitive to Linezolid, who were treated primarily with
vancomycin i.v. followed by Linezolid 600 mg · 2 p.o. for 2 to
4 weeks. Ptt were monitored weekly for haematologic and
hepatic parameters. All ptt had biopsies taken for culture in
relation to operation. Biopsies were cultured aerobic and
anaerobic for 5 days and bacteria identiﬁed according to clinical
microbiological standard procedures.
Results: Eleven ptt, eight women and three men, median age
75.6 (range 57–92) had chronic osteomyelitis or joint infections
with multiresistant coagulase negative staphylococci and/or
enterococci and were treated with Linezolid 600mg · 2 p.o.
Eight ptt had hip prosthesis and two had knee arthroplasty, only
one had primary soft tissue infection of the knee (popliteal cyst).
All received vancomycin therapy as primary antibiotic treat-
ment (1–4 weeks) followed by Linezolid for either two (three
patients) or four weeks (eight patients). Five ptt were cured of
the chronic infection, they all got four weeks Linezolid
treatment. Three of them had no side effects, but two had
nausea. Four ptt died due to cardial insufﬁciency soon after the
Linezolid treatment stopped (age 71, 77, 90, 92 years). They had
no clinical signs of infection when they died. One woman had
nausea and diarrhoea during the treatment, but died from
hepatocellular carcinoma. One pt was not cured despite six
weeks treatment with vancomycin and four weeks treatment
with Linezolid. Nine ptt had no haematologic side effects. The
patient with hepatocellular carcinoma both had hepatic and
haematological side effects. One patient had leucocytosis after
four weeks of Linezolid.
Conclusion: Half of the patients were cured of their very
complicated infections. The patients with chronic multiresistant
Gram-positive infections were able to get Linezolid per oral
treatment and were discharged either to own home or to
nursinghome.
R2030
An intervention to reduce irrational surgical
antibiotic prophylaxis by evidence-based
guidelines, education and feedback
B. Wibowo, H. Parathon, I.C. Gyssens, O. Duerink,
A. Soejoenoes on behalf of the AMRIN Study Group
Objectives: Previous research showed overconsumption of
antibiotics in teaching hospitals in Surabaya (SBY) and Sema-
rang (SMG) on Java, Indonesia. We studied the effect of an
intervention to reduce irrational prophylaxis.
Methods: Prospective intervention study conducted concur-
rently in 2 hospitals. The most frequently performed procedures
in the departments of obstetrics and gynecology (Ob/Gyn) and
surgery (Surg) were selected. Consecutive cases were included
from July 2003 till August 2004. Data on procedures and
antibiotic use were collected. Four periods were deﬁned: a
baseline period (I) during which an evidence based update of
prophylaxis guidelines was developed by consensus of surgical
staff, period II following dissemination of the guidelines on
paper, period III following an interactive training for residents
and period IV, after feedback of the data on practice in previous
periods. Antibiotic use was calculated in Deﬁned Daily Doses
(DDD)/procedure. Quality criteria to evaluate prophylactic
prescribing were derived from the guidelines. We report here
on 2 criteria 1) DDD/procedure for clean procedures without
indication for prophylaxis 2) Number of postoperative days
(>24 h) of prophylaxis; according to the guideline both should
be zero.
Results: Between July 2003 and September 2004, 3173 proce-
dures were studied in the 4 departments.
Conclusion: An identical intervention consisting of updating
consensus guidelines, educational training and feedback in 2
hospitals resulted in signiﬁcant improvements of prescribing in
3 out of 4 departments. Sustainability of the improvements
needs to be explored.
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R2031
Seasonal trends in antimicrobial consumption in
Russia in 2004
S.A. Ratchina, R.S. Kozlov, A.A. Fokin, A.A. Ishmukhametov,
M.N. Denisova (Smolensk, Moscow, RU)
Objectives: The long-term program on the antimicrobial (AM)
consumption evaluation in Russia was implemented by the IAC
and TRGC in 2003. The purpose of this study was to compare
seasonal changes in AM consumption in Russia in 2004.
Methods: Data containing products names, ATC classiﬁcation
codes (WHO, version 2005), drug forms, dosages and number of
packages were collected during pharmacy and hospital audits in
53 and 27 regions of Russia, respectively. Variations of the data
of both audits did not exceed 10%. The use of AMwas expressed
as the number of deﬁned daily doses (DDD) per 1000 inhabit-
ants per day (DID). We compared seasonal variations in AM
consumption as winter (quarter 1 + quarter 4) vs summer
(quarter 2 + quarter 3). To ﬁnd out trends the formula: ([quar-
ter1 + quarter4/quarter2 + quarter3] -1) x 100% was used.
Results: AM consumption increased in 18.1% in winter quarters
compared with summer ones. Major changes were found for
sulfonamides and trimethoprim (J01E) (+ 41.6%), beta-lactams,
penicillins (J01C) (+30.7%) and macrolides, lincosamides, strep-
togramins (J01F) (+25.2%). Amphenicols (J01B) consumption
had the opposite trend (-18.6%). The seasonal changes in J01C
group mostly resulted from the increase in ampicillin/sulbac-
tam (+130.8%), benzathine phenoxymethylpenicillin (+66.7%)
and phenoxymethylpenicillin (+50.0%) usage, in J01E group by
sulfalen (+72.0%), sulfametrol/trimethoprim (+52.5%) and sul-
fadimethoxine (+52.0%) and in J01F group – by midecamycin
(+41.3%), erythromycin (+28.9%) and roxithromycin (+28.6%)
consumption.
Conclusion: Based upon foregoing ﬁndings seasonal changes in
AM consumption with increase in winter quarters might be
related to the increase in incidence of respiratory tract infections,
and in summer quarters – gastrointestinal disturbances which in
the majority of cases are of viral origin and self-limiting. More
detailed survey is ongoing to justify this correlation.
R2032
Intravenous, intrathecal and intraventricular
administration of colistin for the treatment of
multiresistant Acinetobacter baumannii
meningitis
E. Paramythiotou, D. Karakitsos, H. Angelopoulou, J. Poularas,
G. Psoma, G. Stathopoulos, K. Papakonstantinou, G. Samonis, A.
Karabinis (Athens, Heraklion, Crete, GR)
Background-Aim: Infections due to Gram-negative multiresist-
ant bacteria pose a common therapeutic challenge for clinicians.
Colistin has been increasingly used to treat infections caused by
these bacteria. We present two cases of nosocomial meningitis
caused by multiresistant Acinetobacter baumannii that were
succesfully being treated by colistin.
Results: Case 1: A 20-year-old male patient was admitted to our
unit due to severe cranial trauma. The patient developed a
hydrocephalus and a ventriculoperitoneal shunt was placed. A
few days later he developed high fever, meningismus and
lethargy. The cerebrospinal ﬂuid (CSF) examination revealed:
glucose 2 mg/dl, protein 295 mg/dl, LDH 642 iu/dl, cells
48.000/mm, while CSF cultures yielded Acinetobacter baumannii
susceptible only to colistin. The shunt was removed and the
patient was treated with colistin intravenously. After 3 days the
patient was afebrile and CSF was sterile after 13 days of therapy,
respectively. Case 2: A 24-year-old female patient was admitted
to our unit because of subarachnoid haemorrhage with con-
comitant hydrocephalus due to a ruptured cerebral aneurysm.
After 10 days the patient became febrile (40C) and the CSF
examination showed: glucose <2 mg/dl, protein 130 mg/dl,
cells 32.000, LDH 1274, while CSF cultures yielded Acinetobacter
baumannii susceptible only to colistin. Colistin was initiated
intravenously and the drainage was removed. A lumbar
drainage was placed and colistin was administered intrathecal-
ly, but after 3 days the catheter was removed due to thrombosis.
As the patient was still febrile and sterilization of CSF has not
been achieved a ventriculostomy tube was inserted in the left
ventricle with synchronous placement of an Omaya catheter in
the right ventricle for the intraventricular administration of
colistin. The patient was cured 26 days after the beginning of
antibiotic treatment.
Conclusion: Intravenous and/or intraventricular administra-
tion of colistin may be life saving in cases of meningitis caused
by multiresistant Gram – negative bacteria.
R2033
The treatment of acute bacterial meningitis with
meropenem
I. Marincu, L. Negrutiu, L. Marincu (Timisoara, RO)
Objectives: The study of the clinical-biological efﬁciency of
meropenem therapy at patients with acute bacterial meningitis.
Methods: The authors studied a group of 23 patients who were
admitted in the Infectious Diseases Clinic from Timisoara with
acute bacterial meningitis. The diagnosis of the bacterial men-
ingitis was based on clinical ﬁndings (malaise, fever, headache,
stiff neck, vomiting, confusion) and on examination of cerebro-
spinal ﬂuid (CSF) sample (aspect, pressure, Pandy reaction,
PMN leucocytes counts, proteins, clor, glucose and culture on
special mediums). All patients were treated with meropenem
(Meronem - Astra-Zeneca, 1g), 3 · 2 g/24 hours, iv, during a
period between 10 and 14 days and supportive treatment with
Glucosis 10%, Manitol 20%, AINS, corticoterapy, vitamins,
antipyretics, etc.
Results: The biological tests like ESR, ﬁbrinogen, CRP, the
parameters and the bacteriologic data of the CSF, were regis-
tered in the individual ﬁles, following the agreed protocol. The
CSF culture and the direct bacteriological examination have
conﬁrmed: 7 patients with Streptococcus pneumoniaemeningitis, 9
patients with Neisseria meningitis, 5 patients with Staphyloccocus
aureus meningitis and 2 patients with Klebsiella penumoniae
meningitis. The results of the effectuated antibiograms have
conﬁrmed the sensitivity of the isolated germs at meropenem.
The registered side effects were minor and transitory, nausea,
abdominal discomfort and soft stools, after the administration of
the ﬁrst doses of meropenem.
Conclusions: Through its large antibacterial spectrum, high
clinical-biological efﬁciency and reduced side effects, the
meropenem (Meronem – Astra-Zeneca) can be used with
success in the treatment of acute bacterial meningitis.
R2034
Hospital consumption and resistance of
ﬂuoroquinolones between 1996 and 2004
C. Sneessens, D. Govaerts, J. Douchamps (Montigny-le-Tilleul,
BE)
Objectives: The excessive and inadequate consumption of
ﬂuoroquinolones (FQ) has serious consequences for public
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health, such as the increase of bacterial resistance. Therefore our
hospital is evaluating trends in antimicrobial use since 1996.
Methods: A 652-bed general hospital in Belgium (184 230 bed-
days in 2004, including 63% acute beds). Antibiotic committee
was created in 1998 and has many missions like to develop
formalized treatment guidelines for commonly encountered
infectious diseases and to control the consumption of extended-
spectrum (E-S) antibiotics (ATBs). The annual consumption of
ATBs (Class J01 in the ATC classiﬁcation from WHO 2004) in
Deﬁned Daily Doses (DDDs) and total patient days (PDs) for
1996 through 2004 were determined from electronic capture of
billing records. The DDDs/100 PDs ratio was calculated for each
antimicrobial. The microbiology laboratory provided the com-
mittee with data about the frequency of various resistant
pathogens.
Results: Total antimicrobial use (J01) increased between 1996
and 2004 and consumption was respectively 30.27, 31.47, 31.88,
30.90, 30.26, 30.23, 35.37, 36.60 and 43.09 DDDs/100PDs. The FQ
class (J01MA) is one of the most dispensed antimicrobials with a
yearly average of 4.32 DDDs/100PDs. The resistance of various
pathogens to FQ raised between 1996 and 2002 from 37% to 48%
for Pseudomonas aeruginosa, 35% to 45% for Staphylococcus aureus,
with an increased consumption from 2.56 to 7.35 DDDs/100PDs.
Intravenous (IV)/per os (p.o.) ratio (%) were 23/77 in 2002, 25/
75 in 2003 and reached 32/68 in 2004.
Conclusion: Total consumption of ATBs did not change signi-
ﬁcantly between 1996 and 2000, except in 2001 where an increase
of almost all classes of ATBs and FQ especially was observed. In
2003, a 72-hour stop order system of prescribing was imple-
mented to control the use of E-S ATBs. In 2005, clinical
guidelines, educational campaigns and a prescription of IV FQ
restricted to 72-hour were implemented. These measures, which
are presently under evaluation, are hoped: 1) to discourage the
excessive use of IV FQ, 2) to promote p.o. usage because
equivalent biodisponibility and lower cost, 3) to contain resist-
ance development, and 4) to safeguard the value of this ATBs
class.
R2035
Benchmarking antimicrobial drug use in
university hospitals in ﬁve European countries
V. Vlahovic-Palcevski, U. Dumpis, P. Mitt, J. Gulbinovic,
J. Struwe, G. Palcevski, D. Stimac, A˚. Lagergren, U.
Bergman (Rijeka, HR; Riga, LV; Tartu, EE; Vilnius, LT; Huddinge,
SE)
Objectives: Benchmarking antimicrobial drug use in similar
hospitals can be used to identify potential problem areas in
prescribing practice and to aid in establishing appropriate and
attainable goals. We compared the pattern and the extent of
antimicrobial drug use in ﬁve European university hospitals
aiming at establishing best practices.
Methods: A modiﬁed point prevalence study design was used.
All in-patients at the University Hospital Rijeka, Croatia, Tartu
University Hospital, Estonia, Stradins University Hospital, Riga,
Latvia, Vilnius University Hospital, Lithuania and Karolinska
University Hospital-Huddinge, Sweden were surveyed for
antimicrobial drug use during one day in May 2003. The patient
charts of all hospitalized patinets were reviewed and annony-
mous data regarding antimicrobial drug use were entered into a
uniformed data sheet. We determined the prevalence and the
main purpose of antimicrobial drug use in each hospital, as well
as the prevalence of antimicrobial drug use according to
departments. The pattern of antimicrobial drug use was
assessed using the DU90% methodology. The main route of
antibiotic administration was also evaluated. The prevalence of
nosocomial infections with risk factors for such infections and
the type of infections treated were determined.
Results: The prevalence of antimicrobial drug use was 24% in
Rijeka, 30% in Tartu, 26% in Riga, 14% in Vilnius and 32% in
Huddinge. Surgical patients were treated with antimicrobials
more often than medical in Riga (53% vs. 31%), Tartu (39% vs.
26%) and Vilnius (54% vs. 25%). In Rijeka, Tartu, Riga and
Vilnius 2/3 of the patients received antimicrobials intraven-
ously, and in Huddinge less than one half. Broad-spectrum
antimicrobials were most commonly used in Rijeka. The
prevalence of nosocomial infections treated with antibiotics
was 9% at Huddinge with the highest number of risk factors,
and 3–5% in the other centres.
Conclusion: Benchmarking antimicrobial drug use in ﬁve
different university hospitals identiﬁed differences and problem
areas. The high rates of intravenous administration, poor
compliance with the guidelines and prolonged surgical prophy-
laxis were general problems, which deserve speciﬁc attention in
all centres. Changing antimicrobial prescribing practices may
reduce unnecessary antimicrobial drug use and decrease resist-
ance.
R2036
Attitudes of population to antibiotic use in
country with high self-medication: analysis of 103
face-to-face interviews
A. Berzanskyte, R. Valinteliene, F.M. Haaijer-Ruskamp,
A. Stefanovic, V. Kanapeckiene (Vilnius, LT; Groningen, NL)
Self-medication is one of the main reasons of microbial resist-
ance. Survey in 19 European countries revealed Lithuania as the
country with the highest rate of self-medication (24% of all
respondents). It prevailed in almost the half of questioned
residents, who used antibiotics during the last 12 months.
Objective: The aim was to get insight about the attitudes of
population towards antibiotic use.
Methods: The study was carried out as a part of multinational
survey on self-medication with antibiotics in Europe. The
respondents, who agreed to be questioned from the randomly
selected (3000) and responded (746) in urban and rural area
during the ﬁrst phase of the study, were target population.
Sample was made of two equal comparable groups: exposed
group (self-medication) and reference group (non-users).
Respondents were allocated to any of them according to the
given answers in the ﬁrst questionnaire. 103 face-to-face double-
blind interviews were performed in order to ascertain attitudes
towards antibiotics and their use, self-care attitudes, illness
behaviour, etc.
Results: After the performance of interviews shifts between
original groups occurred – 80% of 103 respondents pointed out
about taking antibiotics any time in life.Analysis of basic
knowledge about this medicine showed that a lot of the
respondents (46.6%) considered it as bacteria killer (55.3%
prescribed users, 41.7% self-medicators, 31.3% non-users).
However people often thought, that antibiotics could cure
infections (21.4% cases), kill viruses (9.7%) or have analgesic
(2.7%), antipyretic (9.7%) and anti-inﬂammatory (9.7%) effect.
Respondents tended to take antibiotics for different indications,
even for easy symptoms such as of respiratory tract, diarrhoea,
etc. The major source for self-medication was indicated as over-
the-counter acquisition in community pharmacies. 50% of self-
medicators (30% prescribed users) indicated them as the
possible very easy way to get antibiotics. Leftovers as easy
source prevailed in self-medicators’ group (about 70%), while
only a bit above 30% among the rest.
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Conclusion: Rather often Lithuanian people consider antibiot-
ics as ‘universal’ drug. It became evident that it’s not enough to
ensure the sales of antibiotics only by prescriptions to control
self-medication. The attitudes of people have to be changed by
proper educational campaigns.
R2037
Changes in antimicrobial use in Lithuania
outpatient clinics
A. Stefanovic, R. Valinteliene, A. Palekauskaite, A. Berzanskyte
(Vilnius, LT)
There is no monitoring system of antimicrobial use in Lithuania
neither in hospitals neither in community. So the data from
studies are the single source of information on this topic.
Objective: The aim of the study was to analyze the changes in
use of antimicrobials and diagnostic tests in Lithuanian paedi-
atric and adult outpatient clinics.
Materials and methods: The 1 year prevalence study was
carried out. Study population was children and adults who
were treated in outpatient clinics. Individual patient charts from
paediatric and adult outpatient clinics were randomly selected
and analysed: 4200 records (20 clinics) – in 1997 and 3056
records (11 clinics) – in 2004.
Results: It turned out that antimicrobial prescription rate in
outpatient clinics decreased for children (66.4% in 1997 and
51.9% in 2004) and haven’t changed for adults (34.9% in 1997
and 33.1% in 2004). Penicilines with beta lactamase inhibitors
(40.3%) and macrolides (29.5%) were the most frequently
prescribed antibiotics for children in 2004 while aminopenicil-
lins (31.6%) and macrolides (14.7%) in 1997. For adults amino-
penicillines (44.5%) and tetracyclines (17.9%) were the most
commonly prescribed in 2004 while tetracyclines (28.4%) and
aminopenicillins (26.2%) in 1997). About 80% of all antibiotics
prescriptions were issued for upper respiratory tract infections,
common cold, acute bronchitis, that usually are caused by
viruses. It was found out that 53.2% of children and 50.6% of
adults receive antibiotics without any clinical tests (blood, CRE,
RO, microbiological and urinary tests). Data for 1997 are not
available. Microbiological tests are rarely used for out patients
while prescribing antibiotics: they were performed only for 1.2%
children in 2004 (2.8% in 1997) and for 2% of adults in 2004 (0.4%
in 1997).
Conclusions: No big changes in antimicrobial prescribing rates
were observed in 7-year period – antibiotics were prescribed for
more than half children and every third adult. Structure of
prescribed antibiotics is changing with highly increasing pre-
valence of broad-spectrum antibiotics for children. The analysis
of antibiotic prescription indications conﬁrmed the hypothesis
that antibiotics are used irrational in Lithuanian out patient
sector. The need of multisectoral interventions, including edu-
cation, issue of guidelines and regulations etc. to inﬂuence the
antibiotic usage and combat the resistance problem is essential.
Molecular bacteriology
R2038
Actinobaculum urinale in a 94-year-old male with
sepsis
V. Hasseltvedt, E. Aandahl, L. Hesstvedt, D. Caugant, A.
Høiby (Lillehammer, Oslo, NO)
Objectives: To show an example of the interaction between a
central reference laboratory – with sequencing facilities – and a
peripheral unit when it comes to speciation of a seldomly
diagnosed bacterium from blood culture.
Methods: Blood cultures were drawn according to standard
procedures. There was growth on blood and chocolate agars
aerobically and on the same media under anaerobic conditions
plus lactose agar under aerobic conditions. The bacterium was
subject to resistance testing with our standard antibiotic panel
for such organisms. 16S rRNA sequencing was done, on a
central level, according to their standard procedures.A MED-
LINE search as of 12/10/05 showed 13 ‘‘hits" for ‘‘Actinobacu-
lum" and two ‘‘hits" for ‘‘Actinobaculum urinale" alone.
Results: A male aged 94 years presented with pneumonia,
sepsis and fever of 40C. From a blood culture isolate the
following was observed microscopically: a small Gram-variable,
corynebacterium-like bacterium. The colonies on blood agar
were non-haemolytic, and were catalase and oxidase negative.
The bacterium was resistant for metronidazole but sensitive for
vancomycin. API 20 A showed Actinomyces meyeri/odontolyticus
(ID% 55.2) and Lactobacillus fermentum (ID% 43.3.). Sequencing
data showed that using a 499 bp fragment of the 16S rRNA gene
demonstrated a 100% homology with the 16S rRNA gene of
Actinobaculum urinale. Our laboratory had previously had a blood
culture positive islolate – also from an elderly male – aged 91 –
where the sequencing data demonstrated Actinobaculum schalii.
Conclusion: The ﬁndings demonstrated above show that there
may be signiﬁcant synergy when it comes to interaction between
laboratories on a peripheral and a central level, given that it is
not always cost-effective to do sequencing decentralized.
References:
1) Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD.
1997. Characterization of some Actinomyces-like isolates from
human clinical specimens: Reclassiﬁcation of Actinomyces suis
(Soltys and Spratling) as Actinobaculum schalii comb. nov. and
description of Actinobaculum schalii sp. nov. Int. J. Syst. Bacteriol.
47: 899–903.2) Fendukly F, Osterman B. 2005. Isolation of
Actinobaculum schalii and Actinobaculum urinale from a Patient
with Chronic Renal Failure. J. Clin. Microbiol. July 2005, 43 (7),
3567–3569.
R2039
Using PCR with an unusual purpose of blood
culture positive Brucella spp. infection: a case
report
S. Akhan, A. Karadenizli, Z. Yulugkural, S. Gundes,
H. Uckardes, H. Vahaboglu (Kocaeli, TR)
Brucellosis is an endemic disease in Turkey. Brucellosis cause a
systemic infection which can involve any organ or system of the
body. A 46-year-old man history of nausea, weakness, icterus,
anorexia, and fever of up to 39C was admitted to the Infectious
Diseases policlinic. with 10 day’s Physical examination revealed
scleral, mucous membrane and cutaneous icterus, hepatomegali,
pain and tenderness in the upper right quadrant. Laboratory test
results was found as follows: white blood cell count: 6810/mm3;
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erythrocyte sedimentation rate: 12 mm/h; C-reactive protein:
positive; total bilirubin: 8.17 mg/dl; direct bilirubin: 5.94 g/dl;
AST: 311 U/L; ALT: 291 IU/L; alkaline phosphatase: 535 IU/L;
GGT: 626 IU/L; protrombin time: 19.3 s; activation: 52%. Hep-
atic markers were negative. After cultures were taken, antibiotic
therapy (ampicillin/sulbactam 4 · 2 g IV + gentamicin
1 · 160 mg IV) was began with the diagnosis acute cholangitis.
Ultrasonographic examination of the abdomen has showed
hepatosplenomegali. Upper gastrointestinal endoscopic exam-
ination was found normal. During the clinical follow-up the
patient was subfebril. We found Rose Bengal test positive. After
that, we performed Wright standard tube agglutination test. The
titres of brucella antibodies in serum were 1/320. Brucella
melitensis was isolated from blood on the 8th day. We found
with PCR IS 711 gene region of Brucella spp. (Brucella melitensis
strain 133 IS 711 845 bp : SEQ-2 5’-ATC TTC CGG GGC GAG
TTG GTA-3’; SEQ-1 5’-GGA TCT GAG CCG TTG CCT TGA-3’)
positive in the isolated bacteria. Antibiotic treatment switced to
oral doxycycline 2 · 100 mg and streptomycin 1 · 1 g IM. We
use PCR here to show gene region, which is speciﬁc for Brucella
spp. in the isolated Gram-negative coccobacille. Gastrointestinal,
cardiovascular, genitourinary, haematopoetic, nervous, skeletal
systems may be involved in brucellosis as a complication. PCR
can be used in isolated bacteria from different specimens of
cases, which came with different presentations.
R2040
Phenotypic typic and genotypic detection of
virulence factors in high-level gentamicin-
resistant Enterococcus faecalis and Enterococcus
faecium strains from a Tunisian hospital
N. Klibi, A. Masmoudi, Y. Saenz, L.A. Sechi, A. Boudabbous,
C. Fendri, C. Torres (Tunis, TN; Logrono, ES; Sassari, IT)
Enterococci are recognised as important human pathogens that
are responsible for serious nosocomial infections. Several viru-
lence factors have been described in enterococci, for instance,
aggregation substance (Agg), gelatinase (GelE), cytolysin (Cyl),
enterococccal surface protein (Esp), collagen-binding adhesin
(Ace) and Sex pheromone (Cpd). Phenotypic and genotypic
determination of virulence factors were carried out in all the 46
high-level-gentamicin resistant (HLGR) clinical Enterococcus
faecalis (n = 34) and Enterococcus faecium (n = 12) strains recov-
ered from unrelated patients in La Rabta Hospital of Tunis
during 2000–2003 (all these strains harboured the aac (6’)-aph (2")
gene). The genes encoding virulence factors (agg, gelE, ace, cyl,
esp, cpd and fsrB) were analysed by PCR and sequencing. The
production of gelatinase and hemolysin as well as the adherence
to caco-2 and hep-2 cells or the capacity for bioﬁlm formation
were also investigated in all 46 HLGR enterococci. The percent-
ages of E. faecalis strains harbouring virulence genes were as
follows: gelE and cpd (100%), fsrB (62%), agg (56 %), cylLLS
(41.2%), esp (26.5%), and ace gene (6%). The only virulence gene
detected among E. faecium strains was esp (58%). Gelatinase
activity was detected in 22 E. faecalis strains (65%, most of them
with genotype gelE + -fsrB+), being the remaining 12 strains
gelatinase-negative (with genotype gelE+-fsrB-, and a deletion of
23.9 kb of fsr locus). Fifty-seven per cent of the cylLLS-containing
E. faecalis strains showed B-haemolysis, showing a negative
B-haemolysis reaction the remaining cylLLS-positive strains
(most of these strains lacked cylABM or cylB genes). Our
HLGR E. faecalis strains, in contrast to E. faecium, showed
strong bioﬁlm formation or adherence to caco-2 and hep-2 cells,
although it was not observed a clear association between those
activities and the presence of esp or agg genes, respectively.
R2041
Bacteraemia caused by Corynebacterium
diphtheriae
A. Chudnicka, J. Kro´l, W. Ruminski, H. Klepacka, J. Walory,
M. Koziol-Montewka (Lublin, Warsaw, PL)
The common administration of prophylactic vaccination against
diphtheria in Poland has led to elimination of infections caused
by toxigenic Corynebacterium diphtheriae (C. d) strains. Single
cases of this disease reported in Poland between 1988 and 1996
were associated with common migration of people from coun-
tries in which the vaccine-induced acquired immunity rates
against diphtheria were low (Russia, Ukraine, Belarus) and in
which infections caused by C. d reached epidemic proportions.
Given only a single case of the disease noted in Poland in 2000, it
has been claimed that the country is free from diphtheria since
1997. The C. d strains have not been isolated in Poland for the
last 5 years. The case of bacteraemia caused by C. d and reported
in the present study has been the second encountered within the
last year in Poland. The analysed patient was implanted an
aortic valve 2 years before the isolation of C. d in his blood
sample. The patient had a sudden onset of high fever not
accompanied by any laryngological symptoms. The strain
cultured from the blood was identiﬁed as C. d on the basis of
its biochemical features (API Coryne-bioMerieux). The prelim-
inary identiﬁcation of the species was further conﬁrmed by the
PCR assay (the analysis of the 16sRNA gene sequence). As a
result of the diagnostic procedure and the analysis of the clinical
picture of the patient diphtheria was excluded. The ability of the
cultured strain to produce the diphtheria toxin was evaluated
using the Elek precipitation test. The strain was negative for the
tox gene by the PCR method, which unequivocally conﬁrmed
that the microorganism was not toxigenic. The results of the
employed assays were compared to the reference C. d strain
[PW-8 (tox+)]. The antimicrobial sensitivity testing (MIC) was
conducted using the MHS medium (bioMerieux) and E-tests
(AB BIODISK). In order to broaden the diagnostic procedure
and to improve the knowledge of the patient’s clinical picture
the serum antibody levels directed against C. d were analysed
using the ELISA assay. The above presented case indicates that
the nontoxigenic C. d strains are encountered in Poland as
etiologic agents of infections. These strains give rise to the
diagnostic and therapeutic problems and constitute a challenge
for physicians and microbiologists. Their reporting and a
detailed characterisation are of outstanding importance from
the epidemiological point of view.
R2042
Prevalence and clinical presentation of
Staphylococcus aureus positive for Panton-
Valentine Leukocidin in a university hospital in
the southwestern region of Germany
J. Wuellenweber, T. Konz, D. Velten, W. Witte, M. Herrmann
(Homburg/Saar, Wernigerode, DE)
Objective: The presence of Panton-Valentine Leukocidin (PVL)
in S. aureus has been associated with lethal pneumonia in young
people and persistent severe skin infection. It has also been
found in most strains of the recently described community
acquired MRSA (cMRSA). This study was performed to obtain
information about prevalence, clinical features and resistance
patterns of PVL-positive S. aureus strains in our hospital and
region. Data from January to October, 2005, were available for
ﬁrst results.
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Material and methods: Only the ﬁrst S. aureus isolate from
clinical samples of each patient was investigated for PVL (lukS-
lukF) using published primers including an internal control
amplifying sequences of the nuc-gene of S. aureus. For antimi-
crobial resistance we used the BD Phoenix automated system.
All strains resistant for oxacillin, ciproﬂoxacin or gentamicin, or
positive for PVL were additionally checked for the presence of
the mecA-gene.
Results: MSSA: A total number of 760 isolates could be
included, yielding 21 PVL+ strains (2.8%). PVL+ strains were
predominantly found in younger outpatients with superﬁcial
infections of the head, whereas they were not involved in blood
stream infections, or infections of the urinary tract, bones, or
foreign bodies. Resistance patterns of PVL+ vs. PVL- groups
showed no signiﬁcant differences.
MRSA: Of 136 MRSA strains, only 1 PVL+ strain was identiﬁed
and conﬁrmed as cMRSA. The majority of our MRSA isolates
corresponds to the south German epidemic strain and are of
nosocomial origin.
Conclusion: This study underlines that the prevalence of PVL is
still low in S. aureus isolates from patients in the southwestern
region of Germany.
R2043
Phenotypic and genotypic characterisation of
Staphylococcus aureus isolates from patients with
cystic ﬁbrosis
K. Semczuk, K. Dzierzanowska-Fangrat, H. Dmenska,
D. Dzierzanowska (Warsaw, PL)
Objectives: Staphylococcus aureus is one of the most common
pathogens isolated from patients with cystic ﬁbrosis (CF).
Despite intensive antibiotic therapy the microorganism is
rarely eradicated from the respiratory tract of CF patients. The
ability of S. aureus to form bioﬁlm, is considered an important
virulence factor responsible for chronic airway infections in
these patients. The aim of this study was to determine the
frequency of slime production and the prevalence of icaA and
icaD genes known to play an important role in bioﬁlm formation
in S. aureus.
Methods: During 1997–2004, 221 S. aureus strains were isolated
from sputum of CF patients (age range 1 month–20 years)
treated in the Children’s Memorial Health Institute, Warsaw.
The presence of the icaA and icaD genes was determined by
PCR with primers derived from the icaADBC locus of S. aureus
(GeneBank accession no. AF086783). Slime formation was
detected with Congo red agar and a standard bioﬁlm assay in
tissue culture plates (TCP) with Tripticase soy broth (TSB).
Results: All S. aureus strains carried the icaA and icaD genes.
Majority of tested strains (211/221; 95%) showed a black colony-
forming phenotype on Congo red agar, whereas less than 50% of
isolates were bioﬁlm-positive in TCP-TSB assay.
Conclusions: Although all S. aureus strains isolated from
airways of CF patients possess icaADBC locus, and nearly all
show a black colony phenotype on Congo red agar, only part of
them produce bioﬁlm.
R2044
Detection by PCR method of fastidious micro-
organisms in urine from patients with UTI
symptoms
R. Voiko, J. Remmet (Tallinn, EE)
Objectives: We aimed to demonstrate to clinicians the advant-
age of detection by PCR of the fastidious microorganisms in
urine from the patients with UTI symptoms, when standard
cultures were negative and antimicrobial drugs were not
applied to patients.
Methods: During the period of 08–12, 2004, 1326 urine samples
were sent to the laboratory of microbiology from the nephro-
logical department of the hospital. In standard cultures onto the
CLED agar and blood agar the samples from 662 patients (49%)
showed no growth. From among these patients, 113 were
selected for further investigation with PCR method (within age
range of 17–47 years, not cured with antibiotics). Urine samples
of these patients were investigated with Roche Cobas Amplicor
for Chlamydia trachomatis and Neisseria gonorrhoeae, and with in-
house PCR for Ureaplasma urealyticum, Mycoplasma hominis and
Trichomonas vaginalis. The patients were divided into 3 age
groups. Out of 113 patients 71% were women, what witnesses
once again that UTI is prevalent among women due to
anatomical peculiarities of their urogenital tract.
Results: From 113 samples investigated, 42 (37%) gave positive
results with PCR methods, with microorganisms detected as
follows: C. trachomatis – in 4% of samples, U. urealyticum – 29%,
M. hominis – 12%. N. gonorrhoeae and T. vaginaliswere not found.
The age group of under 25 years, containing 36 samples, gave
the following results: C. trachomatis – in 11% of samples of the
respective group, U. urealyticum – 28%, M. hominis – 11%. In the
age group of 26-35 years (44 samples), C. trachomatis was not
found, U. urealyticum – 27%, M. hominis – 14%. In the age group
of over 35 years (33 samples), C. trachomatis was not found
either, U. urealyticum – 33%, M. hominis – 12%. In samples from
women (80 samples), microorganisms were detected as follows:
C. trachomatis – 11%, U. urealyticum – 31%, M. hominis – 11%.
Among men (33 samples), percent of microorganisms found
was: C. trachomatis – 9%, U. urealyticum – 24%, M. hominis – 15%.
Conclusion: In the case of negative results of standard urine
cultures, investigation with PCR methods for detection of
fastidious micro-organisms is of great help to clinicians. But it
should be considered that 60% of healthy women carry
U. urealyticum and 20% carry M. hominis in their urogenital
tract. Unlikely, in male urogenital tract these microorganisms
should not appear. If present in male urethra, they should
always be treated as pathogens.
R2045
Inﬂuence of a mutation in the gyrA gene on the
relative abundance of many Escherichia coli
proteins
J. Sanchez-Cespedes, D. Bellido, E. Oliveira, J. Vila (Barcelona,
ES)
Objective: The purpose of this study was to analyse the role of
the acquisition of a mutation in the gyrA gene in the expression
of proteins in E. coli.
Materials and methods: Three E. coli strains were used in this
study: 1) the 14366 wild-type E. coli clinical isolate, 2) this strain
was submitted to repeated in-vitro subinhibitory concentrations
of ciproﬂoxacin to generate a ciproﬂoxacin-resistant mutant
(E. coli 14366 M) with a mutation in the gyrA gene (Ser83-Leu).
3) This mutant was further transformed with a plasmid carrying
the wild-type gyrA gene, generating a complementation of the
gyrA gene (E. coli 14366 MC). Puriﬁcation of whole proteins was
performed using a sonicator-based method. Protein extracts
from these three strains were displayed by two-dimensional gel
electrophoresis and then stained using a silver staining protocol
to compare their patterns. The spots in the 14366 wild-type
E. coli, which experienced a variation in their level of abundance
compared to the mutant strain (E. coli 14366 M) and which were
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restored in the transformed E. coli were sliced and characterized
by MALDI TOF/TOF.
Results: To date 14 out of 24 proteins have been characterized.
Among them, 10 proteins have shown an increase in their
abundance with respect to the mutant strain and the other 4
proteins have shown a decrease in their abundance. The
characterized proteins can be distributed into different groups:
i) proteins implicated in cellular permeability (OmpA), ii)
proteins implicated in metabolic functions (aspartate ammo-
nia-lyase, glycerol kinase, aminomethyltransferase) and ii)
proteins implicated in DNA replication (RpoA).
Conclusions: We can infer from this work that a mutation at the
gyrA gene might play an important role in regulating the
expression of several proteins in E. coli, which can be linked to
the supercoiling status of the promotor of the genes.
R2046
Frequency of enterotoxin, toxic shock syndrome
toxin 1 and panton-valentine leukocidin genes in
MRSA vs. MSSA isolated from blood
H. Lagler, E. Presterl, S. Forsthuber, R. Gattringer, K. Stich, C.
Marodi, F. Rozgonyi, A. Georgopoulos, W. Graninger (Vienna,
AT; Budapest, HU)
Materials and methods: The presence of enterotoxin (sea–see,
seg–ser), exfoliativtoxin (eta, etb), TSST-1 (tst) and leukocidin
(lukS-F, lukD-E, lukM) genes was detected by the PCR
technique in 164 Staphylococcus aureus (SA) strains. SA isolates
were collected at the Medical University Hospital Vienna from
blood cultures (=BL) from patients with sepsis. Primers for the
detection of 3 recently published ET genes (sel, sep, seq) were
newly designed for this study. Antibiotic susceptibility was
determined by disc diffusion (Kirby-Bauer Method) and PCR
technique (mecA).
Results: In the 164 BL-strains toxin-gene distribution was as
follows: sea: 31%, seb: 6%, sec1: 0.5%, sec2: 12%, sec3: 1%, sed:
6%, see: 0%, seg: 62%, seh: 2%, sei: 62%, sej: 6%, sek: 1%, sel:
14%, sem: 57%, sen: 62%, seo: 62%, sep: 8%, seq: 1%, ser: 6%, tst:
9%, eta: 4%, etb: 1%, lukS-F: 1%, lukD-E: 54%, lukM: 0%. mecA
positiv strains (n = 45). MRSA (%)/MSSA (%): sea: 93/8, seb: 4/
7, sec1: 0/0.5, sec2: 0/16, sec3: 0/1, sed: 2/7, see: 0/0, seg: 57/63,
seh: 0/3, sei: 57/64, sej: 2/8, sek: 0/2, sel: 0/19, sem: 60/56, sen:
60/63, seo: 62/63, sep: 6/9, seq: 0/2, ser: 4/6, tst: 2/12, eta: 2/5,
etb: 0/1, lukS-F: 0/2, lukD-E: 86/42, lukM: 0/0.
Conclusion: The most commonly found ET genes were seg, sei,
sem, sen, seo, which were mostly found in association with one
another. Genes second most frequent found in combination
were sel with sec. The SA toxin genes sea and luk D-E were
dominant in MRSA strains. MRSA did not harbour sec, seh, sek,
sel and seq. The recently described genes sep, seq and ser were
rarely found in BA strains. Three MSSA strains were lukS-F
(Panton-Valentine leukocidin) positive.
R2047
Anaerobic meningitis due to Peptostreptococcus
anaerobius diagnosed by broad-range PCR. Case
report
T. Freiberger, M. Freibergerova, R. Parizkova, M. Slany (Brno,
CZ)
Introduction: Anaerobic bacteria are recovered from <1% of
patients with acute bacterial meningitis. There have been few
cases of acute bacterial meningitis associated with Peptostrepto-
coccus species reported in the literature up to now. The most
common predisposing factors are meningorectal ﬁstulae and
head-and-neck surgery. Because of their fastidious nature, these
organisms are difﬁcult to isolate from biological materials and
can be often overlooked and underdiagnosed. Molecular detec-
tion methods based on ampliﬁcation of microbial 16S rRNA
genes seem to be a promising diagnostic tool in these situations.
Case report: Here we report a case of 55-year-old man devel-
oping sinusitis, which rapidly progressed to acute bacterial
meningitis with unconsciousness. He underwent surgery after
head injury 20 years ago. Peptostreptococcus anaerobius was
detected from cerebrospinal ﬂuid (CSF) using broad-range
PCR followed by direct sequencing and sequence similarity
analysis. On the basis of this result, metronidazole was added to
conventional antimicrobial therapy with ampicillin and cefotax-
ime. Several days later Peptostreptococcus sp. was cultivated from
maxillary sinus material while cultures from CSF remained
negative. Unfortunately, the patient had to undergo several
neurosurgical intervences and the course of disease was
accompanied by severe complications such as repeated sepsis
caused by G- microorganisms, serious gastrointestinal bleeding
episodes and leg amputation due to ischaemia. Finally, he
recovered with neurological sequelae.
Discussion: A method of broad-range PCR was demonstrated
to be useful in diagnosis of anaerobic meningitis.
Molecular virology
R2048
Linkage of CTL epitopes of HPV16 E7 gene to
HSP70 gene using three-steps PCR
Z. Meshkat, H. Soleimanjahi, M. Mahmoudi, H. Mirshahabi,
Z.M. Hassan (Tehran, IR)
Objectives: DNA vaccines represent an attractive approach to
generating antigen-speciﬁc immunity because of their stability
and simplicity of delivery. For immunotherapy of HPV16
associated disease, the E7 gene is considered a prime candidate,
as it is expressed in all HPV16-positive tumours. Unfortunately,
the E7 gene is a poor inducer of a cytotoxic T-cell response,
when being used as antigen in DNA vaccination. Linkage of
antigens to HSP represents a potential approach for increasing
the potency of DNA vaccines.
Methods: Truncated HPV16 E7 gene is selected from a region
proximal to the COOH-terminal end of the HPV16 E7 gene
(codons 246–279) that encodes several overlapping CTL epi-
topes. These have been deﬁned by peptide binding libraries,
immunological screening assays and epitope elution/sequen-
cing methods. Then the E7 segment is fused to HSP70 gene and
for read through translation of it, stop codon of HSP70 gene is
eliminated and a polyglycine linker is considered between two
parts. In order to have protein expression, one stop codon is
applied at the end of E7 segment. All of the procedures are done
with three-steps PCR using one forward and three reverse
primers.
Results and conclusion: The HSP70/E7 segment is cloned in
pcDNA3 and resulted construct was sequenced by SEQ-LAB
Company. The construct is consider to be used in future for CTL
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cytotoxicity assay and we will compare it with CTL response to
E7 complete gene.
R2049
Evaluation of IFI versus real-time PCR as the gold
standard for diagnosis in genital HSV
M.C. Nogales, C. Castro, I. Pueyo, R. Claro, J. Vargas, E. Martı´n-
Mazuelos (Seville, ES)
Objectives: Herpes simplex virus genital infections have
increased in the last avoiding years. A sensitive and speciﬁc
method for detecting herpes simplex virus type 1 (HSV-1) and
herpes simplex virus type 2 (HSV-2) is important for diagnosing
genital infections and HSV-1 and HSV-2 transmission. The aim
of this study is evaluating the serological diagnostic (IFI) in
comparison with Real Time PCR for the detection of HSV-1 and
HSV-2.
Methods: A total of 93 specimens (39 genital ulceration, 30
vesicle, 21 endocervical, 3 urethral) were collected from 93
patients (54 women and 39 men) with an average age of
30.9 years. All the patients were followed at STD clinic, Seville,
Spain. The samples were collected following the manufactures
rules (STD, Swab Specimen Collection and transport Kit, Roche).
Magnapure (Roche Diagnostic System) was used to extract
nucleic acids. The diagnostic was performed using IFI (Path-
ﬁnder Herpes Simplex Virus types 1 and 2, Bio-Rad) and Light
Cycler, real time PCR (Roche Diagnostic System LC HSV ½
detection). To evaluate IFI we used real time PCR as the gold
standard. Positive and negative controls were used in all cases.
Results: Of the total of 93 samples, 45.16% (38/93) were
positive (66% vesicle, 38.09% endocervical and 35.8% genital
ulceration). The percentage of positive to VHS-1 and VHS-2
were 67.4% and 32.5% respectively. The 40.86% (38/93) were
positive by PCR and 21.5% (20/93) by IFI, PCR detected 22
samples that were negative by IFI and 4 samples were positive
by IFI and negative by PCR. The sensitivity and speciﬁcity
obtained were 42.10% and 92.7% respectively and the positive
and the negative predictive value were 80% and 69.8%.
Conclusions: 1. IFI presents a low sensitive and a high speciﬁc
test for the detection of HSV infections. 2. PCR is an easy,
effective, non-time consuming and objective method for the
diagnosis of herpes simplex genital infection. 3. The incidence of
VHS-1 has increased compared to VHS-2 in genital infection in
this study.
R2050
Molecular characterisation of non-polio
enteroviruses recovered from patients with
aseptic meningitis in a tertiary care hospital in
Korea
S.T. Lee, C-S. Ki, Y. Jee, N.Y. Lee (Seoul, KR)
Objectives: Non-polio enteroviruses are the most common
cause of aseptic meningitis worldwide. In Korea, a few big
outbreaks of aseptic meningitis have been reported thus far and,
from July to September 2005, there might be another outbreak.
In the present study, we performed molecular characterization
of non-polio enteroviruses recovered from patients with aseptic
meningitis during this period in a tertiary care hospital in Korea.
Methods: Twenty-four out of 36 enteroviral isolates recovered
from CSF or stool of patients with aseptic meningitis were
included in the study. Serotyping was performed by seroneu-
tralization. Reverse transcription-polymerase chain reaction
(RT-PCR), and direct sequencing of 5’ untranslated regions
(5’-UTR) followed by a phylogenetic analysis using the PHYLIP
software were done for molecular characterization.
Results: Coxsackie B virus (CVB) serotype 5 was the most
frequently isolated serotype (15/24), followed by CVB1 (4/24),
echovirus (ECV) serotype 9 (4/24), and CVB3 (1/24). The
5’-TTTCCTTTT-3’ region in the 5’-UTR, which is known to be
associated with neurovirulence, were conserved in most strains
except 5 strains including 1 CVB5 and all 4 CVB1 strains.
Phlyogenetic analysis of 5’-UTR showed three major groups and
CVB5 strains clustered into a single group.
Conclusion: In the present study, we demonstrated that the
predominant enteroviral strain recovered from patients with
aseptic meningitis was CVB5. In addition, the CVB5 isolates
might be closely related according to the molecular analysis
results.
R2051
Our ﬁrst experiance with RT-nPCR for detection
of HIV-1 RNA among seropositive persons in
Republic of Macedonia
G. Bosevska, N. Panovski, M. Siskovska, B. Kakaraskoska
(Skopje, MK)
The aim of the study was to establish PCR method in the routine
laboratory work, as well as to detect HIV RNA in seropositive
patients in our country.
Methods: 33 examined persons (age 25 to 52 years) were
divided in two groups: the ﬁrst group consisted of 20 healthy
blood donors randomly selected; and the second group of 13
seropositive persons for HIV. According the mode of the
transmission 10 of them were heterosexual, 1 heterosexual and
intravenous drug user, and 2 homobisexual. 10 persons were
male and 3 female. ELISA test for detection of antibodies against
HIV-1 and HIV-2, and ELFA test for combined detection of HIV
p24 antigen and anti HIV-1, 2 IgG were performed for each
examined person. The RNA from the whole blood was extracted
with a commercial kit based on salt precipitation combined with
high effective inhibitors of RN-aza activities. Detection of HIV
RNA was performed with RT-nPCR kit. The product was
separated with electrophoresis on 1.5% agarose gel. The result
was positive if the band of 210bp has been seen with any
intensity. Measures of precaution were taken during the all steps
of the work and disposition of the HIV infected materials.
Results: In the group of blood donors ELISA, ELFA and
RT-nPCR were negative. Assuming that prevalence of HIV
infection is zero, the clinical speciﬁcity of RT-nPCR is 100%. The
analytical speciﬁcity of the RT-nPCR test was performed with
attempt to ampliﬁcated nucleic acids from HCV, HBV, HPV,
CMV, HSV, RBV, TBC, Chl. trachomatis. None of these showed
reactivity. From the group of 13 seropositive persons, 33
samples were analysed. HIV RNA was detected in 15 samples.
ELISA and ELFA test were positive in all samples. Different
aliquots of the samples were tested independently and show the
same results. After different period of freezing at –70ordm;C of
RNA samples, the RT-nPCR reaction was identical to the ﬁrst
one. Gained amplicons were frozen at –20ordm;C for a week
and the electrophoresis was identical to the previous one. The
reaction is fast, simple for manipulation; with low detection
level of 60 IU/ml. RT-nPCR needs a small amount of RNA, as
well as a small volume of sample. HIV RNA was detected in
different period of time with different clinical presentations of
patients, with or without antiretroviral therapy.
Conclusion: The qualitative RT-nPCR method is recommended
for use in routine laboratory for documentation of HIV infection,
as well as for the clinical management of HIV infected patients.
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R2052
Evaluation of a molecular beacons real-time PCR
method for the diagnosis of enteroviral
meningitis
P. Hornillos, N. Margall, C. Roig, N. Marti, M. Sanchez, M. del
Cuerpo, R. Labeaga, M. Salvador, N. Rabella (Barcelona, ES)
Objective: To compare the efﬁciency of a real-time PCR (RT-
PCR), Cepheid, with cell culture (CC) for the diagnosis of
enterovirus (EV) meningitis.
Methods: An EV strain and a rhinovirus strain were used to
determine the sensitivity and speciﬁcity of the test. RNA was
extracted by QIAamp Viral RNA Mini Kit (QIAGEN). Reverse
transcription and ampliﬁcation were done by QuantiTect
Reverse Transcription and QuantiTect Multiplex PCR noROX
kits (QIAGEN); and the Enterovirus Primer and Probe Set ASR
(Cepheid). Forty-ﬁve cerebrospinal ﬂuid (CSF) samples from 44
patients with suspected viral meningitis were processed by RT-
PCR. Thirty-eight CSF specimens were evaluated by CC.
Samples were inoculated into four cell lines (MRC-5, A-549,
Vero and RD) and viral growth was conﬁrmed by immunoﬂu-
orescence (Chemicon). Eighteen of all CSF samples were
analysed for DNA of HHV-1/HHV-2 by RT-PCR (Roche).
Results: RT-PCR detected 0.05 PFU of the enteroviral strain and
was negative for the rhinovirus isolate. EV was detected in
51.1% of samples (23/45) by RT-PCR and in 23% (9/38) by CC.
Concordance between 2 techniques was 63% (24/38). Of the 38
CSF specimens tested by both methods, none were positive only
by CC, but 13 were exclusively positive by RT-PCR (13/38,
34%). Six of the 8 CSF RT-PCR positive/CC negative cases, had
other positive viral cultures (1 NPA; 1 urine; 3 stool [from the
same patient]; and 1 NPA and stool from one patient). One of
the 2 remaining cases was negative for NPA and the other was
negative for NPA and urine. RT-PCR required 5 h to perform
and median time to isolate the virus was 7 days. No CSF was
positive for HHV-1/HHV-2.
Conclusions: 1) RT-PCR from Cepheid showed a good analyt-
ical sensitivity and speciﬁcity with the strains tested. 2) In our
experience, Cepheid RT-PCR methods were more sensitive than
CC to detect EV meningitis. 3) Results from RT-PCR were
obtained faster than those from CC (5 h vs 7 days).
Molecular typing
R2053
SCCmec typing of methicillin-resistant
Staphylococcus aureus
W. Witte for ESGEM
Objective: MRSA have evolved by integration of SCCmec
elements into the chromosome of particular clonal lineages of
S. aureus, which can be discriminated by multilocus-sequence
typing (MLST, reference method) and spa-sequence typing. As
MRSA belonging to the same clonal lineage can have acquired
different SCCmec elements (ﬁve different basic types known so
far), molecular typing of SCCmec elements has to supplement
typing based in chromosomal genes.
Methods: Different PCR based approaches have been reported
which recognize sequences speciﬁc for different SCCmec-ele-
ments (1, 2, 3).Most reliable are PCR’s for the ccr-complex and the
upstream neighbouring sequence, for KDP (group II elements) as
well as forORFEO24 (group I and subtypes of IVa) and sequences
upstream to the ccrA complex for subdivision of group IV
elements. Furthermore, sequencing of a 400 bp stretch of ccrA
determinants allows differentiation of the different basic types.
Results: Examples for necessity of SCCmec typing are MRSA
exhibiting MLST ST05 and spa t002, which can contain SCCmec
I, II, or IV elements, MRSA of ST45 (elements IVa, IVd), and
ST254 (IVc or IVd), ST30 (IVa, IVc). 1. Oliviera, P., De Lencastre,
H. AAC 46 (2002) 2155–61. 2. Okuma et al. JCM 40 (2002) 4289–
94. 3. Cuny et al. Eurosurveillance (2005) in press.
R2054
Serotyping of Toxoplasma gondii in pregnant
women. Predominance of type II in the Old
World and type I and III in the New World
F. Peyron, J. Lobry, K. Muret, J. Ferrandiz, J. Gomez-Marin,
E. Petersen, V. Meroni, B. Rausher, C. Mercier, S. Picot, M.
Cesbron-Delauw (Lyon, Grenoble, FR; Armenia, CO; Aarhus, DK;
Pavia, IT)
Background: Toxoplasma gondii, a worldwide protozoan, usu-
ally induces asymptomatic infections. It can be life threatening
in immunodeﬁcient patients or in fetuses whose mothers are
acutely infected during pregnancy. Moreover the clinical
outcome of congenital infections cannot be predicted, ranging
from fetal loss to sub-clinical infection. Infected newborns with
no clinical signs are at risk of developing visual impairment in
childhood or adolescence. Factor of virulence are not yet
deﬁned. Genetic analysis indicated an unusual parasite pop-
ulation structure consisting in three clonal lineage of different
virulence as deﬁned in mouse model. Type I is highly virulent
for mice and rarely found in Europe, whereas type II is
avirulent and predominant among Europeans strains. Type III
is relatively virulent and uncommon in Europe. Yet, it is not
clear whether genotypic pattern is associated with clinical
proﬁle of the disease in humans or with geographical
distribution. The main reason is the difﬁculty to obtain
parasitic DNA from patients. Hence, data are limited and
originate from acute or congenital infections or animals. For
addressing the question of type strain, geographical distribu-
tion and severity of clinical toxoplasmosis, a non-invasive
assay is needed.
Method: We developed an ELISA test for serotyping Toxoplasma
gondii strains using polymorphic peptides speciﬁc of the 3 clonal
lineages derived from GRA5 and GRA6, 2 dense granule
organelles. Two hundred and twelve sera from chronically
infected pregnant women from 3 different European countries
were investigated and compared with 40 sera from Colombia
where clinical expression of the disease is more severe and
strain genotypes are mainly from type I and III.
Results: The analysis of genotype-specicifc antibody response
showed a homogenous type II structure in the European
samples and a type I and III in the Colombian population.
Conclusions: We demonstrated that, despite some limitation
due to antigen/antibody speciﬁcity, serotyping gives results
consistent with genotyping and is a promising assay for
investigating relationship between type of strain and toxoplas-
mosis severity.
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R2055
Poultry as a potential source of Campylobacter
jejuni and Campylobacter coli infections in
children in Poland
E. Rozynek, K. Dzierzanowska-Fangrat, P. Jozwiak, J. Popowski,
D. Korsak, D. Dzierzanowska (Warsaw, PL)
Objectives: Contamination of poultry meat with Campylobacter
is considered an important risk factor for human infections. The
aim of this study was to determine the relatedness of Campy-
lobacter strains isolated from children with diarrhoea and
chicken carcasses.
Material and methods: Campylobacter isolates were cultured
from anal swabs from children with diarrhoea and swabs from
chicken carcasses obtained in supermarkets and slaughter-
houses. Species identiﬁcation was performed using standard
methods, and conﬁrmed by PCR with speciﬁc primers. The
isolates were typed using randomly ampliﬁed polymorphic
DNA (RAPD).
Results: A total of 115 Campylobacter isolates were cultured
from chickens (71 C. jejuni and 44 C. coli), and 80 were obtained
from children (63 C. jejuni and 17 C. coli). Cluster analysis of the
RAPD patterns revealed substantial diversity between human
and chicken isolates, both C. jejuni and C. coli; however RAPD
proﬁles of 6 human C. coli isolates were identical to chicken
isolates.
Conclusions: Our results suggest that Campylobacter infections
in children in Poland may come from additional sources, other
than poultry meat.
Molecular biology, including diagnosistics - others
R2057
Diagnosis of Toxoplasma gondii by polymerase
chain reaction method in pregnant women from
Turkey
B. Dinc, G. Bozdayi, A. Biri, S. Kustimur (Ankara, TR)
Objective: To evaluate the prevalance of toxoplasmosis in
various samples sent from Obstetrics and Gynaecology clinic
to Gazi University molecular diagnosis laboratory by PCR.
Methods: One hundred and eighteen samples (90 blood, 27
amniotic ﬂuid, one cord blood) obtained from 109 pregnant
women during the 20th week of pregnancy for genetic diagnosis
were enrolled in the study. Toxoplasma gondii DNA was
extracted by HeliosisTM DNA Extraction kit (Metis Biotechno-
logy, Turkey). Ampliﬁcation was performed in two steps by
using speciﬁc primers for the Toxoplasma gondii B1 gene. The
second PCR products were analysed on a 1.5% agarose gel
stained with ethidium bromide, and the expected 190 base pair
length was conﬁrmed.
Conclusion: PCR method can be used in prenatal diagnosis of
congenital toxoplasmosis and acute infections in immunosup-
pressed patients by using various clinical samples such as blood,
cerebrospinal ﬂuid, amniotic ﬂuid, bronchoalveoler lavage and
urine especially in patients with atypical clinical and serological
ﬁndings in the diagnosis of toxoplasmosis. In conclusion, we
recommend to use PCR, as a direct and rapid assay to support
the serological assays in pregnant women.
R2058
Classiﬁcation of bacterial isolates of the
Jordanian Oil reﬁnery petroleum sludge
M.N. Battikhi, B. Mrayyan, M. Atoum (Zarka, JO)
Objective: The aim of this study is to characterize the bacterial
isolates of the Jordanian oil reﬁnery sludge for the purpose of
utilizing microorganisms in treating industrial wastewater
efﬂuents that contains hydrocarbons.
Methods: Morphological, physiological, biochemical, antimi-
crobial susceptibility tests and 16S-23S rRNA spacer region
polymorphism were used to characterize the isolated thermo-
tolerant Bacillus, with speciﬁc reference Bacillus strains. Data
were coded and analysed by numerical techniques using the
Gower coefﬁcients and by average linkage (UPGMA) analysis.
Results: Study was resulted in allocation of strains into two
areas at 50.0% similarity levels and ten major phenons at 78.0 %
similarity level. Ampliﬁcation of 16S-32S rRNA genes divided
all strains in two areas at 48.0% similarity level however; at
78.0% similarity level ﬁve taxonomically distinct phenons were
evident.
Conclusion: The aim of this study was to evaluate the taxon-
omy of Bacillus strain isolated from petroleum sludge in Jordan,
which might be valuable for solving future industrial pollution
problems.
R2059
PCR-based identiﬁcation and veriﬁcation of
Burkholderia cepacia
H.D. Binnet (Ankara, TR)
Objectives: B. cepacia is a problematic pathogen in patients.
Identiﬁcation of B. cepacia complex is too much difﬁcult for
routine clinical microbiology methods. In this research, we
demonstrated the efﬁcacy of the PCR in the epidemiological
analysis of B. cepacia.
Methods: B. cepacia strains were isolated with using API20 NE.
Bacterial DNA was isolated and analysed by PCR ampliﬁed 16S
rRNA gene fragments with primers PC480-PC1250. All isolates
were digested with enzymes (Tsp 509I, RsaI and TaqI). Target
sequences were ampliﬁed by using forward and reverse primers
labelled with various ﬂuorescent dyes. The labelled PCR
products were determined with automated DNA sequencer
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(CEQ 2000XL, Beckman Coulter, USA). Data were compared
with Gen-Bank database of B. cepacia strains.
Results: 28 clinical isolates were identiﬁed as B. cepacia with
API20 NE, PCR with using PC480–PC1250. Bacterial genomic
DNA was successfully prepared from all B. cepacia cultures. The
16S rRNA gene product was successfully ampliﬁed from the
genomic DNAs. In order to verify the analysis, ampliﬁed
product samples were digested with the Tsp509I, RsaI and
TaqI enzymes. With TaqI enzyme 473, 300 bp fragments were
detected in 17 isolates. In 11 B. cepacia any fragment was not
observed. With RsaI enzyme 365, 150, 100 bp fragments were
detected in all B. cepacia. With Tsp509I enzyme 341, 204 bp
fragments were detected in 23 isolates. These sites were not
detected in remaining 5 isolates. It was also considered that
disappearance of fragments in this sites as a result of mutation.
In our study, t has been aimed to get nucleotide sequences (16S
rRNA) of B. cepacia isolates, which veriﬁed with restrictions
endonuclease enzymes. As a result the nucleotide sequences of
the 16S rRNA were found to be completely identical.
Conclusion: We occurred the oligonucleotide primer pairs
PC480–PC1250 target the 16S rRNA region. This gene has
region of heterogeneity at the genus species and strain levels.
We suggest that the PCR procedure be used in clinical
microbiology laboratories. During this study, when we com-
pared the sequences both nucleotide sequences produced by the
16S rRNA gene sequence and B. cepacia sequence existing at
GeneBank data base. We observed that they were entirely
similar. Moreover, at our study we also conﬁrmed all PCR
products belong to B. cepacia.
R2060
Detection of stx genes in avian pathogenic
Escherichia coli by multiplex polymerase chain
reaction
T. Zahraeisalehi, A. Safarchi, M. Peighambari (Tehran, IR)
Objectives: The purpose of this study was to determine the
presence of selected virulence genes in avian pathogenic
Escherichia coli (APEC).
Methods: We examined 12 APEC isolates, which belonged to
the most common serotypes in Iran. All 12 isolates were tested
for the presence of stx1, stx2, eae, espB and hly genes by
multiplex polymerase chain reaction in two protocols. In the ﬁrst
protocol the isolates were tested with EC and with hly primers
and in the second protocol the isolates were examined with eae,
stx1, stx2 and espB primers.
Results: Seventy ﬁve percent (9) of the isolates carried only stx2
gene sequence and just one isolates had both stx1 and stx2
genes. Furthermore, 2 isolates (16.66 %) possessed eae sequence
and 3 isolates carried espB (25%). The hly gene was not detected
in any of the isolates.
Conclusion: The ﬁndings of this study indicated that the Stx2
may be widespread among APEC in Iran.
R2061
Diagnostic use of two serologic tests for invasive
candidiasis
C. Castro, M. Ramirez, M. Ruiz, I. Aller, C. Palomares, J. Aznar,
E. Martin-Mazuelos (Seville, ES)
Objective: To check the diagnostic utility of two tests (detection
of mannan antigen-Ag- and antimannan antibodies–Ab-) for
invasive candidasis in neutropenic patients.
Methods: A total of 583 sera from 89 neutropenic patients
presenting risk factors for invasive fungal infection were
studied. Patients were attended at the Hospitals V. del Rocio,
and V. Macarena from Seville and Hospital de Jerez, from
September of 2004 to June 2005. Two sera specimens weekly
were extracted from each patients from the inclusion to the
patient discharge from the study. Other samples as blood
culture, LAB, bronquial aspirates or others were taken following
clinical criteria. Culture of these samples were carried out
following the usual techniques of a mycological laboratory.
Antigen detection was performed using AG Platelia Candida and
the corresponding antibody detection using Ac Platelia Candida,
both kits from Bio-Rad.
Results: Of the total 583 studied sera, 124 showed at least one
Ab positive (‡20 U/ml of antimannan antibodies) specimen,
corresponding to 22 patients. Of them, only 5 patients showed
positive results both to Ag and to Ab in two or more specimens.
These positive results corresponded to patients with radiologic
signs or positive cultures for Candida albicans who responded to
treatment.
Conclusion: Calculating signiﬁcant sensitivity for both detec-
tion methods was not feasible due to a low number of probable/
possible cases. Nevertheless, Ag detection showed a higher
correlation with suspicion of Candida infection, but it should be
used in unison to other techniques for detection of invasive
Candida infections.
R2062
The father of modern medicine: the ﬁrst research
of the physical factor of tetanus
I. Katsarou, N. Potamitis, K. Papadopoulos, E. Ikonomopoulou,
A. Tsimara, A. Regli (Zakynthos, Patras, GR)
Hippocrates in Ko-island (460–370 BC) was the one who
changed the ancient medicine in the scientiﬁc direction. After
extended research, the father of modern medicine proposed the
replacement of dark and religious theories about diseases with
the direct clinical observations and logical relation between
reason and result. Our purpose is to describe the knowledge of
Hippocrates about tetanus.
Material: Hippocrates – in the work ‘‘About air, water and
places’’ – gave the advice of sufﬁcient washing of hands in order
to avoid contaminations around birth. He realized the big
danger of open wounds because of the ‘‘contaminating’’ air and
he ﬁrst described a disease with territory results, the tetanus. In
his work ‘‘Aphorism’’ he writes ‘‘…if there are spasms in case of
trauma the prognosis is fatal …all patients with tetanus die in
four days’’. He describes the clinical signs with the following
words ‘‘in case of tetanus, the patient is not able to open his
mouth, the eyes are full of tears, and the lower limbs are not
possible to come in contact’’.
Conclusion: What Hippocrates said about tetanus remain valid
for 23 centuries, up to 1884 when Arthur Nicolaier (1862–1945)
described the clostridium responsible for tetanus after injecting
experimental animals.
R2063
Aetiological role of Chlamydia pneumoniae in
chronic adenotonsillitis
D. Gerceker, O. Genc, F. Sahin, M. Saatci, C. Tezcaner, S. Dizbay
Sak, S. Ozturk (Ankara, TR)
Objectives: Palatine tonsils and nasopharyngeal tonsils (aden-
oids) are lymphoepithelial tissues located in oropharynx and
nasopharynx attempt to defense mechanism against ingested or
inhaled foreign pathogens and induced natural immunity.
Infections caused by many bacteria, fungi and viruses in these
tissues called adenotonsillitis attending with clinical symptoms
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like sore throats, chronic pharyngitis and generalized diffuse
hypertrophy. However, identiﬁcation of pathogens is not easy
from swab samples though clinical symptoms seems to occur
bacterial infections. Consequently, ineffective antibacterial ther-
apy caused chronic infection and surgical procedure is per-
formed. Chlamydia pneumoniae; is an intracellular microorganism
cause to many acute, chronic and persistant respiratory tract
infections like pharyngitis, tonsillitis, bronchitis and pneumonia.
Lately, is claimed, palatine tonsils and nasopharyngeal tonsils
can be act as a reservoir for Chlamydia pneumoniae so persistant
upper respiratory infections and diffu¨se hypertrophy are seen
frequently and also the reason of chronic adenotonsillitis. In this
study we aimed to investigate Chlamydia pneumoniae in lympho-
epithelial tissues and search the aetiology of chronic adenoton-
sillitis in order to avoid surgical process.
Methods: This study, includes 51 patients, performed tonsillec-
tomy or adenoidectomy because of chronic adenotonsillitis were
included to this study. Swab samples were taken before
operation and one of the tonsil or adenoid tissue samples
were placed into 2SP Chlamydia-transport medium and sent to
the microbiology laboratory for PCR detection. The other tissue
sample was sent to pathology laboratory in %10 formalin
solution for immunohistochemistry (IHC) method.
Results: Chlamydia pneumoniae DNA was positive in 2 adenoid
tissue and in 2 swab samples with PCR method though patients
were different. However, C. pneumoniae was conﬁrmed only in 1
adenoid tissue by IHC method as literatures claim the adverse.
Conclusion: As a result, we need more studies to suggest the
effective antibacterial therapy in chronic adenotonsillitis due to
C. pneumoniae instead of surgical procedure and to investigate
the correlation between the two laboratory methods.
Acknowledgement: This work was supported by a grant
TUBITAK.(The Scientiﬁc and technologic Research Council of
Turkey)
Diagnostic/laboratory methods (other than molecular)
R2064
Microbiological ﬁndings in patients with chronic
prostatitis using Meares-Stamey method
P. Honderlick, P. Cahen, J. Gravisse, D. Vignon, H.
Botto (Suresnes, FR)
Microbiological diagnosis of chronic prostatitis is still an
important clinical problem. We evaluate 32 patients (pts) with
chonic prostatitic symptoms using segmented urinalysis culture
according to Meares–Stamey protocol (4 samples; ﬁrst voided
urine U1, midstream urine U2, expressed prostatic secretion EPS
and urines after prostatic massage U3). 12 pts (27%) have a
negative culture for all urines specimens. We looked for all
wellknown uropathogens and more unusual ones as Chlamydia
trachomatis, Mycoplasma, Ureaplasma using PCR methods. 20 pts
(63%) had at least a positive urethral culture. 10 pts have only a
signiﬁcant EPS positive culture and 3 pts showed a 10 fold
greater for U3 and/or EPS cultures than for U2. 7 pts have all
urines samples positive with more than 103 CFU/ml, which
means non-causative organisms or in some cases indeterminate,
based upon patient’s clinical status, microorganism, quantitative
culture, bacteriological criteria…. The recovered uropathogens
were: Enterococcus (3), Haemophilus parainﬂuenzae (2), Streptococ-
cus agalactiae (2), Escherichia coli (2), Klebsiella pneumoniae (1),
Prevotella spp. (1) Corynebacterium spp (1), Staphylococcus coagu-
lase negative (1). The others putative agents for the 7 pts with all
positive specimens were; E. coli (3), Citrobacter koseri (1), K.
pneumomiae (1) non-typable Streptococci (2). In 10 cases EPS was
the only positive sample obtain. About the 13 cases diagnosed,
11 micro-organisms were recognized uropathogens, the Coryne-
bacteria and the Prevotella were recovered from EPS with a count
of 104–105 CFU/ml. The results showed that performed the cost
effective and time consuming 4 glasses test allowed the
laboratory to bring microbiological evidence of chronic bacterial
prostatitis for 13 pts, 65 % of the positive samples.
R2065
Proﬁciency testing in Iranian microbiology
laboratories: survey results of 2121 laboratories
M. Rahbar, R. Sabourian, M. Saremi, S. Hekmat Yazdi,
J. Madjidi (Tehran, IR)
Objectives: The aim of this study was to evaluate proﬁciency
testing among 2121 microbiology laboratories in Iran.
Methods: In January 2005 16th run of proﬁciency testing carried
out among 2121 microbiology laboratories located in all prov-
inces in Iran. Microbiology laboratories divided in two groups:
Hospital microbiology laboratories (631 labs) and non-hospital
laboratories (1490 labs). These laboratories include all govern-
mental and private sector microbiology laboratories. Three
unknown microorganism including Serratia marcescens (WHO
approved strain) Pseudomonas aeruginosa (ATCC27853) and
Enteroccus faecalis (ATCC29212) were chosen. Serratia marcescens
and P. aeruginosa were sent to hospitals microbiology laborat-
ories. S. marcescens and Enterococcus faecalis to non-hospital
microbiology laboratories. We asked all laboratories for identi-
ﬁcation unknown microorganism and susceptible testing of
S. marcescens. We also asked laboratories to return their answers
within 2 weeks receipt of samples. Scoring of answers deter-
mined according to WHO external proﬁciency testing criteria.
The maximum score for identiﬁcation of each organism was 3
score and 5 score for susceptibility testing.
Results: Of 2121 laboratories we received answer from 1482
(69.8%) laboratories, 639 (31.2%) laboratories did not partici-
pated in this survey or sent their answer after deadline. The
mean score of point for identiﬁcation S. marcescens in hospital
laboratories was 1.037(SD ± 0.78040) and 2.13SD (SD ± 0.75707)
for P. aeruginosa. The main score of point for identiﬁcation S.
marcescens in non-hospitals labs was 1.045 (0.60115) and
1.70(SD ± 0.83304) for Enterococcus faecalis. The mean score of
points for susceptibility testing of S. marcescens in hospital labs
was 3.85 (SD ± 1.46494) and 3.79 (SD ± 1.53595) in non-hospital
microbiology labs. The results of this survey reveals that there
are many difﬁculties for identiﬁcation of microorganisms such
as S. marcescens and E .faecalis. In total the results of suscepti-
bility testing were relatively satisﬁed.
Conclusion: The results of this survey showed that unfortu-
nately the majority of microbiology laboratories unable to
identify ordinary microorganism at species levels. It is need
for education and providing culture media and regent for our
laboratories.
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R2066
The innovation of the STAPHYtest 16
identiﬁcation kit produced by PLIVA-Lachema
Diagnostika s.r.o
L. Jancekova, I. Sedlacek, P. Petras (Brno, CZ)
On the basis of requirements of the National Reference Labor-
atory for Staphylococci (NRLS), National Institute for Public
Health, the innovation of the STAPHYtest 16 commercial
identiﬁcation kit was performed. The innovation study was
based on replacement of tests for novobiocin susceptibility
(GLN) and pyrrolidonylarylamidase activity (PYR), two tests in
the old STAPHYtest 16 having low discrimination power. The
innovation started at Czech Collection of Microorganisms
(CCM) in cooperation with PLIVA-Lachema Diagnostika s.r.o.
by chosen media testing. The tests for utilization of cellobiose,
galactose and lactose were concerned, and from these three tests,
the tests for the detection of galactose and lactose were chosen.
The novel STAPHYtest 16 to be innovated using both the clinical
and reference staphylococcal and micrococcal strains were
tested in the National Institute for Public Health. The result of
a correct identiﬁcation to the species level was 95%. The
excluded tests for detection of pyrrolidonylarylamidase and
susceptibility to novobiocin can still be performed using the
detection strip PYRAtest and the detection disc NOVOBIOCIN
which are offered by PLIVA-Lachema Diagnostika as well.
R2067
Possibilities in the use of BacT/Alert SA bottles
for diagnosing vascular catheter infections
P. Cermak, M. Ulrychova, P. Vı´chova, J. Mazurova (Hradec
Kralove, Pardubice, CZ)
Objectives: Infection caused by the insertion of vascular cath-
eters is responsible for a high percentage of nosocomial
infections. Catheter infections cause increased morbidity and
mortality along with the raising cost of treatment. The new
method is based on the transport of bacteria from catheter
surface into solution and cultivation of this solution Bact/Alet
system. Bacteria quantity present on the catheter is determined
on the base of isolated agent and detection time (TTD). The TTD
of positive vials is proportional to quantity of inoculated
bacteria and their metabolic activity.
Methods: 4 ml of sterile physiological solution was added to
a test-tube containing sample of vascular catheter and the
tube was agitated for 2 minutes. The whole volume of the
solution from the tube with vascular catheter was inoculated
into the bottle BacT/Alert SA. Bacteria quantity was deter-
mined by substitution TTD to the equation of TTD depend-
ence on the number of inoculated CFU for separate groups of
species.
Results: In total 187 vascular catheters were elaborated. After
seven days of cultivation 10 catheters were negative (5.34%). At
the evaluating criterion 103 and more detected bacteria, 18
catheters were positive (9.62%). With respect to the correlation
with clinical conditions 2 false positive results (1.06%) and 12
false negative results (6.41%) were found. On the basis of clinical
conditions 28 (13.46%) cases of catheter sepsis in the set of 187
examined patients were diagnosed. Agreement of quantitative
catheter examination with clinical ﬁnding occurred in 179 cases
(92.7%). Coincidence of positive ﬁndings on the catheter with
positive evaluation of clinical condition was seen in 16 cases
(57.14%). The most frequent detected pathogens were coagulase
negative staphylococci.
Conclusion: The method is applicable in clinical practice and is
able to detect most frequent agents of catheter infections.
Number of bacteria caught on the surface of a catheter is a
simple an easy evaluation criteria, but for the correct interpret-
ation it demands correlation with clinical conditions of the
patient.
R2068
Determination of metabolic activity and detection
of microbial cells by electrophysical analysis
O.V. Ignatov, O.I. Guliy, V.D. Bunin, V.V. Ignatov (Saratov,
Moscow, RU)
Objectives and methods: Measurement of electrophysical
properties of microbial cells may be used for creation of new
kind of biosensor systems. There were investigated the micro-
bial cells of some strains with preliminary metabolic enzyme
system of toxic compounds. These processes conduce to the
redistribution of the charges in the microbial cells and may be
register by electro-optical (EO) methods. The electro-optical
analyzer (ELUS EO), which has been developed at the State
Research Center for Applied Microbiology, Obolensk, Russia,
was used as the basic instrument for electro-optical measure-
ments EO analysis is based on the recording of changes in
optical characteristics of cell suspensions under the orienting
effect of an electric ﬁeld. Redistribution of the charges in the
microbial cells may be used for determination of substrates of
enzyme reaction and ﬁnally for determination of substrate
concentration.
Results: Same approach may be used for studies of microbial
cells and some biological agents (antibodies and phages)
binding. Since the AC electrokinetic effects depend on dielectric
properties of bioparticles, their composition, morphology, phe-
notype, the medium, and the frequency of applied electrical
ﬁeld, the EO properties of cell suspensions were used for
discrimination of bacteria before and after selective binding with
antibodies. There were shown the determination of the presence
of particular bacteria within a mixed sample may be achieved by
selection and matching of antibodies speciﬁc to individual
bacterium types and by comparing spectra of bacterium in the
presence and in the absence of speciﬁc antibody. Same princi-
ples were used for investigations of bacteria – phage interaction.
Integration of the electro-optical approach with a bioselective
binding agents has the following advantages: 1) bacteria from
biological samples need not be puriﬁed and 2) exogenous
substrates and mediators are not required for detection.
Conclusions: So electro-optical analysis of cell suspensions
provide new opportunities for creation of new biosensor
methods in biotechnology, environmental control and medi-
cine.This work was supported ISTC grant 615 and 3170PDG.
R2069
Nocardia sp. in cystic ﬁbrosis patients in a Greek
tertiary hospital
E. Papaefstathiou, M. Kanellopoulou, N. Skarmoutsou, I.
Inglezos, E. Fakiri, A. Tsakris, N. Legakis, E.
Papafrangas (Athens, GR)
Objectives: 1) To determine the incidence of Nocardia sp.in
Cystic Fibrosis (CF) patients, 2) to identify them to the species
level and 3) to investigate their susceptibility to common used
antibiotics.
Methods: During an 8 years period, multiple sputum speci-
mens of 68 (CF) adult patients were cultured in appropriate
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media. The identiﬁcation was performed on the basis of adenine,
casein, xanthine, hypoxanthine, tyrosine utilization, urea hydro-
lysis and antimicrobial susceptibility patterns. The susceptibility
testing was obtained by disk diffusion and microdilution
methods according to CLSI/NCCLS guidelines and by epsilom-
eter test (E-test) (AB BIODISK, Solna, Sweden) according to the
manufacture’s recommendations. Bita-Lactamase production
was detected by nitroceﬁn disks (Mast Diagnostics, UK).
Results: In a period of 8 years 7/68 (10.29%) CF patients had
Nocardia sp. in their sputa, without any signiﬁcant change in
their clinical status, radiology ﬁndings and pulmonary function.
The following species were isolated: N. asteroids (I, II, VI) (4/7),
N. farcinica (1/7), N. otitidiscaviarum (1/7), N. transvalensis
complex (1/7). The above isolates were found resistant to:
ampicillin (100%), ciproﬂoxacin, clarithromycin, erythromycin
(71.14% each), cefamandole (42.86%), imipenem, tobramycin,
gentamicin (28.57% each), amikacin, amoxicillin-clavulanic acid,
cefepime, ceftriaxone, (14.28% each). All isolates were sensitive
to linezolid, trimethoprim-sulfamethoxazole (TMP-SMX), cefo-
taxime and doxycycline.
Conclusions: 1) The incidence of Nocardia sp. in our Cystic
Fibrosis (CF) patients is remarkable (10.29%). 2) The predom-
inant isolated Nocardia sp. was: N. asteroides (I, II, VI). 3). All
Nocardia sp have to be tested for their susceptibility proﬁle, since
routinely used antibiotics in CF patients such as Ciproﬂoxacin or
Imipenem may be inactive.
R2070
New rapid ﬂow-through immunoﬁltration assay
system for rapid detection of Trichomonas
vaginalis in ThinPrep specimens
J. Alderete, T. Chang (San Antonio, US)
Objectives: The ThinPrep Pap Test (TP) is preferred over the
traditional Papanicolaou (Pap) smear, and the liquid-based
cytology is being increasingly employed for detection of the
sexually transmitted HPV. Such ﬁxative renders the number
one, non-viral sexually transmitted parasite, Trichomonas vagi-
nalis, undetectable. Given the association of trichomonosis with
cervical cancer, we wanted to develop a rapid ﬂow-through
(Filtration) assay system to detect T. vaginalis in TP specimens.
Methods: Spleen lymphocytes of mice immunized with tricho-
monads after treatment with TP ﬁxative were fused with NS1
myeloma cells to generate hybridomas producing mAbs.
Supernatant of hybridomas were tested for reactivity with
organisms exposed to TP ﬁxative coating microtitre wells.
Immunoreactive mAbs of single cell-cloned hybridomas were
tested for detection of trichomonad antigen in ThinPrep
specimens under optimized conditions. Finally, mAbs were
examined using a Filtration assay system on disposable porous
ﬁlter-membranes with bound antigen. Finally, TP specimens
from patients with trichomonosis and uninfected individuals
were tested for reactivity by mAbs using the Filtration assay.
Results: The mAbs were identiﬁed by standard colorimetric
ELISA at 405 nm that immunoreacted with trichomonads
exposed to TP liquid ﬁxative coated onto microtitre wells.
Then, mAbs detected trichomonad antigen immobilized onto
membranes in a Filtration assay system, and this was done by
both colorimetric ELISA and emission chemiluminescence
(ECL). The Filtration ECL assay was very sensitive and detected
antigen from as little as 10 organisms immobilized on mem-
branes. Filtration ECL yielded rapid, accurate results with fewer
ﬁxed organisms within 30 sec compared to colorimetric ELISA.
The mAbs reacted with organisms added to the ThinPrep
ﬁxative and with antigen in samples of patients with trichomo-
nosis. No immuno-crossreactivity was ever detected with the
mAbs with other trichomonad species, in the absence of T.
vaginalis antigen, and in samples with materials from uninfected
individuals.
Conclusion: A rapid ﬂow-through immunoﬁltration assay
system was developed for detecting T. vaginalis antigen. Indi-
vidual mAbs readily detect in a sensitive and speciﬁc fashion
trichomonad antigen in TP specimens. This demonstrates the
ability to now detect this sexually transmitted infection in the
liquid-based ThinPrep specimens.
R2071
Serological markers for cytomegalovirus
infection in newborns
E. Matveeva, T. Ulanova, V. Krasnov, O. Halezckaya,
A. Obriadina (Nizhny Novgorod, RU)
Objectives: Cytomegalovirus (CMV) infection in newborns is
often a cause of clinical illness. The purpose of this study was to
investigate the diagnostic value of different serological markers
for diagnosis of acute CMV infection in newborns.
Methods: During study period 2004–2005 years 34 mother –
child pairs and 8 newborns were tester for presence of anti-CMV
IgG, IgM and IgG avidity by commercially available enzyme
immunoassay (‘‘Diagnostic systems’’, Russia). To distinguish
between maternal and neonate immune response, IgG to
individual CMV proteins (pp150, pp52, pp38, pp28, gB) were
analysed. The children were monitored for at least 3 months.
Results: Acute CMV infection were conﬁrmed in 7 out of 42
children by laboratory research and clinical signs. In newborns
with proven CMV infection 28.6% was anti-CMV IgM positive,
33.3% had low-avidity IgG and 57.1% had signiﬁcant IgG
elevation during the observation period. Five out of 7 (71.4%)
had IgG proﬁle different from maternal. Presence of anti pp52 in
newborn and absence in their mother samples was the reason
for difference between the mother’s and child’s IgG proﬁles in
all cases.
Conclusions: Paired blood samples from both the mother and
infant are necessary for reliable serological analysis. Transferred
maternal and neonate-synthesized CMV speciﬁc IgG can be
differentiated by detection of antibodies to individual CMV
proteins. These results indicate that raised IgG, detection of anti-
CMV IgM, in particular low avidity immunoglobulin, and
especially different from maternal IgG proﬁles are useful
markers for the identiﬁcation of congenital CMV infection.
R2072
Extremely elevated C-reactive protein
D. Deeren, D. Knockaert, H. Bobbaers, X. Bossuyt, W.E.
Peetermans, S. Vanderschueren (Leuven, BE)
Objective: Measurements of C-reactive protein (CRP) are com-
monly used in clinic to differentiate inﬂammatory from non-
inﬂammatory conditions. We sought to delineate the clinical
signiﬁcance of extremely elevated CRP levels.
Methods: From the 2004 lab ﬁles of a university hospital we
extracted all patients with at least one CRP value >500 mg/L.
We reviewed the electronic records and assessed the clinical
diagnosis of the inﬂammatory event, comorbid conditions and
mortality. Infections were differentiated from non-infectious
inﬂammatory conditions.
Results: CRP surpassed 500 mg/L in 212 samples from 130
patients, representing 0.065% of all samples. Median age was
62 years (range, 2–94). In 80% of patients, maximal CRP was
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reached within the ﬁrst week of admission. A wide variety of
infections caused the CRP elevation in 114 of the 130 patients
(88%), with the lower respiratory tract and the abdomen as
prevailing foci. In the minority without readily identiﬁable
infection, sterile necrosis, ischaemia or heavy tumour burden
were responsible for the excessive acute-phase response. In 88 of
114 (77%) of patients with infection, a causative pathogen could
be identiﬁed. Apart from 5 mycotic infections, all were bacterial.
Blood cultures were positive in 44 of 109 patients (40%),
demonstrating gram-negative bacteraemia in 22, gram-positive
bacteraemia in 20 and candidaemia in 2. Overall, 47 of the 130
patients (36%) died, mostly within the ﬁrst month. Mortality
was especially high in patients with active cancer (28/46, 61%)
and with neutropaenia (11/15, 73%). Of 38 patients without
debilitating conditions, 5 died (13%).
Conclusion: A wide variety of mostly bacterial infections, that
are generally readily identiﬁed, accounts for the majority of
cases of extremely elevated CRP. Mortality is high, especially in
patients with active malignancies, underscoring the importance
of prompt identiﬁcation and control of the source of inﬂamma-
tion.
R2073
The added value of using recombinant-versus
puriﬁed membrane preparation-based antigens in
sero-diagnostics of Mycoplasma pneumoniae
Z. Greenberg, M. Lipson, J. Schlesinger, M.J. Lee (Ashdod, IL)
Objectives: Mycoplasma pneumoniae (MP) is an etiological agent
responsible for 10–30% of community-acquired pneumonia
cases. MP may be detected in all parts of the respiratory
system, and its effects are well recognized and documented. In
respect to diagnosis and treatment, the most prominent struc-
tural feature of MP is the lack of a cell wall. It has been shown
that surface-exposed polypeptides elicit immunogenic response,
in particular those that are involved in the attachment organelle
of MP. This attachment organelle is composed of a complex of
polypeptides, in which P1 Cytadhesin Protein has a major role.
The current SeroMP test of Savyon uses a puriﬁed fraction of MP
membrane proteins that contains the P1 as the major antigenic
factor. In an effort to produce a recombinant antigen-based
assay we evaluated the added value of using the recombinant
methodology.
Methods: Various candidates for the recombinant antigenic
mixture were deﬁned and their coding sequences were
ampliﬁed, cloned in an expression vector, and the His-
tagged polypeptides were afﬁnity-puriﬁed using Ni columns.
The effects of different combinations of recombinant proteins
were evaluated by testing characterized sera in ELISA
utilizing detection systems speciﬁc to IgG, IgM and IgA MP
antibodies.
Results: Applying various combinations of recombinant anti-
gens revealed a lower prevalence in healthy population. An
apparent phenomenon was the clariﬁcation of those sera which
were previously determined as borderline, and deﬁning them as
negatives. In sick population the amount of borderline samples
was substantially reduced as well, by deﬁning them as negatives
or positives. This partition increased the amount of positives,
and compensated for any possible decrease in sensitivity, which
might have been expected due to increasing speciﬁcity. This led
to a better separation between the sick and non-sick patient’s
results. The increase in speciﬁcity was in particular noticeable
when binding to potential cross-reacting antibodies, for example
anti-EBV, was completely abolished. These ﬁndings were
apparent in IgG, IgM and IgA tests.
Conclusions: This work points out speciﬁc improvements by
using recombinant antigens. Moreover, the output parameters
mentioned-above served as a tool for choosing the optimal
combination of recombinant polypeptides to be used as the
antigen in the test. These observations enable the serology test to
provide a better tool for the correct diagnosis of MP.
R2074
Evaluation of four chromogenic media for
surveillance cultures of methicillin-resistant
Staphylococcus aureus
I. Nahimana, P. Francioli, D.S. Blanc (Lausanne, CH)
Screening of MRSA carriage in hospitalized patients is part of
the measures to control MRSA. Thus, rapid and reliable
laboratory procedures for detection of MRSA is of utmost
importance. New chromogenic media have been recently
developed for this purpose. The aim of the study was to
evaluate the performance of 4 chromogenic media, MRSA ID
(bioMe´rieux, France), CHROMagar MRSA (Chromagar, France),
ORSAB (Oxoid, UK), and MRSA Select (Biorad, France). 466
samples were homogenized in NaCl 0.9% before inoculation
onto the media (primo-cultures) and in an enrichment broth.
Most were swabs from nose, throat, perineum and wounds. In
primo-cultures, 93 samples showed the presence of MRSA on at
least one medium. Results for each medium are presented in the
following order: MRSA ID, CHROMagar MRSA, ORSAB and
MRSA Select. After 16–18 h and 42 h of incubation, sensitivities
were 56%, 65%, 52%, 71% and 90%, 82%, 73%, 88%, respectively.
The colour of MRSA colonies was not characteristic for 2
samples on MRSA ID and ORSAB at 16–18 h; and for 7 samples
on ORSAB at 42 h. The speciﬁcity of each medium to identify
MRSA by colony color was 100%, 99%, 99%, 100% after 16–18 h
of incubation and 98%, 97%, 98%, 98% after 42 h, respectively.
The performance was evaluated by calculating the mean time to
report a positive result, and was 1.65 d, 1.72 d, 2.31 d and
1.35 d, respectively. The use of an enrichment broth increased
the detection of MRSA by 16 to 24% for all media. In conclusion,
in order to detect most MRSA, all media should be incubated for
at least 42 h and/or and enrichment broth should be used.
These chromogenic media improve the procedure of MRSA
surveillance cultures and so contribute to reduce hospitalization
costs.
R2075
High blood levels of procalcitonin identify
critically ill patients at high risk of mortality
J.U. Jensen, L. Heslet, T. Jensen, K. Espersen, P. Steffensen,
M. Tvede (Copenhagen, DK)
Objectives: Serum procalcitonin (PCT) has been shown to be a
reliable sepsis marker and elevation of PCT blood levels occurs
early in the course of a bacterial infection. We investigated blood
levels of PCT to evaluate the association between high levels of
Procalcitonin and mortality in 1). The intensive care unit, 2) In a
30 day follow-up period of time basis and 3) In a 90 day follow-
up period of time.
Methods: We enrolled all patients admitted to a multidiscipli-
nary Intensive Care Unit (ICU) in 2002. Daily PCT measure-
ments, were carried out during the study period. The clinical
end point was all cause mortality during the stay in the intensive
care unit, at 30 days after admission to the ICU and at 90 days
after admission to the ICU.
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Results: PCT measurements evaluated in 472 critically ill
patients. Overall ICU mortality of critically ill patients in the
one-year study was 19.1%. Mortalities at 90 days ranged
between 11.6% and 59.6% according to maximum PCT level
obtained (PCT max) in the ICU. For details of mortality and PCT
levels, see table 1.
Conclusion: Strikingly high mortality risk was seen in patients
with a high PCT max. A PCT max of 1.0 ng/ml seemed to divide
high and low mortality risk in these ICU patients. PCT
measurements may be a useful tool in fast stratiﬁcation of
critically ill patients in high and low risk patients.
R2076
Galactomannan and mannan antigens and anti-
mannan antibodies detection for the diagnosis of
invasive aspergillosis and candidiasis in liver
transplant recipients
M. Machetti, S. Di Domenico, A. Pellizzari, E. Furfaro, U.
Valente, C. Viscoli (Genoa, IT)
Objectives: Fungal infections in liver transplanted patients may
decrease the survival rate at 120 days after transplant from 90%
to 65%. Hence it is important a rapid diagnosis to allow an early
antifungal therapy. We studied the utility of galactomannan
(GM), mannan (MAN) and antiMAN antibodies detection for
the rapid diagnosis of invasive aspergillosis (IA) and candidiasis
in liver transplant recipients.
Methods: Four hundred and sixty-ﬁve serum samples were
collected from 46 liver transplanted patients, during the post-
transplant hospitalization in the intensive and sub-intensive care
unit. After a collection period of 13 months, samples were
analysed with the Platelia Aspergillus, Platelia Candida Ag and
Platelia Candida AB tests (BIO-RAD). Positivity cut-off for GM
detection was a GM index (sample OD/control cut-off OD) ‡0.7.
For MAN detection the test was positive if MAN concentration
was ‡0.5 ng/ml, while for antiMAN assay the test was positive
if antibodies content was ‡10 arbitrary units (as deﬁned by the
manufacturer).
Aspergillus results: No cases of IA or Aspergillus colonization
were found in the 46 pts. However 3 of them tested positive for
GM and they were considered as false positive cases.
Candida results: MAN and/or antiMAN test were positive in
20 of 46 pts. Within the ﬁrst 100 days post transplant 98.5% of
MAN and 100% of antiMAN test were positives, vs. 93% of
MAN and 84% of antiMAN negative results.Candida infections:
Five pts. had probable candidiasis (2 with positive cultures
from SwanGanz catheter and 3 with Candida colonisation index
‡0.5). Three of 5 infected patients tested positive for MAN
and/or antiMAN, while 17 of 41 non-infected pts. were
positives for antigens and/or antibodies assays. Cumulative
sensitivity and speciﬁcity of the 2 Candida tests were 60% and
58.5%.
Candida colonisation: Twenty-six of 46 patients (56.5%) had
Candida colonization (included the 5 pts. with probable candidi-
asis) and 14 of 26 colonized patients (53.8%) were positive for
MAN and/or antiMAN test, vs. 6 of 20 between the non-
colonized patients (30%). Moreover the time of ﬁrst colonization
and ﬁrst positivity of the two Candida tests were almost all
within 20 days after transplantation.
Conclusions: Due to the absence of IA, only the speciﬁcity
(93%) was valuable for the GM detection. As for Candida assays,
MAN and antiMAN tests performed poorly and Candida
colonization also seems actively inﬂuence the detection of
Candida antigens and antibodies.
R2077
Cultural ﬁndings of Lactobacillus in pregnant
women with and without bacterial vaginosis
V. Vuksanovic (Podgorica, CS)
Objectives: To determine the presence of lactobacillus in
vaginal swabs of pregnant women with and without bacterial
vaginosis (BV) and their mode of metabolism.
Method: The study involved 137 pregnant women at the age
from 18–45 years out of which 54 pregnant women had the BV
diagnosis and 83 were without BV. BV diagnosis was given
based on Amsel’s clinical criteria and Nugent’s score system.
Isolation and identiﬁcation of lactobacillus was done on MRS
(deMan, Rogosa, Sharpe) plate, produced by Biolife, with the
period of incubation of 72 hours anaerobe and 48 hours aerobe
on separate Petri dishes. Characteristic small colonies were
analysed on catalase test and microscopic preparation. Gram-
positive bacillus catalase negative were identiﬁed as lactobacil-
lus.
Results: Obtained results showed that only 24 (44.5%) pregnant
women with BV had lactobacillus in cultural ﬁnding, wears 78
(93.9%) pregnant women without BV. Out of total 54 pregnant
women with BV 4 (7.4%) had lactobacillus that grows up aerobe
and 6 (11.1%) had facultative anaerobe lactobacillus, while
anaerobe lactobacillus were dominant and they were found in 14
(25.9%) pregnant women with BV. In pregnant women with BV
facultative anaerobe lactobacillus was dominant and they were
found in 36 (43.4%) cases together with aerobe lactobacillus that
were present in 25 (30.1%) pregnant women, while anaerobe
lactobacillus were found in 17 (20.5%) women.
Conclusion: On the basis of v2 tests it was proved that cultural
ﬁnding of lactobacillus has been frequently isolated from
vaginal swab of pregnant women without BV with statistical
signiﬁcance (v2 = 50.94 p < 0.01) where the least presence of
anaerobe lactobacillus was found.
R2078
Evaluations of differents selective mediums to
isolate Helicobacter pylori
M. Quesada, I. Sanfeliu, D. Fontanals, I. Pons, F. Segura,
X. Calvet (Sabadell. Barcelona, ES)
Objective: Development of a new medium to culture and
isolate Helicobacter pylori from faeces, could enable to eliminate
in the future the gastric biopsy as the only way to obtain strains.
The aim of the present study was to optimize mediums of
culture to isolate H. pyloriwhen it is present with other intestinal
tract bacteria.
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Methods: Twenty-nine selective culture mediums were evalu-
ated in several and consecutive assays. They were composed of
11 nutrient and component combinations; as well as by 14
antibiotic combinations (Amphotericin B, Cefalotin, Cefopera-
zona, Cefsulodin, Colistin, Polymixin B, Sulfamethoxazol, Trim-
ethoprim and/or Vancomycin). We cultured between 2 and 13
H. pylori strains and 5 intestinal tract bacteria species (Et)
isolated from clinical samples. Pylori agar (PA) was used as
control of the selective medium, and Columbia agar with 5%
sheep blood (both bioMe´rieux, Lyon, France) and the same
nutrient combinations without antibiotics, were used as control
of non-selective plates. Pure H. pylori and mixed (H. pylori + Et)
suspensions were prepared, cultured and incubated at
37ordm;C on microaerophilia during 4 and 7 days. H. pylori
growth was evaluated as pure and mixed suspensions, tacking
into account the number of colony-forming units (CFU) on each
plate and the colony visualization.
Results: H. pylori was isolated on 3 selective mediums, in spite
of there being 104 CFU Et/ml, where the number and visual-
ization of H. pylori colonies were better with regard to the
obtained on PA. The most selective antibiotic combination was
Amphotericin B, Cefsulodin, Polymixin B, Trimethoprim and
Vancomycin. The number and size of H. pylori colonies
decreased in the presence of other bacteria species.
Conclusions: The new culture mediums evaluated could be
useful to isolate H. pylori from faeces, because increase number
and visualization of H. pylori colonies with regard to commercial
medium used to isolate H. pylori from gastric biopsies.
R2079
A recombinant line-blot avidity assay for the
detection of Epstein–Barr virus infection
J.R. Leo´n, M.S. Garcia-Valdivia, M.A. Rodriguez-Iglesias (Cadiz,
ES)
Epstein–Barr Virus (EBV) is responsible to primary and secon-
dary infections frequently found in clinical routine. Acute
mononucleosis associated to EBV can be determined with
speciﬁc IgM detection but there are many situations with
doubtful clinical interpretation. We present the results of a line-
blot immunoassay for the detection of EBV IgG antibodies
including his avidity as marker of recent infection. We have
studied 50 sera from patients with primary infection and past or
secondary infection. The serological status was determined by
immunoassay detecting EBV IgM, VCA IgG and EBNA IgG
(Liaison, Diasorin). We have evaluated a line-immunoassay
based in EBV recombinant antigens composed by EBNA-1
antigen, VCA antigens (p18 and p23) and EA antigens (p138 and
p54) (Mikrogen). We have detected speciﬁc IgG and the avidity
was determined doubly using or not a wash buffer with 8 M
urea. Twenty-four sera corresponding to mononucleosis associ-
ated to primary infection. Even if we use anti-IgG conjugate we
detected reactivity in 20 sera (83.3%). The more frequent reactive
bands was VCA p23 (15), EA p54 (14) and EA p138 (13).
However these bands were erased with 8 M urea in 10, 11 and
11 sera respectively. There is not reactivity to EBNA-1 antigen in
these samples. Twenty-six sera corresponding to past o reacti-
vated EBV infection. In these samples was critical the presence
or not of EBNA-1 antibodies. Not presence is associated to
subacute infection and is demonstrated by his low avidity VCA
and EA antibodies. When there are EBNA antibodies 20/22
patients presents VCA p23 and EBNA-1 with high avidity. Two
patients was missed EBNA-1 and was related with subacute
process. The presence of high level of EBNA-1 antibodies
(>600U) is strongly correlated with high avidity reactivity
against EA antigen (6/7) and reactivation process. We conclu-
ded that this line-blot immunoassay can be useful for to resolve
subacute or reactivated infections studying the reactivity to
EBNA and/or EA antigens and improves the EBV serological
diagnostic.
R2080
Rapid diagnosis of pneumococcal meningitis
using Binax NOW Urinary Antigen Kit
C. Ebnoether, R. Schlaberg, T. Bregenzer, R. Zbinden (Aarau,
Zurich, CH)
Objectives: The Binax NOW Streptococcus pneumoniae urinary
antigen assay (Binax NOW test) was developed to detect S.
pneumoniae antigens in urine samples in patients with suspected
pneumococcal pneumonia. Sensitivity and speciﬁty are 65.9–
70.4% and 89.7–100% respectively in adults with community-
acquired pneumonia. Maria A. Marcos used Binax NOW test for
the diagnosis of pneumococcal meningitis in CSF samples and
urine. Sensitivity and speciﬁcity were 100% in specimen from
eight patients. Cross-reactivity of rapid antigen tests are well
known for S. pneumoniae and Streptococcus spp. of the oralis
Group, i.e. S. oralis and S. mitis. Cross-reativity results from the
fact that all three species share the C-polysaccharide, which is
detected by Binax NOW. However, bacterial meningitis with
oral streptoccoci are rare and usually iatrogenic.
Methods: We used the Binax Now test manufactured by Binax,
Maine 04103 USA to test CSF-samples from 77 patients with
suspected bacterial meningitis: 14 CSF-samples with Gram-
positive cocci in the Gram-stain, 4 with Gram-negative rods (3)
or Gram-negative cocci (1), 7 CSF-samples with negative direct
stain but positive CSF culture. In addition, 52 CSF-samples with
negative direct stain and negative CSF culture were tested.
Results: In 6 out of 14 CSF-samples with Gram-positive cocci in
the direct stain culture grew S. pneumoniae, 4 grew coagulase
negative Staph., 1 S. haemolyticus and 1 S. milleri and anaerobic
ﬂora, 1 Enterococci, 1 S. oralis/mitis. Binax Now test was positive
for all CSF-samples growing S. pneumoniae and weakly positive
in one sample with S. milleri. In 4 direct stain positive CSF (3
rods, 1 Gram-negative cocci) the Binax Now test was negative.
In 7 Gram-stain negative CSF-samples cultures grew other
species (5 coagulase negative Staph., 1 Enterobacter cloacae, 1
Propioni bacterium) and Binax Now test was negative. It was
negative too in the 52 CSF-samples with negative direct stain
and negative culture. (ppV 86 %, npV 100 %). The patient with
the false positive Binax Now test had a brain abscess (S.milleri
and anaerobic ﬂora).
Conclusion: Binax NOW antigen test on CSF revealed positive
results in all culture positive pneumococcal meningitis. There
was no false negative result and only one false positive (weak)
reaction. In patients with suspected bacterial meningitis Binax
NOW test seems to be a reliable, rapid diagnostic tool to identify
patients with pneumococcal meningitis.
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Methods for antibacterial susceptibility testing
R2081
A new in vitro method for testing antimicrobial
properties of volatile phytotherapeutic
compounds
A. Conrad, I. Engels, F. Daschner, U. Frank (Freiburg i.Br., DE)
Objective: To develop a new system for antimicrobial suscep-
tibility testing of phytotherapeutic compounds containing vola-
tile essential oils.
Methods: A commercially available phytotherapeutic prepar-
ation of nasturtium (N) and horseradish (H) (Angocin Anti-
Infekt N; Repha, Langenhagen, Germany) was used as test drug.
The active ingredients (gently dried and ground N and H, in a
ratio of 2.5:1) were applied to the covers of Columbia blood agar
plates and mixed with sterile H2O. A variety of different
bacterial species including Haemophilus inﬂuenzae, Moraxella
catarrhalis, Escherichia coli, Pseudomonas aeruginosa, Streptococcus
pyogenes, methicillin-susceptible and resistant Staphylococcus
aureus [MSSA., MRSA] were tested (20 isolates each). The test
organisms were plated onto the blood agar plates and placed
above the test substance. The plates were sealed with adhesive
tape and incubated for 24–92 h at 37C. Following incubation,
colony forming units (CFUs) were counted and the MHK90 was
determined for each bacterial species.
Results: The new system designed for testing volatile com-
pounds/essential oils produced reproducible and reliable
results. Relevant antimicrobial activity of the test drug was
found against H. inﬂuenzae (MHK90 50 mg N/20 mg H),
M. catarrhalis (100 mg/40 mg), E. coli (400 mg/160 mg), P.
aeruginosa (400 mg/160 mg), MSSA (400 mg/160 mg), MRSA
(400 mg/160 mg), and S. pyogenes (400 mg/160 mg).
Conclusions: A newly developed in vitro technique for antimi-
crobial susceptibility testing of volatile compounds produced
highly reproducible results. A phytotherapeutic compound
tested with this method showed broad antibacterial activities
against clinically relevant pathogens.
R2082
Effect of beta-lactamic antibiotic on the
electrophysical characteristics of Escherichia coli
O.I. Guliy, O.V. Ignatov, L.N. Markina, V.D. Bunin (Saratov,
Moscow, RU)
Objectives: Study of the adaptation of microbes to antibiotic
action is an important problem that is of theoretical and applied
signiﬁcance. Ampicillin is a beta-lactamic antibiotic that is
produced by aminophenylacetic acid acetylation of 6-aminop-
enicillanic acid. It is a broad-spectrum agent that is active
speciﬁcally toward E. coli. The aim of this work was to study the
effect of ampicillin on the electro-optical (EO) parameters of cell
suspensions of Escherichia coli strains differing in there resistance
to this antibiotic. One can assume that changes in cell morphol-
ogy and cell-wall disturbances in antibiotic-resistant microor-
ganisms should lead to changes in their electrophysical
characteristics. These changes are reﬂected in alterations in the
electro-optical characteristics of cell suspensions, which are
recorded during experiments using electric-ﬁeld cell orientation.
On the basis of these alterations, one can draw tentative
conclusions about the presence or absence of resistance to a
given antibiotic in the cells under study.
Methods: The orientational spectra (OS) of the cells were
measured with an ELBIC EO analyzer at a wavelength of
670 nm.
Results: We examined the effect of ampicillin on the electro-
physical characteristics of ampicillin-sensitive and ampicillin-
resistant Escherichia coli cells. Substantial changes in the OS of
suspensions of cells incubated with various ampicillin concen-
tration took place only at the ﬁrst ﬁve frequencies of the
orienting electric ﬁeld (10 · 1000 kHz) The maximal change in
the magnitude of the electro-optical signal occurred at 50 lg/ml
of ampicillin. The suspension-OS changes did not depend on the
antibiotic-action period. Under the action of ampicillin, sensitive
and resistant E. coli strains gave different EO effects. After
ampicillin incubation of the sensitive strains, K-12 and XL-1,
there occurred a considerable change in the EO-signal magni-
tude. Suspensions of the resistant strains, K-12 (pUC-18) and
XL-1 (pHEN1), showed no changes in this EO parameters after
ampicillin incubation.
Conclusion: Thus, the suspension-OS changes occurring under
the effect of ampicillin may be used as a test for resistance to this
antibiotic in the cells studied. The possibility is suggested of
using electrophysical methods to study the mechanism of
antibiotic action on bacterial cells, with a view to check antibiotic
action of microorganisms.This work was supported by Russian
Science Support Foundation and CRDF Y1-P-06-09.
R2083
Inducible clindamycin resistance in
Staphylococcus aureus isolated from clinical
specimens: ﬁrst report from Iran
M. Rahbar, S. Moulanaee, R. Atifeh, R. Yaghoobi, M. Deldari,
H. Hashemi (Tehran, IR)
Objectives: The aim of this study was to determine incidence of
erythromyvin-induced resistance to clindamycin in Staphylococ-
cus aureus isolated from clinical specimens in Milad hospital of
Tehran, Iran.
Methods: A total of 175 strains of S. aureus isolated from clinical
specimens identiﬁed by conventional microbiological methods.
To detect inducible clindamycin resistance a 15 mcg erythro-
mycin and 2 mcg clindamycin were placed at distance of 15–
20 mm on Muler Hinton agar, Disk diffusion methods was
performed for other antibiotics including linozolid, vancomycin,
mupirocin and co-trimoxazol as recombined by CLSI.
Results: Of 175 isolates of S. aureus 53 (35%) were resistant to
methicillin (MRSA). All isolates were susceptible to linozolid,
and vancomycin and 1.6% were resistant to mupirocin and
28.5% of isolates were resistant to co-trimoxazol. Of 175 isolates
of S. aureus 17 (9.7%) isolates showed inducible cindamycin,
resistance. Of 17 inducible clindamycin isolates of S. aureus, 11
isolates were methicllin resistant (MRSA) and 6 isolates meth-
icillin susceptible (MSSA). 27 isolates were resistant both
erythromycin and clindamycin (constitutve resistant) and 9
isolates were resistant to erythromycin and susceptible to
clindamycin.
Conclusion: This study reveals that 35.7% of S. aureus isolates in
our hospital were resistant to methicillin and 17 (9.7%) isolates
had inducible clindamycinn resitanc. All isolates were suscept-
ible to linozolid and vancomycin.
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Diagnostics – New automated techniques
R2084
Comparison of identiﬁcation and susceptibility
testing in the MicroScan WalkAway and the
VITEK 2 for nonfermenting Gram-negative
bacilli
M. Kaase, B. Baars, A. Anders, G. Geis, T. Sakinc, S. Gatermann
(Bochum, DE)
Objectives: The MicroScan WalkAway 96 SI and the VITEK 2
are automated instruments for rapid organism identiﬁcation and
susceptibility testing. The purpose of this ongoing study is to
compare the performance of identiﬁcation (ID) and antibiotic
susceptibility testing (AST) of nonfermenting gram-negative
bacilli in both instruments.
Methods: 177 clinical isolates of nonfermenting bacilli were
tested using the MicroScan WalkAway 96 SI with Synergies plus
Neg Breakpoint Combo for ID and AST and the VITEK 2 with
the GN card for ID and the AST-N021 for susceptibility testing.
Results: Identiﬁcation results were concordant in 141 isolates
(79.7%). Essential agreement of susceptibility testing results was
deﬁned as a MIC value within one doubling dilution of each
other. This was observed for piperacillin in 86%, for piperacil-
lin/tazobactam in 92.7%, for ceftazidime in 93.7%, for cefepime
in 92.1%, for imipenem in 93.6%, for meropenem in 98.2%, for
gentamicin in 98.9%, for tobramycin in 97.7%, for levoﬂoxacin in
98.9% and for ciproﬂoxacin in 98.9% of the strains tested.
Conclusion: Good agreement between the results of AST with
the two instruments was found for most antibiotics especially
for the aminoglycosides gentamicin and tobramycin, for the
ﬂuorochinolones levoﬂoxacin and ciproﬂoxacin and for me-
ropenem. However, different results were found for identiﬁca-
tion in a substantial portion of nonfermenting gram-negative
bacilli. In order to solve discrepant results susceptibility testing
by standard microdilution methods and identiﬁcation by
molecular methods will be performed in our ongoing study.
Public health and community-acquired infections
R2085
Psoas muscle abscess and pyogenic arthritis due
to Streptococcus milleri in an intravenous drug
abuser
T. Kontopoulou, E. Vaidakis, T. Kalloniatis, O. Tsopra, M.
Studynkova, E. Sioula (Athens, GR)
Objectives: Streptococci of the milleri group are part of the
normal ﬂora of human mucous membranes. They can cause
serious pyogenic infections. Our objective is to stress the fact
that an abscess should be sought when Streptococcus milleri is
isolated from the blood.
Case report: A 33-year-old man was admitted in our depart-
ment because of fever and painful swelling of his right leg. He
had a history of regular intravenous heroin use for at least three
years and was positive for hepatitis C; he had a stomach
operation due to ulcer; he was injured in the spine because of an
accident. The patient had temperature 39.6C, blood pressure
90/60 mmHg, pulse 140/min and respirations 22/min. The
physical examination revealed a red, hot, painful swelling of the
right groin and leg and mild tenderness over the right and left
lower abdominal quadrants. Laboratory values showed eryth-
rocyte sedimentation rate of 110 mm/h, haemoglobin 9.3 g/dl,
haematocrit 27.6%, leucocytes 20340/mm3 (granulocytes 78%),
platelets 20000/mm3, C-reactive protein 18.9 mg/dl, creatinin
3.2 mg/dl. The triplex echo revealed a deep venous thrombosis
of the right leg, from the common femoral vein and below. Chest
radiograph, brain and chest CT were normal. Echocardiogram
was negative for endocarditis. Bone scan revealed chronic
inﬂammation of O2–O5 lumbar vertebrae due to injury. CT of
the abdomen showed large abscess of the right and especially
the left psoas muscle. A percutaneous drainage of the left psoas
muscle was performed under CT assistance. Treatment was
started with penicillin G and gentamicin intravenous. The fourth
hospitalization day the patient developed swelling, pain and
functional incapacity of his right knee. The arthrocentesis
yielded a yellow, turbid ﬂuid with 20560 cells/mm3 (95%
granulocytes). Cultures of blood, abscess and arthric ﬂuid grew
streptococcus milleri. He continued his intravenous antibiotic
treatment for six weeks and oral antibiotics for a further six
weeks and his clinical evolution was completely satisfactory.
Conclusion: Careful history taking and meticulous physical
examination remain crucial for patients with a psoas abscess. CT
is the most efﬁcient diagnostic method. Management consists of
early and effective drainage and long-term antibiotic treatment.
Because of the close contact with iliac veins there is a risk for
thromboembolic complications.
R2086
Research of bacterial contamination in dental
unit waterlines
D. Go¨ksay, A. C¸otuk, Z. Zeybek (Istanbul, TR)
Introduction: Thewater used in dental unit waterlines (DUWLs)
acts as a coolant for the high-speed drills and as an irrigant during
dental procedures. There are a number of possible sources of
water supplied to DUWLs, including public main water supply
connections or water tanks. DUWLs provides an ideal environ-
ment for microbial bioﬁlm and proliferation primarily due to the
high surface/ volume ratio in the tubing and the character of ﬂuid
dynamics in narrow, smooth-walled waterlines. Bioﬁlms can
harbour opportunistic pathogens such as Legionella sp., Pseudo-
monas sp., and therefore dentists, immunocompromised patients
may be at risk. The aim of our study was to determine Legionella,
Pseudomonas, Total Aerobic Heterotrophic Mezophilic Bacteria
(TAHMB) contamination of DUWLs in private dental ofﬁces
Istanbul city of Turkey.
Methods: A total of 59 water samples were taken from high-
speed drill, air-water syringe, oral rinsing cup. R2A Agar and
Nutrient Agar (NA) were used for TAHMB. Pseudomonas Agar
Base with CFC supplement was used for Pseudomonas.
Buffered Charcoal Yeast Extract Agar containing glycine,
vancomycin, polymyxin, cycloheximide was used for Legionella.
In addition two DUs bioﬁlms from the high-speed drill were
investigated according to Method of the Sanden et all.
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Results: In the United States, the American Dental Association
(ADA) and the Centers of Disease Control and Prevention have
suggested a standard for DUWLs water of no more than
200 cfu/ml of aerobic heterotroﬁk bacteria. We found that all of
air-water syringe (range 317–46320 cfu/ml), all of high-speed
drill (range 370–52240 cfu/ml) and 90% of oral rinsing cup
(range 183–119117 cfu/ml) exceed ADA recommendation for
dental unit water. We compared bacterial counts on R2A Agar
versus NA; results of R2A Agar were signiﬁcantly higher than
NA. Of the 59 water samples examined, 14 (24%) were positive
for Pseudomonas sp. All water samples were negative for
Legionella sp.
Conclusion: We suggested that bacterial contamination and
also bioﬁlms in DUs should be controlled to eliminate oppor-
tunistic pathogens and to provide water for dental treatment,
which meets public health standards for ADA recommendation.
R2087
The prevalence of genital Chlamydia trachomatis
and Neisseria gonorrhoeae infection in women
and men attending different health care areas in
Kuwait
N. Al-Sweih, M. Jamal, S. Khan (Kuwait, KW)
Introduction and objective: Chlamydia trachomatis and Neisseria
gonorrhoeae are the most common sexually transmitted diseases
(STDs) worldwide. They may cause pelvic inﬂammatory disease
in females, which contributes to infertility. The objective of this
retrospective study is to determine the prevalence of genital
chlamydia trachomatis and Neisseria gonorrhoeae infection in
women and men attending different health care areas in Kuwait.
Materials and methods: A total of 931 specimens were tested
for both Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(GC) with BD Probe Tec Et system. A total of 604 clinical
specimens from women consisting of 46 urine and 558 endo-
cervical swabs and 327 clinical specimens from men consisting
of 119 urine and 208 urethral swabs were tested.
Results: The overall prevalence of CT was 6.7% (63) and 14%
(131) for GC. Eleven samples (1.2%) were positive for both CT
and GC. The prevalence of CT in different health areas as
follows: Adan 16.8% Amiri 4%, Sabah 3.8%, Jahra 2.6%, and
0.9% for Farwania. The prevalence of GC in different health
areas were 31.4%, 28%, 12.8%, 7%, 0.6% for Adan, Farwania,
Jahra, Sabah and Amiri respectively. The overall prevalence of
CT and GC in men was 75% of the total positive specimens.
Conclusion: The prevalence of CT and GC was high but
differed at various health areas in Kuwait. The ﬁndings indicate
that a major problem of STDs exist among the population in
Kuwait.
R2088
Diagnosis and management of congenital
toxoplasmosis in Slovenia
J. Logar, A. Storman, T. Premru-Srsen, Z. Novak-Antolic,
M. Arnez, A. Kraut, B. Stirn-Kranjc, N. Vidovic-
Valentincic (Ljubljana, Celje, SI)
Objectives: Toxoplasmosis, especially its congenital form
caused by the parasite Toxoplasma gondii, may cause in women
who acquire Toxoplasma infection in pregnancy the severe
lesions in the foetus or even death of the foetus. In accordance
with our previous results stressing the risk of congenital
toxoplasmosis in Slovenia, compulsory screening of pregnant
women for Toxoplasma infection was introduced in 1995
(Ofﬁcial Gazette, Art. 41, 1995; 69: 5297).
Methods: The current policy of the Institute of Microbiology
and immunology, Medical Faculty Ljubljana and 7 regional
laboratories of Institute Public Health in Slovenia is to screen the
sera of pregnant women for the primary Toxoplasma infection
by ELISA IgG and ELISA IgM tests as soon as possible, at the
latest by 10-20 weeks’ gestation.Those who are seronegative on
the ﬁrst visit are re-tested at 20–24 weeks and in the 3rd
trimester for the infection acquired in pregnancy. These women
are given also a booklet containing information on how avoid
this infection. Primary infected pregnant women are evaluated
also by Toxo-IgG avidity test and by PCR of amniotic ﬂuid. In all
women ultrasound scans are performed every four weeks.
Women with conﬁrmed primary T. gondii infection are admin-
istered therapy and followed up at the Department of Gynae-
cology and Obstetrics, University Medical Centre. In the 1st
trimester the women are treated with spiramycin but later
pyrimethamine and sulphadiazine with folinic acid alone is
given or alternating with 3 weeks courses of spiramycin until
delivery. In primary infected but PCR-negative women spira-
mycin is continued beyond the 20th week. Serologically IgG,
IgM and/or IgA positive newborns are treated and followed up
at the Department of Infectious Diseases and Febrile Illnesses
and at the Department of Ophthalmology, University Medical
Centre Ljubljana.
Results: In the period from 1995, two congenitally affected
infants were born to mother who were screened to late in
pregnancy and were therefore not treated in time. To all primary
Toxoplasma infected women but treated in time no affected
child has been born.
Conclusions: Serological screening for Toxoplasma infection
during pregnancy can considerably reduce the incidence of
congenital toxoplasmosis but timely testing, performed repeat-
edly at least 3 times during pregnancy and clinically long-term
monitoring of Toxoplasma infected children is strongly recom-
mended if this disease is not to be missed.
R2089
Pyogenic liver abscess: experience over a 10-year
period
G. Uribarri, D. Lo´pez, J.D. Ruiz-Mesa, A. Villalobos, A. Plata,
I. Pe´rez, S. Santamarı´a, J.M. Reguera (Malaga, ES)
Objectives: The purpose of this study was to determine the
demographic, clinical laboratory, imaging, microbiologic and
management characteristics of pyogenic liver abscess.
Methods: We carried out a descriptive study of 70 patients with
pyogenic liver abscess from January 1995 to July 2005 in Carlos
Haya Hospital, Malaga, a tertiary hospital in southern Spain.
Results: The mean age was 62.3 ± 16.3 years. 57% were male.
Underlying medical illnesses included diabetes mellitus (31.4%),
malignancy (4.3%), alcohol abuse (7.1%), chronic renal failure
(5.7%) and immunosuppressive therapy (4.3%). Biliary tract
disease was the cause in 45.7%, pylephlebitis in 17.1%, direct
extension in 4.3%, and cryptogenic abscesses in 35.7%. Fifty-
three abscesses were solitary, 52 (74.3%) were right sided, 14
(20%) were left sided, and 2 (2.9%) were bilateral. The most
frequent presenting symptoms and signs were fever (94.3%),
chills (75.7%), nausea and vomiting (40%), upper right quadrant
pain (52.9%), jaundice (18.6%), hepatomegaly (27.1%), abnormal
chest ﬁndings (35.7%) and sepsis (14.3%). The most common
laboratory abnormalities noted were leukocytosis, elevated
alkaline phosphatase levels, and increases in ESR and C reactive
protein levels. Ultrasonography was performed in 65 patients,
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with ﬁndings in 84.6%, and computed tomography (CT) in 66
patients, with ﬁndings in all patients. Blood cultures were
performed in 60 patients (85.7%) and abscess cultures in 54
(77.1%), which were positive in 27 (45%) and 40 (74%) cases,
respectively. The most common organisms isolated included E.
coli in 16 patients, K. pneumoniae in 13, S. intermedius in 14, and
anaerobes in 6. All patients were treated with intravenous
antibiotic drugs. Ten patients underwent ultrasound or CT-
guided percutaneous aspiration of the abscess. A percutaneous
drainage catheter was inserted after aspiration in 57%. Surgical
drainage was performed in nine patients, due to an elective
operation or failure of antibiotic treatment (6 patients), failure of
aspiration (2 patients), or failure of percutaneous drainage (1
patient). The overall mortality was 10%.
Conclusion: Biliary tract disease remains the most common
cause of pyogenic liver abscess. In our series, E. coli, strepto-
coccus intermedius and Klebsiella pneumoniae were the most
common pathogens. Percutaneous drainage combined with
intravenous antibiotics was the most common treatment.
Pyogenic liver abscess remains a disease with a signiﬁcant
mortality.
R2090
Spectrum and antimicrobial resistance of
pathogens in community-acquired urinary tract
infections in a general hospital
E. Draghijeva, P. Egbase, S. Mathai (Kuwait, KW)
Objective: The aim of the study was the aetiology and antibiotic
resistance of clinical isolates from patients in London hospital,
Kuwait – general hospital, with different forms of uncompli-
cated community-acquired urinary tract infections (CA-UTIs).
Methods: Between October 2003–2005, a total of 3634 urine
specimens were obtained. The urine cultures were performed in
the laboratory according to conventional methods. The strains
isolated from the patients who had signiﬁcant bacteriuria were
included in the microbiological analysis. The identiﬁcation of
the strains was performed using the API 20E system (Bio-
Merieux). The sensitivity to antibiotics (ampicillin – AMP,
amoxicillin-clavulanate – AMX-CLV, cefuroxime-CFR, ceftriax-
one-CRO, gentamicin-G, nitrofurantoin-NTF, norﬂoxacin-NOR,
penicillin-P, amikacin-A) were determined by disk diffusion
method. The interpretation of the results was realized according
to NCCLS guidelines.
Results: 636 out of 3634urine samples (17.5%) fulﬁlled the
criteria for signiﬁcant bacteriuria and they were analysed. The
isolates were: E. coli 324 (51%), Streptococcus agalactiae (Group
B Streptococcus) 117 (18%), Klebsiella spp. 78 (12%), CNS 45 (7%),
Enterobacter spp. 27 (4%), Candida spp. 18 (3%), Pseudomonas spp.
15 (3%), Proteus spp. 9 (1.5%), S. aureus 3 (0.5%). There is high
resistance of E. coli isolates to Ampicillin, Amoxicillin-clavula-
nate and Cephalotin – 62%, 61% and 82%, respectively. Similar
distinction in Klebsiella spp. was found – 100%, 48% and 50%
respectively. Streptococcus agalactiae isolates from women in our
study showed resistance to Penicillin and quinolones – 38% and
58% respectively.
Conclusions: E. coli continuous to be the most common
clinical isolate in community-acquired urinary tract infections.
About 62% of E. coli isolates were resistant to Ampicillin and
Amoxicillin-clavulanate. There is comparative high resistance
to nitrofurantoin – 31% of clinical isolates. Similar distinction
in Klebsiella spp. isolates was found – 29%. Streptococcus
agalactiae strains isolated from pregnant and non-pregnant
women in our study showed high resistance to Penicillin and
quinolones.
R2091
In vitro antibiotic resistance of E. coli isolates in
community-acquired urinary tract infections
during 2001–2005
E. Ikonomopoulou, C. Verra, H. Pavlidou, K. Papadopoulos,
I. Katsarou, A. Christopoulos, D. Petropoulou, M. Gkioka,
A. Regli, N. Baikoussis (Patras, Zante, GR)
Objectives: The purpose of this study is to compare the in vitro
antibiotic resistance of E. coli isolates during 2001–2005 in
community – acquired urinary tract infections.
Methods: During 1/1/2001–30/10/2005, a total of 3262 E. coli
isolates caused community – acquired urinary tract infections
(1144 E. coli isolates during 2001–2002, 1500 during 2003–2003
and 618 during 1/1/2005–30/10/2005). Isolation was performed
by standard method. The identiﬁcation and the susceptibility
test to other antimicrobial agents were performed by the Vitek
or the mini API system (Biomerieux).
Results: The resistance of E. coli isolates to antibiotics for 2001–
2002/2003–2004/2005 respectively was: Ampicillin 32.8%/35%/
42.2%, Amoxicillin/Clavulanic acid 5.0%/2.4%/4.0%, Cefalo-
thin 11.6%/10.2%/15%, Cefotaxime 1.0%/1.5%/4.7%, Imipe-
nem 0%/0%/0%, Tobramycin 1.7%1.5%/1.0%, Amikacin 0.9%/
0.4%/0%, Netilmicin 1.0%/0.3%/0.6%, Gentamicin 2.1%/2.7%/
3.7%, Trimethoprim – Sulfamethoxazole 15.8%/16.5%/25.0%,
Nitrofurantoin 2.4%/2.5%/2.7%, Nalidixic acid 8.6%/9.2%/
12.6%, Ciproﬂoxacin 7.0%/7.7%/10.0%.
Conclusions: We noticed a rapidly increase in resistance rates
in E. coli isolates to Ampicillin and Trimethoprim–Sulfameth-
oxazole. Resistance rates to cephalosporins and quinolones were
signiﬁcant raised. Resistance to Amoxicillin/Clavulanic acid,
Imipenem, Nitrofurantoin and aminoglycosides remained
almost stable.
R2092
Quality of life in brucellosis
S. Sahan, C. Ataman Hatipoglu, C. Bulut, S. Tekin Koruk,
G. Tuncer Ertem, N. Tulek, S. Kinikli, A.P. Demiro¨z (Ankara,
Samsun, TR)
Objectives: Brucellosis is a systemic disease that may cause
several complications of different systems and it may affect
quality of life of the patients. In our study, we aim to investigate
the quality of life on patients with brucellosis. To our know-
ledge, this is the ﬁrst study that investigates the quality of life in
brucellosis.
Method: In this prospective study, 57 adult patients with
brucellosis who were hospitalized in our clinic at Ankara
Research and Training Hospital between September 2003 and
September 2004 were included. The difference between quality
of life before and after therapy was measured by using the
Medical Outcomes Study 36-Item Short Form Health Survey (SF-
36). Patients who had treatment history for brucellosis, patients
with relapsed brucellosis, and patients who have underlying
diseases like collagenous diseases diabetes mellitus, chronic
renal disease or autoimmune diseases were excluded. In our
study, we used a survey, which had two parts. In the ﬁrst part of
survey, social-demographic changes of patients and variants of
the disease were investigated while in the second part the SF-36
Health Survey was taken place. The survey was applied before
and after therapy.
Results: The differences between physical functioning, role
limitations due to physical problems, bodily pain, general
health, vitality, social functioning, role limitations due to
emotional problems, mental health points before and after
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therapy were found as statistically signiﬁcant (p = 0.000). At the
end of the study each score of 8 scales of SF-36 found as
increased. In addition to these ﬁndings, we found out that the
vitality score was higher in 56–75 age group than the others. The
physical functioning scores of patients were higher if the
patients had fever or did not have chills. The vitality scores of
patients were higher if they did not have any neurological
involvement and also higher in widows when compared to
singles. The scores of social functioning and mental health of
patients without underlying diseases were higher than those of
the patients with underlying diseases.
Conclusion: We concluded that the quality of life increases with
the therapy in brucellosis cases and the SF-36 Health Survey is
suitable to be used in brucellosis.
R2093
Prevalence of Chlamydia trachomatis in female
population in Athens, Greece
A. Georgouli, E. Chinou, M. Alexiou, Z. Chiolou,
P. Giannakakos, P. Golemati (Athens, GR)
Chlamydia trachomatis is a common sexually transmitted patho-
gen in developed countries. It causes genital tract infection in
both men and women, leading to sometimes serious conse-
quences such as infertility, ectopic pregnancy and chronic pelvic
pain. Infection with C. trachomatis is often asymptomatic,
delaying its diagnosis and treatment.
Objectives: To determine the incidence of Chlamydia trachomatis
(CT) in women who attended the Outpatient Dept of our
hospital, for their routine annual visit.
Material and methods: A total of 2.528 women were studied for
the presence of Chlamydia trashomatic in their endocervical
samples. Two age groups were studied: group A 20–40 years
(n = 1138) and group B 40–60 years (n = 1390). CT detection was
conﬁrmed by direct immunoﬂuorescence method using a
monoclonal antibody against MOP antigen of the microorgan-
ism.
Results: CT was detected in 233 out of 2.528 samples (9.2%).
The percentage of CT detection was 13% (149/1138) in group A
and 6% (84/1390) in group B. It is worth to note that a
percentage of 72% of the infected women (168/233) were
asymptomatic.
Conclusion: The Chlamydia trachomatis infection is common and
largely asymptomatic, so early detection strategies with screen-
ing programs among young women are important in prevention
and control.
R2094
Characteristics of 102 tetanus cases in southeast
region of Poland
A. Kalinowska-Nowak, A. Garlicki, M. Bocizga-Jasik, T. Mach
(Cracow, PL)
Introduction: Tetanus is acute infectious disease caused by
anaerobic Gram-positive rod Clostridium tetani. Disease is
affecting nonimmunised persons after inoculation of wound
with Clostridium tetani spores, which are present in the soil.
Regular immunisation with tetanus vaccine is the only effective
way of prophylaxis against this disease. The morbidity rate in
Poland is low (0.004/100 000 citizens). Mainly old people, from
rural region of Southeast part of the country are affected.
Material and methods: 102 patients with tetanus, hospitalized
in the Department of Infectious Diseases of the Jagiellonian
University Collegium Medicum between 1995 and 2004 were
investigated.
Results: Among hospitalised patients 48 (47%) were men, 54
(53%) were women, age ranged from 45 to 90 years (mean age
71 years). 26 patients were younger than 65 years old, and 75
were older than 65. 17 (16%) were town citizens, 85 persons
(84%) were from rural area. Wound caused by injury was the
portal of entry in 89 cases, in 12 patients infection was associated
with chronic varices ulcerations, and in few cases with chronic
skin ﬁstula and animal bite. Only 8 patients visited doctor after
injury, no one has received accurate post exposure prophylaxis.
5 (5%) patients developed localised tetanus, benign course of the
disease was observed in 29 (29%) patients, 68 (67%) had severe,
generalised tetanus. 34 (34%) of patients died, among them 31
were older than 65 years.
Conclusions: 1. Tetanus is mainly observed among old patients.
2. Lack of medical consultation after injury is the principal
reason of tetanus occurrence among non-immunised individu-
als. 3. Active immunisation against tetanus, especially in rural
area should be propagated.
R2095
Temporal trend of health care needs of
extra-European Union citizens coming from
developing countries admitted to a large hospital
in Northern Italy, 1999–2004. Focus on infectious
diseases among 6003 assessed hospitalisations
S. Sabbatani, E. Baldi, R. Manfredi (Bologna, IT)
Objective: All hospitalizations of foreign patients (p) coming
from extra-European Union developing countries during the last
6 years was performed.
Methods: Data regarding foreign p admitted at all Divisions in
the period 1999–2004 were extracted focusing on infectious
diseases (ID)-related diagnoses.
Results: P aged ‡14 years had 6003 admission and 7231 overall
diagnoses. During the 6-year study period, female hospitaliza-
tions had a steady increase with a peak in 2002 (p < 0.001). This
trend is due to the rise of women from Eastern Europe
(p < 0.001) which occurs at a younger mean age vs that of
males (p < 0.001). The admission of clandestines carried out on
emergency basis, accounted for a mean 9.4%. This phenomenon,
very frequent in 1999 (43% of admissions), had a dramatic drop
since 2002 (p < 0.001) depending on an appropriate deed of
indemnity Italian law. The prevalent women diagnoses were ob-
gyn ones: voluntary pregnancy interruption, spontaneous
aborption or pregnancy complications in 30.6% of p and
childbirths or controls of pregnancies with a favourable outcome
in 18.2% of p. These diagnoses covered nearly 50% of
hospitalizations of migrant women: other admissions were
due to organic, dysmetabolic, or functional disorders while ID
(4.6%) were less frequent. Among men, dysmetabolic disorders,
organic-degenerative diseases, or functional illnesses (36.2%)
were prominent and signiﬁcantly more frequent vs women
(p < 0.001), as well as post-traumatic diseases (16.5%) and ID
(12.1%; p < 0.001). Also generic-undeﬁned diagnoses were
proportionally numerous (6.6% of diagnoses): cultural-language
deﬁciencies strongly affected the physician-patient relationship.
Among ID the main causative organisms were Myc. tuberculosis
(14.9%), HIV (7.1%), HBV (3.3%), and HCV (2.6%). Upper-lower
airways represented the most involved organ system (45% of
discharges) followed by the gastroenteric tract (16.4%) and skin-
soft tissues (7.4%) while systemic ID accounted for 14.9% of
episodes. Such disorders predominated (up to 90% of cases)
among non-regular migrants during years 1999–2000, while
after 2002 an increase of ID was observed among p from Eastern
Europe.
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Conclusions: From an health care-social perspective, although a
reduced incidence of ID did not occur during time, the
possibility to attribute them to p of ascertained identity and
housing makes possible to trace index p towards well-planned
and effective therapeutic-preventive interventions.
R2096
Systematic review of fever of unknown origin in
Turkey
O. Sipahi, S. Senol, G. Arsu, H. Pullukcu, M. Tasbakan,
T. Yamazhan, B. Arda, S. Ulusoy (Izmir, TR)
Objectives: In this study it was aimed to review the adult fever
of unknown origin literature from Turkey systematically.
Methods: To ﬁnd out the published series three national
databases (Ulakbim Turkish Medical Literature database,
http://www.turkishmedline.com, http://medline.plek-
sus.com.tr) and two international databases [Pubmed and
Science Citation Index (SCI)] were searched. Keywords for
national databases were ‘‘nedeni bilinmeyen ate’’ or ‘‘nba’’ or
‘‘fever of unknown origin’’ or ‘‘pyrexia of unknown origin’’ or
‘‘fuo’’ or ‘‘puo’’. Keywords for Index Medicus and SCI were
(‘‘fever of unknown origin’’ or ‘‘fuo’’ or ‘‘pyrexia of unknown
origin’’ or ‘‘puo’’) and Turkey. In addition articles, which were
cited by the extracted published articles were included in the
study. In case of presentations from a single study with
intersecting periods, the one with longer period was chosen.
Articles published before 1990, paediatric series, series below 5
patients were excluded. Fever of unknown origin (FUO) was
deﬁned as fever over 38.3C, that continues at least for 3 weeks,
with no diagnosis reached after 1 week of inpatient investiga-
tion in all series (Petersdorf and Beason criteria).
Results: Data for 726 patients with the diagnosis of fever of
unknown origin were obtained from 11 articles. Infections,
collagen vascular diseases and neoplasms were found to be the
reason of fever in 345 (%47.5), 114 (%15.7) and 110 (%15.1) of 726
patients. The most common infectious disease was tuberculosis
(131/345, %37.9) followed by brucellosis (52/345, %15.0) and
infective endocarditis (27/345, %7.8). The most common colla-
gen vascular disease was adult-onset Still’s Disease (46/114,
%40.3), followed by vasculitic syndromes (22/114, %19.2) and
SLE (18/114, %15.7). The most common neoplasm was Hodg-
kin’s disease (29/110, %26.3), followed by non- Hodgkin
Lymphoma (28/110, %24.5) and solid tumours (12/110,
%10.9). Reason of fever could not be deﬁned in 116/726
(%15.9) patients. The invasive procedures helped diagnosis in
(234/726, %32.2) patients.
Conclusion: An infectious disease, especially tuberculosis and
brucellosis, remains a common cause of FUO, in Turkey.
Although several diseases may lead to FUO, lymphomas,
Adult-Onset Still’s Disease and particularly tuberculosis
should be considered in the differential diagnosis of a patient
admitted with FUO. Biopsy, aspiration, serology, bacteriology,
radiology and observation of the clinical course were the most
useful diagnostic procedures.
R2097
Relationship between Chlamydia pneumoniae
seroprevalence and reproductive health of female
health care workers
T. Yavuz, I. Ozdemir, P. Arbak, M. Behc¸et, E. Sert (Duzce, TR)
Objectives: To evaluate the relation between infectious agents
and reproductive health hazards of health care workers
(HCWs), a cross-sectional study consisted of 73 HCWs and 65
bureau workers were designed.
Methods: Reproductive health problems of both groups were
compared with a questionnaire, and then serologic examinations
for Chlamydia pneumoniae IgG, IgA and IgM were performed by
indirect immunoﬂuorescence assay.
Results: The mean age of HCWs (32.9 ± 5.4 years) is lower than
that of the controls (38.0 ± 5.9 years) and the difference was
statistically signiﬁcant (p < 0.05). Most of the HCWs (56/91)
were positive for Chlamydia pneumoniae IgG whereas approxi-
mately half of the controls (25/54) were positive but the
difference was not statistically signiﬁcant (p = 0.053). According
to the presence of Chlamydia pneumoniae IgA, no signiﬁcantly
difference was found between HCWs (46/91) and controls (20/
54). Six HCWs were positive for Chlamydia pneumoniae IgM
while none of the controls were positive. Smoking rates were
similar between HCWs (25/91) and controls (19/54). The mean
weight of the children of subjects positive for Chlamydia
pneumoniae IgG (2896.4 ± 511.7 gr) was statistically signiﬁcantly
lower than that (3656.8 ± 398.5 gr) of subjects negative for
Chlamydia pneumoniae IgG. Preterm birth was signiﬁcantly
(p = 0.02) higher in subjects positive for Chlamydia pneumoniae
IgG (20/91) than in subjects negative for Chlamydia pneumoniae
IgG (4/54).
Conclusion: These data showed that HCWs had a high rate of
C. pneumoniae seropositivity and the rate of low birth weight was
associated with this infection. We considered that future studies
should be focused on the relation of infectious diseases and
reproductive health problems of the HCWs.
R2098
Menengitis caused by Streptococcus pyogenes in a
previously healthy woman
M. Ulug, M.K. Celen, C. Ayaz, M.F. Geyik,
S. Hosoglu (Diyarbakir, TR)
Objectives: Streptococcus pyogenes is a wellknown cause of
variety clinical expressions including local symptoms like
tonsillopharengitis, cervical lymphadenitis, otitis media, cellu-
lytis, eryspelas and more severe diseases like scarlet fever,
osteomyelitis, necrotizing fasciitis, sepsis or the toxic shock
syndrome. Streptococcus pyogenes is not well recognised as a
cause of bacterial menengitis, although there are several report-
sin the literature over the last years. Because of this reason we
reported a case of Streptococcus pyogenes menengitis here.
Case: A forty-year old previously well woman presented a
history of fever, headache, vomiting and sore throat of 3 days
duration. On physical examination, she was unconscious, with a
poor general condition. The temperature was 38.5C, pulse rate
96/minute, respiratory rate 48/minute and blood pressure was
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110/60 mmHg. Examination of the respiratory system, cardi-
vascular system and abdomen were found to be normal.
Neurological examination revealed diminished consciousness
and neck rigidity. Laboratory investigations revealed a haemo-
globin 8.3 g/dl and total leucocyte count of 22700/mm3 (poly-
morphs 94%), C reactive protein was elevated up to 351 mg/dl,
ESR was 57 mm/h. Serum electrolytes, renal and liver function
tests were within normal limits. The cerebrospinal ﬂuid (CSF)
was turbid, with 10000 leucocytes/mm3 (%95 polymorphs and
%5 lymphocytes). The CSF sugar was 61 mg/100 ml and
proteins were 474 mg/100 ml. Direct examination of CSF
showed Gram-positive cocci and diplococci, and cultures
yielded Streptococcus pyogenes. Also her blood cultures yielded
growth of Streptococcus pyogenes too. She was treated initially
with ceftriaxone (4 gr/day). Control lumber puncture was done
at the third day of the treatment, but there was no change in CSF
examination. So vancomycin was added to the treatment. But
she died at the fourth day of the treatment.
Conclusion: Streptococcus pyogenes menengitis is not a compli-
cation of invasive GAS diseases but usually occurs in association
with other illness such as otitis media, pharyngitis or head
trauma. Streptococcus pyogenes menengitis is uncommon and the
incidence seems to be persistently low, neverthless, clinicians
should be aware that sporadic cases may occur and may have a
fulminant course with relevent neurolological sequelae.
R2099
Osteoarticular complications of brucellosis:
evaluation of the clinical, laboratory and
radiological ﬁndings of 19 patients
O. Ural, D. Findik, G. Ural, U. Arslan (Konya, TR)
We carried out a retrospective study of 58 in or outpatients with
brucellosis in our hospital. We evaluated the osteoarticular
involvement, involvement sides, clinical specialities, relapse
ratios and response to therapy. Of the 58 brucellosis patients
who had therapy during the last ﬁve years 19 (32.7%) had
osteoarticular complications. Eleven (57.9%) of the patients were
female and 8 (42.1) male. Sacroiliac joint was the most frequent
involved side found in 11 (57.9%) cases, followed by spondylitis
in 6 patients (31.6%) and knee joint involvement in 2 patients
(10.5%). These patients were prescribed a 6–12 weeks course of
streptomycin, doxycycline and rifampicin. During the follow-up
period after antibiotic therapy relapse was seen in two patients
with osteoarticular involvement. These two patients was taken
under therapy again for 12 weeks with doxycycline and
rifampicin combination. After the treatment of these two
patients, no relapse or damage was encountered in all of the
patients.
R2100
Epidemiology of acute cystitis: the ﬁrst Russian
multicenter study
V. Rafalskiy, O. Romanenkova, N. Sudilovskaya, S. Chemesov,
L. Emelyanova, I. Asisov (Smolensk, Ekaterinburg, RU; Karaganda,
KZ)
Objectives: To evaluate prevalence of AC among young
women in Russia and their behaviour when AC episode
appeared.
Methods: Questionnaire design study was carried out among
students in three Russian and one Kazakhstan cities – Smolensk,
Krasnoyarsk, Yekaterinburg, Karaganda. Questionnaire con-
tained 19 questions concerning frequency of AC onset during
the last year, data about AC relapsing, sexual activity, visits to a
physician for AC management, possible self-treatment of AC,
concomitant diseases and family history of UTI.
Results: 660 females (mean age 19.2 ± 4.3, median – 18.0 years)
were included in the study. Symptoms of AC noted 126
responders (19%), mean age of respondents with symptoms of
AC was 20.9 ± 5.5, median – 19.0 years. Among women with
AC history 32.5% had 1 episode of AC during the year, 15.9% – 2
episodes, 8.7% – 3 episodes, 4–6 episodes had 4.8%, more than 6
episodes – 4.8% of respondents. Duration of AC signs in 50.8%
of respondents was 1 to 3 days, in 23% – 3–5 days, in 9.5% – 5–
7 days, in 4% – 7–10 days, in 8% – 10–14 days. Among women
with AC 44% did not miss their studies or work when AC
appeared, 17.5% could not attend studies or work during 1–
3 days, 6.3% – during 3–5 days, 6.3% – during 5–7 days, 1.6% –
during 7–10 days, >10 days – 2.4% of respondents (ﬁg 1). Family
history of UTI was noted in 46% women with AC and only in
17.9% of respondents, who had never suffered from AC. 35.7%
of women with AC had never had sexual intercourse whereas
60.3% of respondents with AC history had sexual activity.
Number of intercourse per month during last year were in
women with AC history - &#8804; 1 in 11.9%, 1 to 5 – 12.7%, 6 to
10 – 11.1%, 11 to 20 – 11.9%, every day – 8.7% and in women
without AC history: &#8804; 1 – 4.9%, 1 to 5 – 8.5%, 6 to 10 –
5.7%, 11 to 20 – 5.5%, every day in 3.0%. When AC appeared
18.6% of respondents do not seek for medical care, 21.4% were
consulted by non physician (relatives, friends, etc.), and only
60% were under appropriate medical care – 17.1% were
consulted by gynaecologist, 15% – by outpatient urologist,
11.4% – GP, 4.3% – pharmacist, 0.7% – nephrologists, 11.4% –
other physicians.
Conclusion: AC affects 19% of young women in Russia and
Kazakhstan and 34.2% of women have relapses observed during
the year. Risk factor for development of AC is sexual activity
and positive family history of UTI. When AC appeared 18.6% of
respondents do not seek for medical care at all, and only 60% are
under appropriate medical care.
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Emerging infectious diseases
R2101
Review of infections due to Pseudallescheria
boydii
R. Horre, N. Schnitzler, T. Grueger, S. de Hoog, J. Guarro for the
ECMM Pseudallescheria/Scedosporium Infection Working Group
Infections due to Pseudallescheria boydii (Scedosporium apiosper-
mum) are known already since 1899. An analysis of 528
published cases in humans was performed to reveal the
spectrum of disease, risk factors, geographic distribution and
outcome of infection. Initially the fungus was observed mainly
as a cause of mycetoma in temperate climate zones after
traumatic inoculation. Since the seventies of the previous
century, other disease entities have become preponderant.
Particularly pulmonary infections in immunocompromised
patient became relatively frequent, so that the species can be
viewed as a truly emerging fungus in the growing hospitalised
population with severe immune disorders. However, two
disease entities are noted in patient populations without
apparent changes in frequency. The species regularly colonises
lungs of patients with cystic ﬁbrosis, but thus far escaped
attention because its presence was concealed by co-occurring
Aspergillus fumigatus. Another, unique syndrome is delayed
cerebral infection after near-drowning. Since it is unlikely that
the frequency of P. boydii in surface waters, lakes and ditches has
increased dramatically since 1970, we have to assume that also
this clinical picture has long been misdiagnosed. Given the low
susceptibility of the fungus against current antifungals, devel-
opment of proper diagnostics for P. boydii is highly signiﬁcant.
R2102
Alkhurma haemorrhagic fever virus, an emerging
tick-borne ﬂavivirus with high fatality rate in
Saudi Arabia
R.N. Charrel, S. Fagbo, S. Temmam, A.M. Zaki, X. de
Lamballerie (Marseille, FR; Jeddah, SA)
Alkhurma haemorrhagic fever virus (AHFV) has been ﬁrst
isolated in 1995 (reported in 1997) from patients presenting with
either hemorrhagic fever or central nervous system manifesta-
tions. We present here a review of most of the cases reported to
date in patients with emphasizing the clinical, biological and
epidemiological data. Fatality rate is 25% which represents the
most deadly ﬂavivirus recognized at this time.
Objectives: To investigate the transmission routes of AHFV; to
better understand the microevolution of AHFV in Saudi Arabia.
Methods: Ticks were collected in different regions of Saudi
Arabia, identiﬁed using morphological keys and sequencing,
and tested with Flavivirus generic primers. Biological material
found to be positive by PCR ampliﬁcation was sequenced for
ﬁnal identiﬁcation, and used to attempt viral isolation onto Vero
cells and/or via intracerebral inoculation to suckling mice.
Results: One tick (Ornithodoros savignyi) collected from a camel-
resting place near the city of Jeddah was found to be positive for
AHFV RNA. Full coding sequence of one isolate of AHFV (the
ﬁrst one to be detected in ticks) was determined and sequence
analysis was performed for comparison with sequences derived
from human specimens aiming at a better understanding of
AHFV phylogeny and evolution. Different aspects of the
potential transmission routes for AHFV will also be addressed.
Field evidence for the tick-borne transmission of AHFV will be
presented; Additional results provided by tick collection cam-
paigns that are currently organized will be performed. Addi-
tional investigation of the microevolution will be presented
based on human sequences determined in samples collected
over the last 7 years.
Conclusions: Although AHFV is the most deadly ﬂavivirus to
circulate in the world, few investigation have been performed to
date. In these times of surveillance of viruses candidate for
bioterrorism use, a better knowledge of AHFV natural history
and epidemiology is required, as well as a development of
collaborative studies intending to ﬁeld investigation of the
medical, veterinary and entomological aspects.
R2103
Comamonas testosteroni bacteraemia and
perforated acute appendicitis in a patient
M. Gul, P. Ciragil, E. Bulbuloglu, M. Aral, F. Ezberci, S. Alkis
(Kahramanmaras, TR)
Objectives: Comamonas testosteroni (C. testosteroni) is an uncom-
mon isolate in the clinical laboratory as a human pathogen.
However the organism is found worldwide in environmental
sources such as soil and water. We report in our hospital a case
of bacteraemia in patients with perforated acute appendicitis
due to this organism.
Case report: A 22-year-old man; presenting with onset of
abdominal pain as bilateral ﬂank pain followed by periumbilical
localizationofpain, anorexia, nauseaandvomitting.At the timeof
application, he was looking moderate, cooperated and oriented.
Laboratory values are: haemoglobin 15.2 gr/dl, haematocrit
44.9%, leucocyte count 12.000/mm3, differential white count
shows 91.2% neutrophils, 7.0% lymphocytes, 1.8% monocytes.
Blood cultures were incubated in BACT-Alert 3D (bioMe´rieux,
France). Twenty-four hours later the growth from two bottleswas
identiﬁed as C. testosteroni and antibiotic susceptibility test was
performed using the Mini API system (BioMerieux, France). The
resultswere conﬁrmedby conventionalmethods. The patient had
been taken for laparotomy with suspicion of acute appendicitis
and the diagnosis was perforated appendicitis. Before the opera-
tion cefazolin (3 · 1/day) was given to patient. Gram-negative
bacilli and leucocytes were seen in Gram stain of intra-abdominal
ﬂuid taken during operation. In the culture of this ﬂuid the
microorganism was also identiﬁed as C. testosteroni.
Conclusions: For effective therapy; it is useful to know that
C. testosteroni bacteraemia may accompany acute appendicitis
and intra-abdominal perforation cases. It is important for
clinicians to recognize the spectrum of infections that C.
testosteroni is capable of causing, as well as similarities and
differences between these infections. In these regards, our case
report and review of the literature are helpful.
R2104
First serological evidence of spotted fever group
rickettsioses in Taiwan
J-S. Ma, Y-J. Lau, P-Y. Chen, G. Dasch, M. Eremeeva,
A. Loftis (Changhua City, Taichung City, TW; Atlanta, US)
Objectives: To investigate the sero-prevalence of spotted fever
group (SFG) rickettsiae and provide the evidence of SFG
rickettsioses existence in Taiwan, we conducted a retrospective
serosurvey among 553 residents for antibodies against Rickettsia
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conorii, Rickettsia typhi, and Orientia tsutsugamushi by using
indirect immunoﬂuorescence assay (IFA) and enzyme-linked
immunosorbent assay (ELISA).
Methods: A total of 653 sera (453 un-paired sera from healthy
population and 200 paired sera from 100 febrile patients with
clinical suspicion of rickettsial diseases) were tested. IFA and
ELISA were used to detect IgG antibodies against R. conorii
(strain Malish), R. typhi (strain Wilmington), and O. tsutsuga-
mushi (strain Karp). The positive ELISA screening results were
further conﬁrmed by IFA. A serum titre ‡1:40 is considered as
positive and serial dilutions are further tested only in febrile
population to determine the end titre.
Results: Twenty, 26, and 33 out of 453 (4.4%, 5.7%, and 7.3%)
sera in healthy group and 21, 8, and 24 of 100 febrile patients
were positive for IgG antibodies against R. conorii, R. typhi, and
O. tsutsugamushi, respectively. Three patients were demonstra-
ted to have 4 folds or more elevation of anti-R. conorii IgG titres.
There were 20 out of 553 (3.6%) objects had antibodies against at
least 2 of the tested antigens.
Conclusion: Spotted fever group rickettsiosis (SFG) has been
considered as a worldwide new emerging infectious disease.
Seroepidemiologic data and conﬁrmed cases have been reported
in several countries in Asia. To our knowledge, there is no
conﬁrmed case of SFG rickettsiosis reported in Taiwan. The
sero-prevalence rates were 4.4%, 5.7%, and 7.3% in healthy
population and 21%, 8%, and 24% in patients with clinical
suspicion of rickettsial diseases for SFG rickettsioses, murine
typhus, and scrub typhus, respectively. These data suggest that
rickettsial diseases are prevalent in Taiwan. We believe that
these are ﬁrst serological evidence of SFG rickettsoses in Taiwan.
Because of signiﬁcant overlapping in clinical aspects and
serological cross-reactivity among these rickettsial diseases, we
suggest routine testing of antibodies to SFG rickettsiae, in
addition to R. typhi and O. tsutsugamushi for patients with
clinical suspicion of rickettsial diseases in Taiwan. Further
studies for detecting the prevalent species of SFG rickettsiae in
Taiwan are warranted for more speciﬁc testing in future.
R2105
Staphylococcus aureus small colony variant in
patients with cystic ﬁbrosis in Genoa, Italy
G. Manno, M. Mentasti, P. Morelli, E. Poggi, A. De Alessandri,
R. Casciaro, G. Cangemi, E. Di Marco (Genoa, IT)
Background: small colony variants (SCV) are intracellular,
auxotrophes, slow-growing subpopulations of Staphylococcus
aureus (SA), with reduced antibiotic susceptibility, wich can
cause persisting and relapsing infections in CF patients (pts).
Aims Determine prevalence, pts clinical predisposing condi-
tions, microbiological characters and antibiotic susceptibility of
SASCVs strains in CF pts attending the Genoa Centre in 2004.
Methods: SA and SASCV isolates were recovered from sputa
and throat swabs in Mannitol Salt Agar after 48 h at 35C and
identiﬁed by latex agglutination, coagulase test tube, API Staph
system with 48 at 35C and ampliﬁcation of speciﬁc SA-nuc
gene.Auxotrophism was assessed by testing thymidine (T)
haemin and menadione disks. Methicillin susceptibility was
assessed by cefoxitin disk diffusion in Mueller Hinton medium
with 5% blood and conﬁrmed by mecA gene. In pts colonised
with SASCV antibiotic treatment courses before SASCV recov-
ering, variation in FEV1 and BMI were determined.
Results: 25/199 pts had stable SASCV. SCV+ normal SA were
recovered from 14 pts. 11 pts harboured only SCV. 21/25 pts
with SASCV were colonised also by P. aeruginosa. 20/21 SCVs
were T-dependent and only 1 was haemin-dependent; 36% of
strains were methicillin resistant. Before ﬁrst SASCV recovering,
pts had therapy courses with: 11/25 nebulised aminoglico-
sides + varius, 8/25, nebulised aminoglicosides + cotrimossaz-
ole and 4/25 cotrimosazole + various. Pts receiving nebulised
tobramycin were 60%. No signiﬁcant differences in FEV1 and
BMI before and after SASCV sputum recovering were found.
Conclusions: Our data show an increasing occurrence of
SASCV in 2004 (12.5%) compared with previous years (7% in
2000); this ﬁnding could be related to the antibiotic pressure
together with the lung predisposing condition in pts with long
term SA colonisation. Moreover, SASCV could spread among
pts, so accurate microbiological protocols for detection and
antibiotic susceptibility testing are critical.
R2106
Salmonella typhi meningitis complicated with
subdural empyema: a case report
O.C. Aktepe, A. Aslan, A. Bu¨ku¨lmez, O. Eser (Afyon, TR)
Objectives: Intracranial infections caused by Salmonella species
are uncommon. The authors report a case of the rarely
encountered Salmonella typhi subdural empyema following
meningitis.
Case description: A 11-month-old boy was admitted to our
hospital because of fever, despite one week antibiotherapy, and
neurologic irritability. The patient had sign and symptoms of
increased intracranial pressure and progressively change in
mental status. S. typhi was isolated from consecutive two CSF
culture, but haemocultures were negative. Radiologic examina-
tion demonstrated the development of subdural empyema. The
children was discharged without neurologic deﬁcit, after a
10 week intensive antibiotherapy with shunt operation.
Conclusions: S. typhi should be included in the differential
diagnosis of meningitis, and even for subdural empyema,
particularly in children from areas in which salmonellosis
endemic. The reduce morbidity and mortality in such cases,
prolonged antibiotherapy is essential with surgical intervention.
Infection control
R2107
Identiﬁcation of Streptococcus mutans with
antagonic effect
F. Gamboa, M. Chaves, C. Lamby, A. Fajardo, A. Arevalo
(Bogota, CO)
Dental caries is an infectious process that ends destroying the
tooth. Streptococcus mutans is considered the main agent causing
this disease. The search for microorganisms with antagonic
action on S. mutans can be an alternative, which might avoid or
control this disease.
Objectives: To identify S. mutans strains with antagonic effect
upon S. mutans.
Methods: Saliva samples were taken in 66 children and
cultured on Blood agar and Mitis Salivarius Bacitracin agar.
After incubation at 37C in anaerobic atmosphere for 48 hours, a
bacterial recount was made and the compatible colonies with S.
mutans were subjected to biochemical tests. The determining of
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the antagonic effect was made using the technique of double
layer in agar.
Results: In children with and without caries, the frequency of S.
mutans was, respectively, 91.7% and 96.7%. In the group of
patients without caries, only two strains got no antagonic action,
three strains got full antagonic action (100%), and the remaining
presented different ways of inhibitory action. In the group of
patients with caries only 5 strains didn´t have any antagonic
action, 32 strains had full antagonic action (100%), and the
others strains had variable inhibitory action.
Conclusions: Were identiﬁed 112 S. mutans strains with great
antagonic potential, which after accomplishing other require-
ments could be used in prevention or caries control strategies.
R2108
Infection control practice in forensic medicine
B. Aydin, E. Tanyel, B. Colak, N. Fisgin, N. Tulek (Samsun,
Kocaeli, TR)
Objectives: Forensic medicine workers have greater occupa-
tional risk for infectious diseases because of unique character-
istics of forensic autopsy practice. In addition of needles and
scalps, they are exposed to broken glass, bone shards and
fragmented projectiles, as well as large amount of blood and
open tissues on a daily basis. In this study, we aimed to evaluate
the infection control measures and implementations in forensic
medicine practice in Turkey.
Material and method: Between April–June, a questionnaire
survey on infection control measures was mailed to Forensic
Medicine doctors. The questionnaire consisted of 36 questions
that were designed based on Universal Precautions and
protective barriers for Forensic Medicine practice. The compli-
ance with precautions and conditions during performance of
death body examination, transportation and autopsy and
vaccination status were evaluated. Data were analysed by
using Epi-Info pragramme(version 5.0).
Results: Totally 111 doctors from 27 cities were responded the
questionnaire. Their autopsy number average per month was
21.0 ± 27.7 (0–160), death body examination was 9.2 ± 11.8 (0–
55). 43.2% of doctors were doing death body examination in
somewhere. Percentage of wearing glove, mask, special clothes
and use of handwashing/disinfectant were 81.5%, 63%, 54.3%,
and 81.5 respectively in ﬁeld. Percentage of wearing mask,
protective eyewear, special gloves and boats were 59.6%, 25.5%,
72.3%, 61.7%. There was only two negative pressure room in
between 27 institutes or department. 78.4% of doctors were
vaccinated against hepatitis B and 44.1 % of applied tetanus
booster dose.
Discussion: According to the results, we need national stand-
ards and implementations against infection risk in Forensic
Medicine practice.
R2109
Surveillance of intensive care associated
infections in Scotland
J. McCoubrey, J. Reilly, M. Booth, F. MacKirdy, A. Timmins
(Glasgow, UK)
Objectives: To evaluate the feasibility of carrying out surveil-
lance of ICU acquired infection (ICUAI) in Scotland (i) using the
HELICS surveillance protocol and deﬁnitions, and (ii) an
existing electronic system for data collection.
Methods: Patient based surveillance comprising of HELICS
Level 2 surveillance of Blood Stream Infections (BSI), Catheter
Related Infections (CRI) and Ventilator Associated Pneumonia
(VAP) was piloted for a minimum of two and a maximum of
three months between 01/05/2005 and 31/08/2005 in ﬁve ICUs
in Scotland. ICUAI surveillance data were collected through the
existing Ward Watcher audit system currently in place in all
ICUs throughout Scotland. Amongst the data collected in Ward
Watcher are demographics, diagnoses and severity of illness
scores. Ward Watcher has been developed to facilitate the
collection of the additional data items required for surveillance
of ICUAI according to the HELICS protocol. The surveillance
methods were evaluated by means of several questionnaires that
were sent to key contacts at all pilot sites in order to determine
their opinion and experience with various aspects of the study.
These included surveillance methodology, applicability of the
HELICS protocol and deﬁnitions and the data collection system.
Daily deﬁned dose (DDD) data for all antibiotics dispensed to all
ICUs in Scotland between April 2004 and March 2005 were
collated to provide a measure of antibiotic use in the ICU.
Results: During the pilot period a total of 386 patients were
admitted to the 5 pilot sites that participated in the pilot study,
199 patients stayed for two days or more. A total of 32 (16%)
patients developed 44 episodes of infection according to the
HELICS infection deﬁnitions. Data collection using the existing
electronic data collection system was simple and straightfor-
ward and the quality of the data was deemed to be acceptable.
The HELICS infection deﬁnitions for pneumonia, BSI and some
CRIs were applicable in all pilot sites. Local and General CVCRI
criteria were not applicable in all hospitals due to the diagnostic
testing procedures carried out in some laboratories.
Conclusion: Surveillance of infections acquired in ICU in
Scotland using electronic data capture and the HELICS deﬁni-
tions for infection is a feasible process with a minimal require-
ment for additional staff resources. Collection of dispensed
DDD for all hospitals in Scotland is feasible and could contribute
to our understanding of antimicrobial resistance.
R2110
Diving suit: sterile, ambulatory, personal device
for protective and preventive isolation of
nosocomial invasive fungal infections in
neutropenic patients hospitalised in laminar air
ﬂow room who need a disruption of isolation
A. Thiebaut, M. Perraud, D. Lyonnet, S. Ozil (Lyon, FR)
Background: Patients with long neutropenia present high risk
to develop invasive pulmonary aspergillosis (API) of poor
prognosis. Pulmonary computed tomographic Scan (CT scan)
allows earlier diagnosis of API and improve management in
these patients (D. Caillot, JCO, 1997). However, CT scan need an
isolation breaking which is potentially dangerous. We propose a
diving suit to maintain the preventive isolation.
Materials and methods: The diving suit is sterile, personal,
ambulatory and transparent to permit monitoring, visual and
conversational contact. It is supplied with air with a self-
contained station of ventilation (12 hours). The air contamin-
ation is controlled with 2 HEPA ﬁlters. Fifteen patients treated
for haematologic malignancies like acute leukaemia have tested
it after giving inform consent.
Results: The diving suit has been validated for air contamin-
ation, physiological (CO2), CT scan feasibility and patients
acceptation. All patients (5 male, 10 females) presented a severe
neutropenia (PMN <0.5 G/l during more than 10 days) at time
of CT scan. Three patients have had already pulmonary CT scan
before using diving suit and 2 claimed to be claustrophobic. No
patient describe dyspnoea, neither pain nor discomfort. All
patients felt reassured and agreed for a new CT scan with this
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clothing. Two patients have had another CT scan with diving
suit for suspicion of pulmonary aspergillosis. Diving suit was
very easy to manipulate and did not disrupt monitoring or
treatments administration. Diving suit was also compatible with
Doppler and Radio Magnetic Nuclear. For one of these patients
with fever resistant to antibacterial treatment, 3 thoracic CT scan
were performed (1 per week) without any sign of API. The
fourth CT scan allowed the diagnosis of API with halo sign. This
diagnosis has been demonstrated by histology after surgery. In
this case report, contamination has not been possible during ﬁrst
CT scan because of the diving suit, this information is very
important to explain to the patient and his family.
Conclusion: Pulmonary CT scan needs very often to be
performed in neutropenic patients to assess API diagnosis. An
ambulatory, personal protective clothing allows no disruption of
isolation for immunocompromized patients during a CT scan. It
can also be proposed for medical staff protection when treating
patients with SARS or other highly contagious agents.
R2111
Prevention of infections caused by showers
L.P. Andersen, L. Junker, M. Meyer, M. Høg, B. Rubenhagen
(Copenhagen, DK)
Introduction: In clinical settings with immunocompromized
patients infections caused by shower water, not only Legionella
spp. but also Pseudomonas-like water contaminants, is evident.
Material and methods: Different methods for water decontam-
ination (heat, chemical, ﬁltration) were investigated for the effect
of contamination of water. Shower heads with ﬁlters were
installed in two departments to investigate the effect on the
incidence of infections caused by water-related bacteria one year
before and during the use of ﬁlter shower heads. Water samples
were concentrated by ﬁltration and examined for total germ
count, identiﬁcation of pathogenic bacteria and Legionella count
regularly (time-scedule depend on the experiment).
Results: Shower heads and shower tubes were highly contam-
inated 48 hours after heat decontamination as well as chemical
decontamination. Shower with ﬁlter reduced the bacteria from
water signiﬁcantly, but became increasingly contaminated with
skin bacteria followed by water bacteria after one week. By
adding decontamination of the shower heads with alcohol
before use this contamination was almost reduced completely
for the ﬁrst two weeks. The number of infections related to water
bacteria were low both before and after use of ﬁlters and even
though the number of infections decreased in the departments it
was not signiﬁcant.
Conclusion: Ordinary shower heads and tubes should be heat
decontaminated daily to keep an acceptable low number of
bacteria in shower water. Alternatively shower heads with
ﬁlters can be used at least two weeks if they are decontaminated
with alcohol before use.
R2112
How to decrease device-associated urinary tract
infections in adult intensive care units?
H. Erdogan, A. Erdogan, H. Arslan (Antalya, Ankara, TR)
Introduction: In year 2003, we found that our device-asssociat-
ed urinary tract infection (UTI) rates were considerably higher
than those reported by intensive care units (ICUs) participating
in the National Nosocomial Infections Surveillance System
(NNIS). We aimed to decrease the high device-associated UTI
rates.
Methods: We performed a prospective NI surveillance study in
three adult ICUs, total 15 bed capacity, in Baskent University
Alanya Hospital from January 2003 through October 2005.
Nosocomial infections were identiﬁed using the NNIS deﬁni-
tions. The ICU staff was trained for the prevention of UTI.
Infection control strategies with device insertion and mainten-
ance practice were also checked. To facilitate hand washing we
replaced the old water taps with the new ones with electronic
taps. Manuspray was used more effectively.
Results: From 2003 to 2005, the urinary catheter utilization rates
were 0.76; 0.76; 0.74 and the urinary tract catheter-associated
infection rates were 19.1;13.6;4.8 per 1000 catheter days, respect-
ively.
Conclusion: Hand washing, gloves, and universal precautions
are extremely important to minimize device-associated UTI and
clusters.
R2113
The effect of air ionisation on microbial content
of the air
A. Javadi, M. Mohseni, B. Ataei, S. Mobasheri Zadeh,
M. Davarpanah, A. Mohammad Alizadeh (Isfahan, Shiraz,
Tehran, IR)
Objective: To evaluate whether air ionization reduces the
microbial content of air.
Methods: Two air ionizers were placed in two boxes, and the
third space was considered as control group. Negative air ion
generation was performed in ﬁrst two boxes for three hours. Air
sampling was done at the beginning of experiment and every
30 minutes up to three hours in three groups. Colony counts and
bacteriologic studies were performed and compared in three
groups.
Results: In all 30 minutes intervals (except at the beginning of
experiment), colony counts in AI groups were lower than
control group. Coagulase negative staphylococcus (CNS) was
the most common bacteria isolated, followed by Bacillus spp,
Acinetobacter and Escherichia coli. The two latter microorganisms
were not detected in AI groups.
Conclusion: Our ﬁndings qualitatively indicate that AI can
reduce the microbial content of the air. Regarding the type of
microbial air pollution and the amount of air cleaning needed,
this method can be used solely or in combination with other air
cleaning methods.
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R2114
Sexually transmitted infections among registered
female sex workers grouped according to age
A. Nicoloudi, N. Kalliakostas, S. Tsitlakidou, T. Vlachou,
S. Diamantopoulou, E. Zagotzidou, M.-E. Alexandrou (Athens,
GR)
Objectives: 1. To assess the prevalence of ST pathogens among
different age groups of asymptomatic sex workers.2. To com-
pare patterns of sexually transmitted diseases (STDs) among
Greek and immigrant sex workers.
Material and methods: A number of 258 asymptomatic female
sex workers, aged 19–30, 31–0, 41–5, were examined for STIs, as
well as a control group of 320 asymptomatic women of the same
age who attended the out patients Gynaecology dpt of our
hospital, during two years period (from October 2003 to October
2005). Vaginal and endocervical samples were examined micro-
scopically for Trichomonas vaginalis, yeast, clue cells and
N. gonorrhoeae and cultured for aerobic and anaerobic bacteria.
Chlamydia trachomatis was detected with DIF (Cellabs Pty Ltd,
Australia).
Results: Among sex workers aged 19–0, Bacterial vaginosis
(BV) was found in 14% of immigrants and 7% of Greeks. Candida
albicans was isolated in 22% and 7% respectively. In sex workers
aged 31–0, C. albicans was found in 17% of Greeks and 5% of
immigrants. The prevalence rate of C. lbicans in Greek sex
workers aged 19–0 was 7% and in those of control group was
15%. The prevalence rate of C. lbicans among immigrant sex
workers aged 19–0 and women of control group was similar
(22% and 21% respectively).
Conclusions: 1. The prevalence of BV in immigrant sex workers
aged 19–0 was higher (14%) than in Greeks (7%). 2. C. albicans
was detected in higher rate (22%) in immigrant sex workers
aged 19–0 than in Greeks (7%). 3. C. albicans in Greek sex
workers aged 19–0 was isolated in lower rate (7%) than in
women of control group (15%). 4. The prevalence rate of C.
albicans was found higher among Greek prostitutes aged 31–0
(17%) than in immigrants (5%). 5. C. trachomatis was detected in
higher rate in immigrant sex workers (6%) than in Greeks (1%).
6. T. vaginalis was not detected in sex workers (immigrant and
Greek), while in immigrants of control group was found in 5%.
R2115
Vaginal infections in women undergoing in vitro
fertilization
A. Nicoloudi, A. Kazakos, N. Kalliakostas, M. Dimopoulou,
E. Koufogiorga, D. Patili, E. Zagotzidou (Athens, GR)
Objective: The purpose of this study was to investigate the
prevalence rate of pathogens bacteria in vaginal and cervical
samples from women undergoing in vitro fertilization.
Material and methods: Vaginal and cervical smears were
examined from 99 women aged 18–50, who visited our hospital
for pre-IVF screening (Group A) and from 320 women of the
same age who attended the out patient Gynaecology dpt (Group
B) during the last three years. Vaginal and cervical samples were
examined microscopically for Trichomonas vaginalis, yeast, clue
cells and cultured for aerobic and anaerobic bacteria. Chlamydia
trachomatis was detected with DIF (Cellabs Pty Ltd, Australia).
Urogenital mycoplasmas were identiﬁed by biochemical method
(Mycoplasma system, Lioﬁlchem s.r.l., Italy). In Group A, 69%
were Greeks and 31% immigrants.
Results: No signiﬁcant difference was found between Group A
and Group B referring the prevalence of Bacterial vaginosis (BV),
Candida albicans and Streptococcus agalactiae. T. vaginalis was
found only in Group B (3%). In Group A the prevalence of BV
was higher in Greeks (10%) than in immigrants (3%), while in
Group B was 8% and 11% respectively. In Group A, C.
trachomatis was found in 7 women (4% Greeks and 13%
immigrants), while in Group B in 8% and 11% respectively.
The incidence of Ureoplasma urealyticum in Group A was 10% in
Greeks and 19% in immigrants, while in Group B was 23% and
29% respectively.
Conclusions: 1. There was no signiﬁcant difference in the
prevalence of BV, C. albicans and S. agalactiae between Group A
and Group B. 2. The incidence of BV in Greeks of Group A was
signiﬁcantly higher than in immigrants. In Group B the
incidence of BV in immigrants was higher in comparison to
Greeks. 3. The prevalence of C. trachomatis and U. urealiticum
was considerably higher among immigrants than Greeks. 4. C.
trachomatis was found more frequently in Greeks of Group B
than those of Group A. 5. U. urealiticum was detected in higher
rate (26%) in Group B than in Group A (14%).
R2116
Incidence of candidaemia as an indirect marker
for nosocomial infection control
E. Padilla, M.A. Rada, J. de Otero, C. Capo´, A. Serra (Manacor,
ES)
Objectives: To know the incidence of candidemia in Hospital
de Manacor within the last four years, its meaning and case
analysis.
Methods: A prospective analysis of candidemia episodes in a
207 beds hospital in Mallorca was made through the years 2002,
2003, 2004, and 2005, as a part of the hospital infection control
strategy. The incidence of cases was computed in relation to the
total of positive blood cultures, to 1000 hospital admissions, and
to 105 stays. The data was adjusted to the annual complexity
index. Blood cultures were processed in Bactec 9120 and 9050
systems. All the clinical cases were studied, and the results were
interpreted in relation to other nosocomial control parameters.
Results: 12 cases were recorded (2 in 2002, 1 in 2003, 7 in 2004,
and 2 until October 2005), resulting in a 0.57%, 0.41%, 2.53%, and
0.95% incidence in relation to the total number of blood positive
cultures. It disclosed a 0.1%, 0.09%, 0.72% and 0.24% for 1000
hospital admissions, and 1.8%, 1.5%, 11.8% and 3.62% for 105
stays, respectively. The annual complexity index adjustment did
not change the incidence values. Ten patients were male, and
the median age was 75.5 years. The 91.6% of the cases were
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hospital-acquired infection: two in the intensive care unit, four
in the medical acute area, and ﬁve in the surgical area. Seven of
the candidemias were catheter-related (four central vein cath-
eter), two had an urinary focus, two an abdominal origin, and
one was related to a skin ulcer. All the isolated yeasts were
identiﬁed as Candida albicans, except one Candida glabrata and
one Candida parapsilosis. Global mortality was 58.3%, and
directly attributed mortality 41.6%, with just one therapeutic
failure. The transient increase of candidemia incidence related to
the increase of MRSA infection during 2004 (11, 19, and 51 in
2002, 2003 and 2004 respectively) led to introduce new strategies
in nosocomial control policies. The increase of candidemia
incidence was also related to the increase of wide spectrum
antibiotics use.
Conclusion: The characteristics of the analysed cases are similar
to other studies. An increase of candidemia incidence can help
to identify the necessity of improving nosocomial infection
control policies.
R2117
Microbial keratitis in health area of Santiago de
Compostela (Galicia, Spain)
F. Pardo, P.A. Romero, L. Moldes, R. Tourin˜o, M. Ballina,
T. Rodriguez-Ares (Santiago de Compostela, ES)
Objective: The aim of this study is to analyse the microbiolo-
gical and clinical characteristics of microbial keratitis in the
Health Care Area of Santiago de Compostela (459.180 inhabit-
ants), to detemine how patients with suspected microbial
keratitis should be empirically treated.
Methods: The results of 152 corneal scrapes performed in the
Ophthalmology Service of Clinical Universitary Hospital of
Santiago between November 1999 and November 2005 were
reviewed. All samples were collected by the Ophthalmologist
and processed immediately at the "bedside", in proteose-agar
and saboraud-dextrose-agar. Medical records were reviewed for
all patients. Risk factors and microbial isolations were analysed.
Results: 152 samples were evaluated from 137 patients with
suspected microbial keratitis (72 males, 65 females). Mean age
was 58.3 years (<1–99). 16% of the patients were contact-lens
user, 8% had a trauma contaminated with vegetable matter and
3% had a corneal transplant. There was a positive culture in
77.7% (118/152) of scrapes. The 10.2% of the samples had
polimicrobial culture. The 83.1% were bacterial keratitis and the
most frequent isolate were Staphylococcus aureus (18.5%), fol-
lowed by Gram-negative rods (17.6%), and Streptococcus pneu-
moniae (7.7%). The 16.9% were fungal keratitis, and the
commonest isolate were Candida spp. and Fusarium spp.
Conclusions: 1. In ocular injury contaminated with vegetable
matter we isolate coagulase negative Staphilococci predomin-
antly, probably due to patients manipulation, and they are part
of the saprophytic ﬂora. 2. Pseudomonas aeruginosa and Serratia
marcescens were the most frequent Gram-negative rods isolated.
When Pseudomonas aeruginosa is isolated, there is a polimicrobial
keratitis. 3. All Staphylococcus aureus isolated were methicillin
susceptible. 4. Early diagnosis and prompt treatment with
vancomycin/ciproﬂoxacin or vancomycin/ceftacidime are
important for successful management, when bacterial keratitis
is suspected.
R2118
Relationship between pathogenicity,
susceptibility to antibiotics and serotyping of 335
Tunisian strains of Streptococcus agalactiae
A. Ferjani, S. Mhalla, N. Hannechi, J. Boukadida (Sousse, TN)
Objectives: Group B Streptococci (GBS) are an important cause
of serious infections among newborns and adults out side
perinatology. Interrelationship between serotypes and the
pathogenicity orients toward the vaccinal prevention and the
survey serotypes-sensitivity to antibiotics provides epidemio-
logical enlightenments on the resistance to antibiotics.
Methods: Strains of GBS isolated from all specimens in a
teaching hospital were collected during a period of 21 months
from 01/01/04 to 30/09/05. Strains were identiﬁed according to
the conventional characters in particular by a positive hippurate
test and by group B speciﬁc latex agglutination (biome´rieux).
Serotypes were identiﬁed by serum agglutination test with
type-speciﬁc antiserum (strep-B-latex-statens Serum Institute,
Copenhagen, Denmark). The susceptibility to antibiotics was
determined according to the CA- SFM recommendations.
Results: 335 strains of group B Streptococcus (GBS) were kept.
GBS is the main Streptococcus isolated (with more of 80% of the
total Streptococcus) essentially from vaginal specimens (48%)
and urine samples (32%). Thirty three percent of strains were
isolated from non-pregnant adults who are essentially diabetics
with a median age of 57 years and a sex-ratio of 0.22. Serotypes
III, V and Ia were being most common from all clinical isolate
sources. All strain isolated from blood (n = 16) came from
newborns. Serotype III prevailed among GBS vaginal isolates
(50%). All isolates were susceptible to penicillin, and to
glycopeptides. Resistance to erythromycin was found in 30%,
to lincomycin in 32% and to tetracycline in 93%. Only one strain
expressed a high-level resistance (RHN) to aminoglycosids. GBS
isolates resistant to macrolid belong to serotypes V and III.
Conclusion: 2/3 of GBS were isolated in perinatology and 1/3
remaining concern essentially diabetic adult with a predomin-
ance of serotype III. The main antimicrobial resistances were
noted for tetracycline (veterinary use antibiotics), macrolid and
chloramphenicol. Study the relationship between serotyping
and pathogenicity give possibilities of prevention by vaccin-
ation.
R2119
Mumps cases in Minsk, Belarus, 2001–2003
Alena V. Atrasheuskaya, E.M. Blatun, M.V. Kulak, E.K. Bukin,
Alina V. Atrasheuskaya, I.A. Karpov, G.M. Ignatyev
(Novosibirsk, RU; Minsk, BY)
Objectives: In Belarus, a mandatory single dose of mumps
vaccine was instituted in 1981, and a two dose regimen – in 1995.
The absence of information on mumps virus genotypes circu-
lating in the Republic of Belarus has made it difﬁcult to assess
the situation. Moreover, by now no serological data is available
on mumps outbreaks in Belarus. Thus, the purpose of this study
was to isolate and sequence mumps virus strains from clinical
mumps cases in Minsk, Belarus, and to estimate the role of
vaccine failure in vaccinated patients.
Methods: During 2001–2003 ﬁfteen mumps case were enrolled
in our study. All mumps cases were clinically, laboratory and
phylogenetically characterized here. Detection of mumps anti-
bodies and IgG avidity testing was performed using commercial
test kits. Plague reduction neutralization assay was performed
with the wild-type measles viruses of the genotypes A, C and H,
as well as with the Leningrad-3 mumps vaccine virus.
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Results: The diagnosis of mumps infection was conﬁrmed
laboratory (by RT-PCR) in all subjects. The nucleotide sequence
of RT-PCR material isolated from all patients was identical and
belonged to the genotype H group of MuV. The majority of
those ﬁfteen patients had low AI, and only two (13%) had high
AI. Thus, according to the IgG speciﬁc avidity 87% of all
patients developed PIR and 13 % patients developed SIR. The
level of VF was well conﬁrmed by the PRN titres. The PRN
assay with L-3 mumps vaccine strain helped to determine the
history vaccination in four cases with the earlier unknown
status. Thus, mumps in the previously vaccinated patients
presented here were mostly (87%) attributed to primary
vaccine failure
Conclusions: For the ﬁrst time, MuVs were genetically charac-
terized in Belarus. Phylogenetic analysis revealed the presence
of genotype H within 2001–2003 years in the city of Minsk,
Belarus. Our results here support the notion that total speciﬁc
IgG antibody levels may not be an accurate reﬂection of level of
protection. For estimating the vaccine failure (VF) the IgM and
IgG evaluation seems to be insufﬁcient. In the current study, we
mostly took into account IgG avidity and the presence of
neutralizing antibodies to evaluate the immune response to
MuV. The PRN assay data was very helpful in the conﬁrmation
vaccination status and level of VF. Mumps in the previously
vaccinated patients presented here were mostly attributed to
primary vaccine failure.
Clinical epidemiology of nosocomial infections (POWI, VAP, UTI,
BSI, …)
R2120
Airborne fungal contamination in the operating
rooms of medical university hospitals, Yazd
A.A. Jafari, H. Rajabion, M. Amrolahi, M.A. Karimi (IR)
Objectives: Skin is one of the natural defence mechanisms of
the human body act as an important barrier to prevent the
penetration of pathogen microorganisms. Damaging of the skin
in the patient, who is under operation and as a result of the post
operating treatment usually using wide spectrum antibiotics, the
opportunistic nosocomial agents especially the airborne fungal
spores are a danger for patients. The general objective of the
present study was to evaluate the types and frequency of
ﬁlamentous fungi and yeast, present in the air of the operating
rooms in the Yazd three major hospitals.
Methods: In the current cross sectional descriptive study, we
used the contact plating method for air sampling collecting and
culturing. We used 921 plates containing Sabouraud dextrose
agar for air sampling of 7 operating rooms in 3 hospitals. The
fungi, which isolated were diagnosed by microscopic and
macroscopic methods and the results were analysed using
SPSS software.
Results: Totally 1115 colonies from 13 genus’s of fungi were
isolated that Penicillium (22.4 %), yeast (19.4 %), Clodosporium
(18.2 %) and Aspergillus niger (13.8%) were the most frequently
isolated fungi. Operating rooms of hospital B had the most
contaminated rooms in this study. There was seen a statistical
signiﬁcant differential between operating room of 3 hospitals
(F = 43.7, Pval = 0). The average isolated fungal spores was 2 in
surgery operating room of hospital B known as most contam-
inated room but in women’s operating room of hospital A and
the open heart surgery this was 0.6 c.f.u in each sample
(F = 17.6%, Pval = 0). However Wednesdays show more con-
tamination in compare with Monday and Saturday but there
wasn’t seen any statistically signiﬁcant differences between
weekly days (F = 0.45, P val = 0.665).
Conclusion: It seems that the operating rooms in the current
study are highly contaminated with fungal spores and it is
necessary to have more attention especially in open-heart
surgery operating room. It seems that in hospital B the cooler
system can act as the important source of contamination and
also using the fungal anti-septic is necessary for all rooms.
R2121
Morganella morganii infections in a general
tertiary hospital
D. Kofterides, M. Falagas, P. Kavvadia, E. Mantadakis,
I. Bliziotis, E. Saloustros, S. Maraki, G. Samonis (Athens, GR)
Objectives: Morganella morganii is a commensal Gram-negative
bacillus of the intestinal tract of humans and other mammals
and reptiles. Few reports exist in the literature regarding
infections caused by this organism.
Methods: A retrospective study at the 650-bed University
Hospital of Heraklion, Crete, Greece was performed during a
4-year period (2001–2004) to identify and analyse infections
caused by M. morganii. Patients in whom the organism was
isolated from clinical specimens were identiﬁed from the records
of the Microbiology laboratory, while their clinical data were
collected from the medical records. Deﬁnitions of the Centers for
Disease Control and Prevention (CDC) were used to identify the
infections, while the outcome was recorded as cure or failure.
Results: Twenty-four patients had M. morganii isolated from
clinical specimens during the study period. Thirteen patients
(54%) suffered from skin and soft tissue infections, 5 from
pyelonephritis, 3 from female genital tract infections, 1 from
pneumonia, 1 from gangrenous appendicitis, and 1 from
tonsillitis. M. morganii was a constituent of polymicrobial
infections in 14 patients (58%). The patients received various
antibiotics, i.e., 6 patients received ciproﬂoxacin, 6 piperacillin/
tazobactam, 1 ticarcillin/clavulanic acid, 1 ceftriaxone, 1 imipe-
nem, and 1 cefuroxime monotherapy, whereas the remaining 8
received antibiotic combinations. Two of 24 patients (8%) died,
despite antibiotic treatment.
Conclusion: Skin and soft tissue infection was the commonest
type of infection due to M. morganii in our series. M. morganii is
commonly a part of polymicrobial infections and can rarely
cause fatalities in debilitated patients.
R2122
Investigation of an outbreak caused by multi-
resistant Acinetobacter baumannii isolates in the
ICU of a regional hospital
F. Markou, A. Poulou, A. Karakolios, D. Vrizas, E. Iliopoulou,
P. Rozi (Serres, GR)
Objective: Acinetobacter baumannii isolates show increasing rele-
vance in nosocomial infections. Since they can easily develop
resistance to several antimicrobials, such infections may be
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difﬁcult to treat even with combination therapy. In our regional
hospital A. baumannii isolates are scarcely isolated and usually
exhibit susceptibility to several antimicrobial classes. In this study
we present an outbreak of multi-resistant A. baumannii isolates
that was undertaken in our ICU during a short period of time.
Methods: Over a period of 10 days in April 2005, 5 A. baumannii
isolates were recovered from various clinical specimens (blood,
bronchial secretions and surgical wounds) obtained from sep-
arate patients hospitalized in different wards. Identiﬁcation of
the isolates and antimicrobial susceptibility testing was per-
formed by Microscan system (Dade Behring). Two of the
patients were hospitalized in the ICU, 2 in surgical wards and
one in a medical ward. However, medical records revealed that
the latter 3 patients had previously been admitted to the ICU
and subsequently transferred to other wards.
Results: All isolates were identiﬁed as A. baumannii that
exhibited resistance to all carbapenems, ﬂuorocinolones, ami-
noglycosides, expanded spectrum cephalosporins, as well as to
aztreonam and piperacillin/tazobactam. They showed interme-
diate susceptibility to ampicillin/sulbactam while all were
susceptible to colistin. E-test MBL (AB Biodisk, Sweden) did
not show production of a metallo-b-lactamase in any of the
isolates. In spite of the therapeutic treatment 3 of the patients
died from septicaemia. The identical biochemical identiﬁcation
proﬁles and antimicrobial resistance patterns of the isolates in
combination with the fact that all patients were previously
admitted in the ICU suggested the hypothesis of nosocomial
infection from a common A. baumannii strain. An epidemiolog-
ical investigation was undertaken and an A. baumannii isolate
showing the same biochemical and antimicrobial susceptibility
proﬁles was isolated from the ﬂoor of the ICU. Thereafter, all
patients were isolated, strict infection control measures and
antiseptic techniques were implemented. No other episodes of
multi-resistant A. baumannii were noticed.
R2123
The analysis of diagnostics of hospital-acquired
pneumonia in the intensive care unit
H. Demchuk, Y. Mostovoy (Vinnitsa, UA)
Aims: To estimate the recognizing of the fatal hospital-acquired
pneumonia (HAP) in ICU.
Material and methods: We analysed hospital charts and
autopsy reports of 278 patients (145 male and 133 female) that
died during 2001–2004 year in ICU of the city hospital. The
presence of the clinic symptoms HAP, the coverage by X-ray
examination of chest, microbiology examination of sputum, the
diagnostics HAP during life, coincidence of clinical and path-
ologoanatomic diagnoses, adequacy of antimicrobial therapy,
average terms of medical treatment was evaluated.
Results: HAP was diagnosed at 49.3% of patients during life.
Average age of the patients was 63.7 ± 2.3 years. Stroke (63.8%),
ischaemic heart disease (77.0%), hypertonic disease (59.5%),
chronic obstructive pulmonary diseases (49.2%), surgical opera-
tion (15.0%), diabetes mellitus (12.8%) were prevailed in the
structure of patients morbidity. Clinic symptoms of HAP were
observed at 57% of patients. The X-ray examination of chest was
conducted 40.5% of patients. Bacteriological examinations were
provided 18% of patients. Causal pathogens were obtained at 3.6
% of patients. There were S. aureus (7 strains), S. pneumoniae (1
strains), P. vulgaris (1 strains), P. aeruginosa (2 strains). During
life HAP was diagnosed at 51.4% of patients, from them in the
day of death at 18.9%, is exposed only autopsy at 49.6%. HAP by
mistake was determined at 13.0%. The antimicrobial therapy
was prescribed by 68%, however it was appointed in 2 days
from the origin of the HAP signs. Average duration of stay in
ICU was 7.6 ± 3.2 day.
Conclusion: Underestimation of the clinic symptoms HAP, the
tardy X-ray examination of chest results in the late diagnostics
HAP at severe patients in ICU, to the postponement of
prescription of the proper antibacterial treatment and death of
patient.
R2124
Antimicrobial resistance of Escherichia coli and
Proteus mirabilis isolated in bacteraemia in a
tertiary care hospital
C. Papadopoulou, P. Sikalidou, M. Tsivitanidou, S. Karampa, D.
Soﬁanou (Thessaloniki, GR)
Objectives: The aim of this study was to determine the
antimicrobial resistance in Escherichia coli and Proteus mirabilis
isolated from blood cultures.
Methods: The study period covered four years from January
2001 to December 2004. The blood cultures were performed
using the BacT/Alert 30 automated system. Identiﬁcation of
microorganisms and susceptibility testing were performed using
the VITEK 2 automated system (bioMerieux France). Conﬁrma-
tion of extended spectrum beta-lactamases (ESBL) production
was performed by double-disk-synergy test (DDST).The three
dimensional test was employed to detect AmpC-like beta-
lactamases.
Results: During the study period a total of 96 E. coli and 23
P. mirabilis were isolated from blood cultures sent in our
laboratory. E. coli isolates were obtained from patients hospit-
alized in internal medicine department (n = 40; 42%), pediatrics
units (n = 28; 29.2%), surgical units (n = 14; 14.4%), nephrology
department (n = 14;14.4%). P. mirabilis isolates were recovered
from patients hospitalized mostly in intensive care unit (n = 14;
61%), internal medicine department (n = 5; 19.5%),surgical
department (n = 5; 19.5%).Resistance rates to commonly used
antimicrobials like ampicillin (AMP), amoxicillin/clavulanate
(AMC), amikacin (AN), ciproﬂoxacin (CIP), co-trimoxazole
(STX) and third generation cephalosporins were 57%, 21%, 4%,
17% a, 30% and 23% respectively for E. coli . P. mirabilis isolates
presented 96% resistance to AMP and AMC, 96% to CIP and
STX, 30% to AN and 91% resistance to third generation
cephalosporins. All isolates of E. coli and P.mirabilis were
susceptible to imipenem. Out of the 22 E. coli resistant to third
generation cephalosporins 20(91%) were found to be ESBL
producers. For P. mirabilis 21 out of 23 isolates were resistant to
third generation cephalosporins and cefoxitin. All strains gave
positive the three dimensional test suggesting an AmpC type
beta lactamase production.
Conclusion: Highly resistant P. mirabilis and E. coli were
responsible for bacteraemias in our hospital. The high incidence
of resistance to third generation cephalosporins was mainly due
to AmpC-type beta-lactamases in P. mirabilis and ESBL produc-
tion in E. coli. Continuous surveillance studies in order to
observe changes in resistance, which might affect therapeutic
choices are necessary.
R2125
Peritonitis due to Corynebacterium striatum in a
CAPD patient
F. Polydorou, E. Kampilaki, S. Chrysohoidou, K. Moldovanidou,
K. Emertzidou, E. Papadimitriou (Thessaloniki, GR)
Coryneforms are occasionally pathogenic microorganisms
implicated in several infections like sepsis in immunocompro-
mised patients, endocarditis in patients with prosthetic valves,
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post-traumatic meningitis and peritonitis in patients undergoing
continuous ambulatory peritoneal dialysis (CAPD). A case of
severe peritonitis from Corynebacterium striatum in a CAPD
patient is investigated. It regards a 58-year-old woman with
chronic renal failure who has been under CAPD therapy since
1993. The patient developed several peritonitis episodes mainly
caused by Staphylococcus spp. In March 2003 the patient
presented obvious peritonitis accompanied by abdomen pain,
fever, tachycardia, and turbid peritoneal ﬂuid with 4.500 cells/
mm mainly neutrophils (95%)and lymphocytes 5%. Initially the
patient was administered with empiric therapy with cefuroxime
and amikacin (according to the CAPD Unit’s protocol) but
without signiﬁcant improvement. After a transient decrease in
the number of cells in the peritoneal ﬂuid, the cells increased up
to 1050/mm despite the continuation of the antibiotic therapy.
From the culture of the peritoneal ﬂuid (two bags and exit-site of
peritoneal catheter) a coryneform bacterium was isolated, which
was identiﬁed as C. striatum. The antibiotic susceptibility test
indicated that the bacterium was sensitive to vancomycin,
teicoplanin, chlorampenicol, rifampicin, levoﬂoxacin, cefotaxi-
me but resistant to ampicillin, cephalothin, cefuroxime and
amikacin. This suggested the discontinuation of the empiric
therapy, and the patient was subsequently administered with
vancomycin and rifampicin resulting to the successful treatment
of the peritonitis. The culture and the isolation of the bacterium
was performed according to the common methods of the
laboratory and the bacterium was identiﬁed from the morphol-
ogy of the colonies, Gram stain and API Coryne. The antibiotic
susceptibility test was performed using the agar diffusion disk
method. Peritonitis is a frequent complication in CAPD patients
and is usually caused by Staphylococcus spp. Coryneforms are an
uncommon cause of peritonitis, they are usually sensitive to the
antibiotics of the empiric therapy of CAPD peritonitis and may
generally induce mild infections. This case was unusual
considering the severity of the infection as well as the increased
resistance of the bacterium to the antibiotics.
R2126
A six-year prospective surveillance study for
nosocomial infections in neurology unit
M.F. Geyik, S. Hosoglu, U. Aluclu, C. Ayaz, M.K. Celen
(Diyarbakir, TR)
Objectives: The aim of this study was to assess the epidemi-
ology of nosocomial infection (NI) s in neurology unit in a
university hospital.
Methods: The study was carried out at the Dicle University
Hospital, Diyarbakir, Turkey (1050-bed). This study was per-
formed prospectively, from 1st January 1999 to 31st December
2004. Active surveillance for NIs were performed by infection
control team, using the criteria proposed by the Centers for
Diseases Control and prevention (CDC) and National Nasoco-
mial Infections Suveillance (NNIS) methodology.
Results: During six-year follow up period, 219 nosocomial
infection episodes were detected in 203 patients out of 3323
inpatients. The overall incidence rates (NI/100) and incidence
densities (NI/1000 days at risk) of nosocomial infections were
6.6% and 4.4/1000 patients-days, respectively. The most
common nosocomial infections by primary site were urinary
tract infection (Table). The most prevalent microorganisms were
Escherichia coli (27%), Klebsiella spp. (14%), Pseudomanas aerugi-
nosa (13%), Enterobacter spp (12%), coagulase-negative staphy-
lococci (10%) and Staphylococcus aureus (7%).
Conclusion: The results may contribute to observe the magni-
tude and characteristics of NIs and to plan and evaluate policies
and guidelines of infection control in neurology units.
R2127
Septicaemia in paediatric surgery in Kuwait: a
four-year prospective study
E. Mokaddas, S. Al-Ramadan, S. Shetty, A. Kumar (Dasma, KW)
Introduction: Blood stream infections account for most of the
noscomial infections in the neonatal and paediatric intensive
care units. The objectives of this study were to determine the
incidence, risk factors, microbiological aetiology and anti-
microbial susceptibility pattern of septicaemia in paediatric
surgery patients.
Methods: Over a period of four years (2001–2004), all the
documented cases of septicaemia were investigated. Risk factors
such as low birth weight, prematurity, ICU stay, use of
ventilators underlying disease and surgical interventions were
determined. Blood and other cultures were incubated. All
positive cultures were subjected to identiﬁcation and anti-
microbial susceptibility testing. Outcome of septicaemia was
then analysed.
Results: 58 patients who developed 80 episodes of microbio-
logically documented bacterial and fungal sepsis were analysed.
23 were neonates and 35 were infants. Half of the patients were
admitted to the ICU. Twenty-ﬁve patients had gastrointestional
problems with surgical interventions. The 31 Gram-negative
septic episodes included Pseudomonas aeruginosa, Enterobacteria-
cae, Acinetobacter baumanii and Stenotrophomonas maltophilia. The
39 Gram-positive septic episodes included coagulase negative
Staphylococcus, Staphylococcus aureus, Enterococcus faecalis and
Viridans streptococcus. Candidemia accounted for 10 episodes.
All Gram-negative isolates were uniformly susceptible to third
generation cephalosporins, aminoglycosides, piperacillin/tazo-
bactam and carbapenems. All Gram-positive isolates were
uniformly susceptible to Glycopeptides.
Conclusions: The main risk factors for septicaemia in pediatric
surgery includes prematurity, ICU stay and underlying disease.
The main etiological pathogens included coagulase negative
staphylococcus, Pseudomonas aeruginosa and Enterobacteriaceae;
empirical therapy with piperacillin/tazobactam for Gram-neg-
ative sepsis and glycopeptides for Gram-positive sepsis proved
to be effective.
R2128
Increasing Candida spp. as a cause of nosocomial
urinary tract infections: a 6-month survey in Iran
M. Rahbar, S. Moulanaee, F.S. Mogaddam, M. Yaghoobi
(Tehran, IR)
Objectives: To determine the causative agents of hospital
acquired urinary tract infections and susceptibility testing of
isolated urinary pathogens.
Methods: Between April to October 2005 all urine isolates
from hospitalized patients in Milad hospital of Tehran were
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collected. Cultures of urine samples were performed by
conventional methods. Antimicrobial susceptibility testing
was performed by using disk diffusion methods as recom-
mended by NCCLS.
Results: 83 isolates from urine culture were analyzed. There
were 3 groups of causative agents: Gram-negative rods inclu-
ding E. coli – 28 isolates, Klebsiella pneumoniae -6, K. oxytoca 1,
K. planticola -1, Pseudomonas aeruginosa –5, Acinetobacter baumnnii
– 6 and other. Gram-negative rods-5. Candida spp. including C.
albicans with 9 isolates and other Candida spp. with 11 isolates in
total comprised 23% of all causative agents. Enterococci inclu-
ding E. faecalis with 9 isolates and E. faecium with 3 isolates were
the only Gram-positive cocci isolates. Drug resistant was
prevalent among all isolated organism. For example 96% of
isolated E. cole were resistant to ampicillin. Resitance of this
organism to nalidixic acid co-trimoxazol oﬂoxacin, ceftizoxim,
cefotaxim were 70%, 51%, 62%, 62% and 7% respectively. All
isolates of Acinetobacter baumannii and Klebsiella spp. and
enterococci were multidrug resistant.
Conclusion: This study reveals that Candida spp. after E. coli
were the predominant organism isolated from urinary tract
infection in our hospital. Catheterization was the predominant
predisposing factor.
R2129
Asymptomatic bacteriuria prevalence among
pregnant women in a university hospital, Aydin,
Turkey
S. Kirdar, B. Bozdogan, S. Demircan, S. Yaman-Karadam,
A.R. Odabasi, H. Yuksel, A. Baz, P. Erkan, N. Aydin (Aydin, TR)
Objective: Asymptomatic bacteriuria is a risk factor for devel-
opment of pyelohephritis, which is a cause of the morbidity and
mortality of foetus and mother. In the present study, asympto-
matic bacteriuria was screened among the pregnant women who
presented themselves to Adnan Menderes University Hospital
for antenatal care.
Methods: Urine samples were collected from 102 women
during each trimester of pregnancy. Patients with urinary
symptoms, active vaginal bleeding, or who were previously on
antibiotics therapy, were excluded from the study. Bacteriuria
considered positive if the urine cultures grew >105 colony-
forming units of a single uropathogen.
Results: The average age of the asymptomatic bacteriuria
positive women were 28.2 year old which was not signiﬁcantly
different from the average for all pregnant women included in
the study (27.7 year-old). Among 102 women, 12 had asympto-
matic bacteriuria in 1st trimester, 1 in second and 3 in third
trimester. A total of 14 pregnant women had asymptomatic
bacteriuria during at least one of the trimesters. Escherichia coli
was the commonest bacteria isolated (6 isolates) during 1st
trimester followed by group B Streptococci (3 isolates). One
coagulase (-) Staphylococci, one Enterococci spp, and one Proteus
mirabilis were also isolated during the ﬁrst trimester. One
pregnant woman had E. coli during all of the three trimesters
despite treatment and 2 women had S. aureus and E. coli only
during third trimester.
Conclusion: The prevalence of asymptomatic bacteriuria found
to be 11.7%, 0.9%, and 2.9% during ﬁrst, second and third
trimester, respectively, among pregnant women who attended
to antenatal care unit of Adnan Menderes University Hospital,
Turkey. Pregnant women should be screened for asymptomatic
bacteriuria and treated to avoid serious complications for both
mother and foetus.
R2130
Infective endocarditis: results of a 5-year
microbiological survey in the cardiology centre,
Iasi, Romania
M. Dan, A. Mereuta, E. Dabija, L. Colar, G.I.M. Georgescu,
C. Arsenescu-Georgescu, D. Buiuc (Iasi, RO)
Objectives: To characterize the epidemiological and microbio-
logical spectrum of infective endocarditis in the Cardiology
Center of Iasi, Romania.
Methods: We reviewed all episodes of infective endocarditis
from April 2001 to September 2005 in the Cardiology Center of
Iasi. Infective endocarditis was diagnosed using Duke’s criteria.
Classiﬁcation of infective endocarditis based on the etiological
agents was related to epidemiological characteristics including
age, gender, nature of the injured valve, mortality rates and
antibiotic treatment before blood culture was drawn.
Results: During the 5 years that were investigated, there were
60 deﬁnite infective endocarditis 3978 admissions. There were 44
(73.33%) episodes of endocarditis with positive blood cultures
and 16 (26.66%) with negative blood culture, involving 36 males
and 24 females (mean age = 47.93 years old). The most fre-
quently involved sites of infection were the native valves 46
(76.66%), especially the aortic ones 39 (65%). In descending
order of frequency, we isolated: 43.18% gram-positive cocci (19
strains), 5.90% gram-positive bacilli (7), 13.63% stable cell-wall
deﬁcient forms (6), HACEK-group 11.36% (5), fungi 6.81% (3),
anaerobes 6.81% (3), gram-negative bacilli 2.27% (1). From the
total 16 strains of cell-wall deﬁcient forms (36.36%), 10 returned
to their typical morphology (5 gram-positive cocci, 2 Gram-
positive bacilli, 2 anaerobes, 1 gram-positive bacillus) and 6
were L-stable.
Conclusion: 1. Our study found an increased frequency of cell-
wall deﬁcient forms. With only one exception all these forms
were isolated from patients under beta-lactams therapy
(p = 0.002). 2. The lack of serological tests for Coxiella and
Brucella may explain, in part, the high percentage of negative
blood cultures, however, we report cell wall deﬁcient forms as
another possible cause for negative blood cultures. 3. Not
signiﬁcant correlations were observed between causative agents
and age, gender or valve type. Only HACEK group was
associated with male gender (p < 0.05). 4. Microscopic detection
of L forms appears early enough and may be improved in order
to adjust the therapy. The right treatment protocols remain to be
established.
R2131
Postsurgical meningitis: the role of the infectious
diseases specialist
R. Benı´tez, V. Abril, J. Vicente, P. Segarra, S. Escriva´, M. Gomis,
L. Castellano, M. Garcı´a-Deltoro, E. Ballester, M. Garcı´a-
Rodrı´guez, E. Ortega (Valencia, ES)
Introduction: Postsurgical meningitis is a rare complication of
neurosurgical procedures with relevant morbidity and mortal-
ity. Highly resistant bacteria are often implicated, and it is
difﬁcult to get adequate CSF concentrations of some antimicro-
bial agents.
Methods: Chart review of postsurical meningitis treated by
neurosurgeons in collaboration with an infectious diseases
physician since 2003.
Results: 15 patient were analysed, 9 were males and 6 females.
Median age was 40 ± 21.8 years, (20–87). 10 patients (66.6%) had
history of brain tumor, 2 (13.3%) cerebral cyst, 2 (13.3%) had
Arnold Chiari Malformation and 1 patient (6.6%) had vertebral
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fracture. Most common symptoms: fever 14 cases (93.3%),
meningismus in 6 (40%), headache in 5 (33.3%) and CSF ﬁstula
in 5 (33.3%). CSF was obtained by lumbar puncture in 9 cases
(60%) and by intraventricular drainage system in 4 (26.7%). CSF
ﬁndings were consistent with bacterial meningitis. Aetiologies:
Coagulase negative Staphylococci (3), Enterobacteriaceae (5), Non-
fermenters (4) and no isolation (3). 12 patients received
antimicrobials agents previously, most of them amoxicillin-
clavulanate (10). Dosages of antimicrobial agents of initial
therapy were corrected in 13 of 15 patients by the infectious
diseases physician. Most visual empiric therapy was ceftazi-
dime + vancomycin (10). Most frequent consolidation therapies
were cephalosporin + quinolone (4) and rifampin + vancomy-
cin (3). Duration of therapy was 18.4 ± 3.2 days (14–21). One
patient died and another relapsed successfully treated.
Conclusions: Several factors make difﬁcult the management of
patients with postsurgical meningitis. Cooperation between
neurosurgeons and infectious diseases specialists optimizes the
treatment of these patients. The infectious diseases physician
improves initial empirical antimicrobial choice and dosages,
adjust the antibiotic therapy once a pathogen is recovered, and
establishes the proper duration of treatment and clinical
controls.
R2132
Efﬁcacy of doxycycline in treatment of bone and
prosthetic joint infections
J.L. del Pozo, J.R. Yuste, E. Garcı´a-Quetglas, M. Garcı´a-Cenoz,
A. Manubens, J.R. Azanza (Pamplona, ES)
Objectives: Few data exist on the usefulness of doxycycline
(DOX) in osteoarticular infections associated or not to the
presence of a biomaterial. The aim of this study was to evaluate
the efﬁcacy and safety of DOX for the treatment of patients with
bone and prosthetic joint infections (BPJI).
Methods: Patients diagnosed of BPJI treated with DOX from
January 2001 to December 2004 were assessed for the followings
variables: age, gender, underlying diagnosis, microbiological
isolates, treatment and outcome. Only patients with more than
10 days of DOX treatment were included. Finally, the medical
records of 14 patients were reviewed. All patients had proven
BPJI and underlying diseases included: Prosthetic joint infec-
tions (7), osteomyelitis (4) and chronic osteomyelitis associated
with orthopaedic hardware (3). Patients were monitored for
relapsing infection for as long as possible after the end of
treatment.
Results: Monomicrobial infections were the most common
(78%). Isolated microorganisms included: Coagulase negative
staphylococci (CNS) (7), methicillin resistant Staphylococcus
aureus (4), methicillin susceptible S. aureus (3), Corynebacterium
spp. (2), and Streptococcus viridans (1). Four patients received
initially DOX and ten patients received DOX after several
courses of ineffective antibiotherapy (DOX was used as ‘‘rescue’’
therapy). Successful outcome was observed in 64% (9 of 14) of
patients, failure of treatment was observed in 28% (4 of 14) of the
patients, and 1 episode required change of the treatment because
of antibiotic resistance. The infections in patients with failure
were caused by the following microorganisms (3 CNS and 1
CNS + S. aureus). Patients received DOX for a median of
120 days (range 30 to 240). No serious side effects were
observed. Successful outcome was observed in all the patients
diagnosed of osteomyelitis. Clinical cure was achieved in 60% of
patients in which biomaterial withdrawal was performed. This
rate of success was superior to that seen in patients in which
biomaterial was retained (40%).
Conclusions: Although the number of subjects in this analysis
is small, these data suggest that doxycycline may be a reason-
able treatment alternative for patients with certain types of
osteoarticular infections.
R2133
Bacterial colonisation of vascular prostheses in
re-operated patients
J. Niedzwiadek, E. Mazur, P. Terlecki, M. Koziol-Montewka,
A. Mijas, J. Wronski (Lublin, PL)
Objectives: The aim of our study was to estimate bacterial
colonisation of the vascular prostheses in re-operated patients
depending on the number of thrombectomies performed after
primary reconstruction.
Methods: 18 patients (15 M, 3 F; mean age 62 years) without
clinical symptoms of graft infection, on whom graft thrombec-
tomies were done as an emergency operations took part in our
research. Unsealed Dacron prostheses were used in all patients
for primary reconstruction. Swabs obtained from outer and
inner surfaces of the prostheses during operation were inocu-
lated on the bacteriological media and incubated in aerobic
conditions. Species of bacteria were identiﬁed on the ground of
their biochemical characteristics. Antimicrobial susceptibility of
isolated strains was evaluated by disc-diffusion method.
Results (in table):
Conclusions: 1. Bacterial colonisation of prosthesis occurred in
50% of examined patients (without clinical signs of infection).
2. Most frequently isolated species proved to be S. aureus and S.
epidermidis. 3. Every consecutive thrombectomy performed on a
given graft increases the probability of its bacterial colonisation.
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R2134
Pseudomonas aeruginosa bacteraemia: analysis of
262 episodes
C. Ezpeleta, J.A. Alava, J. Unzaga, C. Busto, E. Gomez, I. Atutxa,
V. Cabezas, R. Cisterna (Bilbao, ES)
Objective: The aim of this study is to evaluate the trend in
incidence of Pseudomonas aeruginosa bacteraemia (PAB), under-
lying diseases, source of infection, antibiotic treatment and
mortality.
Methods: Prospective study of all patients with PAB. Study
period Nov 93–Jun 05. Blood cultures were performed by means
of BACTEC 9240. Te infection control team studies every patient
with positive blood cultures. Variables under surveillance are
age, sex, underlying illnesses, predisposing conditions, source of
bacteremia, nosocomial/community acquired, antibiotic suscep-
tibility, treatment and outcome.
Results: 262 episodes, 177 males (67.56%), age 67.17% >60years,
Underlying illnesses: Neoplasia 41.92%, Diabetes 16.79%, COPD
12.6%, HIV 8.4%. Hospital acquired 49.62% ranging over time
from 38.7% to 57.6%. Source of PAB: Primary 29.0%, Urinary
tract 21%%, Respiratory 19.47%, Abdominal 10.31%. Predispo-
sing conditions: mechanical ventilation 8.8%, ICU 9.9%, surgery
13%, urinary catheter 25.19%, antibiotic 42.37%, intravascular
catheter 48.5%, immunosuppressive therapy 27.1%, neutrope-
nia: 16.41%. Inappropriate antibiotic therapy 20.23%. Crude
mortality 32.06. Time to positivity of blood cultures 80.92% less
than 48 h. Polymicrobial bacteremia: 20.23%. Sensitivity to
antibiotics: Amikacin 94.7%, Imipenem 90.91%, Ceftazidime
89.02%, Gentamicin 86.74%, and Ciproﬂoxacin 77.65%. Nosoco-
mial bacteremia: 130 cases, 63.85% males, 56.1% older than 60 y.
Underlying illnesses: neoplasia 44.6%, VIH 7.7%. Source of
bacteraemia: primary 33%, urinary 20.7%, respiratory 14.6%,
catheter related 10%, surgical site 5.3%. Crude mortality
nosocomial acquired: 35.66%.
Conclusions: The incidence of PAB in our hospital remained
stable over the last 11 years with a peak incidence in 1997 and
2002. Neoplasia was the most common underlying disease.
Sensitivity to antibiotics didn’t change over time and the most
active antibiotics are Amikacin, Imipenem and Ceftazidime.
R2135
Bacteriology of burn wound infections in a burn
care centre, Mashhad, Iran and determination of
the antibiotic susceptibility patterns of isolated
bacteria
K. Ghazvini, T. Rashed, J. Ghanaat, M. Malek Jafarian (Mashhad,
IR)
Objectives: Burn site infections, as a nosocomial infection, are a
major cause of mortality and morbidity in burn units. It is
crucial for every burn institution to determine the pattern of
microbial colonization in burn wound and the antimicrobial
susceptibility proﬁles. This study was carried out on patients
admitted to the Burn Unit, Emam Reza University Hospital,
Mashhad, with the aim to verify the pattern of microbial
colonization of burn wounds and determine the susceptibility of
isolated bacteria against antibiotics.
Methods: Throughout the study period 344 samples were
obtained from the 126 burn patients. After isolation and identi-
ﬁcation of bacteria, their susceptibility patterns against 14
commonantibioticswere studiedutilizing agar diffusionmethod.
Results: The results show that 27.7% of wounds were sterile at
ﬁrst dressing, but by passing the time the rate of contamination
increase in the way that only 5% of wound were sterile at the
third week. Pseudomonas aeroginosa was the most common
isolated bacterium (31.7%). Most of bacteria were resistant
against amoxicillin but ciproﬂoxacin and imipenem was the
most effective antibiotics among tested antibiotics.
Conclusion: The obtained results about causative agents and
their antibiotic susceptibility pattern particularly about gram
negative bacilli and Staphylococcus aureus emphasis that we not
only aren’t in suitable position but also are very far from
eradication of these infections, so implementation of improved
infection control practices and policies is urgently required.
R2136
Unusual anaerobic Gram-negative bacterium
from an abscess
F. Polydorou, E. Kampilaki, K. Moldovanidou, S. Chysohoidou,
F. Pastore, K. Emertzidou (Thessaloniki, GR)
Bilophila wadsworthia is a Gram-negative anaerobic bacterium,
which has been recently described (1989) and can rarely be
isolated from infections. These infections usually involve
gangrenous appendicitis and less frequently absesses of the
peritoneal cavity and bacteraemia. This study presents the
case of a 74-year-old man who was admitted to the Urologic
clinic with an absesse of the left semiscrotum, reporting
symptoms of high fever and diabetes mellitus. The absesse
was opened and drained and the collected pus was send to
the laboratory. The sample was cultured using the common
culture media. In the aerobic conditions culture Escherichia coli
and Morganella morganii were isolated. Under anaerobic
contitions small, conﬂuence, transparent, gray colonies were
grown, after four days of incubations. These colonies
appeared, in the Gram stain, as a Gram (-) negative bacterium
of a medium size. The bacterium was strongly catalase
positive, slightly urease positive, asaccharolytic and nitrate-
nitrite reducing. Using the API 20A system the microorganism
was identiﬁed as a Bacteroides corrodens, which was not in
agreement with the biochemical properties of the isolated
bacterium (catalase positive, urease slightly positive). After
subcultures in bacteroides bile esculin agar, small, transparent
colonies, with black pigment in the centre were isolated which
were considered as Bilophila wadsworthia. After the antibiotic
susceptibility tests of all the isolated bacteria, (E. coli, M.
morganii, B. wadsworthia) the patient was administered with
triple antibiotic therapy containing metronidazole, amikacin
and cefuroxim. Although B. wadsworthia is part of the normal
ﬂora of the intestine, it is not commonly isolated in inﬂam-
mations and absesses of the appendicitis, or of the peritoneal
cavity and in cases of bacteraeimia. This is due to its growth
difﬁculties in the common culture media, as a slowly growing
bacterium, as well as to the identiﬁcations difﬁculties when
using the different identiﬁcation microsystems for anaerobic
bacteria.
R2137
Investigating an Acinetobacter baumannii
outbreak in a Portuguese hospital
J. Mapril (Carnaxide, PT)
Objectives: To describe the epidemiology, antimicrobial sus-
ceptibility ang genomic proﬁle of an outbreak of multiresistent
Acinetobacter baumannii in a Portuguese hospital.
Methods: During 3 months, from May to July, 12 patients were
detected with multiresistent Acinetobacter baumannii mainly in
respiratory secretions (7), but also in blood (1), urine (4),
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exudates (2) and catheter (2). Patients were cared in two units:
Internal Medicine/Nephrology Department and Cardiothoracic
Surgery Unit. Species identiﬁcation was done by using the Vitek
system (bioMerieux, France). Antimicrobial susceptibility test-
ing was done by using the Vitek automated microdilution
system and by disk diffusion method. Six strains were studied
by RAPD and PFGE (5 from the Internal Medicine/Nephrology
Department and 1 from the Cardiothoracic Surgery Unit).
Results: 12 patients had clinical relevant multiresistent Acine-
tobacter baumannii with similar proﬁles on TSA. For those 6
strains studied 4 proved to belong to the same cluster ‘‘A’’ (all
patients from the Internal Medicine/Nephrology Department)
and the other 2 to different clusters ‘‘B’’ and ‘‘C’’ (1 from the
Internal Medicine/Nephrology Department and 1 from the
Cardiothoracic Surgery Unit).
Conclusions: The examined isolates from the Internal Medi-
cine/Nephrology Department were compatible with the spread
of clone (A) between the studied patients. Nevertheless, other
clones were also circulating in the hospital at the same time.
R2138
Preliminary study on colonisation of
A. baumannii in paediatric intensive care unit
H. Guducuoglu, K. Aygul, G. Yaman, H. Izci, M. Berktas (Van,
TR)
Objectives: In recent months, there have been several outbreaks
in various Pediatric Intensive Care Units (PICU) in our country
with high mortality rates. For this reason, we planned to
investigate the possible colonisations in PICU of our hospital
and evaluate the clonal relatedness of the clinical samples. And
we also planned to eradicate the pathogen microorganisms from
this unit to prevent an outbreak.
Methods: For this reason many samples were collected from
PICU of our hospital and then the isolated microorganisms were
identiﬁed by PhoenixTM NMIC/ID, Becton Dickinson, USA
kits. The results were also conﬁrmed by conventional methods.
Results: As a result, a total of 23 microorganisms were isolated
from the samples of the screening. Twenty of them were A.
baumannii and A. baumannii/calcoaceticus complex, three of them
were Escherichia coli, Enterobacter cloacae and Acinetobacter lwofﬁi/
haemolyticus. A. baumannii and A.baumannii/calcoaceticus complex
strains were isolated from different samples like ventilation
device, entubation sets, medicine pumps of some patients,
naked hand of mothers and staffs, and head, neck and
abdominal sites of some patients. These microorganisms were
evaluated as colonisation. The antimicrobial resistance rates of
A. baumannii and A. baumannii/calcoaceticus complex strains were
as followed: amikacin 60%, aztreonam 100%, cefepime 100%,
ceftazidime 100%, chloramphenicol 100%, ciproﬂoxacin 15%,
gentamicin 100%, imipenem 5%, levoﬂoxacin 15%, meropenem
10%, piperacillin 100%, trimethoprim/sulphamethoxazole 20%.
Conclusion: As a result of this study, we detected a colonisation
of A. baumannii and A. baumannii/calcoaceticus complex in our
PICU and it was found out that these microorganisms have
gained high resistance to multiple antimicrobial agents. The
clonal relatedness and the source of origin of these strains will
be investigated by pulsed ﬁeld gel electrophoresis. Meanwhile if
any new Acinetobacter strains will be isolated from clinical
samples from PICU of our hospital, the new isolates will be
compared and the clonal relatedness will be investigated with
the colonized bacteria. We gave advices for the eradication of
Acinetobacter, education of the employees and taking serious
preventions on controlling colonisations.
R2139
One-year infection survey in a cardiac surgery
unit
B. Nocita, F. Poletti, G. Spoladore, B. Castiglioni, E. Carretto,
P. Marone, C. Pellegrini, M. Vigano`, L. Minoli (Pavia, IT)
Objective: Aim of this study was to evaluate infection rate and
type after cardiac surgery, including both those typical of ICUs
and those strictly related to surgery, in order to implement
infection control programmes based on epidemiology and risk
factors.
Methods: Between April 2004 and March 2005 the number and
type of surgical procedures performed in the Cardiac Surgery
Division of Policlinico San Matteo, Pavia, was matched with
clinical and microbiological data from our Institute. Infection
was deﬁned according to CDC criteria.
Results: A total of 885 patients who had undergone cardiac
surgery with either traditional or a minimally invasive
approach, including heart transplant patients and left ventric-
ular assistance device users, were included. 100/885 patients
(11.3%), 67 male and 33 female, presented at least one infection
and 57/100 suffered from more than one infection, for a total
of 261 infectious episodes. The most common complications
were bloodstream infections (42.5%), UTI (21.8%), VAP (11.1%)
and surgical site infections (8%). 20/111 bloodstream infections
were line sepsis and in 10 cases we observed recurrent
bacteraemia from the same microorganism, probably due to
indwelling catheters or misdiagnosed infectious foci. We
observed 3 cases of invasive fungal infections. Incidence of
infections was higher in patients undergoing combined proce-
dures. Staphylococcus aureus with a high prevalence of methi-
cillin-resistant strain (62.9%) and Pseudomonas aeruginosa were
the most common pathogens. We observed contained out-
breaks of vancomycin-resistant enterococci and Enterobacteria-
ceae producing ESBL. A large number of episodes were
polymicrobial, especially sepsis and VAP. The mortality
attributable to infections was higher than overall (32 vs.
7.9%), with death occurring mainly during the ﬁrst 30 days
after aortic surgery and re-operations.
Conclusion: In the literature only few data on post-cardiac
surgery infections are available but for surgical site infections.
Our survey documented that the incidence of infections was
11%, mainly consisting of life-threatening infections. They had a
signiﬁcant effect on mortality and their incidence increased with
a greater length of stay in the ICU. This knowledge could be
used for optimising empiric antimicrobial treatments and
implementing preventive strategies.
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Travel medicine, tropical and parasitic diseases
R2140
Characteristics in laboratory analysis of
leptospirosis
I. Katsarou, A. Provis, K. Zarkadis, E. Katsouli, A. Tsimara,
K. Papadopoulos, E. Ikonomopoulou, A. Regli (Zakynthos,
Patras, GR)
Leptospirosis in an animal-disease, which is caused by lepto-
spira. The person who is contaminated with leptospira, accord-
ing to the kind of the bacteria, is likely to stay: asymptomatic, to
have a mild self-containing, non-icteric version of the disease or
ﬁnally to sustain an acute often lethal condition (Weil–syn-
drome). Responsible for contamination to the human are
domestic or wild animals, mostly rats and mice. The target is
to analyse the laboratories proﬁle of patients with leptospirosis
who have been hospitalized in the pathological clinic of our
hospital.
Material: In a two-year period of time from 2002–2004, 5 ﬁve
patients have been hospitalized, one woman and four men aged
from 42 to 78 with symptoms compatible to leptospirosis. Two
of them developed Weil syndrome and were transferred to
special center in third grade hospital.
Results: From the laboratory proﬁle: anaemia 5/5 (Ht-average
29%), leucocitopenia – 2/5 (average 3500), leucocytosis 3/5
(average 17000) thrombocytopenia 5/5 (average 65000). Liver
dysfunction 5/5 (SGOT av. 99/ SGPT av.84/ TBILL av.1.6/ GGT
av.288/ ALP av. 456), CPK av.725. Renal dysfunction –5/5
(creatinine av. 3.5). Two of the ﬁve patients developed Weil-
syndrome (acute renal failure, haemmoragic signs and severe
liver dysfunction) and were transferred to third grade hospitals.
Conclusion: The laboratory proﬁle of patients with leptospiro-
sis, apart from the multi-organic dysfunction is not character-
istic. This makes the taking of the patient’s history of
fundamental signiﬁcance. According to the centre of informa-
tion related to the Weil disease, if a patient has a clinical history,
which is likely to refer to the disease, he must be considered as
being ill until this has been excluded. Because of the rising
incidence, the severance of the clinical symptoms, leptospirosis
is being included to the obligatory declared cases to the national
epidemiological center of observation and intervention.
R2141
The role of the veterinary laboratory agency:
conﬁrmation of brucellosis from human isolates
J.A. Stack, L.L. Perrett (Weybridge, UK)
Infection with Brucella primarily presents as ‘undulant fever’ in
man. Clinical diagnosis is often difﬁcult; fever, night sweats,
headache and arthralgia are debilitating and similar to other
zoonotic diseases. There are no vaccines suitable for humans,
complications such as osteoarthritis may occur and the chronic
stage of the illness is difﬁcult to treat. Brucellosis is sometimes
misdiagnosed, especially if a full history of the patient is
unknown. Those at most risk are from countries where the
disease is endemic (much of the world) and are farmers, abattoir
workers, butchers, veterinarians and those who consume
unpasteurised milk or milk products. To assist in diagnosis,
consideration must be given regarding the possibility that the
patient may have travelled or lived abroad, exposure from a low
infectious dose can lead to these symptoms. Laboratory workers
are at risk, at VLA we have Containment (biosafety) Level 3
facilities that enable us to handle the organism safely. The
laboratory criteria for diagnosis isolation of the organism from a
clinical specimen and/or rise in serum antibody level.
We are OIE FAO WHO reference laboratory for brucellosis,
engaged on surveillance and research on the disease primarily
in animals. Due to our expertise and facilities we are able to
conﬁrm isolates referred to us from our Health Protection
Agency. We perform ‘classical’ and more rapid molecular
diagnosis and can identify isolates to biovar level, including
information that can be used to help trace the route of infection.
These methods are described in the presentation.
R2142
Pyrexia of unknown origin complicated by
dengue fever and pseudo-rupture of the
gallbladder: a case report
S.K. Surrun, C.K. Thomas-Golbanov (Singapore, SG)
Introduction: Pyrexia of unknown origin is one of the most
difﬁcult clinical problems to elucidate. We present a patient with
pyrexia of unknown origin complicated by dengue fever and
pseudo-rupture of the gallbladder.
Case report: A 64-year-old Chinese lady, without any previous
signiﬁcant medical history, was admitted with fever of two
weeks’ duration. The clinical examination was unremarkable.
The blood investigations revealed thrombocytopenia and a
raised ESR. The initial laboratory work-up was normal but the
paired dengue serology was positive. The full autoimmune
serology was negative and complement levels were normal.
The chest radiograph was normal. During the hospital stay she
developed right upper quadrant abdominal pain and a CT scan
of the chest and abdomen showed ﬂuid collection around the
gallbladder suggestive of a perforation. A cholecystetomy was
performed but the gallbladder looked normal and the histo-
pathology was also normal. After the operation the patient
improved but the fever persisted. The clinical examination did
not reveal any focus of infection. Repeat laboratory work-up
was normal except for a raised ESR and hypoalbuminaemia.
Repeat CT scan of the chest and abdomen showed minimal
pleural effusion. The bone marrow trephine biopsy was
normal.
Discussion: Our patient had pyrexia of unknown origin and the
episode of dengue fever seemed to have been superimposed on
it. However the CT-scan ﬁndings of a possible rupture of the
gallbladder and the fact that dengue fever is associated with
cholecystitis prompted us to do a cholecystectomy. The opera-
tive and histological ﬁndings revealed a normal gallbladder
conﬁrming that the CT-scan ﬁndings were that of a pseudo-
rupture of the gallbladder. After the operation the patient
improved but the fever persisted and the clinical examination
was unremarkable. As the repeat laboratory investigations was
normal except for a raised ESR and hypoalbuminaemia, the CT-
scan of the thorax and abdomen unremarkable, the trephine
bone marrow biopsy normal and the auto-immune serology
negative, the problem of pyrexia of unknown origin was still
present and unresolved.
Conclusion: Pyrexia of unknown origin can be even more
challenging when associated with dengue fever and its compli-
cations.
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R2143
Sternoclavicular arthritis as ﬁrst manifestation of
brucellosis: a case report
Y.Z. Demiroglu, T. Turunc, D. Kilic, A. Pourbagher, H. Uncu,
A.M. Pourbagher, H. Arslan (Ankara, TR)
Objectives: In this report we aimed to attract attention to this
rare complication of brucellosis. Sternoclavicular arthritis is
uncommon for brucellosis. We report a 44-year old male patient
presenting with one month history of fever, night sweat, left
sternoclavicular swelling and pain over the sternum. Physical
examination revealed a ﬂuctuant mass over the body of sternum
extending to the left parasternal region. Ultrasound examination
showed focal collection with internal echoes representing
abscess in the left parasternal region. Pus material obtained by
US- guided needle aspiration yielded Brucella melitensis. The
patient was cured with medical therapy.
Conclusion: Brucellosis should be considered in the differential
diagnosis of sternoclavicular arthritis even in the patients
without immunosuppression and in intravenous drug users
particularly living in endemic areas.
R2144
Myiasis on the scalp by Chrysomya bezziana
H. Davami (Jahrom, IR)
Objectives: Myiasis is the invasion of tissue of animal by the
larval stage of ﬂies (diptera). It is an accidental infestation in
human. Chrysomya bezziana is the agent of myiasis. Introducing
the case: In this report a ﬁfty six years old patient with myiasis
on the scalp caused by Chrysomya bezziana is introduced. He is a
rural man referred to clinic with a mass on tempero-occipital
area. He did not mentioned about any trauma or ulcer on his
scalp. In physical examination an ulcer sized 2 · 3 centimetre
full of larva was observed. The diagnosis was myiasis and the
parasites were removed and the tetanus vaccine was inoculated
and the oral antibiotics were prescribed.
Conclusion: Parasitological examination was determined the
agent as Chrysomya bezziana.
R2145
A Strongyloides stercoralis gastrointestinal
infection burdened by an extraordinary treatment
resistance, probably supported by an underlying
Sjogren’s syndrome which required long-term
corticosteroid treatment
R. Manfredi, S. Sabbatani, P. Baccarini, G. Marinacci, F. Chiodo
(Bologna, IT)
Introduction: In the majority of otherwise healthy patients (p),
Strongyloidiasis (S) remains underestimated: only when some
primary-secondary immunodeﬁciency occurs, S may involve
multiple organs, outside the more obvious gut localization,
towards disseminated-relapsing manifestations.
Case report: A female p who suffered from Sjogren syndrome
treated since over 20 y with cyclic oral steroids, due to dyspeptic
signs-symptoms underwent an endoscopy which detected a
histopathology-conﬁrmed gastroduodenal S. After a 3-day
albendazole a repeated endoscopy-histology showed a persisting
S, so that a further albendazole cycle was administered, but 2
subsequent controls (4 and 10 months after) demonstrated the
persistence of S. stercoralis infection. Upon Hospital admission
(9 months later), our p suffered from weight loss and anaemia.
Stool, sputum, and urine search for S. sterocoralis tested negative,
as well as HIV and HTLV-1 serology, and tumoural markers. A
2-day ivermectine at 12 g/day, preceded a 3-day albendazole
course performed the subsequent week, and a 3-day mebendaz-
ole one week later. Repeated endoscopy was performed one and
2 months after discharge, conﬁrming a sustained cure of S,
associated with improved general conditions and a body weight
regain. During the entire evaluation-treatment period, the con-
current steroid therapy (prednisone, 25 mg/day), deemed neces-
sary for the concurrent Sjogren disease, was never interrupted.
Discussion: S is endemic in tropical-subtropical regions, where
severe associations were demonstrated in HTLV-1-infected p. In
developed countries, p with a broad spectrum of underlying
diseases, or receiving immunosuppressive drugs, may suffer
from S refractory to ﬁrst-line therapy, due the frequency of re-
infestation. Although anecdotal reports regarded p with chronic
disorders and collagen vascular disease, no p with Sjogren
syndrome was reported to date. The described report is
therefore an unique association of a difﬁcult-to treat S occurring
in a p with a steroid-controlled Sjogren syndrome. Since
controlled trials and deﬁnite recommendations are lacking,
either albendazole, thiabendazole, ivermectin or mebendazole at
different dosages-schedules were used, while the management
of relapses lacks of evidence-based guidelines. Clinicians should
also consider that S is expected to increase its frequency, based
on environmental changes (increased temperature-humidity),
just in countries where an increasing number of p become at risk
for opportunism.
Resistance & mechanisms of action of antifungals
R2146
Antifungal resistance patterns among oral
Candida species from patients receiving head and
neck radiotherapy
I. Glazar, M. Abram, S. Pezelj-Ribaric, M. Muhvic-Urek, B.
Matica (Rijeka, Zagreb, HR)
Objectives: Patients receiving radiotherapy treatment for
head and neck cancer are highly susceptible to oral candidi-
asis. This infection is a common source of discomfort and a
potential source of systemic infection. This study was con-
ducted to understand the current status of resistance to
antifungal agents among patients hospitalized in Clinical
hospital Rijeka.
Methods: Oral swabs were collected from 32 hospitalized
patients receiving head and neck radiotherapy treatment for
malignant disease. Yeasts isolates were tested for their suscep-
tibilities to two antifungal agents (amphotericin B and ﬂucon-
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azole) by using commercially available Etest (AB Biodisk, Solna,
Sweden).
Results: At the time of sampling, 14 (43.75%) patients were
found to be colonized with yeasts. All the isolates were Candida
albicans. Antifungal susceptibility patterns showed that 100% of
isolates were susceptible to amphotericin B (mean MIC –
0.1045 microg/ml), while 92.8% were susceptible to ﬂuconazole
(mean MIC – 0.11 microg/ml).
Conclusion: The frequence of resistant Candida is low in
patients with cancer receiving head and neck radiotherapy
treatment. However, it is important to continuously determine
the distribution and susceptibility patterns of yeasts which
should assist in developing optimal prophylactic strategies that
can reduce clinically detectable oral candidiasis in this group of
patients.
R2147
In vitro Candida albicans model for evaluating
the inhibitory effect of known and potential
antifungal agents on germ tube formation
A. Igloi, F. Hernadi, F. Peles, P. Kereszturi, A. Szabo (Debrecen,
HU)
Objectives: C. albicans can differentiate from spherical yeast cell
to a ﬁlamentous hypha form through the development of a germ
tube. This ability of C. albicans can be considered an important
pathogenic factor. This in vivomorphological transformation can
also be brought about in vitro. However, the above-mentioned
transition either takes place in conventional media only to a
minor degree or the yeast cells multiply by budding alone.
Previously we were able to develop a C. albicans cell differen-
tiation model in which this morphological transformation can be
detected in a signiﬁcant part of the cells (87%). Our aim was to
establish if our in vitro model was suitable for a quantitative
examination of the effect of known and potential antifungal
agents on fungal cell differentiation.
Methods: The investigation of inhibitory effect of known
antifungal agents was performed by using ATB FUNGUS strip
(bioMerieux). The new antifungal compounds were investigated
by macrodilution method. The effect of antifungal agents on
morphological transformation was examined by counting the
differentiated forms and spherical cells in Buerker-chamber
under light microscope.
Results: The morphological transformation was inhibited
almost up to 100% by polyenes (amphotericin B and nystatin)
and 64–92.3% by imidazoles (econazole, ketoconazole and
miconazole). The 5-ﬂuorocytosine did not show serious inhib-
itory effect. 9 new piridazine-azole compounds out of the 22 that
we examined inhibited germ tube formation (30.3–100%). An
inhibitory effect was noticed in 4 compounds out of the 5
examined benzylidene-benzosuberones (42.9-57.1%).
Conclusion: It can be stated that we were able to develop a
C. albicans cell differentiation model that can be used to examine
the quantitative effects on morphological transformation of
antifungal agents used in clinical practice and potential agents.
It can be claimed from our examinations that polyenes that bind
to the ergosterol of cell membrane and imidazoles that inhibit
the ergosterol synthesis produced an inhibitory effect on the
morphological transformation, while 5-ﬂuorocytosine that inhib-
its the fungus nucleic acid synthesis does not. It seems that the
inhibition of morphological transformation is connected with
the destruction of cell membrane. However, to be able to state
this with certainty further experiments are needed.
Fungal infections
R2148
Second-line combination antifungal therapy with
caspofungin plus low-dose amphotericin B
deoxycholate in patients with invasive fungal
infections failing primary treatment
L. Pagani, B. Allegranzi, C. Vedovelli, P. Mian, P. Viale (Bolzano,
Verona, Udine, IT)
Objectives: Combination antifungal treatment (CAT) appears
an appealing option in patients (pts) with invasive fungal
infections (IFI), especially in those experiencing failure to
primary therapy.
Methods: From June 2004 to April 2005, 14 pts affected by IFI (7
with candidaemia due to C. albicans, 3 due to C. glabrata, and 4
with pulmonary aspergillosis), who had failed primary antifun-
gal therapy, were consecutively treated with Caspofungin (CAS)
70 mg on 1st day, and 50 mg thereafter, plus low dose (LD)
Amphotericin B deoxycholate (dAmB) 0.5 mg/kg/d. All pts had
high-risk underlying conditions (4 acute myelogenous leukae-
mias, 4 solid tumours, 4 prolonged ICU stays, and 2 major
abdominal surgical interventions). Failure to prior therapy was
determined by: 1) fever and worsening of clinical conditions,
and 2) persistent candidaemia, or 3) worsening of lung CT scan
together with increase of Aspergillus galactomannan antigenaemia
(AGA), after 96 hours (hrs) from the start of antifungal therapy.
Results: All 14 pts, who were critically ill at the time of
switching therapy, survived; within 72–96 hrs from the begin-
ning of CAT, clinical stability and fever clearance, together with
negative blood culture, or negative AGA were observed, and
conﬁrmed thereafter. LD dAmB did not require any premedi-
cation, but none of the pts suffered from side effects, nor
treatment discontinuation was needed. Mean CAT duration was
26 days. None of the pts relapsed within a follow up period of at
least 60 days from the end of treatment.
Conclusion: CAT including new drugs, such as CAS, is an
appealing option supported by promising data. CAT with CAS
and LD dAmB appears effective in critically ill pts with IFI
failing primary treatment. The synergistic activity of dAmB,
even at LD, and CAS seems to be clinically relevant; considering
the safety demonstrated, LD dAmB allows also remarkable cost
sparing in comparison with lipid formulations. Wider studies
are warranted in this setting.
R2149
Oral candidiasis in antineoplastic chemotherapy-
treated patients
E. Chinou, P. Iordanou, P. Giannakakos, M. Georgouli,
H. Skouteli, P. Golemati (Athens, GR)
Objective: The incidence of Candida species and the sensitivity
to antifungal agents in chemotherapy-associated oral mucositis
were determined in an analysis of nosocomial patients with
various solid tumours and haematologic malignancies.
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Methods: Smears were taken from the lesions when oral
candidiasis was clinically diagnosed and were plated out in
Sabouraud Dextrose Agar (SDA). Candida spp. were identiﬁed
by assessing germ tube and chlamydospore formation and by
examining Api 20C sugar assimilation patterns. For in vitro
susceptibility of isolated yeasts to antifungal agents we used a
commercial method (the Fungitest panel), which allows sus-
ceptibility testing for 5 antifungal drugs at two different
concentrations in modiﬁed RPMI 1640 (amphotericin B, 5-ﬂuor-
ocytosine, ketoconazole, itraconazole, miconazole and ﬂuconaz-
ole). During the study all the patients received antineoplastic
chemotherapy.
Results: Fifty cases of oral candidiasis were diagnosed from 193
patients (25.8%). Candida albicans was isolated from 28 patients
followed by C. tropicalis (14 patients) and C. krusei (4 patients).
Fluconazole is frequently used for prophylaxis and treatment of
fungal infections in the immuonocompromised patients of our
hospital. The ﬁndings from in vitro antifungal susceptibility
testing conﬁrm that the antifungals tested are effected against C.
albicans strains except itraconazole in two isolates and also
conﬁrm the innate resistance to ﬂuconazole of the four C. krusei
strains isolated.
Conclusion: The results of this study denote the need for
constant surveillance of the oral mucosa in cancer patients under
antineoplastic chemotherapy. The good response of the patients
to antimycotic treatment underlines the importance early diag-
nosis, which is expected to reduce the risk of haematogenous
systemic candidiasis.
R2150
Invasive fungal infections and antimycotic
resistance – a 7-year-surveillance
M. Baier, W. Pﬁster, B. Edel, K. Bauer, J. Ro¨del, E. Straube (Jena,
DE)
Objectives: We conducted a 7-year surveillance to assess
frequency, distribution and antimycotic resistance of different
yeasts and moulds causing invasive mycoses in our University
hospital.
Methods: All fungal isolates cultured from BALs, blood cul-
tures, ascites ﬂuids and wound swabs from 1998 to 2004 were
analysed. Considering clinical data only probable agents of
invasive mycosis were taken into account.
Results: From 1998 to 2000 the total number of patients with
candidiasis was increasing from 408 to 508. In 2001 481, in 2002
412, in 2003 480, and in 2004 437 cases were detected. C.
albicans was identiﬁed in 58.8% of all yeast isolates in 1998 and
in 65.9% in 2004. C. glabrata followed by C. krusei were the
most frequently isolated non-albicans species (for 2004: C.
glabrata 16.5 %, C. krusei 6.4 %). In case of fungaemia C. albicans
was identiﬁed in approx. 50% of cases in the period from 1998
to 2002, but an increase up to 82.6% was observed in 2004. The
total number of candida septicaemias varied from 16 to 28 per
year. Pneumonia was the most frequent invasive candidiasis
recorded (1998: 285 cases = 69.9 % of all candidiasis, 2004:
297 = 68.0% respectively). Rates of antimycotic resistance for
ﬂuconazol (FLU) and itraconazol (ITR) were as follows:
C. albicans: FLU: 1999 = 1.5%, 2004 = 2.5%; ITR: 1999 = 2.3%,
2004 = 1.3%; C. glabrata: FLU: 1999 = 23.1%, 2004 = 20.8%; ITR:
1999 = 23.9%, 2004 = 22.4%. All strains of yeasts tested against
voriconazol were sensitive with exception of 2 strains of
C. glabrata and one isolate of C. krusei. Almost all cases of
systemic mould infections were lung infections with Aspergillus
ssp. In the 7-year period a total of 193 systemic mould
infections were observed.
Conclusion: C. albicans is still today the leading causative agent
for invasive candidiasis in our setting. The number of non-
albicans species was not increasing. The in vitro-sensitivity of
C. albicans against ﬂuconazol was only slightly decreasing and
against itraconazol increasing in the observation period. Almost
all yeast strains were sensitive to voriconazol.
R2151
Isolation of Rhizopus microsporus varietas
microsporus from urine in patient with renal
mucormycosis
V. Adamkova, E. Bendova (Prague, CZ)
Isolated renal mucormycosis is an uncommon kidney infection
affecting usually immunocompromised patients. Primary renal
mucormycosis is a rare infection that occasionally causes acute
illness with sepsis. We report a unique case of isolation fungus
Rhizopus microsporus var. microsporus from urine in patient with
renal mucormycosis in the microbiological literature.
A 37-year-old man with diabetes mellitus, with gastric resection
and with defect of calprotectin metabolism was admitted with a
ﬁve-day history of scrotal pain and weight loss. The preliminary
diagnosis was sepsis at orchiepididimitis. Urine and blood
culture were negative. Necrotic and nephrotic syndrome devel-
oped during hospitalization. Renal biopsy showed membrano-
proliferative glomerulonephritis; renal insufﬁciency developed;
CT demonstrated an enlarged left kidney. The urine specimen
was opaque with ﬂuff. Fluff was examinated in 20% KOH
preparations by direct microscopy and revealed numerous
nonseptate hyphae. Culture grew moulds on Sabouraud agar.
This mould grew as a ﬂoccose aerial mycelium which was
brown to grey in surface coloration; it did not grow at 50C.
Microscopically, the colonies were composed of broad hyphae
with stolons which bore rhizoids and fascicles of unbranched
sporangiophores. Our identiﬁcation was Rhizopus sp. The
species identiﬁcation was conﬁrmed by M. vanova as Rhizopus
microsporus, var. microsporus. Rhizopus microsporus was repeat-
edly isolated from urine. Treatment was changed to amphoter-
icin B lipid complex. A simple nephrectomy was performed.
Examination of the enlarged kidney showed presence of
identical mould. Postoperatively the patient was continued on
systemic amphotericin B, he started to urinate. He died of heart
failure 3 months after nephrectomy.
Renal mucormycosis is usually not clinically suspected and are
diagnosed only through surgical, pathological or postmortem
examinations. Identiﬁcation of the genus and species requires
culture of tissue and assessment of the morphology of the fungal
growth. They usually become nonviable when their walls are
damaged by tissue homogenization. The availability of lipid
formulation of amphotericin B within the past few years has
provided an attractive alternative for the management of
zygomycosis. The mortality rate of primary renal mucormycosis
is high, with an overall survival rate of only 36%.
R2152
Isolation of keratinophilic fungi from sample
soils of yards farms and forest in Khorasan and
Golestan provinces of Iran
H. Moallaei, F. Zaini, M. Pith, M. Mahmodi (Sabzevar, Tehran,
IR; Angers, FR)
Objectives: We have studied a small scale method for Isolating
and of keratinophilic fungi from sample soils of yard farms and
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forests and determination of dominanants species in Khorasan
and Golestan provinces of Iran.
Methods: 290 soil samples were collected from various areas of
Khorasan and Golestan provinces of Iran to determine the
prevalence of keratinophilic fungi and dominant species.
Results: A total of 1503 species of fungi from 290 sample soils
including 25 genera and 31 species were isolated viz. Annixiopsis
stercoraria (23.355%), Fusarium spp. (13.37%), Chrtysosporium spp.
(13.03%), Aspergillus spp. (12.97%), Paecilomyces lilacinus (6.98%),
Penicillium spp. (5.23%), and other fungi (25.07%). McNemar’s
Test showed that non-keratinolytic fungi are dominant in this
investigation. (P < 0.05, v2 = 29.24) and also showed that in
whole studied area Anixiopsis stercoraria (23.35%) and Fuzarium
oxysparum (11.97%) are dominant (P < 0.05, v2 = 4).
Conclusion: Anixiopsis stercoraria is the most prevalent kera-
tinophilc fungi and also dominant species that isolated from 290
soil samples of three different geographical regions included
mountain states, forest states and desert states. The distribution
pattern of the different keratinophilic fungi and their signiﬁ-
cance are discussed.
R2153
Candidaemias in intensive care units of a tertiary
hospital in Spain
L. Rodriguez-Otero, I. Villamil-Cajoto, P. Vazquez-Ferreiro, M.
Garcia-Zabarte, C. Garcia-Riestra, B.J. Regueiro (Santiago de
Compostela, ES)
Introduction: Invasive fungal infections are an important cause
of morbidity and mortality in intensive care unit (ICUs) patients.
The distribution of species Candida causing nosocomial candid-
aemia is changing due to the use of antifungal drugs mainly.
Objectives: Know the incidence of candidaemia and species
distribution comparing the groups Candida albicans versus other
non-albicans Candida species in ICUs patients, from 1 September
1999 to 31 December 2004.
Methods: An incident case was deﬁned by the ﬁrst isolation
during the study period of any Candida species from blood of a
patient in ICUs. The incidence rates of candidaemia per number
of admissions in UCIs were determined for C. albicans and other
species of Candida no albicans.
Results: During 64-month-period a total of 206 episodes of
fungaemia were collected in a tertiary hospital in Spain. Seventy-
eight consecutive episodes of candidaemia concerning to ICUs.
C. albicans was the most prevalent isolated species (n = 35,
44.9%); the remaining strains (n = 43, 55.1%) were non-albicans
Candida species mostly represented by C. parapsilosis and lesser
by C. glabrata. The distribution by year and species was: in 1999
non-albicans Candida species (n = 1) of a total 1 candidaemia. In
2000 there were 10 episodes of candidaemia, Candida albicans
(n = 5, 50%) versus non-albicans Candida species (n = 5, 50%). In
2001 candidaemia total was 16 episodes and the distribution was
C. albicans (n = 6, 37.5%), versus non-albicans Candida species
(n = 10, 62.5%). In 2002 were 15 fungaemias; C. albicans (n = 7,
46.7%) and non-albicans Candida species (n = 8, 53.3%). In 2003
16 fungaemias was detected and the distribution was C. albicans
(n = 7, 43.8%) and non-albicans Candida species (n = 9, 56.2%).
And ﬁnally in 2004, 20 fungaemias being of C. albicans (n = 10,
50%); non-albicans Candida species (n = 10, 50%). The overall
incidence rate per 1000 admissions was 7.07, ranging from 4.78 in
2000 to 11.2 in 2004 (7.22 in 2001; 6.16 in 2002 and 5.99 in 2003). In
C. albicans the incidence rose from 2.39 in 2000 to 5.6 in 2004 (2.71
in 2001; 2.87 in 2002; 2.62 in 2003). The incidence of non albicans
Candida species showed tendency rose too and were 2.39 in 2000,
4.51 in 2001, 3.29 in 2002, 3.37 in 2003 and in 2004 5.6.
Conclusions: Although the global incidence rose and most
studies show an increased shift incidence of candidaemia
from C. albicans to non-albicans Candida species, our group
observed no shift despite a signiﬁcant increase in the use of
ﬂuconazole.
R2154
Disseminated infection due to Candida
guilliermondii in a patient with acute
myelogenous leukaemia. A case study
C. Panzaru, M. Dan, C. Burcoveanu, A. Mereuta (Iasi, RO)
Objective: To evaluate the origin of candidaemia in a patient
with acute myeloid leukaemia
Methods: We used biphasic media (Haemoline Performance
Duo: bioMerieux-France) for blood cultures. Isolates were
identiﬁed using ID 32C (API yeast identiﬁcation system,
bioMerieux) and susceptibility tests were performed with ATB
FUNGUS (bioMerieux). The strains were considered clinically
signiﬁcant based on standard deﬁnitions established by the
European Organization for Research and Treatment of Cancer/
Invasive Fungal Infections (2002).
Results: A 43-years-old patient admitted with acute myeloid
leukaemia, developed bronchopneumonia and sepsis during
profound neutropenia. Fever and pulmonary inﬁltrates did not
improve by using empiric antibacterial therapy (cefoperazone-
sulbactam, sulphametoxazol-trimethoprim). Blood and sputum
cultures were performed and the patient received voriconazole.
Both cultures, from blood and sputum, yielded Candida guillier-
mondii after 48 hours of incubation. The isolates had the same
biochemical and antimicrobial spectrum, and were susceptible
to amphotericin B and ﬂuconazole. After a few days of therapy
with voriconazole, fever disappeared and the clinical state of
patient improved. A culture from pharyngeal swab, performed
after 11 days, yielded the same microorganism.
Conclusion: 1. The emergence of less common but medically
important fungal pathogens, including Candida guilliermondii,
contributes to the rate of morbidity and mortality, especially in
the increasingly expanding population of immunocompromised
patients. 2. We consider that the oropharyngeal colonization
with Candida guilliermondii and profound neutropenia predis-
posed our patient to develop bronchopneumonia and candid-
aemia.
R2155
Fungaemia caused by yeasts in patients of a
university hospital, Cracow: epidemiology and
risk factors proﬁle over a 9-year period
J. Keˆdzierska, A. Pietrzyk, A. Keˆdzierska, U. Pradel (Cracow, PL)
Objectives: Fungaemia is reported as the 4th cause of septicae-
mia in the international literature, with inherent serious
morbidity and signiﬁcant mortality. No local epidemiological
data on this problem are yet available. Aim of the study was to
evaluate local epidemiology of systemic fungal infections in
adults considering potential risk factors, during the last decade.
Methods: 28 704 samples of peripheral venous blood collected
from 6031 patients with symptoms of systemic infection were
analysed. Patients were treated in the Departments of: Haema-
tology (HAEM), Neurotraumatology and Neurosurgery
(NT&N), General and Gastroenterological Surgery (G&GES),
Infectious Diseases, Internal Medicine and Metabolic Diseases.
Blood samples were incubated using automatic BactT/Alert
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system. Identiﬁcation of fungi was performed using commer-
cially available ID 32C kit.
Results: (1) 242 cases of fungaemia were documented (median
age: 51.5 ± 18.7; average hospitalisation: 53.6 ± 37.9 days); (2)
highest no. of fungaemia episodes were found in patients with
non-neoplastic gastrointestinal tract disease (30.5%), solid
tumours (24.1%) and haematopoietic system neoplasms
(16.4%); (3) a rising tendency of fungaemia episodes was
observed: from 0.6 to 2.5 episodes/1000 treated (mean 2.0/
1000); (4) highest incidence was conﬁrmed in the G&GES and
NT&N Departments: a rise from 0.2 to 4.5 episodes/1000
(p < 0.002) and from 0.8 to 4.0 episodes/1000 (p < 0.02), in the
HAEM Department it decreased systematically; (5) main risk
factors for developing fungaemia were: preceding antibiotic
therapy (92.1% cases), central catheterization (81.1%), stay at the
ICU (66.7%), surgical procedures (66.5%); mechanical ventilation
(66.2%), immunodeﬁciency involved only 1/5 of patients
(20.0%); (6) total mortality was over 30%; highest percentage
of deaths was registered in the G&GES (41%) and NT&N (35%)
Departments; (7) a total of 255 yeast strains were identiﬁed in
blood samples, representing 4.0% of all positive blood cultures;
(8) general aetiology: C. parapsilosis (33.9%), C. albicans (30.7%),
C. glabrata (10.0%) and C. tropicalis (8.8%); (9) in onco-haema-
tological patients Candida non-albicans (71%) and non-Candidal
strains (21%) dominated.
Conclusion: Results obtained by us conﬁrm current worldwide
trends relating to the epidemiology of hospital acquired
systemic fungal infections: their incidence, aetiology as well as
the risk factors involved.
R2156
Scopulariopsis brevicaulis fungaemia: case report
and implications for the diagnostic microbiology
laboratory
H. Kennedy, B. Gibson, C. Williams (Glasgow, UK)
Objectives: To describe an unusual case of fungal infection by
Scopulariopsis brevicaulis in a paediatric patient with acute
lymphoblastic leukaemia (ALL) and to discuss the challenges
in laboratory detection of this organism from blood culture.
Case: A 10-year-old girl receiving maintenance chemotherapy
after relapse of ALL following bone marrow transplantation was
admitted with fever and a dry cough. Her CRP level was
141 mg/L. Blood cultures at this time were negative. A CT scan
revealed multiple pulmonary lesions suggestive of fungal
pneumonia. AmBisome was added to empirical antibiotic
therapy. Bronchial lavage was not performed. Blood cultures
collected 10 days later yielded S. brevicaulis. Voriconazole was
added but blood cultures remained intermittently positive.
Microbiological response and complete resolution of fever was
ﬁnally achieved after the addition of oral terbinaﬁne. AmBisome
was later discontinued and the patient discharged. To date, she
remains asymptomatic and apyrexial on oral voriconazole and
terbinaﬁne. However, some pulmonary lesions remain.
Methods: Inoculated blood culture bottles were processed
using the BacTAlert automated system (BioMerieux), which
detects growth due to microbial production of CO2. Antifungal
MICs were determined at the HPA Mycology Reference Labor-
atory, Bristol, UK.
Results: S. brevicaulis was cultured from blood specimens on 5
occasions (over a period of 4 weeks). However, on 3 of these
occasions the inoculated blood culture bottles failed to signal
positive. Fortunately, manual observation of the bottles prior to
discard revealed several small cream-coloured spherical struc-
tures (fungal balls). Culture of the intact fungal balls and the
blood culture ﬂuid yielded no growth. However, culture of the
disrupted fungal balls yielded S. brevicaulis. Antifungal MICs
were: amphotericin 1 mg/L, voriconazole 8 mg/L, itraconazole
16 mg/L, caspofungin 4 mg/L and terbinaﬁne 0.5 mg/L.
Conclusions: S. brevicaulis fungaemia is rare and this report
reveals that its detection by automated blood culture systems
may be problematic. In the present case, laboratory diagnosis
relied signiﬁcantly upon manual examination of the inoculated
blood culture bottles. The presence of antifungal agents may
reduce the sensitivity of detection of the automated system. In
addition, the compact structure of the S. brevicaulis fungal balls
may represent a micro-environment from which CO2 is less
readily released into the culture medium.
R2157
Risk factors for invasive aspergillosis in
haematologic malignancy patients in a tertiary
teaching hospital in Korea
H.J. Yoon, Y.S. Park, Y.K. Kim, M.S. Kim, S.Y. Shin, Y-A. Kim,
Y.H. Kim, J.W. Cheong, J.Y. Choi, Y.G. Song, J.M. Kim (Seoul,
KR)
Introduction: Invasive aspergillosis (IA) is an important cause
of morbidity and mortality in patients with haematologic
malignancies (HM). The changes in the population at risk for
IA due to intensiﬁed and new treatment strategies require a
continuous re-evaluation of risk factors for IA. We conducted a
retrospective case control study at a tertiary teaching hospital in
order to identify risk factors for IA among patients with HM
during the hospital construction period.
Methods: In this study, we evaluated the risks among 41 case
patients who developed proven, probable, or possible IA
according to standardized deﬁnitions in HM patients between
July 2000 and May 2005. Control patients with no signs and
symptoms of IA were matched for the time and place. The
clinical data analysed included demographic characteristics;
Charlson comorbidity score at the time of diagnosis of IA, the
type of haematologic neoplasm risk factors for IA present at or
within 1 month before the diagnosis of infection and previous
antifungal use within 3 months of diagnosis of infection. Risk
factors associated with IA were identiﬁed in a multivariable Cox
regression model.
Results: In total, 41 IA cases (eight proven, ten probable, 23
possible), and 170 controls were analysed. Forty-three patients
(20.4%) had AML, 27 (12.8%) had ALL, 85 (40.3%) had
lymphoma, 33 (15.6%) had myeloma, 7 (3.3%) had myelodys-
plastic syndrome, and 18 (8.5%) had other disease. Anatomic
sites of infection included lungs (n = 31), sinus or nose (n = 6),
skin (n = 2), spine (n = 1), and skeletal muscle (n = 1). Variables
that increased the risk for IA included duration of hospitaliza-
tion (HR, 1.022; 95% CI, 1.002–1.042; p, 0.031), AML (HR, 0.031;
95% CI, 0.001–0.762; p, 0.033), malnutrition (HR, 4.812; 95% CI,
1.309–17.689; p, 0.018), and high iron level (HR, 1.001; 95% CI,
1.000–1.001; p, 0.017). Twenty patients died (48.8%) among IA
and death was attributed to IA.
Conclusion: Results of risk factor analysis indicated that
important variables predictive of IA included longer duration
of hospitalization, non-AML, malnutrition, and high iron level.
These results contribute to the further characterization of
patients groups at high risk of IA and may help to target
costly prophylactic measures against IA.
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R2158
Fungaemia in paediatric patients
M. Bosch, A. Viudes, J. Pema´n, E. Canto´n, E. Colombo, J.
Frasquet, C. Pe´rez-Belle´s, M. Gobernado (Valencia, ES)
Objective: To deﬁne the epidemiological pattern of paediatric
fungaemia in our hospital during the last 10 years.
Methods: Retrospective study of all fungaemia episodes from
La Fe University Children’s Hospital. All yeasts were isolated
from blood cultures from January 1995 to December 2004. Data
such as demographical aspects, hospital department and con-
comitant diseases were collected. Isolates were identiﬁed by the
Vitek 2 system (BioMerieux, France).
Results: During the study period, 154 episodes of fungaemia
were diagnosed. The more frequent species isolated were
C. parapsilosis (46.1%), followed by C. albicans (42.86%), C.
guilliermondii (3.25%), C. tropicalis (1.95%), C. glabrata (1.30%), C.
lusitaniae (1.30%), Saccaromyces cerevisiae (1.30%), C. krusei
(0.65%), Trichosporum asahii (0.65%) and Pichia ohmeri (0.65%).
The majority (67.32%) of fungaemia episodes occurred in
Neonatal, Paediatric, Reanimation and Burns Intensive Care
Units; 27.45% were from Medical Departments and 5.88 % from
Surgical Departments. C. parapsilosis was the most frequent
species isolated in Intensive Care Units and Medical Depart-
ments (49.52% and 40.48%, respectively). However, C. albicans
was more frequent in Surgical Departments (44.4%) than C.
parapsilosis (33.3%). Fungaemia was more frequent in neonates
(58.44%) and in boys (59.09%).
Conclusions: C. parapsilosis is the most prevalent species caus-
ing fungaemia in our Children’s Hospital. Fungaemia is more
frequent in Intensive Care Units, in boys, and in neonates. This
study has been partially ﬁnanced by a Grant (2/2005/0140) of
Fundacio´ per a la Investigacio´ Hospital La Fe.
R2159
Antifungal susceptibility of Candida
guilliermondii isolated from blood cultures
M. Bosch, E. Canto´n, J. Pema´n, A. Viudes, E. Colombo, J.
Frasquet, C. Pe´rez-Belle´s, M. Gobernado (Valencia, ES)
Background: C. guilliermondii is isolated with a low frequency
from blood cultures (1–5%). Fungaemias due to this species have
been reported in cancer, surgical and intensive care unit
patients. Risk factors for acquiring a fungaemia by this species
are treatment for malignancy, neutropenia and bone marrow
transplantation.
Objective: To study the incidence and susceptibility patterns of
C. guilliermondii isolated from blood cultures in La Fe University
Hospital during the last ten years.
Methods: Retrospective study of all candidaemia episodes by
C. guilliermondii diagnosed from January 1995 to date in our
hospital. Mycology, laboratory and clinical records were
reviewed. The susceptibility study was carried out using a
microdilution method according to CLSI guidelines (document
M 27-A2).
Results: In the period of study we found 584 episodes of
candidaemia, seven of them were due to C. guilliermondii
(1.19%). Five cases (patients no. 1, 2, 3, 4 and 5) were children.
Prematurity, intravenous catheter and previous antibiotic use
were the most important risk factors associated in children.
Most of them survived the episode after antifungal treatment. In
adults (patients 6 and 7), the risk factors were the same as
reported by other authors and all died in spite of antifungal
treatment. The antifungal MICs (mg/ml), antifungal treatment
received and outcome of patients are shown in the Table.
Conclusions: C. guilliermondii is a very unusual cause of
candidaemia in our hospital. During the ten-year period, the
majority of cases are found in children. In one of cases with fatal
outcome, good correlation between clinical outcome and the in
vitro activity of the antifungal agents is observed.This study has
been partially ﬁnanced by a Grant (2/2005/0140) of Fundacio´
per a la Investigacio´ Hospital La Fe.
R2160
Oral colonisation by Candida and Staphylococcus
in denture wearers
E. Eraso, M. Villar-Vidal, C. Marcos, J. Lo´pez-Vicente, A. Egan˜a,
A. De-Juan, J.M. Aguirre, G. Qundo´s (Bilbao, ES)
Objective: To investigate the microbial oral colonization in
Spanish denture wearers.
Patients and methods: Forty-six persons carrying dentures
were randomly recruited from our Odontology Clinics, 28
with different types of denture stomatitis and 18 without
stomatitis. Swabs were taken from the denture and the under-
lying mucous. Microbiological culture and isolation were per-
formed following standard procedures in Columbia agar, and
Candida ID2 and S. aureus ID chromogenic agar plates (bio-
Me´rieux, France). Yeasts were identiﬁed by conventional myc-
ological methods, as the germ tube induction test in serum,
microscopical morphology and chlamydospore production in
corn meal agar with Tween 80, and by ID 32C (bioMe´rieux).
Identiﬁcation of Candida dubliniensiswas conﬁrmed by PCR with
speciﬁc primers. Staphylococci were identiﬁed by catalase
reaction, differential growth in Mannitol-Salt agar, Slidex
Staph Plus latex reagent and ID 32 STAPH (bioMe´rieux).
Slidex MRSA detection test (bioMe´rieux) was used for the
evaluation of methicillin resistance.
Results: Thirty-six patients were carriers of yeasts (19 with
different types of denture stomatitis and 16 without stomatitis)
and 85 yeast isolates have been obtained: 42 of them from
dentures and 43 from oral mucosa. Candida albicanswas the most
commonly yeast from the 67.4% of patients (63.5% of isolates).
Other species isolated were: Candida tropicalis (19.6% of patients
and 17.6% of isolates), Candida glabrata (10.9% of patients and
11.8% of isolates), Candida guilliermondii (4.3% of patients and
2.4% of isolates), and C. dubliniensis and Candida krusei (both
2.2% of patients and 1.2% of isolates). Forty percent of denture
wearers were colonized by Staphylococci, being Staphylococcus
aureus in three patients (6.5%). MRSA was not isolated. Staphy-
lococcus epidermidis was isolated from ﬁve patients (10.9%),
Staphylococcus warneri from eight patients (17.4%) and Staphylo-
coccus saprophyticus from two patients (4.3%). In 12 patients there
was a mixed colonization by Candida and Staphylococcus. One
patient was colonized by C. dubliniensis, C. krusei and S. aureus.
Conclusion: We have found a high incidence of colonization
with Candida albicans and Staphylococci in denture wearers with
independence of the presence of denture stomatitis.[This study
was in part supported by grant from the Fondo de Investigacio´n
Sanitaria del Ministerio de Sanidad de Espan˜a (PI030662/2003)].
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R2161
Scedosporium apiospermum lung infection with
fatal outcome in an immunocompetent host
C. Pizzocolo, S. Abgrall, H. Gros, J. Cailhol, O. Bouchaud
(Bobigny, FR)
Introduction: Invasive infection by Scedosporium apiospermum, a
common soil fungus with an ubiquitary distribution, have been
largely reported in immunosuppressed patients (haematological
malignancy, organ transplantation, AIDS, steroids treatments).
Scientiﬁc literature reports only few description of invasive
infections of the immunocompetent host. In this report, we
describe a case of S. apiospermum invasive lung infection with
histological conﬁrmation in a immunocompetent patient.
Case report: A 68-year-old man was admitted in our Depart-
ment complaining of dyspnoea, haemoptysis, weight loss,
asthenia and anorexia of 6 months’ duration. He also reported
night sweat and pyrexia. On admission, his physical examina-
tion showed cachexia, hyperpyrexia and purulent sputum. He
had an inﬂammatory anaemia and biological inﬂammatory
syndrome without leucocytosis. The patient had history of lung
tuberculosis 40 years before. Chest X-ray and computed tomog-
raphy (CT) showed a huge cavity with declivous necrotic
material affecting the upper right lobe. Bronchoscopy evidenced
bronchial distortion (tuberculosis’ sequelae). M. tuberculosis and
non-speciﬁc bacteria did not grow from any specimens of
bronchial washing and sputum and no malignant cells were
found. Mantoux test and Aspergillus spp. serology and anti-
genemia were negative. A three-week culture of sputum and
bronchial washing grew S. apiospermum; serology was strongly
positive. An antifungal treatment with voriconazole was started,
but one month later, in reason of no amelioration on CT control
and persistence of fever and weight loss, a surgical approach
was decided. He underwent an upper and medium lobectomy
of the right lung. Subsequent nosocomial pneumonia with
respiratory failure caused patient’s death few days later.
Histology of surgical specimen conﬁrmed S. apiospermum infec-
tion.
Discussion: Invasive pseudoallescheriasis of the immunocom-
petent host is poorly reported in literature. This case report
highlights importance of differential diagnosis in infection of
pre-existing lung cavities in immunocompetent patients, inclu-
ding tuberculosis, common bacterial infections, Aspergillus spp.,
mycetoma and rare fungal infection like Scedosporium spp., for
which a delayed diagnosis potentially worsen prognosis. Indi-
cations of an early medical and surgical treatment needs to be
deﬁned, such as value of antifungal associations (ex. voricon-
azole and terbinaﬁne).
R2162
Aspergillus fumigatus infections in patients with
chronic granulomatous disease hospitalised in a
children’s memorial health institute, Warsaw,
Poland
B. Garczewska, D. Dzierzanowska, P. Jozwiak (Warsaw, PL)
Objectives: The aim of this study was to assess serological and
molecular methods usefulness for diagnosis of invasive asp-
ergilosis in patients with chronic granulomatous disease (CGD)
presenting at the Children’s Memorial Health Institute, Warsaw,
Poland.
Methods: Samples were obtained from 3 patients hospitalized
in our institute with clinically proven or suspected active fungal
infection. For all patients galactomannan detection (PLATELIA
ASPERGILLUS TEST, BioRad) and polymerase chain reaction
(nested-PCR) were performed in serum samples. Simulta-
neously, various clinical materials (blood, urine, BAL, CSF,
sputum wound and mucosal swabs) were taken for routine,
mycological diagnosis. All clinical samples were inoculated on
Sabouraud plates and cultivated for 14 days at 28–30C under
aerobic conditions. Isolates were identiﬁed by microscopic and
biochemical methods. Antifungal susceptibility testing was
performed according to NCCLS recommendations.
Results: For all patients, antigen detection results in serum
samples were negative. In serum samples from two patients
during active infection, Aspergillus DNA was detected by PCR
method. During this time, Aspergillus fumigatus was also detect-
able in bronchoalveolar lavage ﬂuid (BAL) of both patients and
in cerebrospinal ﬂuid (CSF) of single patient. In 1 of 3 patients
with symptomatic pulmonary and sinusal aspergilosis, PCR
result for Aspergillus sp. was negative. In both patients PCR
results became negative after two months of antifungal treat-
ment with voriconazole (VZ).
Conclusions: 1. Our results indicate high usefulness of PCR
method for Aspergillus sp. detection and empirical antifungal
therapy monitoring in CGD patients.2. Sandwich ELISA test
for galactomannan detection in serum is not a reliable method
for invasive aspergilosis diagnosis because of false negative
results.
R2163
Susceptibility of clinical isolates of Cryptococcus
neoformans and Cryptococcus gattii to
voriconazole
I.S. dos Santos, L.C. Severo, A.C. Pasqualotto (Porto Alegre, BR;
Manchester, UK)
Cryptococcosis is an important human infection generally
associated with high mortality. At the moment, clinical data
favours the combination of amphotericin B desoxycholate and
5-ﬂucytosine as ﬁrst-line therapy for serious Cryptococcus
infections such as meningoencephalitis. However, this regimen
is associated with a considerable toxicity. Voriconazole is a
recently available triazole antifungal drug with broad-spec-
trum activity, including activity against Cryptococcus species.
Although several studies have been published in the last
years revealing the in vitro activity of voriconazole against
Cryptococcus neoformans, little information is available for
Cryptococcus gattii. The purpose of this study was to analyse
the in vitro susceptibility of clinical isolates of Cryptococcus
against voriconazole. Susceptibility tests were performed
according to the protocol M27A-2, Clinical and Laboratory
Standards Institute (CLSI, former NCCLS). Cryptococcus was
identiﬁed by standard mycological techniques based on
characteristics of growth appearance on Sabouraud dextrous
agar and Niger agar. Species identiﬁcation was performed
based on the production of urease and using canavanine-
glycine-bromthymol blue medium. Minimal inhibitory con-
centrations (MICs) for voriconazole were determined for 37
isolates of C. neoformans var. grubii and 7 isolates of C. gattii.
The MIC for 95.5% of these isolates was 0.03 lg/ml, and a
MIC of 0.62 lg/ml was found for a single isolate of C. gattii.
No resistant strain was found. Since previous studies have
reported that C. gattii is less susceptible than C. neoformans to
many antifungal drugs, including voriconazole, close monit-
oring is required. The results of this study reinforce the potent
in vitro of voriconazole against Cryptococcus species.
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R2164
Chronic mucocutaneous candidiasis with
secondary adrenal insufﬁciency: a case report
A.T. Bastug, M.A. Huner, E. Akinci, A. Erbay, M.A. Cevik,
H. Bodur (Ankara, TR)
Objective: Chronic mucocutaneous candidiasis is a complex of
disorders in which patients have chronic and recurrent Candida
albicans infections of skin, nails and mucous membranes and
several other disorders such as other infectious diseases,
autoimmune disorders, endocrinopathies, thymoma, dental
enamel dysplasia, vitiligo, alopecia totalis and interstitial kera-
titis can be seen. Chronic mucocutaneous candidiasis can be
familial or sporadic and is generally seen in childhood but also
there are some cases reported in adults. In our case chronic
mucocutaneous candidiasis with secondary adrenal insufﬁ-
ciency is reported.
Case: A 34-year- old woman was admitted with the complaint
of oral and oesophageal candidiasis. The patient was suffering
from oral and oesophageal candidiasis for one year period and
Candida albicans which was sensitive to Amphotericin B, inter-
mediate sensitive to Fluconazole and resistant to itraconazole
was isolated from the cultures of oral and oesophageal biopsy
specimens and although proper antifungal therapy was given
four times, recurrent lesions were appeared within one month
after the antifungal therapy. When the patient was admitted
except oropharengeal and oesophageal mucous membranes
there was no other tissue involvement and from the cultures of
oral plaques Candida albicans was isolated and the antifungal
sensitivity was same. The patient was diagnosed with cell
mediated immune deﬁciency in which T cell activation markers
of CD69 and CD25 expressions were 20–30% (half of the control
of 50–60%). This test is done with various dilutions 1/50
concentration of Candida antigen. The candidin skin test with
1/400 concentration of Candida antigen was positive at
48 hours. Anti-HIV was negative and CD4, CD8 counts were
normal. Caspofungine 50 mg/day intravenously was given for
14 days as antifungal therapy and the lesions were disappeared
on ﬁfth day of the therapy. Beta glucan 10 mg/day therapy was
given to support the immunity. Because endocrinopathy is seen
50% of the patients with chronic mucocutaneous candidiasis the
hormone levels were examined. Cortisol level was 2.6 lg/dl and
the cortisol levels increased by insulin-hypoglycaemia test and
synacthen test so secondary adrenal insufﬁciency was conﬁrmed
and deltacortril was given 5 mg/day.
R2165
Species distribution and antifungal susceptibility
of Candida isolates collected from hospitalised
patients
L.M. Junie, D. Tatulescu , C. Costache, I. Colosi, P. Ciobanca
(Cluj Napoca, RO)
Background: Human candidiasis is increasing now in incidence
and in clinical manifestation, due to the high frequency of
prolonged antibiotic therapy, the invasive procedures and
immune deﬁciencies. The immunosuppression by transplant,
the drug therapy for cancer and AIDS favour the disseminated
infections. Knowledge of clinical manifestations and predispo-
sing factors is proﬁtable in order to establish the proper
prophylaxis and treatment.
Objectives: Patients hospitalized for clinical assumption of
candidiasis were assessed. The aim of this study was to evaluate
species distribution and antifungal susceptibility of Candida
isolates recovered from pathological products, at some hospitals
in Cluj-Napoca.
Methods: In a period of 2 years, 338 Candida isolates were
collected. All isolates of Candida spp. were identiﬁed by the
germ tube test and the API test (bioMerieux). Identiﬁcation of
species was followed by examination with broth the microdi-
lution method, as described in NCCLS M27-A2, of the antifun-
gal susceptibility to six agents, with readings after 24 and 48 h of
incubation. MIC of antifungal agents was determined by the E
test.
Results: The candidiase aetiology was established in 338
patients. 70% of the candidiasis were nosocomial infections,
5% occurred in patients hospitalized in an intensive care unit,
25% in patients hospitalized for cancer therapy. Mucosal
candidiasis prevails (63.1%) followed by cutaneous candidiasis
(25.2%) and disseminated candidiasis (10.8%). The overall
species distribution was:41% C.albicans, 22.3% C. parapsilosis,
12.4% Candida glabrata, 12% Candida tropicalis, 2% C. krusei, 0.7%
C. guilliermondii, and 5.8% Candida spp.
Conclusions: An important issue in candidiasis therapy is the
occurrence of the resistant strains, both to common antifungal
drugs and to those recently discovered. Our data suggest that
the Candida species distribution and the antifungals resistance
rate are similar to those reported previously in USA and Europe,
but disparities in the species distribution and in the antifungal
susceptibility of Candida isolates from other studies and coun-
tries are described. Our future goal is to study the susceptibility
of Candida to antifungal drugs in order to struggle against these
wide spread infections. The ﬁndings emphasize the need for
continuous surveillance and further clinical investigational
studies.
AIDS and HIV infection
R2166
Predicting factors of loss to follow-up after
HIV-positive testing in a hospital in Paris, France
in 2004
G. Pahlavan, S. Retout, P. Ye´ni, F. Mentre´, E. Bouvet (Paris, FR)
Objective: Deﬁning predictors of loss to follow-up in an
anonymous and free of charge HIV voluntary counselling and
testing (VCT) centre in Paris.
Methods: Bichat’s hospital VCT is an important HIV testing
centre with a positive rate around 2%. Our study is retrospective
concerning all HIV positive screened patients from 01 January
2004 to 31 December 2004. Information was collected by
reviewing patients ﬁles using a standardized questionnaire.
Our cohort was divided in two groups (loss of follow up versus
followed up), and compared for each variable. The entering
variables are age group, gender, sexual orientation, partner HIV
positive, contamination factor, condom systematic use, employ-
ment status, medical care coverage, residence status and
ethnical origin. Data was analysed using Splus software, in
addition to descriptive data analyses, associations between ‘‘lost
to follow-up’’ status and variables were assessed for statistical
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signiﬁcance using Fisher exact test for discrete variables and
Wilcoxon test for the age.
Results: During the study, 5634 persons applied for HIV
testing, 114 were positive. 101 are included in our study (13
were withdrawn). 65% men, 35% women. 62% heterosexuals.
89% sexual contamination. Mostly migrants from Africa 61.4%.
29% Africans lost to follow-up for 9% French. The only
signiﬁcant predictor of loss to follow-up found by a univariate
model is the ethnical origin (p = 0.04). Interactions between the
variables selected in the ﬁnal multivariate model were also
considered and will be presented at the congress.
Conclusion: In our study the HIV positive patients are mostly
immigrants in a difﬁcult social status. The observed rate of 31%
of loss to follow up raises the issue of ﬁnding alternative
approaches to insure that persons undergoing testing for HIV,
return for the results and then have efﬁcient access and linkage
to care. We propose additional emphasis in patients counselling,
regarding the predictor found in order to target the messages for
persons with higher risk of loss to follow-up. At Bichat hospital,
trained navigators are now present at the VCT to help the
immigrant population. Their collaboration needs to be empha-
sized and its impact on the rate of loss to follow up, measured.
Our results and the many missing data, emphasize the need to
collect complete information during pretest counselling.
R2167
Detection of HIV sequences in respiratory tract
bacteria of Cambodia and Kenya AIDS-positive
patients
V. Zajac, M. Kovac, S. Ciernikova, M. Mego, V. Stevurkova,
A. Liskova, V. Krcmery (Bratislava, Nitra, Trnava, SK)
Objectives: The hypothesis whether bacteria from respiratory
tract of HIV-1 positive patients carry HIV-like sequences was
examined.
Material and methods: Bacteria and Patients. Respiratory tract
(nose, pharyngeal svabs) bacteria were isolated from 38 Cam-
bodian and 24 Kenyan HIV-1 positive patients.
PCR ampliﬁcation. Polymerase chain reaction speciﬁc for HIV
sequences was carried out using these primers:
P38F: ATAATCCACCTATCCCAGTAGGAGAAT
P39R: TTTGGTCCTTGTCTTATGTCCAGAATG
P1F: CATTTGGAAAGGACCAGCAAAACTACT
E1R: TCATATGCTTTAGCATCTGATGCACAA
E68F: AGCAGCAGGAAGCACTATGG
E69R: CCAGACTGTGAGTTGCAACAG
G3F: TTGGACATAAGACAAGGGCCAAAA
G4R: GTCGTTGCCAAAGAGTGATTTGAG
Hybridization. 32P-labeled probes used were following: 38-39;
68-69, P1-E1 and G3-G4. DNA sequencing. The sequencing
reaction was performed using Big Dye Terminator kit and
sequences were resolved on 310 Genetic Analyzer.
Results: Bacteria were diluted to concentration 10)10 and
single colonies were analysed. Around 34% of bacteria
isolated from Cambodian and 33% from Kenyan AIDS
patients were found to be positive in colony hybridization
with HIV-speciﬁc PCR probes prepared using mentioned
primers on pHB10 template. Bacterial DNA of all patients was
isolated and 200–300 ng were analysed in dot blot using the
same HIV speciﬁc probes. Approximately 31% of DNA
isolated from Cambodian and 31.5% of Kenyan HIV-positive
patients were positive in dot blot assay. Reproducibility of
results between dot blot and colony hybridization was more
than 90%. Bacterial DNA of positive isolates was ampliﬁed in
PCR reaction with all four sets of primers. Sequencing of
these products revealed high homology with the reference
HIV sequence, while these sequences were not present in
samples isolated from healthy individuals. Bacteria bearing
HIV-like sequences were classiﬁed as Klebsiella pneumoniae
(48%), Staphylococcus aureus (13%), Staphylococcus pyogenes
(9%), Escherichia coli (4%), Proteus mirabilis (4%) and Candida
albicans (17%), Candida tropicalis (9%) respectively.
Conclusions: 1. HIV-1 sequences were detected in respiratory
tract bacteria of Cambodian (34%) and Kenyan (33%) AIDS
patients by colony and dot blot hybridization (31; 31.5%) using
HIV-1 speciﬁc probes. 2. PCR ampliﬁcation and subsequent
sequencing of positive bacterial DNA samples revealed high
homology with HIV-1.
R2168
Trends of HIV infection in Giurgiu county,
Romania
L. Manolescu, P. Marinescu, C. Sultana, S. Ruta (Bucharest,
Giurgiu, RO)
Background: Romania encountered three major waves of HIV
infection: ﬁrst occurred between 1987–1991, in children from
institutions. The second occurred between 1994–1995 in children
from families. Since then a third wave of epidemic is predictable
in sexually active adolescents and young adults.
Objective: To analyse the existing information concerning the
extent and the dynamic of the HIV/AIDS epidemic in Giurgiu
county during 1995–2005.
Methods: Virological, immunological and clinical status of all
new HIV diagnosed patients were evaluated from 1995 till
present in a prospective study.
Results: We observed a decrease in the number of new HIV
infected individuals, in 1995 there were 62 new HIV diagnosed
patients in 1998, 28; in 2000, 20; in 2003, 6 and in 2005 only 3 new
HIV infected. The median age at diagnoses increased year by
year from 8.9 ± 6.24 years old in 1995, to 14.2 ± 8.78 years old in
1997, 17.47 ± 8.80 in 2000 and then in 2003 to 27.5 ± 14.30 years
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old. We also observed a decrease in the rate of AIDS to HIV in
new infected persons from 1.27 in 1995 to 0.5 in 2003 and 0.1 in
2005. No difference in gender incidence of HIV infection was
noticed. The vertical transmission is still in the low range (<5%).
The percentage of new diagnosed HIV individuals that started
antiretroviral therapy increased from 43.5% in 1995 to 83.3% in
2003.
Conclusion: The weigh of paediatric AIDS in Romanian epi-
demic is balanced after 1996 by continuous spread of the disease
in adult population. The number of new HIV infected individ-
uals by year of diagnose is decreasing in Giurgiu County and
the trend is to diagnose patients in early stages. The epidemic,
driven initially by a nosocomial tragedy in Romania now risks
spreading more widely through increased sexual risk behaviour
together with sexually transmitted infections.
R2169
Unilateral lipomasty in a cohort of HIV (+)
individuals
P. Panagopoulos, S. Tsiodras, A. Antoniadou, A. Papadopoulos,
G. Poulakou, I. Katsarolis, L. Galani, H. Giamarellou (Athens,
GR)
Purpose: To describe a series of HIV (+) male individuals that
presented in a tertiary care HIV clinic with unilateral lipomasty
and to document the possible risk factors.
Methods: A population of 110 HIV (+) male patients (pts) was
studied. All pts initiating HAART were prospectively followed
according to a structured clinical protocol that included regular
visits to the clinic with complete clinical and laboratory
evaluation. Any signs and/or symptoms of breast enlargement
and other morphological body shape changes were carefully
recorded. An ultrasound test documented lipomasty and exclu-
ded gynaecomasty or neoplasia. A 2:1 age and gender matched
control group of seropositive pts was used for comparison with
lipomasty patients.
Results: 9 out of 110 (8%) pts (median age of 48 yrs) presented
with a unilateral painless breast enlargement andwere compared
with 18 controls. The two groups did not differ with regards to
immunological and virological parameters. All lipomasty pts
showedother signs of lipodystrophywhereas none of the controls
did. Therewereno signiﬁcant differences between the twogroups
regarding current HAART regimens or ever use of NRTIs or
NNRTIs. However 8/9 (88.9 %) lipomasty pts were PI experi-
enced compared to 8/18 (44.4 %) controls (p < 0.05). Lipomasty
patients were more likely than controls to a) have prior D4T
exposure (p < 0.01), b) greater cumulative NNRTI use (p < 0.05)
and c) greater duration of the currentHAART regimen (p < 0.01).
Lipomasty was signiﬁcantly associated with hypercholesterole-
mia (p < 0.05) and hypertriglyceridaemia (p < 0.01).
Conclusion: Unilateral lipomasty is occasionally detected in
HIV pts. In the current study it was frequently observed in
association with other morphological body shape changes as
well as with dyslipidaemia. Prior exposure to PIs, D4T and
greater duration of the HAART regimen may be associated with
the development of unilateral lipomasty.
R2170
Wet cupping associated with transmission of HIV
infection: case report
A. Alothman, G. Al Ghamdi (Riyadh, SA)
Background: Wet Cupping (Hijama) is a common traditional
alternative therapy in Saudi society. Due to the presence of
contaminated instruments, it may be a route of transmission to
various viral infections including HIV. According to the medical
literature, there has been no previous report on the association
between wet cupping and transmission of HIV.
Case report: A 39-year-old man presented with a high fever,
progressive shortness of breath and easy fatigability. The patient
was diagnosed to have PCP. HIV serology was ordered and it
was positive as well as the western-blot. The patient denied any
previous sexual relationship, except with his two wives. No past
history of blood transfusion or any other IV drug use. However,
he had at least six (6) times when he had wet cupping ‘‘hijama’’
episodes at local barbers in Riyadh, 6 years ago. The local
barbers are known to use contaminated instruments between
customers.
Discussion: Wet cupping may be associated with the transmis-
sion of several viral infections (similar to tattooing) in contam-
inated setting. We believe in our case, the mode of HIV
transmission was through wet cupping ‘‘Hijama’’ by using
contaminated instruments. Due to lack of other risk factors to
transmit HIV and due to the literature on tattooing in transmis-
sion of other viral infections including HIV, we think that
wet cupping can likely be associated with transmission of viral
infection between customers if contaminated instrument is used.
R2171
Hyperlactataemia during highly active
antiretroviral therapy. Frequency, possible
pathogenetic pathways, and clinical signiﬁcance
L. Calza, R. Manfredi, F. Chiodo (Bologna, IT)
Introduction: Despite the increasing evidence of hyperlactate-
mia as an emerging side effect of HAART, its frequency,
pathogenesis, management, outcome, and prevention are still
under active investigation.
Methods: A case-control study has been performed on >1000
HIV-infected patients (p) in the year 2004. When evaluating
HAART-treated p with adherence levels >90%, p with hyper-
lactacidemia were compared with p with normal lactate levels in
relation with a broad spectrum of variables.
Results: Of the 755 evaluable p, 272 (36%) experienced at least
one evidence of hyperlactacidemia (mean value 24.7 ± 8.8 mg/
mL). Only 56 p of the study group (7.4%) experienced two or
more subsequent alterations, with progressively increasing
levels in 73.2% of p, while a grade 4 hyperlactatemia
(>39.6 mg/dL) was found in 5 p only (0.7%). When comparing
the 272 p with elevated lactacidemia with the 483 controls, no
signiﬁcant difference was seen as to age, gender, type of risk for
HIV infection, duration and stage of HIV disease, CD4 + lym-
phocyte count, HIV plasma viral load, and type and duration of
use of single and combined antiretroviral drugs (HAART). In an
univariate analysis, p with hyperlactacidemia showed a signi-
ﬁcantly longer anti-HIV therapy (p < 0.004), a more frequent
lipodystrophy syndrome (p < 0.005), hypertriglyceridemia
(p < 0.02), and raised serum creatinphosphokinase (p < 0.02)
and aldolase (p < 0.001) levels. The prevalence of signs-
symptoms referable to lactic acidosis (nausea, vomiting,
abdominal pain, fatigue, myalgia) was low (2–3%) and compar-
able between p and controls. Hyperlactacidemia never deter-
mined HAART interruption or modiﬁcation in our single centre
cohort.
Conclusions: Hyperlactacidaemia emerged as a proportionally
frequent HAART complication, although laboratory abnormal-
ities greatly exceed in frequency the occurrence of a sympto-
matic metabolic acidosis. No correlations were found with use
and duration of speciﬁc anti-HIV drugs, although an association
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with a longer exposure to antiretrovirals, and other concurrent
HAART-associated adverse events, was found.
R2172
An observational study of subcutaneous multiple
lipomatosis in patients receiving highly active
antiretroviral therapy. Possible correlations with
metabolic abnormalities and pathogenetic
insights
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Introduction: As a consequence of HAART administration, the
lipodystrophy syndrome and a broad spectrum of metabolic
abnormalities emerged. Localized fat accumulation may occur
as visceral adipositiy, increased breast size, gynaecomastia,
lipomastia, and the so-called buffalo hump, although very
limited reports are to date available on the role lipomatosis
during HIV infection.
Methods: Sixteen patients (p) of >1000 treated with HAART as
of end of August, 2005 (>1.5%) (13 males and 3 females aged 36–
58 years) experienced multiple ultrasonography-conﬁrmed sub-
cutaneous lipomas (3 to >20 lesions), predominantly involving
the trunk and upper and lower limbs, usually associated with
local discomfort.
Results: Among involved p, the duration of HIV seropositivity
at lipomatosis onset varied between 32 and 116 months, and no
p had developed full-blown AIDS. Our 16 p experienced 5–14
different anti-HIV therapeutic lines: almost all available protease
inhibitors (PI) and nucleoside analogues had been used previ-
ously or during the occurrence of lipomatosis, while a NNRTI
was used by in 4 p only. All p were given a PI-based HAART
since 16–74 (mean 28.2 ± 13.9) months. While the virological-
immunological situation of HIV disease was favourable, a broad
spectrum of concurrent lipodistrophy syndrome and dysmeta-
bolic-related alterations were found. In detail, an evident
lipoatrophy was present in 13 p out of 16, associated with
central adiposity in 10 p. Hypertriglyceridaemia, hypercholes-
terolaemia, and hyperglycaemia were detected at in 12, 8, and 2
p, respectively. The subsequent follow-up (8–66 months) was
characterized by the occurrence of further lesions in 8 p (with 3
p undergoing plastic surgery with satisfactory results) and a
substantially stable disease in the remaining 8 p, in absence of
spontaneous regression, even when the initial HAART regimen
was changed.
Conclusion: Sucutaneous lipomas have not been reported with
increased frequency during HIV infection, including the
HAART era. An accurate diagnostic workup (ultrasonography
and eventually ﬁne-needle biopsy) is needed to prevent the rare
occurrence of malignant degeneration. The frequent association
of lipomatosis with other clinical-metabolic disturbances related
to HAART should deserve further epidemiological and patho-
genetic studies to better investigate their eventual, mutual
relationship and to identify eventual prevention strategies.
R2173
Efavirenz versus nevirapine, their signiﬁcantly
different proﬁle on lipid metabolism and its
correlates
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Introduction: Altered metabolism represents an emerging fea-
ture of HIV-infected patients (p) treated with HAART, but
limited informations are avilable regarding the two non-nucle-
oside reverse transcriptase inhibitor (NNRTI): efavirenz (E) and
nevirapine (N).
Methods: Among over 1000 p treated with HAART for
>12 months, the metabolic pattern of NNRTI was assessed
according to three different backgrounds. The ﬁrst one included
antiretroviral-naı¨ve p starting a NNRTI-based regimen; the
second included a large spectrum of p experienced with 2 to 10
therapeutic lines (but still NNRTI-naı¨ve); the third group
included p who added for the ﬁrst time a NNRTI only on late
rescue therapies with ‡4 drugs (and including protease inhib-
itors).
Results: 386 p treated with E were compared with 334 p taking
N in our prospective observational survey lasting 12 to
30 months, by a multivariate analysis of serum lipid-glucose
levels, and other metabolic abnormalities. Among the 213 p
naı¨ve to antiretrovirals, an altered triglyceridemia was more
common (p<.001) in the E versus the N group. Considering the
344 antiretroviral-experienced p who introduced a NNRTI for
the ﬁrst time, the frequency of hypertriglyceridaemia appeared
greater in the E group (p < 0.0001), with earlier development of
this feature in p on E versus N (p < 0.0001). Also in the 163 p
receiving salvage HAART, the rate of hypertriglyceridemia-
hypercholesterolemia-hyperglycemia tested greater among p
treated with E versus N (p < 0.04 to p < 0.005), and the time to
peak alterations was more rapid in the E group (p < 0.04).
Comparing the 386 p receiving E with the 334 p on N, the
frequency of elevated triglyceride, cholesterol, and glucose
levels was greater in E-treated p (p < 0.0001 to <0.005). Some
grade of lipodystrophy was present in 276 pre-treated p, but an
appreciable ameliorement occurred after NNRTI introduction in
14 p of the E group, versus with 39 p on N (p < 0.005).
Conclusion: A sufﬁciently prolonged follow-up shows that E
may not resolve dysmetabolism, but might also prompt meta-
bolic abnormalities with more frequency and intensity com-
pared with N. The two available NNRTI have a signiﬁcantly
different dysmetabolic proﬁle, which leads to an increased
interest in pathogenetic and prevention studies.
R2174
Eighteen years of research on AIDS: contribution
of and collaborations between different world
regions
M. Falagas, I. Bliziotis, B. Kondilis, P. Papastamataki, G.
Zouglakis, E. Soteriades (Athens, GR)
Objectives: The scientiﬁc community invests signiﬁcant
resources on HIV/AIDS research to confront the current
epidemic. We reviewed the medical literature, in order to
evaluate the contribution of different world regions on HIV/
AIDS research during the past 18 years.
Methods: We retrieved articles, using an elaborative methodo-
logy, from 3 journals focusing on HIV/AIDS between 1986 and
2003, indexed in the Journal Citation Reports (JCR) and the Web
of Science databases of the Institute for Scientiﬁc Information
(ISI). Comparisons were made by dividing the world either into
9 geographic regions, and by using the human development
index (HDI) categorization.
Results: A total of 9.502 articles on HIV/AIDS were retrieved
from 3 AIDS journals over an 18-year study period (Table). USA
and Western Europe together and 5 developed out of 9 world
regions made up a striking 83% and 92% of the world’s research
production on HIV/AIDS, respectively. Researchers from coun-
tries included in the high, medium, and low HDI category
produced 2, 240, 9, and 15 articles per billion population,
respectively. About half of articles originating in Latin America
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and the Caribbean and half in Asia were produced in collabor-
ation with the USA. On the contrary, 40% of articles from Africa
and 58% from Eastern Europe were produced in cooperation
with Western Europe. Collaboration between researchers within
developing regions was negligible.
Conclusion: The vast majority of the world’s research on AIDS
is produced in the developed world. International collaborations
are limited and in general follow traditional cultural and
political lines of international relationships. Cooperation of
scientists among the developing world is minimal.
R2175
Evolution of antiretroviral drug resistance and
resistance mutations in multi-treated HIV-1
infected patients during the last three years
A. Sua´rez, E. Va´zquez, C. Sa´nchez, J.J. Picazo (Madrid, ES)
Objectives: Drug resistance mutations in the human immuno-
deﬁciency virus (HIV-1) reverse transcriptase (RT) and protease
genes is a major cause of antiviral therapy failure. Therefore, we
evaluated the evolution of mutations and antiretroviral resist-
ance in multi-treated patients over a three-year period.
Methods: The plasma of 326 HIV-1 infected patients (94 in 2002,
119 in 2003 and 113 in 2004) was analysed. Most patients were
males (75%), mean age 41 years (range 20–73). Drug resistance
was genotyped by sequencing RT and protease genes using the
ViroSeq HIV Genotyping System (Abbott). The Stanford data-
base was used to interpret resistance data (http:/hivdb.stand-
for.edu/hiv/).
Results: On the HIV-1 RT region 955 mutations were detected,
277 of which were associated with resistance to non-nucleoside
reverse transcriptase inhibitors (NNRTIs). On the protease gene
865 were found, 722 of these were secondary mutations.
Changes at codons 184, 215 and 103 were most frequent in the
RT region, but at position 184 they decreased over the time by
21% in 2002, 15% in 2003 and 8% in 2004. L63P was always the
most prevalent protease mutation. Mutations at new codons 65,
116 and 238 (2003) and 33, 43, 68, 211 and 228 (2004) in the RT
region were observed. Multi-drug resistant mutation Q151M
was found in 4 cases (two in 2003). The resistance associated
with protease inhibitors and NRTIs increased in 2003 and in
2004, except for Lamivudine and Abacavir. NNRTIs had similar
percentages of resistance during the study period. From 2002 to
2004 we notice a statistically signiﬁcant (p < 0.001) increase in
susceptibility to Lamivudine. Wild type sequence was detected
in 9 cases, and genotyping was not available because not enough
cDNA was obtained in 72 patients.
Conclusion: Resistance frequently limits the efﬁcacy of antiret-
roviral drugs in the treatment of HIV-1. The detection of key
mutations associated with antiretroviral resistance can be of use
in the clinical management of these patients.
R2176
Nasal carriage and antibiotic resistance of
Staphylococcus aureus in HIV-infected patients
T. Kakabadze, T. Tsertsvadze, N. Macharashvili, E.
Dolmazashvili (Tbilisi, GE)
Objectives: To evaluate the rate and risk factors of nasal
S. aureus carriage in asymptomatic HIV patients; to assess
antibiotic resistance of yielded S. aureus strains.
Methods: In this prospective case controlled study anterior
nares swabs/cultures were obtained from 91 asymptomatic
adult HIV patients attending out-patient department of AIDS
and immunodeﬁciency of Tbilisi, Georgia and 60 HIV negative
persons. Antibiotic resistance was testing by using disk-diffu-
sion method. To determine the susceptibility to methicillin,
oxacillin was used as a marker. HIV patients undergo investi-
gation about their past medical history and behaviour.
Results: A total 39 swabs (42.8%) yielded S. aureus from HIV
positive patients and 14 swabs (23.3%) fromHIV negative persons.
Antimicrobial resistance was determined for isolates from HIV
positive patients. Yielded S. aureus strains were resistant to:
clindamicin – in 30.7% of cases, chloramphenicol – 41%, oxacyllin
– 53.8%, amoxicillin-clavulan acid- 64.1%, ampicillin – 97.4%,
penicillin G – 100%, ciproﬂoxacin – 23.08%, trimetoprim – 48.7%,
erythromycin – 41.02%, amycacin – 28.2%, tetracycline – 46.15%.
All isolated S. aureus strains were susceptible to vancomycin.
Conclusions: High rate of S. aureus carriage was detected in
studied HIV population. The S. aureus carriage was not
correlated to CD4+ T-cell count or granulocytopenia, but was
inﬂuenced by previous hospitalisation, skin infection, antibiotic
use and IDU practice. High rate of antimicrobial resistance may
be related to uncontrolled use of cheaper oral antibiotics in
Georgia. The prevalence of methicillin (oxacyllin) and ciproﬂ-
oxacin resistant S. aureus colonization was higher in HIV
infected then in general population of Georgia.
R2177
An epidemiological study regarding knowledge,
attitude and source of information on HIV-AIDS
among the teachers of secondary and higher
secondary schools of Ahmedabad City, India
R. Patel (Ahmedabad, IN)
Background: Apart from parents, teachers are the most import-
ant source of information for students. Assessment of teachers for
AIDS gives baseline information regarding their knowledge and
attitude which can be utilized in the future to decide the strategy
for health education. Keeping this in mind, present study was
done with an objective to determine the teachers knowledge
regarding nature, mode of transmission, source of information
and attitude toward people leaving with AIDS (PLWA).
Method: Study design: Cross-sectional study.Setting: Meeting
of 182 teachers of secondary and higher secondary schools of
Ahmedabad. A pretested, semi structured, self administered
proforma was given to all teachers attending the meeting
Analysis was done with statistical software Epi-info for calcu-
lating various indicators like Mean, Standard deviation, Pro-
portion, Chi-square test.
Results: Out of the total, 68% were males and 32% were
females.88% knew that AIDS could be transmitted by having
multiple sex partner. 79% knew about risk of HIV by infected
blood transfusion and use of contaminated needles. 19% of
males and 8% of females believe that AIDS can be transmitted
by kissing to an AIDS patient. 12% of females and 20% of male
teachers believe that an HIV patient must not be allowed to do
any job or business. Only 67% of respondents knew that AIDS
could be prevented by proper use of condom.
Conclusion: Knowledge about other sexually transmitted dis-
eases was comparatively lower than that of AIDS. Knowledge
regarding multiple sex partner and use of contaminated needle,
as mode of transmission of AIDS was comparatively higher in
females. Responses like transmission of AIDS by mosquito bite
and hand shaking with AIDS patient shows level of incorrect
concept regarding AIDS transmission. 80 % of respondents had
shown their readiness to receive information about HIV.
Newspaper, banners, posters and television had come up as
major source of information among teachers.
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R2178
Epocal modiﬁcation of re-imbursement facilities
of all lipid-lowering drugs in Italy. Lack of
consideration of HIV-infected patients with
HAART-related dyslipidaemia, who lose their
right to free access to statins, ﬁbrates, and omega-
3 derivatives
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Introduction: The signiﬁcant HAART-prompted advances
achieved in the management of HIV disease are at risk to be
frustrated by the modiﬁed re-imbursement modalities of all
lipid-lowering drugs (LLD) available in Italy. The remarkably
increased life expectancy attained thanks to HAART, is bur-
dened by signiﬁcant risks to develop a diet- and exercise-
uncontrolled hypercholesterolaemia-hypertriglyceridaemia,
often concomitant with insulin resistance and visceral adiposity,
factors which strongly predispose to cardiovascular events and
stroke.
Methods: The novel prescribing rules of LLD based on a
computer-generated score, were matched with the present
situation of ~1000 HIV-infected patients (p) treated with
HAART, in order to assess the frequency and type of dyslipid-
aemia, and the estimated rate of need of LLD prescriptions.
Results: The rate of hypertrigyceridaemia and hypercholester-
olaemia exceeded 28% and 19% of p respectively, while around
22% of p had a mixed dyslipidaemia. Over 200 p were currently
treated with statins and/or ﬁbrates, with the eventual adjunct of
omega-3 fatty polyunsaturated acids. When applying the risk
score proposed for the general population, <10% of these p
reached the threshold of a >20% risk of a major vascular event in
the next decade (due to the proportionally lower mean age, the
absence of familial dyslipidaemia, diabetes mellitus, elevated
systolic pressure, and anti-hypertension therapy), while only
very few p needed a secondary prophylaxis. As a result, >90% of
HIV-infected p presently treated with LLD due to present
antiretroviral therapy recommendations have lost all rights to
LLD re-imbursement in Italy, and are at serious risk to give up
LLD due to not sustainable linked costs.
Conclusion: The recent dispositions of the Italian Health Care
System did not consider HIV-infected p, who are exposed to a
frequent, severe, jatrogenic dyslipidaemia, and an elevated
major vascular risk despite their lower mean age, and the lack of
multiple generic risk factors. Most HAART beneﬁts might be
blunted by the sudden lack of LLD re-imbursement, which is
estimated to regard the majority of treated HIV-infected p. A
comparison with LLD re-imbursement facilities in other coun-
tries is also warranted, to draw some epidemiological and
pharmacoeconomic elements suggesting a re-extension of
re-imbursement facilities of these life-saving drugs to HIV-
infected p.
R2179
Long-term statin use does not act on immune
markers of HIV disease progression, in HIV-
infected dyslipidaemic patients treated with a
virologically effective HAART regimen. A
prospective study, controlled versus ﬁbrates, and
lifestyle changes
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Introduction: Recently statins were hypothesized to act unfa-
vourably on the immune system through an altered cytokine
pattern and a Th1/Th2 imbalance, as shown in non-HIV-
infected patients (p) [JAIDS 2005;39:503] while a small experi-
ence claimed a p < 0.05 loss of absolute CD4+ count of p treated
with a protease inhibitor (PI)-based HAART in a 6–18-month
period [HIV Clin Trials 2003;4:164] although the 4 compared p
groups were small in size (5–11 p each) and not homogeneous (a
group received PI only).
Methods and results: From >1000 HIV-infected p we identiﬁed
all p on HAART since >12 months with compliance >90% and
with altered fasting cholesterol (>200 mg/dL) and/or triglycer-
ides (>250 mg/dL) of >6-month duration. When comparing the
quarterly immunological trend of the 88 p prospectively taking
statins (pravastatin, ﬂuvastatin or rosuvastatin) for a predom-
inant hypercholesterolemia, versus the 103 p receiving ﬁbrates
(bezaﬁbrate, fenoﬁbrate or gemﬁbrozil) for a prevailing hyper-
triglyceridaemia, versus the 76 p who underwent a diet/exercise
program only, no signiﬁcant difference in mean-median CD4+
count occurred among the three p groups during a mean follow-
up which now reaches 15.3 ± 6.7 (range 6–26) months. All p
remained evaluable when still on an HAART regimen ensuring
virologic suppression and an unchanged hypolipidaemic ther-
apy.
Discussion: Examining the broad-spectrum pleiotropic activ-
ities attributed to statins also the virologic course of HIV
infection received limited evidences from a study claiming a
direct anti-HIV activity of statins by down-regulating the
small signaling Rho protein (which acts on cell viral entry) [J
Exp Med 2004;200:541] while neither virologic failure nor viral
blips occurred among 78 HAART-stable p who started a statin
[JAIDS 2005;39:637]. To increase confusion, efavirenz increases
statin metabolism [JAIDS 2005;39:307] while also the anti-
triglyceride ﬁbrates may have extensive pleiotropic effects
[Curr Vasc Pharmacol 2005;3:87]. In fact, both ﬁbrates and other
molecules interacting with the peroxisome proliferator-activa-
ted receptors (PPAR) (eg risoglitazone-pioglitazone) may
affect major T-lymphocyte cytokine mediators [Circ Res
2002;90:703; J Immunol 2004;172:5790]. Based on our experience
and waiting for enlarged in vivo studies conducted on
affordable p samples, we stay with the last statement of N.
Shaﬁq about ‘‘The Statinth wonder of the world: a panacea for
all illnesses or a bubble about to burst’’ [J Negat Results Biomed
2005;4:3]
R2180
HIV-associated malignant bladder carcinoma
during the HAART era: an infrequent but
intriguing ﬁnding
R. Manfredi, S. Sabbatani, L. Calza, F. Chiodo (Bologna, IT)
Background: Most of AIDS-related malignancies declined after
HAART introduction. The 1993 AIDS notiﬁcation system reports
AIDS-linked disorders only upon diagnosis, while pathologies
occurring in patients (p) already diagnosed with AIDS are
signiﬁcantly underestimated. Increasing cancer may be caused
by the prolonged p’s life expectancy, the residual immune
imbalance, and the late detection of HIV disease (so-called
‘‘AIDS presenters’’). Among solid tumours, bladder neoplasms
are extremely infrequent with only three anecdotal episodes
reported to date.
Methods: Since more conﬁdence with HIV-cancer association is
needed, we report two recent cases of relapsing HIV-associated
bladder carcinoma.
Results: Our experience of two cases of transitional, papillary,
stage G2 bladder carcinoma, shares some common points
between involved p: it interested male p in their ﬁfth decade
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of life, speciﬁc risk factors were excluded and HIV infection
lasted from around two years and was favourably controlled by
HAART. While the single relapse of bladder carcinoma experi-
enced by our ﬁrst patient required endoscopic surgery, the
multiple recurrences and the advancing disease (G3) stage led to
a radical cystectomy in the second p, despite repeated endo-
scopic, surgical, and cytotoxic therapy, but cancer appeared
under control in both p during the subsequent 10–14-month
follow-up. The urologic support was valuable for early diagno-
sis and appropriate therapy and monitoring, which needed
repeated endoscopic-surgical interventions, and intravesical
chemotherapy, although only radical surgery proved effective
in our second p.
Conclusions: Although the proportionally rare occurrence of
HIV-associated bladder cancer and the lack of correlation
with HIV disease progression, could result in a trivial
pathogenetic association, this neoplasm is borne by an
increasing incidence. Only three cases were presented by
the international literature as single reports: two of them in
the pre-HAART era. Clinicians facing HIV p with haematuria
should consider a bladder carcinoma, to avoid a missed or
delayed diagnosis.
R2181
Pulmonary tuberculosis in patients with and
without HIV/AIDS
A. Hadadi, M. Rasoolinejad, S. Davoudi, M. Rasteh, M. Nikdel,
M. Mohraz (Tehran, IR)
Object: Pulmonary TB is still the most common form of the
tuberculosis in HIV infected patients, with different presenta-
tions according to the degree of immunosuppression. The aim
of this study was to investigate the impact of HIV infection on
the clinical, laboratory and radiological presentation of tuber-
culosis.
Methods: We compared 80 HIV negative pulmonary TB
patients with 40 HIV positive pulmonary TB patients during
1999–2005 in a teaching hospital of Tehran University of Medical
Sciences, Iran.
Results: Tuberculosis was more common in men in both
groups. The mean age of HIV positive patients was lower than
HIV negatives (35/95 ± 10/4 versus 46/95 ± 20/39 p = 0.002).
Weight loss and chronic cough were signiﬁcantly more
frequent in HIV negative patients (76/3% vs 45% p < 0/001
and 93/8% vs 80% p < 0.05 respectively), whereas fatigue were
more prominent in HIV positive (45% vs 21/3% p < 0.001).
Cavitations and inﬁltrations were reported in the CXR of HIV/
TB patients less than HIV negative patients (OR = 0/21, 95%
CI 0/05-0/97, P = 0.01 and OR = 0/27%, 95% CI 0/09–0/75%,
P = 0.02 respectively). Primary involvement pattern was
observed more than secondary involvement in HIV/TB
group (OR = 3/95, 95% CI 1/73–9/03, P = 0.001). The labora-
tory ﬁndings in HIV/TB patients were as follows: more
negative PPD skin (75% VS 50%) tests, higher ESR (86/5%
VS 63/7%), lower mean Hb (10/6 VS 12/4) and lower mean
leukocyte (6545 vs 9195) and lymphocyte count (1281 vs 1838).
In all of the above mentioned ﬁndings, the differences between
two groups were signiﬁcant. 47.3% of patients had Lympho-
cyte count less than 1200, which means they were in AIDS
stage.
Conclusion: By suppressing the immune system, HIV can alter
the clinical, laboratory and radiological features of tuberculosis.
So it is crucial to consider tuberculosis in differential diagnosis
of every HIV patients with respiratory symptoms.
R2182
Human immunodeﬁciency virus type-1
associated lymphoma: Tunisian experience
L. Ammari, B. Kilani, H. Tiouiri ben Aissa, F. Kanoun,
R. Abdelmalek, F. Zouiten, A. Goubontini, T. Ben
Chaabane (Tunis, TN)
Background: Tunisia is one of African countries where sero-
prevalence of human immunodeﬁciency virus (HIV)infection is
low. However, lymphoma is considered as the second AIDS-
deﬁnig illness after Kaposi’s sarcoma in our experience.
Objectives: We report clinical, epidemiological, and histopath-
ological ﬁndings in patients with HIV–associated lymphoma.
Methods: We retrospectively reviewed all patients aged above
15 years and hospitalized for haematologic disorders from
January 1985 and December 2004 in the department of infectious
diseases of Rabta Hospital. Patients with a diagnosis of agressive
lymphoma were included. The stage of lymphoma was based on
Ann Arbor system.
Results: 10 patients were reported with HIV-associated lym-
phoma; 60% were heterosexual and 40% intravenous drug users.
The mean age was 34 years (21–45 years) and sex ratio was
4.The mean interval between the diagnosis of HIV infection and
lymphoma was 2.4 years. The lymphoma was the ﬁrst AIDS-
deﬁning illness in 3 cases. CD4+ lymphocyte count below
200 cell/mm3 are observed in 7 cases, and a mean plasma HIV
viral load was 619750 copies/ml. 2 patients were under highly
active antiretroviral therapy (HAART) before the diagnosis of
lymphoma. All patients had B systemic symptoms (fever, night
sweats, fatigue, or loss of body weight). 5 patients had HIV-
associated non Hodgkin lymphoma (HIV-NHL): a diffuse large-
cell lymphomas (3 cases), a Burkitt’s lymphoma (1case) and
immunoblastic lymphoma (1case). One patient had a probably
primary cerebral lymphoma. 3 patients with HIV-HL were at
stage III or IV. Extranodal involvement was observed in 6 cases.
6 patients were treated with chemotherapy and/or radiother-
apy. From all patients, only one is still alive15 months after
diagnosis.
Conclusion: In our experience, lymphoma remains the most
lethal complication of AIDS, associated with a very poor
prognosis. Survival may be improved by early diagnosis and
restauring immune status with HAART.
R2183
HIV-asociated tuberculous meningitis: a
descriptive study
B. Gimena, J. Sousa, J. De la Fuente, A. Ocampo, B. Maure (Vigo,
ES)
Background and objective: Human immunodeﬁciency virus
(HIV) infected patients have extra-pulmonary involvement of
tuberculosis infection more frequently than non HIV-infected
patients. This study was undertaken to characterize the clinical
manifestations and outcomes of tuberculous meningitis in HIV-
infected patients and the potential role of the highly active
antiretroviral therapy (HAART).
Methods: We reviewed the clinical charts of patients with HIV-
infection and tuberculous meningitis (TM) during two periods:
1989–1995 and 1996-forward. TM was considered deﬁnite if
mycobacterium tuberculosis (myt) was stained, ampliﬁed or
cultured from cerebrospinal ﬂuid (CSF). TM was considered
probable if there were according features from CSF and cultured
myt from other sites, clinical response to therapy and no other
microorganism implicated.
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Results: We recorded 25 patients, 13 with TM deﬁnite, 20
(80%) before HAART use. Twenty-two patients (88%) were
males. The mean age was 35 ± 10.56 (21–62) years. The main
risk practice for HIV infection was intravenous drug use, in 17
patients (68%). HIV infection diagnosis and tuberculous men-
ingitis diagnosis was concomitant in 9 patients (36%). Seven-
teen patients (68%) did not have previous tuberculosis.
According to the Medical Research Council criteria 9 patients
(36%) had stage I disease, 11 (44%) had stage II disease and 5
(20%) had stage III disease. The median CD4+ cell count was
110 ± 127 (6–504). Adenosine deaminase was measured from
CSF in 23 patients and was high in 15 (65.22%). Ziehl stain was
positive in only 1 case (4%), and culture in 13 patients. Chest
ﬁlm was normal in 18 patients (72%). CT of the head in 22
patients were: meningeal enhancement in 4 (16%) cases, non-
enhancing lesion in 4 and normal in 16 (48%). The treatment
regimen was isoniazid, rifampicin, pyrazinamide and etham-
butol in 21 patients (84%) with adjuvant corticosteroids in 14
patients (56%). Only 1 patient had ventricular-drainage proce-
dure. Eight patients (33%) died, 5 of them (20.83%) directly
attributable to the TM. We did not ﬁnd differences in
presenting features, imaging procedures or laboratory tests
nor mortality between these two periods.
Conclusions: We observed a reduction in incidence of the TM
in HIV-infected patients since HAART introduction without
new cases in our institution since 2001, but we did not ﬁnd
differences in presenting features or the outcome of the
disease.
R2184
HIV/AIDS in children: the disease taken too
rarely into account
I. Kacprzak-Bergman, I. Zaleska, T. Czerniak (Wroclaw, PL)
Objectives: In Poland in the period 1987–2005 about 90 cases of
HIV infection in children were diagnosed. During this time 12
children died because of AIDS. The aim of this study was the
analysis of age of HIV diagnosis and suspected age of infection.
Methods: In our department about 100 children were diag-
nosed to HIV from 1996 to 2005. Among them this infection was
found in 25 individuals. Diagnosis was based on various clinical
symptoms and virological examinations.
Results: In 23 children maternal transmission was conﬁrmed.
The age of diagnosis was from 1 month to 10 years. Only 4
children were diagnosed in their ﬁrst month of life. In 8
individuals HIV infection was showed between 3rd and
6th month of life, in 3 children between 8th and 12th month.
Five patients were diagnosed at the age 2–4 years, and 3
patients between 5th and 10th year of life. In admission at our
department 2 children was with clinical category N, none with
category A, however 11 persons with category B and 5 persons
with category C (symptomatic AIDS). In relation to maternal
infection, the diagnosis of children preceded HIV diagnosis in
mothers. In two cases HIV infection was hidden by mother and
revealed barely after documented HIV in child. Twenty-one
mothers were unaware of infection. In some of them the
disease was advanced. In two children the source of infection
remained unknown. These patients were with category B and
C.
Conclusions: In Poland testing to HIV is not obligatory in
pregnant women. Thus this infection is not too common in our
country, we postulated to introduce such examination together
with examination to syphilis before and during pregnancy. In
children with recurrent infections the HIV aetiology ought to be
considered.
R2185
Comparison of aetiology and resistance in
respiratory isolates of AIDS patients vs. non-
AIDS patients in South Sudan and Kenya
K. Kutna (Trnava, SK)
Objectives: Immunodeﬁciency with reduced clearance of res-
piratory pathogens, multiple courses of antibiotic therapy in
consequence of opportunistic infections and long-term rifampin
therapy for tuberculosis (TB) and cotrimoxazol chemoprophy-
laxis have been associated with antibiotic resistance in HIV
positive patient population.
Methods: In a small point prevalence survey, we compared
aetiology and resistance phenotype in two groups of patients in
Sub-Saharan Africa – 50 HIV positive patients in Nairobi and
182 HIV negative patients in OPD in Mapuordit in South Sudan.
Samples were transferred to Slovakia by air and aetiology and
resistance was determined from respiratory tract isolates.
Results: In comparison of aetiology among ﬁrst group 79 HIV
positive patients in Nairobi (A) (85 samples) and 105 samples
from 182 patients from HIV population in South Sudan is
different. Moraxella catharralis was signiﬁcantly less frequent (28
vs 14%, P < 0.05) in patients in Nairobi. Vice-versa, Streptococcus
pyogenes (9% vs 0%, P < 0.02) and S. aureus (21% vs 12%,
P < 0.05) were more frequently detected in Sudan as well as
Enterobacteriaceae (24% vs. 12.9%, P < 0.05).We observed follow-
ing differences: in Sudan, there was no evidence of AMP-R H.
inﬂuenzae (in Kenya 50% AMP-R) and MRSA (in Kenya 8%) as
well as PEN-R pneumococci (in Kenya 6.6%). All 105 isolates
from South Sudan were 100% sensitive to all antibiotics. We
have observed that respiratory tract isolates from patients with
HIV on HAART have signiﬁcant different aetiology and
resistance proﬁle: HIV positive patients: Moraxella catharalis is
among pathogens signiﬁcant more frequent in HIV positive
patients (24.7% vs 14%, P < 0.04) as in HIV negative patients.
Vice-versa, Str. pyogenes, S. aureus and Enterobacteriaceae most
often colonized respiratory tract in HIV negative patients
(P < 0.05). Concerning resistance phenotypes, in South Sudan
resistance phenotypes didn’t occur (either 1 ERY-R Str. pyogenes
or PEN-R pneumococcus, any MRSA – methicillin resistant
staphylococcus and AMP-R H. inﬂuenzae). No resistance is
apparently explainable due to reason of absolute inaccessibility
and no exposition to antibiotics due to 21 years civil war and
related therefore isolation.
Conclusion: Concerning HIV positive population, resistance
phenotypes were narrower also in consequence antecedent
exposition ATB, because HIV patients have more often oppor-
tunistic infectionsplus they received cotrimoxazol inprophylaxis.
R2186
HAART in HIV patients: analysis of ﬁrst therapy
regimen. MACOVI study (Ma´laga HIV cohort)
J. De La Torre, J.L. Prada, I. Perez de Pedro, J. Santos, J. Aguilar,
E. Nun˜o, S. Santamaria, R. Palacios, A. Del Arco, M. Godoy, F.
Moreno for the Grupo malaguen˜o para el estudio de las enfermedades
infecciosas
Objectives: To analyse the ﬁrst highly active antiretroviral
therapy (HAART) in a study in the real life in patients naive HIV
and to describe the causes by which this treatment is inter-
rupted.
Methods: Multicentre, retrospective and observational cohort
study from all the HIV naive patients, diagnosed from January-
1997, starting a ﬁrst HAART until December-2003 in any
hospital of Ma´laga area (south of Spain).
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Results: A total of 603 patients who started a ﬁrst HAART
regimen were included in analyses. 151 (26%) stay with the same
pattern with a mean time of 22.8 ± 17.7 months. Switching
before one year was observed in 36%. Causes were toxicity
22.1%, simpliﬁcation 20.5%, virological failure 15%, structured
treatment interruption 7.1% and other causes 7.2%. The main
toxicities were: gastrointestinal effects (25.5%), principally vomit
and diarrhoea by protease inhibitors (PIs); neuropsiquiatric
(24.8%), overall efavirez related effects and stavudine-associated
peripheral neuropathy; haematologic (15.7%), essentially zid-
ovudine-associated anaemia; skin problems (15%) mostly non-
nucleoside reverse transcriptase inhibitor (NNRTI) and abacavir
associated hypersensitivity reactions and ﬁnally kidney diseases
(9%) all by indinavir-associated lithiasis. PIs were associated
signiﬁcantly with gastrointestinal and kidney problems in
comparation with NNRTI and nucleoside reverse transcriptase
inhibitor (NRTI) (p > 0.001); and the NNRTIs were linked with
neuropsiquiatric and skin signs (p > 0.001). The triple NRTIs
formulation was lesser toxic (p > 0.001). There were no differ-
ences in withdrawn ratio or virological failure rates by HAART
regimens, even with CD4+ under 100/mm3.
Conclusion: More than 33% of ﬁrst HAART regimen were
discontinued before one year and the main cause was toxicity
followed by virological failure. There were no differences
between PIs and NNRTIs in failure and toxicity rates as
HAART discontinuation causes. The toxicities causing HAART
modiﬁcation or discontinuation were gastrointestinal, princi-
pally PIs linked, neuropsiquiatrics and cutaneous, both attached
to NNRTIs. Three NRTIs co-formulation was the lesser toxicity-
discontinue regimen.
Hepatitis
R2187
Hepatitis B virus genotyping, core promoter and
precore/core mutations among Afghan hepatitis B
infected individuals: a preliminary report
S. Amini-Bavil-Olyaee, S. Alavian, A. Adeli, R. Sarrami-
Forooshani, F. Sabahi, E. Sabouri, H. Tavangar, M. Azizi,
F. Mahboudi (Tehran, IR)
Introduction: In spite of continuation of hepatitis B virus (HBV)
vaccination, HBV infection remains as an important public
health problem worldwide. Although the HBV genotype distri-
bution has been determined in some parts of the South Central
Asia, no survey has been conducted to clarify HBV genotype in
Afghanistan.
Materials and methods: Twelve Afghan HBV infected patients
living in Afghanistan were enrolled in this study. Partial HBsAg
and basic core promoter, precore and core (BCP/preC/C)
regions were ampliﬁed and subjected for direct sequencing. In
parallel, precore G1896A mutation was also determined by an
ampliﬁcation-created restriction site method.
Results: Results revealed HBV genotype D (95% bootstrap
value), sub-genotype D1 (98% bootstrap value) and subtype
ayw2 in all Afghan isolates. Afghan isolates clustered in a
separate branch in the D1 sub-genotype called D1’, supported
by 82% bootstrap value. The percentage of intra-genotypic
distance among Afghan isolates was 1.05% and inter-genotypic
distance with the other genotype D was 2.87% and with other
genotypes was 7.50–11.1%. The wild type, mixed infection and
precore mutant were found in six, two and four HBV isolates,
respectively. The A1762T/G1764A BCP dual mutation was
found in one isolate. Three isolates presented single mutation in
the BCP dual mutation region, whereas two of them showed a
novel G1764T mutation.
Conclusion: In conclusion, this preliminary study revealed
HBV genotype D, sub-genotype D1, and subtype ayw2 of HBV
among hepatitis B infected patients from Afghanistan. Further
investigation should be carried out for better understanding of
HBV genotype distribution in other virgin parts of the South
Central Asia.
R2188
Primary sclerosing cholangitis as a sole
manifestation of hyper IgM syndrome
M. Nabavi, M. Gharaguzlo, M. Bemanian, A. Keshavarzi
(Semnan, Tehran, IR)
Primary sclerosing cholangitis (PSC) is a chronic liver disease
characterized by inﬂammation, destruction and ﬁbrosis of the
intrahepatic and extrahepatic bile ducts that leads to cirrhosis of
the liver. PSC is often complicated by recurrent episodes of
bacterial cholangitis .The cause of PSC is unknown but many
investigators suspect that it is an autoimmune disease. Other
aetiologies, such as infectious agents, toxins or recurrent
infections of the bile ducts are also possible causes. About 30%
of patients with PSC have elevated serum gamma-globulin
concentrations and about half have elevated serum IgM
concentrations. About half of patients have serum antibodies
against a perinuclear antigen in neutrophil cytoplasm (ANCA).
The most common symptoms are fatigue, jaundice, pruritus,
and abdominal pain. PSC is said to progress relentlessly to
cirrhosis, although a patient’s condition may remain stable
years. We report a 12 years old female diagnosed as a case of
hyper-IgM syndrome who presented with recurrent infections
and sclerosing cholangitis. She developed also Evans syndrome
(autoimmune haemolytic anaemia and thrombocytopenia).
Immunological evaluation showed decreased levels of serum
IgG and IgA with elevated levels of IgM. Liver biopsy demon-
strated the presence of idiopathic sclerosing cholangitis. The
patient was started on monthly IVIG therapy at 400 mg/kg and
also prophylactic antibiotics, prednisolone and vitamin E with
normalization of her IgG and IgM levels and a decrease in the
incidence of infections and normalization of liver function.
R2189
Evaluation of immunity to hepatitis A virus in
patients with chronic viral hepatitis B and C
V. Karabassi, M. Pouyiouka, C. Petrochilou, G. Roussos,
A. Karﬁ, M. Toutouza (Athens, GR)
Objectives: Our study was conducted to estimate the immu-
nological status to hepatitis A virus (HAV) in patients with
chronic hepatitis B and C and to identify the risk of hepatitis A
superinfection and the need of vaccination against HAV in these
patients.
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Methods: There were examined a total of 630 patients of our
hospital aged from 35 to 65 (65% men, 35% women). There were
two (2) groups of patients. Group A: 420 patients with chronic
hepatitis B and Group B: 210 patients with chronic hepatitis C.
The diagnosis was conﬁrmed with the help of clinical data,
biochemical tests and serological markers. At the same time we
also controlled 480 healthy individuals. Serum samples from the
patients and the healthy individuals were tested for the
detection of total and IgM antibodies against HAV. The tests
were performed by immunoenzymatic methodology (MEIA,
AXSYM - ABBOTT)
Results: In Group A were found to be positive for total anti-
HAV 320 out of 420 (76.2%) patients with chronic hepatitis B. In
Group B were detected positive total anti-HAV in 168 out of 210
(80%) patients with chronic hepatitis C. The presence of anti-
HAV was related to the patients’ age. There was a signiﬁcant
tendency towards higher prevalence of anti-HAV in older
patients. In group of healthy individuals 226 out of 480
(47.1%) persons were positive for total anti-HAV. None was
found to be positive for anti-HAV IgM.
Conclusions: This study showed that there is a signiﬁcant
prevalence of HAV in the patients with chronic hepatitis B and
C: 76.2% and 80% respectively compared to 47.1% in healthy
persons. It was demonstrated that HAV infection may have a
more clinical course in patients with chronic liver disease
particularly among older patients. Therefore, vaccination
against HAV should be recommended, mainly in younger
persons, with previously screening for anti-HAV because
natural immunity is common.
R2190
Prevalence of HIV, hepatitis B and C among
intravenous drug users on methadone
maintenance treatment in Slovenia
Z. Baklan, M. Poljak, T. Fras-Stefan, A. Pisec, J. Misigoj-Krek
(Maribor, Ljubljana, Koper, SI)
Objectives: Intravenous drug users (IDU) are known to be at
high risk of acquiring blood-borne infections. The aim of our
study was to determine the prevalence of HIV, hepatitis B (HBV)
and hepatitis C (HCV) infections among IDU on methadone
maintenance treatment (MMT) in Slovenia and to establish the
differencies between 3 Slovenian regions.
Methods: A cross-sectional study among IDU on MMT from 3
regions (coastal region, Ljubljana city-capital, Slovene Styria)
was carried out in the year 2000. 40 IUD were randomly selected
from each region. The blood samples from 120 IUD on MMT
were tested to HIV (anti-HIV 1/2 antibodies and p24 HIV
antigen), to HBV (HbsAg antigen, antibodies anti-HBs and anti-
HBc) and to HCV (anti-HCV antibodies, HCV RNA and HCV
genotype).
Results: Of the 120 IUD, 86 (71.6%) were male and 34 (28.4%)
female. The mean age was 26.2 ± 6.9 years (range 18–48). The
mean length of self reported injecting drug use was
5.4 ± 4.0 years. The mean age of ﬁrst injecting drugs being
21.2 ± 4.7 years (range 15–44). All tested persons were HIV
negative. AntiHBc antibodies as a sign of HBV infection were
detected in 14 (11.7%) IUD, 2 of them had also markers of
active HBV infection (HBsAg positive). IUD with markers of
HBV infection were older than those without markers (32.6 vs.
25.7 years; p < 0.001) and had a longer history of drug
injection (9.2 vs. 5.0 years; p < 0.001). AntiHBs as a sole
marker of HBV were found in 14 (11.7%) IUD. 92 (76.7%) of
IUD had no markers of HBV infection and they were still
susceptible to HBV infection. Anti-HCV antibodies were
detected in 33 (27.5%) IUD, 28 (84.8%) of them were also
HCV RNA positive, indicating an active HCV infection. The
HCV prevalence were signiﬁcantly different between regions
(p = 0.021). The antiHCV positive IUD were older than those
without HCV infection (31.1 vs. 24.6 years; p < 0.001) and had
a longer history of drug injection (8.2 vs. 4.4 years; p < 0.001).
Genotype 1 was found in 19 (67.9%) out of 28 HCV RNA
positive IUD.
Conclusion: The prevalences of HIV (0%), HBV (11.7%) and
HCV (27.5%) were among the lowest found to date among IUD.
Only 11.7% of IUD on MTT were successfully vaccinated against
HBV infection and 76.7% of IUD on MMT were still susceptible
to HBV infection. Therefore, a more intense action concerning
vaccination against HBV is needed.
R2191
Fulminant fungal peritonitis and ascites in a
HIV-infected patient with HCV-related chronic
hepatitis. A role for prolonged nimesulide
self-administration?
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, IT)
Background: The mortality rate of HIV-infected patients (p)
with liver disease is substantially increasing.
Methods: An exceedingly rare case of Candida albicans fulmi-
nant peritonitis and ascites in a p with HIV-HCV-coinfection
and stable cirrhosis, and possibly related to exaggerated self-
administered nimesulide, is reported.
Results: A 46-y-old p with HIV infection known since 14 years
received isolated 3TC-d4T since six years with a favourable
laboratory response: HIV-RNA 480 copies/mL, CD4+ lympho-
cyte count 428 cells/lL. Neither liver biopsy nor speciﬁc
treatment was performed for a concurrent stable HCV liver
cirrhosis. Two months before admission, our p had a shoulder
fracture, and uncontrolled nimesulide self-medication was
performed during six weeks. A rapidly worsening ascites and
oliguria led to admission. Slightly increased ALT, amylase,
and bilirubin were detected, but a rapidly increasing ascites and
diffuse edema occurred, paracentesis, and diuretic-albumin
administration failed, and the worsening ascites-anuria evolved
into kidney failure. One day later our p deceased and necropsy
examination showed a diffuse polyvisceritis and a micronodular
hepatitis with abundant ascites, in absence of kidney-urinary
tract anomalies and other signs of decompensated cirrhosis.
After p’s death multiple ascites cultures yielded isolated Candida
albicans.
Conclusions: HIV-infected p have increased risks of liver
toxicity. NSAID are implicated in severe, and possibly lethal
hepatotoxicity. The exceedingly rapid and severe evolution
towards a Candida-infected ascites associated with refractory
anuria, in absence of decompensated cirrhosis, acute hepato-
toxicity, and kidney involvement at autopsy, was never
observed after NSAID/nimesulide use. Animal models
showed a NSAID-induced increased enteric vascular permeab-
ility causing infectious peritonitis. Clinicians facing p with
advanced chronic hepatitis but no decompensated cirrhosis
should remind that NSAID may act on liver-bowel function and
could prompt a liver-kidney damage, possibly complicated with
infectious ascites.
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R2192
Acute reactivation of a severe pulmonary
tuberculosis during associated interferon
pegylate-ribavirin treatment carried out for a
known chronic hepatitis C
R. Manfredi, S. Sabbatani, F. Chiodo (Bologna, IT)
Introduction: Tuberculosis (T) may be reactivated starting from
a latent T infection, when immunodeﬁciency (usually jatrogen-
ic), or other risk factors, become apparent. Post-primary T
episodes were described also decades after a primary Myc.
tuberculosis infection, in patients (p) who show apparently
limited radiographic signs at chest X-ray. Some grade of
immunodeﬁciency may also depend on associated IFN-ribavirin
for an underlying chronic HCV hepatitis, as expressed by the
frequent emerging of leuko-neutropenia, and altered cytokine
network.
Case report: In a p aged >50 years with negative history of T, an
occasional chest X-ray showed ﬁbrous-calciﬁc inﬁltrates at
upper right lobe. After 11 years, due to a progressive chronic
HCV hepatitis, IFN plus ribavirin were started with good
tolerability for 7 months, until a sudden occurrence of cough
and haemoptisis associated with a pulmonary lesion suggestive
of T became apparent, in the same area where some reliquates
were demonstrated 11 years before. A HRCT examination
disclosed 2 excavated inﬁltrates. Both direct microscropy and
culture of sputum-BAL proved positive for Myc. tuberculosis
(susceptible to all tested compounds), while a positive Mantoux
became evident. An absolute lymnphopenia (nadir 966 cells/
lL), prompted a T-cell subset study, which showed an imbal-
ance of the CD4/CD8 ratio and an absolute CD4+ count of
290 cells/lL. Notwithstanding 5 consecutive weeks of isoniaz-
ide-ethambutol-rifampicin-pyrazinamide administration, the
sputum remained positive, thus conﬁrming the role of immu-
nodeﬁciency in prompting a difﬁcult-to-treat T.
Discussion: Animal models demonstrated that an increased
release of immunosuppressive cytokines (IL-10-TGF-ß), may
prompt a T reactivation, while a maintained T-cell competence
enhances T latency. Although a few cases of non-infectious lung
involvement, interstitial pneumonia, and bronchiolitis obliterans
were described during IFN therapy administered to transplant
p, no episodes of reactivated T were reported. Although our
disease occurrence seems unique, the increased use of IFN and
potent agents for the management of chronic hepatitis or other
diseases, might support the reactivation of latent T. A careful
medical history, Mantoux reaction, and a chest X-ray, are
mandatory before starting IFN. The immunosuppression related
to IFN-ribavirin may go beyond the expected leuko-lymphope-
nia, and also act against the quantitative-functional role of T
lymphocytes, thus playing a key role in latent T reactivation.
R2193
Immune response tp standard dose of hepatitis B
vaccine in HIV clients of Kermanshah
behavioural disease counselling centre in 2004
A. Janbakhsh, S. Vaziri, B. Sayad, M. Rezaei, M. Afsharian,
H. Montazeripour (Kermanshah, IR)
Objectives: Because of HIV and Hepatitis B coinfection and due
to having the same transmission ways among HIV positive
cases, Hepatitis B has turned into a major health concern. The
increasing number of HIV cases and their relevant problems,
especially opportunistic infections, demands for Hepatitis B
vaccination. This study, therefore was conducted to evaluate the
immune response against Hepatitis B vaccine and related factors
among HIV positive cases and the probable approaches to
improve its level.
Methods: In this cross-sectional study, 169 HIV positive cases
who were Kermanshah’s Behavioural Diseases Counselling
Center’s clients, with negative HBs-Ag and HBc-Ab, were
vaccinated against hepatitis B virus with a 20 lg of recombinant
HBsAg at 0–1–6 month schedule in deltoid region. A month
after the last shot, their HBs-Ab titre was measured. Titres
higher than 10 lIU/ml were considered as a suitable immune
response. Data included in this study were: age, gender, CD4
count, antiretroviral treatment history, hepatitis C coinfection
and injecting drug abuse. Then these data were analysed
through v2 test.
Results: Among 169 under study cases, immune response was
totally 52.7% and then 51.9% and 66.7% for males and females
respectively (PV = 0.313). Immune response was 54.3%, 44.3%,
and 45.3% in CD4 count>500, 200–449, and < 200 respectively
(PV = 0.039). In cases with antiretroviral treatment and without
antiretroviral treatment the immune response was 81.8%
and50.6% respectively (PV = 0.045); In IDUs and HCV co-
infected cases, the immune response rate was 51% and 51.3%
respectively (PV = 0.294).
Conclusion: In this study the CD4 count and the history of
antiretroviral treatment correlation with immune response level
was signiﬁcant, but other factors like age, HCV co-infection,
drug abusing, and gender were ineffective factors in immune
response to hepatitis B vaccine. Therefore, early vaccination
among cases with higher CD4 counts or cases under antiretro-
viral treatment seems necessary.
R2194
Interferon-alpha response to hepatitis B/C and B/
D co-infections versus HBV infection alone
S. Akhan, Z. Yulugkural, F. Ozkan (Kocaeli, TR)
In patients with chronic hepatitis B, estimates of the rates of
HCV co-infection vary from 9% to 30%, depending on the
geographic region. HCV infection can suppress HBV replication.
But clinicians must exercise caution when treating coinfected
patients with combination interferon plus ribavirin given this
risk of HBV reactivation. The clinical course of chronic hepatitis
D (CDH) is generally more severe than that of other forms of
viral hepatitis. Although the prevalence of HDV infection has
declined in the Mediterranean basin in the last decade, it is still
an important public health problem. Until now, the only drug
that has been shown to be effective for treatment of CDH is
interferon-a (IFN-a). We have 231 HBV infected patients 8 of
them have HCV and 12 HDV coinfection. From them 7
HBV + HCV, 9 HBV + HDV and 42 HBV patients were proper
with liver biopsy (chronic hepatitis necroinﬂammatory score
>4), DNA and ALT levels to begin the IFN-a therapy. They have
now IFN-a at least 3 months. Our aim is to compare the IFN-a
effects in patients who have co-infection C or D and who have
hepatitis B infection alone. In patients who have co-infected, the
decrease of DNA level before treatment and after 3 months was
not signiﬁcant (Wilcoxon signed ranks test p = 0.213). But the
patients who have only HBV infection the decrease in 3 months
is statistically signiﬁcant (p = 0.0001). If we look at ALT levels in
ﬁrst group the decrease is not signiﬁcant (but the p value found
0.07), in the second group statistically signiﬁcant. In both groups
platelet, haemoglobin and polymorphonuclear cell counts
decreases statistically signiﬁcant (p < 0.05). HBV infected
individuals have the risk B and C or B and D co-infection.
This effects the therapy. Dual infections present unique
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management challenges and treating this patients is more
difﬁcult. We should know the propensity for developing more
severe liver disease.
R2195
Quality assurance in HBV DNA and HCV RNA
quantiﬁcation
L. Tagliaferro, P. Menegazzi, M.A. De Donno, M. Ulivi, J.L.
McDermott, O.E. Varnier (Lecce, Genoa, IT)
Objectives: Assessment of accuracy and reproducibility of the
Real-time PCR test for the HBV and HCV in diagnostic
laboratory. Standardized molecular methods for the quantiﬁca-
tion of viral nucleic acids is needful to monitor chronically
infected patients, allowing evaluation of therapy efﬁcacy and
antiviral drug dosing by clinicians.
Methods: We developed two ‘‘in house’’ rapid, single tube
LightCycler Real Time PCR for accurate quantiﬁcation of HBV
and HCV viraemia with dual hybridization probes technology
(FRET). For each virus a serial ten-fold dilution quantitative
standard curve was performed and memorized, using interna-
tional WHO HBV/HCV human reference standard plasma
(HBV and HCV Accurun series, BBI Inc.). During each assay one
reference standard was used and viral nucleic acids were
quantiﬁed by interpolation with the memorized Accurun
standard curve. To evaluate the test reproducibility the Coefﬁ-
cient of Variation (CV) and Standard Deviation (SD) of Accurun
samples were monitored.
Results: A total of 1095 plasma samples for HBV DNA and 3068
for HCV RNA were quantiﬁed; 91 and 279 Real Time PCR
assays were respectively performed from October 2002 to
September 2005. 462 samples resulted HBV DNA positive,
with a range from 85 to 5 · 1011 DNA copies/ml, the HBV
reference standard crossing point displayed a CV of 6.75% and
DS of 1.89.1739 samples were HCV RNA positive (range from 57
to 2.5 · 109 IU/ml); two different HCV reference standard were
utilized, the ﬁrst (170.000 IU/ml) displayed a crossing point CV
of 3.55% and DS of 1.08, and the second standard (910.000 IU/
ml) displayed a crossing point CV of 4.15% and DS of 1.16.
Conclusions: The very low CV and DS values of the standard of
this two ‘‘in house developed’’ Real Time PCR protocols
demonstrate the good accuracy and reproducibility of the
tests; therefore representing a valid diagnostic tool in monitor-
ing HBV and HCV chronic infections. An External Quality
Assessment (EQA) program for dosing viral nucleic acids would
be a needed addiction.
R2196
Seroepidemiology of hepatitis A in patients with
chronic hepatitis C
M. Christoﬁdou, F. Kolonitsiou, E. Mylonas,
G. Dimitracopoulos (Patras, GR)
Hepatitis A virus (HAV) rarely causes fulminant hepatitis in
general population. Yet it is a cause of signiﬁcant morbidity in
patients with chronic liver disease in whom routine HAV
vaccination is recommended. However, studies of HAV sero-
prevalence in population with chronic Hepatitis C virus (HCV)
infection are scarce. A cohort of 185 patients with chronic
Hepatitis C (CHC) were examined between January 2004 and
February 2005.Patients were stratiﬁed in four groups on the
basis of the mode of HCV transmission. The HAV seropreva-
lence in patients with CHC was compared with that in 72 blood
donors, aged 18–50 years.Among patients with CHC, 126 were
patients of hepatological clinic (HP), 37 were dialysis patients
(DP), 9 were multitransfused adults with b-thalassaemia (BTH)
and 13 were intavenous drug users (IDU). The patients of the
ﬁrst two groups were 50–70 years old, whereas the other two
groups were composed of younger people aged 20–30.The
majority of HP, DP and BTH patients received blood or blood
products before the implementation of routine screening for
HCV (1990). The dialysis treatment and other parenteral
exposure during a hospital admission in the past, were different
reasons of the CHC in the above groups. IDU were contamin-
ated with HCV by injecting drugs. Sera of the above 185 CHC
patients antiHCV (+) (MEIA AXSYME Abbott) and HCV RNA
(+) (TMA VERSANT Bayer) were tested also for anti-HAV
(MEIA AXSYME Abbott). The prevalence of anti-HAV was 77%
in HP, BTH and IDU, whereas in DP was 70%. In the group of 72
antiHCV (-) blood donors, the prevalence of antiHAV was only
17%. The much higher prevalence of anti-HAV found in HP and
DP, groups with older patients, is more likely to be related to
HAV infection during infancy. In aˆOˆI`, a group with younger
population the high rate of anti-HAV seems to be related to the
multiple transfusions and to the passive transmission of anti-
HAV, whereas in IDU, a group consisting of young men, the
lifestyle as also the higher possibility of parenteral contamin-
ation with HAV, were the probable reasons of high seroposi-
tivity. Although the prevalence of anti-HAV in HP, DP, BTH
and IDU was high, immunization of patients with chronic
hepatitis C, without immunity to HAV, may be necessary.
R2197
Prevalence of HBV and HCV infection in a high-
security prison
P. Sergouniotis, A. Sergounioti, G. Margonis, F. Sergouniotis,
E. Papoulia (Amﬁssa, GR)
Prisoners are a high-risk group for HBV and HCV infection,
because of the increased frequency of intravenous drug use and
its special demographic composition.
Objectives: The purpose of this study was to determine the
prevalence of HBV and HCV infection in the prisoners of a high
security prison in Greece.
Methods: A total of 150 out of 249 prisoners (60.2%) consented
to serologic testing. Ninety-seven (64.5%) of them were foreign-
ers and 53 (35.5%) were Greeks. The sera were tested for HBsAg,
anti-HBs, anti-HBc and anti-HCV. All tests were performed
using MEIA method (Axsym, Abbott Laboratories). Specimens
positive for the above tests were double-checked using the same
method.
Results: 1) The HBsAg carriers represented the 11.3% of this
social group, with higher prevalence among foreigners (12.4%)
in comparison with Greek prisoners (9.4%). Similar results have
been described in studies from other Greek prisons (9.3–13.4%).
2) The prevalence of HBV infection is 45.4% and 37.7% among
foreigners and Greek prisoners respectively (average 41.6%). 3)
The prevalence of HCV infection is 17.3%. HCV infection
appears oftener among Greeks than among foreigners 24.5% and
13.4% respectively – which is a relatively low ratio, compared to
the results reported by other studies (24.5–68.5%). 4) 3.3% of the
prisoners were carriers of both HBV and HCV. 12% of them
have had natural exposure to these viruses.
Conclusions: Our results indicate the importance of policies to
prevent transmission of HBV and HCV infection in prison
population. The measures required should include hepatitis B
vaccination, HCV testing and counselling, medical management
of infected persons, and substance abuse treatment in incarcer-
ated populations.
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R2198
Depression and social support in asymptomatic
hepatitis B carriers
K. Hizel, A. Kockar, F. Yetkin (Ankara, Malatya, TR)
Objective: To understand the effects of chronic hepatitis B
(CHB) infection on the psychological status of these patients.
The second aim is to investigate the effect of perceived social
support on depression in CHB patients.
Methods: Recently diagnosed (<6 months) 110 chronic hepatitis
B (HBV) patients with normal liver enzymes level have been
included to the study. Patients were investigated for depression,
social support and attribution variables. Socio-demographic
variables of the patients including gender, age, family status,
having children, education level, income was recorded. their
illness was discovered.
Results: In the total sample mean depression scores were
7.28 ± 7.93. 72.7% had scores less than 9. 20% of the patients
had scores between 10 and 18 indicating mild to moderate
depression; 4.6% of the patients had scores between 19 and 29
indicating moderate to severe depression; and 2.7% of the
patients received scores of more than 30 indicating severe
depression. Thus a total of 27.3% of the patients had depression
ranging from mild to severe. There was no signiﬁcant effect of
Socio-demographic variables and age on depression scores.
Patients who had mentioned that their families had pulled away
from them had signiﬁcantly higher depression scores than
patients whose families had supported them (6.75 ± 6.96 vs.
21.67 ± 21.01; p = .002). Similar to this result was that patients,
whose friends had pulled away, had signiﬁcantly higher
depression scores than patients whose friends had supported
them (6.65 ± 6.57 vs. 18.17 ± 17.81; p = 0.001). Social support
was a negative predictor of depression.
Conclusion: Although physical harm was not present in the
patients, depression can be a common psychological symptom.
Providing sufﬁcient information about the disease to the
patients and their families may help in changing their attribu-
tions, thus decreasing depressive symptomatology as well as
increasing support provided to the patients by their families and
friends. Social support mechanisms prove to be a positive aspect
in relation to the psychological functioning of patients in coping
with a chronic illness.
R2199
HBeAG negative serological status and low viral
replication levels characterise chronic HBV-
infected women at reproductive age in Greece. A
two-year, prospective, single-centre study
I. Elefsiniotis, I. Glynou, I. Magaziotou, A. Fotiou, H. Brokalaki,
N. Fotos, G. Saroglou, H. Kada (Athens, GR)
Objective: To evaluate the seroprevalence of HBsAg in 26746
women at reproductive age in Greece and the HBeAg/anti-HBe
serological status of the HbsAg (+) ones as well as serum HBV-
DNA levels at labour in a subgroup of 63 HbsAg (+) pregnant
women.
Methods: Between August 2003 and September 2005 a total of
26746 women at reproductive age (range 16–45 years) were
prospectively evaluated. Serological markers were detected
using enzyme immunoassays. Serum HBV-DNA was calculated
using a sensitive quantitative PCR assay.
Results: The majority of the study population came from
Greece (67%) whereas 20.3% of them came from Albania, 6.9%
from Eastern European countries, 3.8% from African countries,
0.9% from Asian countries, 0.5% from countries of Northwestern
Europe, 0.2% from Australia and 0.2% from North American
countries. Overall, 1.53% of the study population were HbsAg
(+) and the majority of them (65%) were Albanian. Among
Albanian women the mean prevalence of HBsAg was 4.9%,
5.57% among Asian women and 1.29% among women from
Eastern European countries. The prevalence of HBsAg among
African (0.29%) and Greek women (0.57%) was very low. Only
4.2% of HbsAg (+) women were also HbeAg (+) whereas the
vast majority of them (>95%) were HbeAg (-)/antiHBe (+). None
of the females from countries of North America, Northwestern
Europe and Australia were HBsAg(+). Undetectable levels of
viraemia (<200 copies/ml) were observed in 28.6% of pregnant
women evaluated at labour and 15.9% exhibited extremely low
levels of viral replication (<400 copies/ml). Only 12.7% of
pregnant women evaluated at labour exhibited extremely high
serum HBV-DNA levels (>10 000 000 copies/ml) whereas 48.5%
of them exhibited HBV-DNA levels between 1500 and
40 000 copies/ml.
Conclusion: The overall prevalence of HBsAg is relatively low
among women at reproductive age in Greece but is higher
enough among speciﬁc populations (Asian, Albanian). The
HBeAg(-)/antiHBe(+) serological status is a ﬁnding observed in
the vast majority of HBsAg(+) women of our study population
and a signiﬁcant proportion of them (44.5%) exhibit extremely
low or even undetectable viral replicative status at labour,
suggesting possibly that only a proportion of HBsAg(+) women
in Greece exhibit an extremely high risk of vertical transmission
of the infection.
R2200
Comparison of anti-HCV and HCV RNA results
by real-time reverse transcriptase quantitative
polymerase chain reaction
N. Kasifoglu, T. Us, Y. Akgu¨n (Eskisehir, TR)
Objectives: In this study we compared HCV RNA results
determined by Real-time Reverse Transcriptase quantitative
PCR with anti-HCV results and investigated the relationship
between these parameters with ALT/AST levels of patients.
Methods: 690 tests from 508 different patients of Medical
Faculty of Osmangazi University were studied between January
2002 and December 2004. Anti-HCV (Abbott Axsym System
HCV 3.0), HCV RNA (real time Taqman technology, Roboscreen
kit and ABI Prism 7700 Perkin Elmer) results and ALT and AST
levels of patients were examined.
Results: In our study group, 455 (65.9%) tests of 690 were found
positive for anti-HCV and 235(34.1%) tests were negative. In 235
(51.6%) tests of 455 tests which were found to be positive for
anti-HCV, HCV RNA was found to be positive and in 220
(48.4%) tests of them HCV RNA was negative. In 20 (8.5%) of
235 serum samples that were negative for anti-HCV, HCV RNA
was found to be positive and in 215 (91.5%) of them HCV RNA
was negative. When considering about liver enzyme levels, of
690 serum samples, 338 showed normal enzyme levels; in 272
both ALT and AST were elevated, in 23 only AST was elevated,
in 57 only ALT was elevated. In ALT and AST elevated group, in
137 of 272 samples anti-HCV and HCV RNAwere positive, in 46
only anti-HCV was positive, in 10 only HCV RNA was positive
and in 79 both of them were negative.
Conclusion: Anti-HCV negative but viraemic patients can
occur. Therefore, PCR is an important test in determining the
cases that show no seroconversion and that are uncertain.
Quantitative real time PCR is a very useful tool in monitorizing
the answer of patients undergoing therapy, as in our study.
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R2201
Acute Brucella hepatitis: two case reports
M.K. Celen, C. Ayaz, M.F. Geyik, S. Hosoglu, M. Ulug
(Diyarbakir, TR)
Introduction: Brucellosis is an infection disease, which is
appeared acute or chronic progress and is fall into many
organs. Acute Brucella hepatitis is a rare manifestation of the
disease. It progresses with increasing of liver function tests
usually. Because of this reason two cases, which were pro-
gressed with acute Brucella hepatitis in our clinic was submitted.
Case 1: A 42-year-old male patient which was come with fever,
sweating, back pain and appetite complains, was hospitalized.
His fever was 38.2C, pulse 88/minute and the other physical
examination was normal. His laboratory ﬁndings follow; WBC:
4200/mm3 (lymphocyte 48%) CRP: 25.5 mg/L (N < 5 mg/L),
total bilirubin 0.87 mg/dl, ALT: 484 IU/ml, AST: 401 IU/ml,
ALP: 298 IU/ml and PTT were normal. His hepatitis markers
(HBsAg, Anti-HBc-IgM, Anti-HCV and Anti-HAV IgM) were
negative. His Brucella agglutination was 1/320 and Rose-Bengals
test was positive. Brucella spp. was grown from his blood
cultures than doxocycline 200 mg/day and rifampicin 600 mg/
day were given to the patient. In 5th days of the therapy his
fever decreased and in 19th days the liver function tests
decreased to normal level.
Case 2: A 38-year-old female patient goes to doctor with
arthralgy and morning rigidity. The doctor diagnosed reactive
arthritis and gives her NSAID. The patient came to us with fever
39.2C, pulse 92/minute a week later, and she was hospitalized
in our clinic. Her other physical examination was normal. Her
laboratory ﬁndings were: WBC: 6200/mm3 (lymphocyte 58%),
CRP: 42.5 mg/L (N < 5 mg/L), total bilirubin: 0.72 mg/dl, ALT:
374 IU/ml, AST: 312 IU/ml, ALP: 238 IU/ml. Prothrombin time
was normal. Her hepatitis markers (HBsAg, Anti-HBc IgM,
Anti-HCV and Anti-HAV IgM) were negative. Her Brucella
agglutination was 1/640 and Rose-Bengals test was positive.
Brucella spp. was grown from her blood cultures then strepto-
mycin 1 gr/day and doxocycline 200 mg/day were given to the
patient. In 7 days of the therapy her fever decreased. Her liver
function tests were decreased 3 weeks later.
Conclusion: Brucella infection is endemic in our region in
particular. Acute Brucella hepatitis, a rare manifestation of
brucellosis, was studied carefully with these cases.
R2202
The effect of pegylated interferon on quality of
life in the treatment of chronic active hepatitis C
S. Nayman Alpat, G. Usluer, H. Yavuz, E. Doyuk Kartal, N.
Erben, C. Bal, I. O¨zgu¨nes (Eskisehir, TR)
Objective: Hepatitis C virus (HCV) infection is a world wide-
spread disease and a very serious health problem. Pegylated
(PEG) interferon (IFN) is developed because of disadvantages of
IFN alfa, which has been used in the treatment of HCV infection
since 1986. Health related quality of life (HRQOL) in patients
treated with PEG IFN alfa 2a was superior to patients treated
with IFN alfa. This study was designed to evaluate the effect of
PEG IFN used in the treatment of chronic hepatitis C on
HRQOL.
Methods: 40 patients who have been treated in Eskisehir
Osmangazi University Hospital Department of Infectious Dis-
eases and Eskisehir Yunusemre State Hospital Department of
Gastroenterology at the period of time between 01.03.2003 and
01.04.2005 attended the study. 22 patients in the ﬁrst group
were treated with PEG IFN alfa 2a (180 mg/week) and
ribavirin (1000–1200 mg/day), 18 patients in the other group
were treated with PEG IFN alfa 2b (1.5 mg/kg) and ribavirin
(1000–1200 mg/kg) for 48 weeks. Patients answered the short
form-36 (SF-36) to evaluate the quality of life at the beginning
of treatment, 12th, 24th, 48th weeks and 24th week after the
treatment.
Results: There was no statistically signiﬁcant difference
between two groups on frequency of adverse reactions and
laboratory ﬁndings. There was also no statistically signiﬁcant
difference between two groups on reduction of drug doses,
making pause during treatment and discontinuing the treat-
ment. Sustained virological response was 80% in naı¨ve patients
the ﬁrst group and it was 83.3% in naı¨ve patients the second
group (P = 1). They were 60% and 25% respectively at relapsed
patients (P = 0.293). SF-36 was evaluated and physical function,
role physical, role emotional, vitality, mental health, social
function, bodily pain, general health scores were obtained at the
beginning of treatment 12th, 24th, 48th week and 24th week after
treatment. There was no statistically signiﬁcant difference on
median of each scores obtained from both groups during the
period of treatment. In both groups decrease of the SF-36 vitality
score from the beginning to the end of treatment was statistically
signiﬁcant. Decrease of other scores we had during treatment
was not statistically signiﬁcant.
Conclusion: HRQOL should be considered in diseases need
long-term treatment and have similar cure rates such as chronic
viral hepatitis.
R2203
Evolution of antigenaemia and viraemia in mono-
infected and HIV-co-infected patients not
responsive to chronic hepatitis C treatment
S. Garcinun˜o Pe´rez, M.A. Bratos Pe´rez, B. Sanchez Borge,
S. Garcı´a de Cruz, L. Barrio Revenga, M.P. Gutie´rrez Rodrı´guez,
A. Ordun˜a Domingo, A. Rodrı´guez Torres (Valladolid, ES)
Introduction and purpose: Hepatic disease from hepatitis C
virus (HCV) is a serious problem, especially in patients
coinfected with human immunodeﬁciency virus (HIV). In
addition to a more rapid progression to cirrhosis, such
coinfected patients respond more poorly to treatment than
monoinfected patients. The aim of our study is to investigate
viral kinetics through the concentrations of core antigen and
HCV RNA in monoinfected and HIV positive coinfected
patients not responding to treatment with pegylated interferon
plus ribavirin.
Materials and methods: Twenty-seven patients with chronic
hepatitis C were studied (15 HCV monoinfected patients and 12
HCV-HIV coinfected), controlling their evolution for 12 months
following onset of treatment with pegylated interferon and
ribavirin. HCV RNA concentration was determined by PCR
following reverse transcription of RNA to complementary DNA
(Cobas Amplicor, Roche Diagnostics); antigen core concentra-
tion was determined by ELISA (Ortho Trak C, Ortho Clinical
Diagnostics).
Results: Until the third month of treatment, monoinfected
patients showed a stronger decrease in the concentrations of
antigen core than in HCV RNA. These levels remained steady
until the ninth month; from then until the end of the study
period the patients presented a signiﬁcant increase in HCV RNA
concentrations. However, from the six month on, the antigene-
mia increase was stronger in HIV coinfected patients, HCV RNA
levels remaining more or less constant.
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Conclusions: Our study shows that the viral kinetics of patients
not responding to treatment is different in HCV monoinfected
and HCV-HIV coinfected patients. A stronger decrease in
antigen core concentrations is produced during the ﬁrst three
months of treatment in monoinfected patients, while a greater
increase in antigen core concentrations from the sixth month of
treatment on is produced in coinfected patients.
R2204
Hepatitis B virus/hepatitis D virus co-infection in
Greece
E. Peteinellis, M. Theodorou, A. Hounda, H. Drakoulis,
A. Papanastasiou, A. Georgoulios, A. Toliopoulos,
A. Mavrommati, E. Sagana (Athens, GR)
Objectives: Hepatitis D virus (HDV) is a single RNA viroid that
requires a helper function provided by Hepatitis B virus (HBV)
and causes a severe and rapidly progressive form of liver
disease. HDV infection is still a major public health problem.
HBV endemicity has declined in Greece due to HBV vaccination.
Our country has received a great number of socioeconomic
immigrants from countries with high endemicity of HBV
infection and this might inﬂuence the prevalence of HDV
infection. Our intention is to investigate the prevalence of HDV
infection in Western Attica among Greeks and socioeconomic
immigrants with Chronic Hepatitis B(CHB).
Materials/methods: Sera obtained from 484 patients (114 immi-
grants, 373 Greeks) with CHB as deﬁned by HBsAg (+) and/or
HBV DNA (+) and/or HBcIgM Ab(-) were tested for HDV IgG
and/or IgM and/or HDVAg. 29 individuals’ sera with HBsAg (-
)/HbcAb (+) were analyzed for HDVAb. Serological markers for
HBV infection were performed by MEIA AXSYM ABBOT and
for HDV infection by ELISA. HBV DNA was measured by PCR
assay Amplicor Monitor Roche.
Results: 1) Immigrants: 21/114(18%) were HDV Ab and/or
Ag(+). 2)Greeks: 82/373 (22%) were HDV Ab and/orAg(+). 3)
28/373 patients with HBV DNA low levels (1000 copies/ml),
abnormal ALT and HBcIgM Ab(-) were: 9/28 (32%) HDV Ab(+).
4) 29/373 patients with high HBV levels (>100 000 copies/ml),
abnormal ALT and HBcIgMAb (-) were: 1/29 (3%) HDV Ab(+).
5) 4/29 (14%) individuals with HBsAg (-)/ HbcAb (+) were
HDV Ab (+).
Conclusions: 1) Although the prevalence of HBV infection in
immigrants (17% from our previous study) is much greater than
in Greek population (2%), the prevalence of HDV infection in
CHB immigrant patients (18%) is less than in CHB Greek
patients (22%). 2) CHB patients with low viral load, abnormal
ALT and HBcIgMAb (-) exhibit a higher percentage of HDV
infection (32%) than CHB patients with high viral load,
abnormal ALT and HBcIgMAb (-) (3%). This indicates that in
case of coinfection the HDV virus suppresses the HBV virus
replication as referred in the bibliography. 3) HBsAg (-)/ HbcAb
(+) individuals exhibit an unexpected high prevalence of HDV
antibodies (14%). According to the bibliography 10% of indi-
viduals with HbcAb (+) as the only marker of HBV infection
have detectable HBV DNA levels in their sera. These individuals
may be carriers of HDV infection. Further studies have to be
done in this setting.
R2205
Quality of life and adherence to treatment in
HIV/HCV co-infected patients and co-treated
with antiretroviral plus chronic hepatitis C
therapy
A. Pardo, L. Navarro, I. Gascon, P. Mas, A. Rocher, J. Ventura,
A. Pellicer, E. Arroyo, J. Polache, R. Fuster, R. Anton, A. Garcia,
D. Camacho, M. Gonzalez, M. Martinez, T. Aznar (Alicante,
Valencia, Castellon, ES)
Objectives: Assess adherence to treatment and quality of life in
HIV/HCV co-infected patients, co-treated for both pathologies.
Methods: An observational prospective study was carried out
by the Outpatient Pharmacy Service. Adult patients were
eligible considering three conditions: HIV/HCV co-infectioned
presence, following antirretroviral therapy for at least
6 months, and starting treatment with peg-interferon + ribavi-
rina combination for chronic hepatitis C. Quality of life as well
as adherence to antiretroviral and HCV treatment were
evaluated at the beginning of the treatment and 3 months
later. Adherence was assessed with the validated questionnaire
SMAQ (Simpliﬁed Medication Adherence Questionnaire) and
the pharmacy records (adherence >90%). Quality of life was
assessed with the EuroQOL-5D test (score from 5 (no affected
by treatment) to 15 (signiﬁcantly affected) and visual analogi-
cal scale about ‘‘how is your health status today’’ from 0 to
100).
Results: During the period of study, 27 patients were enrolled,
3 of them left the study before the 1st month. The median age
was 38.73 (28–49), 62.5% were men and the HIV risk factors
were: injection drug user 66.7%, sexual contact 16.7% and other
12.5%. 90.9% of the patients had undetectable HIV-RNA viral
load and a CD4 basal average recount of 631.28 (237–1360).
12.5% of the patients discontinue treatment due to adverse
effects and 16% needed a dosage decrease. Patients considered
adherent to treatment according to SMAQ were the 50% at the
basal visit and 73% at the 3rd month (p < 0.05) and according to
the pharmacy records 70.8% to 100% (p < 0.05). Quality of life,
by EuroQOL-5D health dimensions score, was 5.84 (SD: 1.35) at
visit 0, and 6.38 (SD: 1.89) at 3rd month (p < 0.05); and in the
visual analogical scale 69.9 vs 60.54 (N.S.), respectively. 91.0% of
patients had adverse effects related with the HCV treatment and
17.1% because of the antiretroviral drugs.
Conclusions: Adherence to treatment is not decreased by
introducing the HCV treatment in HIV pre-treated patients.
Despite of the difﬁcult treatment with many adverse effects, the
patients compliance is correct. It can be explained because the
monitoring of this patients is increased and have educational
interventions by pharmacist and physicians in each visit during
the HVC treatment. Quality of life is signiﬁcantly lower after
3 months of treatment compared with the basal measure,
although it is not related with non-adherence.
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R2206
Human papillomavirus genotype determination
using Inno-LiPA HPV genotyping assay. Is the
easy detection of mixed populations of HPV
useful?
P. Honderlick, M.L. Clement, R. Beddock, D.E. Ha, C. Pinet,
D. Vignon (Suresnes, FR)
HPV, particularly some genotypes (HPV 16, HPV 18...) are
recognized as a main cause of cervical cancer, HPV also play a
major role in the development of different types of cervical
lesions. The aim of the study was to determined the effectiveness
of the Inno-LiPA (Innogenetics) HPV genotyping assay and to
looked at the distribution of genotypes or combination of
genotypes in our population. This technique of ampliﬁcation
followed by an hybridization on strips allowed simultaneously
the detection of 24 genotypes of HPV. 218 endocervical scrapes
were tested and compared to results of gynaecological evaluation
and cytological examination. All women have atypical or positive
index cytology (ASCUS or CIN1 to CIN 3). HPV-DNA was
detected in 52% of the samples. According to our results, some
genotypes are more frequently represented as HPV 53, HPV 31,
HPV 66, HPV 16 all at high risk of cervical carcinoma. 53% of the
positive specimens showed only a single genotype on LiPA strip.
To consider only ‘‘single types’’HPV16,HPV31 andHPV53were
themost frequent ones. Among the 54 combinations of genotypes
a great diversity was observed without any predominance (42
different combinations). To enter all the details, we noticed that
insidemixedHPVgenotypeswe canextract 6 various associations
more prevalent than others (53 + 66, 31 + 53, 31 + 66, 45 + 53,
6 + 31, 31 + 68/73). They represent more than 75% of HPV
genotypes among the group of patients infectedwith mixedHPV
types and 36% of all HPV positive patients. Informations
provided by this test about single or mixed genotypes contained
in cervico-vaginal samples is auseful tool combinedwith cytology
and clinical examination results. Inno-LiPA HPV genotyping
assay allow to record precise genotypic and epidemiological data
of interest for the follow up of the patients. Larger studies are
necessary to evaluate the predictive values of the accumulation of
multiple HPV genotypes observed for many patients.
R2207
Primary cytomegalovirus infection in patients
with Guillain-Barre´ syndrome
C. Steininger, A. Seiser, N. Gueler, E. Puchhammer-Sto¨ckl,
T. Popow-Kraupp (Vienna, Klosterneuburg, AT)
Objectives: Guillain-Barre´ syndrome (GBS) is associated with
cytomegalovirus (CMV) infection in 10–15% of cases as identiﬁed
by the presence of CMV-speciﬁc IgM-antibodies in serum.
Presence of IgM-antibodies may indicate primary CMV infection
as well as reactivation from latency. The aim of the present study
was to identify primary CMV infection in patients with GBS.
Methods: We studied 46 CMV-seropositive patients with GBS
between 1998 and 2003. Sera obtained from these patients were
tested by an avidity assay and CMV-speciﬁc polymerase chain
reaction (PCR). Virological ﬁndings were compared with clinical
characteristics.
Results: Primary CMV infection that occurred <6 months
before onset of GBS was identiﬁed in 10/46 (22%) patients by
detection of low-avidity IgG-antibodies (n = 9) or IgM-anti-
bodies in the absence of IgG-antibodies (n = 1). High-avidity
IgG-antibodies were found in 2/6 (33%) IgM-antibody-positive
patients. Recent CMV activity was identiﬁed in 17/46 (37%)
patients by detection of CMV-DNA in serum. Thirteen of the
PCR-positive patients had also high-avidity IgG-antibodies
suggestive for reactivation of latent infection. The likelihood of
the presence of CMV-DNA in serum decreased signiﬁcantly
with increasing antibody avidity (P = 0.041). Patients with
primary infection were younger (P = 0.033) and had more
frequently urinary retention requiring catheterization
(P = 0.007) than other CMV-seropositive patients.
Conclusions: CMV-associated GBS is common in CMV-sero-
positive patients and a considerable proportion may be attrib-
uted to primary infection. Reactivation of latent virus or
reinfection by a different CMV strain, however, also have to
be considered as relevant events associated with this neurolog-
ical illness.
R2208
Symptomatic, primary cytomegalovirus infection
in otherwise healthy adults. Increased incidence
or increased resort to improved laboratory
facilities?
R. Manfredi, L. Calza, F. Chiodo (Bologna, IT)
Background: The increased availability of serological-biomo-
lecular assays for the diagnosis of acute Cytomegalovirus (CMV)
infection, allows us to include these assays in the workout of
fever of unknown origin (FUO) in immunocompetent adults.
Methods: A retrospective study of patients (p) diagnosed with
primary CMV infection during assessment of a FUO, was
performed at our centre of Bologna (Italy).
Results: One hundred and 11 p aged 13–42 years (females in 67
cases: 61.4%), were assessed for a FUO since the year 2001. The
diagnostic workup also included CMV serology with IgG-IgM
search,while pp65 antigenemia and CMV viremia were carried
out in selected p. Of 111 p, 16 (14.4%) had a positive CMV IgM
assay, conﬁrmed in 6 p by biomolecular testing and antigen
search. An altered leucocyte count and differential were always
present, while T-lymphocyte subsets showed a transient reversal
of CD4+/CD8+ T-lymphocyte ratio, with a reduced percentage
and absolute number of CD4+ cells (250–580/lL), and an
expanded CD8+ phenotype. Concurrent signs-symptoms inclu-
ded fever in all p, associatedwith amononucleosis-like syndrome
in 13 p. A moderate (2–4-fold) rise of serum transaminases was
found in 12 episodes, in association with an ultrasonography-
conﬁrmed hepatosplenomegaly In 3 p, the predominant
signs-symptoms were fever, asthenia, fatigue, and anorexia. A
normalization of liver enzymes and leucocyte differential pre-
ceded the disappearance of lymphadenopathy andhepatospleno-
megaly,while positive IgMserology lasteduntil 36 months in one
p (mean time to disappearance: 10–26 months).
Conclusions: Primary CMVirosis is a self-limiting disorder,
whose apparent increased frequency is probably attributable to
a more easy access to speciﬁc and sensitive laboratory testing.
Although a treatment is not indicated in otherwise healthy p,
clinicians should maintain an elevated suspicion for a primary
CMVirosis whem assessing p with FUO, since CMVmay cause a
prolonged febrile syndrome, and undiagnosed p are at risk to be
exposed to further, second level diagnostic workup, due to an
apparently unexplained, prolonged disease, usually associated
with constitutional symptoms.
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R2209
First detection of human astroviruses in raw
sewage samples in Baranya County, Hungary
E. Meleg, F. Jakab, B. Kocsis, K. Ba´nyai, B. Melegh,
G Szucs (Pecs, HU)
Background: Routine procedures for monitoring viruses in
water samples have not been drawn up for the water-microbio-
logy screening panel. Enteric viruses, including astroviruses, are
able to persist under environmental conditions and may cause
public health problems by contaminating natural and drinking
water resources.
Objectives: The aim of the study was to clarify whether human
astrovirus-associated gastroenteritis cases observed among hos-
pitalized children give a good indication on the real impact of
this virus on the population, or whether only a small proportion
of the true number of HAstV infections is being observed by
physicians.
Methods: To obtain data on whether HAstVs are shed in the
environment, 35 raw sewage samples from 22 sewage plants in
different regions of Baranya County, Hungary were tested for
astrovirus using the polyethylene-glycol method for concentra-
tion and the guanidinium thiocyanate-silica procedure for
extraction of viral RNA. Reverse transcription-polymerase
chain reaction with HAstV-speciﬁc primer pairs Mon2/PRBEG
and Mon2/JWT4 was used for ampliﬁcation and the speciﬁcity
of amplicons was conﬁrmed by sequence analysis.
Results: Among the 35 raw sewage samples, 15 (43%) contained
HAstV and by sequence analysis, 10 genotype HAstV-1 and 1
genotypeHAstV-2were identiﬁed. Four sampleswereuntypable.
Conclusion: This investigation applied for the ﬁrst time a
molecular virological method to detect human astroviruses in
sewage in Hungary, as was this viral screening test in conjunc-
tion with a routine bacterial and chemical water assay.
R2210
Seroprevalence of human parvovirus B19
infection
P. Karapavlidou, K. Koraki, I. Mihailidou, D. Soﬁanou
(Thessaloniki, GR)
Objectives: Parvovirus B19, a small, nonenveloped ssDNA
virus, causes infections ranging from asymptomatic to poten-
tially fatal. Erythema infectiosum in children, aplastic crisis in
patients with chronic haemolytic disorders and hydrops fetalis
are clinical manifestations caused by parvovirus B19 viraemia.
The purpose of this study was to determine the seroprevalence
of human parvovirus B19 acute infection in a tertiary care
hospital in Greece.
Methods: Sera from 467 patients of different age and sex groups
were examined for the presence of IgM antibodies against
human parvovirus B19 for routine virological diagnostics during
the period from May 2001 to August 2005. For the determination
of speciﬁc IgM titre in sera, a commercial enzyme-linked
immunosorbent assay (ELISA) using high speciﬁc recombinant
parvovirus B19 antigen was used (Novatec, Germany).
Results: Out of the 467 patient samples, 329 came from children
and 138 from adults (mainly pregnant women). IgM antibodies
to parvovirus B19 were present in 35 patients (18 women and 17
men). Positivity rates were 9.7% (32/329) for children and 2.1%
(3/138) for adults. No IgM positive sera were observed in
patients with haemoglobinopathies. The seasonal distribution of
acute infections in rank order was: winter 40%, spring 31.4% and
summer 28.5%. No IgM positive samples were found during
autumn period. Annual positivity rates were: 9%, 10.7% and 7%
in 2001, 2004 and 2005, respectively, while in the years 2002 and
2003 ranged below 4.5%.
Conclusion: In our study, children were most commonly
affected by parvovirus B19 and infections were most prevalent
during winter season. Clinicians should be alert to suspect
parvovirus B19 in some clinical manifestations and laboratories
should be able to detect it.
R2211
High-risk human papilloma virus in women with
abnormal pap-smears of the uterine cervix in the
northwest of Spain
P. A´lvarez, M. Herna´ndez, G. Guinarte, E. Fernandez,
M. Pascual, V. Pulian, M. Garcı´a (Pontevedra, ES)
Objectives: High-risk human papillomavirus (HR-HPV) is
considered the most important aetiological factor of uterine
cervical cancer. The aim of this study was to know the
relationship between high-risk human papillomavirus (HR-
HPV) detection and cytological ﬁndings among women with
primary abnormal pap-smears of the uterine cervix in the North
West of Spain.
Methods: 313 women aged 17–66 years with previous cytolo-
gical abnormalities were included in the study. All patients
underwent cytological study and cervical scrapings were
collected for HR-HPV detection by PCR using Amplicor HPV
Test (Roche, Diagnostics).
Results: Cytological ﬁndings observed in the 313 patients
studied were squamous metaplasia and inﬂammation in 108/
313 (34.5%), atypical squamous cells in 61/313 (19.5%), atypical
glandular cells in 4/313 (1.3%), low-grade squamous intraepit-
helial lesions (LG-SIL) in 81/313 (25.8%) and high-grade
squamous intraepithelial lesions (HG-SIL) in 20/313 (0.6%).
The remainder 39 patients presented a normal cytology. The
prevalence of HR-HPV increased from 23% (14/61) in atypical
squamous cells to 68% (55/81) in LG-SIL and 75%(15/20) in HG-
SIL, respectively. HR-HPV were detected in 28/108 (26%) and
9/30 (23%), of women with metaplasia and without lesions,
respectively. For women with age under 30, the overall HR-HPV
prevalence were 55.5%, which was signiﬁcantly higher than
those of women aged 30–39 (34.8%, p = 0.008) or women age
older than 40 (32.5%, p = 0.002).
Conclusion: HR-HPV detection was more frequent in patients
with LG-SIL, specially in the etary group under 30 years old.
HG-SIL correlates with HR-HPV detection in 75% of cases, the
most cases were found in women older than 30 years old. The
prevalence of HR-HPV in atypical squamous cells, metaplasia
and normal cytology described in our study, suggests that a
positive HR-HPV screening in conjunction with a previous
abnormal cytology can be employed to select women, to whom
follow up is recommended.
R2212
Hospital-based study of pneumonia and
inﬂuenza hospitalisations among adults, Seoul,
Korea, 1995–2004: implications for prevention
through immunisation
H.J. Cheong, P.E Kilgore, B. Nyambat, J.W. Park, J.Y. Song,
W.J. Kim (Seoul, KR)
Background: Epidemics of inﬂuenza may cause secondary
bacterial pneumonia and exacerbation of chronic underlying
diseases in high-risk groups. In 1998, South Korea initiated a
national program of mass vaccination targeting the elderly
= 65 years of age. At present, there are limited data on the
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burden of inﬂuenza in adults of South Korea. We analyzed
hospital discharge records to describe pneumonia and inﬂuenza
hospitalizations and excess hospitalizations among those with
chronic underlying cardiac and pulmonary disease.
Methods: Among patients 15 years of age and older, we
selected hospital discharge records from 1995 through 2004
using a standardized list of pneumonia and inﬂuenza (P/I)
diagnostic codes from the International Classiﬁcation for Dis-
eases, 10th Edition. To determine excess hospitalizations asso-
ciated with inﬂuenza, we analsyed hospitalizations for
pneumonia, asthma, chronic obstructive pulmonary disease
(COPD), and congestive heart failure (CHF) during the inﬂu-
enza A and B epidemics of 2002–03 and 2003–04.
Results: During the 10-year study period, we identiﬁed a total
of 3553 hospitalizations associated with P/I. Forty-ﬁve percent
of these hospitalizations occurred among patients aged = 65 -
years. A seasonal peak of pneumonia and inﬂuenza hospitali-
zations was identiﬁed from November through January. Among
patients with P/I, a total of 557 (16%) deaths were identiﬁed
during the 10-year period. Case-fatality associated with P/I was
signiﬁcantly higher among patients = 65 years of age compared
with younger adults (P < 0.05). During the 2002–03 and the
2003–04 inﬂuenza epidemics, a total of 82 and 88 excess
hospitalizations were identiﬁed, respectively. During these two
inﬂuenza seasons, most excess hospitalizations were associated
with pneumonia (n = 70), CHF (n = 68) and COPD (n = 24).
Conclusions: A substantial proportion of P/I hospitalizations
occur among patients = 65 years of age nearly 1 out of every 6
patients with P/I died. Preliminary data suggest that the
inﬂuenza season appears to correlate with a substantial number
of excess hospitalizations due to pneumonia, CHF and COPD.
R2213
Clinical manifestations, haematologic ﬁndings
and clinical course in patients with infectious
mononucleosis
C. Cristea, E. Ceausu, P.I. Calistru, S-A. Florescu, C.P. Popescu,
A. Motoc, R. Rusu (Bucharest, RO)
Objectives: To study clinical manifestations, haematological
ﬁndings and clinical course in patients with infectious mono-
nucleosis (IM) caused by Epstein–Barr virus (EBV).
Methods: In 2004 in our clinic 72 cases of IM were diagnosed
and treated. The diagnosis was based on clinical criteria (fever,
pharyngitis, lymphadenopathy), haematologic manifestations
(lymphocytosis >60%) and presence of immunoglobulin M
antibodies to viral capsid antigen (VCA ) of EBV, detected by
enzyme-linked immunosorbent assay (ELISA) technic.
Results: The patients’ age ranged between 1.2–29 years. The
main clinical features were: lymphadenopathy 88%, pharyngitis
78%, fever 78%, splenomegaly 54%, hepatomegaly 43%, rash
16%, palatal enanthem 12%. Haematologic abnormalities were:
leucocytosis (the highest value 27.000/mm3) 73%, absolute
lymphocytosis 72%, atypical lymphocytes 45%, neutropenia
(2000–3000/mm3) 62%, thrombocytopenia (<140.000/mm3) 44%.
Elevated levels of transaminases enzymes (the highest value
621 U/L) were recorded in 68% of patients. Streptococcus
pyogenes was isolated from throat culture in 38% of patients.
The mild and moderate forms of IM counted 95%. Management
was consists in supportive treatment and nonsteroidal anti-
inﬂammatory agents; corticosteroids were used in 4 patients (2
cases with severe airway obstruction, 1 case with prolonged
high fever, 1 case with severe thrombocytopenia).
Conclusions: The most frequent complication was hepatitis.
Streptococcal pharyngitis was associated with IM in 38% of
cases. Corticosteroid therapy was used in 5% of cases.
R2214
Correlation of quantitative measurement of BK
polyomavirus (BKV) DNA with the clinical
course of BKV infection in renal transplant
patients
M.P. Romero Go´mez, C. Jimenez, J.E. Echevarria, M.R. Gonza´lez
Montes, S. Hierro Cuesta, P. Pen˜a Garcia (Madrid, ES)
Objectives: To investigate the use of a quantitative PCR assay
for monitoring of BK viral load and to investigate the correlation
of BK viral load to the clinical data.
Methods: Four patients with known BK replication were
included in the study. One suffered from BK nephropathy
(renal dysfunction and viral particles in graft biopsy) and the
other three did not show any such renal dysfunction. BK
replication was deﬁned as the presence of decoy cells in urine
specimen in two or more consecutive specimens in an interval of
less than one month. In these patients the immunosuppression
therapy was decreased slowly. The presence of the BK virus in
urine and blood was monitored using two different tests, a
qualitative in-house nested PCR and a quantitative real-time
PCR (afﬁgeneBKV trender; Sangtec Molecular Diagnostics,
Sweden).Clinical evaluation e.g. serum creatinine levels, and
immunosuppression therapy was correlated to analytical data.
Results: As expected, viral loads were higher in urine than in
blood as it was expected. After reduction of immunosuppressive
drug dose a reduction in virus load in both in urine and blood,
together with the disappearance of decoy cells was obser-
ved.Patient 1. Treated for BKV nephropathy. The blood samples
showed a median viral load of 3.0E + 06 copies/ml (range, 4.28
E + 04 to 9.90E + 06), and the urine samples showed a median
viral load of 1.54E + 10 copies/ml (range 0.0E + 00 to
4.65E + 10). The serum creatinine levels were above normal
values. Patient 2: The blood samples showed a median viral load
in blood of 1.12E + 06 copies/ml (range, 1.67E + 03 to
5.80E + 06). The urine samples showed a median viral load of
1.45E + 12 copies/ml (range 1.50E + 07 to 6.62E + 12). Patient 3:
The blood samples in this patient showed a median viral load in
blood of 1.975E + 04 copies/ml (range, 0.00 E + 00 to
2.93E + 04). The urine samples showed a median viral load of
8.25E + 11 copies/ml (range 0.00 E + 07 to 6.62E + 12). Patient
4: The blood samples in this patient showed a median viral load
in blood of 1.67E + 07 copies/ml (range, 1.60 E + 05 to
3.94E + 07). The urine samples showed a median viral load of
3.47E + 12 copies/ml (range 8.90 E + 09 to 1.64E + 13).
Conclusions: Serial measurement of viral loads by quantitative
PCR BKV could be a useful tool in monitoring the course of BKV
infection, and so we can prevent early the course of the illness,
making adjustments in the immunosupression drugs. Quantita-
tion of BKV DNA should always be interpreted together with
clinical ﬁndings.
R2215
Cytomegalovirus associated disease in
immunocompetent patients
F. Dodi, A. Mularoni, M. Camera, G. Pagano (Genoa, IT)
Cytomegalovirus (CMV) is common and reaches most of
population. Clinical CMV disease in normal host varies from
an inapparent infection to the mononuclesosis-like syndrome.
Severe illness can occur after reactivation of the latent virus in
immunosuppressed host. On the contrary CMV severe disease is
a relatively exceptional event in the immunocompetent patient.
Case reports: 10 cases of CMV-related disease in previously
healthy immunocompetent subjects were admitted to our
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Department between 2001 and 2005. 7 were men and 3 women,
median age was 42 years (range 21–68). Only 1 pt had
comorbidities: NIDDM, MGUS and hepatic steatosis. The most
frequent symptoms of presentation were: fever, chills, headh-
ache, fatigue and spleen enlargement. Each pt had acute,
anicteric hepatitis. Transaminases levels went above 5/6 times
their normal ranges. We performed an ecotomography to 8 pts:
in 5 of them a liver enlargment was shown. Levels of LDH and
ALP also were high, till twice their normal range. Each pt had
increased lymphocyte/monocyte count (>50%). Atypical lymph-
ocytosis was a feature on blood examination in 5/10 pts.
T-lymphocytes subset showed a transient reversal of CD4+/
CD8+ ratio with reduction of CD4+ percentage and increased
number and percentage of CD8+ lymphocytes. Five pts had a
more severe form of disease with organ involvement: 1 pericar-
ditis, 1 polisierositis, 1 meningitis, 3 interstitial pneumonia.
Diagnosis was performed with pp65 direct antigenemia test in 8
pts: 6 resulted positive. ELISA serology was positive for CMV
IgM antibodies in 10/10 pts. The measurement of IgG avidity
improved the diagnosis in 2/10 pts. Antiviral therapy was given
just in 2 pts, because of their severe clinical conditions. A
woman with polisierositis and interstitial pneumonia and
another one with meningitis were treated with Ganciclovir
(5 mg/kg twice daily) for 14 days. All the patients completely
recovered and no sequelae were observed after discharge.
Conclusions: We must remain aware of the protean manifes-
tations of CMV infection in immunocompetent persons. The
rapid diagnosis of CMV infection could be important to avoid
further, second-level diagnosis workouts. However, early inves-
tigation of rapid treatment may be important. Use of gancyclovir
treatment should be considered in the rare patient with severe
organ-based pathological conditions.
R2216
Herpes zoster and patient age
A. Bica, S. Mera, M. Lupse, C. Bondor (Cluj-Napoca, RO)
Objective: To analyse the correlation between age and clinical
form, anatomical site and pain in zoster.
Material and method: We retrospectively analysed the case
records of our patients with Herpes Zoster admitted in Hospital
of Infectious Diseases between 1 Jan 2000–31 Dec 2004. We
performed four groups of different ages excluding all those with
acquired immunosuppression. Statistical was performed in
EPIINFO 6, Excel statistical analysis and SPSS10.
Results: 289 patients with median age 58.2 (max 86 years and
min 2 years of age), 94% adults, 56% women. The divide on age
groups was: younger than 18 years 6% of cases, 19–40 years 9%
of cases, 41–65 years 37% of cases and older than 65 years 48%
of cases. After clinical form we recorded: 147 cases with typical
form, 71 case with extension, 19 with dissemination and 50
patients with septic complication. Age did not inﬂuence the
appearance of clinical form neither the typical nor the dissem-
inated one. Anatomical site for exanthema was: cervical in 50
cases, trigeminal in 39 cases, Ramsay Hunt syndrome in 8 cases,
thoracic in 123 cases, lombar-sacrat in 50 cases and dissemin-
ation in 19 cases. Except Ramsay-Hunt syndrome which rare
appear over 65 (p < 0.05 ) and trigeminal zoster which is more
frequent over 65 (p = 0.08), age did not inﬂuence the anatomical
site of exanthema. Post herpetic neuralgia complicated 137 cases
frequently over 65 years (p = 0.00042).
Conclusions: 1) zoster is rare under 40 years; 2) the clinical
form of disease is not inﬂuenced by age; 3) patient age not
inﬂuence the anatomical site excepting Ramsay Hunt syndrome
and trigeminal form; 4) post herpetic neuralgia complicate the
course of disease over 65 years.
Mycobacterial infections (including diagnosis)
R2217
Performance of Amplicor/Cobas PCR for
Mycobacterium tuberculosis detection in clinical
specimens
S. Kanavaki, A. Skroubellou, S. Karabela, E. Varonou,
A. Raftopoulou, S. Anagnostou, M. Kolettou, M. Makarona,
S. Nikolaou (Athens, GR)
Objectives: We evaluate the commercially available nucleic
acid ampliﬁcation technique Amplicor/Cobas PCR, Roche,
USA, which has been suggested as accurate enough to be
routinely used for the rapid diagnosis of tuberculosis.
Material and methods: Using the Lowenstein-Jensen (LJ) cul-
ture as the ‘golden standard’ and culture positive results as a
reference, we evaluated the sensitivities of microscopy and
Amplicor/Cobas PCR in 115 culture positive sputum samples.
Samples were derived from TB patients attended in our Hospital.
Results: Overall sensitivities were 46% (53/115 samples) for
microscopy and 84.3% (97/115 samples) for Amplicor/Cobas
PCR. In particular, Amplicor/Cobas PCR sensitivity was
increased in smear positive samples (96.2%), while limited to
74% in smear negative samples.Conclusions: Our results indi-
cate that Amplicor/Cobas PCR is a promising method in TB
diagnosis, taking into consideration that it is well standardized
and provides a fast and accurate result, especially in smear
positive patients. However, cost-effectiveness studies are
required to support introduction of this method routinely, at
least in high-burden environments.
R2218
Antimicrobial susceptibility rates of
Mycobacterium tuberculosis against ﬁrst-line
drugs
O¨.K. Azap, H. Arslan, F. Timurkaynak, E. Oruc¸, T. Togan,
G. Yapar (Ankara, TR)
Objectives: Mycobacterium tuberculosis infects one third of the
world’s population. Culture is the ‘‘gold standard’’ for detecting
mycobacteria in clinical specimens. Testing of M. tuberculosis
isolates for drug susceptibility is important to guide therapy.
The aim of this study is to report the antibacterial susceptibility
rates of M. tuberculosis strains isolated in our laboratory.
Methods: Laboratory records between January 2001 and Janu-
ary 2005 were evaluated retrospectively. Susceptibility rates
against ﬁrst line drugs (Isoniazid (INH), rifampin (RMP),
ethambutol (EMB), streptomycin (STM)) were recorded. Lowen-
stein-Jensen agar and BACTEC 460 TB system were used for
culture. Acid-fast stain was performed for each sample.
Results: A total of 5602 materials (2104 respiratory specimen,
1275 urine, 788 body ﬂuids, 445 tissue specimen, 990 others)
were admitted to the laboratory for acid-fast stain and myco-
bacterium culture. M. tuberculosis was detected by culture in 145
(2.5%) of 5602 samples. Acid-fast stain was positive in 46 (31.7%)
of 145 samples. Growth was detected only in BACTEC 460 TB
but not in Lowenstein Jensen agar for 16 (11%) of the 145
samples. Seven of these 16 samples were pus and the others
were, bronchoalveolar lavage ﬂuid and tissue specimen. The
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results of acid-fast stain were also negative for these 16 samples.
One hundred and ﬁfteen (79.3%) of 145 M. tuberculosis strains
were sensitive to all four antibiotics (INH, RMP, EMB, STM)
tested. Sixteen (11%) were resistant to only INH, 3 (2%) were
resistant to only RMP, 3 (2%) were resistant to both INH and
RMP, 3 (2%) were resistant to INH and EMB, 2 (1.3%) were
resistant to INH, RMP and STM and 3 (2%) were resistant to all 4
antibiotics tested.
Conclusion: 1. Eleven percent of the positive culture result
were obtained only by BACTEC 460 TB system, this demon-
strates that BACTEC 460 TB is superior to conventional methods
(Lowenstein Jensen agar and acid fast stain) in the detection of
M. tuberculosis.2. As approximately 20% ofM. tuberculosis strains
are resistant to at least one ﬁrst line antibiotic, treatment of
tuberculosis should be guided by antimicrobial susceptibility
results in our country.
R2219
Salivary gland mass as the only manifestation of
tuberculosis
P. Hashemi, E. Razmpa (Tehran, IR)
Objectives: Salivary gland involvement is included among the
les commonly encountered forms of cervicofacial tuberculosis.
However, since the incidence of extrapulmonary tuberculosis at
all sites has been increasing steadily since 1985, the diagnosis of
Mycobacterium tuberculosis must enter into the differential diag-
nosis. In this study, the frequency of tuberculosis and its
distribution according to sex and type of gland has been
determined.
Methods: This is a retrospective case series study and the data
were collected through observation of the ﬁles of the patients
that were operated during 1996–2003 in Imam And Amir Aalam
hospital due to salivary gland mass. There are no exclusion
criteria.
Results: Overall, 164 patients had salivary gland mass resection
between 1996–2003.Among them, 5 cases of salivary gland
mycobacterium infection were reported. Four cases (80%) were
in submandibular gland and the last one (20%) was in parotid
gland. Mean age was 37/4 (SD: 9/09), the minimum of age was
25 and the maximum was 49. All the patients were female and
midwife. Malignancy was seen in 36 patients (23/4%). Mean age
in malignancy was 48 and that of nonmalignant was 38/3. This
difference was statistically signiﬁcant (p = 0/01). Mixed tumour
was the most prevalent diagnosis among the population.
Conclusion: At present study, the frequency of mycobacterium
salivary gland infection was 3/2%. In a study done in 1993, this
was 2/3which is not statistically signiﬁcant. In other studies,
almost all the cases were in parotid gland; whereas in our study
4 out of 5 were in submandibular gland. These results need to be
proved by other prospective studies.
R2220
Susceptibility of Mycobacterium tuberculosis on
anti-TB drugs in Kosovo
G. Mulliqi - Osmani, A. Kurti, F. Bislimi, X. Jakupi, B. Tigani,
X. Kurhasani (Pristina, CS)
Objective: Objective of the study is presentation of the level of
multi-drug resistance of Mycobacterium tuberculosis in bacterio-
logical conﬁrmed cases in Kosova.
Methods: Samples have been examined at the Reference
Laboratory for Tuberculosis at the Department of Microbiology;
National Institute for Public Health of Kosova.During the study
period, that covers mid of 2003–2004, 6267 samples have been
processed, mainly referred from suspected TB hospitalized cases
at the Clinic for Lung Diseases, University Clinical Center of
Kosova, in addition to the ones coming from other clinics and
primary health care services. Processing of samples has been
based in the standards for processing TB suspected samples and
proportion method for susceptibility testing on anti TB drugs
has been used. Lowenstein Jensen media, with following
concentration of anti TB drugs have been utilized: isoniazid
(INH) 0.2 lg and 1 lg, rifampicin (RMP) 20 lg, ethambutol
(EMB) 2 lg, streptomycin (SM) 4 lg and Ethionamide (ETH)
30 lg. Incubation, interpretation and reporting of the results
have been done according to the international standards.
Results: During the study period, from 6267 samples received
at TB reference laboratory of the Department of Microbiology,
National Institute for Public Health of Kosova, referred from all
levels of the Kosovo health care services, 720 of them have
resulted positive based in cultivation. On 264 samples in whom
susceptibility testing on anti TB drugs has been determined,
following rates of resistance has been gained: INH, (both
concentrations), 7.1% during 2003 and 9.7% in the year 2004;
EMB rate of resistance 21.4% in 2003 and 29.7% in 2004; SM,
21.4% in 2003 and 4.8% in 2004; RMP 17.8% in 2003, comparing
with 5.45% in the year 2004 and M. tuberculosis rate of resistance
on ETH was 25% in 2003, followed by 40.6% in the year 2004.
Five cases have been reported as multi-drug resistant during the
year 2004 due to their expressed resistance at all ﬁve tested
drugs, presenting multi drug resistance of M. tuberculosis at
2.2%.
Conclusions: Scale of multi drug resistance of Mycobacterium
tuberculosis is still at the low level, emphasizing the need for
continual monitoring of the susceptibility of M. tuberculosis on
anti TB drugs with more advanced methods and implementa-
tion of TB prevention strategy in Kosovo.
R2221
Predictive values of diagnostic tests in patients
with tuberculous pleural effusion in Iran
Z. Ahmadinejad, H. Bagherian, Z. Hatmy, S. Phyroosbakhsh,
M. Bahador, V. Ziaee (Tehran, IR)
Objectives: Tuberculous pleural effusion occurs in 30% of
patients with tuberculosis (TB). Rapid diagnosis of a tuberculous
pleural effusion would greatly facilitate the management of
many patients. The purpose of this study was to determine
sensitivity, speciﬁcity, and predictive values of clinical, laborat-
ory, radiographic ﬁndings in patients with tuberculous pleural
effusion.
Methods: The cross sectional study was performed between
august 2002 and March 2004 at a referral teaching hospital.
Major clinical, laboratory, and radiographic ﬁndings were
evaluated in 88 cases of pleural effusion, 33 with conﬁrmed
TB pleural effusion (TBPE) and 55 with a diagnosis other than
TB (NTBPE).
Results: The sensitivity of culture of pleural effusion and tissue
were 3% and 9.1% respectively. The mean of adenosine
deaminase (ADA) values in TBPE was 36.7 U/L (±18.72), and
the mean in the NTBPE was 28.2 U/L (±17.0). Both the
sensitivity and speciﬁcity of ADA estimation in diagnosing
tuberculosis were 55%. The sensitivity of PCR was 3% with
speciﬁcity of 12.7% (positive predictive value, 50%; negative
predictive value, 70%). Younger age (p < 0.024), positive history
of exposure to TB patient (p < 0.02), and the combination of
fever, weight loss and sweating (p < 0.01), were associated with
tuberculous pleural effusion. There were also signiﬁcant
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association between Positive sputum smear (p < 0.001), positive
sputum culture (p < 0.006), positive pleural biopsy (p < 0.001),
pleural LDH>200 (p < 0.005), pleural lymphocytes>50%
(p < 0.015) and TBPE.
Conclusions: In our region with a high incidence of tubercu-
losis, the most frequent cause of exudative pleural effusion is
tuberculosis. We suggest that the diagnostic planning of pleural
effusion should be determined in each region with a view to the
adoption of regionally optimized diagnostic and therapeutic
facilities.
R2222
Antituberculotic chemotherapy selects
methicillin-resistant Staphylococcus aureus in
HIV-positive Cambodian children
A. Doczeova, E. Kalavsky, A. Liskova, V. Krcmery,
A. Augustinova (Trnava, SK)
Introduction: The aim of this study is to assess the role of
tuberculosis (TB) and antituberculotic chemotherapy in HIV
positive Cambodian children on HAART (21 months) on
immune reconstruction, frequency and etiology of opportunistic
infections.
Methods: 28 HIV positive children on HAART (Lamivu-
dine + Stavudine + Nevirapine or Efavirenz), 13 of them with
TB on antituberculotic chemotherapy (RIF + INH + PZA) in the
project House of Family (HOF), Bl. Maximilian Coble’s Clinic,
were analysed for CD4 cells, occurrence of clinical symptoms of
opportunistic infections, aetiology and antimicrobial resistance
of cultures from infection site.
Results: Children with TB (n = 13) had mean increase of CD4
cells somewhat slower than those children without TB (n = 15).
After 21 months of HAART the mean CD4 cell count increased
from 135 to 802 in TB positive children and from 207 to 1027 in
TB negative children. Upper respiratory tract infections (URTI)
were commonest opportunistic infections in both groups,
children with TB or without TB. In children with TB was on
second place pneumonia and in TB negative children bacterial
skin and soft tissue infections (SSTI). Pneumonia and upper
respiratory tract infections were more often in TB positive
children. Those children receiving antituberculotic chemother-
apy had higher proportion of multiresistant grampositive
bacteria (MRSA, PEN-R pneumococci) and other resistant
respiratory isolates (M. catarhalis, H. inﬂuenzae).
Conclusion: Pneumonia and URTI are more frequent infections
in HIV positive children with TB comparing children without
TB. Moreover, HIV positive children with TB are more likely to
be colonized with MRSA which suggests the role of rifampin
and/or INH + PZA in selection process of multiresistant
bacteria due to prolonged (6–9 months) exposition.
R2223
Moxiﬂoxacin as supportive therapy in pulmonary
tuberculosis
M. Schmidt-Ioanas, M. Vogelbusch, S. Kim, H. Lode (Berlin, DE)
Background: There is increasing evidence on the role of
moxiﬂoxacin as therapeutic choice in pulmonary tuberculosis.
Aim: To determine the reasons of administration and the
adverse events of moxiﬂoxacin in patients with conﬁrmed
pulmonary tuberculosis.
Methods: A retrospective study included all patients between
2000 and 2003 with diagnosis of pulmonary tuberculosis that
received at least one dosage of moxiﬂoxacin during hospital
stay. Bacteriological ﬁndings at admission, reasons of adminis-
tration of moxiﬂoxacin and adverse events possibly related to
moxiﬂoxacin were recorded.
Results: A total of 47 patients (mean age 51.7 ± 17.2 years; 31
(39.7%) males) with pulmonary tuberculosis that received
moxiﬂoxacin were identiﬁed. Twenty-two patients had positive
AFB in sputum at admission. The reasons for administration of
moxiﬂoxacin were: resistance to the at least one of the ﬁrst-line
anti-TB drugs, n = 14 (29.7%); adverse events to at least one of
the ﬁrst-line anti-TB drugs, resulting in discontinuation and
subsequent replacement with moxiﬂoxacin, n = 13 (27.6%);
concomitant respiratory infections, n = 9 (19.1%); empirical
treatment before TB diagnosis, n = 9 (19.1%). Mean duration
of therapy was 5.8 days (1–30 days). A total of 45 (95.7%)
patients presented at least one adverse event that could be
possibly related to moxiﬂoxacin; the most frequently observed
were: increased hepatic enzymes (n = 25), diarrhea (n = 6) and
nausea and vomiting (n = 6). Six patients discontinued treat-
ment with moxiﬂoxacin because of adverse events. At hospital
discharge, after a mean of 2.9 months, 18 patients (38.2%)
produced a valid sputum sample and 16 had a negative
bacteriological ﬁnding.
Conclusion: Almost half of patients with pulmonary tubercu-
losis received moxiﬂoxacin to replace a ﬁst-line anti-TB drug.
Moxiﬂoxacin was well tolerated and substantially contributed to
the bacteriological cure.
R2224
Quick Mycobacterium isolation in cases of fever
of unknown origin due to extrapulmonary
mycobacteriosis
I. Neonakis, V. Kafarakis, Z. Gitti, M. Baritaki, Z. Haroniti,
S. Maraki, Y. Tselentis (Heraklion, Crete, GR)
Objectives: In order to draw clinician’s attention to extrapul-
monary mycobacteriosis (MB) as cause of Fever of Unknown
Origin (FUO) and to stress the laboratory’s ability for quick
Mycobacterium isolation and determination of antibiotic suscep-
tibilities within a few days, we report on three cases of patients
with MB, diagnosed over the past two years in our laboratory.
Methods: Two male (68 and 69 years old) and one female
(71 years old) patient were hospitalized with FUO. Two of them
were patients with already diagnosed haematological disorders,
namely myelodysplastic syndrome and hairy cells leukaemia.
There were no indications of pulmonary involvement. Within
the course of investigation, bone marrow biopsies were per-
formed and blood samples were taken. Bone marrow aspirations
and blood samples were directly inoculated into mycobacterial-
speciﬁc MB/BacT/Alert Blood Culture Vials (Biomerieux) and
placed in the MB/Bact/Alert automatic colorimetric detection
system (Organon Teknika). After (mean) 7.2 days of inoculation
positive signals were given. Acid-fast staining along with DNA
probes (AccuProbe System-GenProbe) and reverse hybridiza-
tion (GenoType System-Hain) were used for further identiﬁca-
tion. From the bone marrow samples of the two patients
Mycobacterium tuberculosis was isolated, whereas from the blood
sample of the third patient Mycobacterium avium was detected.
Susceptibilities were determined with the proportional method.
For each patient, proper combined antituberculous chemother-
apy was given and full recovery was achieved.
Conclusions: Although the prevalence of extrapulmonary my-
cobacterial infections is constantly increasing over the last few
years, clinicians rarely include MB in their differential diagnosis
of FUO, especially when there are no clinical indications of
pulmonary involvement. As MB is a curable disease, all efforts
towards isolation of mycobacterium are warranted. Since their
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introduction a few years ago, the use of mycobacterial-speciﬁc
liquid cultures has offered quick and easy mycobacterium
isolation. Timely diagnosis of extrapulmonary MB is of great
relevance, as this could prevent a series of unnecessary invasive
practices or even surgeries. The presence of mycobacterium
should never be ruled out if no pulmonary symptoms or signs
are present and MB should always be included in the differen-
tial diagnosis of FUO, especially in patients with underlined
haematological disorders.
R2225
Genetic diversity of Mycobacterium avium
isolates among Slovenian patients
M. Pate, M. Zolnir-Dovc, M. Ocepek, B. Krt (Ljubljana, Golnik, SI)
Objectives: The objectives of this study were to characterize the
genetic diversity of human Mycobacterium avium isolates collec-
ted at the National Reference Laboratory for Mycobacteria (UC
Golnik) between 2002 and 2004.
Methods: A total of 60 isolates from 27 patients were collected
over a three-year period and identiﬁed with the classical
biochemical tests and a commercially available AccuProbe
Mycobacterium avium Culture Identiﬁcation Test (Gen-Probe Inc.,
San Diego, CA, USA). All the isolates were tested with duplex
PCR discriminating between M. avium and M. intracellulare in
order to discover any double infections. IS1245-IS1311 spacer
PCR typing and IS1245 RFLP were performed to study the
genetic diversity of the isolates.
Results: Duplex PCR revealed double infection (M. avium/M.
intracellulare) in four isolates from one patient. IS1245-IS1311
spacer PCR typing showed heterogenic patterns usually com-
prising up to 6 bands. Albeit simple and rapid, the method
lacked sufﬁcient discriminatory power. Fifty-ﬁve out of 60
isolates were successfully IS1245 RFLP typed. The patterns
showed a high degree of heterogeneity, with the number of the
bands mostly ranging from 20 to 30. When using the shorter of
the two different IS1245 probes, the patterns generally consisted
of fewer bands and were easier to read. In 12 patients, sequential
isolates (n = 45) collected in different time periods, were
compared. Infections were clinically important and treated in
7 patients. Identical RFLP patterns were seen in the majority of
the sequential isolates from certain patients.
Conclusions: In comparison with IS6110 RFLP patterns of M.
tuberculosis, IS1245 RFLP patterns of humanM. avium strains are
quite diverse and substantially harder to interpret, partly due to
numerous bands and partly due to frequent occurrence of faint
bands. The latter can be eliminated with careful primer design
for the IS1245 probe to avoid cross-hybridization with IS1311.
Identical patterns of the sequential isolates collected from
certain patients over a longer period of time indicate clinical
importance of the infection. M. avium infection will remain a
challenging clinical problem due to the ubiquitous nature of the
bacillus, increasing number of immunocompromized patients
and demanding treatment trials.
R2226
Characterisation of Mycobacterium tuberculosis
populations during chronic infection: an Italian
longitudinal study
F. Zara, F. Meacci, V. D’Amato, A. Sarassi, P. Troupioti,
R. Brerra, M. Pardini, G. Orr, D. Isola, L. Pagani, G. Oreﬁci,
L. Fattorini, M.R. Oggioni (Pavia, Siena, Sondalo, Rome, Cagliari,
IT)
Drug-resistance of Mycobacterium tuberculosis (MT), due to the
selection of carrying mutations clones, is the cause of treatment
failures in tuberculosis (TB) infections. The single selected
mutations, conferring drug-resistance, are the only molecular
changes characterizing the evolution of MT subpopulations in
the host, during chronic infections. Up to now, no detailed
information on the evolution of the bacterial population in the
host is available.
Objectives: To investigate the evolution of the infecting MT
population over time, to get a molecular characterisation of drug
resistant MT strains circulating in Italy, to clarify the epidemi-
ological relationship of the strains and sub-clones identiﬁed in
the study population and to elucidate the role of resistant sub-
populations in the clinical outcome.
Methods: Longitudinal samples and strains are investigated for
their resistance genotype by commercial polymerase chain
reaction (PCR) and in house Real Time PCR. MT isolates are
further characterized by determination of ﬁrst and second line
drug susceptibility (DST) and by mycobacterial interspersed
repetitive units (MIRU) typing.
Results: During ﬁrst ten months of study 110 longitudinal
sputum samples and strains are obtained from 54 patients
attending to the Sondalo TB hospital. DST data have been
obtained for all strains and molecular work and data analysis
are ongoing. Preliminary results show a very good concordance
between genotypic and phenotypic drug resistance detection.
Six out of 53 baseline sputum samples by real time PCR show a
rifampin mixed population (wild type and rpoB mutant). MIRU
typing analysis is ongoing, in order to clarify if these cases are
co-infections or true heteroresistance.
Conclusion: These preliminary results only allow us to conﬁrm
that frequency of resistance and number of serial samples and
isolates of MT will permit a suitable statistical analysis of the
results.This work is supported by grants from Italian Ministry of
Health "AIDS project – Co-infections, opportunistic infections
and tumours AIDS-related" grant no 50F.26.
Infection in the immunocompromised host & transplant recipients
R2227
Microbiology of diabetic foot: our experience
R.A. Monno, F. Giorgino, M. Melchiorre, L. Fumarola, D. De
Vito, R. Giorgino (Bari, IT)
Objectives: To investigate the aetiology of infection in patients
with diabetes and foot disease and evaluate the suitability of
techniques to obtain a proper sample to identify the pathogens
responsible for the infection.
Methods: A total of 13 patients with infected diabetic foot
ulcers were studied. Samples were collected after sterile saline
washing of the wound and included one swab of skin
surrounding the lesion, three swabs of the ulcer base, three
tissue curettages obtained by a sterile scalpel taken after ﬂushing
the ulcer with povidone iodide solution and saline. Samples for
anaerobics were placed in prereduced tyoglicollate broth.
Cultures were performed by standard procedures after micro-
scopic examination. Data from all patients were also recorded.
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
Results: Microorganisms were isolated in 12 out of 13 patients.
in 11 patients, a polimicrobial ﬂora was found. In 5 of these, the
same microorganisms were isolated from all of the three
samples collected. In 3 patients with mixed ﬂora, the same
bacteria were isolated from swabs and curettage of the ulcer
base but not from the swab collected from the skin surrounding
the lesion. In one patient C. albicans and in two patients S. aureus
were isolated only from the bioptic specimens, respectively.
Anaerobes (Peptostreptococcus spp. and Bacteroides spp.) were
recovered from two patients. Interestingly, one of these patients
had also fever and the same anaerobe was isolated from the
blood culture. This patient underwent amputation of multiple
ﬁngers. The predominant ﬂora consisted of S. aureus, followed
by coagulase-negative staphylococci, P. aeruginosa and other
Enterobacteriaceae. A. baumanii was also isolated. All S. aureus
isolated were MRSA and also resistant to macrolides and to
ﬂuorochinolones. P. aeruginosa was fully susceptible only to
meropenem. Enterococcus spp. were not GRE.
Conclusions: Our data show that multiple sampling, even if
time consuming and expensive, may help to identify microor-
ganisms that may be missed when only one swab of the ulcer is
collected. The heterogeneousness of microorganisms involved in
infected diabetic foot ulcers and the complex resistance patterns
involved suggest that the clinician should obtain detailed
information on the infectious agents of the ulcer and the speciﬁc
drug sensitivity before considering antibiotic treatment of these
potentially life-threatening infections.
R2228
Epidemiology and outcome of severe sepsis in
patients with diabetes mellitus
L. Leonidou, M. Michalaki, A. Leonardou, E. Polyzogopoulou,
V. Kyriazopoulou, H. Bassaris, C.A. Gogos (Patras, GR)
Objectives: Diabetes mellitus is an immuno-compromising
disease predisposing to severe infections. The aim of the present
prospective study was to determine the epidemiology and
outcome of severe sepsis in patients with diabetes mellitus.
Patients and methods: The study included 76 diabetic patients
(40 women and 36 men ) with severe sepsis. The patients had a
mean age of 74 years, (min 40, max 103) and mean AˆI`E´
27.4 ± 4.1. Thirty-two of the patients (41%) had a ﬁrst-degree
relative with diabetes melitus. Fifteen patients (19.7%) were
under insulin treatment. Sepsis was deﬁned according to the
following criteria: (a) temperature >38 or <36 (b) heart rate ‡90/
min (c) respiratory rate ‡20 breaths/min or PaCO2 £ 32 mmHg
(d) WBC >12 000 or<4000. Severe sepsis was deﬁned as the
presence of sepsis plus at least one organ dysfunction. Immuno-
compromised patients were excluded. The severity of sepsis was
classiﬁed by the sepsis-related organ failure assesment score
(SOFA).
Results: Mean serum glucose values of diabetics at admission
were 295 ± 164 mg/ml, mean fasting glucose values in the ﬁrst
24 hours in hospital were 214 ± 94 mg/ml. The patients had
mean SOFA score 3.6 ± 3.2, mean CRP 15.8 ± 10 and mean
Hba1c 8 ± 1.7. Thirty one patients (40.8%) had respiratory tract
infections, 22 (28.9%) had urine tract infections, 9 (11.8%) had
soft tissue infections, 6 (7.9%) had intra-abdominal infections, 2
(2.6%) had endocarditis, one (1.3%) had infection of the central
nevrous system, one (1.3%) had ostomyelitis and 4 (5.3%) had
infection of unknown origin. Thirteen patients (17.1%) had
bacteraemia. Pathogens isolated were S. aureus in 4 patients,
E. coli in 2 patients, P. aeruginosa in 1 patient, Enterococcus spp. in
1 patient, E. cloace in 1 patient, S. pneumoniae in 1 patient, S.
viridans in 1 patient, S. epidermidis in 1 patient and Streptococcus
spp. for 1 patient. Seventeen out of 76 patients died with an
overall mortality of 22.1%. There was no statistical difference in
mortality of patients without bacteraemia compared to the
patients with bacteraemia.
Conclusion: Diabetes melitus is associated with poor clinical
outcome and mortality in sepsis. Tight glycaemic control should
be a priority in diabetic patients with sepsis.
R2229
Changing assistance issues at a reference
infectious disease day-hospital service, compared
with the natural history of HIV infection in the
HAART era
R. Manfredi, L. Calza, G. Salvucci, F. Chiodo (Bologna, IT)
Objective: To evaluate frequency and features of admissions
performed at a Day-Hospital service in Northern Italy, a
retrospective evaluation of all admissions of the last decade
(1994–2004) was performed.
Methods and results: Before HAART introduction (years 1994–
1996), the proportionally low mean number of admissions (110/
year) was linked to the elevated prevalence ofHIV disease, which
accounted for 89.4% of Day-Hospital hospitalizations, their
recurrence, and their prolonged duration. Immediately after
HAART introduction, the number of Day-Hospital admissions
showed a signiﬁcant increase, from 171 (year 1997), to 318 (2002),
338 (2003), and 347 (2004) (p < 0.0001 versus the pre-HAART era),
although this phenomenon paralleled a drop of percentage of
HIV-related admissions (from 59.1% of 1997, to a minimum of
25.6% of the year 2001; p < 0.0001). While HIV-associated
hospitalizations decreased, a temporal increase of admissions
due to chronic liver disease occurred (p < 0.0001). The reduction
of admission duration allowed an increase of overall number of
hospitalizations of each examined year (p < 0.0001) and themean
bed occupation rate showed a continued rise (8.2 in the year 2000,
to 10.9 in the year 2004 (p < 0.0001).
Discussion: The modiﬁcations occurred at our Day-Hospital
service during the last years are largely attributable to the
signiﬁcant changes occurred in the spectrum of infectious
disorders which came to our attention: from a low number of
prolonged hospitalizations typical of patients with advanced
HIV disease, the HAART era led to a progressive broadening of
the spectrum of disease and a notable reduction of admission
time. Notwithstanding this situation, no signiﬁcant modiﬁcation
was observed as to mean weight of diagnosis-related group
(DRG) features: from a mean 1.03 rate per patient of the year
2000, to a mean 1.05 ﬁgure in 2004. The evolution of assistance
features in a Day-Hospital setting, seems strictly linked to the
modiﬁcation of prevailing disorders. A permanent monitoring
of the features of health care provision at an Infectious Disease
Day-Hospital service may allow to consider signiﬁcant temporal
modiﬁcations, and contribute to ensure adequate assistant
planning, including the eventual revision of structural, profes-
sional, technical and funding resources.
R2230
Use of cefazolin for bacteraemia by methicilin-
sensitive Staphylococcus aureus in chronic
haemodialysis patients
N. Espinosa, L. Gil, M. Ruı´z-Pe´rez, M.J. Marcos, J.L. Haro,
J.M. Cisneros (Seville, ES)
Introduction: Bacteraemia by Staphylococcus aureus is a common
and serious complication in long-term haemodialysis patients.
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Vancomycin is the usual treatment but several cases are
produced by methicilin-sensitive strains.
Objective: To evaluate the efﬁcacy and security of cefazolin use
in chronic haemodialysis patients with bacteraemia by meticilin-
sensitive S. aureus.
Patients and methods: Retrospective study of patients in
chronic haemodialysis (CH) with bacteraemia by MS S. aureus
treated with cefazolin during the period between January-2002
and December-2004. Risk factors related to mortality and relapse
were analysed.
Results: 33 patients in CH (21 males, 64%) with a median age of
61 years old (18–82) and with MS S. aureus bacteraemia, were
included. They were treated with cefazolin (20 mg/kg admin-
istered IV post-dialysis during a median of 21 days (4–26 days).
Only one patient (3%) had to stop treatment due to secondary
effects. Bacteraemia was community acquired in 25 cases (76%)
and catheter-related in 30 episodes (91%). Charlson index was
greater than 4 points in 85% of cases, and the most prevalent
pathologies were diabetes and vascular disease. Median Pitt
index was 1 pt (0–8) at the onset of bacteraemia and 4 patients
(12%) died (two of them were relapses) in the initial follow-up
(90 days). Relapse was observed in 4 patients (12%). Factors
related to mortality in univariant analysis were: ischemic
cardiopathy (37.5% vs. 4%; p = 0.03) and the severity of illness
graduated by Pitt index (4.2 pts vs 1 pts; p < 0.01). Factors
related to relapse were: duration of treatment less than 21 days
(60% vs. 3%; p = 0.007), Pitt index > 4 pts (66% vs. 6%; p = 0.03),
and Charlson index (10 + 2 vs 6.4 + 3; p = 0.01). Duration of
treatment was the only factor related with relapse in the
multivariant analysis and so was Pitt index respect to mortality.
Conclusion: Cefazolin is an efﬁcacy and safe alternative for
bacteraemia by MS S. aureus in CH patients. Duration of
treatment is related with a high risk of relapse. Pitt´s index is
useful for predicting mortality in this group of patients.
R2231
Herpes group virus reactivation in oncologic
patients undergoing chemotherapy
A. Georgouli, E. Chinou, M. Alexiou, Z. Chiolou,
P. Giannakakos, P. Golemati (Athens, GR)
Viral infection is an important cause of morbidity and mortality
in oncologic patients, especially those undergoing chemother-
apy. Herpes simplex virus (HSV), Varicella zoster virus (VZV),
Epstein–Barr virus (EBV) and Cytomegalovirus (CMV), all
members of the herpes virus group, are the most important
pathogens, being able to remain latent after the initial infection
and be reactivated under immunossupression.
Objectives: To assess the serologic incidence of herpes group
viruses reactivation in seropositive oncologic patients undergoing
chemotherapy without previous prophylactic antiviral treatment.
Methods: Overal 580 pts (255 M, 325 F), of mean age 49 years,
undergoing chemotherapy for solid tumour (n = 335) or haem-
atologic malignancy (n = 245), were studied serologically before,
during and one month after chemotherapy course. All patients
were IgG seropositive for one or more of the herpes group
viruses. HSV: 493/580 (85%), VZV: 487/580 (84%), EBV: 476/580
(82%), CMV: 506/580 (87.2%). ELISA was the method used for
the antibodies detection.
Results: IgM serum speciﬁc antibodies against HSV, VZV, EBV
and CMV were detected in 5.3% (31/580), 5.7% (33/580), 6.9%
(40/580) and 8.3% (48/580) of the patients correspondingly. The
incidence of the IgM seropositivity was not signiﬁcantly corre-
lated with the patients’ age or sex and was almost identical
among the patients with solid tumours and those with haem-
atologic malignancies.
Conclusion: The incidence of serologic HSV, VZV, EBV and
CMV reactivation in oncologic patients undergoing chemother-
apy is not so high as to justify the administration of prophylactic
antiviral treatment in all cases.
R2232
Assessment of Staphylococcus aureus
colonisation post lung transplantation
L. Archer, A. Fisher, P. Botha, K. Gould (Newcastle upon Tyne,
UK)
Colonisation with potentially pathogenic bacteria following lung
transplantation may reﬂect some underlying disease process.
We reviewed our transplant database for both Cystic Fibrosis
(CF) and non-CF recipients for the incidence of S. aureus post-
transplant. 213 lung transplants were carried out at this centre in
6 years to 2003. 85(40%) were CF patients and 128 (60%) were
non-CF. Routine Bronchoalveolar Lavage (BAL) is performed at
1 week, then 1, 3, 6 and 12 months post-transplant, with other
routine respiratory specimens being submitted for culture as
necessary. Of 85 CF patients transplanted only 8 (8.2%) had S.
aureus isolated at time of transplant, 1 patient remained
colonised at week 1, 2 patients at 1 month, there was no increase
by 3 months, 4 patients at 6 months and the same number at
1 year post-transplant. There were 6 patients who had S. aureus
isolated from other respiratory specimens and the remaining 1
patient never grew S. aureus again. Of the 78 (91.8%) patients
who did not grow S. aureus at time of transplant, only 23 (27%)
had positive cultures with S. aureus. Of these 23 patients 3 (13%)
grew S. aureus at 1 week, 5 (22%) by 1 month and 8 (34%), 15
(65%), 17 (74%) by 3.6 and 12 months respectively. S. aureus was
isolated from other respiratory samples of the remaining 6
patients post transplant. 128 non-CF patients were transplanted
in the same period. 36 (28.1%) were colonised with S. aureus
post-transplant. Only 4 (3.1%) however had S. aureus at time of
transplant, and of these 4 patients only 1 patient grew the
organism again. In the 32 patients who grew S. aureus post
transplant only, 5 (15.6%) were isolated at 1 week, 14 (43.7%), 15
(46.8%), 17 (53.1%) at 1, 3 and 6 months with no increase by 1
year. The remaining 15 patients had S. aureus isolated from
routine respiratory specimens only.
Conclusion: S. aureus colonisation occurs at a similar rate in CF
and non-CF transplant recipients. Further study is required to
determine whether or not there is any underlying lung pathol-
ogy.
R2233
Cryptosporidium parvum infection in a child after
allogeneic bone marrow transplant
M. Faraci, E. Castagnola, C. Moroni, E. Lanino, G. Morreale,
P. Terranova, L. Pescetto, L. Ricagni, R. Bandettini (Genoa, IT)
Aims: To describe a case of infection by Cryptosporidium parvum
in a boy receiving an allogeneic bone marrow transplant (BMT)
for acute myeloid leukaemia (AML).
Case report: P.S. is an 11-year-old boy received a partially
matched allogeneic BMT from his father after radio and
chemotherapy and GvHD (graft versus host disease) prophy-
laxis including antithymocyte globulin, cyclosporine (CSA) and
methotrexate. At day+ 19 (after engraftment of white cells) the
patient developed severe haematic diarrhoea in absence of
bacterial, fungal and viral positive blood and stool cultures. A
rectal biopsy demonstrated the presence of red, basophilic
microorganism identiﬁed as Cryptosporidium parvum. The pres-
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
ence of the protozoa was conﬁrmed at day+ 24 by direct
research of it in patient’s stool. Despite the discontinuation of
immunosuppresant therapies and the introduction of azithro-
mycin alone or associated with paromomycin and metronidaz-
ole a colonscopic examination revealed the persistence of
Cryptosporidium associated to acute bowel GvHD. Therefore
methylprednisolone (MPD) was started, but severe diarrhoea
persisted, and sclerosant cholangitis followed by acute pancre-
atitis developed. At day+ 48 Cryptosporidium was demonstrated
also in gastric ﬂuid. Nitazoxamide, a drug with action against
Cryptosporidium, was administered (200 mg every 12 hours)
with improvement of the pancreatic damage, but persistence
of watery diarrhoea. This drug was administered alone or
associated to paromomycin, metronidazole and azithromycin
for 4 times. Until engraftment the patient presented a low
number of T and B lymphocytes with an increase of natural
killer. At day+ 94, CSA and steroids were discontinued and
other immunosuppressant therapies were administered for
treatment of intestinal acute GvHD. An improvement of
intestinal disease was observed and 3 negative testing for
Cryptosporidium were demonstrated from day+ 115. At present
the patient is negative for Cryptosporidium, GvHD is controlled
by speciﬁc therapy, his immunological reconstitution reveals an
increased of T cells and morphological bone marrow feature
conﬁrmed the complete remission of acute leukaemia.
Comments: In our patient immunocompromission maintained
the persistent infection by Cryptosporidium; in spite of an
effective anti-protozoal treatment and of discontinuation of
immunosuppressive drugs clearance of the infection was
obtained only when immune function reached an ‘‘acceptable’’
level.
R2234
Study of bacterial colonisation in in-dwelling
bladder catheters
E. Chinou, M. Alexiou, H. Skouteli, A. Georgouli, P. Golemati
(Athens, GR)
Objectives: The aim of this study was to identify the microor-
ganisms isolated from the lumen of catheters and to evaluate the
antimicrobial resistance of these strains according to the length
of catheterization, the antimicrobial therapy and the underlying
disease.
Methods: Three different pieces of 204 indwelling catheters
were taken from the post surgical patients of urologic ward. The
sections were rinsed once in 10 ml of buffer then placed in 10 ml
of Tryptic Soy broth and after vortex mixing for 2 min, were
plated out on blood agar, Mc Conkey agar No 2 and S.D.A. The
resulting isolates were identiﬁed using Api system and the
antimicrobical susceptibility test was determined with disk
diffusion method. A urine specimen was obtained the ﬁrst 24 h
of hospitalization and after the removal of bladder catheter.
Results: 204 post surgical patients with various urologic
malignancies were enrolled in the study. The mean duration
of catheterization was 8 days (3–18 days). All the patients
received postoperative antimicrobial prophylaxis for 5 days.
Bacterial bioﬁlm was recovered on 164 of the catheters. Gram-
positive cocci were the common bioﬁlm organism (S. epidermides:
58/191 and Enterococus faecalis 56/191) followed by E. coli (30/
191) and Candida sp. (17/191). No one of the organisms present
on the bioﬁlm were recovered from the urine. In the 40 cases in
which no bioﬁlm was recovered, the patients were receiving
antibiotics at the time of catheter removal. 84% of the catheters
were colonized by a single species while 16% were colonized
with mixed bacterial communities. 82% of isolated strains of
S. epidermides were resistant to oxacillin while 50% of E. coli
produced E.S.B.L.
Conclusion: Urinary bladder catheterization in our urologic
patients was frequently followed by bacterial and/or fungal
colonization without bacteriuria. The presence of Gram-positive
cocci with high prevalence may inhibits the development of
extensive bioﬁlm by the Gram negative urinary tract pathogens.
R2235
Staphylococcus lugdunensis early prosthetic valve
endocarditis in a HIV-positive patient
I.S. Kourbeti, D.E. Alegakis, G.E. Roditakis, G. Samonis
(Heraklion, GR)
Background: S. lugdunensis is considered a perineal skin com-
mensal and it causes a wide range of infections from superﬁcial
skin to fulminant clinical disease. Infective Endocarditis (IE)
caused by S. lugdunensis has been associated with left-sided
native valve disease and life-threatening complications resem-
bling disease caused by S. aureus. Prosthetic valve endocarditis
(PVE) due to this pathogen is rare.
Case report: A 33-year-old HIV positive man was admitted to
the CCU with acute chest pain and dyspnoea. He had under-
gone aortic valve (AoV) replacement because of congenital
bicuspid AoV 40 days prior to his presentation. Upon the
presentation he was febrile to 38C and in heart failure. He was
diagnosed with acute myocardial infarction on the basis of
increased myocardial enzymes and a new left bundle branch
block. Transthoracic echocardiography demonstrated dehis-
cence and rocking movement of the metallic AoV, a small
vegetation of the ring, severe paravalvular leakage and regur-
gitation. 3 sets of blood cultures were obtained and treatment
with vancomycin, gentamicin and rifampicin was started as
treatment for PVE. Two sets of blood cultures yielded coagulase
negative Staphylococcus (CNS) identiﬁed as S. lugdunensis. The
pathogen was reported as sensitive to methicillin and vanco-
mycin was changed to dicloxacillin. Three days later he
developed acute tubular necrosis and he was transferred to
the Intensive Care Unit where he exhaled.
Discussion: 40–50% of prosthetic valve endocarditis cases are
due to CNS, particularly S. epidermidis and a subacute presen-
tation is typical. S. lugdunensis was ﬁrst described as a separate
species in 1988. It is indigenous to human beings; it predom-
inantly causes skin and soft tissue infections and is only
occasionally responsible for IE. An association of IE with
inguinal skin breaks has been reported. The majority of the
patients are older than 50 years and they acquire the infection in
the community. Native mitral and aortic valves are involved
and the disease is associated with high mortality rates. PVE due
to this pathogen mainly concerns bioprosthetic valves. IE is not
considered a complication of AIDS. In the HIV positive
population it is mainly associated with intravenous drug
abuse. PVE in this population has been associated with the
same risk factor. To our knowledge this is the ﬁrst case of early
PVE in an HIV positive individual caused by S. lugdunensis.
R2236
Aetiologic structure of catheter-associated
bloodstream infections in a cancer hospital
Z.V. Volkova, I.N. Petukhova, N.V. Dmitrieva (Moscow, RU)
Objective: To analyse aetiologic structure of bloodstream
pathogens associated with central venous catheter infections.
In 116 pts with fever due to probable catheter-associated
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bloodstream infections (CAI) were analysed. Blood from cath-
eter, from peripheral vein and the tip of removed catheter were
tested. ‘‘BactAlert’’ aerobic and anaerobic vials for blood culture
were used. Catheter tip was cultured by standard procedure.
Identiﬁcations and susceptibility testing was performed with
‘‘ATB-Expression’’ and ‘‘Vitek 2’’.
Results: CAI was diagnosed in 42/116 (36.2%) pts with
suspected CAI. In 39/42 (92.9%) pts catheter blood was positive
including: 9/42 (21.4%) pts with pathogens growth from all
three specimens, 13/42 (30.9%) pts with positive culture of
catheter blood and catheter tip, 6/42 (14.3%) pts with positive
catheter blood and venous blood and 11/42 (26.2%) pts with
growth only from catheter’s blood. In 1 pts growth was revealed
from catheter tip and venous blood. In 2/42 (4.8%) pts only
catheter tip was colonized. All pts had fever >38ordm;C, 4/42
(9.5%) pts had local infections in catheter site. In 38/42 (90.5%)
one microorganisms was isolated from each specimen, in 3/42
(7.1%) – two microorganisms and in 1/42 (2.4%) – three
microorganisms. Thus 47 pathogens were isolated. Gram-posit-
ive microorganisms were isolated in 38/47 (80.9%). There were:
Staphylococcus spp. – in 33/47 (70.2%) of cases. Coagulaso-
negative staphylococci prevailed. 26/47 (55.3%) of strains were
MR-CNS and 3/47 (6.4%) – MS-CNS. 4/47 (8.5%) of strains were
Staphylococcus aureus (2 – MRSA and 2 – MSSA). Enterococcus
spp. were isolated in 5/47 (10.6%) of cases. All these pathogens
were susceptible both to Vancomycin, Teicoplanin and Linezo-
lid. Other pathogens were represented with gram-negative
organisms: 5/47 (10.6%) – Stenotrophomonas maltophilia, 2/47
(4.3%) – Acinetobacter baumanii, 1/47 (2.1%) – Alcaligenes xylos-
oxidans, 1/47 (2.1%) – Enterococcus aerogenes. Yeasts were isolated
in 2/47 (4.3%) of cases: Candida albicans – 1 and Candida
parapsilosis – 1.
Conclusion: Staphylococcus spp., predominantly CNS were the
most common cause of CAI. But in some pts non-fermenting
gram-negative pathogens and yeasts can cause CAI as well.
Community-acquired infections including CAP, sepsis, STD, ….
R2237
Fatal Aerococcus urinae endocarditis: a case report
D.H. Forster, A. Becker, M. Elgas, E. Kniehl (Karlsruhe, DE)
Objective: A. urinae is a microaerophilic, Gram-positive coccus
growing in pairs and clusters that is negative for catalase and
PYR and produces a-haemolysis. As a fastidious organism it
needs blood supplemented media and sometimes incubation in
a CO2 enriched atmosphere. It strongly resembles viridans
streptococci or lactobacilli. Identiﬁcation is hampered because
A. urinae is not included in the code-books of commonly used
identiﬁcation systems. A. urine is a rare cause of UTI (0.3–0.8% of
all cases), mainly in elderly men with underlying urinary tract
pathologies, but underdiagnosis is probably common. More-
over, A. urinae has been described as a very rare cause of
endocarditis. To the best of our knowledge, only 12 cases of A.
urinae endocarditis, 9/12 in men, have been published so far
with a striking mortality of 66.6%. We describe another case of
fatal A. urinae endocarditis in a 62-year-old man with urinary
tract pathology.
Case report: The patient was admitted with pulmonary oedema
due to suspected aortic insufﬁciency. TEE revealed a destructing
aortic valve endocarditis leading to aortic insufﬁciency grade IV
and tricuspid valve involvement due to abscess formation. He
was empirically treated with beta-lactams and gentamicin.
Multiple blood cultures but not urine culture (UC) grew A.
urinae. The strain was susceptible to penicillin and identiﬁed by
16S rDNA sequencing. The patient was considered inoperable
and died 4 days after admission of cardiogenic shock and sepsis.
6 months ago the patient was evaluated because of lower
abdominal and inguinal pain. An urine dipstick test showed
leukocyturia and bacteriuria, a UC grew Gram-positive bacteria
reported as lactobacilli. Urological examination showed a
benign prostate hyperplasia. A second dipstick test still revealed
leukocyturia/bacteriuria but UC was sterile. One might specu-
late that a) ‘‘lactobacilli’’ in the ﬁrst UC were in fact A. urinae, b)
isolation of the pathogen in subsequent UC was hampered by
the culture conditions, i.e. a lacking CO2 atmosphere and c)
early antimicrobial therapy might have prevented the fatal
course.
Conclusion: Isolation of a-haemolytic cocci from urine and
blood cultures, especially in elderly male patients, that cannot be
identiﬁed biochemically should make one think of A. urinae. 16S
rDNA sequencing identiﬁes the pathogen deﬁnitely. Clinicians
should be informed about the impact of A. urinae, especially
about the poor prognosis of endocarditis.
R2238
Aetiology and antimicrobial resistance of
community-acquired urinary tract infections in
childhood in Turkey
H. Erdogan, H. Arslan (Antalya, TR)
Objectives: To determine the aetiology and antimicrobial
resistance of community-acquired urinary tract infections
(UTIs) in childhood in Turkey.
Methods: This study was performed at the Baskent University
Alanya Hospital, which has 100 beds capacity. Patients between
3 month and 15 years of age with community-acquired UTI
were included in the study from October 2003 to December 2004.
We interviewed face to face the patients and ﬁlled a form.
Midstream urine samples obtained from patients were inocula-
ted onto 5% blood agar and Eosin-Methylene Blue agar with
0.01 mL calibrated loops by semi-quantitative technique.
Patients who had dysuria or pollakuria or fever and both ‡105
bacteria and pyuria were included in the study. Recurrence UTI
was the exclusion criterion. The isolated bacteria were identiﬁed
by conventional methods. Antimicrobial susceptibility was
performed by a disc diffusion method, according to the
NCCLS criteria. Quality was assured by testing Escherichia coli
ATCC 25922.
Results: A total of 51 patients were admitted in our study.
Forty-nine percent of patients were 6 year old or younger and
96% were female. The most common pathogen was E. coli (90%).
Antibiotic resistance rates for E. coliwere as follows; Amoxicillin
71.7%, trimethoprim/sulfamethoxazole 54.3%, amoxicilline/cla-
vulanate 43.5%, cefazolin 21.7%, nitrofurontoin 6.5%, ceftriaxone
4.3%, gentamicin %4.3, amikacin 2.2%, ciproﬂoxacin 2.2%.
Conclusion: E. coli, the most common pathogen, had a high rate
of resistance to most of the drugs commonly recommended for
UTI treatment. We recommend gentamicin and amikacin as ﬁrst
line drugs while waiting results of sensitivity testing.
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R2239
Isolation of vaginal pathogens in different groups
of women
S. Baka, E. Panagiotopoulou, E. Plati, V. Efstratiou, G. Kaparos,
E. Kouskouni (Athens, GR)
Objectives: Vulvovaginitis is probably the most common infec-
tion treated by gynecologists all over the world. The environ-
ment of the vagina is dynamic since constant changes on the
microbial ﬂora are determined by the metabolic activity of the
host, the pre-existent bacteria and exogenous factors such as
hygiene habits, age or sexual activity. The aim of the study was
to assess the prevalence of pathogens in the vaginal secretions of
women attending our hospital.
Methods: We studied 1233 symptomatic women, which were
divided into 3 groups. Group A comprised 813 non-pregnant
women of reproductive age, group B 177 pregnant women and
group C 243 postmenopausal women. In order to identify
aerobic microorganisms we inoculated vaginal secretions on
blood agar, MacConkey agar, Chapmann and Sabouraud, and
then incubated the plates at 37C for 24 hours, whereas
anaerobic cultures were carried out on Wilkins-Chalgren agar
at 37C for 48 hours. The isolated strains were identiﬁed using
the BD Phoenix Automated Microbiology System (BD Diagnos-
tic Systems, USA). Ureaplasma urealyticum (Uu) was identiﬁed by
urease production, whereas Mycoplasma hominis (Mh) was
detected using DNA agar and incubation for 48 hours in
anaerobic conditions.
Results: The most commonly isolated microorganisms were: a)
in group A, Gardnerella vaginalis (Gv) (30.1%), anaerobic bacteria
(24.4%), Candida spp. (20.8%) and Gram-negative rods (14.3%) b)
in group B, Candida spp. (30.1%), Gv (28.2%), anaerobic bacteria
(21.1%) and Gram-negative rods (10.5%) c) in group C, Gv
(31.4%), anaerobic bacteria (26.9%), Gram-negative rods (17.0%)
and Candida spp. (12.7%). Moreover, Uu was isolated in 41.0%,
33.3% and 23.1%, whereas Mh was detected in 3.4%, 2.6% and
1.9%, respectively, for groups A, B and C.
Conclusion: The most commonly isolated pathogens were
similar between our study groups with small differences in
the isolation rates. As expected, candidiasis was increased in
pregnancy. In the non-pregnant group as well as in the
postmenopausal group more than half of the microorganisms
isolated were those responsible for the speciﬁc clinical entity of
bacterial vaginosis (Gv and anaerobes). High isolation rates
were observed for Ureaplasma urealyticum in all groups.
R2240
Micro-organisms isolated from leucorrhoea in a
military hospital, Algiers
M. Naim, D. Tiouit, M. Chabani, A. Lazizi, I. Boudjemaa
(Algiers, DZ)
Objectives: The purpose of this study is to determine the most
commonly isolated micro-organisms from leucorrhoea observed
in Sexually transmitted infection (STI) clinic in central military
hospital of Algiers.
Methods: We performed a retrospective study from January
1998 to December 2004 of 6490 vaginals discharges in micro-
biology laboratory of central military hospital. This study
concern the women between 20 and 60 years old with genital
infection symptoms. Every woman was tested for the presence
of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas
vaginalis, Candida albicans, Gardnerella vaginalis and other no
speciﬁc bacteria. Vaginal and cervical samples processed by
conventional methods: -microscopic exams, culture in appro-
priate medium and identiﬁcation by conventional test or
manual biochemical systems( API20 NE,API20 E,API NH).
We also used commercials kit for detection of Mycoplasma
(Mycoplasma Duo) and Direct Fluorescent Assay for research
Chlamydia trachomatis.
Results: -Global results:from 6490 samples 3166 (48%)were
positive.-the frequent micro-organisms isolate were: Candida
albicans 1568(49%), Mycoplasma 371(11%), Enterobacteria 313
(10%), Streptococcus agalatiae 297 (9%), Chlamydia trachomatis
200 (6%), Trichomonas vaginalis 143 (4.5%), Gardnerella vaginalis 19
(0.6%) and Neisseria gonorrhoeae 3 (0.09%).
Conclusion: This study show a low frequency of speciﬁc agent
of the STI but a high prevalence of endogenic infection as the
vaginal candidiasis.
R2241
Extemporaneous biopsy in invasive streptococcal
infection: a guide for surgeons?
L. Legout, M. Assal, S. Taylor, J. Romand, D. Lew, L. Bernard, P.
Hoffmeyer (Geneva, CH)
Group A streptococci (GAS) affect either the skin (cellulitis) or
the deeper soft tissue (necrotizing fasciitis or myonecrosis). In
these last two cases, the infection is extremely rapidly
progressing infection with systemic choc. Because infection
initially spreads along fascia or through muscle with no or
minimal skin involvement, early in its course the extent of
disease may be not recognized. Early aggressive excision of
infected, necrotic tissue is essential for survival, in association
with adequate treatment.
Patients and methods: We evaluate the role of extemporaneous
biopsy performed in cases of invasive severe GAS infection
suspected.
Results: 5 patients (4 men, 1 woman) were admitted in
operating room with the suspicion of necrotizing fasciitis
because of hypotension and multi-organ dysfunction without
cause. The underlying conditions were diabetes mellitus (n = 2).
The local signs were erythema (n = 4), oedema (5), bullae
(n = 3), anaesthesia (n = 2) of the thigh (n = 4) or of the chest
(n = 1), diffuse rash on the trunk and thighs (n = 1). Anaesthesia
followed a period of exquise pain treated with non-steroidal
anti-inﬂammatory drugs. The C-reactive protein, leukocyte
count were increased (n = 5). In operating room, at the incision
into the infected area, the surgeon found small resistance in the
fascia plane (n = 2), brownish ﬂuid (n = 3) but no pus. The
extemporaneous biopsy performed in operating room, only 5–
12 hours after the admission of the patients in hospital showed
polynuclear inﬁltration of the deep dermis (n = 5), the fascia
(n = 3), liponecrosis (n = 3), multiple thrombi (n = 3) and
myonecrosis (n = 1). The diagnosis of necrotizing fasciitis
(n = 2) and myonecrosis (n = 1) was etablished on clinical
suspicion and histological basis and was retrospectively con-
ﬁrmed. Immediately, aggressive debridment (n = 2) and ampu-
tation (n = 1) of all the entire thigh were decided while they
received intravenous immunoglobulins, clindamycin and pen-
icillins. During the ﬁrst week, wound revision was performed
every day, in operating room.The necrotizing cellulitis (n = 1),
toxic shock syndrome with rash (n = 1) was diagnosed for the
others. They received penicillins-clindamycin (n = 2) and im-
munoglobulins (n = 1). GAS grew on tissue culture (n = 5), on
blood culture (n = 4). The rate of survival was 100%.
Conclusion: We believe that an extemporaneous biopsy can
guide the surgeon in the decision of aggressive debridment or
amputation, when severe invasive GAS soft tissue infections is
suspected.
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R2242
Bacteraemia in a general hospital, Bilbao, Spain
1994–2005
C. Ezpeleta, I. Atutxa, C. Busto, E. Gomez, V. Cabezas,
J.A. Alava, J. Unzaga, R. Cisterna (Bilbao, ES)
Objective: The aim of this study is to assess the features of
bacteraemia in the hospital of Basurto in the last 11 years (Jan
1994–Sept 2005).
Methods: Blood cultures are performed by means of BACTEC
9240. The Infection Control team studies every patient with
positive blood cultures. Variables under surveillance are
patient’s age and sex, underlying illness, predisposing condi-
tions, source of bacteraemia, nosocomial/community acquired,
microorganism and antibiotic susceptibility, antimicrobial treat-
ment, complications and outcome. A computer based surveil-
lance system is used.
Results: 7051 episodes of bacteraemia were studied during this
period. Incidence from 1994 to 2005 between 17.6 and 22.05
cases/1000 discharges. The incidence remained stable at among
19 cases/1000 dischargeswith two peaks of incidence in 1995 and
2004. Men (57.51%) aged over 70 y (48.14%) accounted the
majority of cases. The most frequent underlying illness was
neoplasia present in 1644 patients (23.32%). The urinary (26.86%),
gastrointestinal (17.23%) and respiratory tract (14.55%) were the
most common sources of bacteraemia. Aetiology: Gram– 54.73%
(range: 49.7–58.72), Gram+ 42.61% (range: 39.18–42.98%) and
yeast 2.58% (range: 1.39–3.93%). E. coli (30.54%), S. aureus 10.71%,
S. pneumoniae 9.56%, S. epidermidis 5.95%, P. aeruginosa 3.46% and
Salmonella spp. (3.31%) are the most frequent agents of bacter-
aemia. Susceptibility to antibiotics: Methicillin resistant S. aureus
12.48% (Range 0% 1994 to 21.33% 2004); E. coli resistant to
Ciproﬂoxacin 12.82% (Range 9.7% 1994 to 15.20% 2004), and to
Cefotaxime 0.86% (Range 0% 1994 to 3.8% 2004). In 81.4%
episodes appropriated antibiotic treatment was started the same
day that blood cultures were obtained. Crude mortality until the
end of the episode 16.89% (range: 13.8–21.36%). Nosocomial
bacteraemia accounted 29.88% (range: 26–38.7%) of cases. Inci-
dence of nosocomial bacteremia ranged between 3.82-7.41/1000
discharges. Nosocomial acquired bacteraemia aetiology: Gram+
53.22%, Gram- 40.51% and Yeast 6.14%. Coagulase Negative
Staphylococci 23.09%, E. coli 17.73%, S. aureus 16.56%, P.
aeruginosa 5.66%. Crude mortality until the end of the episode
25.11% (range: 17.0–30.34%).
Conclusions: Incidence of bacteraemia remained stable in last
11 years with two peaks of incidence in 1995 and 2004. A trend
toward a decrease in fungi was observed in community and
nosocomial acquired cases. 51.5% of cases of Methicillin Resist-
ant S. aureus bacteraemia were community acquired.
R2243
CAP in patients with diabetes
R. Erzen, E. Music, V. Tomic (Golnik, SI)
Objectives: Infections cause considerable morbidity and mor-
tality in patients with diabetes. Due to impaired immunity
infections have more severe and prolonged course. In patients
with diabetes many aspects of humoural and cellular immunity
is impaired. In our study we wanted to analyse the impact of
impaired immunity to clinical course, offending microorgan-
isms, treatment and outcome of CAP in patients with diabetes.
Methods: Study is retrospective. It includes all patients with
diabetes hospitalized due to CAP at our hospital in 2004. All
data are from patients ﬁles.
Results: 94 episodes of CAP in 90 patients with diabetes were
treated, 56% were men, aged 39 to 96 years, average age was
74.8 years. 30% of patients had insulin dependent diabetes, in
60% late complications of diabetes were present. 85% of patients
had also other chronic diseases. Multilobar inﬁltrations on chest
x-ray were present in 32% of patients, 12% had parapneumonic
effusion. Haemoculture was performed in 54% of patients,
positive in 18%, S. pneumoniae being found in 5 patients, and
other pathogens rarely (Bacteroides sp., S. aureus, P. mirabilis).
Examination of sputum was done in 61%, was positive in 23%,
S. pneumoniae was most frequent isolate (7 patients), followed by
P. mirabilis, P. aeruginosa, K. pneumoniae, MRSA and C. albicans (1
patient). Microbiologic examination of tracheal aspirate was
performed in 20% of patients with positive isolation in 74%.
Here S. aureus was most frequently isolated (5 patients),
followed by Enterobacteria (4 patients), P. aeruginosa (2 patients)
and S. pneumoniae (1 patient). 14% of patients had infection of
urinary tract simultaneously, caused most frequently by E. coli.
2% of patients developed empyema. 60% of patients were
treated with amoxicillin clavulanate, 21% with respiratory
quinolones. Average length of hospital stay was 13.8 days.
Mortality rate was 17%.
Conclusion: CAP in patients with diabetes tends to have a
severe and prolonged course. Multilobar involvement on chest
X-ray is frequent. Hospital stay is longer and mortality rate
higher than in whole population. S. pneumoniae and S. aureus are
most frequent offending microorganisms. Amoxicillin, clavula-
nate and respiratory quinolones seem to be best therapeutic
options.
R2244
FASTCAP Study (FAdoi Study on CAP).
Retrospective and perspective study on
community-acquired pneumonia in internal
medicine
F. Blasi, A. Bulfoni, S. Costantino, I. Iori, D. Legnani (Milan,
Udine, Rome, Reggio Emilia, IT)
Objectives and methods: A one-year (Jan–Dec 2002) retro-
spective study was performed on the management of patients
with CAP hospitalized in Internal Medicine, and compared
with a one year perspective phase (June 2003–May 2004) on
the same kind of patients, following the implementation of
FADOI (Internal Medicine Association) Italian guidelines on
RTIs.
Results: We report the retrospective results and a trend on
perspective. 31 Internal Medicine Departments were involved.
1443 cases, (613 F, mean age 79.3 years, 961/1443 PSI score Class
IV and 482/1443 Class V, pathogen isolation: 11.4%) were
included in retrospective analysis. Prior antibiotic treatment was
administered to 18.4% of the patients. First line antibiotic
treatment (50.7% monotherapy, 49.3% combination, mean dur-
ation = 9.2 days) obtained a clinical success in 1029 patients
(71.3%). Second line treatment was administered to 222 patients,
treated more frequently with combination therapy (57.7%). The
mean duration of second line therapy was 8.8 days, and a
clinical success was obtained in 70.7% of cases. The mean
duration of hospitalization was 12.2 days, and the overall
mortality was 231/1443 patients (16%). The analysis of perspec-
tive phase (about 1400 patients) is ongoing and the results will
be available on early 2006. However, some positive trends can
be noted: preliminary data showed a slight improvement in
aetiological diagnosis (14.7% vs 11.4%), in clinical success of ﬁrst
line therapy (72.8% vs 71.3%) and in overall mortality (14.9% vs
16%).
Conclusion: The data of this study reﬂect the real management
of CAP in Internal Medicine Wards in Italy.
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R2245
Fulminant septic shock in a splenectomised
patient caused by an Haemophilus inﬂuenzae type
b strain harbouring six copies of the capsulation
b locus
M. Cerquetti, R. Cardines, M. Giufre`, A. Castella, M. Rebora, P.
Mastrantonio, M.L. Cioﬁ degli Atti (Rome, Turin, Savigliano, IT)
Objectives: Haemophilus inﬂuenzae type b (Hib) strains isolated
from invasive disease generally possess a duplication of the
capsulation (cap) b locus. Ampliﬁcation up to ﬁve copies has
been reported and has been proposed to be a mechanism to
evade host defence. Splenectomized individuals are known to be
particularly prone to infections caused by encapsulated bacteria.
We report a case of Hib septicaemia, associated with dissem-
inated intravascular coagulation and sudden death in a previ-
ously splenectomized adult patient. To investigate whether
unusual virulent traits of the microorganism might have
contributed to the severe clinical presentation observed, geno-
typic characterisation of the Hib isolate was performed. In
particular, the number of copies of the capb locus was
determined.
Methods: Pre-mortem blood culture was positive for Hib. The
capsular type b of the case isolatewas conﬁrmed by PCR capsular
genotyping. Genetic relatedness between the case isolate and the
prototype Hib strain 40F, belonging to the major Hib clone
endemically present in Italy, was investigated by pulsed-ﬁeld gel
electrophoresis (PFGE). The number of copies of the cap b locus
was determined by Southern blot analysis, based on the size of
the restriction fragments after digestion of the chromosome with
KpnI and SmaI restriction enzymes.
Results: By PFGE, the case isolate showed a restriction pattern
identical to strain 40F, indicating that it belonged to the major
invasive Hib clone endemically present in Italy. When the
number of copies of capb locus was investigated, the case isolate
appeared to contain a mixed population of 6, 5, 4, 3 and 2–copy
arrangements of the locus. The result was conﬁrmed by analysis
of individual colonies showing distinct subpopulations contain-
ing exclusively a 6, 5, 4, 3, or 2-copy arrangement.
Conclusion: The detection of six copies of the capb locus in a
Hib isolate is noteworthy since it is the highest number of copies
yet reported. Although splenectomized patients are at risk for
serious systemic infections caused by encapsulated bacteria,
severe Hib cases are more common in asplenic or splenectom-
ized children than in adults. Our results suggest that the
unusual ampliﬁcation of the capb locus might have contributed
to the particularly severe clinical presentation.
R2246
Prevalence of Chlamydia trachomatis infection in
Iranian women suffering from cervicitis: a cross-
sectional study
N. Badami, M.R. Khorramizadeh, J. Zaeimi Yazdi (Tehran, IR)
Objectives: The aim of this study was to determine the
prevalence of Chlamydia trachomatis among a randomized
statistical group of women suffering from cervicitis in Iran.
Methods: During a 12-month-period, Jan 2003 to Jan 2004, 142
endocervical samples were taken from women suffering from
cervicitis attending to Mirzakoochakkhan Women Hospital in
Tehran, Iran. Direct ﬂuorescent antibody (DFA) and polymerase
chain reaction (PCR) techniques were used to detect C. tracho-
matis in endocervical samples.
Results: Twenty-two (15.5%) [95%CI, 9.54–21.4] out of 142
samples were diagnosed as Chlamydia positive according to
PCR results, while DFA diagnosed 20 (14.1%) [95%CI, 8.37–19.8]
of cases as Chlamydia positive. No statistically signiﬁcant
difference was found among two diagnosis methods applied
in this study, (i.e. PCR and DFA). Prevalence was the highest
(25%) among women aged 25 to 29 years and 35 to 39 years. The
v2 test showed there was a signiﬁcant relationship between
positive test result and bearing a history of STI (P = 0)
Conclusion: The results of this study showed high prevalence
of C. trachomatis infection among women suffering from cervi-
citis and suggest that patients diagnosed with genital Chlamydia
infection should be referred to the genitourinary medicine clinic
for further STI screening and partner notiﬁcation.
R2247
Acanthamoeba cornal ulcer as a complication of
orthokeratology
K. Kowalewska-Grochowska, J. Carson, J. Underhill,
P. Tomlin (Edmonton, Saskatoon, CA)
Objectives: Orthokeratology is a recently favoured non-surgical
procedure to reduce myopia, which involves nightly use of rigid
gas permeable lenses to ﬂatten the cornea to reduce refractile
errors. Despite the recent surge in popularity of this procedure,
there are serious risks associated with it that may be overlooked.
We describe a case of Acanthamoeba keratitis in an adult as a
complication of orthokeratology.
Methods: Contact lenses were cultured on non-nutrient 1.5%
agar plates with a lawn of non-mucoid E. coli. After incubation
at 37 C scrapings from surface of the agar were observed for
presence of characteristic trophozoites and cysts. Clinical details
were obtained by review of the case with the patient’s attending
physician.
Results: The patient was a 29 years old otherwise healthy
female who presented to her physician with severe eye pain,
conjunctival suffusion, photophobia and decreased visual acuity
over the past 12 days. On examination she showed unilateral
corneal ulcer. The patient was a rigid contact lens wearer for a
year prior to this event. She wore contact lenses overnight only,
for correction of vision, and wore no lenses during the day.
There was no history of eye trauma. No corneal scrapings were
available for culture but the hard contact lens grew Acanth-
amoeba species after 24 hours of incubation on the plates as well
as in the original container.
Conclusion: Orthokeratology is a recent, increasing trend
among the optometrists, encouraged for use particularly in
children, who may have problems with handling contact lenses
during daily activities. Nevertheless, Acanthamoeba keratitis is
an alarming emerging complication of this procedure, partic-
ularly because of lack of effective treatment. Ulcerative keratitis
occurs at 20.9/10 000 extended wear lenses per year. However,
the risk of developing the disease increases 10–15 times in
extended daily wear with overnight use. This is a serious
potential problem in all orthokeratology recipients. In view of
increasing popularity of this procedure questions should be
raised about how these lenses and methods are being regulated,
marketed and monitored.
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Lyme, borelliosis, toxoplasmosis
R2248
Borrelia burgdorferi genospecies in the
environment of forestry
E. Cisak, J. Chmielewska-Badora, J. Zwolinski, A. Wo´jcik-
Fatla (Lublin, PL)
Objective: The objective of the study was detection of three
pathogenic Borrelia burgdorferi sensu lato (s.l.) genospecies
(Borrelia burgdorferi sensu stricto (s.s.), Borrelia afzelii and Borrelia
garinii) in Ixodes ricinus ticks and forestry workers from three
provinces of the Lublin region (eastern Poland).
Methods: Eighty-seven sera of forestry workers from the Lublin
region, seropositive with B. burgdorferi s. l. antigen in ELISA test
(Bellco Biomedica, Austria) were examined for the presence of
species-speciﬁc antibodies against B. burgdorferi s. s., B. afzelii
and B. garinii by the use of ELISA test (Test-Line, Czech
Republic). All the seropositives forestry workers were subjected
to clinical examinations. Species-speciﬁc primers designed for
differentiation of B. burgdorferi into three above mentioned
genospecies were used in nested-PCR reaction in 54 out of 664
examined I. ricinus ticks in which B. burgdorferi s.l. DNA was
found. Ticks were collected from the same three provinces from
which forestry workers were examined.
Results: The study showed high percentage of infections with
an unidentiﬁed genotype B. burgdorferi (55.2%). It was observed
that among identiﬁed genospecies of B. burgdorferi s.l. in forestry
workers, mixed infections with three genotypes are dominant,
i.e. B. burgdorferi s.s., B. afzelii and B. garinii. Considering
infections, the percentage of individual or mixed infections was
as follows: B. burgdorferi s.s. (35.6%), B. afzelii (31.0%) and B.
garinii (33.4%). Out of 46 seropositive workers in 3 clinical
borrelioses were diagnosed. The main clinical manifestations
included: borreliosis erythema, periodical strong arthralgic pain,
dysfunction of extremities, headaches and dizziness. A correla-
tion was observed between clinical symptoms and genotype
infection with B. burgdorferi. In 54 out of 664 I. ricinus ticks in
which B. burgdorferi s.l. DNA was detected, B. burgdorferi
genospecies were identiﬁed in 51 individuals (94.5%). The
majority of examined ticks (96.1%) showed infections with one
genotype. Considering identiﬁed infections (single and coinfec-
tions) the percentage was as follows: B. burgdorferi s.s. (51.8%),
B. afzelii (33.3%) and B. garinii (5.5%).
Conclusion: Among identiﬁed infections, B. burgdorferi s.s.
seems to be dominant in forestry workers as well as in I. ricinus
ticks in three provinces of the Lublin region.
R2249
Socio-economic conditions and other factors
inﬂuencing Lyme borreliosis incidence in the
Czech Republic
B. Kriz, C. Benes (Prague, CZ)
Objectives: Analysis of factors inﬂuencing the Lyme borreliosis
(LB) occurrence.
Methods: Analysis of surveillance data collected by ﬁeld
epidemiologists, data from the meteorological service and
from the demographic and economic institutions.
Results: Reliable data of LB infections in the Czech Republic are
available since year 1988. The hypothesis is validated by
comparison of the trend of Tick borne encephalitis (TBE)
incidence and LB incidence in years 1988–2004 (correlation
r = 0.87). Incidence of both infections reached the peak in 1995.
The seasonal distribution of TBE and LB is almost similar (1993–
2004, r = 0.9) with the maximum cases occurring in July. During
years 1993–2004 sex speciﬁc incidence was higher in females
than in males(ratio 1.5:1). Age speciﬁc incidence of LB has two
peaks, in the age group of 5–9-year-old children (30.9/100 000
per year) and in the age group of 55–64 years olds (48.2/
100 000). The percentage of forest men and other persons
working in the forests or ﬁelds among the LB cases in years
1997–2004 was 1.8%. Ticks bite infects the patients during their
recreational activities mainly. Unemployment remained in the
years 1991–1995 approx. at the same level (between 2 and 3%).
During the next years the percent of unemployed persons
increased quickly up to 9.3% in the year 1999 (7.8% in year 2001,
8.3% in year 2004). This trend differs signiﬁcantly from the trend
of LB incidence that peaked in year 1995 (r = 0.39). The
percentage of unemployed persons among the LB cases was
3.8% in contrary to the Czech Republic ﬁgures which were in the
same period 5–9%. Gross domestic product in US $ per capita
increased from 2600$ in year 1991 to 6700$ in year 2003. Since
that year varies between 4800$–5600$. This trend therefore
differs from the trend of TBE incidence as well (r = 0.12). Retired
persons comprised 25% of LB cases in years 1997–2004.
Conclusions: The behavioural and socioeconomic aspects of
TBE cases remained stable despite the political changes, which
occurred in Czech Republic since the beginning of nineties and
therefore are not responsible for the increase of LB incidence in
recent years. The increase of LB incidence was inﬂuenced by
natural, ecological and climate conditions.
Acknowledgment: Research was supported by EC grant
cCASHh no.EVK2-CT-2000-00070 and EC grant BOVAC no.
COOP-CT-2004-512598.
Antimicrobial clinical trials
R2250
Efﬁcacy of cefepime plus clarithromycin versus
cefepime alone in patients with
ventilator-associated pneumonia after cardiac
surgery: prospective clinical trial
E. Bachinskaya, N.V. Beloborodova, E. Nonikov (Moscow, RU)
Ventilator-associated pneumonia (VAP) is the most frequently
occurring infectious complication after major cardiac surgical
operation. The VAP rate in cardiovascular surgery averages
1–2%. Usually there is early-onset VAP, which is caused by
community-acquired pathogens including atypical microorgan-
isms.
Objectives: To estimate potential role of Chlamydia pneumoniae
andMycoplasma pneumoniae in early-onset VAP development. To
compare efﬁcacy of cephalosporin and macrolide combination
versus cephalosporin alone for early VAP treatment in patients
undergone cardiosurgical operation.
Methods: A total 50 patients undergone major cardiovascular
surgery were administrated cefuroxime or ceftriaxone for
antimicrobial prophylaxis. Inclusion criteria – new and persist-
ent inﬁltrate on chest radiography occurred during ﬁrst 7 days
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of mechanical ventilation (at least 48 hours after mechanical
ventilation start) associated with two of the following: body
temperature >38C or <36C, leukocytosis (>10 · 109/L) and/or
> 10% of immature forms of leucocytes or leucopenia (<5 · 109/
L), purulent tracheal secretions. Early VAP patients were
divided into 2 groups: 1 group (n = 30) received cefepime plus
clarithromycin (IV), 2 group received cefepime alone. We
investigated a procalcitonin (PCT) level a 72 hours before
antimicrobial therapy beginning. Serological ELISA tests were
conducted in 22 VAP patients for ﬁnding of antibodies to
Chlamydia pneumoniae and Mycoplasma pneumoniae.
Results: We observed diagnostic level of IgM to Chlamydia
pneumoniae (9%) and to Mycoplasma pneumoniae (9%). Clinical
efﬁcacy (cure and improve rates) of cefepime/clarithromycin
combination was 53%, compare for cefepime alone – 30% (NS).
Also we observed reduction of procalcitonin level from 1.65
(25% – 0.75, 75% – 3.32) ng/ml to 0.7 ng/ml (25% – 0.53, 75% –
2.74) with cefepime/clarithromycin therapy that conﬁrmed the
evidence of antimicrobial therapy adequacy. Patients who
received only cefepime had increase of procalcitonin level
from 0.61 (25% – 0.41, 75% – 2.52) ng/ml to 1.31 (25% – 0.38,
75% – 3.41) ng/ml. Total postoperative mortality rate were
similar in both groups (30%). Major cause of death was not
infection but thromboembolic and other complications.
Conclusion: Combination of cefepime with clarithromycin is
more preferable for treatment of early VAP in cardiac patients
compare with cefepime alone.
Paediatric infections
R2251
An urban case of lymphocytic choriomeningitis
virus encephalitis and hydrocephaly due to a new
variant strain traced back to infected wild Mus
musculus colony
S. Emonet, K. Retornaz, X. de Lamballerie, R.N. Charrel
(Marseille, FR)
A ﬁve-year-old boy was admitted at the emergency ward in
August 2004 for a typical summer meningitis with fever, neck
stiffness, vomiting and prostration. CSF showed elevated pro-
tein level (1.3 g/L) and discrete hypoglycorachia (2.3 mmol/L).
PCR and RT-PCR tests searching Herpesviridae and enterovi-
ruses, respectively were negative. Treatment consisted of acy-
clovir and cefotaxime for 8 days. The outcome was favourable.
Forty-ﬁve days later, the boy was admitted again with clinical
manifestations compatible with encephalitis. Cerebral tomogra-
phy and MRI showed a major hydrocephaly associated with
pachymeningitis which revealed to be non spontaneously
resolutive and necessitated to install a permanent ventriculo-
peritoneal derivation. This convalescent-phase serum contained
IgG (1/512) but no IgM directed against LCM virus; the acute-
phase serum tested retrospectively showed IgG (1/128) and IgM
(1/64). RT-PCR with primers speciﬁc for LCM virus was found
positive; the PCR product was sequenced and found to be >13%
divergent from all LCM virus sequences available in the
GenBank database. Interview of the mother revealed that their
home was infested with "mice". Attempts to trace this case back
to rodents were achieved by trapping rodents outside and inside
the apartment lot. A total of 20 mice (presumably Mus musculus,
deﬁnitive identiﬁcation is pending) were captured inside a
apartment lot in the vicinity of the boy’s ﬂat. Capture was
performed with glue-traps, and mice were still alive when
brought to the laboratory. They were euthanized and organs
were collected. One kidney of each rodent was used for nucleic
acid puriﬁcation and was tested with the same primers. A total
of 13/20 kidneys were positive, and crude extract were used for
Vero cells inoculation. Full genome sequencing has been
performed and comparative analysis with other LCM virus
strains reported in the literature indicated that this strain is a
distant variant of LCMV; a detailed phylogenetic and compar-
ative sequence analysis will be presented. Additionally, evalu-
ation of new classic and/or real-time RT PCR diagnostic system
will be presented. This case underlines the importance to
develop sensitive and speciﬁc diagnostic tools for LCM virus,
which remains at least in France but probably worldwide a
neglected human pathogen.
R2252
Viral, mycoplasmal and chlamydial upper
respiratory tract infections among paediatric
outpatients
D. Findik, U. Arslan, R. Kutlu, F. Isik, A.F. Genc (Konya, TR)
Objectives: The aim of this study was to investigate the viruses
and atypical bacteria in upper respiratory tract infections of
children.
Methods: Two throat swab specimens were collected from each
children with acute respiratory infections visiting public hospi-
tal outpatient department. One of the swabs was used for
bacteriological cultures and one of them for PCR analysis. In this
study real-time PCR method was used to investigate the viruses
and atypical bacteria in respiratory tract infections.
Results: Bacteriological culture negative specimens were
chosen for this study. A total number of 100 specimens were
evaluated for the detecion of RSV A, RSV B, CMV, Adenovirus,
Mycoplasma pneumoniae and Chlamydia pneumoniae and 31% were
positive at least 1 virus or atypic bacteria. Among them
respiratory synsitial virus A were detected from 8 specimens,
while RSV B were detected from 3 specimens. CMV were
detected from 17 specimens, and Adenovirus from 1 specimen.
Chlamydia pneumoniae were detected from 2 specimens and
Mycoplasma pneumoniae was not found from these specimens.
From ﬁve specimens RSV A and CMV were detected as mixed
viruses. From one specimen RSV A, RSV B, CMV Chylamidia
pneumoniae were detected as mixed infection.
Conclusion: The results of this study demonstrate that CMV
and RSV A are the two most common viruses isolated from
paediatric outpatients with upper respiratory tract infection.
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Real-time PCR method can be applied in clinical practice for
arriving at a correct diagnosis and administration of effective
treatment.
R2253
Rotavirus: a new future for an old known virus
A. Cedrato, J.C. Peuchot, M.I. Rubio, P. Prebianca, G. Mosquera,
D. Perez Bournissen (San Martin, AR)
Objective: To show that the infection caused by rotavirus is one
of the main aetiologies causing mild to severe diarrhoea in the
total amount of children hospitalized due to gastrointestinal
symptoms.
Material and methods: This study is an observational and
retrospective study performed at the Hospital Interzonal Gen-
eral de Agudos, Eva Pero´n de San Martı´n, Buenos Aires,
Argentina, between January and September 2005. 173 patients
were assessed due to Gastrointestinal symptoms with an age
range from 1 months old to 4 years old.
Results: Out of 173 patients hospitalized due to gastrointesti-
nal symptoms, 49 patients (28.32%) were identiﬁed with
Rotavirus in the stool. The average age of the 49 patients
was 9 months. The average days of hospitalization was
6.54 days, being April the months with the highest incidence.
31.07% of the 49 patients showed metabolic acidosis and more
than one-third had mild to severe dehydration. 5.88% were
admitted to Paediatric Intensive Care Unit with the diagnosis
of hypovolemic shock.
Conclusions: Rotavirus is the most common cause in the world
of vomits and diarrhea with great morbimortality especially in
less developed countries. This disease produces a high rate of
admittance as well as a high cost of hospitalization, with loss of
working days for the children’s parents, being the appearance of
the vaccine a major ﬁnding to solve this issue of Public Health.
We believe that the use of this vaccine is the chosen method to
signiﬁcantly diminish the global incidence of this disease.
R2254
Intestinal S. aureus colonisation in Italian and
Swedish infants is effected differently by
antibiotic treatment, siblings and pets
E. Lindberg, I. Adlerberth, P. Matricardi, S. Tripodi, A. Wold
(Goteborg, SE; Rome, IT)
Objectives: The skin bacterium Staphylococcus aureus has
become a frequent colonizer of the intestinal tract of Swedish
infants. Whether such colonization is common in other countries
as well is not known. Here we compared intestinal colonization
by S. aureus in Swedish and Italian infants and studied the effect
of some life-style factors on such colonization.
Methods: One hundred infants each from Sweden and Italy
were followed with rectal swabs at 3 days of age and quanti-
tative stool cultures at 1, 2, 4, and 8 weeks and 6 and 12 months
of age. Individual S. aureus strains colonizing an infant were
identiﬁed by RAPD and their toxin production, faecal popula-
tion counts and time of persistence in the microﬂora was
determined and related to different life-style factors.
Results: Sixty-six percent of the Italian infants had S. aureus in
their stools at some time-point during the ﬁrst year of life
compared with 83% in Sweden (p = 0.0003). Most colonized
infants in both cohorts had a strain that persisted in the
microﬂora for more than a month and half of the strains
produced one or more superantigenic toxins (SEA-D or TSST-1).
Having elder siblings was positively associated with S. aureus
colonization in the Italian cohort (p = 0.02), while the presence
of pets in the family correlated negatively with S. aureus
colonization in the Swedish cohort (p = 0.03). Antibiotic treat-
ment was signiﬁcantly more common in the Italian cohort
(p = 0.0001) and was negatively associated with S. aureus
colonization while the vice versa were seen in the Swedish
cohort. Sectio-delivery and exclusive breastfeeding showed a
marginal and non-signiﬁcant positive association with S. aureus
colonization. When examining only vaginally delivered infants
breast-fed up to four months of age and not treated with
antibiotics, Italian infants were still less likely to be colonized by
S. aureus than Swedish infants, but the signiﬁcance was gone.
Conclusion: Variations in antibiotic treatment affected the S.
aureus colonization, but could not explain the whole difference.
The underlying causes of this country-speciﬁc colonization
pattern remain to be determined. Possibly, Italian infants
harbour a more complex microﬂora, conferring greater resist-
ance to implantation of S. aureus.
R2255
Wound infection caused by V. parahaemolyticus
and V. alginolyticus
H. Kirikou, A. Sergounioti, A. Stathi, E. Petridou, I. Flieger,
A. Pangalis (Athens, GR)
The genus Vibrio includes more than 35 species, mostly marine
in origin, many of which may cause disease in human. The best
known halophilic species belonging to this genus are Vibrio
parahaemolyticus and Vibrio alginolyticus. The former is a
common human pathogen causing gastroenteritis and, less
often, tissue infections. The latter has been associated with
otitis and also with wound infection after exposure to sea water.
We present a case of a mixed wound infection in a child, from
which both Vibrio parahaemolyticus and Vibrio alginolyticus were
recovered.
Case report: A 10-year-old boy was admitted to our hospital on
5th August 2005 because of a wound of the external malleolus of
the right foot, lameness, pain and fever. The patient reported
that he was injured when he hit his foot against a sharp stone at
the seashore the previous afternoon. The wound was treated on
cite with povidone iodine, but it kept bleeding and started
producing pus. On admission to the hospital, his temperature
was 38.5C. The wound was remarkably deep and wide and
covered with pus. Sample was taken for full microbiological
investigation, surgical debridement subsequently followed and
antibiotic therapy with cefuroxime per os was started. From the
specimen’s culture, Vibrio parahaemolyticus, Vibrio alginolyticus,
Clostridium perfrigens and Bacillus brevis were recovered. All
Vibrio’s strains’ antibiotic susceptibilities were tested using the
automatic VITEK 2 system (Biome´rieux, Marcy L’E´toile, and
France). V. parahaemolyticus showed intermediate susceptibility
to ticarcillin and V. alginolyticus was resistant to it. They were
both susceptible to ticarcillin/clavulanic acid, piperacillin, pip-
eracillin/tazobactam, ceftazidime, aztreonam, imipenem,
meropenem, gentamicin, amikacin, and ciproﬂoxacin.The anti-
biotic regimen failed to reduce the fever and stop the pus
production after 8 days of administration, so cefuroxime was
replaced with amoxicillin/ clavulanic acid per os for 12 days,
which ﬁnally succeeded to treat the infection. Nevertheless, the
patient’s foot recovered full function only after three months.
Conclusions: Our patient suffered from a mixed infection
caused by four different microorganisms, two of which were
Vibrio species. Although appropriate management resulted to
the patient’s clinical improvement and prevented possible
complications, such as necrotizing fasciitis, full recovery was
Clinical Microbiology and Infection, Volume 12, Supplement 4, 2006
2006 Clinical Microbiology and Infection, Volume 12, Supplement 4
ISSN: 1470-9465
slow, as Vibrio infections are severe and often followed by
prolonged morbidity.
R2256
Bacteraemia caused by Clostridium baratii and
Kawasaki syndrome. First case report
C. Iaria, G. Stassi, A. Arena, G.B. Costa, A. La Mazza,
L. Silipigni, D.C. Salpietro, A. Cascio (Messina, IT)
Background: The clinical spectrum of clostridial bacteraemia
ranges from an asymptomatic patient having an incidental
positive blood culture to a full-blown, life-threatening infection.
Kawasaki syndrome is an acute, self-limited systemic vasculitis
of unknown aetiology that occurs in children. Its importance is
due to the coronary artery aneurysms that develop in 20–25% of
cases if the treatment is not given early in the course of the
disease.
Case presentation: A 3-year-old male presented for evaluation
of fever, abdominal pain, vomiting and polymorphous erythe-
matosus rash on the extremities of 3 days duration. Three weeks
before he presented with irregular fever and micropapulous
exanthema over the truncus for 3 days followed after two days
by perianal hyperaemia, scrotal oedema and balanopreputial
hyperaemia and swelling. On admission, he was febrile (38.5C).
Physical examination showed: periungual peeling on the palms
and ﬁngers; severe hyperaemia of perianal region with peeling
areas; erythematosus pharynx, strawberry tongue, dry and
ﬁssured lips, angular cheilitis; unilateral enlarged jugulodigas-
tric nodes. Laboratory examinations revealed a white blood cell
count of 5000/lL with 54% neutrophils and 38% lymphocytes.
Platelet count 222.000/lL, C-reactive protein concentration of
50 mg/l and an erythrocyte sedimentation rate of 27 mm/h,
serum IgA 297 mg/dl. Within the normal range anti-streptoly-
sin O, IgM, IgG, blood urea, glycaemia, creatinine, plasma
bilirubin, transaminases, gamma-glutamyltransferase, CD4+T-
cells, CD8+ T-cells, CD19, NK cells, CD4/CD8 rate. No reactive
for EBV, CMV, HSV-1, HSV-2, VZV, Adenovirus, Parvovirus
B19, Coxsackie, Echovirus and Chlamydia pneumoniae. Results of
urine analysis showed sterile pyuria. Two blood cultures were
processed by the hospital microbiology laboratory using a
standard blood culturing system (BACTEC 9120; Becton Dick-
inson). The anaerobic bottles gave a positive result at day 3 after
inoculation. The biochemical proﬁles produced by the RapID
ANA II System (Remel, Inc., Lenexa, KS) showed that the
organism was Clostridium baratii with a probability of 99%.
Conclusions: Our report highlights the importance of C. baratii
as a potential human pathogen and documents the association
with symptoms never before reported in clostridial infections.
R2257
Hydrocephalus: a rare complication of mumps
meningoencephalitis
S. O¨ncel, E. C¸iftc¸i, N. Belet, N. Dalgic¸, S. Fito¨z, E. Ince,
U¨. Dogru (Ankara, TR)
Meningoencephalitis is the most frequent and generally benign
complication of mumps; however hydrocephalus may develop
as a result of mumps meningoencephalitis. In this report two
patients with hydrocephalus related to mumps meningoen-
cephalitis are presented.
Patient 1: an 8-year-old boy, who had a 5-day history of fever,
malaise, headache and vomiting was admitted to our hospital.
Physical examination revealed bilateral parotis swelling, neck
stiffness, and positive Kernig and Brudzinski signs. He had also
horizontal nistagmus and bilateral papilledema. Cranial compu-
ted tomography showed dilatation of lateral ventricles. Cerebro-
spinal ﬂuid examination revealed pleocytosis (250 leucocytes/
lL with 90% lymphocytes and 10% neutrophils). CSF protein
concentration was 152 mg/dL, and glucose concentration was
30 mg/dL (simultaneous serum glucose: 91 mg/dL). Serum
mumps IgM and IgG were positive. Symptomatic treatment
was initiated. Vertigo, ataxia and dysmetria developed; however
patient’s complaints and neurological ﬁndings resolved com-
pletely. Hydrocephalus persisted but did not progress.
Patient 2: a 6-year-old boy with fever and vomiting was
admitted to our hospital. She had had bone marrow transplan-
tation because of ganglioneuroblastoma 9 months previously.
She developed parotis swelling two weeks before and the
diagnosis of mumps was established by his paediatrician.
Physical examination revealed neck stiffness, and positive
Brudzinski sign. Cranial computed tomography showed dilata-
tion of all ventricles. Cerebrospinal ﬂuid examination revealed
pleocytosis (160 leucocytes/lL with 85% lymphocytes and 15%
neutrophils). CSF protein concentration was 206 mg/dL, and
glucose concentration was 17 mg/dL (simultaneous serum
glucose was 97 mg/dL). Serum mumps IgM and IgG were
positive. The patient was followed with supportive treatment.
All complaints and neurological ﬁndings of the patient com-
pletely resolved. Hydrocephalus persisted but did not progress.
Hydrocephalus should be taken into consideration in patients
with mumps meningoencephalitis.
R2258
The incidence, serotyping and antibiotic
resistance of non-typhoidal Salmonella and
Shigella species in childhood acute gastroenteritis
in a district of the capital city of Turkey
E.B. Bingo¨ler, E. Ince, H. Gu¨riz, E. C¸iftc¸i, B. Erdem, I. Kutlu,
A.T. Soy, A.D. Aysev, U¨. Dogru (Ankara, TR)
Objective: To determine the incidence, clinical features, sero-
types and antibiotic resistance of non-typhoidal Salmonella (NTS)
and Shigella strains among children in our district.
Methods: Children aged 0–16 years, who presented to the
Ankara University Medical School, Department of Paediatrics
with acute diarrhoea were included in the study. Patients were
clinically evaluated. The stool samples were examined directly
and then inoculated into McConkey and Salmonella Shigella
agar. The NTS and Shigella colonies were identiﬁed by conven-
tional biochemical methods. The Salmonella colonies were
treated with Salmonella polivalent O anti-sera and serotyped
with the Kauffmann–White scheme. S. dysenteriae, S. ﬂexneri, S.
boydii and S. sonnei antisera were used for Shigella serogrouping.
S. ﬂexneri strains were agglutinated serially and subserotypes
were identiﬁed. Antimicrobial susceptibility of the isolates was
determined with disk diffusion method as advocated by the
National Committee for Clinical Laboratory Standards.
Results: In a two-year period, stool cultures were obtained from
1335 children. Forty-four (3.3%) NTS and 132 (9.8%) Shigella
strains were isolated. There were no signiﬁcant difference in
clinical features between children less than 1 year of age and
those who were older. The frequencies of the isolated NTS
serotypes were as follows: Sixty-eight percent S. enteritidis, 17%
S. typhimurium, 7.3% S. irumu and 7.3% S. paratyphi B. The
frequencies of the isolated Shigella species were as follows: 92%
S. sonnei and 7.6% S. ﬂexneri. Other Shigella species were not
detected. Among 10 S. ﬂexneri isolates, three were identiﬁed as S.
ﬂexneri type 4. Twenty-three percent ampicillin and 9% trimeth-
oprim-sulfamethoxazole resistance were found among NTS
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species. No ciproﬂoxacin and ceftriaxone resistance were detec-
ted. Eighteen percent ampicillin, 70% trimethoprim-sulfameth-
oxazole, 8% chloramphenicol and 83% tetracycline resistance
were found among Shigella species. All Shigella strains were
found to be susceptible to ciproﬂoxacin and ceﬁxime. S. ﬂexneri
was more resistant to ampicillin, chloramphenicol and cephalo-
thin than S. sonnei.
Conclusions: Shigella and NTS species are still major bacterial
pathogens in acute gastroenteritis of children. The changing
pattern of the antibiotic resistance and serotypes among districts
should be studied and treatment recommendations should be
determined accordingly.
R2259
A pragmatic clinical score to reduce unnecessary
antibiotic use in children with pharyngitis in
developing countries
P.R. Smeesters, D. Campos Junior, L. Van Melderen, E. de
Aguiar, J. Vanderpas, A. Vergison (Brussels, Gosselies, BE;
Brası´lia, BR)
Background: Clinical diagnosis of Group A Streptococcus
(GAS) pharyngitis has a low positive predictive value. Diagnosis
has to be conﬁrmed by bacteriology. Some clinical scores help to
identify children at risk of GAS pharyngitis necessitating a
microbiological diagnosis. In developing countries, the access to
microbiological resources is limited and all children with
pharyngitis are empirically treated with antibiotics to prevent
subsequent rheumatic fever. The efﬁcacy of this prevention
remains controversial.
Objectives: To develop a clinical score allowing, by identifying
‘‘non GAS’’ pharyngitis, the reduction of empirical antibiother-
apy for children with pharyngitis in developing countries.
Methods: We prospectively included children with pharyngitis
in 3 public hospitals of Brası´lia (Brasil) during 9 months in 2004.
We ﬁlled a clinical form and performed throat swabs. Conjunc-
tivitis, coryza, cough, diarrhoea and viral exanthema were
considered as ‘‘viral signs’’, while fever higher than 38.5C,
tender cervical node, headache, petechia on the palate, abdom-
inal pain and sudden onset (<12 hours) were noted as ‘‘bacterial
signs’’. Children under current antimicrobial treatment were
excluded. Bilateral chi-square and multivariate analysis were
performed to determine the score categories. The outcome
measures were: sensitivity, speciﬁcity, likelihood ratios and
post-test probabilities of ‘‘non GAS’’ infection with the score
approach as compared with throat culture.
Results: 163 (74%) of the 220 children had ‘‘non GAS’’ pharyn-
gitis (negative culture). We established 3 categories (age, viral
and bacterial signs) with 3 possible answers each. Based on the
score results, the children were sorted in 2 groups. Antibiotics
treatment was indicated for children in group 1 while those in
group 2 were treated without antibiotics. Use of this score would
prevent 41% (67/163) of unnecessary antimicrobial prescrip-
tions. The speciﬁcity of the score for ‘‘non GAS’’ pharyngitis in
group 2 was 84%. Therefore, 16% of children with pharyngitis
and positive GAS culture would not have been treated with
antibiotics; this is less than the expected carriage rate.
Conclusion: Such a clinical score could be helpful to reduce
unnecessary antibiotic prescriptions for pharyngitis in children
from developing countries. In our children population, it would
have reduced the antibiotic prescription by 41% without
resorting to microbiology. However, it should be validated for
routine clinical use.
R2260
Penicillin + gentamicin versus
ampicillin + gentamicin in the empiric treatment
of early neonatal sepsis
T. Metsvaht, H. Padari, K. Lang, I. Lutsar (Tartu, EE)
Increasing antibiotic pressure with rising resistance and nar-
rowing of antibiotic choices have been the leading trends in
antibacterial treatment over the last decades. Narrow spectrum
penicillins have been shown to have the least effect on normal
bowel colonisation in neonates but their comparative efﬁcacy for
empiric treatment of early neonatal sepsis is poorly documen-
ted.
Objective: The aim of our study was to compare the clinical
efﬁcacy of two antibiotic regimens – Pen + Genta and
Amp + Genta – in the empiric treatment of early neonatal
sepsis.
Materials: Case histories of all neonates, treated in the NICU of
Tartu University Hospitals from the 1st of January 2003 to 31st
of December 2004 (n = 256) were analysed retrospectively. From
January to October 2003 the preferred primary antibiotic
regimen was Amp + Genta, since November 2003 Pen + Genta
was used. Primary end-point was change of antibiotic treatment
from the study regimen within 96 hours.
Results: Overall 218 infants needed early empiric antibiotic
treatment, 108 received Amp + Genta and 95 Pen + Genta. The
two groups were comparable in demographic parameters; there
were 24 (23.5%) and 28 (30.1%) VLBW infants in the
Amp + Genta and Pen + Genta groups, respectively. Change
in antibacterial treatment within 96 h was considered necessary
in 13 (12%) and 9 (9.5%) patients in Amp + Genta and
Pen + Genta group, respectively. The number of sepsis episodes
and their aetiology is presented in the table.
Conclusion: In the empiric treatment of early neonatal
sepsis the combination of Pen + Genta is as effective as
Amp + Genta.
R2261
A series of unfortunate events after paronychia
due to Staphylococcus aureus: pericarditis,
pneumonia, lung abscess, empyema and
osteomyelitis
E. C¸iftc¸i, N. Belet, S. O¨ncel, T. Uc¸ar, M. Ileri, T. Kendirli, H.
Gu¨riz, N. Dalgic¸, S. Fito¨z, E. Ince, E. Tutar, S. Atalay, U¨.
Dogru (Ankara, TR)
Staphylococcus aureus is an important agent of soft tissue
infections. If staphylococcal infections are inefﬁciently treated,
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more severe infections such as septicemia, endocarditis, pneu-
monia, arthritis, and osteomyelitis might occur. In this report, a
child with paronychia is presented. A 4-year-old boy presented
with dyspnoea, and abdominal pain was admitted our clinic.
His complaints had started with painful swelling in the left
second ﬁnger. He was initially treated with topical mupirocin.
His paronychia did not resolve and one-week later oral
amoxicillin-clavulanate had also been initiated. Because of the
progressive infection the patient was hospitalized, surgical
drainage was performed and parenteral antibiotic therapy was
initiated; however, the patient’s condition had deteriorated, and
the patient had been referred to our hospital. He had fever
(38.4C), tachypnea (52/minute), tachycardia (143/minute). His
arterial blood pressure was 99/73 mmHg. Cracking rales were
determined on the right hemithorax. His heart sounds pro-
foundly low. The liver and the spleen were palpable for 7 cm
and 2 cm, respectively, from the costal margins. Paronychia was
present on the left second ﬁnger. White blood cell count was
25 200/lL, erythrocyte sedimentation rate was 74 mm/hour,
and C-reactive protein was 8.7 mg/dL. Chest X-ray revealed
cardiomegaly, and massive pericardial effusion was demonstra-
ted by echocardiography. Approximately 500 mL of purulent
ﬂuid was drained by pericardiocentesis, and pericardial tube
drainage was applied. Vancomycin and ceftriaxone were initi-
ated. Chest computed tomography revealed pneumonia, lung
abscess, and empyema on the left lung. On the follow up,
osteomyelitis of the left tibia also developed. However, these
localized infections did not require surgical intervention. Peri-
cardial ﬂuid culture and blood cultures were positive for
methicillin-sensitive S. aureus, and antibiotic therapy was
changed to ampicillin-sulbactam. On follow up, the patient’s
clinical condition improved. Pericardial drainage was discon-
tinued. Antibiotic therapy was switched to oral therapy and the
patient was discharged on day 38 of hospitalization. Oral
antibiotic therapy was discontinued two weeks later. The patient
did not develop any sequelae. Localized infections due to
S. aureus may cause life-threatening complications especially if
they are not treated sufﬁciently. Systemic antibiotic therapy with
early surgical drainage is the mainstay of therapy.
Immunology, host defenses, immunotherapy
R2262
Safety and efﬁcacy of recombinant
interferon-gamma-1b immune adjuvant in 20
patients receiving high-dose donor granulocyte
transfusions. An observational study during
2000–2004
A. Safdar, G. Rodriguez, B. Lichtiger, R. Champlin, E. Freireich,
H. Kantarjian (Houston, US)
Background: Response to antimicrobial therapy alone is often
sub-optimal in severely immunosuppressed cancer patients
with difﬁcult-to-treat opportunistic infections (OIs).
Methods: Patients receiving G-CSF donor primed (~5.5 · 1010
per transfusion) granulocyte transfusions (GTX) plus recombin-
ant interferon-gamma-1b (rIFN-g1b) were evaluated.
Results: The mean age was 43 ± 17 y, 10 (50%) were men, 16
(80%) had acute leukaemia, 3 (15%) MDS and APACHE –II score
was 19 ± 17 (range, 17–22). Most patients (n = 18, 90%) had
relapse or refractory cancer. In 6 (30%) allogeneic haemato-
poietic stem cell transplantation (HSCT) recipients, GTX plus
rIFN-g1b was given 59 ± 100 (range, 12–372) days after trans-
plantation. Seventeen patients (85%0 had severe neutropenia
during GTX plus cytokine therapy. In 19 patients (95%) with
invasive fungal infection (IFI), 5 (25%) had possible, 3 (15%)
probable and 8 of 11 (55%) with deﬁnitive IFI had disseminated
systemic mycosis. One patient (5%) had refractory Pseudomonas
sepsis. Eight patients (40%) were receiving >600 mg prednisone
equivalent dose during GTX-cytokine therapy. Cytokine doses
that accompanied 10 ± 7 (range, 4–28) GTX included, 9 ± 7
doses of rIFN-g1b (mean cumulative dose [c.d.] 1188 ± 2621 lg).
Other concomitant cytokines were G-CSF 12 ± 3 G-CSF doses
(c.d. 7128 ± 4721 lg) in 15 patients (75%) and GM-CSF 12 ± 9
doses (c.d. 5624 ± 4410 lg) in 14 patients (70%). In 2 patients
with fever and one patient each with skin rash and transient
dyspnoea were attributed to GTX. In 8 patients, 3 each with
fever, and reversible liver dysfunction, and 1 each with fever,
and tachycardia were considered rIFN-g1b associated adverse
reactions. Four weeks after therapy, 9 patients (45%) had
completed or partial response; another 3 (15%) had stable
systemic mycosis.
Conclusions: Adjuvant GXT plus rIFN-g1b therapy was toler-
ated without serious adverse reactions. Therapeutic efﬁcacy
needs further prospective evaluation.
Vaccines
R2263
Comparison of immune response in immunised
and non-immunised mice after challenge with
tick-borne encephalitis virus
E.K. Bukin, A. Atrasheuskaya, M. Rasshepkina, M. Vorob’eva,
G.M. Ignatyev (Koltsovo, Moscow, RU)
Objectives: Tick-borne encephalitis (TBE) virus is an important
human pathogen that causes dangerous central nervous system
disease in large endemic areas. Despite the efﬁcacious vaccines
existing, the understanding of immunopathogenesis of TBEV
infection is relevant for treatment development.
Methods: As it was described earlier, BALB/c mice is a suitable
animal model for TBE. We investigated the immune response in
BALB/c mice immunized with TBE vaccine and infected after
with TBE virus (strain Absettarov). We also compared it with
the immune response in non-immunized mice infected with the
same dose of the virus. Speciﬁc humoural (IgM and IgG) and
cellular (enzyme-linked immunospot assay and cell prolifer-
ation test) immunity was studied, as well as serum levels of
some cytokines (tumour necrosis factor-alpha - TNF-a, interleu-
kine/IL-1beta, 2, 6, 10, 12 and interferon-gamma – IFN-g).
Results: Control group of animals demonstrated 100% mortal-
ity rate. In contrast, immunized mice challenged at day 7 after
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the last vaccination showed 100% protection. We found the
signiﬁcant difference in the speciﬁc and nonspeciﬁc immune
responses between immunized and non-immunized mice. No
speciﬁc IgM were found in immunized group after infection
with TBEV in contrast to the control group. Serum IgG antibody
titres against TBEV increased on day 5 post infection in
immunized animals. A statistically signiﬁcant increase in pro-
liferation rate of splenocytes and number of IFN-g producing
cells in immunized group was observed since day 7 post-
infection. The animals from control group did not develop
speciﬁc cellular immunity against TBEV after the lethal chal-
lenge. The most interesting ﬁnding was the prominent differ-
ence in dynamics of IL-6, IL-2, IL-12 and IFN-g. TBE vaccination
induced dominant Th1 response (IFN-g, IL-12) at the early stage
of the infection. Whereas serum levels of proinﬂammatory
cytokines (TNF-a, IL-1beta) and IL-6 progressively increased in
non-immunized mice until the death.
Conclusion: Immunization of BALB/c mice with TBE vaccine
revealed the formation of both cellular and humoural immune
responses. Probably the strong cellular response and early shift
to Th1 cytokine proﬁle are markers of protective immunity
against TBE virus in immunized animals.
R2264
Evaluation of measles-speciﬁc humoural and
cell-mediated immunity in infants aged 9 months
after vaccination with AIK-C and Schwarz
measles vaccine strains, in Ilam, Iran
F. Azizi Jalilian, N. Sadeghifard, M. Abdi, R. Amini, J. Zaeimi
Yazdi (Ilam, Tehran, IR)
Objectives: The aim of this study was determination of
immunogenicity of AIK-C and Schwarz measles vaccine strains
in infants aged 9 months, in Ilam, Iran.
Methods: One hundred infants aged 9 months were enrolled in
two groups (ﬁfty infants in each group). In this study two live
attenuated measles vaccines including Alk-C and Schwarz were
used. Each group of infants was injected by one of these
vaccines. After vaccination, the humoural and cellular immune
response directed against Alk-C and Schwarz vaccines were
evaluated by Viral Neutralization Test (VNT) and Lymphocyte
Transformation Test (LT) methods
Results: Injection of Alk-C resulted in 58% cellular immunity
and 88% humoural immunity against measles. The rate of
inducted cellular and humoural immunity against measles after
injection of Schwarz were 44% and 68% respectively. There is a
signiﬁcant difference between Alk-C and Schwarz mediated
immunity.
Conclusion: We conclude that Alk-C vaccine is more immuno-
genic than Schwarz vaccine in infants and can induce effective
immunization against measles at nine months of age particularly
as a ﬁrst dose.
R2265
Anti-rabies vaccine and its application for
predator rabies prevention in Ukraine
A.S. Fedchuk, I.N. Grigorasheva, V.P. Lozitsky, T.L. Gridina,
Y. Boschenko (Odessa, UA)
Objectives: Rabies is the emergent disease, which is registered
now in more than 80 countries all over the world. This disease
goes on without clinical character and the virus conservation
and transfer occur in natural conditions and the infectious
agent’s reservoir is formed in ecological system. The biological
ﬁre-wall in the problem of rabies virus dissemination could be
created with the use of living vaccines. The scope of the
proposed research is the enhancement of the anti-rabies vaccine
efﬁcacy as the result of its use in the wild-life conditions.
Methods: The rabies vaccine strain Vnukovo-32M has passed
successfully the tests on the reversions’ absence during ten
passages. The proposed preparation contains the additional
component, which assists the vaccine virus penetration through
animal tissues. The vaccine material was placed along with
colouring agent into pharmaceutical blister packs, which were
freezed afterwards. The vaccination was conducted during the
autumn-winter period of 2001/2004 year in 9 districts of Odesa
region. Proposed vaccine bites were placed manually on the
borders of the forests and fox pathways in a number of 20 bites
per square kilometre. The wild animals were shot in a planned
manner and the laboratory diagnostics of the rabies was
performed through Babes-Negri bodies detection in the brain
tissues of the animals.
Results: We have shown that the main exponent of the rabies
distribution in the southern region of Ukraine is the level of the
fox rabies detection. The results of this factor monitoring taken
for the last 6 years show that the foxes are the main reservoir of
rabies in wild nature in Ukraine. We have registered that the
modernized per-oral anti-rabies vaccine content accompanied
by the special way of its application resulted in 16.8% decrease
of rabies cases among wild-life foxes in comparison with the
previous year.
Conclusions: The experience gained during the anti-rabies
vaccine preparation and use has shown that it is necessary to
modernize the vaccine preparation technology with the scope of
prolongation of the longitude of its action. It is shown also that
the proposed form of the vaccine bite and compilation of the bio-
dependent calendar of vaccination serve the success.
R2266
Vaccination coverage and attitudes towards
inﬂuenza of hospital healthcare workers, Piraeus
O. Kosmopoulou, T.A. Peppas, T. Sahinidis, N. Zachos,
I.F. Hager, A. Grivas, N. Galanakis (Piraeus, Athens, GR)
Objective: To estimate coverage and attitudes toward inﬂuenza
vaccination (INV) among healthcare workers (HW) of a tertiary
Piraeus Hospital.
Methods:
Time: October, 2005. An anonymous questionnaire completed
by HCWs regarding INV coverage, INV intention for the
forthcoming season, reasons if not vaccinated, awareness and
inﬂuenza epidemic/pandemic risk estimate, as well as history of
inﬂuenza like illness (ILI) reported during the previous inﬂu-
enza season. Data entry in PC, analysis by SPSS.
Results: A return of 208 HCW (M: 86 F: 122, medical: 87,
nursing/technicians: 121, m. age: 38.4 ± 8.2 years) question-
naires was entered for analysis. INV last season was reported in
20/208 (9.6%) a rate higher in medical personnel [13.7%, but non
signiﬁcantly so v nursing HCW]. Similar rates observed for
previous seasons (10.3%, fall 2003). Awareness of INV indication
was 71%, non-INV reasons given were negligence, doubts about
necessity, fear of adverse events/injections and difﬁculty in
obtaining. Intention for INV was expressed in 50.2% of HCW for
the coming season, a rate lower than those anticipating a
possible ﬂu pandemic [56.7%]. A´lso of note was the rate of HCW
reporting ILI during the previous ﬂu season (33%).
Conclusions: The rate of inﬂuenza vaccination coverage was
found quite low (~10%), as shown in similar European papers,
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and far lower than the US respective ﬁgures. Strategies to
increase acceptance, compliance are warranted as are prompt
central and local administrative interventions to ensure optimal
coverage at the soonest possible time.
R2267
Effect of two different strategies to raise inﬂuenza
vaccine coverage among medicine students
A´. Torres-Lana, C. Rodrı´guez, A´. Arias, M.P. Are´valo, A. Sierra
(La Laguna, ES)
Objectives: Inﬂuenza vaccine coverage is low among health
care workers in Spain, including medicine students. The main
goal of this study is to assess the effect of two different strategies
to rise this coverage among Medical students.
Method: Two inﬂuenza vaccine campaigns were compared:
season 2003 (October–November) versus season 2004 (same
months). During the ﬁrst season an indirect method of motiva-
tion was used: a news sheet about inﬂuenza was located on the
students panel inside the different classrooms, except ﬁrst and
second year of Medicine. During the 2004 season we planned a
direct strategy which consisted in a brieﬁng with student elected
delegates or representatives of each year from the forth to the
sixth year (the last year) of Medicine. This meeting was
performed in September and was conducted by one of us. The
content of the meeting was a deep explanation of the reasons to
be vaccinated against inﬂuenza. We used in-home slides and a
set of slides downloaded from the CDC web site. Furthermore,
we designed a data collection sheet for each student with a full
explanation about the campaign, the aims and reasons of
vaccination and the possible adverse reactions. The students
had to ﬁll this data collection sheet and signed it. This sheet was
given out and explained to all students by their representatives.
All the process was performed again the ﬁrst week of Novem-
ber. Vaccines were purchased by the Gobierno de Canarias
(Government of the Canarias Autonomous Community).
Results: 95 students were vaccinated in 2003: 6 in the third year
(5.1% of the students in this year), 16 in their fourth year (15.6%);
31 from ﬁfth year (32.6%) and 42 from sixth (40.0%). The results
in 2004 were 6.6% (no brieﬁng), 43.3%, 23.2% y 67.8% for 3rd,
4th, 5th and 6th respectively. Overall, the coverage among
classes with brieﬁng was 29.4% in 2003 and 42.6% in 2004. In
both years, the same class showed the lower coverages: they
were studying forth year in 2003 and ﬁfth year in 2004. The class
who studied third year in 2003 and forth year in 2004 rised from
a coverage of 5% to 43%.
Conclusions: To rise low coverages of inﬂuenza vaccination
among Medicine students is necessary to involve the students
themselves through their delegates and representatives. A full
explanation of the reasons, and a reiteration in a short period of
time as well, is desirable. We also felt that we established a
strong bond with our students for further collaboration.
R2268
Evaluation of protective antibody to measles
virus in vaccinated medical students
M. Davarpanah, A. Emami Naeini, M. Darvishi, B. Ataei,
R. Neirami (Shiraz, Isfahan, IR)
Background: Measles remains one of the dangerous infections
worldwide that regarding to World Health Organization’s
report, still takes life of more than one million of under the
age of ﬁve children. Vaccination has been available since
40 years ago. In Iran, it has started with national program of
vaccination since 1973 in 2 occasions at 9 and 15 months of age.
Recently several cases of early middle age measles infection
have reported from different areas in Iran. To ﬁnd out the
reasons of increased prevalence, we decided to evaluate
antibody against measles in early adulthood, which is the
infection’s most dangerous range of age.
Method: In a randomized cross-sectional study, we selected
241(127 male and 114 female) students from Isfahan University
of Medical Science. These people have the age between 18 and
22 and the history of vaccination against measles (9 and
15 months). They did not have any past medical history or
clinical evidences of infection with measles. IgG level against
measles has been measured by ELISA method in their serum
and the results have been analysed by SPSS software, Chi square
statistical test and analysis of variance test (ANOVA).
Results: Regarding to brochures available with ELISA kit,
results of serum antibodies evaluated as follow: Titre less than
8 IU/ll as negative, between 8 IU/ll and 12 IU/ll as interme-
diate and more than 12 IU/ll as positive. Among 241 samples,
98 samples (40.7%) were positive and104 (43.1%) and 39 (16.2%)
samples were negative and intermediate respectively. (Table 1).
There was not any meaningful difference in antibody titre
between males and females. (Table 2).
Discussion: This study cleared that just 40.7% of the samples
had protective antibody against measles and nearly 60% of them
had potency of infection while exposed to wild virus. It is
important that measles makes high mortality and morbidity
rates and control of this disastrous infection needs lots of
investment by the government. With reviewing and performing
similar studies, it could be possible that reconsidering the
vaccination program is worth wise.
R2269
Opsonophagocytic killing of S. aureus by PMNs
from haemodialysis patients
A. Kropec, B. Rumberger, J. Gattermann, A.I. Fattom, K. Taylor,
J. Huebner (Freiburg, DE; Rockville, US)
Objective: Haemodialysis patients are at increased risk for
S. aureus infection, which is usually cleared by a functional
opsonophagocytosis mechanism mediated by speciﬁc antibod-
ies, complement, and PMNs. These patients would beneﬁt from
a vaccine directed against S. aureus capsular polysaccharides but
may have an impaired neutrophil killing activity related to the
underlying disease.
Patients and methods: S. aureus Loewenstein, freshly prepared
leucocytes from 10 healthy human subjects or 11 haemodialysis
patients, anti-staphylococcal human hyperimmune sera (AltaS-
taph, Nabi Biopharmaceuticals in concentrations of 1:100 to
1:2000), and baby bunny complement were mixed and incubated
on a rotor rack at 37C for 90 minutes. Aliquots were plated
before and after incubation and the % killing rate was calcula-
ted.
Results: Healthy individuals showed an average killing of 62%
using a 1:100 dilution of AltaStaph (range 36.8–76.7%) while
leukocytes from haemodialysis patients showed an average
killing of 64.3% with a range between 36.9 and 86.8%. Dilution of
the sera resulted in reduced killing in all patients. The
differences between the two groups were not statistically
signiﬁcant.
Conclusions: Our data indicate that PMNs from haemodialysis
patients are capable of phagocytosis and that opsonic killing of
S. aureus is not impaired in these patients compared to healthy
controls. Susceptibility to infections in this population may be
related to other factors involved in opsonophagocytosis such as
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complement and other conditions (e.g. uncontrolled glucose
levels and uraemia). Further studies to explore these compo-
nents are under way.
R2270
Determination of anti-HBS titre mean induced by
hepatitis B vaccine among health care workers in
an Iranian hospital
M. Talebi Taher, M. Akbari (Tehran, IR)
Objectives: HBV is a major cause of viral hepatitis, cirrhosis
and liver cancer worldwide. Health care workers are one of the
high-risk groups in affecting and transmission of this virus.
Methods: In this descriptive cross-sectional study, 102 HCWs of
ﬁroozgar hospital including faculty members, residents, interns,
students, nurses and clerks were selected and enrolled through
convenience sampling. All participants had to complete three-
dose vaccination schedule. After blood sampling the samples
were transferred to laboratory. Check list was consisted of age,
sex, occupational group, smoking, alcohol abuse chronic renal
and hepatic failure , diabetes and duration after the last dose of
vaccine.
Results: Statistical analysis was done with SPSS 11.5 software.
P < 0.05 was considered statistically signiﬁcant. Multiple linear
regression model was used to predict effecting factors on Anti-
HB titre .102 Anti-HBS titres of HCWs were determined and the
mean was 70.43(95% CI, 57.02–83.84). Also, Anti-HBS titres of 30
individuals (29.4%)were less than 10 mIu/ml and 72 individuals
(70.6%) were equal or more than 10 mIu/ml. There was a
signiﬁcant statistical correlation between Anti-HBS titre and age
and duration after the last dose of vaccine (p < 0.05).
Conclusion: Following-up for complete three-dose injection,
vaccination before or at the onset of working should be
attended. HCWs who are one of the high-risk groups in
affecting and transmission of HBV, are recommended to
determine their Anti-HBS titre after three-dose vaccination.
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